data_1b4q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1b4q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.266 0.555 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.11 -71.18 0.15 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 20.030000000000001 110.153 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.6 m -73.18 -40.84 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.442 -0.786 . . . . 12.91 110.489 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.8 m120 -55.98 -34.06 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 110.38 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.5 m -74.54 -18.33 60.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.922 -1.111 . . . . 0.0 110.349 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' NZ ' ' CZ ' ' A' ' 17' ' ' PHE . 5.2 mtpm? -98.0 -42.5 7.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.077 . . . . 22.870000000000001 111.442 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.34 126.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.728 -1.233 . . . . 25.190000000000001 109.696 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.61 159.07 35.1 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.956 -1.127 . . . . 34.609999999999999 107.956 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.09 136.56 61.63 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.789 1.659 . . . . 11.720000000000001 111.501 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.04 73.3 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.71 -0.956 . . . . 10.24 110.71 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -140.57 130.63 24.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.253 . . . . 25.359999999999999 109.536 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -101.54 133.81 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.46 -0.775 . . . . 10.890000000000001 109.876 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.36 137.48 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.277 -1.009 . . . . 15.82 108.277 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 45' ' ' VAL . 44.0 t -120.54 128.54 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.366 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' ' NZ ' ' A' ' 8' ' ' LYS . 80.8 m-85 -95.34 118.78 32.71 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.142 -1.058 . . . . 9.9299999999999997 108.142 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.25 -176.21 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.485 1.136 . . . . 10.619999999999999 111.42 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.4 mtmt -145.02 93.16 5.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.766 -1.938 . . . . 38.729999999999997 105.766 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -48.32 82.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.369 1.379 . . . . 24.579999999999998 110.577 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -177.78 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.047 -0.723 . . . . 34.82 109.047 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.12 126.81 38.77 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 21.460000000000001 109.099 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.18 -22.98 42.71 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.465 2.11 . . . . 13.859999999999999 113.061 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -67.89 -43.15 79.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.332 -1.48 . . . . 0.0 109.44 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.07 -38.14 89.99 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.41 -40.06 93.0 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.419 -0.956 . . . . 59.590000000000003 108.419 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.623 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.31 -45.2 68.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.8 78.69 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.38 -36.14 73.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.299 -0.876 . . . . 45.490000000000002 109.076 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -70.08 -41.69 73.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.761 -0.587 . . . . 34.969999999999999 111.14 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 ' CG2' ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -72.58 -69.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.899 -1.126 . . . . 0.0 110.591 -178.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' H ' ' CG2' ' A' ' 31' ' ' ILE . 5.0 mt -51.64 -16.58 0.66 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.136 -0.978 . . . . 17.280000000000001 110.022 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.84 -29.78 68.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.012 -1.055 . . . . 24.109999999999999 108.292 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -93.41 1.65 56.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.481 -0.762 . . . . 44.07 110.617 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 mt -88.02 128.66 53.0 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.806 -1.184 . . . . 19.629999999999999 109.111 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -69.49 70.14 1.46 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.656 1.571 . . . . 21.539999999999999 109.73 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.2 mm -80.68 155.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.211 -0.931 . . . . 0.0 109.395 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.3 mmtp -54.36 -168.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.205 -0.935 . . . . 29.41 109.771 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 38' ' ' LYS . 71.0 mt-30 -54.76 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.692 0.758 . . . . 0.0 111.413 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 52.8 0.34 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.452 -1.059 . . . . 15.27 110.452 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 -32.46 11.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -1.109 . . . . 8.7799999999999994 109.158 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 tp -95.57 135.19 37.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.39 -0.596 . . . . 7.1299999999999999 109.39 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 26.2 tt0 -143.76 172.4 12.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 22.030000000000001 109.94 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 55.7 m-85 -133.06 111.0 10.6 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.272 -1.381 . . . . 16.329999999999998 107.272 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' VAL . 53.0 t -96.16 106.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 6.5800000000000001 112.279 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 48' ' ' THR . 42.4 m-20 -83.54 98.08 9.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.872 -0.788 . . . . 15.32 108.872 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 pt -62.05 2.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 10.92 110.657 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 46' ' ' ASP . 1.8 p -96.55 -35.53 11.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.003 -1.061 . . . . 21.719999999999999 109.372 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.81 28.81 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 22.449999999999999 109.775 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 48' ' ' THR . 12.4 t -144.49 -3.55 0.81 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.047 -1.033 . . . . 25.629999999999999 110.145 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.676 HD21 ' CD2' ' A' ' 52' ' ' HIS . 5.4 t30 69.94 -179.14 0.23 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 109.159 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' HD21 ' A' ' 51' ' ' ASN . 0.1 OUTLIER 53.98 27.22 7.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 108.563 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -43.07 -55.97 3.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.377 -0.827 . . . . 18.870000000000001 110.442 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -59.46 -32.69 70.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 45.210000000000001 111.225 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.6 mp0 -62.12 -44.55 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.786 -1.196 . . . . 33.020000000000003 110.256 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.87 -54.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.788 -1.195 . . . . 9.8399999999999999 109.628 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.63 -44.81 77.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.671 -1.233 . . . . 17.84 107.671 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -54.37 -34.41 61.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.937 -1.505 . . . . 18.84 106.937 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -78.26 -45.77 21.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.904 -0.776 . . . . 12.99 108.904 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.5 mt -53.75 -35.82 61.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.721 -1.215 . . . . 14.609999999999999 107.721 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 18.3 tp60 -60.47 -57.46 12.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.235 0.54 . . . . 40.450000000000003 109.66 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -67.48 -35.22 78.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 41.810000000000002 110.113 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.58 -48.64 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.948 . . . . 21.77 109.925 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -111.58 -63.9 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 11.380000000000001 109.468 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.45 -45.9 0.53 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.692 -1.242 . . . . 14.789999999999999 110.043 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.57 26.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -1.16 . . . . 17.809999999999999 110.283 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 31.21 6.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 29.760000000000002 109.132 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.45 167.58 16.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 18.260000000000002 111.056 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.14 133.88 21.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.956 -1.127 . . . . 8.1999999999999993 107.956 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD2' ' H ' ' A' ' 82' ' ' SER . 19.4 Cg_endo -81.04 -165.46 4.5 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.577 0.991 . . . . 7.79 111.918 -0.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.448 ' NH1' ' HG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -148.55 91.76 1.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 105.884 -1.895 . . . . 26.050000000000001 105.884 177.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.3 157.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.288 -0.882 . . . . 8.6799999999999997 112.181 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.91 90.45 2.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.677 -0.639 . . . . 14.07 111.262 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -71.91 115.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.132 -2.173 . . . . 9.3399999999999999 105.132 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.45 -153.12 32.87 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 105.85 -2.9 . . . . 12.42 105.85 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -83.77 0.18 48.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.31 -1.7 . . . . 44.859999999999999 109.436 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -89.52 118.81 29.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.256 -0.902 . . . . 0.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HG ' ' NH1' ' A' ' 71' ' ' ARG . 30.8 t -76.35 142.67 41.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.79 -17.68 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.053 -1.029 . . . . 20.449999999999999 109.214 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 -157.61 21.8 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.303 -1.119 . . . . 13.82 110.303 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.78 -147.13 19.7 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.048 -1.221 . . . . 12.42 110.048 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.62 -61.11 1.92 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.492 -1.005 . . . . 0.0 109.688 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -51.02 -25.11 4.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.25 -49.31 19.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.496 -0.753 . . . . 27.059999999999999 109.183 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.457 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -54.02 -59.19 4.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 15.31 110.08 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -50.24 -51.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 91' ' ' SER . 7.7 m -45.67 -36.78 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 21.789999999999999 108.96 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.04 -41.92 27.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.508 -0.745 . . . . 0.0 111.344 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -58.13 -57.14 14.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.916 -1.115 . . . . 0.0 110.022 -178.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.9 -26.59 68.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.361 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 87' ' ' SER . 48.9 m -81.88 -20.44 38.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.452 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.33 -8.03 73.14 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.512 -1.035 . . . . 25.640000000000001 110.512 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.88 -24.48 64.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.036 -1.273 . . . . 50.259999999999998 108.371 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 tp -61.74 -66.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.624 0.726 . . . . 24.170000000000002 110.899 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.06 -28.28 16.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -48.11 76.11 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.143 -1.058 . . . . 28.030000000000001 108.143 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.83 -34.22 71.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.832 -1.173 . . . . 40.960000000000001 107.832 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.404 HD13 ' N ' ' A' ' 98' ' ' LEU . 8.9 mp -70.92 -39.98 72.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.677 -0.86 . . . . 15.050000000000001 108.677 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.78 -55.66 21.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.83 -0.544 . . . . 0.0 111.599 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -29.29 9.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.86 -1.15 . . . . 38.640000000000001 110.93 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.2 pt -101.28 -19.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.747 -1.22 . . . . 0.0 109.08 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.78 40.53 8.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.288 -1.125 . . . . 18.539999999999999 110.288 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.08 -13.54 50.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -1.21 . . . . 10.84 109.684 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.573 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.57 176.21 6.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.716 -179.792 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.58 -68.45 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.812 . . . . 20.030000000000001 110.664 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.43 -38.37 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 12.91 110.438 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 32.9 m120 -55.08 -37.56 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 28.329999999999998 109.483 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 m -75.11 -12.77 60.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.974 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -97.13 -46.05 6.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.109 -0.994 . . . . 22.870000000000001 110.865 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.82 136.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.852 -1.155 . . . . 25.190000000000001 109.906 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -146.92 153.28 45.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.766 -0.827 . . . . 34.609999999999999 108.766 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.14 131.71 44.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.644 1.562 . . . . 11.720000000000001 110.323 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.62 26.93 70.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.673 -1.371 . . . . 10.24 109.673 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -139.48 135.35 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -1.131 . . . . 25.359999999999999 109.363 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.63 135.6 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.304 -0.872 . . . . 10.890000000000001 109.92 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.49 141.9 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.847 -1.168 . . . . 15.82 107.847 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.68 124.79 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 8.9399999999999995 110.917 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -90.1 123.89 34.34 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.365 -1.346 . . . . 9.9299999999999997 107.365 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.4 pt -133.48 -176.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.19 0.995 . . . . 10.619999999999999 111.235 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.6 mtmt -145.02 93.49 5.52 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 106.455 -1.683 . . . . 38.729999999999997 106.455 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -46.87 80.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.691 1.594 . . . . 24.579999999999998 110.896 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.626 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.5 m -175.39 -37.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.794 -0.817 . . . . 34.82 108.794 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 128.97 31.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.283 -0.886 . . . . 21.460000000000001 110.018 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.67 -14.65 37.15 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.999 1.799 . . . . 13.859999999999999 112.158 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -69.05 -45.43 70.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.648 -1.282 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 108.94 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.539 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -64.45 -55.84 18.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.549 -0.719 . . . . 59.590000000000003 110.343 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 4.8 ptp180 -50.36 -35.68 29.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.548 -1.345 . . . . 0.0 109.118 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' A' ' 27' ' ' ARG . . . -62.22 -36.82 83.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -71.66 -48.67 46.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.615 -0.678 . . . . 45.490000000000002 109.666 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.76 -31.42 70.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.563 -0.711 . . . . 34.969999999999999 111.023 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.31 -55.26 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.673 -1.267 . . . . 0.0 109.677 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 3.4 mt -59.89 -21.96 61.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.642 -1.286 . . . . 17.280000000000001 109.146 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -64.86 -26.7 68.44 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.523 -0.917 . . . . 24.109999999999999 108.523 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -90.95 3.17 55.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.553 -0.717 . . . . 44.07 110.38 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' ILE . 17.0 mt -91.21 127.99 49.08 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.805 -1.184 . . . . 19.629999999999999 109.494 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -64.99 68.58 0.27 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 121.676 1.584 . . . . 21.539999999999999 109.663 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 4.2 mm -82.98 151.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' O ' ' A' ' 39' ' ' GLN . 42.7 mmtt -53.41 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.265 -0.897 . . . . 29.41 109.854 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.613 ' O ' ' O ' ' A' ' 38' ' ' LYS . 6.1 mp0 -50.64 -128.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.645 0.736 . . . . 0.0 110.788 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 49.46 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 O-C-N 121.022 -1.049 . . . . 15.27 110.501 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -98.47 -13.83 20.34 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.229 -1.159 . . . . 8.7799999999999994 109.62 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -107.76 129.01 55.08 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.617 -0.883 . . . . 7.1299999999999999 108.617 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.54 165.39 27.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.063 -1.023 . . . . 22.030000000000001 110.443 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -128.39 112.98 15.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.759 -1.201 . . . . 16.329999999999998 107.759 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.6 106.92 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 6.5800000000000001 111.326 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -81.99 101.98 10.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.53 -0.915 . . . . 15.32 108.53 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.26 -5.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.001 -1.062 . . . . 10.92 110.762 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 50' ' ' THR . 7.0 t -95.27 -23.15 17.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 21.719999999999999 109.432 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 18.33 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 22.449999999999999 109.613 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 11.2 t -144.39 -2.96 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.118 -0.989 . . . . 25.629999999999999 110.139 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.0 m-20 74.88 -176.97 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.071 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.426 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 55.62 27.57 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 108.724 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.84 -59.58 2.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 18.870000000000001 110.186 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -58.06 -28.69 64.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 45.210000000000001 110.964 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -64.34 -44.92 90.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.714 -1.241 . . . . 33.020000000000003 109.54 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.41 -53.73 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.919 -1.113 . . . . 9.8399999999999999 109.434 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.29 -41.46 75.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.663 -1.236 . . . . 17.84 107.663 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.86 -33.4 64.51 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.293 -1.373 . . . . 18.84 107.293 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -77.6 -47.62 18.91 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.871 -0.789 . . . . 12.99 108.871 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' OG1' ' A' ' 64' ' ' THR . 69.6 mt -54.3 -36.11 63.34 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.211 -1.033 . . . . 14.609999999999999 108.211 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.5 tp60 -58.24 -51.54 69.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.758 -0.589 . . . . 40.450000000000003 109.551 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -66.44 -52.93 41.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.096 -1.003 . . . . 41.810000000000002 111.073 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.52 -31.76 73.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 21.77 110.813 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 19.2 p -112.35 -70.62 0.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.179 -0.95 . . . . 11.380000000000001 109.856 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 145.98 -43.09 0.92 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.001 -1.64 . . . . 14.789999999999999 109.001 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB2' HH21 ' A' ' 71' ' ' ARG . . . -98.67 131.64 44.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -1.045 . . . . 17.809999999999999 110.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 33.02 2.72 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 29.760000000000002 108.962 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 174.05 11.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.44 -0.787 . . . . 18.260000000000002 110.769 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.48 136.81 26.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.473 -0.936 . . . . 8.1999999999999993 108.473 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.738 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 41.5 Cg_endo -84.87 -173.63 10.52 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.897 -0.876 . . . . 7.79 109.867 0.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.738 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -136.52 102.69 5.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.375 -2.084 . . . . 26.050000000000001 105.375 176.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 73' ' ' PHE . 94.4 t -88.5 158.99 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.71 0.767 . . . . 8.6799999999999997 111.527 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.402 ' N ' ' CG1' ' A' ' 72' ' ' VAL . 60.0 m-85 -145.3 87.37 1.8 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.769 -0.582 . . . . 14.07 110.62 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.4 mp -71.36 107.94 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 105.926 -1.879 . . . . 9.3399999999999999 105.926 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.96 -154.53 53.09 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.492 -2.643 . . . . 12.42 106.492 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -82.89 -3.42 56.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.556 -1.556 . . . . 44.859999999999999 109.289 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.74 117.07 28.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 0.0 110.59 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.8 t -72.66 153.04 41.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.085 -1.01 . . . . 0.0 109.385 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.35 -29.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 20.449999999999999 109.614 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.67 -136.2 7.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.439 -1.465 . . . . 13.82 109.439 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -115.38 -145.77 8.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.473 -1.451 . . . . 12.42 109.473 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.44 -57.76 4.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 109.795 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -52.76 -27.59 18.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.496 -0.753 . . . . 0.0 109.242 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.64 -49.14 27.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -0.83 . . . . 27.059999999999999 109.085 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 3.2 tt -52.74 -60.94 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 15.31 109.554 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.466 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.85 -49.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.819 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 t -48.78 -48.5 41.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.803 -1.185 . . . . 21.789999999999999 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.8 mt -70.01 -39.72 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 110.978 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.17 -57.55 12.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 110.728 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.45 -23.92 67.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.977 -1.077 . . . . 0.0 109.203 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -81.96 -22.01 36.9 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 109.506 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.19 -10.44 74.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.885 -1.286 . . . . 25.640000000000001 109.885 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.03 -31.43 71.09 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.197 . . . . 50.259999999999998 109.405 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.88 -60.46 3.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 24.170000000000002 110.413 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.24 -32.32 62.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.601 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.433 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.97 -44.54 92.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.942 -1.133 . . . . 28.030000000000001 107.942 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 5.5 ttt180 -61.32 -37.39 83.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.23 -1.026 . . . . 40.960000000000001 108.23 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.52 -33.94 69.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.38 -0.97 . . . . 15.050000000000001 108.38 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -65.53 -56.56 11.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.827 -0.546 . . . . 0.0 111.572 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.6 OUTLIER -48.18 -33.25 8.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 38.640000000000001 110.521 -178.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.9 pt -101.5 -9.35 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.97 42.01 31.13 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.399 -1.08 . . . . 18.539999999999999 110.399 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.38 -15.41 43.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -1.187 . . . . 10.84 109.189 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.76 -172.99 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.736 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.84 -68.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.695 -0.628 . . . . 20.030000000000001 110.731 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -73.48 -40.04 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.355 -0.841 . . . . 12.91 110.365 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 17.6 m-20 -55.21 -37.46 67.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.982 -1.074 . . . . 28.329999999999998 109.104 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m -74.71 -12.68 60.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.97 -47.2 5.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 22.870000000000001 110.362 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.85 136.18 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.862 -1.148 . . . . 25.190000000000001 109.964 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -146.87 154.19 46.96 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.369 -0.975 . . . . 34.609999999999999 108.369 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.06 130.83 42.36 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.413 1.409 . . . . 11.720000000000001 109.97 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.01 64.67 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.785 -1.326 . . . . 10.24 109.785 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -138.9 132.77 30.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 25.359999999999999 109.401 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.1 t -102.68 127.54 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.253 -0.904 . . . . 10.890000000000001 109.4 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.29 140.7 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.507 -0.923 . . . . 15.82 108.507 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.3 t -122.27 124.22 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.346 -0.846 . . . . 8.9399999999999995 111.088 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -92.51 116.33 28.89 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.192 . . . . 9.9299999999999997 107.783 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 pt -127.65 -178.97 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.308 1.051 . . . . 10.619999999999999 111.47 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.7 mtmt -140.72 90.99 9.5 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 105.749 -1.945 . . . . 38.729999999999997 105.749 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.1 Cg_exo -47.14 80.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.718 1.612 . . . . 24.579999999999998 110.52 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 19' ' ' LYS . 17.9 m -175.68 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.571 -0.9 . . . . 34.82 108.571 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.3 124.24 47.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.374 -0.829 . . . . 21.460000000000001 109.66 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.28 -16.39 17.45 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 122.299 1.999 . . . . 13.859999999999999 112.901 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.34 -42.38 65.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.517 -1.364 . . . . 0.0 109.846 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -31.72 73.08 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -61.5 -40.39 94.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.639 -0.875 . . . . 59.590000000000003 108.639 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.584 HH11 ' HG2' ' A' ' 27' ' ' ARG . 13.5 mtt-85 -54.28 -48.26 71.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 108.679 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.28 74.25 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.366 -0.834 . . . . 0.0 109.072 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -71.38 -45.74 62.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.817 . . . . 45.490000000000002 109.524 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 33' ' ' SER . 37.5 mt-10 -70.53 -32.86 70.48 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.599 -0.688 . . . . 34.969999999999999 110.927 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.4 -57.02 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.818 -1.176 . . . . 0.0 110.796 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.568 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -59.54 -22.02 61.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.632 -1.292 . . . . 17.280000000000001 109.818 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 8.9 p -64.51 -23.31 67.23 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.122 -0.986 . . . . 24.109999999999999 108.708 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -93.05 -1.28 56.71 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.442 -0.786 . . . . 44.07 110.048 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.63 128.7 51.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.864 -1.147 . . . . 19.629999999999999 108.996 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.06 67.9 0.94 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.685 1.59 . . . . 21.539999999999999 109.581 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm -80.14 148.97 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 39' ' ' GLN . 52.3 mttt -53.65 -167.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.553 -0.717 . . . . 29.41 110.271 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.7 mm100 -52.65 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.758 0.789 . . . . 0.0 111.519 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.5 51.65 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.533 -1.027 . . . . 15.27 110.533 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.55 -28.55 13.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.463 -1.022 . . . . 8.7799999999999994 108.636 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.14 130.8 44.35 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.598 -0.89 . . . . 7.1299999999999999 108.598 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.2 tp10 -141.14 171.83 13.52 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 22.030000000000001 109.893 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.435 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 29.9 m-85 -134.34 109.0 8.51 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.23 -1.396 . . . . 16.329999999999998 107.23 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.26 102.41 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.543 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.09 97.34 7.5 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.628 -0.878 . . . . 15.32 108.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 pt -61.98 1.61 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 10.92 110.831 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 46' ' ' ASP . 6.4 p -95.56 -28.19 14.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.021 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.23 19.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -0.808 . . . . 22.449999999999999 109.385 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 15.0 t -143.68 -0.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.945 . . . . 25.629999999999999 109.962 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.63 -172.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.712 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.29 10.32 2.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 108.045 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -35.21 -68.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.802 -0.561 . . . . 18.870000000000001 111.515 -178.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.72 -29.87 60.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 45.210000000000001 110.994 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.581 ' OE2' ' NE2' ' A' ' 52' ' ' HIS . 11.4 mt-10 -64.83 -42.11 95.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.781 -1.199 . . . . 33.020000000000003 109.738 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.5 -53.01 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.829 -1.169 . . . . 9.8399999999999999 109.167 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.04 -43.14 77.55 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.573 -1.269 . . . . 17.84 107.573 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -54.15 -34.02 59.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.021 -1.474 . . . . 18.84 107.021 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -78.51 -45.83 21.04 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 12.99 108.882 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.9 mt -53.45 -33.7 55.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.907 -1.146 . . . . 14.609999999999999 107.907 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 12.0 tp60 -60.84 -57.53 12.26 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.333 0.587 . . . . 40.450000000000003 109.441 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -67.49 -35.49 79.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 41.810000000000002 109.995 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.09 -48.15 74.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 21.77 109.982 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -110.82 -61.89 1.62 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.517 -0.74 . . . . 11.380000000000001 109.344 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.64 -49.36 0.49 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.883 -1.287 . . . . 14.789999999999999 109.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 140.68 31.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 17.809999999999999 110.537 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 37.74 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.272 -1.01 . . . . 29.760000000000002 108.272 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.42 165.34 17.27 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.158 0.98 . . . . 18.260000000000002 111.764 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.08 130.87 23.87 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.2 -1.407 . . . . 8.1999999999999993 107.2 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -77.03 -165.02 4.2 Favored 'Cis proline' 0 C--N 1.309 -1.522 0 CA-C-O 122.579 0.991 . . . . 7.79 112.328 0.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.534 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -151.03 89.92 1.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.543 -2.021 . . . . 26.050000000000001 105.543 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.48 156.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.639 0.733 . . . . 8.6799999999999997 111.896 -176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.06 91.25 2.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.751 -0.593 . . . . 14.07 111.04 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 74' ' ' ILE . 6.6 mm -72.96 114.56 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 106.047 -1.835 . . . . 9.3399999999999999 106.047 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.74 -154.83 34.76 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.117 -2.793 . . . . 12.42 106.117 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.12 -1.06 51.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.452 -1.616 . . . . 44.859999999999999 109.271 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.14 118.66 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.273 -0.892 . . . . 0.0 110.407 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -75.47 150.15 38.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.411 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 1.6 pp -114.66 -22.7 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.274 -0.891 . . . . 20.449999999999999 109.122 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.5 -128.91 4.48 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.128 -1.189 . . . . 13.82 110.128 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 -137.26 4.24 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.861 -1.296 . . . . 12.42 109.861 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -72.39 -63.99 1.04 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.49 -1.006 . . . . 0.0 110.119 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -53.51 -26.71 21.98 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 110.108 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 4.2 t0 -75.25 -46.43 33.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 27.059999999999999 109.199 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.1 tt -53.48 -59.16 4.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 15.31 109.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -51.25 -51.5 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.443 -0.786 . . . . 0.0 110.758 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -47.11 -39.12 12.68 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.903 -1.123 . . . . 21.789999999999999 109.203 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -78.98 -41.8 28.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.495 -0.753 . . . . 0.0 112.124 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -57.24 13.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.579 -1.325 . . . . 0.0 110.625 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -26.22 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.939 -1.101 . . . . 0.0 109.516 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.4 m -80.34 -21.29 42.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.7 -9.96 74.06 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.331 -1.107 . . . . 25.640000000000001 110.331 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -68.36 -29.19 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.003 -1.293 . . . . 50.259999999999998 108.397 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.21 -63.87 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 24.170000000000002 110.792 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -52.68 -30.95 34.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -65.15 -49.26 70.54 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.148 -1.056 . . . . 28.030000000000001 108.148 178.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -55.86 -36.15 67.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.574 -1.269 . . . . 40.960000000000001 107.574 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.3 mp -72.86 -37.34 67.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.664 -0.865 . . . . 15.050000000000001 108.664 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.11 -55.06 20.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.642 . . . . 0.0 111.566 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -48.84 -33.93 11.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.85 -1.156 . . . . 38.640000000000001 110.751 -178.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.95 -14.78 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.823 -1.173 . . . . 0.0 109.04 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.3 8.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.418 -1.073 . . . . 18.539999999999999 110.418 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.78 -19.14 29.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.279 . . . . 10.84 109.855 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.67 -175.42 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.711 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 7' ' ' SER . 24.1 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.223 0.535 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.18 -73.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 20.030000000000001 110.447 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.31 -37.4 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 12.91 110.059 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.412 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 1.9 m120 -55.89 -37.09 68.39 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.106 -0.996 . . . . 28.329999999999998 109.582 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 57.2 m -74.5 -12.85 60.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -97.54 -44.33 6.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 110.755 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.33 137.66 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.821 -1.175 . . . . 25.190000000000001 109.611 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -147.83 137.83 12.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.331 -0.988 . . . . 34.609999999999999 108.331 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -51.66 129.21 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.067 1.178 . . . . 11.720000000000001 109.671 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.37 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.22 -1.552 . . . . 10.24 109.22 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -141.5 137.66 32.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -1.068 . . . . 25.359999999999999 109.402 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.53 137.28 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 10.890000000000001 109.843 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.62 144.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.224 -1.028 . . . . 15.82 108.224 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.11 123.55 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 8.9399999999999995 111.132 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -90.73 122.61 33.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.533 -1.284 . . . . 9.9299999999999997 107.533 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.97 -170.67 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.337 1.065 . . . . 10.619999999999999 110.893 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 21' ' ' THR . 15.6 mtmm -149.24 91.16 4.54 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 105.983 -1.858 . . . . 38.729999999999997 105.983 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.504 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.3 Cg_exo -47.26 75.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.776 1.651 . . . . 24.579999999999998 111.004 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 19' ' ' LYS . 21.9 m -170.74 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.089 -0.708 . . . . 34.82 109.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.0 133.61 23.02 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.229 -0.92 . . . . 21.460000000000001 110.076 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.53 -24.96 77.14 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 122.156 1.904 . . . . 13.859999999999999 111.854 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.6 -37.94 73.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.867 -1.146 . . . . 0.0 109.242 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -39.87 91.83 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -61.63 -40.79 96.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.015 -0.735 . . . . 59.590000000000003 109.015 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.05 -47.43 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.13 74.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.181 -0.949 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.61 -44.66 64.03 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 45.490000000000002 110.038 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.8 mm-40 -70.19 -34.47 72.99 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.499 -0.751 . . . . 34.969999999999999 110.979 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -78.65 -57.43 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.782 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.546 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 2.8 mt -60.55 -20.43 60.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.625 -1.297 . . . . 17.280000000000001 110.086 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.517 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.6 p -65.34 -26.49 68.05 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 109.026 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -90.45 4.57 50.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 44.07 110.616 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.45 128.51 46.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.776 -1.203 . . . . 19.629999999999999 109.638 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.35 65.37 0.72 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.872 1.714 . . . . 21.539999999999999 110.021 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.2 mm -78.88 153.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.291 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.0 mmmt -55.6 -169.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 29.41 109.424 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.581 ' O ' ' O ' ' A' ' 38' ' ' LYS . 23.3 mm-40 -52.5 -129.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.445 -0.784 . . . . 0.0 111.086 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.53 48.57 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.834 -0.906 . . . . 15.27 110.834 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -97.68 -18.84 18.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.18 -1.188 . . . . 8.7799999999999994 109.344 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -107.4 130.09 54.85 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.585 -0.894 . . . . 7.1299999999999999 108.585 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -141.72 166.85 23.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 22.030000000000001 110.515 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -127.68 109.79 12.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.314 -1.365 . . . . 16.329999999999998 107.314 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -95.04 107.79 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 6.5800000000000001 111.36 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -81.65 101.79 10.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.269 -1.012 . . . . 15.32 108.269 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.6 pt -63.33 -5.62 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 10.92 110.905 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 t -93.54 -13.59 27.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.845 -1.159 . . . . 21.719999999999999 109.405 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.93 11.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 22.449999999999999 109.443 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.5 t -142.63 -12.3 0.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 25.629999999999999 110.058 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.6 t-20 82.71 -172.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.42 -0.8 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 57.59 30.27 18.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.126 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -45.02 -58.65 3.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 18.870000000000001 109.94 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.6 m120 -53.78 -33.94 57.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 45.210000000000001 110.712 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -63.62 -45.94 87.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.754 -1.216 . . . . 33.020000000000003 109.534 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.23 -52.67 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 9.8399999999999999 109.451 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.27 -40.56 77.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.67 -1.233 . . . . 17.84 107.67 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.71 -32.99 63.79 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.157 -1.423 . . . . 18.84 107.157 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -77.7 -46.37 22.08 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.934 -0.765 . . . . 12.99 108.934 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.76 -36.88 65.32 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.09 -1.078 . . . . 14.609999999999999 108.09 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.3 tp-100 -59.47 -52.57 65.03 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.759 -0.83 . . . . 40.450000000000003 108.759 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.73 -44.14 78.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 41.810000000000002 110.218 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.8 tp -64.1 -42.23 96.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 21.77 110.13 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.614 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 4.6 p -114.05 -74.02 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.438 -0.788 . . . . 11.380000000000001 109.702 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 157.8 -38.89 0.54 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.716 -1.354 . . . . 14.789999999999999 109.716 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.43 133.44 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -1.194 . . . . 17.809999999999999 110.208 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.9 21.65 14.29 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.885 -0.783 . . . . 29.760000000000002 108.885 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.88 171.57 15.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.529 -0.732 . . . . 18.260000000000002 110.316 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.26 138.39 24.23 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.636 -0.875 . . . . 8.1999999999999993 108.636 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.68 -167.75 6.06 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 124.854 -0.894 . . . . 7.79 110.95 -1.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.594 ' NH1' ' HG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -141.0 92.98 2.54 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.966 -1.865 . . . . 26.050000000000001 105.966 177.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.2 t -84.21 155.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.731 0.777 . . . . 8.6799999999999997 111.691 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -143.03 88.51 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.861 -0.525 . . . . 14.07 110.639 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.4 mp -71.29 109.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.987 -1.857 . . . . 9.3399999999999999 105.987 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.76 51.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 106.792 -2.523 . . . . 12.42 106.792 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -86.12 -5.3 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.538 -1.566 . . . . 44.859999999999999 109.152 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -89.04 116.42 27.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 79' ' ' ILE . 29.3 t -72.31 152.76 41.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.467 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.489 ' N ' ' HG ' ' A' ' 78' ' ' SER . 3.7 pt -114.33 -23.37 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 20.449999999999999 109.702 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.8 -148.76 19.53 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.747 -1.341 . . . . 13.82 109.747 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -102.12 -148.65 21.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.945 -1.262 . . . . 12.42 109.945 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -58.23 3.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 t -53.19 -27.2 20.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.1 m-20 -73.66 -45.72 50.86 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 27.059999999999999 108.817 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -56.26 -60.9 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.539 -0.726 . . . . 15.31 109.952 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -49.66 -48.03 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.318 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.3 m -49.71 -45.92 49.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.704 -1.247 . . . . 21.789999999999999 109.494 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 mt -70.6 -38.65 74.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -60.4 -58.51 8.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.176 -0.953 . . . . 0.0 110.489 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.414 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -61.89 -25.88 67.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.029 -1.044 . . . . 0.0 109.308 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.79 -15.32 52.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.69 -7.41 62.18 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.673 -1.371 . . . . 25.640000000000001 109.673 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.83 -27.92 66.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.203 -1.175 . . . . 50.259999999999998 109.016 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.22 -63.76 1.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -0.847 . . . . 24.170000000000002 110.319 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.95 -30.24 45.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.55 -43.43 97.11 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.068 -1.086 . . . . 28.030000000000001 108.068 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.402 HH21 ' HB3' ' A' ' 77' ' ' ASP . 2.0 tpt180 -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.32 -0.992 . . . . 40.960000000000001 108.32 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.62 -37.88 70.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.425 -0.797 . . . . 15.050000000000001 109.204 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.18 -56.81 12.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 111.856 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -46.82 -27.51 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.794 -1.191 . . . . 38.640000000000001 110.264 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.71 -17.81 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.723 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.86 39.37 13.68 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.25 -1.14 . . . . 18.539999999999999 110.25 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 -10.19 58.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.178 . . . . 10.84 109.638 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.553 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.3 pt? -95.25 -176.98 3.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 109.964 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.597 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.583 0.706 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.25 -68.76 0.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.787 . . . . 20.030000000000001 110.678 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -72.94 -38.49 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.134 -0.979 . . . . 12.91 110.289 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' HH ' ' A' ' 59' ' ' TYR . 7.5 m120 -55.1 -37.28 66.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.061 -1.024 . . . . 28.329999999999998 109.379 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 m -74.97 -12.7 60.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.743 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -97.16 -45.77 6.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 22.870000000000001 110.753 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.16 134.45 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.908 -1.12 . . . . 25.190000000000001 109.391 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -147.61 149.61 34.39 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 34.609999999999999 109.186 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.18 126.17 21.25 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.421 1.414 . . . . 11.720000000000001 110.024 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.7 21.34 61.93 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.607 -1.397 . . . . 10.24 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -137.64 134.01 34.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -1.058 . . . . 25.359999999999999 109.272 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.6 137.51 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.18 -0.95 . . . . 10.890000000000001 109.617 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.19 147.13 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.211 -1.033 . . . . 15.82 108.211 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.2 t -132.74 122.04 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.932 . . . . 8.9399999999999995 110.803 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -89.43 126.12 35.43 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.478 -1.304 . . . . 9.9299999999999997 107.478 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.74 -172.18 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.174 0.988 . . . . 10.619999999999999 111.319 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.744 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.6 mtmt -147.49 96.31 4.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.747 -1.575 . . . . 38.729999999999997 106.747 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' CG2' ' A' ' 21' ' ' THR . 11.2 Cg_exo -49.22 66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.843 1.696 . . . . 24.579999999999998 111.147 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 19' ' ' LYS . 16.8 p -162.62 -35.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.984 -0.747 . . . . 34.82 108.984 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.13 128.47 35.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 21.460000000000001 110.072 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.25 -14.78 40.42 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 122.12 1.88 . . . . 13.859999999999999 111.996 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -70.54 -43.14 70.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.691 -1.256 . . . . 0.0 109.798 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -31.19 71.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.351 -0.843 . . . . 0.0 109.55 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.82 -47.74 83.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 59.590000000000003 109.544 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.647 HH11 ' HG3' ' A' ' 27' ' ' ARG . 2.4 mmm-85 -51.08 -41.29 59.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 0.0 108.803 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.33 82.75 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 11.5 mt-30 -71.57 -46.1 60.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 45.490000000000002 109.663 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 97.3 mt-10 -68.83 -34.6 75.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.518 -0.738 . . . . 34.969999999999999 110.916 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -76.8 -56.64 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.741 -1.225 . . . . 0.0 110.045 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.544 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -58.51 -20.85 49.49 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.667 -1.271 . . . . 17.280000000000001 109.14 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 8.9 m -65.22 -30.44 71.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.25 -0.906 . . . . 24.109999999999999 108.78 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.519 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -88.65 3.32 51.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 44.07 110.262 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' ILE . 18.1 mt -91.87 127.77 48.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.826 -1.171 . . . . 19.629999999999999 109.432 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.05 63.55 0.31 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.866 1.711 . . . . 21.539999999999999 110.485 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.1 mm -80.25 147.19 6.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.2 mttp -53.46 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 29.41 110.342 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' LYS . 33.1 mt-30 -49.81 -128.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 111.435 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.53 47.75 0.08 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.87 -0.892 . . . . 15.27 110.87 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -101.24 -15.33 17.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -1.207 . . . . 8.7799999999999994 109.193 179.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.4 tp -110.18 128.73 55.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.404 -0.962 . . . . 7.1299999999999999 108.404 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.1 tt0 -141.32 169.8 16.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.067 . . . . 22.030000000000001 110.317 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.476 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.0 m-85 -133.12 112.87 12.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.048 -1.093 . . . . 16.329999999999998 108.048 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -95.9 102.09 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 6.5800000000000001 111.149 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.7 m-20 -80.19 100.2 8.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.234 -1.024 . . . . 15.32 108.234 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 pt -62.45 -0.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 10.92 110.196 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 46' ' ' ASP . 33.9 p -95.6 -27.03 15.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 21.719999999999999 109.597 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.48 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 22.449999999999999 109.484 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.477 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 14.7 t -145.17 -3.27 0.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 25.629999999999999 110.164 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.688 HD22 ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 67.89 -162.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.048 -1.032 . . . . 0.0 108.526 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.688 ' CD2' HD22 ' A' ' 51' ' ' ASN . 20.1 m170 56.56 11.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.685 -1.26 . . . . 0.0 108.141 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -35.75 -69.22 0.11 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 18.870000000000001 111.36 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.1 m-20 -53.04 -31.28 40.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.062 -1.024 . . . . 45.210000000000001 110.895 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.8 -46.21 79.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.782 -1.199 . . . . 33.020000000000003 109.912 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.86 -52.3 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.748 -1.22 . . . . 9.8399999999999999 109.68 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.89 -41.64 82.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.63 -1.248 . . . . 17.84 107.63 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 9.9 m-20 -55.66 -34.23 64.8 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.279 -1.378 . . . . 18.84 107.279 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.547 ' HH ' HD22 ' A' ' 6' ' ' ASN . 58.8 t80 -78.15 -50.31 12.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.84 -0.744 . . . . 12.99 109.204 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.5 mt -52.42 -33.07 42.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.164 -1.05 . . . . 14.609999999999999 108.164 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.2 tp60 -60.42 -56.59 19.61 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.656 -0.653 . . . . 40.450000000000003 109.302 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -65.69 -41.19 92.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 41.810000000000002 109.867 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -65.72 -37.22 85.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 21.77 109.815 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 6.5 p -113.23 -63.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 11.380000000000001 109.555 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 61' ' ' GLN . . . 144.83 -49.21 0.69 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.007 -1.637 . . . . 14.789999999999999 109.007 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.22 44.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.047 . . . . 17.809999999999999 109.958 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.32 36.12 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.519 -0.919 . . . . 29.760000000000002 108.519 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.41 169.52 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.547 -0.721 . . . . 18.260000000000002 110.226 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.81 135.41 24.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.107 -1.072 . . . . 8.1999999999999993 108.107 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -81.98 -166.22 4.9 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 124.784 -0.923 . . . . 7.79 111.157 -0.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.584 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -143.03 91.18 2.26 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.789 -1.93 . . . . 26.050000000000001 105.789 177.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.09 154.23 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 8.6799999999999997 111.211 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -143.47 88.67 2.02 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.397 -0.521 . . . . 14.07 110.2 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 74' ' ' ILE . 15.7 mm -71.6 101.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.024 -1.843 . . . . 9.3399999999999999 106.024 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.22 -149.85 39.68 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.345 -2.702 . . . . 12.42 106.345 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' CB ' ' NZ ' ' A' ' 76' ' ' LYS . 8.4 mtmp? -86.97 -6.78 58.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.568 -1.549 . . . . 44.859999999999999 109.474 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HB3' HH21 ' A' ' 97' ' ' ARG . 3.0 m-20 -91.48 121.6 33.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 110.582 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -73.62 155.82 38.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 80' ' ' GLY . 2.8 pp -119.0 -16.61 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.233 -0.917 . . . . 20.449999999999999 109.69 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' C ' HH21 ' A' ' 71' ' ' ARG . . . 136.23 -150.43 20.44 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.081 -1.207 . . . . 13.82 110.081 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.457 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.76 -145.3 11.81 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.955 -1.258 . . . . 12.42 109.955 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.89 -62.13 1.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.489 -1.007 . . . . 0.0 110.03 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 t -54.23 -26.43 28.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.349 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -73.88 -45.79 48.68 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -0.874 . . . . 27.059999999999999 109.007 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.457 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 2.6 tt -54.11 -59.66 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.41 -0.806 . . . . 15.31 109.7 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -43.49 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 110.503 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.619 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 18.8 m -55.27 -35.48 65.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 21.789999999999999 110.146 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.02 -34.35 32.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 0.0 111.258 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.41 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -62.23 -60.57 3.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.004 -1.06 . . . . 0.0 111.124 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.712 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.86 -17.42 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.859 -1.151 . . . . 0.0 109.523 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.544 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 40.4 m -80.26 -62.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.495 -0.753 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.77 4.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.401 -1.479 . . . . 25.640000000000001 109.401 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.37 -30.46 69.41 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.271 -1.135 . . . . 50.259999999999998 108.952 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.73 -64.18 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.431 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -55.01 -31.4 61.02 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.46 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.61 -45.44 90.34 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.422 -0.955 . . . . 28.030000000000001 108.422 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.445 HH21 ' HB3' ' A' ' 77' ' ' ASP . 3.1 ttt180 -61.25 -34.99 76.06 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.273 -1.01 . . . . 40.960000000000001 108.273 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.419 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -70.93 -36.14 72.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.721 -0.844 . . . . 15.050000000000001 108.721 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -64.57 -57.5 8.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.782 -0.574 . . . . 0.0 111.346 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 96' ' ' THR . 1.1 pt20 -47.48 -31.72 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.895 -1.128 . . . . 38.640000000000001 110.349 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.86 -11.8 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.995 -1.066 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 73.75 44.51 31.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.507 -1.037 . . . . 18.539999999999999 110.507 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.42 -11.86 50.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -1.218 . . . . 10.84 109.484 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.72 -178.11 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 0.0 110.059 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.393 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 7' ' ' SER . 24.1 mt-10 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -62.19 -72.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.391 -0.818 . . . . 20.030000000000001 110.248 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.84 -39.62 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 12.91 109.929 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 3.3 m120 -55.6 -37.31 67.94 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 28.329999999999998 109.575 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 59.3 m -74.47 -13.02 60.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.97 -48.34 5.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 22.870000000000001 110.277 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 128.38 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.974 -1.079 . . . . 25.190000000000001 109.869 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -147.85 160.44 38.03 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.56 -0.904 . . . . 34.609999999999999 108.56 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.0 129.19 33.17 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.658 1.572 . . . . 11.720000000000001 111.165 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.54 29.94 50.82 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.865 -0.894 . . . . 10.24 110.865 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -144.8 136.21 25.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.88 -1.364 . . . . 25.359999999999999 110.074 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.24 133.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 10.890000000000001 109.38 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.68 144.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.347 -0.983 . . . . 15.82 108.347 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.42 124.46 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 8.9399999999999995 110.957 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -90.07 121.21 31.92 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.397 -1.334 . . . . 9.9299999999999997 107.397 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -130.7 -175.57 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.276 1.036 . . . . 10.619999999999999 111.2 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.7 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.9 mtmt -148.72 86.59 5.75 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.689 -1.597 . . . . 38.729999999999997 106.689 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 21' ' ' THR . 15.6 Cg_exo -44.26 76.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.791 1.661 . . . . 24.579999999999998 110.928 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 19' ' ' LYS . 34.2 m -172.02 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.436 -0.95 . . . . 34.82 108.436 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.5 129.62 29.91 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 21.460000000000001 109.505 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.74 -19.92 56.08 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 122.085 1.857 . . . . 13.859999999999999 112.099 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.679 -1.263 . . . . 0.0 109.551 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -32.95 74.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 108.44 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -62.51 -45.51 92.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 59.590000000000003 108.879 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -49.55 -45.2 47.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.12 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.58 84.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.135 -0.978 . . . . 0.0 108.811 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -70.4 -42.57 71.48 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.46 -0.775 . . . . 45.490000000000002 109.659 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.37 -36.05 76.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 34.969999999999999 111.06 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.77 -56.53 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.837 -1.164 . . . . 0.0 110.497 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 2.5 mt -59.78 -19.91 53.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.576 -1.328 . . . . 17.280000000000001 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -65.65 -27.58 68.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.135 -0.978 . . . . 24.109999999999999 108.919 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -90.11 3.81 52.24 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.316 -0.865 . . . . 44.07 110.431 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.7 mt -92.49 125.86 54.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.824 -1.172 . . . . 19.629999999999999 109.805 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.98 67.72 0.92 Allowed 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.802 1.668 . . . . 21.539999999999999 109.893 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 mm -79.43 150.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.7 mtpm? -54.19 -171.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.366 -0.834 . . . . 29.41 110.192 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' LYS . 16.7 mt-30 -50.78 -131.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.617 0.722 . . . . 0.0 111.447 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.14 49.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.242 -0.911 . . . . 15.27 110.933 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.8 -17.51 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -1.074 . . . . 8.7799999999999994 109.383 179.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.0 tp -107.88 130.9 54.97 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.48 -0.933 . . . . 7.1299999999999999 108.48 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.1 tp10 -141.58 169.27 17.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -0.988 . . . . 22.030000000000001 110.418 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.402 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 31.6 m-85 -131.92 109.96 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.606 -1.257 . . . . 16.329999999999998 107.606 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.0 t -94.67 104.01 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 6.5800000000000001 111.186 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -80.71 101.34 9.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.782 -0.822 . . . . 15.32 108.782 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.59 -7.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 10.92 110.198 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -100.49 46.93 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 21.719999999999999 108.804 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.03 20.25 0.31 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.025 -0.732 . . . . 22.449999999999999 109.025 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 9.0 t -144.51 -5.22 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 25.629999999999999 109.513 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 50' ' ' THR . 4.2 t-20 81.38 177.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.38 27.13 11.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.997 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.14 -60.69 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 18.870000000000001 110.41 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 81.6 m-20 -57.47 -29.51 64.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 45.210000000000001 111.022 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.13 -43.95 93.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.724 -1.235 . . . . 33.020000000000003 109.747 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.1 -53.67 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 9.8399999999999999 109.431 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.43 -43.17 83.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.839 -1.171 . . . . 17.84 107.839 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 26.3 m-20 -54.9 -34.93 63.58 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.345 -1.354 . . . . 18.84 107.345 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -78.76 -47.3 17.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.878 -0.729 . . . . 12.99 109.245 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.76 -32.77 53.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.213 -1.032 . . . . 14.609999999999999 108.213 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.709 ' NE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -59.49 -55.59 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.879 -0.785 . . . . 40.450000000000003 108.879 179.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -67.45 -35.5 79.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.181 -0.95 . . . . 41.810000000000002 110.109 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.3 tp -64.88 -46.42 81.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.1 -1.0 . . . . 21.77 109.91 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.4 p -110.06 -58.5 2.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.47 -0.769 . . . . 11.380000000000001 109.481 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 150.01 -52.46 0.52 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.573 -1.411 . . . . 14.789999999999999 109.573 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 138.28 35.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -1.093 . . . . 17.809999999999999 110.261 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' N ' ' NE2' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -95.59 32.28 1.85 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.459 -0.941 . . . . 29.760000000000002 108.459 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 165.79 22.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 18.260000000000002 110.207 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -116.79 138.35 24.54 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.056 -1.09 . . . . 8.1999999999999993 108.056 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -80.66 -168.13 6.53 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 124.8 -0.917 . . . . 7.79 111.361 -0.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.539 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.68 90.75 2.03 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.852 -1.907 . . . . 26.050000000000001 105.852 177.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.23 155.58 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.737 0.779 . . . . 8.6799999999999997 111.551 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -144.12 89.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.818 -0.551 . . . . 14.07 110.921 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -71.72 110.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.084 -1.821 . . . . 9.3399999999999999 106.084 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.66 -153.34 52.5 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.729 -2.548 . . . . 12.42 106.729 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -84.15 -3.74 58.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.564 -1.551 . . . . 44.859999999999999 109.41 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.424 ' HB2' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -90.05 118.37 29.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.937 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -72.68 152.26 41.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.031 -1.043 . . . . 0.0 109.416 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -113.87 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -0.969 . . . . 20.449999999999999 109.336 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' HH22 ' A' ' 71' ' ' ARG . . . 132.51 -155.96 21.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.124 -1.19 . . . . 13.82 110.124 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.95 -147.16 22.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.201 -1.16 . . . . 12.42 110.201 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.56 -60.2 2.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.526 -0.985 . . . . 0.0 109.867 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 t -52.43 -25.84 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.286 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.19 -49.08 25.05 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.801 . . . . 27.059999999999999 109.333 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.5 tt -54.7 -59.23 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 15.31 110.145 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.41 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.16 -45.41 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.105 -178.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 -47.47 66.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.736 -1.228 . . . . 21.789999999999999 109.492 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.23 -36.54 77.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.903 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -60.77 -59.18 5.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 110.478 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.53 -24.19 67.37 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.432 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -82.55 -16.52 48.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.464 -0.773 . . . . 0.0 109.813 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 -9.88 56.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.819 -1.313 . . . . 25.640000000000001 109.819 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -67.7 -28.18 67.45 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -1.174 . . . . 50.259999999999998 108.809 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.32 -65.7 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 24.170000000000002 110.084 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.24 -30.38 37.78 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.43 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -62.86 -44.68 95.46 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.465 -0.939 . . . . 28.030000000000001 108.465 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.686 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -63.06 -34.11 76.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.662 -0.866 . . . . 40.960000000000001 108.662 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.11 -35.68 71.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 15.050000000000001 109.023 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -65.11 -56.9 10.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.608 -0.683 . . . . 0.0 111.574 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -46.01 -31.09 2.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 38.640000000000001 110.395 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.4 pt -104.45 -14.44 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.86 40.5 21.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.304 -1.118 . . . . 18.539999999999999 110.304 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.42 -8.06 59.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.239 . . . . 10.84 109.474 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.18 -178.99 4.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.561 179.724 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.254 0.55 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.17 -69.16 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 20.030000000000001 110.432 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -73.51 -40.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 12.91 110.443 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 68.4 m-80 -55.21 -29.94 58.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.067 -1.021 . . . . 28.329999999999998 109.497 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 m -75.29 -18.44 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -98.1 -44.03 6.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 111.212 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.26 129.18 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.174 . . . . 25.190000000000001 110.585 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.05 158.4 38.91 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.151 -1.055 . . . . 34.609999999999999 108.151 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.0 127.95 27.9 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.544 1.496 . . . . 11.720000000000001 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.12 28.16 46.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.753 -0.939 . . . . 10.24 110.753 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -143.14 136.88 28.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.969 -1.313 . . . . 25.359999999999999 109.933 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.79 134.4 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.386 -0.821 . . . . 10.890000000000001 109.392 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.15 143.0 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.437 -0.949 . . . . 15.82 108.437 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.7 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.405 -0.809 . . . . 8.9399999999999995 110.739 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.62 122.74 33.04 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.487 -1.301 . . . . 9.9299999999999997 107.487 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.6 pt -132.11 -174.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.104 0.954 . . . . 10.619999999999999 111.224 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mtmt -145.77 94.63 5.03 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.585 -1.635 . . . . 38.729999999999997 106.585 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.0 Cg_exo -46.49 82.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.561 1.508 . . . . 24.579999999999998 110.945 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 19' ' ' LYS . 14.7 m 178.95 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 34.82 108.41 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.96 121.88 54.42 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 21.460000000000001 109.711 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.04 -17.57 45.75 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.724 1.616 . . . . 13.859999999999999 111.778 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -68.87 -42.63 76.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.563 -1.335 . . . . 0.0 108.291 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -36.73 83.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -61.15 -39.37 89.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.8 -1.185 . . . . 59.590000000000003 107.8 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.69 -47.15 70.74 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.42 74.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.407 -0.808 . . . . 0.0 108.865 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 33' ' ' SER . 5.4 mt-30 -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.852 . . . . 45.490000000000002 109.745 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.3 mm-40 -69.82 -34.17 73.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 34.969999999999999 111.029 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.48 -55.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.544 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.5 mt -59.25 -24.13 62.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.671 -1.268 . . . . 17.280000000000001 109.696 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.2 p -63.85 -22.22 66.81 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.289 -1.004 . . . . 24.109999999999999 108.289 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -90.09 0.43 57.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.527 -0.733 . . . . 44.07 109.862 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 127.45 47.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 19.629999999999999 109.656 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.0 66.65 0.58 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.644 1.562 . . . . 21.539999999999999 109.777 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.07 148.15 6.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.9 mttp -54.55 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -0.826 . . . . 29.41 110.272 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' LYS . 17.0 mt-30 -51.1 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.641 0.734 . . . . 0.0 111.191 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.24 48.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.924 -0.87 . . . . 15.27 110.924 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -99.8 -17.36 17.71 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.129 -1.218 . . . . 8.7799999999999994 109.137 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -108.55 126.92 53.46 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.967 -1.123 . . . . 7.1299999999999999 107.967 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 23.2 tp10 -139.59 163.67 31.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.993 -1.067 . . . . 22.030000000000001 110.253 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.527 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.9 m-85 -126.32 110.84 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.677 -1.231 . . . . 16.329999999999998 107.677 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.61 107.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 6.5800000000000001 111.235 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' THR . 4.7 m-20 -82.59 99.61 9.65 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.469 -0.937 . . . . 15.32 108.469 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.2 pt -62.03 5.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 10.92 110.61 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ASP . 16.9 p -97.22 -25.53 15.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.089 -1.007 . . . . 21.719999999999999 109.812 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.91 23.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 22.449999999999999 109.943 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.543 ' C ' HD21 ' A' ' 51' ' ' ASN . 12.0 t -146.74 0.6 0.76 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 25.629999999999999 110.489 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 50' ' ' THR . 2.2 m-80 66.45 -177.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.227 -0.921 . . . . 0.0 109.245 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.58 29.92 16.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 108.8 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.85 -56.69 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 18.870000000000001 110.002 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 68.8 m-20 -57.02 -31.4 65.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 45.210000000000001 111.0 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.5 -45.13 92.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.752 -1.218 . . . . 33.020000000000003 109.739 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.86 -53.98 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.869 -1.144 . . . . 9.8399999999999999 109.677 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.26 -40.67 78.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.723 -1.214 . . . . 17.84 107.723 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 61.2 m-20 -54.96 -33.73 62.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.037 -1.468 . . . . 18.84 107.037 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -78.86 -48.72 14.15 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.058 -0.719 . . . . 12.99 109.058 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.3 mt -53.96 -33.21 56.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.141 -1.059 . . . . 14.609999999999999 108.141 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 6.9 tp60 -60.58 -57.68 11.68 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.165 -0.68 . . . . 40.450000000000003 109.165 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.09 -36.22 81.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.359 -0.838 . . . . 41.810000000000002 110.023 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 tp -65.38 -49.17 70.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.094 -1.004 . . . . 21.77 109.704 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 2.2 p -109.05 -67.2 1.0 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.74 . . . . 11.380000000000001 109.563 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 161.33 -49.07 0.36 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.258 -1.449 . . . . 14.789999999999999 110.874 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.662 ' CB ' HH12 ' A' ' 71' ' ' ARG . . . -97.81 136.95 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.304 . . . . 17.809999999999999 110.771 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.58 25.21 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.253 -1.388 . . . . 29.760000000000002 107.253 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.15 169.42 18.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.665 0.745 . . . . 18.260000000000002 110.254 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.0 135.09 24.1 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.02 -1.104 . . . . 8.1999999999999993 108.02 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -83.72 -164.69 3.61 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 124.868 -0.888 . . . . 7.79 110.797 -0.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.662 HH12 ' CB ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -152.41 93.47 1.8 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.036 -2.209 . . . . 26.050000000000001 105.036 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 73' ' ' PHE . 65.7 t -82.5 160.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.859 0.838 . . . . 8.6799999999999997 111.971 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' N ' ' CG1' ' A' ' 72' ' ' VAL . 83.9 m-85 -144.47 91.83 2.23 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 116.174 -0.467 . . . . 14.07 110.584 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 mm -71.73 104.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.881 -1.896 . . . . 9.3399999999999999 105.881 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.32 -149.64 51.11 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 106.101 -2.8 . . . . 12.42 106.101 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -84.77 -1.17 55.97 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.489 -1.595 . . . . 44.859999999999999 109.245 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' OD2' ' NH2' ' A' ' 97' ' ' ARG . 85.2 m-20 -89.5 111.76 22.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -72.97 147.67 44.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.89 -21.13 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.289 -0.882 . . . . 20.449999999999999 108.983 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.12 -149.42 18.87 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.18 -1.168 . . . . 13.82 110.18 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.52 -140.66 9.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.405 -1.078 . . . . 12.42 110.405 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -70.06 -65.61 0.7 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.729 -0.865 . . . . 0.0 110.334 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -50.83 -27.9 8.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.821 . . . . 0.0 109.692 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -73.92 -49.47 24.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.354 -0.841 . . . . 27.059999999999999 109.345 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.446 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 6.0 tt -56.01 -60.09 3.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 15.31 110.411 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.59 -47.17 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 -178.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 t -49.46 -46.34 47.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.791 -1.193 . . . . 21.789999999999999 109.444 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.22 -39.11 75.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.878 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -60.58 -58.39 8.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.894 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.63 -24.75 65.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 109.102 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -79.97 -43.78 21.43 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.653 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.69 -9.96 30.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.393 -1.483 . . . . 25.640000000000001 109.393 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.58 -26.06 65.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -1.082 . . . . 50.259999999999998 108.911 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.52 -64.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 24.170000000000002 110.212 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.24 -30.82 40.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.32 -44.09 95.94 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.511 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 8.9 tpt180 -61.27 -35.49 77.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.411 -0.959 . . . . 40.960000000000001 108.411 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 98' ' ' LEU . 9.6 mp -70.6 -38.93 74.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.857 0.837 . . . . 15.050000000000001 108.82 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -65.55 -53.81 36.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.824 -0.548 . . . . 0.0 112.033 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -48.31 -32.17 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.78 -1.2 . . . . 38.640000000000001 110.42 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.2 pt -103.83 -14.4 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.572 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 78.99 45.4 9.06 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.283 -1.127 . . . . 18.539999999999999 110.283 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.56 -11.81 53.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -1.121 . . . . 10.84 109.187 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.57 -177.85 4.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.14 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.599 179.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -63.67 -69.49 0.27 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.476 -0.765 . . . . 20.030000000000001 110.619 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.64 -39.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 12.91 110.169 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.1 m-20 -55.75 -37.98 69.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.212 -0.93 . . . . 28.329999999999998 109.271 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -74.94 -12.03 60.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -97.21 -45.33 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 22.870000000000001 110.721 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.54 138.95 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.788 -1.195 . . . . 25.190000000000001 110.029 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.27 136.77 11.21 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 107.947 -1.131 . . . . 34.609999999999999 107.947 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -50.02 131.51 30.51 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 120.997 1.131 . . . . 11.720000000000001 109.699 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 20.64 70.06 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.209 -1.556 . . . . 10.24 109.209 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -137.82 132.98 33.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -1.06 . . . . 25.359999999999999 109.013 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.32 135.5 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.154 -0.966 . . . . 10.890000000000001 109.754 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.3 142.86 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.268 -1.012 . . . . 15.82 108.268 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -124.86 128.07 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 8.9399999999999995 111.201 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -94.74 114.69 26.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.352 -0.981 . . . . 9.9299999999999997 108.352 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.74 -172.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.537 1.161 . . . . 10.619999999999999 111.587 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -145.89 94.65 4.98 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 105.481 -2.044 . . . . 38.729999999999997 105.481 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.532 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.1 Cg_exo -49.21 79.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.392 1.394 . . . . 24.579999999999998 111.06 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.607 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.8 m -177.59 -32.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.539 -0.726 . . . . 34.82 109.442 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.77 124.68 45.09 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 21.460000000000001 109.6 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.78 -17.63 23.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.382 2.054 . . . . 13.859999999999999 113.164 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -69.91 -49.71 49.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.269 -1.52 . . . . 0.0 109.391 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.521 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -59.96 -33.08 71.45 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -61.13 -42.67 98.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.815 -0.809 . . . . 59.590000000000003 108.815 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.477 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 1.1 mtt-85 -54.52 -47.81 72.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.008 -1.058 . . . . 0.0 108.754 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -70.07 -41.81 73.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.36 -0.837 . . . . 45.490000000000002 109.435 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 42.5 mt-10 -72.19 -38.74 68.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.565 -0.709 . . . . 34.969999999999999 111.461 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -74.19 -55.69 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.813 -1.18 . . . . 0.0 110.093 -178.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -60.02 -20.08 56.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.538 -1.351 . . . . 17.280000000000001 109.649 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -65.73 -30.2 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.103 -0.998 . . . . 24.109999999999999 109.539 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 30' ' ' GLU . 2.9 mp0 -93.85 4.93 53.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 44.07 110.902 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.35 132.18 40.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.767 -1.208 . . . . 19.629999999999999 108.604 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.85 62.52 0.59 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.577 1.518 . . . . 21.539999999999999 110.258 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.3 mm -78.32 146.94 7.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.032 -1.043 . . . . 0.0 108.225 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 39' ' ' GLN . 18.6 mtpt -53.65 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.062 -1.024 . . . . 29.41 109.944 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 41' ' ' LEU . 26.9 mt-30 -52.29 -127.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.691 0.758 . . . . 0.0 112.363 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.81 48.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.102 -0.799 . . . . 15.27 111.102 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -99.66 -33.04 10.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.263 -1.14 . . . . 8.7799999999999994 108.81 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 tp -94.42 132.81 38.67 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.466 0.65 . . . . 7.1299999999999999 109.446 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.6 tp10 -142.01 174.05 10.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 22.030000000000001 109.515 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.475 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 46.7 m-85 -136.63 112.02 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.196 -1.409 . . . . 16.329999999999998 107.196 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.31 104.01 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 6.5800000000000001 111.775 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.6 m-20 -82.68 97.62 8.63 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.603 -0.888 . . . . 15.32 108.603 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.53 1.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 10.92 110.499 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.491 ' H ' ' C ' ' A' ' 46' ' ' ASP . 18.1 p -93.61 -17.26 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.027 -1.046 . . . . 21.719999999999999 108.635 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 7.27 5.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.49 -0.756 . . . . 22.449999999999999 109.546 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.0 t -142.31 -3.99 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 25.629999999999999 110.009 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 53' ' ' THR . 8.7 t30 66.55 -151.73 0.21 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 51.24 13.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.667 -1.271 . . . . 0.0 108.631 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 51' ' ' ASN . 4.3 p -41.59 -55.95 2.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.79 . . . . 18.870000000000001 110.733 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.9 m120 -52.31 -36.81 54.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 45.210000000000001 110.503 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -65.92 -45.01 83.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.06 . . . . 33.020000000000003 109.493 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -67.35 -52.55 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 9.8399999999999999 109.563 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -56.2 -43.74 78.78 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.231 -1.396 . . . . 17.84 107.231 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -55.5 -34.51 64.67 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.85 -1.537 . . . . 18.84 106.85 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -78.71 -48.81 14.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 120.245 -0.582 . . . . 12.99 109.506 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -51.95 -34.35 41.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.924 -1.139 . . . . 14.609999999999999 107.924 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' OE1' ' NH2' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -61.16 -58.2 9.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.304 0.573 . . . . 40.450000000000003 109.768 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -68.47 -35.65 77.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.177 -0.952 . . . . 41.810000000000002 110.861 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.94 -48.24 77.3 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 21.77 110.107 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -113.08 -61.79 1.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 11.380000000000001 109.423 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 160.9 -56.75 0.31 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.647 -1.381 . . . . 14.789999999999999 109.647 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.58 29.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -1.116 . . . . 17.809999999999999 109.296 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -108.95 20.85 17.96 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.026 -1.102 . . . . 29.760000000000002 108.026 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.01 165.63 17.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.346 -0.846 . . . . 18.260000000000002 109.524 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.6 131.08 22.06 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 8.1999999999999993 108.859 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 82' ' ' SER . 33.5 Cg_endo -84.65 -165.96 4.15 Favored 'Cis proline' 0 C--N 1.309 -1.548 0 CA-C-O 122.521 0.967 . . . . 7.79 111.674 -1.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -152.73 92.48 1.66 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.794 -2.299 . . . . 26.050000000000001 104.794 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.62 157.4 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.782 0.801 . . . . 8.6799999999999997 112.021 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -139.81 88.45 2.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.718 -0.614 . . . . 14.07 111.297 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.434 HD13 HG22 ' A' ' 74' ' ' ILE . 3.0 mm -71.93 113.88 9.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.921 -2.252 . . . . 9.3399999999999999 104.921 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.2 -154.52 29.18 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.796 -2.922 . . . . 12.42 105.796 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -83.01 0.34 45.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.218 -1.754 . . . . 44.859999999999999 108.622 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.46 110.01 19.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -74.35 142.33 45.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.675 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 1.9 pt -107.2 -22.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.979 -1.076 . . . . 20.449999999999999 109.166 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.28 19.05 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.212 -1.155 . . . . 13.82 110.212 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.79 -145.25 15.3 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.198 -1.161 . . . . 12.42 110.198 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.444 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 t -71.8 -60.53 2.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 t -51.38 -24.2 4.56 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.428 0.632 . . . . 0.0 109.483 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 3.5 t70 -76.73 -51.4 11.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.808 . . . . 27.059999999999999 109.394 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.2 tt -51.27 -58.91 4.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 15.31 109.975 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -50.2 -54.23 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.551 -0.718 . . . . 0.0 109.865 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' VAL . 74.3 m -44.68 -36.69 3.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.335 -0.853 . . . . 21.789999999999999 109.119 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.3 mt -80.83 -43.49 19.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.493 -0.754 . . . . 0.0 111.409 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.01 -56.2 23.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 111.018 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -26.0 64.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.742 -1.224 . . . . 0.0 108.911 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.8 m -79.18 -60.82 2.22 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.17 -7.93 6.01 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.061 -1.215 . . . . 25.640000000000001 110.061 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -70.12 -26.15 63.83 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.064 -1.256 . . . . 50.259999999999998 108.856 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 tp -60.08 -62.34 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.819 . . . . 24.170000000000002 110.717 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.12 -28.8 42.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.8 -49.48 68.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.317 -0.994 . . . . 28.030000000000001 108.317 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' NH1' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.22 -33.39 65.32 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.412 -1.329 . . . . 40.960000000000001 107.412 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.454 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.7 mp -72.51 -41.0 66.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.88 -0.785 . . . . 15.050000000000001 108.88 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -64.77 -52.07 58.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.731 -0.605 . . . . 0.0 111.693 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -34.1 27.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.836 -1.165 . . . . 38.640000000000001 111.007 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.9 pt -99.55 -18.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.63 -1.294 . . . . 0.0 109.097 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.6 40.95 7.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.605 -0.998 . . . . 18.539999999999999 110.605 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.75 -10.98 56.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.09 -1.241 . . . . 10.84 109.436 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.598 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.58 178.15 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.63 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.191 0.519 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.27 -75.74 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.178 -0.951 . . . . 20.030000000000001 110.483 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -74.24 -36.44 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 12.91 109.818 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.407 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 50.7 m-20 -56.14 -38.23 70.56 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 28.329999999999998 109.81 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.3 m -74.1 -12.46 60.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.095 -1.003 . . . . 0.0 109.86 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -97.63 -45.37 6.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 22.870000000000001 110.72 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.21 130.67 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.828 -1.17 . . . . 25.190000000000001 110.116 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.67 157.21 36.28 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.018 -1.104 . . . . 34.609999999999999 108.018 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.89 131.54 46.14 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.897 1.731 . . . . 11.720000000000001 111.588 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.74 21.76 68.08 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.488 -0.863 . . . . 10.24 111.073 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -140.11 132.76 28.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.972 -1.311 . . . . 25.359999999999999 109.415 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.74 133.75 41.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.401 -0.812 . . . . 10.890000000000001 109.404 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.93 142.9 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.673 -0.862 . . . . 15.82 108.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.9 t -125.91 126.8 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.202 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -94.18 116.91 29.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 9.9299999999999997 107.881 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 pt -127.82 -171.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 122.635 1.207 . . . . 10.619999999999999 111.527 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.5 mtmt -149.32 87.47 5.27 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 105.823 -1.918 . . . . 38.729999999999997 105.823 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' CG2' ' A' ' 21' ' ' THR . 16.7 Cg_exo -47.21 73.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.712 1.608 . . . . 24.579999999999998 110.861 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.8 p -161.88 -37.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.038 -1.097 . . . . 34.82 108.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.39 129.76 28.47 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 21.460000000000001 109.434 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -56.98 -24.55 57.99 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.404 2.07 . . . . 13.859999999999999 112.579 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.65 -41.64 87.9 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.38 -1.45 . . . . 0.0 108.76 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.654 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.12 -35.06 76.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.72 -1.215 . . . . 59.590000000000003 107.72 178.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.63 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -54.62 -47.98 72.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 179.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.58 76.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.316 -0.865 . . . . 0.0 108.841 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' OG ' ' A' ' 33' ' ' SER . 27.4 mt-30 -70.95 -41.66 70.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.467 -0.771 . . . . 45.490000000000002 109.75 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -71.31 -37.33 71.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 34.969999999999999 111.281 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.511 ' CG2' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.46 -58.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 110.525 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 ' H ' ' CG2' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -58.51 -22.75 56.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.623 -1.298 . . . . 17.280000000000001 109.945 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 5.7 m -64.92 -25.65 67.97 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -92.99 -0.82 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.81 . . . . 44.07 110.066 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.91 130.9 44.88 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.935 -1.103 . . . . 19.629999999999999 108.465 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.23 65.93 1.05 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.766 1.644 . . . . 21.539999999999999 110.592 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.6 mm -80.71 147.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.4 mttt -54.82 -166.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 29.41 110.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 1.7 mp0 -52.63 -131.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.834 0.826 . . . . 0.0 111.983 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.97 49.18 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.537 -1.025 . . . . 15.27 110.537 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -97.51 -30.44 12.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.307 -1.113 . . . . 8.7799999999999994 108.723 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.9 133.83 39.6 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.092 -0.707 . . . . 7.1299999999999999 109.092 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 22.1 tt0 -142.61 174.3 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 22.030000000000001 110.003 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.532 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 41.5 m-85 -136.98 110.68 8.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.438 -1.319 . . . . 16.329999999999998 107.438 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.11 104.77 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 6.5800000000000001 111.886 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.8 m-20 -81.44 102.53 10.58 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.512 -0.921 . . . . 15.32 108.512 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.5 pt -64.08 -2.13 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 10.92 111.54 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.25 -17.89 23.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.788 -1.195 . . . . 21.719999999999999 108.739 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 13.42 1.74 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.466 -0.771 . . . . 22.449999999999999 109.471 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.505 ' C ' HD21 ' A' ' 51' ' ' ASN . 14.5 t -142.81 -0.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 25.629999999999999 109.847 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.505 HD21 ' C ' ' A' ' 50' ' ' THR . 3.5 m-80 67.2 -171.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.21 31.37 18.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.833 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.519 ' H ' ' HG1' ' A' ' 53' ' ' THR . 0.6 OUTLIER -46.35 -53.71 10.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 18.870000000000001 109.806 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.2 m120 -54.94 -37.42 66.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 45.210000000000001 110.817 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.9 mp0 -62.1 -46.96 86.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.91 -1.119 . . . . 33.020000000000003 110.167 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.67 -54.75 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.784 -1.197 . . . . 9.8399999999999999 110.172 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -56.81 -41.11 77.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.523 -1.36 . . . . 17.84 107.705 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 6.0 m-20 -54.56 -33.93 60.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.959 -1.496 . . . . 18.84 106.959 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -79.67 -48.32 13.9 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.108 -0.637 . . . . 12.99 109.385 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.7 mt -52.69 -33.65 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.047 -1.033 . . . . 14.609999999999999 108.283 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.5 tp-100 -59.58 -54.85 41.78 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.321 0.581 . . . . 40.450000000000003 109.538 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.41 -42.27 83.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 41.810000000000002 110.347 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.7 tp -62.6 -47.23 84.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 21.77 110.562 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -108.94 -63.39 1.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.266 -0.896 . . . . 11.380000000000001 109.671 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.02 -38.97 1.02 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.399 -1.481 . . . . 14.789999999999999 109.399 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.32 140.29 32.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -1.151 . . . . 17.809999999999999 110.012 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 24.79 11.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.504 -0.924 . . . . 29.760000000000002 108.504 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.723 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.96 169.32 16.14 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.556 0.693 . . . . 18.260000000000002 110.909 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.9 133.36 21.27 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.291 -1.003 . . . . 8.1999999999999993 108.291 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 82' ' ' SER . 23.6 Cg_endo -86.74 -163.76 2.75 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 CA-C-O 122.617 1.007 . . . . 7.79 111.86 -1.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.723 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -145.04 95.72 2.73 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.489 -2.041 . . . . 26.050000000000001 105.489 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.4 t -85.54 156.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.366 -0.834 . . . . 8.6799999999999997 111.653 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.74 91.33 2.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.604 -0.685 . . . . 14.07 111.549 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 74' ' ' ILE . 3.4 mm -71.58 115.37 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.01 -2.218 . . . . 9.3399999999999999 105.01 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.45 -155.56 18.13 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 105.707 -2.957 . . . . 12.42 105.707 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.76 5.26 16.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.215 -1.756 . . . . 44.859999999999999 108.637 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 m-20 -89.52 115.04 26.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.387 -0.821 . . . . 0.0 110.793 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 t -77.41 141.92 39.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.306 -0.871 . . . . 0.0 109.678 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -109.64 -17.65 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.163 -0.961 . . . . 20.449999999999999 109.197 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.11 -160.19 21.3 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.071 -1.212 . . . . 13.82 110.071 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' CA ' HH21 ' A' ' 71' ' ' ARG . . . -89.26 -148.25 17.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.054 -1.218 . . . . 12.42 110.054 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 t -71.55 -60.37 2.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -1.005 . . . . 0.0 110.026 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 t -51.24 -25.38 5.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.192 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.38 -47.91 25.37 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.423 -0.798 . . . . 27.059999999999999 109.03 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -54.04 -59.41 4.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.457 -0.777 . . . . 15.31 110.015 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -51.38 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.371 -0.831 . . . . 0.0 110.309 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 9.0 m -46.82 -34.36 5.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.153 -0.967 . . . . 21.789999999999999 108.975 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.24 -38.94 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 111.734 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.417 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.5 OUTLIER -60.21 -59.19 5.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.08 -19.21 62.71 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.98 -1.075 . . . . 0.0 109.633 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.0 m -81.49 -45.5 15.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.062 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.77 -11.16 27.65 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.308 -1.117 . . . . 25.640000000000001 110.308 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -69.3 -25.5 64.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.279 . . . . 50.259999999999998 108.32 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.4 tp -59.91 -67.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.568 0.699 . . . . 24.170000000000002 110.848 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.452 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.32 -29.61 24.33 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -46.78 81.1 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.828 -1.175 . . . . 28.030000000000001 107.828 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -59.51 -34.12 72.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.897 -1.149 . . . . 40.960000000000001 107.897 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.4 mp -70.15 -40.48 74.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.612 -0.884 . . . . 15.050000000000001 108.612 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.32 -52.49 46.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.815 -0.553 . . . . 0.0 112.185 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -29.34 7.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.691 -1.255 . . . . 38.640000000000001 110.926 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.0 pt -102.7 -22.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.731 -1.231 . . . . 0.0 109.011 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.498 ' O ' ' CE ' ' A' ' 38' ' ' LYS . . . 90.0 47.54 3.86 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.387 -1.085 . . . . 18.539999999999999 110.387 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.15 -14.98 28.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.147 -1.208 . . . . 10.84 110.0 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -94.6 177.82 5.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.724 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -61.93 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.791 -1.193 . . . . 20.030000000000001 111.482 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.36 -39.34 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.268 -0.895 . . . . 12.91 110.57 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 70.0 m-20 -54.38 -37.3 64.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 28.329999999999998 108.979 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.0 m -74.71 -11.23 60.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.376 -0.827 . . . . 0.0 109.192 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.44 -51.24 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 22.870000000000001 109.688 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -78.91 133.82 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 25.190000000000001 109.621 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 9' ' ' ILE . 6.6 mp0 -144.53 152.32 52.84 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.028 -1.101 . . . . 34.609999999999999 108.028 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.88 129.05 32.89 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.246 1.298 . . . . 11.720000000000001 109.243 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.53 22.83 78.11 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.349 -1.5 . . . . 10.24 109.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.77 128.56 42.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -1.064 . . . . 25.359999999999999 108.973 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -100.37 129.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.461 -0.774 . . . . 10.890000000000001 109.272 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.05 142.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.34 -0.985 . . . . 15.82 108.34 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.12 123.72 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 8.9399999999999995 111.055 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.05 117.35 29.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.403 ' CD1' HE21 ' A' ' 29' ' ' GLN . 16.5 pt -130.06 -172.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.578 1.18 . . . . 10.619999999999999 111.518 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' THR . 26.2 mtmt -150.2 85.58 5.42 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 105.841 -1.911 . . . . 38.729999999999997 105.841 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 21' ' ' THR . 18.4 Cg_exo -45.83 81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.483 1.456 . . . . 24.579999999999998 110.766 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' LYS . 32.6 m -173.67 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.169 -1.048 . . . . 34.82 108.169 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 127.08 36.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.799 . . . . 21.460000000000001 108.841 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.68 -22.69 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.192 1.928 . . . . 13.859999999999999 113.075 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -68.72 -42.35 77.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.284 -1.51 . . . . 0.0 108.96 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -37.2 79.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 26' ' ' ARG . 8.0 mmm-85 -62.21 -41.75 98.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.192 -0.67 . . . . 59.590000000000003 109.192 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -54.02 -49.5 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.12 -0.987 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.2 75.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.155 -0.966 . . . . 0.0 108.909 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.52 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 3.8 mm-40 -71.14 -42.28 69.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.361 -0.837 . . . . 45.490000000000002 109.723 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 33' ' ' SER . 48.4 mt-10 -70.89 -35.83 72.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.548 -0.72 . . . . 34.969999999999999 111.142 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.0 -56.45 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.927 -1.108 . . . . 0.0 110.798 -178.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -58.67 -23.91 60.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.457 -1.402 . . . . 17.280000000000001 109.891 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 2.5 p -63.28 -19.35 64.5 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.977 -1.077 . . . . 24.109999999999999 108.321 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -92.99 -4.38 52.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.539 -0.725 . . . . 44.07 110.071 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.5 mt -88.74 129.78 47.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.014 -1.054 . . . . 19.629999999999999 108.979 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.11 68.43 1.89 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.563 1.508 . . . . 21.539999999999999 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 37' ' ' ILE . 3.6 mm -80.44 142.42 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -57.3 156.25 7.85 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.231 -0.918 . . . . 29.41 110.076 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -58.31 141.56 50.71 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.478 0.656 . . . . 0.0 111.664 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.26 47.16 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.524 -0.735 . . . . 15.27 112.04 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.08 -35.1 9.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.75 -1.441 . . . . 8.7799999999999994 110.072 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 tp -93.54 134.91 35.32 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.485 -0.76 . . . . 7.1299999999999999 109.719 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -144.37 175.05 10.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 22.030000000000001 109.708 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.52 ' CD1' ' OE1' ' A' ' 29' ' ' GLN . 39.7 m-85 -137.63 109.06 6.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.078 -1.452 . . . . 16.329999999999998 107.078 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.26 106.43 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 6.5800000000000001 111.682 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -83.79 98.31 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.69 . . . . 15.32 109.3 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.93 -9.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 10.92 110.811 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -96.07 40.65 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.824 -1.176 . . . . 21.719999999999999 107.824 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.47 10.32 0.43 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.47 -0.892 . . . . 22.449999999999999 110.657 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 t -127.86 -3.38 5.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.329 -2.1 . . . . 25.629999999999999 105.329 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 71.88 -175.24 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.676 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER 54.64 18.44 2.05 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 52' ' ' HIS . 1.8 m -29.96 -56.58 0.18 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.443 -0.799 . . . . 18.870000000000001 110.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -59.26 -33.01 70.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.412 -0.805 . . . . 45.210000000000001 111.859 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' HIS . 61.5 mm-40 -60.61 -46.84 88.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.708 -1.245 . . . . 33.020000000000003 109.124 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.29 -55.42 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 9.8399999999999999 109.66 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.67 -41.14 80.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 17.84 108.474 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.1 -35.61 59.81 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.84 -1.171 . . . . 18.84 107.84 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -80.0 -44.01 20.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.87 -0.789 . . . . 12.99 108.87 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.44 -37.02 46.54 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.517 -1.29 . . . . 14.609999999999999 107.517 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -61.23 -55.98 25.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.808 -0.812 . . . . 40.450000000000003 108.808 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.99 -37.22 83.82 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.4 -0.813 . . . . 41.810000000000002 110.127 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.94 -52.14 52.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 21.77 109.881 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.679 ' HG1' ' H ' ' A' ' 65' ' ' GLY . 1.4 p -109.72 -65.39 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.599 -0.688 . . . . 11.380000000000001 109.852 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.679 ' H ' ' HG1' ' A' ' 64' ' ' THR . . . 155.46 -42.18 0.58 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.703 -1.237 . . . . 14.789999999999999 110.042 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.94 139.4 33.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -1.173 . . . . 17.809999999999999 110.363 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.01 31.3 6.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.392 -0.966 . . . . 29.760000000000002 108.392 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.34 173.05 10.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.676 0.751 . . . . 18.260000000000002 111.295 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.11 129.14 24.83 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 107.669 -1.234 . . . . 8.1999999999999993 107.669 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -82.59 -166.13 4.74 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 CA-C-O 122.504 0.96 . . . . 7.79 112.02 -0.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -145.73 90.42 1.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 105.42 -2.067 . . . . 26.050000000000001 105.42 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.3 t -83.93 157.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 8.6799999999999997 112.355 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -145.14 89.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 14.07 111.111 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 74' ' ' ILE . 3.6 mm -71.13 116.41 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.006 -2.22 . . . . 9.3399999999999999 105.006 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.26 -158.88 16.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 105.867 -2.893 . . . . 12.42 105.867 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -80.96 2.98 24.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.197 -1.766 . . . . 44.859999999999999 108.787 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' CG ' HH21 ' A' ' 97' ' ' ARG . 17.2 m-20 -88.76 114.77 25.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.365 -0.835 . . . . 0.0 110.219 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -75.53 142.15 42.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 110.079 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -108.76 -20.64 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.174 -0.954 . . . . 20.449999999999999 108.822 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.07 -162.22 21.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.04 -1.224 . . . . 13.82 110.04 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.78 -148.27 12.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.137 -1.185 . . . . 12.42 110.137 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -70.53 -60.44 2.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.993 . . . . 0.0 110.04 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.8 t -50.61 -24.18 3.1 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.448 -0.783 . . . . 0.0 109.282 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.65 -49.13 16.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.424 -0.798 . . . . 27.059999999999999 109.283 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.468 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.4 tt -52.54 -59.88 3.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 15.31 110.043 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.78 -53.13 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.254 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.7 t -44.91 -36.0 3.11 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.119 -0.988 . . . . 21.789999999999999 109.246 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -81.66 -41.2 21.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.507 -0.746 . . . . 0.0 111.855 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -57.65 -57.68 11.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.81 -1.181 . . . . 0.0 110.63 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.602 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.91 -26.1 67.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.998 -1.064 . . . . 0.0 109.671 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.0 m -80.15 -24.26 40.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.01 -7.52 82.0 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.616 -0.994 . . . . 25.640000000000001 110.616 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.06 -26.15 63.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.934 -1.333 . . . . 50.259999999999998 108.392 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.13 -64.52 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.766 -0.583 . . . . 24.170000000000002 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 -29.61 40.85 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.21 -48.05 74.73 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.777 -1.194 . . . . 28.030000000000001 107.777 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.443 HH21 ' CG ' ' A' ' 77' ' ' ASP . 10.4 tpt180 -57.21 -32.71 66.78 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.681 -1.229 . . . . 40.960000000000001 107.681 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 98' ' ' LEU . 9.0 mp -72.43 -40.7 66.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.57 -0.9 . . . . 15.050000000000001 108.57 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.43 -53.41 48.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.661 -0.649 . . . . 0.0 111.647 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -33.57 15.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.747 -1.22 . . . . 38.640000000000001 110.714 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 pt -99.57 -17.43 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.672 -1.267 . . . . 0.0 109.006 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.5 42.57 8.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.216 -1.154 . . . . 18.539999999999999 110.216 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.7 -12.92 52.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 10.84 109.525 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.585 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.7 174.75 6.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.449 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.662 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.14 -71.28 0.18 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.344 -0.847 . . . . 20.030000000000001 110.666 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.64 -40.92 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 12.91 110.559 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 11.7 m120 -54.78 -35.99 64.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.223 -0.923 . . . . 28.329999999999998 109.509 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.8 m -75.1 -12.83 60.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.156 -0.965 . . . . 0.0 109.437 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -96.78 -49.81 4.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 22.870000000000001 110.549 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 126.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 25.190000000000001 109.819 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 157.07 43.46 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.358 -0.979 . . . . 34.609999999999999 108.358 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.68 130.34 39.91 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.748 1.632 . . . . 11.720000000000001 111.299 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.93 24.38 60.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.952 -0.859 . . . . 10.24 110.952 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -143.28 135.36 26.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.326 . . . . 25.359999999999999 109.952 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.8 137.37 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.36 -0.837 . . . . 10.890000000000001 109.257 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.59 143.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 15.82 108.732 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.17 121.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.399 -0.813 . . . . 8.9399999999999995 110.535 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -89.97 123.31 33.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.504 -1.295 . . . . 9.9299999999999997 107.504 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.71 -172.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.447 1.117 . . . . 10.619999999999999 111.723 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.2 mtmt -144.02 96.67 5.42 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.236 -1.764 . . . . 38.729999999999997 106.236 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 11.2 Cg_exo -51.28 75.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.601 1.534 . . . . 24.579999999999998 110.586 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.9 m -170.68 -32.74 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.739 -0.837 . . . . 34.82 108.739 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.33 127.14 39.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 21.460000000000001 109.767 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.37 -12.09 19.0 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.213 1.942 . . . . 13.859999999999999 112.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -72.25 -45.04 61.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.614 -1.304 . . . . 0.0 109.552 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -36.52 84.2 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.46 -33.29 69.59 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.671 -1.603 . . . . 59.590000000000003 106.671 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.13 -59.66 5.11 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.722 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.53 64.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.371 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.502 ' CD ' ' CD1' ' A' ' 44' ' ' PHE . 6.5 mm-40 -68.66 -32.91 73.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.224 -0.923 . . . . 45.490000000000002 108.841 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -71.63 -40.62 69.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 34.969999999999999 111.02 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 HG21 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -77.67 -59.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.896 -1.127 . . . . 0.0 111.017 -178.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.507 ' H ' HG21 ' A' ' 31' ' ' ILE . 4.9 mt -57.21 -22.66 42.45 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.806 -1.184 . . . . 17.280000000000001 110.215 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.0 m -66.56 -33.41 75.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.027 -1.045 . . . . 24.109999999999999 109.11 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.75 9.37 39.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 44.07 111.03 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 37' ' ' ILE . 14.4 mt -90.09 134.72 31.09 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.537 -1.352 . . . . 19.629999999999999 108.969 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.46 64.18 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 121.814 1.676 . . . . 21.539999999999999 110.231 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 mm -84.74 144.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.37 -0.831 . . . . 0.0 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -55.84 153.34 8.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.119 -0.988 . . . . 29.41 109.914 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -56.14 138.1 50.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 111.482 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.05 14.14 51.72 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.534 -0.729 . . . . 15.27 111.831 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.88 -21.74 14.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.825 -1.397 . . . . 8.7799999999999994 109.828 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -102.78 127.82 49.77 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 7.1299999999999999 109.387 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 44' ' ' PHE . 17.1 tp10 -142.77 164.69 29.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 22.030000000000001 109.85 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.502 ' CD1' ' CD ' ' A' ' 29' ' ' GLN . 14.1 m-85 -126.19 114.4 18.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.342 -1.355 . . . . 16.329999999999998 107.342 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -95.59 102.6 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 6.5800000000000001 111.553 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.24 102.98 9.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.695 -1.224 . . . . 15.32 107.695 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 pt -61.74 -1.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 10.92 111.434 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -93.11 -13.55 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.714 -1.241 . . . . 21.719999999999999 109.147 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 7.16 5.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 22.449999999999999 109.578 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 t -143.94 -0.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.157 -0.964 . . . . 25.629999999999999 109.936 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t30 68.51 -159.09 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 108.592 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.38 16.88 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.113 . . . . 0.0 108.537 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -41.8 -59.03 1.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.46 -0.775 . . . . 18.870000000000001 110.483 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.3 m-20 -53.48 -36.52 61.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 45.210000000000001 110.765 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.23 -45.37 84.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.976 -1.078 . . . . 33.020000000000003 110.213 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.51 -56.1 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.889 -1.132 . . . . 9.8399999999999999 109.771 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -55.85 -43.2 76.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.696 -1.224 . . . . 17.84 107.696 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 2.5 m-20 -55.93 -34.69 65.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.032 -1.469 . . . . 18.84 107.032 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -77.09 -46.1 24.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.823 -0.806 . . . . 12.99 108.823 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.1 mt -53.6 -36.26 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.762 -1.199 . . . . 14.609999999999999 107.762 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 21.1 tp60 -61.12 -57.07 14.05 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.957 -0.757 . . . . 40.450000000000003 108.957 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -65.9 -34.52 78.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.223 -0.923 . . . . 41.810000000000002 110.09 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.17 -52.75 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 21.77 109.89 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -109.88 -61.88 1.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.588 -0.695 . . . . 11.380000000000001 109.606 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 151.73 -37.85 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.682 -1.367 . . . . 14.789999999999999 109.682 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.62 130.57 47.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.243 -1.151 . . . . 17.809999999999999 110.622 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 37.15 1.54 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.174 -1.047 . . . . 29.760000000000002 108.174 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.77 168.91 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.052 0.93 . . . . 18.260000000000002 111.688 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.79 129.23 25.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.106 -1.442 . . . . 8.1999999999999993 107.106 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.94 -166.88 5.35 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 CA-C-O 122.425 0.927 . . . . 7.79 111.78 1.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.71 89.75 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.553 -2.017 . . . . 26.050000000000001 105.553 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.5 t -85.01 155.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.8 0.81 . . . . 8.6799999999999997 111.934 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -145.42 90.79 2.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 14.07 110.566 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.2 mp -72.01 112.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.731 -1.951 . . . . 9.3399999999999999 105.731 177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.85 -152.7 45.67 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.497 -2.641 . . . . 12.42 106.497 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -83.42 -0.67 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.534 -1.568 . . . . 44.859999999999999 109.09 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' HE ' ' A' ' 97' ' ' ARG . 7.4 m-20 -89.05 115.8 26.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.747 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 t -73.76 150.92 40.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.26 -26.82 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.194 -0.941 . . . . 20.449999999999999 109.592 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.91 -145.67 17.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.879 -1.288 . . . . 13.82 109.879 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.3 -144.18 10.93 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.998 -1.241 . . . . 12.42 109.998 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -71.03 -62.17 1.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.437 -1.037 . . . . 0.0 110.023 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -53.49 -25.53 16.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.446 -0.783 . . . . 0.0 109.572 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.38 -46.84 37.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.281 -0.887 . . . . 27.059999999999999 109.115 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.8 tt -54.55 -59.7 4.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.577 -0.702 . . . . 15.31 109.912 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -50.97 -48.72 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.796 . . . . 0.0 110.492 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 4.6 t -50.05 -43.44 51.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.833 -1.167 . . . . 21.789999999999999 109.292 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.2 -35.58 63.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.381 -0.824 . . . . 0.0 111.428 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -59.84 -61.47 2.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.87 -1.144 . . . . 0.0 110.274 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.581 ' NE2' ' HG ' ' A' ' 91' ' ' SER . 2.2 pp0? -62.07 -20.15 63.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 110.102 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.581 ' HG ' ' NE2' ' A' ' 90' ' ' GLN . 70.4 m -82.43 -22.77 35.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 109.668 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.92 66.33 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.437 -1.065 . . . . 25.640000000000001 110.437 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -68.49 -27.81 66.46 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.986 -1.303 . . . . 50.259999999999998 108.704 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.55 -64.64 0.87 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 24.170000000000002 110.311 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.83 -29.95 43.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.426 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.48 -47.06 83.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 28.030000000000001 108.357 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.649 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.46 -37.46 78.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.971 -1.122 . . . . 40.960000000000001 107.971 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.07 -34.47 68.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.518 -0.919 . . . . 15.050000000000001 108.518 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -64.92 -57.6 8.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.784 -0.572 . . . . 0.0 111.737 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.66 -34.17 7.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.907 -1.121 . . . . 38.640000000000001 110.665 -178.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.5 pt -100.29 -11.66 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.816 -1.178 . . . . 0.0 109.331 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.94 41.56 22.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.229 -1.148 . . . . 18.539999999999999 110.229 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.04 54.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -1.197 . . . . 10.84 109.243 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 pp -97.59 -174.22 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 109.558 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.445 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.8 pt-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.257 0.551 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.19 -74.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 20.030000000000001 110.617 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -73.26 -38.42 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 12.91 110.186 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 94.3 m-20 -55.98 -35.26 66.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.001 -1.062 . . . . 28.329999999999998 109.496 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 66.4 m -74.85 -13.07 60.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -97.4 -41.33 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 22.870000000000001 110.654 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.24 140.56 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.849 -1.157 . . . . 25.190000000000001 110.249 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -150.05 136.86 11.08 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.076 -1.083 . . . . 34.609999999999999 108.076 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.78 133.33 50.3 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 120.999 1.133 . . . . 11.720000000000001 109.739 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.66 18.44 73.18 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.081 -1.608 . . . . 10.24 109.081 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -137.88 135.31 36.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -1.078 . . . . 25.359999999999999 109.489 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.53 134.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.293 -0.879 . . . . 10.890000000000001 109.744 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.87 140.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.335 -0.987 . . . . 15.82 108.335 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.66 127.87 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.217 -0.927 . . . . 8.9399999999999995 111.177 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.49 121.35 34.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.064 -1.087 . . . . 9.9299999999999997 108.064 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.3 pt -131.34 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.331 1.062 . . . . 10.619999999999999 111.337 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 21' ' ' THR . 4.4 mtmp? -146.31 91.19 5.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -46.37 83.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.616 1.544 . . . . 24.579999999999998 110.484 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.4 m -177.78 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 34.82 108.395 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.85 125.74 41.1 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 21.460000000000001 109.765 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.24 -19.12 40.68 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.321 2.014 . . . . 13.859999999999999 112.605 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -69.9 -42.91 72.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.611 -1.306 . . . . 0.0 109.627 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.509 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -65.86 -34.29 77.8 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.654 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.07 -42.62 99.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.79 -0.819 . . . . 59.590000000000003 108.79 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.565 HH11 ' HG2' ' A' ' 27' ' ' ARG . 6.5 mtt-85 -53.57 -45.07 69.81 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.231 -0.918 . . . . 0.0 108.656 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -36.49 78.93 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 108.849 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 7.5 mt-30 -70.62 -44.02 68.08 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.694 0.759 . . . . 45.490000000000002 109.333 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -70.97 -36.47 72.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.652 -0.655 . . . . 34.969999999999999 111.177 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -75.52 -56.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.88 -1.138 . . . . 0.0 110.211 -178.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.537 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.9 mt -59.43 -21.3 59.79 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.757 -1.215 . . . . 17.280000000000001 109.254 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.654 -0.869 . . . . 24.109999999999999 108.654 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -92.82 -0.01 57.33 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.48 -0.762 . . . . 44.07 110.127 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.77 128.71 53.31 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.766 -1.209 . . . . 19.629999999999999 108.832 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.9 69.22 0.85 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.648 1.566 . . . . 21.539999999999999 109.417 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.4 mm -80.43 153.42 4.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.579 -0.701 . . . . 0.0 109.21 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -54.88 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.522 -0.736 . . . . 29.41 110.034 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.559 ' O ' ' O ' ' A' ' 38' ' ' LYS . 11.8 mt-30 -53.33 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.726 0.774 . . . . 0.0 111.036 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.85 54.67 0.75 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.079 -1.208 . . . . 15.27 110.079 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.13 -27.02 14.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.576 -0.955 . . . . 8.7799999999999994 109.3 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -97.09 131.73 43.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.762 -0.829 . . . . 7.1299999999999999 108.762 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 19.3 tt0 -141.23 173.07 11.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.85 . . . . 22.030000000000001 109.929 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 43.9 m-85 -135.35 111.75 9.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.349 -1.352 . . . . 16.329999999999998 107.349 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.74 104.9 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.872 . . . . 6.5800000000000001 111.971 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.8 m-20 -82.25 101.79 10.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.614 -0.884 . . . . 15.32 108.614 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 pt -61.97 -1.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 10.92 111.256 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' THR . 14.2 t -93.5 -17.06 23.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 21.719999999999999 109.303 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.0 12.82 1.23 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 22.449999999999999 109.52 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 7.3 t -140.81 -17.08 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 25.629999999999999 109.674 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 50' ' ' THR . 6.3 t-20 81.14 -175.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.451 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 58.49 24.18 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 108.873 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 52' ' ' HIS . 3.6 p -43.32 -51.93 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.805 . . . . 18.870000000000001 110.292 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -53.81 -35.4 61.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 45.210000000000001 110.144 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.03 -44.89 87.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.057 -1.027 . . . . 33.020000000000003 109.753 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.44 -53.9 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.019 . . . . 9.8399999999999999 109.647 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.53 -42.12 82.27 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.701 -1.222 . . . . 17.84 107.701 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.35 -33.67 63.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.067 -1.456 . . . . 18.84 107.067 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -77.35 -45.26 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.787 -0.82 . . . . 12.99 108.787 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 ' O ' ' OG1' ' A' ' 64' ' ' THR . 89.9 mt -55.49 -38.11 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.962 -1.125 . . . . 14.609999999999999 107.962 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 4.2 tp-100 -59.09 -49.29 78.43 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.522 0.677 . . . . 40.450000000000003 109.44 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -66.37 -54.22 27.05 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 41.810000000000002 110.65 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.81 -36.0 81.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 21.77 111.442 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 12.9 p -105.59 -68.38 0.87 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.021 -1.049 . . . . 11.380000000000001 109.812 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 144.26 -41.25 1.12 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.7 -1.76 . . . . 14.789999999999999 108.7 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.58 142.45 29.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.553 -0.969 . . . . 17.809999999999999 109.855 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.86 26.93 10.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 29.760000000000002 107.992 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.49 168.07 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.946 0.879 . . . . 18.260000000000002 111.238 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.22 132.39 22.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.309 -1.367 . . . . 8.1999999999999993 107.309 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -83.06 -167.52 5.64 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.616 1.007 . . . . 7.79 112.114 -0.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 91.77 2.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.716 -2.327 . . . . 26.050000000000001 104.716 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 73' ' ' PHE . 80.8 t -83.69 158.54 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.72 0.771 . . . . 8.6799999999999997 112.175 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.406 ' N ' ' CG1' ' A' ' 72' ' ' VAL . 65.6 m-85 -146.32 84.36 1.63 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.557 . . . . 14.07 111.55 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -70.7 114.43 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.885 -2.265 . . . . 9.3399999999999999 104.885 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -158.09 30.69 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 105.658 -2.977 . . . . 12.42 105.658 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -81.35 0.98 34.79 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.426 -1.632 . . . . 44.859999999999999 109.403 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -87.42 115.09 24.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 110.516 -179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -73.1 136.47 44.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' ILE . 2.8 pp -105.59 -7.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.159 -0.963 . . . . 20.449999999999999 109.281 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.34 -154.88 16.67 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.225 -1.15 . . . . 13.82 110.225 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 -141.52 12.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.34 -1.104 . . . . 12.42 110.34 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 p -71.42 -66.42 0.63 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.594 -0.944 . . . . 0.0 110.333 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 t -49.01 -29.39 4.83 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 109.358 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.56 -47.26 33.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.283 -0.886 . . . . 27.059999999999999 109.139 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 1.3 tt -54.58 -58.5 7.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 15.31 109.664 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -54.71 -49.0 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.383 -0.823 . . . . 0.0 110.526 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.535 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 6.5 m -45.29 -37.58 4.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.932 -1.105 . . . . 21.789999999999999 109.09 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.26 -38.77 34.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.453 -0.78 . . . . 0.0 111.84 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -59.95 -60.48 3.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.831 -1.168 . . . . 0.0 111.017 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 87' ' ' SER . 1.6 pp0? -58.65 -24.02 60.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 m -80.74 -57.0 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.69 -8.49 6.89 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.702 -1.359 . . . . 25.640000000000001 109.702 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -69.29 -26.42 64.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.313 -1.11 . . . . 50.259999999999998 108.566 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp -60.09 -65.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 24.170000000000002 110.599 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.61 -28.44 32.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.35 -47.85 77.79 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.442 -0.947 . . . . 28.030000000000001 108.442 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -58.18 -34.03 69.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.97 -1.122 . . . . 40.960000000000001 107.97 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -72.42 -40.82 66.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 15.050000000000001 109.292 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.97 -52.14 57.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.0 111.808 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -51.19 -33.14 26.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.819 -1.176 . . . . 38.640000000000001 111.114 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.1 pt -100.72 -14.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.0 43.49 7.56 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.354 -1.099 . . . . 18.539999999999999 110.354 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.25 -16.55 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.242 . . . . 10.84 109.839 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.4 179.11 5.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 109.771 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.685 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.78 -71.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.506 -0.746 . . . . 20.030000000000001 110.613 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -72.63 -37.97 57.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 12.91 110.108 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 69.4 m-20 -55.39 -38.42 68.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.184 -0.947 . . . . 28.329999999999998 109.521 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -74.14 -11.9 60.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.508 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 42.6 mttm -97.55 -45.03 6.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 22.870000000000001 110.47 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.63 139.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 25.190000000000001 109.56 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -149.81 136.17 10.61 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.213 -1.032 . . . . 34.609999999999999 108.213 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.45 124.75 15.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 120.752 0.968 . . . . 11.720000000000001 109.628 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.62 55.18 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.368 -1.493 . . . . 10.24 109.368 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 8' ' ' LYS . 25.0 ttpt -137.29 135.67 37.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.335 -1.097 . . . . 25.359999999999999 109.409 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.96 132.9 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.829 . . . . 10.890000000000001 109.403 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.48 139.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 15.82 108.805 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.76 126.94 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 8.9399999999999995 110.794 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.08 120.01 33.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.604 -1.258 . . . . 9.9299999999999997 107.604 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 -174.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 122.615 1.198 . . . . 10.619999999999999 112.232 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mttm -141.54 95.09 7.29 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 105.558 -2.015 . . . . 38.729999999999997 105.558 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.523 ' O ' ' OG1' ' A' ' 21' ' ' THR . 14.0 Cg_exo -49.9 76.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.37 1.38 . . . . 24.579999999999998 110.834 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.656 ' N ' ' O ' ' A' ' 19' ' ' LYS . 87.8 m -172.0 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.228 -0.656 . . . . 34.82 109.228 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.79 124.64 47.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 21.460000000000001 110.266 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.12 -20.05 29.34 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.193 1.928 . . . . 13.859999999999999 112.872 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -66.9 -47.47 71.71 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.481 -1.387 . . . . 0.0 108.784 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -63.02 -36.22 82.85 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -60.59 -40.78 93.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.163 -1.051 . . . . 59.590000000000003 108.163 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -47.79 77.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.21 75.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.297 -0.877 . . . . 0.0 108.915 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.467 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 9.6 mt-30 -69.89 -40.98 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.59 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 68.8 mm-40 -69.33 -39.85 77.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.597 -0.689 . . . . 34.969999999999999 111.364 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.07 -55.93 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.882 -1.136 . . . . 0.0 110.947 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.447 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -56.75 -26.3 56.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.738 -1.226 . . . . 17.280000000000001 109.536 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.498 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.7 t -64.41 -26.94 68.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.16 -0.963 . . . . 24.109999999999999 109.02 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.553 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -92.03 0.31 57.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 44.07 110.288 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.65 133.54 37.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.763 -1.21 . . . . 19.629999999999999 108.319 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.24 62.99 0.7 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.578 1.519 . . . . 21.539999999999999 109.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 37' ' ' ILE . 3.0 mm -79.92 141.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -55.78 152.78 9.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.275 -0.891 . . . . 29.41 109.977 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 24.8 mp0 -57.08 141.15 46.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.436 0.636 . . . . 0.0 111.431 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.0 9.18 39.24 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.484 -0.76 . . . . 15.27 111.902 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -30.42 12.17 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.823 -1.399 . . . . 8.7799999999999994 109.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.58 131.76 42.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.518 -0.739 . . . . 7.1299999999999999 109.543 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -141.85 171.43 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 22.030000000000001 109.444 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CG ' ' OE1' ' A' ' 29' ' ' GLN . 39.3 m-85 -133.23 110.02 9.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.145 -1.428 . . . . 16.329999999999998 107.145 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.98 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.476 -0.765 . . . . 6.5800000000000001 111.434 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 48' ' ' THR . 3.8 m-20 -81.81 100.69 9.71 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.445 -0.946 . . . . 15.32 108.445 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.41 1.92 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 10.92 110.734 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 46' ' ' ASP . 17.5 p -95.83 -23.17 17.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 21.719999999999999 109.04 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.13 9.62 2.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 22.449999999999999 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 14.2 t -137.05 -7.69 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.841 . . . . 25.629999999999999 109.404 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.574 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 69.6 -163.81 0.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.497 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.3 OUTLIER 54.63 21.47 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.994 -1.066 . . . . 0.0 108.545 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -40.29 -59.91 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 18.870000000000001 110.739 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 7.9 m120 -54.18 -35.06 61.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 45.210000000000001 111.034 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.99 -46.36 88.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 33.020000000000003 109.963 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.01 -53.18 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.979 -1.076 . . . . 9.8399999999999999 109.518 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -56.53 -44.44 80.82 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.566 -1.272 . . . . 17.84 107.566 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 24.9 m-20 -53.61 -33.03 53.57 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.977 -1.49 . . . . 18.84 106.977 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -78.64 -48.56 14.83 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.94 -0.763 . . . . 12.99 108.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.7 mt -52.02 -36.4 50.02 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.524 -1.287 . . . . 14.609999999999999 107.524 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.9 tp60 -61.96 -55.31 30.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.794 -0.817 . . . . 40.450000000000003 108.794 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -39.19 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 41.810000000000002 109.678 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.2 tp -64.09 -45.62 87.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 21.77 109.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.636 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -117.64 -71.71 0.72 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.633 -0.667 . . . . 11.380000000000001 109.569 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.636 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 158.47 -34.26 0.5 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.317 -1.513 . . . . 14.789999999999999 109.317 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB1' HH21 ' A' ' 71' ' ' ARG . . . -95.93 137.13 35.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 17.809999999999999 110.019 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.88 30.19 7.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.066 -1.087 . . . . 29.760000000000002 108.066 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.33 171.04 11.51 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.926 0.869 . . . . 18.260000000000002 111.501 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -115.26 132.12 23.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.494 -1.299 . . . . 8.1999999999999993 107.494 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.741 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 28.5 Cg_endo -81.04 -164.84 4.09 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 CA-C-O 122.032 0.763 . . . . 7.79 110.925 0.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.741 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -150.81 93.25 1.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.376 -2.083 . . . . 26.050000000000001 105.376 177.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.61 156.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.827 0.822 . . . . 8.6799999999999997 112.352 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.37 92.92 2.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.875 -0.516 . . . . 14.07 110.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.4 mm -72.43 113.74 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.832 -1.914 . . . . 9.3399999999999999 105.832 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.58 -145.62 42.26 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 106.622 -2.591 . . . . 12.42 106.622 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -87.56 -3.48 58.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.677 -1.484 . . . . 44.859999999999999 109.5 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.36 116.47 25.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.221 -0.924 . . . . 0.0 110.619 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -75.77 143.97 41.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.778 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -113.43 -18.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.189 -0.944 . . . . 20.449999999999999 109.335 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.43 -159.2 19.96 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.109 -1.196 . . . . 13.82 110.109 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' CA ' ' NH1' ' A' ' 71' ' ' ARG . . . -92.51 -143.7 12.98 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.391 -1.064 . . . . 12.42 110.655 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -71.33 -62.63 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -1.015 . . . . 0.0 110.383 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 t -51.0 -24.99 4.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.359 -0.838 . . . . 0.0 109.189 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -76.05 -45.52 33.81 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 27.059999999999999 109.219 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 3.0 tt -55.0 -58.41 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 15.31 109.829 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -52.06 -52.3 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 111.003 -178.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' VAL . 5.0 t -44.84 -38.99 4.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.059 -1.025 . . . . 21.789999999999999 109.251 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.84 -41.5 23.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.545 -0.722 . . . . 0.0 111.631 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -55.83 29.53 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.868 -1.145 . . . . 0.0 110.398 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -25.49 67.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.944 -1.098 . . . . 0.0 109.452 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.9 m -77.98 -62.22 1.74 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.419 -0.8 . . . . 0.0 109.024 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -9.25 5.53 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.09 -1.204 . . . . 25.640000000000001 110.09 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.22 -24.36 64.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.117 -1.225 . . . . 50.259999999999998 108.177 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.61 -67.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.638 -0.664 . . . . 24.170000000000002 110.47 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -51.58 -28.99 15.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.429 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.22 -49.18 70.69 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.074 -1.084 . . . . 28.030000000000001 108.074 178.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.489 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.68 -34.65 67.59 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.926 -1.139 . . . . 40.960000000000001 107.926 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD11 ' N ' ' A' ' 98' ' ' LEU . 8.3 mp -72.89 -38.52 66.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.479 -0.934 . . . . 15.050000000000001 108.479 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -64.49 -53.64 44.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.576 . . . . 0.0 111.555 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.87 23.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 38.640000000000001 110.76 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.58 -15.3 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.69 -1.256 . . . . 0.0 109.007 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.66 44.39 8.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.588 -1.005 . . . . 18.539999999999999 110.588 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.45 55.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -1.219 . . . . 10.84 109.87 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.553 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -95.79 -177.55 4.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.783 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.5 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.205 0.526 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.26 -73.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 20.030000000000001 110.572 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -72.94 -37.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 12.91 109.884 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 18.0 m120 -55.73 -38.34 69.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.184 -0.948 . . . . 28.329999999999998 109.301 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 m -74.18 -10.03 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -95.96 -53.5 3.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 22.870000000000001 109.627 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.57 128.11 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.844 . . . . 25.190000000000001 110.067 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.36 155.67 39.45 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.072 -1.084 . . . . 34.609999999999999 108.072 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.56 130.06 38.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.895 1.73 . . . . 11.720000000000001 111.537 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.89 64.4 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.874 -0.89 . . . . 10.24 110.874 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -142.47 133.33 25.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.351 . . . . 25.359999999999999 109.928 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.23 136.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.890000000000001 109.037 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.79 144.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 15.82 108.55 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.66 126.88 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 8.9399999999999995 110.77 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -92.68 123.91 36.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 9.9299999999999997 107.571 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.92 -176.43 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.383 1.087 . . . . 10.619999999999999 111.342 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 21' ' ' THR . 14.6 mtmm -143.32 92.73 6.61 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.385 -1.709 . . . . 38.729999999999997 106.385 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' C ' ' OG1' ' A' ' 21' ' ' THR . 12.2 Cg_exo -47.79 82.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.629 1.553 . . . . 24.579999999999998 110.442 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 179.1 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.025 -0.731 . . . . 34.82 109.025 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 130.63 28.4 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 21.460000000000001 110.266 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -59.69 -20.33 57.77 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.393 2.062 . . . . 13.859999999999999 112.654 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -70.37 -43.96 69.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.533 -1.355 . . . . 0.0 109.622 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -32.37 74.01 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.557 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.3 mmm-85 -64.04 -43.71 94.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.643 -0.873 . . . . 59.590000000000003 108.643 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.565 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 2.1 mtt-85 -51.75 -45.46 63.69 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.0 83.55 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -70.21 -42.15 72.71 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.43 -0.794 . . . . 45.490000000000002 109.296 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.74 -38.36 76.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.683 . . . . 34.969999999999999 111.078 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.81 -58.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.8 mt -57.71 -21.46 40.84 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.512 -1.367 . . . . 17.280000000000001 109.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -65.94 -24.96 66.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.052 -1.03 . . . . 24.109999999999999 108.769 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -91.32 1.38 57.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 44.07 110.191 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.48 126.78 55.19 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.903 -1.123 . . . . 19.629999999999999 109.163 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.55 67.64 0.76 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.773 1.648 . . . . 21.539999999999999 109.66 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.16 150.66 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.406 -0.809 . . . . 0.0 108.907 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 39' ' ' GLN . 30.0 mttm -53.47 -169.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.85 . . . . 29.41 110.309 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 38' ' ' LYS . 56.6 mm-40 -51.52 -127.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.529 0.681 . . . . 0.0 111.344 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.37 53.18 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.421 -1.072 . . . . 15.27 110.421 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -23.33 14.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -1.045 . . . . 8.7799999999999994 108.942 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -102.73 131.89 49.25 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.565 -0.902 . . . . 7.1299999999999999 108.565 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.522 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 25.9 tt0 -141.5 173.9 11.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.305 -0.872 . . . . 22.030000000000001 110.04 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 38.5 m-85 -135.22 109.84 8.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.57 -1.27 . . . . 16.329999999999998 107.57 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.58 103.49 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.096 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.98 101.5 9.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.219 -0.925 . . . . 15.32 108.731 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.3 -2.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.089 -1.007 . . . . 10.92 110.237 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 50' ' ' THR . 10.5 p -96.28 -29.79 13.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 21.719999999999999 109.346 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.55 18.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 22.449999999999999 109.273 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.519 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 10.7 t -140.5 -13.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -0.88 . . . . 25.629999999999999 109.91 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' CG ' ' N ' ' A' ' 52' ' ' HIS . 0.5 OUTLIER 78.7 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.545 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 2.4 m170 53.61 12.32 0.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.702 -1.249 . . . . 0.0 108.406 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -35.97 -67.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.718 -0.614 . . . . 18.870000000000001 111.077 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -53.96 -31.51 50.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.227 -0.921 . . . . 45.210000000000001 111.067 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' OE1' ' CE1' ' A' ' 52' ' ' HIS . 57.4 mt-10 -65.26 -46.61 79.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.041 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.44 -53.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.952 -1.092 . . . . 9.8399999999999999 109.453 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.493 HE22 ' HZ3' ' A' ' 19' ' ' LYS . 3.4 mt-30 -57.27 -43.43 83.08 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.824 -1.176 . . . . 17.84 107.824 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -54.78 -33.84 61.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.217 -1.401 . . . . 18.84 107.217 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -78.8 -49.21 13.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.969 -0.692 . . . . 12.99 109.136 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.06 -32.89 49.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.434 -0.951 . . . . 14.609999999999999 108.434 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 3.9 tp-100 -59.77 -53.89 52.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.675 -0.641 . . . . 40.450000000000003 109.385 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -66.92 -48.25 69.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 41.810000000000002 111.031 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.62 -39.02 92.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 21.77 110.554 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 10.5 p -106.49 -66.67 0.99 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.32 -0.862 . . . . 11.380000000000001 109.912 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 143.48 -42.15 1.1 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.694 -1.763 . . . . 14.789999999999999 108.694 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.22 136.62 38.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -1.02 . . . . 17.809999999999999 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 25.42 9.04 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.313 -0.995 . . . . 29.760000000000002 108.313 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.725 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -83.02 169.45 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.67 . . . . 18.260000000000002 110.354 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' NZ ' ' A' ' 19' ' ' LYS . 10.9 t -113.67 138.53 22.68 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 107.916 -1.142 . . . . 8.1999999999999993 107.916 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 82' ' ' SER . 30.6 Cg_endo -84.95 -165.92 4.05 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 CA-C-O 122.299 0.875 . . . . 7.79 111.203 -0.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.725 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -143.41 92.77 2.4 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.131 -2.174 . . . . 26.050000000000001 105.131 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.2 t -83.63 156.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.877 . . . . 8.6799999999999997 111.387 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -146.22 92.05 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.635 -0.666 . . . . 14.07 111.105 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 74' ' ' ILE . 13.3 mm -72.97 106.32 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.598 -2.001 . . . . 9.3399999999999999 105.598 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.96 -152.1 46.81 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 105.793 -2.923 . . . . 12.42 105.793 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -81.76 4.06 23.46 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.388 -1.654 . . . . 44.859999999999999 108.507 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.664 ' CB ' HH21 ' A' ' 97' ' ' ARG . 23.6 m-20 -89.63 108.96 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.0 110.754 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 t -74.44 141.99 44.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.29 -13.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 20.449999999999999 109.443 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.96 -163.89 15.24 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.309 -1.117 . . . . 13.82 110.309 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 84' ' ' ASP . . . -86.58 -146.26 9.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.23 -1.148 . . . . 12.42 110.23 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 t -72.61 -59.7 2.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.553 -0.969 . . . . 0.0 110.049 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -50.24 -26.48 4.75 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 108.922 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 81' ' ' GLY . 16.7 m-20 -75.23 -47.81 26.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.526 -0.734 . . . . 27.059999999999999 109.09 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 1.7 tt -53.89 -59.15 5.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 15.31 109.776 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.603 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -52.35 -50.73 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 110.539 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.5 t -46.26 -41.54 13.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 21.789999999999999 109.869 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.85 -40.08 55.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 112.173 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -59.27 -59.5 5.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.646 -1.284 . . . . 0.0 110.858 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.603 ' OE1' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.96 -22.69 50.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.333 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 m -79.82 -60.09 2.48 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 109.119 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 -11.72 6.46 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.62 -1.392 . . . . 25.640000000000001 109.62 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' A' ' 96' ' ' THR . 36.7 tp10 -69.24 -25.58 64.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -1.163 . . . . 50.259999999999998 108.994 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.3 tp -58.48 -64.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.356 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -52.61 -27.41 16.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -63.57 -48.2 78.4 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.425 -0.91 . . . . 28.030000000000001 108.784 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.715 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.0 mmm180 -58.73 -34.28 71.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.052 . . . . 40.960000000000001 108.17 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.6 -39.68 73.65 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.805 -0.813 . . . . 15.050000000000001 108.805 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -66.03 -53.83 33.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.767 -0.583 . . . . 0.0 111.941 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.715 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -49.47 -33.36 14.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.207 . . . . 38.640000000000001 110.612 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.22 -13.23 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.697 -1.252 . . . . 0.0 109.331 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 46.42 8.91 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.549 -1.02 . . . . 18.539999999999999 110.549 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.07 -14.47 41.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -1.16 . . . . 10.84 109.586 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -95.48 174.61 6.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 109.951 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.649 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' A' ' 7' ' ' SER . 10.2 pt-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.57 -72.91 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.78 . . . . 20.030000000000001 110.018 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.7 m -73.62 -40.32 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 12.91 110.126 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.463 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 73.8 m-20 -56.08 -27.23 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.201 -0.937 . . . . 28.329999999999998 110.399 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 24.9 m -74.71 -21.7 59.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.08 -1.012 . . . . 0.0 110.528 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -97.58 -45.36 6.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.973 -1.079 . . . . 22.870000000000001 111.293 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.39 129.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.014 -1.054 . . . . 25.190000000000001 110.123 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -146.79 153.05 45.91 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 34.609999999999999 108.664 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.03 122.86 12.56 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.218 1.279 . . . . 11.720000000000001 109.963 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.0 24.32 49.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.83 -1.308 . . . . 10.24 109.83 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -139.23 134.58 32.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -1.145 . . . . 25.359999999999999 109.232 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.02 137.36 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 10.890000000000001 110.11 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.51 153.06 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.499 -0.926 . . . . 15.82 108.499 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.94 121.65 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.234 -0.916 . . . . 8.9399999999999995 110.629 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.98 121.1 31.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.201 -1.407 . . . . 9.9299999999999997 107.201 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.2 pt -133.48 -168.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.472 1.129 . . . . 10.619999999999999 111.872 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.636 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.2 mtmt -145.59 96.65 4.75 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 106.205 -1.776 . . . . 38.729999999999997 106.205 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.51 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.4 Cg_exo -51.82 74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.379 1.386 . . . . 24.579999999999998 110.736 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.636 ' N ' ' O ' ' A' ' 19' ' ' LYS . 11.5 m -171.32 -32.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.919 -0.771 . . . . 34.82 108.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.22 128.57 34.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 21.460000000000001 110.074 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.82 -13.28 25.85 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.162 1.908 . . . . 13.859999999999999 112.118 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -71.34 -47.5 56.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.709 -1.244 . . . . 0.0 109.706 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -28.39 70.01 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.015 -1.053 . . . . 0.0 108.9 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -61.27 -42.64 98.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.29 -1.004 . . . . 59.590000000000003 108.29 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -54.24 -49.14 70.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.176 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -37.43 75.46 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.878 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.54 -42.15 71.59 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.333 -0.854 . . . . 45.490000000000002 109.618 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.77 -37.33 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.386 -0.821 . . . . 34.969999999999999 111.02 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.28 -57.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.99 -1.069 . . . . 0.0 110.197 -178.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -55.38 -24.62 30.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 17.280000000000001 109.394 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -65.28 -27.9 68.96 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.119 -0.988 . . . . 24.109999999999999 108.489 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -90.89 3.66 53.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.812 . . . . 44.07 110.286 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 37' ' ' ILE . 20.0 mt -91.83 131.5 35.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.795 -1.191 . . . . 19.629999999999999 109.257 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.88 64.61 0.43 Allowed 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.707 1.605 . . . . 21.539999999999999 110.31 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.8 mm -82.25 149.05 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 108.887 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.4 mmmt -53.22 -174.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 29.41 110.057 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 39' ' ' GLN . 4.3 mp0 -52.32 -121.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.674 -0.641 . . . . 0.0 111.123 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 48.31 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.402 -0.904 . . . . 15.27 110.866 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -18.26 16.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.241 -1.152 . . . . 8.7799999999999994 109.372 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -105.56 126.7 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 7.1299999999999999 108.83 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 36.7 tt0 -140.4 164.97 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 22.030000000000001 109.689 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.618 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 23.3 m-85 -126.45 114.91 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.593 -1.262 . . . . 16.329999999999998 107.593 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.87 102.06 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 6.5800000000000001 111.131 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 48' ' ' THR . 7.4 m-20 -80.44 100.06 8.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.478 -1.304 . . . . 15.32 107.478 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.6 pt -61.17 2.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 10.92 110.749 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 46' ' ' ASP . 5.1 t -94.88 -20.24 19.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.999 -1.063 . . . . 21.719999999999999 109.086 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.58 13.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 22.449999999999999 109.309 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.1 t -140.69 -14.71 0.94 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.22 -0.925 . . . . 25.629999999999999 109.902 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 50' ' ' THR . 1.1 m-20 78.97 -176.19 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.8 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.403 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER 57.76 30.16 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 109.089 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 p -44.69 -54.12 6.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 18.870000000000001 109.906 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.0 m-20 -54.15 -37.32 64.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 45.210000000000001 110.732 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -62.24 -46.58 88.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.112 . . . . 33.020000000000003 109.636 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.9 -55.7 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.969 -1.082 . . . . 9.8399999999999999 109.59 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -56.69 -40.45 75.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.694 -1.254 . . . . 17.84 107.878 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 22.9 m-20 -55.04 -32.53 61.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.015 -1.476 . . . . 18.84 107.015 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -78.8 -47.94 15.74 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.766 -0.827 . . . . 12.99 108.766 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.452 ' O ' ' OG1' ' A' ' 64' ' ' THR . 65.8 mt -54.53 -33.59 60.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.375 -0.972 . . . . 14.609999999999999 108.375 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.7 tp60 -59.25 -55.78 30.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.751 -0.593 . . . . 40.450000000000003 109.8 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.7 -50.42 62.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.028 -1.045 . . . . 41.810000000000002 111.106 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.06 -34.83 78.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.867 -1.146 . . . . 21.77 110.657 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.6 p -110.74 -70.44 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.306 -0.871 . . . . 11.380000000000001 109.915 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 147.04 -41.85 0.94 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.606 -1.798 . . . . 14.789999999999999 108.606 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.22 140.39 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.436 -1.037 . . . . 17.809999999999999 110.047 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 24.43 13.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.192 -1.04 . . . . 29.760000000000002 108.192 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.95 174.1 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.923 0.868 . . . . 18.260000000000002 110.935 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.61 134.33 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.454 -1.313 . . . . 8.1999999999999993 107.454 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -80.7 -163.93 3.62 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 CA-C-O 122.245 0.852 . . . . 7.79 111.257 0.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 91.74 1.89 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.296 -2.113 . . . . 26.050000000000001 105.296 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.65 157.81 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.822 0.82 . . . . 8.6799999999999997 112.185 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -145.22 88.28 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.801 -0.562 . . . . 14.07 110.624 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.4 mp -71.0 109.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.469 -2.048 . . . . 9.3399999999999999 105.469 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.57 -154.64 52.1 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.036 -2.826 . . . . 12.42 106.036 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -84.51 0.2 50.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.354 -1.674 . . . . 44.859999999999999 108.934 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.7 114.91 25.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -71.69 149.45 45.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.366 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.0 -23.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.95 . . . . 20.449999999999999 109.342 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.64 -142.71 14.08 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.948 -1.261 . . . . 13.82 109.948 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -111.06 -144.19 9.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.898 -1.281 . . . . 12.42 109.898 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -71.04 -61.12 1.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -1.003 . . . . 0.0 109.801 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.9 t -52.99 -26.27 14.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.5 m-20 -73.53 -48.33 33.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.345 -0.847 . . . . 27.059999999999999 109.236 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.76 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.382 -0.824 . . . . 15.31 109.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.42 -49.43 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 0.0 110.015 -178.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -49.5 -41.32 40.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 21.789999999999999 109.357 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt -75.46 -36.67 60.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 111.253 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 -62.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.995 -1.066 . . . . 0.0 110.644 -178.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -61.19 -16.61 46.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.949 -1.095 . . . . 0.0 109.971 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.675 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 13.5 m -85.25 -18.61 33.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.891 . . . . 0.0 109.425 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.79 -13.49 52.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.891 -1.283 . . . . 25.640000000000001 109.891 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.55 -26.76 65.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.149 -1.207 . . . . 50.259999999999998 108.966 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.95 -63.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 24.170000000000002 110.157 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.1 -31.31 41.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.1 m -63.56 -43.99 95.46 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.696 -1.224 . . . . 28.030000000000001 107.696 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -60.0 -35.65 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.403 -0.962 . . . . 40.960000000000001 108.403 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 98' ' ' LEU . 9.9 mp -71.18 -40.23 71.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.445 -0.784 . . . . 15.050000000000001 109.237 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -65.08 -53.53 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 112.29 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -47.57 -31.54 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.728 -1.233 . . . . 38.640000000000001 110.503 -177.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 pt -104.17 -14.18 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.918 -1.114 . . . . 0.0 109.649 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.26 41.94 11.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.433 -1.067 . . . . 18.539999999999999 110.433 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.13 -12.32 53.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 10.84 109.561 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.62 -174.82 3.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.389 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.91 -70.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 20.030000000000001 110.25 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -73.1 -40.34 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 12.91 110.097 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 8.6 m-20 -54.79 -38.27 67.09 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.073 -1.017 . . . . 28.329999999999998 109.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -74.72 -12.35 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.212 -0.93 . . . . 0.0 109.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -97.24 -46.8 5.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.206 -0.934 . . . . 22.870000000000001 110.608 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.1 135.09 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.776 -1.202 . . . . 25.190000000000001 109.385 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.49 150.36 40.25 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.715 -0.846 . . . . 34.609999999999999 108.715 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.39 124.37 15.91 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.41 1.407 . . . . 11.720000000000001 110.021 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.08 28.45 45.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.764 -1.334 . . . . 10.24 109.764 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -140.91 137.22 32.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 25.359999999999999 109.761 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.63 135.05 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.382 -0.824 . . . . 10.890000000000001 109.643 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.42 141.39 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.048 . . . . 15.82 108.172 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 t -124.19 127.28 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 8.9399999999999995 111.078 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.84 121.04 34.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.24 -1.393 . . . . 9.9299999999999997 107.24 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.0 pt -131.14 -176.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.361 1.077 . . . . 10.619999999999999 111.254 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.5 mtmt -143.9 91.81 6.51 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.1 Cg_exo -47.18 78.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.892 1.728 . . . . 24.579999999999998 111.05 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' LYS . 88.2 m -174.1 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.852 -0.796 . . . . 34.82 108.852 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.75 130.04 29.95 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 21.460000000000001 109.857 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -57.94 -21.59 50.37 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.277 1.985 . . . . 13.859999999999999 112.209 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -70.43 -38.18 74.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.635 -1.291 . . . . 0.0 108.523 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER -66.73 -36.63 82.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -64.08 -40.53 96.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.918 -0.771 . . . . 59.590000000000003 108.918 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.9 OUTLIER -53.66 -48.84 69.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.433 -0.792 . . . . 0.0 109.291 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.52 72.98 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.372 -0.83 . . . . 0.0 109.161 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.626 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.57 -43.39 69.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.375 -0.828 . . . . 45.490000000000002 109.477 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 22.0 mm-40 -71.13 -35.78 71.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.554 -0.716 . . . . 34.969999999999999 111.256 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.48 -58.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 110.478 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 2.9 mt -58.99 -17.98 29.95 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.563 -1.336 . . . . 17.280000000000001 109.634 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.486 ' HG ' HE21 ' A' ' 34' ' ' GLN . 5.8 t -65.87 -29.93 70.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 24.109999999999999 109.037 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.486 HE21 ' HG ' ' A' ' 33' ' ' SER . 1.6 mp0 -91.72 5.88 48.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 44.07 110.49 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.9 mt -90.56 127.98 50.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.758 -1.213 . . . . 19.629999999999999 109.304 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.43 68.99 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.8 1.666 . . . . 21.539999999999999 109.94 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.6 mm -82.13 150.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.416 -0.802 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 39' ' ' GLN . 1.5 mmmm -54.68 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.466 -0.771 . . . . 29.41 110.392 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.599 ' O ' ' O ' ' A' ' 38' ' ' LYS . 91.1 mm-40 -52.61 -137.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.618 0.723 . . . . 0.0 110.884 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.27 52.82 0.09 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.107 -1.197 . . . . 15.27 110.107 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -98.52 -20.28 17.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -1.048 . . . . 8.7799999999999994 109.151 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.54 129.7 50.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.632 -0.877 . . . . 7.1299999999999999 108.632 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.9 tp10 -142.13 164.89 28.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.995 . . . . 22.030000000000001 109.955 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 56.5 m-85 -125.96 111.75 15.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.319 -1.363 . . . . 16.329999999999998 107.319 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -94.47 101.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 6.5800000000000001 111.305 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.16 101.42 9.65 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.873 . . . . 15.32 108.644 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.12 -6.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 10.92 109.251 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 p -96.92 43.08 1.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.332 -0.988 . . . . 21.719999999999999 108.332 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.14 14.09 0.45 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 22.449999999999999 107.801 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -139.49 -2.94 1.54 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.19 -1.041 . . . . 25.629999999999999 108.19 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.7 OUTLIER 70.21 -176.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.806 178.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.3 m80 53.61 18.06 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.007 -1.058 . . . . 0.0 108.552 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.501 ' H ' ' HG1' ' A' ' 53' ' ' THR . 0.2 OUTLIER -32.96 -55.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.403 0.621 . . . . 18.870000000000001 110.861 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -57.85 -33.3 68.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 45.210000000000001 111.275 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' HIS . 73.2 mm-40 -63.45 -43.7 96.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.829 -1.17 . . . . 33.020000000000003 109.925 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.8 -56.76 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.983 -1.073 . . . . 9.8399999999999999 109.581 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -54.9 -43.06 72.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.555 -1.276 . . . . 17.84 107.555 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.28 -33.61 65.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.41 -1.33 . . . . 18.84 107.41 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -76.6 -47.33 22.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 12.99 108.732 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 64' ' ' THR . 63.0 mt -54.78 -36.5 64.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.901 -1.148 . . . . 14.609999999999999 107.901 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 1.1 tp-100 -59.67 -52.37 65.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.266 0.555 . . . . 40.450000000000003 110.045 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.0 -51.0 66.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 41.810000000000002 110.839 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.94 -32.43 73.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.086 -1.009 . . . . 21.77 110.721 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.3 p -110.06 -74.05 0.66 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 11.380000000000001 109.53 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.22 -37.86 1.05 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.985 -1.646 . . . . 14.789999999999999 108.985 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.68 134.74 45.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -1.002 . . . . 17.809999999999999 109.908 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 32.5 4.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.538 -0.912 . . . . 29.760000000000002 108.538 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 167.72 19.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 18.260000000000002 110.294 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.55 134.5 21.98 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.288 -1.004 . . . . 8.1999999999999993 108.288 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.697 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 29.5 Cg_endo -86.08 -170.62 7.0 Favored 'Cis proline' 0 C--N 1.309 -1.513 0 C-N-CA 124.83 -0.904 . . . . 7.79 110.119 -0.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.716 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.08 102.78 4.94 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.54 -2.022 . . . . 26.050000000000001 105.54 176.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.07 159.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 8.6799999999999997 111.763 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -146.21 90.92 2.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.623 -0.673 . . . . 14.07 110.836 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.542 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -72.65 112.97 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.801 -1.926 . . . . 9.3399999999999999 105.801 177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.87 -152.47 39.55 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.401 -2.679 . . . . 12.42 106.401 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -83.37 -0.16 48.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.514 -1.58 . . . . 44.859999999999999 108.708 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.474 ' HB3' HH21 ' A' ' 97' ' ' ARG . 5.7 m-20 -89.45 115.05 26.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 0.0 110.599 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 t -73.71 150.71 41.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 109.449 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.98 -22.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 20.449999999999999 109.225 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.22 -146.75 18.39 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.581 -1.408 . . . . 13.82 109.581 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.19 -149.2 21.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.604 -1.398 . . . . 12.42 109.604 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -71.26 -59.47 2.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -1.181 . . . . 0.0 109.657 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -50.27 -27.31 5.85 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 -46.85 32.15 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.853 -0.795 . . . . 27.059999999999999 108.853 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -55.3 -59.78 4.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.581 -0.699 . . . . 15.31 110.353 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -49.08 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.419 -0.8 . . . . 0.0 110.472 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.33 36.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.875 -1.141 . . . . 21.789999999999999 109.564 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 mt -74.1 -38.04 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 111.988 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.419 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -60.3 -59.11 5.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -178.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -60.47 -24.45 65.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.003 -1.061 . . . . 0.0 109.664 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.0 m -80.76 -24.63 38.53 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.443 -0.786 . . . . 0.0 109.378 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.14 -9.61 76.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.32 -1.112 . . . . 25.640000000000001 110.32 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.71 -26.53 65.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.046 -1.267 . . . . 50.259999999999998 108.872 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 tp -59.53 -64.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 24.170000000000002 110.605 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.27 -31.12 42.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -63.67 -46.38 85.86 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 178.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.474 HH21 ' HB3' ' A' ' 77' ' ' ASP . 9.6 tpt180 -58.81 -38.32 78.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.294 -1.002 . . . . 40.960000000000001 108.294 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.32 -36.19 71.5 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.657 -0.868 . . . . 15.050000000000001 108.657 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -65.87 -54.65 23.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.706 -0.621 . . . . 0.0 111.974 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -50.21 -33.17 18.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.163 . . . . 38.640000000000001 110.908 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -100.12 -11.44 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.778 -1.201 . . . . 0.0 109.409 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.15 40.63 15.82 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.462 -1.055 . . . . 18.539999999999999 110.462 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.46 -20.49 29.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.136 -1.214 . . . . 10.84 109.3 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.18 -175.87 3.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.0 109.041 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.49 179.801 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.32 -68.28 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.406 -0.809 . . . . 20.030000000000001 110.214 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.68 -39.81 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 12.91 110.244 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.4 m120 -55.64 -34.96 65.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.12 -0.987 . . . . 28.329999999999998 109.043 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.4 m -74.63 -12.73 60.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -96.66 -48.32 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 22.870000000000001 109.848 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.51 132.06 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 25.190000000000001 109.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.91 157.25 34.38 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.132 -1.062 . . . . 34.609999999999999 108.132 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.28 130.62 36.43 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.708 1.605 . . . . 11.720000000000001 111.312 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.73 28.18 65.64 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 120.408 -0.901 . . . . 10.24 110.944 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -140.62 132.85 28.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.316 . . . . 25.359999999999999 109.7 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.36 136.86 31.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.379 -0.825 . . . . 10.890000000000001 109.263 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.67 142.37 23.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.564 -0.902 . . . . 15.82 108.564 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 40.5 t -125.63 125.92 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 8.9399999999999995 110.968 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -93.79 121.89 35.7 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.903 -1.147 . . . . 9.9299999999999997 107.903 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.3 pt -131.07 -175.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.613 1.197 . . . . 10.619999999999999 111.839 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 21' ' ' THR . 39.2 mttm -140.92 97.39 7.11 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 105.166 -2.161 . . . . 38.729999999999997 105.166 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 21' ' ' THR . 10.3 Cg_exo -51.12 71.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.441 1.427 . . . . 24.579999999999998 110.895 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 19' ' ' LYS . 24.7 m -170.03 -32.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.185 -0.947 . . . . 34.82 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.32 133.17 24.19 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 21.460000000000001 109.882 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.46 -24.11 77.01 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 122.411 2.074 . . . . 13.859999999999999 112.991 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -67.23 -47.87 69.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.366 -1.458 . . . . 0.0 109.921 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -33.8 72.05 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -61.75 -42.24 98.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.548 -0.908 . . . . 59.590000000000003 108.548 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 27' ' ' ARG . 7.4 mtt-85 -56.15 -45.06 79.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 109.077 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.17 76.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.029 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' O ' ' OG ' ' A' ' 33' ' ' SER . 10.4 mt-30 -70.33 -41.16 73.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.488 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 26' ' ' ARG . 55.4 mm-40 -72.4 -39.08 68.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.614 -0.679 . . . . 34.969999999999999 111.64 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -72.91 -56.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.766 -1.209 . . . . 0.0 109.769 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.531 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -60.81 -19.01 58.81 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.577 -1.327 . . . . 17.280000000000001 109.536 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 3.5 m -66.54 -27.7 67.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.039 -1.038 . . . . 24.109999999999999 108.706 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 2.3 mp0 -91.53 -0.07 57.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 44.07 110.393 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.8 129.69 49.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.771 -1.206 . . . . 19.629999999999999 108.626 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.8 67.11 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.441 1.427 . . . . 21.539999999999999 109.451 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.9 mm -76.97 150.65 5.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.154 -0.966 . . . . 0.0 108.64 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' GLN . 6.9 mmmt -52.75 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 29.41 110.557 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' LYS . 90.5 mt-30 -52.03 -124.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.628 0.728 . . . . 0.0 111.88 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.25 48.62 1.17 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.425 -1.07 . . . . 15.27 110.425 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -33.92 12.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -1.094 . . . . 8.7799999999999994 109.201 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.0 tp -92.83 133.79 35.72 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.544 0.688 . . . . 7.1299999999999999 109.472 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.0 tt0 -143.57 174.05 11.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.471 -0.768 . . . . 22.030000000000001 109.055 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.518 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.7 m-85 -136.82 109.62 7.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.084 -1.45 . . . . 16.329999999999998 107.084 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 78.0 t -95.0 107.13 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 6.5800000000000001 111.967 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.5 m-20 -82.45 100.06 9.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.595 -0.891 . . . . 15.32 108.595 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.63 2.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 10.92 111.145 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -94.97 -31.0 13.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.873 -1.142 . . . . 21.719999999999999 108.395 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.47 22.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.48 -0.762 . . . . 22.449999999999999 109.658 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.1 t -141.22 -2.47 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.134 -0.978 . . . . 25.629999999999999 109.996 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 4.5 m-20 65.25 -168.6 0.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.492 -0.755 . . . . 0.0 109.994 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 51.37 19.14 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.68 -62.2 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.727 -0.608 . . . . 18.870000000000001 110.78 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.5 m120 -56.13 -36.74 68.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 45.210000000000001 110.805 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 1.1 mp0 -61.83 -44.57 96.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.937 -1.102 . . . . 33.020000000000003 109.912 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.32 -54.18 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.666 -1.271 . . . . 9.8399999999999999 109.627 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -56.91 -44.91 82.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.566 -1.334 . . . . 17.84 107.765 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.97 -34.72 57.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 18.84 107.284 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -78.36 -46.88 18.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.87 -0.732 . . . . 12.99 109.218 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.3 mt -52.59 -38.29 59.76 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.116 -1.068 . . . . 14.609999999999999 108.116 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -57.17 -55.54 33.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.641 -0.874 . . . . 40.450000000000003 108.641 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.08 -29.16 68.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.848 . . . . 41.810000000000002 109.585 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 2.0 tt -64.5 -68.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.951 . . . . 21.77 109.792 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -52.95 2.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.801 -0.562 . . . . 11.380000000000001 109.721 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.432 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 152.72 -42.93 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.051 -1.547 . . . . 14.789999999999999 111.128 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . . . -96.48 144.62 26.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.839 -1.389 . . . . 17.809999999999999 110.69 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.55 23.89 13.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.55 -0.907 . . . . 29.760000000000002 108.55 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.702 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.38 170.03 15.77 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 18.260000000000002 110.589 -178.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.18 132.44 21.73 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 107.839 -1.171 . . . . 8.1999999999999993 107.839 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD2' ' H ' ' A' ' 82' ' ' SER . 27.8 Cg_endo -83.98 -168.32 5.97 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 CA-C-O 122.533 0.972 . . . . 7.79 112.15 -0.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.702 HH12 ' H ' ' A' ' 68' ' ' THR . 1.8 tpm_? -146.01 90.4 1.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.635 -1.987 . . . . 26.050000000000001 105.635 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.3 t -83.78 155.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.279 -0.888 . . . . 8.6799999999999997 111.794 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -142.69 91.77 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 14.07 111.535 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 74' ' ' ILE . 4.0 mm -72.02 114.3 10.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 105.249 -2.13 . . . . 9.3399999999999999 105.249 176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.38 -159.1 11.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.959 -2.856 . . . . 12.42 105.959 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -78.3 1.71 20.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.211 -1.758 . . . . 44.859999999999999 108.699 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.599 ' CB ' HH21 ' A' ' 97' ' ' ARG . 1.4 m-20 -88.43 112.09 22.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.735 . . . . 0.0 110.055 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 t -76.79 143.65 39.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.267 -0.896 . . . . 0.0 110.453 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -107.37 -21.41 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.028 . . . . 20.449999999999999 108.92 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.26 -146.63 18.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.218 -1.153 . . . . 13.82 110.218 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.91 -143.67 13.31 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.227 -1.149 . . . . 12.42 110.227 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.424 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.6 -61.73 1.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.517 -0.99 . . . . 0.0 109.964 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -52.73 -23.68 7.22 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.59 -0.694 . . . . 0.0 109.5 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.53 -51.55 12.67 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 27.059999999999999 109.272 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -50.92 -60.3 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 15.31 110.037 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -49.54 -51.93 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 110.066 -178.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 91' ' ' SER . 3.2 t -44.44 -37.7 3.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.229 -0.92 . . . . 21.789999999999999 108.953 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.2 mt -81.89 -40.96 21.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.53 -58.66 7.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.88 -1.137 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -24.83 66.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.004 -1.06 . . . . 0.0 109.411 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 87' ' ' SER . 50.2 m -79.87 -45.51 18.53 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.3 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.3 -9.22 26.69 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.377 -1.089 . . . . 25.640000000000001 110.377 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -69.69 -25.11 63.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.988 -1.301 . . . . 50.259999999999998 108.534 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.07 -63.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.479 0.657 . . . . 24.170000000000002 110.732 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.17 -28.26 39.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.448 -0.782 . . . . 0.0 108.915 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.4 -50.05 66.92 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.65 -0.82 . . . . 28.030000000000001 108.803 178.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.599 HH21 ' CB ' ' A' ' 77' ' ' ASP . 27.1 mtp180 -58.91 -31.05 68.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.912 -1.144 . . . . 40.960000000000001 107.912 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.4 mp -72.37 -40.49 67.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.051 -1.092 . . . . 15.050000000000001 108.051 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -64.9 -52.3 57.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.93 -0.481 . . . . 0.0 111.888 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -33.2 24.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.71 -1.244 . . . . 38.640000000000001 110.691 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.7 pt -99.76 -16.34 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.693 -1.255 . . . . 0.0 108.764 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.18 44.28 8.19 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.428 -1.069 . . . . 18.539999999999999 110.428 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.92 -13.85 46.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -1.155 . . . . 10.84 109.657 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.1 pt? -95.01 -175.61 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.504 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.06 -69.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.414 -0.804 . . . . 20.030000000000001 111.218 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.9 m -73.27 -38.68 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 12.91 110.5 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 98.2 m-20 -55.73 -34.06 64.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.043 -1.036 . . . . 28.329999999999998 109.442 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.8 m -74.58 -13.83 60.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.022 -1.049 . . . . 0.0 110.001 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -97.42 -45.75 6.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.012 -1.055 . . . . 22.870000000000001 110.693 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.48 129.09 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.909 -1.12 . . . . 25.190000000000001 110.389 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.77 158.52 35.21 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 107.965 -1.124 . . . . 34.609999999999999 107.965 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -56.7 135.9 73.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.743 1.629 . . . . 11.720000000000001 111.418 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.81 27.64 68.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.75 -0.94 . . . . 10.24 110.75 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -142.6 131.85 23.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.347 . . . . 25.359999999999999 109.619 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.5 127.79 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.218 -0.926 . . . . 10.890000000000001 108.959 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.88 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.613 -0.884 . . . . 15.82 108.613 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -125.31 126.11 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.541 -0.724 . . . . 8.9399999999999995 111.259 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -92.67 119.1 31.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 pt -129.34 -173.79 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 122.311 1.053 . . . . 10.619999999999999 111.345 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -146.2 88.04 6.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.95 -1.871 . . . . 38.729999999999997 105.95 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' ' OG1' ' A' ' 21' ' ' THR . 17.7 Cg_exo -45.79 77.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.851 1.701 . . . . 24.579999999999998 110.834 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 19' ' ' LYS . 15.6 m -174.07 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.082 -1.081 . . . . 34.82 108.082 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 126.16 42.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 109.083 -0.71 . . . . 21.460000000000001 109.083 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.82 -24.6 56.83 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.069 1.846 . . . . 13.859999999999999 112.166 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -70.39 -38.18 74.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.799 -1.188 . . . . 0.0 108.782 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -36.35 84.02 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.581 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.5 mmm-85 -65.27 -42.93 92.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.962 -0.755 . . . . 59.590000000000003 108.962 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -50.14 -45.37 53.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 108.771 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.71 82.12 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.616 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 25.3 mt-30 -71.41 -45.77 61.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.791 . . . . 45.490000000000002 109.652 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -69.99 -34.41 73.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.524 -0.735 . . . . 34.969999999999999 110.787 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.93 -57.58 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 0.0 110.83 -178.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.57 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -59.49 -20.89 58.7 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.593 -1.317 . . . . 17.280000000000001 109.487 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 7.6 m -64.5 -22.29 66.92 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.142 -0.974 . . . . 24.109999999999999 108.415 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -93.02 -2.21 55.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.486 -0.759 . . . . 44.07 109.963 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.8 mt -88.7 130.38 45.33 Favored Pre-proline 0 N--CA 1.484 1.267 0 O-C-N 120.86 -1.15 . . . . 19.629999999999999 108.956 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 67.19 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.669 1.58 . . . . 21.539999999999999 109.875 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.49 149.56 5.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 108.685 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 39' ' ' GLN . 36.6 mttt -53.56 -168.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.345 -0.847 . . . . 29.41 110.29 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 21.8 mp0 -52.01 -123.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.6 0.714 . . . . 0.0 111.748 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 51.14 1.8 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.628 -0.989 . . . . 15.27 110.628 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.59 -27.31 14.07 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.549 -0.971 . . . . 8.7799999999999994 108.796 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.3 tp -97.25 130.87 44.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.606 -0.887 . . . . 7.1299999999999999 108.606 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 1.2 tp10 -140.62 172.97 11.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.442 -0.786 . . . . 22.030000000000001 109.874 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.458 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 35.9 m-85 -135.74 110.06 8.43 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.416 -1.327 . . . . 16.329999999999998 107.416 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.9 103.16 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 6.5800000000000001 111.676 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.3 m-20 -81.29 100.87 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.671 -0.863 . . . . 15.32 108.671 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.8 pt -63.69 -0.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.165 -0.96 . . . . 10.92 111.098 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 t -92.31 -14.34 28.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.717 -1.239 . . . . 21.719999999999999 108.965 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.54 8.04 4.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.789 . . . . 22.449999999999999 109.307 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -142.97 -0.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 25.629999999999999 109.797 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 53' ' ' THR . 13.3 t-20 67.38 -156.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.28 12.32 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.803 -1.186 . . . . 0.0 108.684 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -37.83 -62.89 0.51 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.524 -0.735 . . . . 18.870000000000001 110.892 -178.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -53.53 -32.57 51.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 45.210000000000001 110.481 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -65.67 -45.28 83.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.889 -1.132 . . . . 33.020000000000003 109.82 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.21 -50.29 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.922 -1.111 . . . . 9.8399999999999999 109.469 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -58.07 -42.38 85.4 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.275 -1.38 . . . . 17.84 107.275 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.09 -33.11 64.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.036 -1.468 . . . . 18.84 107.036 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -78.78 -51.82 9.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.98 -0.748 . . . . 12.99 108.98 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.44 -32.55 50.33 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.134 -1.061 . . . . 14.609999999999999 108.134 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.6 tp60 -59.13 -54.56 45.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.808 -0.557 . . . . 40.450000000000003 109.849 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -67.47 -49.61 62.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 41.810000000000002 110.878 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -65.28 -33.33 75.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.036 -1.04 . . . . 21.77 110.993 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.7 p -107.91 -66.75 1.01 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.162 -0.961 . . . . 11.380000000000001 109.47 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 141.96 -41.37 1.22 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.757 -1.737 . . . . 14.789999999999999 108.757 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.5 140.85 32.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 17.809999999999999 109.655 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 25.67 10.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.363 -0.977 . . . . 29.760000000000002 108.363 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.724 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -83.85 168.04 16.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.036 0.922 . . . . 18.260000000000002 111.471 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.54 134.79 21.54 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 107.725 -1.213 . . . . 8.1999999999999993 107.725 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 82' ' ' SER . 22.3 Cg_endo -85.62 -162.97 2.69 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 CA-C-O 122.512 0.963 . . . . 7.79 111.929 -0.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.724 HH12 ' H ' ' A' ' 68' ' ' THR . 1.5 tpm_? -144.94 97.38 3.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.271 -2.122 . . . . 26.050000000000001 105.271 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.87 157.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 8.6799999999999997 111.483 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -144.92 91.21 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 14.07 111.503 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 mm -72.37 112.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.343 -2.095 . . . . 9.3399999999999999 105.343 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 -153.13 36.03 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 105.476 -3.05 . . . . 12.42 105.476 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -83.65 2.82 35.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.219 -1.754 . . . . 44.859999999999999 108.67 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.647 ' CB ' HH21 ' A' ' 97' ' ' ARG . 5.5 m-20 -88.84 113.38 24.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 110.3 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.5 t -75.1 145.8 41.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 79' ' ' ILE . 2.6 pp -111.92 -16.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.264 -0.898 . . . . 20.449999999999999 109.334 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.92 -149.36 18.05 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.237 -1.145 . . . . 13.82 110.237 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.73 -147.52 20.93 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.096 -1.202 . . . . 12.42 110.096 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.418 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 t -71.78 -62.73 1.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.479 -1.012 . . . . 0.0 110.218 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.5 t -52.25 -24.46 7.37 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.71 -47.35 31.91 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.358 -0.839 . . . . 27.059999999999999 109.111 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.6 -59.39 4.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.728 . . . . 15.31 110.189 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -50.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 110.436 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 22.7 m -47.59 -36.86 11.34 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.03 -1.044 . . . . 21.789999999999999 109.049 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.0 mt -82.47 -37.81 24.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 0.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.42 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.47 -60.22 4.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.694 -1.254 . . . . 0.0 110.728 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.666 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.0 pp0? -61.42 -17.79 55.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.005 -1.059 . . . . 0.0 109.588 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.447 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 73.3 m -80.51 -63.47 1.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.72 -13.02 4.51 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.125 -1.19 . . . . 25.640000000000001 110.125 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.02 -29.65 67.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.15 -1.206 . . . . 50.259999999999998 108.535 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.08 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.574 -0.704 . . . . 24.170000000000002 111.051 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -28.62 52.92 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -48.92 73.07 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.616 -0.833 . . . . 28.030000000000001 108.816 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.647 HH21 ' CB ' ' A' ' 77' ' ' ASP . 29.0 mtp180 -60.46 -31.29 70.29 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.968 -1.123 . . . . 40.960000000000001 107.968 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.6 mp -71.75 -39.08 70.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.288 -1.004 . . . . 15.050000000000001 108.288 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -66.04 -54.15 29.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.919 -0.488 . . . . 0.0 111.913 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.65 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.786 -1.196 . . . . 38.640000000000001 110.947 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 pt -100.29 -14.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.625 -1.297 . . . . 0.0 109.07 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.35 44.13 8.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.291 -1.124 . . . . 18.539999999999999 110.291 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.27 38.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.236 . . . . 10.84 109.653 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.04 -179.97 5.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.577 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.597 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.187 0.518 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.48 -75.58 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 20.030000000000001 110.69 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -73.95 -35.67 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.97 . . . . 12.91 110.017 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -56.43 -35.56 67.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 109.377 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 66.8 m -75.0 -13.22 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.916 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -97.02 -47.74 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.124 -0.985 . . . . 22.870000000000001 110.349 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.5 133.38 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 25.190000000000001 110.385 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -151.25 160.06 32.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.903 -1.147 . . . . 34.609999999999999 107.903 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.77 130.27 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.754 1.636 . . . . 11.720000000000001 111.435 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.49 22.99 63.55 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 120.335 -0.936 . . . . 10.24 111.046 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -141.12 134.11 29.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.974 -1.309 . . . . 25.359999999999999 109.62 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.9 t -100.66 133.98 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.479 -0.763 . . . . 10.890000000000001 109.435 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.64 141.22 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.487 -0.931 . . . . 15.82 108.487 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' VAL . 25.3 t -122.74 124.14 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.824 . . . . 8.9399999999999995 111.307 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -91.61 120.51 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.588 -1.264 . . . . 9.9299999999999997 107.588 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -133.45 -170.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 122.667 1.223 . . . . 10.619999999999999 112.192 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.1 mtmt -146.57 96.43 4.45 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 105.707 -1.96 . . . . 38.729999999999997 105.707 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -50.68 82.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.282 1.321 . . . . 24.579999999999998 110.504 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -179.36 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 34.82 109.699 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.36 122.33 56.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.252 -0.905 . . . . 21.460000000000001 109.082 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -54.56 -10.89 2.67 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.34 2.027 . . . . 13.859999999999999 112.765 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.68 -49.98 23.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.422 -1.424 . . . . 0.0 110.186 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -26.76 68.03 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.667 -1.271 . . . . 0.0 107.896 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -62.97 -37.69 88.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.092 -1.077 . . . . 59.590000000000003 108.092 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -59.17 -50.51 73.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 108.991 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -36.8 74.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.312 -0.868 . . . . 0.0 109.003 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 5.5 mm-40 -69.39 -42.85 74.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 45.490000000000002 109.705 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.16 -38.16 69.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.493 -0.754 . . . . 34.969999999999999 110.876 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -75.93 -54.95 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.016 -1.053 . . . . 0.0 110.405 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.532 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -58.36 -22.6 54.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.322 -1.486 . . . . 17.280000000000001 108.726 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.8 m -65.39 -29.89 70.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.936 . . . . 24.109999999999999 108.585 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -89.1 0.46 56.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.779 . . . . 44.07 109.562 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 131.51 40.34 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.127 -0.983 . . . . 19.629999999999999 108.696 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.84 66.6 1.26 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.843 1.695 . . . . 21.539999999999999 110.418 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -81.05 146.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.98 -1.075 . . . . 0.0 108.492 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 39' ' ' GLN . 11.1 mtmt -54.39 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 29.41 110.96 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.55 ' O ' ' O ' ' A' ' 38' ' ' LYS . 52.7 mt-30 -52.42 -133.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.766 0.793 . . . . 0.0 111.784 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.51 50.24 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.336 -1.106 . . . . 15.27 110.336 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -97.04 -29.75 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 8.7799999999999994 108.726 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 132.02 40.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.978 -0.749 . . . . 7.1299999999999999 108.978 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 11.6 tp10 -143.47 169.43 17.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.434 -0.791 . . . . 22.030000000000001 109.387 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.2 m-85 -132.03 109.64 10.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.3 -1.37 . . . . 16.329999999999998 107.3 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 16' ' ' VAL . 57.2 t -93.47 103.2 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 6.5800000000000001 112.068 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -81.51 102.65 10.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 15.32 108.193 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 pt -62.94 0.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.364 -0.835 . . . . 10.92 111.765 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 50' ' ' THR . 9.0 t -95.93 -26.43 15.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.71 -1.244 . . . . 21.719999999999999 109.451 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 20.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 22.449999999999999 109.596 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 11.0 t -143.3 1.94 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.148 -0.97 . . . . 25.629999999999999 109.702 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.702 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.41 -176.51 0.18 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.702 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.26 20.89 10.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.666 -1.271 . . . . 0.0 108.391 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.31 -61.68 1.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 18.870000000000001 110.789 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.08 -32.7 68.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 45.210000000000001 111.218 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 4.7 mp0 -62.46 -44.36 96.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.101 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.68 -53.22 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.144 . . . . 9.8399999999999999 109.553 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.07 -44.94 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.609 -1.307 . . . . 17.84 107.511 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -55.7 -33.33 64.07 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.003 -1.48 . . . . 18.84 107.003 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.95 -47.75 17.85 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.937 -0.764 . . . . 12.99 108.937 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.4 mt -53.15 -35.02 59.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.882 -1.155 . . . . 14.609999999999999 107.882 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.1 tp60 -60.62 -54.74 41.71 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.228 0.537 . . . . 40.450000000000003 109.982 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -66.2 -45.3 81.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.966 -1.084 . . . . 41.810000000000002 110.693 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.99 -40.73 91.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.987 -1.071 . . . . 21.77 110.68 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.1 p -107.83 -65.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.786 . . . . 11.380000000000001 109.761 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.537 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 140.89 -38.49 1.55 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.786 -2.125 . . . . 14.789999999999999 107.786 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' HH21 ' A' ' 71' ' ' ARG . . . -98.21 138.33 35.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.682 -0.893 . . . . 17.809999999999999 109.813 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 38.37 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.206 -1.035 . . . . 29.760000000000002 108.206 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 166.78 14.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.245 1.021 . . . . 18.260000000000002 112.623 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.79 126.77 27.51 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 8.1999999999999993 107.22 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.722 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 35.4 Cg_endo -82.34 -173.93 12.53 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 CA-C-O 122.148 0.811 . . . . 7.79 111.222 1.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.727 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -140.94 98.7 3.44 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.215 -2.143 . . . . 26.050000000000001 105.215 176.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.2 t -89.4 157.95 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.745 0.783 . . . . 8.6799999999999997 112.6 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -146.5 88.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.839 -0.538 . . . . 14.07 111.329 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.2 mp -72.44 124.39 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 104.433 -2.432 . . . . 9.3399999999999999 104.433 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.26 -160.24 17.49 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 106.501 -2.64 . . . . 12.42 106.501 -176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -83.21 -1.95 54.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.395 -1.65 . . . . 44.859999999999999 109.984 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB2' HH21 ' A' ' 97' ' ' ARG . 4.2 m-20 -89.31 124.2 34.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.018 -1.051 . . . . 0.0 110.356 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 t -75.0 147.12 41.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 110.025 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -109.28 -21.09 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.681 -0.859 . . . . 20.449999999999999 108.681 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.99 -153.01 19.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.941 -1.264 . . . . 13.82 109.941 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.99 -147.02 21.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.966 -1.254 . . . . 12.42 109.966 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -69.71 -61.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -1.103 . . . . 0.0 109.863 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -51.06 -23.64 3.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.553 -0.717 . . . . 0.0 109.293 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.01 -47.38 25.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.451 -0.78 . . . . 27.059999999999999 109.016 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.7 tt -54.24 -60.03 3.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 15.31 109.834 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -50.27 -52.16 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.082 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.616 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 37.4 m -46.16 -35.92 5.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.143 -0.973 . . . . 21.789999999999999 108.899 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.8 mt -82.08 -40.05 22.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 111.615 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -58.71 -59.11 5.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.164 . . . . 0.0 110.777 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.3 pp0? -62.81 -19.74 64.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.927 -1.108 . . . . 0.0 109.768 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.552 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 70.7 m -83.86 -24.28 30.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.32 -9.54 76.57 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.106 -1.197 . . . . 25.640000000000001 110.106 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.128 -1.219 . . . . 50.259999999999998 108.21 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.6 -65.81 0.63 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.44 0.638 . . . . 24.170000000000002 110.887 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.01 -28.29 37.29 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.468 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.42 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -48.45 73.51 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.683 -0.858 . . . . 28.030000000000001 108.683 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.668 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.84 -33.87 72.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.762 -1.199 . . . . 40.960000000000001 107.762 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 98' ' ' LEU . 8.1 mp -70.1 -38.0 75.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.29 -1.004 . . . . 15.050000000000001 108.29 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -64.93 -58.03 7.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.917 -0.49 . . . . 0.0 111.635 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.39 -28.36 3.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.914 -1.116 . . . . 38.640000000000001 111.087 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -103.74 -19.8 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.709 -1.244 . . . . 0.0 109.214 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.39 41.89 7.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.38 -1.088 . . . . 18.539999999999999 110.38 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.78 -13.97 49.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -1.205 . . . . 10.84 109.437 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.07 -176.37 3.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 109.367 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.121 -0.987 . . . . 0.0 109.609 179.867 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -56.86 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 20.030000000000001 109.846 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 59' ' ' TYR . 14.9 m -73.14 -39.7 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.65 -0.656 . . . . 12.91 110.964 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -57.21 -34.26 68.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.797 -1.189 . . . . 28.329999999999998 109.973 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m -74.14 -13.59 60.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.021 -1.05 . . . . 0.0 109.426 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -96.98 -52.42 3.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 22.870000000000001 110.3 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.19 126.29 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 25.190000000000001 109.989 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.13 155.37 40.03 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.121 -1.066 . . . . 34.609999999999999 108.121 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.25 132.35 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.926 1.751 . . . . 11.720000000000001 111.411 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 22.75 64.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.767 -0.933 . . . . 10.24 110.767 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.77 135.1 27.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.875 -1.368 . . . . 25.359999999999999 110.121 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.15 135.42 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 10.890000000000001 108.99 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.33 141.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.39 -0.967 . . . . 15.82 108.39 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.386 -0.821 . . . . 8.9399999999999995 110.426 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -90.86 119.04 30.74 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.148 -1.427 . . . . 9.9299999999999997 107.148 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.32 -175.04 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.294 1.045 . . . . 10.619999999999999 111.178 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.76 ' O ' ' N ' ' A' ' 21' ' ' THR . 21.6 mtmt -146.19 88.65 6.21 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.459 -1.682 . . . . 38.729999999999997 106.459 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.457 ' O ' ' CG2' ' A' ' 21' ' ' THR . 12.9 Cg_exo -46.76 69.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.016 1.81 . . . . 24.579999999999998 110.921 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.76 ' N ' ' O ' ' A' ' 19' ' ' LYS . 20.8 p -162.3 -36.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.007 -1.108 . . . . 34.82 108.007 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 128.94 32.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 21.460000000000001 109.469 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.98 -20.2 43.88 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.056 1.837 . . . . 13.859999999999999 111.756 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.66 -40.89 72.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.677 -1.265 . . . . 0.0 108.518 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -36.48 83.67 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.553 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -65.14 -36.06 83.07 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.792 -0.818 . . . . 59.590000000000003 108.792 178.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.683 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -56.54 -50.67 71.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 109.243 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.03 67.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.24 -36.89 74.78 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.282 -0.886 . . . . 45.490000000000002 108.696 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 67.1 mm-40 -71.4 -39.69 70.97 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.811 -0.555 . . . . 34.969999999999999 111.4 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -77.15 -65.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.837 -1.165 . . . . 0.0 110.925 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' H ' HG21 ' A' ' 31' ' ' ILE . 3.1 mt -52.8 -22.77 5.75 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.853 -1.155 . . . . 17.280000000000001 110.191 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 5.0 p -66.64 -26.17 66.94 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.755 -1.215 . . . . 24.109999999999999 108.773 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -93.3 4.11 54.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.373 -0.829 . . . . 44.07 110.506 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 37' ' ' ILE . 16.5 mt -90.46 131.46 38.18 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.83 -1.168 . . . . 19.629999999999999 109.385 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -66.67 66.72 0.53 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.898 1.732 . . . . 21.539999999999999 110.132 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' LYS . 1.9 mm -81.67 153.37 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.214 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.2 mmmm -54.05 -168.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 29.41 110.028 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' LYS . 40.1 mt-30 -51.78 -134.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.6 0.714 . . . . 0.0 110.831 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.09 54.57 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.063 -1.215 . . . . 15.27 110.063 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.37 -17.69 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.402 -1.058 . . . . 8.7799999999999994 109.241 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.3 tp -105.54 130.33 53.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.64 -0.874 . . . . 7.1299999999999999 108.64 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 28.8 tt0 -139.37 173.51 11.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 22.030000000000001 110.17 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.511 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 40.0 m-85 -134.58 110.82 9.58 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.782 -1.192 . . . . 16.329999999999998 107.782 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.3 t -96.19 104.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 6.5800000000000001 111.621 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.33 103.19 10.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.055 -1.091 . . . . 15.32 108.055 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.7 pt -62.41 -3.85 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 10.92 110.811 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -93.8 -15.83 24.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.286 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.04 10.8 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 22.449999999999999 109.467 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 15.3 t -142.86 -18.53 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.248 -0.907 . . . . 25.629999999999999 110.059 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 50' ' ' THR . 0.5 OUTLIER 84.33 -170.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.597 -0.689 . . . . 0.0 109.452 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER 56.17 24.21 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 108.792 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 8.7 p -42.84 -52.83 4.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 18.870000000000001 110.394 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.9 m-20 -52.63 -34.72 52.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 45.210000000000001 110.481 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -64.69 -45.09 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.129 . . . . 33.020000000000003 109.28 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.43 -50.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.05 -1.032 . . . . 9.8399999999999999 109.43 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.0 mt-30 -57.65 -39.54 77.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.5 -1.375 . . . . 17.84 107.447 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 11.8 m-20 -56.31 -32.56 64.74 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.189 -1.412 . . . . 18.84 107.189 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 5' ' ' VAL . 5.4 t80 -76.13 -51.56 11.95 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.064 -0.717 . . . . 12.99 109.064 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.493 ' O ' ' OG1' ' A' ' 64' ' ' THR . 22.5 mt -54.22 -32.06 54.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.059 -1.089 . . . . 14.609999999999999 108.059 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.3 tp-100 -63.2 -56.5 16.1 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.458 -0.777 . . . . 40.450000000000003 110.167 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -55.59 15.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 41.810000000000002 111.733 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -31.56 72.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.904 -1.122 . . . . 21.77 111.229 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.6 p -109.9 -63.32 1.39 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.974 -1.079 . . . . 11.380000000000001 109.81 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 140.73 -45.59 0.97 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.944 -1.662 . . . . 14.789999999999999 108.944 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.638 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.05 138.49 35.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.983 . . . . 17.809999999999999 109.261 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.939 ' HG2' HH11 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -107.64 26.43 10.29 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.912 -1.144 . . . . 29.760000000000002 107.912 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 173.26 12.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.743 -0.598 . . . . 18.260000000000002 109.588 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.5 t -117.79 137.64 24.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 8.1999999999999993 108.559 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.72 -165.73 3.98 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.678 -0.968 . . . . 7.79 110.585 -0.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.638 ' NH1' ' O ' ' A' ' 66' ' ' ALA . 1.8 tpt180 -148.46 98.08 2.84 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.848 -1.908 . . . . 26.050000000000001 105.848 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.16 159.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -0.87 . . . . 8.6799999999999997 111.219 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -145.34 94.9 2.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.7 -0.625 . . . . 14.07 110.783 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 74' ' ' ILE . 6.7 mm -72.92 105.59 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.775 -1.935 . . . . 9.3399999999999999 105.775 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.07 -147.25 48.96 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.723 -2.951 . . . . 12.42 105.723 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -84.37 3.44 35.89 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.477 -1.602 . . . . 44.859999999999999 108.791 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.652 ' CB ' HH21 ' A' ' 97' ' ' ARG . 74.7 m-20 -89.94 109.06 20.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.479 -0.763 . . . . 0.0 110.756 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 t -74.05 145.14 44.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 109.281 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -113.33 -22.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.205 -0.935 . . . . 20.449999999999999 109.33 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.478 ' HA2' HH21 ' A' ' 71' ' ' ARG . . . 134.62 -154.44 21.48 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.788 -1.325 . . . . 13.82 109.788 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -101.13 -142.85 13.19 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.005 -1.238 . . . . 12.42 110.005 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -66.07 0.68 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.444 -1.033 . . . . 0.0 110.501 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t -51.65 -24.48 5.63 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -74.97 -47.95 26.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.373 -0.829 . . . . 27.059999999999999 109.369 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -55.03 -58.8 6.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.434 -0.791 . . . . 15.31 110.516 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -47.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.805 . . . . 0.0 110.664 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -43.25 47.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 21.789999999999999 109.172 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.9 mt -72.86 -41.08 65.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 111.984 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.4 -57.22 13.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.846 -1.159 . . . . 0.0 110.615 -177.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -25.45 67.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 109.323 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.5 m -82.58 -19.24 38.85 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.37 64.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.273 -1.131 . . . . 25.640000000000001 110.273 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.67 -25.35 65.66 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.143 -1.21 . . . . 50.259999999999998 109.152 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.62 -63.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 24.170000000000002 110.295 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -52.17 -27.36 14.15 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.456 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -62.71 -48.13 80.6 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.417 -0.913 . . . . 28.030000000000001 108.678 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.675 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.5 mmm180 -60.42 -32.91 71.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.036 . . . . 40.960000000000001 108.539 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 98' ' ' LEU . 8.4 mp -71.96 -39.43 69.35 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.399 -0.813 . . . . 15.050000000000001 109.243 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -65.74 -52.03 54.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.646 -0.658 . . . . 0.0 111.876 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.675 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -47.83 -34.2 8.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 38.640000000000001 110.404 -178.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.7 pt -101.98 -11.37 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.846 -1.159 . . . . 0.0 109.268 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 43.58 14.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.427 -1.069 . . . . 18.539999999999999 110.427 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.52 -17.18 34.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.162 -1.199 . . . . 10.84 109.67 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 3.8 pp -97.46 -177.48 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.631 -179.95 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.4 pt-20 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.819 -0.808 . . . . 2.1800000000000002 108.819 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.98 -72.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.58999999999999997 109.788 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.53 -36.32 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.1000000000000001 110.317 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -58.37 -36.58 73.72 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.795 -1.19 . . . . 2.0 109.655 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 66.3 m -73.81 -13.35 60.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.92000000000000004 109.302 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -97.19 -48.65 5.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 1.8200000000000001 110.329 -179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.0 125.44 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.777 -1.202 . . . . 1.04 109.018 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.3 148.32 31.29 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.327 -0.99 . . . . 2.5699999999999998 108.327 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.21 135.93 30.92 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.196 1.931 . . . . 0.34000000000000002 111.741 -178.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.17 72.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.386 -1.085 . . . . 0.28000000000000003 110.386 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -144.11 140.05 29.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.022 -1.281 . . . . 2.1699999999999999 110.233 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.94 137.17 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 1.04 109.515 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.38 143.47 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 1.05 108.505 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.2 t -125.0 123.79 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 1.02 110.584 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -91.49 119.99 31.92 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.126 -1.435 . . . . 0.20000000000000001 107.126 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -131.28 -173.17 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.312 1.053 . . . . 1.04 111.676 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 27.1 mtmt -147.13 90.94 5.24 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 106.926 -1.509 . . . . 1.8700000000000001 106.926 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -45.9 75.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.507 1.472 . . . . 0.41999999999999998 110.383 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.2 m -169.21 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.927 -0.768 . . . . 1.8500000000000001 108.927 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.56 131.5 25.82 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.23000000000000001 110.266 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -60.04 -19.68 57.12 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 122.249 1.966 . . . . 0.37 112.054 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -70.22 -41.38 73.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.764 -1.21 . . . . 0.81000000000000005 109.026 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -33.71 76.66 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.36 -0.936 . . . . 1.4299999999999999 108.592 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.38 -45.43 93.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 108.779 179.483 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.64 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -49.22 -46.75 46.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.958 -1.088 . . . . 3.1899999999999999 109.589 -179.396 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.76 80.96 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.14 -1.024 . . . . 1.03 108.559 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -69.06 -46.62 67.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 1.9199999999999999 109.868 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -37.84 85.14 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.607 -0.683 . . . . 1.8700000000000001 111.231 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.5 -54.8 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.81 -1.181 . . . . 1.21 110.861 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 4.4 mt -58.18 -20.79 43.9 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.675 -1.266 . . . . 1.03 108.987 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -66.87 -28.08 68.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 1.8500000000000001 109.404 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -91.22 3.09 55.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 1.6499999999999999 109.896 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' ILE . 15.6 mt -91.5 127.01 52.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 1.0800000000000001 109.556 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.14 65.24 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.922 1.748 . . . . 0.29999999999999999 109.916 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.503 HG22 HD11 ' A' ' 37' ' ' ILE . 15.1 mm -78.45 146.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.574 -0.898 . . . . 1.04 108.574 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.1 mttt -52.59 -178.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -0.984 . . . . 2.3599999999999999 108.807 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.531 ' O ' ' O ' ' A' ' 38' ' ' LYS . 47.6 mt-30 -52.05 -123.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.994 -1.066 . . . . 3.3100000000000001 111.948 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.42 49.36 0.06 OUTLIER Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.439 -0.788 . . . . 0.88 111.534 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -105.05 -24.76 12.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.265 . . . . 1.05 109.395 179.136 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 37' ' ' ILE . 18.8 tp -102.58 131.4 49.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 1.05 109.086 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 161.9 36.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 2.0099999999999998 109.897 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -125.02 116.49 22.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.435 -1.32 . . . . 0.20000000000000001 107.435 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.71 105.31 17.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.446 -0.784 . . . . 1.0700000000000001 111.997 -177.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.75 100.43 8.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.011 -1.107 . . . . 1.1200000000000001 108.011 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 pt -61.96 -2.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 1.1200000000000001 111.589 -178.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 -22.11 18.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.705 -1.247 . . . . 1.8799999999999999 109.222 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.63 15.6 1.0 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 1.27 109.341 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 4.11 1.44 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.068 -1.02 . . . . 1.1100000000000001 109.976 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 65.98 -175.6 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 2.9700000000000002 109.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 53' ' ' THR . 6.0 m170 59.59 18.99 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 2.8700000000000001 109.754 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 53' ' ' THR . 0.0 OUTLIER -34.47 -65.14 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.542 -0.724 . . . . 1.24 110.377 -179.685 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 3.6 m-20 -54.73 -36.64 64.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 1.98 111.37 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.91 -45.45 92.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.641 -1.287 . . . . 2.1200000000000001 109.713 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.03 -51.94 54.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.998 -1.064 . . . . 1.0900000000000001 109.002 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.79 -42.94 85.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.784 -1.198 . . . . 0.63 107.774 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -56.35 -32.86 65.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.182 -1.414 . . . . 1.1200000000000001 107.182 178.129 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -79.03 -50.91 10.33 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.011 -0.737 . . . . 1.6699999999999999 109.011 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.9 mt -54.68 -28.1 45.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.007 -1.058 . . . . 1.04 108.221 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 7.2 tp60 -63.1 -56.44 16.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.709 . . . . 1.97 109.652 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -69.75 -38.05 76.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.447 -0.783 . . . . 2.9100000000000001 110.749 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.85 -40.52 95.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.125 -0.984 . . . . 1.5600000000000001 110.164 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.9 p -113.09 -70.8 0.79 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 109.266 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.85 -36.2 0.67 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.411 -1.476 . . . . 0.35999999999999999 109.411 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HB2' ' NH2' ' A' ' 71' ' ' ARG . . . -102.21 130.15 48.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 1.0900000000000001 110.292 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 25.36 5.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.565 -1.272 . . . . 2.1200000000000001 107.565 177.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.95 167.81 20.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.658 0.742 . . . . 1.04 110.04 -179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.72 136.92 22.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 1.04 107.438 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -78.46 -165.02 4.3 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 CA-C-O 122.562 0.984 . . . . 0.26000000000000001 111.871 -0.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -146.6 90.71 1.95 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.453 -2.054 . . . . 2.9199999999999999 105.453 177.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 73' ' ' PHE . 22.0 t -84.25 151.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 1.05 111.394 -176.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' N ' HG11 ' A' ' 72' ' ' VAL . 67.0 m-85 -141.85 92.25 2.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.797 -0.565 . . . . 0.23999999999999999 110.284 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.3 mm -71.65 107.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.576 -2.009 . . . . 1.22 105.576 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.84 -147.59 50.45 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.505 -2.638 . . . . 0.20999999999999999 106.505 -176.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.34 -4.89 59.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.539 -1.565 . . . . 2.4199999999999999 109.356 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.747 ' HB3' HH21 ' A' ' 97' ' ' ARG . 11.9 m-20 -89.03 117.22 27.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.096 -1.003 . . . . 1.26 110.76 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -74.31 151.68 39.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 1.03 110.092 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.47 -19.48 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 1.3 109.377 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.68 -150.38 19.51 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.176 -1.17 . . . . 0.31 110.176 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.07 -142.02 11.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.343 -1.103 . . . . 0.32000000000000001 110.343 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.78 -61.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.539 -0.977 . . . . 1.3 110.271 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -53.57 -27.61 27.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.457 -0.777 . . . . 0.93000000000000005 109.622 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.09 -45.64 56.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.306 -0.871 . . . . 1.6000000000000001 109.07 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 6.2 tt -56.5 -64.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.629 -0.67 . . . . 1.0800000000000001 109.732 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.53 -47.52 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 1.04 110.11 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -48.43 47.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.905 -1.122 . . . . 1.3999999999999999 109.288 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.18 -31.89 62.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.27 -0.894 . . . . 1.05 111.553 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -61.36 -60.27 3.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.574 -1.328 . . . . 2.0600000000000001 109.372 -178.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -25.74 67.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 3.2200000000000002 110.514 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.8 m -79.61 -25.29 41.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.234 -0.917 . . . . 0.81999999999999995 110.783 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.48 -11.43 70.18 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.11 -1.196 . . . . 0.5 110.11 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.95 -31.26 70.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 1.95 108.567 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.86 -63.34 1.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.475 -0.766 . . . . 1.0800000000000001 110.638 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -54.95 -30.22 58.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.457 -0.942 . . . . 1.0800000000000001 108.457 -178.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.2 m -65.34 -41.55 93.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.989 -1.115 . . . . 1.1100000000000001 107.989 178.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.747 HH21 ' HB3' ' A' ' 77' ' ' ASP . 1.2 tpt180 -64.6 -34.84 79.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.332 -0.988 . . . . 3.0499999999999998 108.332 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.4 mp -71.74 -32.93 68.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.409 -0.807 . . . . 1.1000000000000001 109.023 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -70.0 -57.26 5.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 2.2799999999999998 111.84 -178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -44.88 -30.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.688 -1.258 . . . . 0.40999999999999998 110.407 -177.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.6 pt -104.65 -15.76 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.949 -1.094 . . . . 1.05 108.885 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.3 43.56 10.45 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.346 -1.102 . . . . 0.17999999999999999 110.346 179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -13.38 49.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.068 -1.254 . . . . 0.98999999999999999 109.564 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.437 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 2.4 pt? -95.02 -175.32 3.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 1.73 109.326 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.943 -1.027 . . . . 2.2400000000000002 108.984 179.206 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.515 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.475 -0.565 . . . . 18.329999999999998 109.475 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -111.84 -75.26 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 29.77 109.23 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.4 -10.15 2.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.11 -71.18 0.15 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 20.030000000000001 110.153 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.6 m -73.18 -40.84 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.442 -0.786 . . . . 12.91 110.489 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.8 m120 -55.98 -34.06 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 110.38 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.5 m -74.54 -18.33 60.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.922 -1.111 . . . . 0.0 110.349 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' NZ ' ' CZ ' ' A' ' 17' ' ' PHE . 5.2 mtpm? -98.0 -42.5 7.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.077 . . . . 22.870000000000001 111.442 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.34 126.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.728 -1.233 . . . . 25.190000000000001 109.696 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.61 159.07 35.1 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.956 -1.127 . . . . 34.609999999999999 107.956 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.09 136.56 61.63 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.789 1.659 . . . . 11.720000000000001 111.501 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.04 73.3 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.71 -0.956 . . . . 10.24 110.71 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -140.57 130.63 24.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.253 . . . . 25.359999999999999 109.536 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -101.54 133.81 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.46 -0.775 . . . . 10.890000000000001 109.876 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.36 137.48 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.277 -1.009 . . . . 15.82 108.277 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 45' ' ' VAL . 44.0 t -120.54 128.54 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.366 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' ' NZ ' ' A' ' 8' ' ' LYS . 80.8 m-85 -95.34 118.78 32.71 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.142 -1.058 . . . . 9.9299999999999997 108.142 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.25 -176.21 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.485 1.136 . . . . 10.619999999999999 111.42 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.4 mtmt -145.02 93.16 5.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.766 -1.938 . . . . 38.729999999999997 105.766 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -48.32 82.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.369 1.379 . . . . 24.579999999999998 110.577 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -177.78 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.047 -0.723 . . . . 34.82 109.047 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.12 126.81 38.77 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 21.460000000000001 109.099 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.18 -22.98 42.71 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.465 2.11 . . . . 13.859999999999999 113.061 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -67.89 -43.15 79.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.332 -1.48 . . . . 0.0 109.44 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.07 -38.14 89.99 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.41 -40.06 93.0 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.419 -0.956 . . . . 59.590000000000003 108.419 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.623 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.31 -45.2 68.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.8 78.69 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.38 -36.14 73.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.299 -0.876 . . . . 45.490000000000002 109.076 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -70.08 -41.69 73.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.761 -0.587 . . . . 34.969999999999999 111.14 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' CG2' ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -72.58 -69.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.899 -1.126 . . . . 0.0 110.591 -178.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' H ' ' CG2' ' A' ' 31' ' ' ILE . 5.0 mt -51.64 -16.58 0.66 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.136 -0.978 . . . . 17.280000000000001 110.022 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.84 -29.78 68.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.012 -1.055 . . . . 24.109999999999999 108.292 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -93.41 1.65 56.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.481 -0.762 . . . . 44.07 110.617 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 mt -88.02 128.66 53.0 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.806 -1.184 . . . . 19.629999999999999 109.111 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -69.49 70.14 1.46 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.656 1.571 . . . . 21.539999999999999 109.73 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.2 mm -80.68 155.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.211 -0.931 . . . . 0.0 109.395 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.3 mmtp -54.36 -168.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.205 -0.935 . . . . 29.41 109.771 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 38' ' ' LYS . 71.0 mt-30 -54.76 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.692 0.758 . . . . 0.0 111.413 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 52.8 0.34 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.452 -1.059 . . . . 15.27 110.452 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 -32.46 11.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -1.109 . . . . 8.7799999999999994 109.158 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 tp -95.57 135.19 37.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.39 -0.596 . . . . 7.1299999999999999 109.39 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 26.2 tt0 -143.76 172.4 12.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 22.030000000000001 109.94 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 55.7 m-85 -133.06 111.0 10.6 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.272 -1.381 . . . . 16.329999999999998 107.272 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' VAL . 53.0 t -96.16 106.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 6.5800000000000001 112.279 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 48' ' ' THR . 42.4 m-20 -83.54 98.08 9.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.872 -0.788 . . . . 15.32 108.872 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 pt -62.05 2.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 10.92 110.657 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 46' ' ' ASP . 1.8 p -96.55 -35.53 11.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.003 -1.061 . . . . 21.719999999999999 109.372 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.81 28.81 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 22.449999999999999 109.775 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 48' ' ' THR . 12.4 t -144.49 -3.55 0.81 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.047 -1.033 . . . . 25.629999999999999 110.145 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.676 HD21 ' CD2' ' A' ' 52' ' ' HIS . 5.4 t30 69.94 -179.14 0.23 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 109.159 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' HD21 ' A' ' 51' ' ' ASN . 0.1 OUTLIER 53.98 27.22 7.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 108.563 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -43.07 -55.97 3.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.377 -0.827 . . . . 18.870000000000001 110.442 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -59.46 -32.69 70.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 45.210000000000001 111.225 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.6 mp0 -62.12 -44.55 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.786 -1.196 . . . . 33.020000000000003 110.256 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.87 -54.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.788 -1.195 . . . . 9.8399999999999999 109.628 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.63 -44.81 77.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.671 -1.233 . . . . 17.84 107.671 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -54.37 -34.41 61.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.937 -1.505 . . . . 18.84 106.937 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 1' ' ' ALA . 33.5 t80 -78.26 -45.77 21.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.904 -0.776 . . . . 12.99 108.904 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.5 mt -53.75 -35.82 61.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.721 -1.215 . . . . 14.609999999999999 107.721 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 18.3 tp60 -60.47 -57.46 12.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.235 0.54 . . . . 40.450000000000003 109.66 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -67.48 -35.22 78.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 41.810000000000002 110.113 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.58 -48.64 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.948 . . . . 21.77 109.925 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -111.58 -63.9 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 11.380000000000001 109.468 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.45 -45.9 0.53 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.692 -1.242 . . . . 14.789999999999999 110.043 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.57 26.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -1.16 . . . . 17.809999999999999 110.283 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -110.94 31.21 6.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 29.760000000000002 109.132 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.45 167.58 16.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 18.260000000000002 111.056 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.683 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.2 t -111.14 133.88 21.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.956 -1.127 . . . . 8.1999999999999993 107.956 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD2' ' H ' ' A' ' 82' ' ' SER . 19.4 Cg_endo -81.04 -165.46 4.5 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.577 0.991 . . . . 7.79 111.918 -0.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.448 ' NH1' ' HG ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -148.55 91.76 1.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 105.884 -1.895 . . . . 26.050000000000001 105.884 177.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.3 157.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.288 -0.882 . . . . 8.6799999999999997 112.181 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.91 90.45 2.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.677 -0.639 . . . . 14.07 111.262 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -71.91 115.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.132 -2.173 . . . . 9.3399999999999999 105.132 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.45 -153.12 32.87 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 105.85 -2.9 . . . . 12.42 105.85 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -83.77 0.18 48.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.31 -1.7 . . . . 44.859999999999999 109.436 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -89.52 118.81 29.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.256 -0.902 . . . . 0.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HG ' ' NH1' ' A' ' 71' ' ' ARG . 30.8 t -76.35 142.67 41.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.79 -17.68 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.053 -1.029 . . . . 20.449999999999999 109.214 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 -157.61 21.8 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.303 -1.119 . . . . 13.82 110.303 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.78 -147.13 19.7 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.048 -1.221 . . . . 12.42 110.048 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.62 -61.11 1.92 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.492 -1.005 . . . . 0.0 109.688 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -51.02 -25.11 4.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.25 -49.31 19.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.496 -0.753 . . . . 27.059999999999999 109.183 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.457 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -54.02 -59.19 4.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 15.31 110.08 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -50.24 -51.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 91' ' ' SER . 7.7 m -45.67 -36.78 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 21.789999999999999 108.96 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.04 -41.92 27.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.508 -0.745 . . . . 0.0 111.344 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -58.13 -57.14 14.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.916 -1.115 . . . . 0.0 110.022 -178.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.9 -26.59 68.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.361 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 87' ' ' SER . 48.9 m -81.88 -20.44 38.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.452 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.33 -8.03 73.14 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.512 -1.035 . . . . 25.640000000000001 110.512 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.88 -24.48 64.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.036 -1.273 . . . . 50.259999999999998 108.371 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 tp -61.74 -66.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.624 0.726 . . . . 24.170000000000002 110.899 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.06 -28.28 16.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -48.11 76.11 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.143 -1.058 . . . . 28.030000000000001 108.143 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.83 -34.22 71.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.832 -1.173 . . . . 40.960000000000001 107.832 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.404 HD13 ' N ' ' A' ' 98' ' ' LEU . 8.9 mp -70.92 -39.98 72.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.677 -0.86 . . . . 15.050000000000001 108.677 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.78 -55.66 21.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.83 -0.544 . . . . 0.0 111.599 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -29.29 9.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.86 -1.15 . . . . 38.640000000000001 110.93 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.2 pt -101.28 -19.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.747 -1.22 . . . . 0.0 109.08 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.78 40.53 8.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.288 -1.125 . . . . 18.539999999999999 110.288 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.08 -13.54 50.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -1.21 . . . . 10.84 109.684 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.573 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.57 176.21 6.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.716 -179.792 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.683 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.438 -0.578 . . . . 18.329999999999998 109.438 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 4' ' ' PHE . 47.3 tt0 -166.24 -83.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 29.77 109.096 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.84 -6.99 0.88 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.135 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.7 m-85 -62.58 -68.45 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.812 . . . . 20.030000000000001 110.664 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.43 -38.37 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 12.91 110.438 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 32.9 m120 -55.08 -37.56 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 28.329999999999998 109.483 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 m -75.11 -12.77 60.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.974 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -97.13 -46.05 6.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.109 -0.994 . . . . 22.870000000000001 110.865 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.82 136.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.852 -1.155 . . . . 25.190000000000001 109.906 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -146.92 153.28 45.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.766 -0.827 . . . . 34.609999999999999 108.766 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.14 131.71 44.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.644 1.562 . . . . 11.720000000000001 110.323 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.62 26.93 70.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.673 -1.371 . . . . 10.24 109.673 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -139.48 135.35 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -1.131 . . . . 25.359999999999999 109.363 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.63 135.6 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.304 -0.872 . . . . 10.890000000000001 109.92 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.49 141.9 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.847 -1.168 . . . . 15.82 107.847 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.68 124.79 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 8.9399999999999995 110.917 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -90.1 123.89 34.34 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.365 -1.346 . . . . 9.9299999999999997 107.365 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.4 pt -133.48 -176.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.19 0.995 . . . . 10.619999999999999 111.235 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.6 mtmt -145.02 93.49 5.52 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 106.455 -1.683 . . . . 38.729999999999997 106.455 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -46.87 80.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.691 1.594 . . . . 24.579999999999998 110.896 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.626 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.5 m -175.39 -37.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.794 -0.817 . . . . 34.82 108.794 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 128.97 31.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.283 -0.886 . . . . 21.460000000000001 110.018 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.67 -14.65 37.15 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.999 1.799 . . . . 13.859999999999999 112.158 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -69.05 -45.43 70.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.648 -1.282 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 108.94 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.539 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -64.45 -55.84 18.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.549 -0.719 . . . . 59.590000000000003 110.343 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 4.8 ptp180 -50.36 -35.68 29.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.548 -1.345 . . . . 0.0 109.118 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' A' ' 27' ' ' ARG . . . -62.22 -36.82 83.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -71.66 -48.67 46.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.615 -0.678 . . . . 45.490000000000002 109.666 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.76 -31.42 70.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.563 -0.711 . . . . 34.969999999999999 111.023 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.31 -55.26 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.673 -1.267 . . . . 0.0 109.677 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 3.4 mt -59.89 -21.96 61.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.642 -1.286 . . . . 17.280000000000001 109.146 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -64.86 -26.7 68.44 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.523 -0.917 . . . . 24.109999999999999 108.523 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -90.95 3.17 55.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.553 -0.717 . . . . 44.07 110.38 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' ILE . 17.0 mt -91.21 127.99 49.08 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.805 -1.184 . . . . 19.629999999999999 109.494 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -64.99 68.58 0.27 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 121.676 1.584 . . . . 21.539999999999999 109.663 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 4.2 mm -82.98 151.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' O ' ' A' ' 39' ' ' GLN . 42.7 mmtt -53.41 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.265 -0.897 . . . . 29.41 109.854 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.613 ' O ' ' O ' ' A' ' 38' ' ' LYS . 6.1 mp0 -50.64 -128.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.645 0.736 . . . . 0.0 110.788 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 49.46 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 O-C-N 121.022 -1.049 . . . . 15.27 110.501 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -98.47 -13.83 20.34 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.229 -1.159 . . . . 8.7799999999999994 109.62 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -107.76 129.01 55.08 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.617 -0.883 . . . . 7.1299999999999999 108.617 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.54 165.39 27.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.063 -1.023 . . . . 22.030000000000001 110.443 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -128.39 112.98 15.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.759 -1.201 . . . . 16.329999999999998 107.759 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.6 106.92 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 6.5800000000000001 111.326 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -81.99 101.98 10.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.53 -0.915 . . . . 15.32 108.53 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.26 -5.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.001 -1.062 . . . . 10.92 110.762 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 50' ' ' THR . 7.0 t -95.27 -23.15 17.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 21.719999999999999 109.432 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 18.33 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 22.449999999999999 109.613 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 11.2 t -144.39 -2.96 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.118 -0.989 . . . . 25.629999999999999 110.139 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.0 m-20 74.88 -176.97 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.071 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.426 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 55.62 27.57 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 108.724 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.84 -59.58 2.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 18.870000000000001 110.186 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -58.06 -28.69 64.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 45.210000000000001 110.964 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -64.34 -44.92 90.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.714 -1.241 . . . . 33.020000000000003 109.54 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.41 -53.73 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.919 -1.113 . . . . 9.8399999999999999 109.434 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.29 -41.46 75.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.663 -1.236 . . . . 17.84 107.663 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.86 -33.4 64.51 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.293 -1.373 . . . . 18.84 107.293 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -77.6 -47.62 18.91 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.871 -0.789 . . . . 12.99 108.871 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' OG1' ' A' ' 64' ' ' THR . 69.6 mt -54.3 -36.11 63.34 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.211 -1.033 . . . . 14.609999999999999 108.211 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.5 tp60 -58.24 -51.54 69.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.758 -0.589 . . . . 40.450000000000003 109.551 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -66.44 -52.93 41.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.096 -1.003 . . . . 41.810000000000002 111.073 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.52 -31.76 73.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 21.77 110.813 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 19.2 p -112.35 -70.62 0.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.179 -0.95 . . . . 11.380000000000001 109.856 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 145.98 -43.09 0.92 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.001 -1.64 . . . . 14.789999999999999 109.001 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB2' HH21 ' A' ' 71' ' ' ARG . . . -98.67 131.64 44.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -1.045 . . . . 17.809999999999999 110.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 33.02 2.72 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 29.760000000000002 108.962 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 174.05 11.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.44 -0.787 . . . . 18.260000000000002 110.769 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.1 t -122.48 136.81 26.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.473 -0.936 . . . . 8.1999999999999993 108.473 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.738 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 41.5 Cg_endo -84.87 -173.63 10.52 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.897 -0.876 . . . . 7.79 109.867 0.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.738 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -136.52 102.69 5.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.375 -2.084 . . . . 26.050000000000001 105.375 176.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 73' ' ' PHE . 94.4 t -88.5 158.99 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.71 0.767 . . . . 8.6799999999999997 111.527 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.402 ' N ' ' CG1' ' A' ' 72' ' ' VAL . 60.0 m-85 -145.3 87.37 1.8 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.769 -0.582 . . . . 14.07 110.62 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.4 mp -71.36 107.94 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 105.926 -1.879 . . . . 9.3399999999999999 105.926 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.96 -154.53 53.09 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.492 -2.643 . . . . 12.42 106.492 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -82.89 -3.42 56.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.556 -1.556 . . . . 44.859999999999999 109.289 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.74 117.07 28.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 0.0 110.59 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.8 t -72.66 153.04 41.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.085 -1.01 . . . . 0.0 109.385 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.35 -29.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 20.449999999999999 109.614 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.67 -136.2 7.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.439 -1.465 . . . . 13.82 109.439 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -115.38 -145.77 8.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.473 -1.451 . . . . 12.42 109.473 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.44 -57.76 4.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 109.795 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -52.76 -27.59 18.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.496 -0.753 . . . . 0.0 109.242 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.64 -49.14 27.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -0.83 . . . . 27.059999999999999 109.085 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 3.2 tt -52.74 -60.94 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 15.31 109.554 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.466 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.85 -49.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.819 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 t -48.78 -48.5 41.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.803 -1.185 . . . . 21.789999999999999 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.8 mt -70.01 -39.72 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 110.978 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.17 -57.55 12.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 110.728 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.45 -23.92 67.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.977 -1.077 . . . . 0.0 109.203 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -81.96 -22.01 36.9 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 109.506 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.19 -10.44 74.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.885 -1.286 . . . . 25.640000000000001 109.885 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.03 -31.43 71.09 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.197 . . . . 50.259999999999998 109.405 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.88 -60.46 3.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 24.170000000000002 110.413 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.24 -32.32 62.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.601 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.433 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.97 -44.54 92.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.942 -1.133 . . . . 28.030000000000001 107.942 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 5.5 ttt180 -61.32 -37.39 83.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.23 -1.026 . . . . 40.960000000000001 108.23 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.52 -33.94 69.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.38 -0.97 . . . . 15.050000000000001 108.38 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -65.53 -56.56 11.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.827 -0.546 . . . . 0.0 111.572 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.6 OUTLIER -48.18 -33.25 8.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 38.640000000000001 110.521 -178.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.9 pt -101.5 -9.35 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.97 42.01 31.13 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.399 -1.08 . . . . 18.539999999999999 110.399 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.38 -15.41 43.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -1.187 . . . . 10.84 109.189 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.76 -172.99 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.736 -179.839 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.659 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.317 0.579 . . . . 18.329999999999998 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 4' ' ' PHE . 1.3 pt20 -151.78 -77.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 29.77 108.778 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.43 -7.6 0.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.4 m-85 -61.84 -68.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.695 -0.628 . . . . 20.030000000000001 110.731 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -73.48 -40.04 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.355 -0.841 . . . . 12.91 110.365 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 17.6 m-20 -55.21 -37.46 67.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.982 -1.074 . . . . 28.329999999999998 109.104 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m -74.71 -12.68 60.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.97 -47.2 5.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 22.870000000000001 110.362 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.85 136.18 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.862 -1.148 . . . . 25.190000000000001 109.964 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -146.87 154.19 46.96 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.369 -0.975 . . . . 34.609999999999999 108.369 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.06 130.83 42.36 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.413 1.409 . . . . 11.720000000000001 109.97 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.01 64.67 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.785 -1.326 . . . . 10.24 109.785 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -138.9 132.77 30.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 25.359999999999999 109.401 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.1 t -102.68 127.54 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.253 -0.904 . . . . 10.890000000000001 109.4 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.29 140.7 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.507 -0.923 . . . . 15.82 108.507 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.3 t -122.27 124.22 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.346 -0.846 . . . . 8.9399999999999995 111.088 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -92.51 116.33 28.89 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.192 . . . . 9.9299999999999997 107.783 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 pt -127.65 -178.97 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.308 1.051 . . . . 10.619999999999999 111.47 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.7 mtmt -140.72 90.99 9.5 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 105.749 -1.945 . . . . 38.729999999999997 105.749 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.1 Cg_exo -47.14 80.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.718 1.612 . . . . 24.579999999999998 110.52 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 19' ' ' LYS . 17.9 m -175.68 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.571 -0.9 . . . . 34.82 108.571 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.3 124.24 47.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.374 -0.829 . . . . 21.460000000000001 109.66 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.28 -16.39 17.45 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 122.299 1.999 . . . . 13.859999999999999 112.901 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.34 -42.38 65.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.517 -1.364 . . . . 0.0 109.846 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -31.72 73.08 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -61.5 -40.39 94.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.639 -0.875 . . . . 59.590000000000003 108.639 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.584 HH11 ' HG2' ' A' ' 27' ' ' ARG . 13.5 mtt-85 -54.28 -48.26 71.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 108.679 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.28 74.25 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.366 -0.834 . . . . 0.0 109.072 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -71.38 -45.74 62.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.817 . . . . 45.490000000000002 109.524 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 33' ' ' SER . 37.5 mt-10 -70.53 -32.86 70.48 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.599 -0.688 . . . . 34.969999999999999 110.927 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.4 -57.02 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.818 -1.176 . . . . 0.0 110.796 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -59.54 -22.02 61.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.632 -1.292 . . . . 17.280000000000001 109.818 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 8.9 p -64.51 -23.31 67.23 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.122 -0.986 . . . . 24.109999999999999 108.708 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -93.05 -1.28 56.71 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.442 -0.786 . . . . 44.07 110.048 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.63 128.7 51.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.864 -1.147 . . . . 19.629999999999999 108.996 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.06 67.9 0.94 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.685 1.59 . . . . 21.539999999999999 109.581 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm -80.14 148.97 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 39' ' ' GLN . 52.3 mttt -53.65 -167.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.553 -0.717 . . . . 29.41 110.271 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.7 mm100 -52.65 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.758 0.789 . . . . 0.0 111.519 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.5 51.65 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.533 -1.027 . . . . 15.27 110.533 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.55 -28.55 13.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.463 -1.022 . . . . 8.7799999999999994 108.636 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.14 130.8 44.35 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.598 -0.89 . . . . 7.1299999999999999 108.598 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.2 tp10 -141.14 171.83 13.52 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 22.030000000000001 109.893 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 29.9 m-85 -134.34 109.0 8.51 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.23 -1.396 . . . . 16.329999999999998 107.23 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.26 102.41 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.543 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.09 97.34 7.5 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.628 -0.878 . . . . 15.32 108.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 pt -61.98 1.61 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 10.92 110.831 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 46' ' ' ASP . 6.4 p -95.56 -28.19 14.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.021 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.23 19.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -0.808 . . . . 22.449999999999999 109.385 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 15.0 t -143.68 -0.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.945 . . . . 25.629999999999999 109.962 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.63 -172.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.712 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.29 10.32 2.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 108.045 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -35.21 -68.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.802 -0.561 . . . . 18.870000000000001 111.515 -178.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.72 -29.87 60.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 45.210000000000001 110.994 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.581 ' OE2' ' NE2' ' A' ' 52' ' ' HIS . 11.4 mt-10 -64.83 -42.11 95.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.781 -1.199 . . . . 33.020000000000003 109.738 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.5 -53.01 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.829 -1.169 . . . . 9.8399999999999999 109.167 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.04 -43.14 77.55 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.573 -1.269 . . . . 17.84 107.573 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -54.15 -34.02 59.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.021 -1.474 . . . . 18.84 107.021 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -78.51 -45.83 21.04 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 12.99 108.882 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.9 mt -53.45 -33.7 55.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.907 -1.146 . . . . 14.609999999999999 107.907 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 12.0 tp60 -60.84 -57.53 12.26 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.333 0.587 . . . . 40.450000000000003 109.441 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -67.49 -35.49 79.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 41.810000000000002 109.995 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.09 -48.15 74.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 21.77 109.982 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -110.82 -61.89 1.62 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.517 -0.74 . . . . 11.380000000000001 109.344 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.64 -49.36 0.49 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.883 -1.287 . . . . 14.789999999999999 109.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 140.68 31.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 17.809999999999999 110.537 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 37.74 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.272 -1.01 . . . . 29.760000000000002 108.272 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.42 165.34 17.27 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.158 0.98 . . . . 18.260000000000002 111.764 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.626 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.2 t -115.08 130.87 23.87 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.2 -1.407 . . . . 8.1999999999999993 107.2 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -77.03 -165.02 4.2 Favored 'Cis proline' 0 C--N 1.309 -1.522 0 CA-C-O 122.579 0.991 . . . . 7.79 112.328 0.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.534 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -151.03 89.92 1.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.543 -2.021 . . . . 26.050000000000001 105.543 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.48 156.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.639 0.733 . . . . 8.6799999999999997 111.896 -176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.06 91.25 2.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.751 -0.593 . . . . 14.07 111.04 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 74' ' ' ILE . 6.6 mm -72.96 114.56 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 106.047 -1.835 . . . . 9.3399999999999999 106.047 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.74 -154.83 34.76 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.117 -2.793 . . . . 12.42 106.117 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.12 -1.06 51.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.452 -1.616 . . . . 44.859999999999999 109.271 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.14 118.66 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.273 -0.892 . . . . 0.0 110.407 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -75.47 150.15 38.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.411 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 1.6 pp -114.66 -22.7 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.274 -0.891 . . . . 20.449999999999999 109.122 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.5 -128.91 4.48 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.128 -1.189 . . . . 13.82 110.128 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 -137.26 4.24 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.861 -1.296 . . . . 12.42 109.861 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' N ' ' O12' ' A' ' 106' ' ' GSH . 1.5 t -72.39 -63.99 1.04 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.49 -1.006 . . . . 0.0 110.119 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -53.51 -26.71 21.98 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 110.108 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 4.2 t0 -75.25 -46.43 33.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 27.059999999999999 109.199 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.1 tt -53.48 -59.16 4.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 15.31 109.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -51.25 -51.5 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.443 -0.786 . . . . 0.0 110.758 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -47.11 -39.12 12.68 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.903 -1.123 . . . . 21.789999999999999 109.203 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -78.98 -41.8 28.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.495 -0.753 . . . . 0.0 112.124 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -57.24 13.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.579 -1.325 . . . . 0.0 110.625 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -26.22 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.939 -1.101 . . . . 0.0 109.516 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.4 m -80.34 -21.29 42.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.7 -9.96 74.06 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.331 -1.107 . . . . 25.640000000000001 110.331 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -68.36 -29.19 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.003 -1.293 . . . . 50.259999999999998 108.397 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.21 -63.87 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 24.170000000000002 110.792 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -52.68 -30.95 34.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -65.15 -49.26 70.54 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.148 -1.056 . . . . 28.030000000000001 108.148 178.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -55.86 -36.15 67.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.574 -1.269 . . . . 40.960000000000001 107.574 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.3 mp -72.86 -37.34 67.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.664 -0.865 . . . . 15.050000000000001 108.664 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.11 -55.06 20.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.642 . . . . 0.0 111.566 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -48.84 -33.93 11.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.85 -1.156 . . . . 38.640000000000001 110.751 -178.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.95 -14.78 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.823 -1.173 . . . . 0.0 109.04 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.3 8.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.418 -1.073 . . . . 18.539999999999999 110.418 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.78 -19.14 29.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.279 . . . . 10.84 109.855 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.67 -175.42 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.711 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.626 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.476 -0.564 . . . . 18.329999999999998 109.476 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.34 -70.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 29.77 109.405 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 7' ' ' SER . 24.1 mt-10 -59.43 -11.76 4.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.757 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.18 -73.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 20.030000000000001 110.447 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.31 -37.4 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 12.91 110.059 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.412 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 1.9 m120 -55.89 -37.09 68.39 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.106 -0.996 . . . . 28.329999999999998 109.582 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 57.2 m -74.5 -12.85 60.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -97.54 -44.33 6.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 110.755 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.33 137.66 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.821 -1.175 . . . . 25.190000000000001 109.611 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -147.83 137.83 12.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.331 -0.988 . . . . 34.609999999999999 108.331 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -51.66 129.21 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.067 1.178 . . . . 11.720000000000001 109.671 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.37 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.22 -1.552 . . . . 10.24 109.22 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -141.5 137.66 32.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -1.068 . . . . 25.359999999999999 109.402 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.53 137.28 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 10.890000000000001 109.843 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.62 144.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.224 -1.028 . . . . 15.82 108.224 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.11 123.55 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 8.9399999999999995 111.132 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -90.73 122.61 33.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.533 -1.284 . . . . 9.9299999999999997 107.533 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.97 -170.67 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.337 1.065 . . . . 10.619999999999999 110.893 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 21' ' ' THR . 15.6 mtmm -149.24 91.16 4.54 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 105.983 -1.858 . . . . 38.729999999999997 105.983 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.504 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.3 Cg_exo -47.26 75.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.776 1.651 . . . . 24.579999999999998 111.004 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 19' ' ' LYS . 21.9 m -170.74 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.089 -0.708 . . . . 34.82 109.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.0 133.61 23.02 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.229 -0.92 . . . . 21.460000000000001 110.076 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.53 -24.96 77.14 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 122.156 1.904 . . . . 13.859999999999999 111.854 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.6 -37.94 73.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.867 -1.146 . . . . 0.0 109.242 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -39.87 91.83 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -61.63 -40.79 96.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.015 -0.735 . . . . 59.590000000000003 109.015 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.05 -47.43 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.13 74.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.181 -0.949 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.61 -44.66 64.03 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 45.490000000000002 110.038 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.8 mm-40 -70.19 -34.47 72.99 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.499 -0.751 . . . . 34.969999999999999 110.979 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -78.65 -57.43 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.782 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.546 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 2.8 mt -60.55 -20.43 60.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.625 -1.297 . . . . 17.280000000000001 110.086 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.517 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.6 p -65.34 -26.49 68.05 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 109.026 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -90.45 4.57 50.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 44.07 110.616 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.45 128.51 46.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.776 -1.203 . . . . 19.629999999999999 109.638 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.35 65.37 0.72 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.872 1.714 . . . . 21.539999999999999 110.021 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.2 mm -78.88 153.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.291 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.0 mmmt -55.6 -169.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 29.41 109.424 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.581 ' O ' ' O ' ' A' ' 38' ' ' LYS . 23.3 mm-40 -52.5 -129.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.445 -0.784 . . . . 0.0 111.086 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.53 48.57 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.834 -0.906 . . . . 15.27 110.834 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -97.68 -18.84 18.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.18 -1.188 . . . . 8.7799999999999994 109.344 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -107.4 130.09 54.85 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.585 -0.894 . . . . 7.1299999999999999 108.585 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -141.72 166.85 23.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 22.030000000000001 110.515 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -127.68 109.79 12.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.314 -1.365 . . . . 16.329999999999998 107.314 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -95.04 107.79 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 6.5800000000000001 111.36 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -81.65 101.79 10.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.269 -1.012 . . . . 15.32 108.269 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.6 pt -63.33 -5.62 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 10.92 110.905 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 t -93.54 -13.59 27.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.845 -1.159 . . . . 21.719999999999999 109.405 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.93 11.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 22.449999999999999 109.443 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.5 t -142.63 -12.3 0.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 25.629999999999999 110.058 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.6 t-20 82.71 -172.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.42 -0.8 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 57.59 30.27 18.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.126 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -45.02 -58.65 3.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 18.870000000000001 109.94 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.6 m120 -53.78 -33.94 57.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 45.210000000000001 110.712 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -63.62 -45.94 87.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.754 -1.216 . . . . 33.020000000000003 109.534 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.23 -52.67 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 9.8399999999999999 109.451 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.27 -40.56 77.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.67 -1.233 . . . . 17.84 107.67 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.71 -32.99 63.79 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.157 -1.423 . . . . 18.84 107.157 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -77.7 -46.37 22.08 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.934 -0.765 . . . . 12.99 108.934 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.76 -36.88 65.32 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.09 -1.078 . . . . 14.609999999999999 108.09 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.3 tp-100 -59.47 -52.57 65.03 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.759 -0.83 . . . . 40.450000000000003 108.759 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.73 -44.14 78.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 41.810000000000002 110.218 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.8 tp -64.1 -42.23 96.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 21.77 110.13 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.614 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 4.6 p -114.05 -74.02 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.438 -0.788 . . . . 11.380000000000001 109.702 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 157.8 -38.89 0.54 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.716 -1.354 . . . . 14.789999999999999 109.716 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.43 133.44 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -1.194 . . . . 17.809999999999999 110.208 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.9 21.65 14.29 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.885 -0.783 . . . . 29.760000000000002 108.885 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.88 171.57 15.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.529 -0.732 . . . . 18.260000000000002 110.316 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.49 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 19.4 t -116.26 138.39 24.23 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.636 -0.875 . . . . 8.1999999999999993 108.636 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.68 -167.75 6.06 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 124.854 -0.894 . . . . 7.79 110.95 -1.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.594 ' NH1' ' HG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -141.0 92.98 2.54 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.966 -1.865 . . . . 26.050000000000001 105.966 177.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.2 t -84.21 155.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.731 0.777 . . . . 8.6799999999999997 111.691 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -143.03 88.51 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.861 -0.525 . . . . 14.07 110.639 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.4 mp -71.29 109.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.987 -1.857 . . . . 9.3399999999999999 105.987 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.76 51.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 106.792 -2.523 . . . . 12.42 106.792 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -86.12 -5.3 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.538 -1.566 . . . . 44.859999999999999 109.152 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -89.04 116.42 27.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 79' ' ' ILE . 29.3 t -72.31 152.76 41.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.467 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.489 ' N ' ' HG ' ' A' ' 78' ' ' SER . 3.7 pt -114.33 -23.37 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 20.449999999999999 109.702 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.8 -148.76 19.53 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.747 -1.341 . . . . 13.82 109.747 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -102.12 -148.65 21.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.945 -1.262 . . . . 12.42 109.945 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -58.23 3.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 t -53.19 -27.2 20.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.1 m-20 -73.66 -45.72 50.86 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 27.059999999999999 108.817 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -56.26 -60.9 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.539 -0.726 . . . . 15.31 109.952 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -49.66 -48.03 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.318 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.3 m -49.71 -45.92 49.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.704 -1.247 . . . . 21.789999999999999 109.494 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 mt -70.6 -38.65 74.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -60.4 -58.51 8.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.176 -0.953 . . . . 0.0 110.489 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.414 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -61.89 -25.88 67.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.029 -1.044 . . . . 0.0 109.308 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.79 -15.32 52.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.69 -7.41 62.18 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.673 -1.371 . . . . 25.640000000000001 109.673 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.83 -27.92 66.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.203 -1.175 . . . . 50.259999999999998 109.016 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.22 -63.76 1.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -0.847 . . . . 24.170000000000002 110.319 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.95 -30.24 45.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.55 -43.43 97.11 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.068 -1.086 . . . . 28.030000000000001 108.068 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.402 HH21 ' HB3' ' A' ' 77' ' ' ASP . 2.0 tpt180 -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.32 -0.992 . . . . 40.960000000000001 108.32 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.62 -37.88 70.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.425 -0.797 . . . . 15.050000000000001 109.204 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.18 -56.81 12.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 111.856 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -46.82 -27.51 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.794 -1.191 . . . . 38.640000000000001 110.264 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.71 -17.81 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.723 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.86 39.37 13.68 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.25 -1.14 . . . . 18.539999999999999 110.25 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 -10.19 58.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.178 . . . . 10.84 109.638 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.553 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.3 pt? -95.25 -176.98 3.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 109.964 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.597 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.622 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.375 -0.602 . . . . 18.329999999999998 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.39 -74.36 0.34 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 29.77 108.919 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -58.59 -10.48 2.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.76 . . . . 0.0 109.098 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.25 -68.76 0.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.787 . . . . 20.030000000000001 110.678 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -72.94 -38.49 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.134 -0.979 . . . . 12.91 110.289 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' HH ' ' A' ' 59' ' ' TYR . 7.5 m120 -55.1 -37.28 66.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.061 -1.024 . . . . 28.329999999999998 109.379 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 m -74.97 -12.7 60.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.743 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -97.16 -45.77 6.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 22.870000000000001 110.753 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.16 134.45 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.908 -1.12 . . . . 25.190000000000001 109.391 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -147.61 149.61 34.39 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 34.609999999999999 109.186 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.18 126.17 21.25 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.421 1.414 . . . . 11.720000000000001 110.024 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.7 21.34 61.93 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.607 -1.397 . . . . 10.24 109.607 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -137.64 134.01 34.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -1.058 . . . . 25.359999999999999 109.272 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.6 137.51 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.18 -0.95 . . . . 10.890000000000001 109.617 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.19 147.13 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.211 -1.033 . . . . 15.82 108.211 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.2 t -132.74 122.04 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.932 . . . . 8.9399999999999995 110.803 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -89.43 126.12 35.43 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.478 -1.304 . . . . 9.9299999999999997 107.478 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.74 -172.18 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.174 0.988 . . . . 10.619999999999999 111.319 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.744 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.6 mtmt -147.49 96.31 4.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.747 -1.575 . . . . 38.729999999999997 106.747 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' CG2' ' A' ' 21' ' ' THR . 11.2 Cg_exo -49.22 66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.843 1.696 . . . . 24.579999999999998 111.147 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 19' ' ' LYS . 16.8 p -162.62 -35.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.984 -0.747 . . . . 34.82 108.984 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.13 128.47 35.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 21.460000000000001 110.072 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.25 -14.78 40.42 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 122.12 1.88 . . . . 13.859999999999999 111.996 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -70.54 -43.14 70.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.691 -1.256 . . . . 0.0 109.798 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -31.19 71.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.351 -0.843 . . . . 0.0 109.55 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.82 -47.74 83.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 59.590000000000003 109.544 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.647 HH11 ' HG3' ' A' ' 27' ' ' ARG . 2.4 mmm-85 -51.08 -41.29 59.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 0.0 108.803 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.33 82.75 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 11.5 mt-30 -71.57 -46.1 60.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 45.490000000000002 109.663 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 97.3 mt-10 -68.83 -34.6 75.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.518 -0.738 . . . . 34.969999999999999 110.916 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -76.8 -56.64 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.741 -1.225 . . . . 0.0 110.045 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.544 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -58.51 -20.85 49.49 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.667 -1.271 . . . . 17.280000000000001 109.14 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 8.9 m -65.22 -30.44 71.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.25 -0.906 . . . . 24.109999999999999 108.78 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.519 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -88.65 3.32 51.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 44.07 110.262 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' ILE . 18.1 mt -91.87 127.77 48.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.826 -1.171 . . . . 19.629999999999999 109.432 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.05 63.55 0.31 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.866 1.711 . . . . 21.539999999999999 110.485 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.1 mm -80.25 147.19 6.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.2 mttp -53.46 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 29.41 110.342 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' LYS . 33.1 mt-30 -49.81 -128.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 111.435 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.53 47.75 0.08 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.87 -0.892 . . . . 15.27 110.87 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -101.24 -15.33 17.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -1.207 . . . . 8.7799999999999994 109.193 179.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.4 tp -110.18 128.73 55.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.404 -0.962 . . . . 7.1299999999999999 108.404 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.1 tt0 -141.32 169.8 16.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.067 . . . . 22.030000000000001 110.317 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.476 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.0 m-85 -133.12 112.87 12.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.048 -1.093 . . . . 16.329999999999998 108.048 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -95.9 102.09 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 6.5800000000000001 111.149 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.7 m-20 -80.19 100.2 8.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.234 -1.024 . . . . 15.32 108.234 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 pt -62.45 -0.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 10.92 110.196 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 46' ' ' ASP . 33.9 p -95.6 -27.03 15.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 21.719999999999999 109.597 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.48 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 22.449999999999999 109.484 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.477 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 14.7 t -145.17 -3.27 0.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 25.629999999999999 110.164 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.688 HD22 ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 67.89 -162.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.048 -1.032 . . . . 0.0 108.526 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.688 ' CD2' HD22 ' A' ' 51' ' ' ASN . 20.1 m170 56.56 11.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.685 -1.26 . . . . 0.0 108.141 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -35.75 -69.22 0.11 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 18.870000000000001 111.36 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.1 m-20 -53.04 -31.28 40.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.062 -1.024 . . . . 45.210000000000001 110.895 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.8 -46.21 79.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.782 -1.199 . . . . 33.020000000000003 109.912 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.86 -52.3 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.748 -1.22 . . . . 9.8399999999999999 109.68 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.89 -41.64 82.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.63 -1.248 . . . . 17.84 107.63 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 9.9 m-20 -55.66 -34.23 64.8 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.279 -1.378 . . . . 18.84 107.279 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.547 ' HH ' HD22 ' A' ' 6' ' ' ASN . 58.8 t80 -78.15 -50.31 12.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.84 -0.744 . . . . 12.99 109.204 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.5 mt -52.42 -33.07 42.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.164 -1.05 . . . . 14.609999999999999 108.164 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.2 tp60 -60.42 -56.59 19.61 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.656 -0.653 . . . . 40.450000000000003 109.302 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -65.69 -41.19 92.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 41.810000000000002 109.867 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -65.72 -37.22 85.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 21.77 109.815 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 6.5 p -113.23 -63.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 11.380000000000001 109.555 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 61' ' ' GLN . . . 144.83 -49.21 0.69 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.007 -1.637 . . . . 14.789999999999999 109.007 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.22 44.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.047 . . . . 17.809999999999999 109.958 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.32 36.12 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.519 -0.919 . . . . 29.760000000000002 108.519 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.41 169.52 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.547 -0.721 . . . . 18.260000000000002 110.226 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 3.3 t -120.81 135.41 24.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.107 -1.072 . . . . 8.1999999999999993 108.107 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -81.98 -166.22 4.9 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 124.784 -0.923 . . . . 7.79 111.157 -0.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.584 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -143.03 91.18 2.26 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.789 -1.93 . . . . 26.050000000000001 105.789 177.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.09 154.23 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 8.6799999999999997 111.211 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -143.47 88.67 2.02 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.397 -0.521 . . . . 14.07 110.2 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 74' ' ' ILE . 15.7 mm -71.6 101.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.024 -1.843 . . . . 9.3399999999999999 106.024 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.22 -149.85 39.68 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.345 -2.702 . . . . 12.42 106.345 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' CB ' ' NZ ' ' A' ' 76' ' ' LYS . 8.4 mtmp? -86.97 -6.78 58.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.568 -1.549 . . . . 44.859999999999999 109.474 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HB3' HH21 ' A' ' 97' ' ' ARG . 3.0 m-20 -91.48 121.6 33.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 110.582 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -73.62 155.82 38.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 80' ' ' GLY . 2.8 pp -119.0 -16.61 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.233 -0.917 . . . . 20.449999999999999 109.69 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' C ' HH21 ' A' ' 71' ' ' ARG . . . 136.23 -150.43 20.44 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.081 -1.207 . . . . 13.82 110.081 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.457 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.76 -145.3 11.81 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.955 -1.258 . . . . 12.42 109.955 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.89 -62.13 1.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.489 -1.007 . . . . 0.0 110.03 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 t -54.23 -26.43 28.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.349 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -73.88 -45.79 48.68 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -0.874 . . . . 27.059999999999999 109.007 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.457 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 2.6 tt -54.11 -59.66 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.41 -0.806 . . . . 15.31 109.7 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -43.49 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 110.503 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.619 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 18.8 m -55.27 -35.48 65.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 21.789999999999999 110.146 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.02 -34.35 32.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 0.0 111.258 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -62.23 -60.57 3.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.004 -1.06 . . . . 0.0 111.124 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.712 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.86 -17.42 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.859 -1.151 . . . . 0.0 109.523 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.544 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 40.4 m -80.26 -62.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.495 -0.753 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.77 4.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.401 -1.479 . . . . 25.640000000000001 109.401 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.37 -30.46 69.41 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.271 -1.135 . . . . 50.259999999999998 108.952 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.73 -64.18 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.431 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -55.01 -31.4 61.02 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.46 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.61 -45.44 90.34 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.422 -0.955 . . . . 28.030000000000001 108.422 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.445 HH21 ' HB3' ' A' ' 77' ' ' ASP . 3.1 ttt180 -61.25 -34.99 76.06 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.273 -1.01 . . . . 40.960000000000001 108.273 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.419 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -70.93 -36.14 72.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.721 -0.844 . . . . 15.050000000000001 108.721 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -64.57 -57.5 8.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.782 -0.574 . . . . 0.0 111.346 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 96' ' ' THR . 1.1 pt20 -47.48 -31.72 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.895 -1.128 . . . . 38.640000000000001 110.349 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.86 -11.8 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.995 -1.066 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 73.75 44.51 31.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.507 -1.037 . . . . 18.539999999999999 110.507 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.42 -11.86 50.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -1.218 . . . . 10.84 109.484 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.72 -178.11 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 0.0 110.059 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.393 179.81 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.698 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.658 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.563 -0.532 . . . . 18.329999999999998 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.658 ' NE2' ' H3 ' ' A' ' 1' ' ' ALA . 10.6 mp0 -132.4 -74.02 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 29.77 109.119 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 7' ' ' SER . 24.1 mt-10 -58.62 -8.26 1.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.056 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.8 m-85 -62.19 -72.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.391 -0.818 . . . . 20.030000000000001 110.248 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.84 -39.62 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 12.91 109.929 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 3.3 m120 -55.6 -37.31 67.94 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 28.329999999999998 109.575 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 59.3 m -74.47 -13.02 60.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.97 -48.34 5.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 22.870000000000001 110.277 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 128.38 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.974 -1.079 . . . . 25.190000000000001 109.869 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -147.85 160.44 38.03 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.56 -0.904 . . . . 34.609999999999999 108.56 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.0 129.19 33.17 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.658 1.572 . . . . 11.720000000000001 111.165 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.54 29.94 50.82 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.865 -0.894 . . . . 10.24 110.865 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -144.8 136.21 25.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.88 -1.364 . . . . 25.359999999999999 110.074 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.24 133.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 10.890000000000001 109.38 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.68 144.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.347 -0.983 . . . . 15.82 108.347 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.42 124.46 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 8.9399999999999995 110.957 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -90.07 121.21 31.92 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.397 -1.334 . . . . 9.9299999999999997 107.397 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -130.7 -175.57 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.276 1.036 . . . . 10.619999999999999 111.2 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.7 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.9 mtmt -148.72 86.59 5.75 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.689 -1.597 . . . . 38.729999999999997 106.689 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 21' ' ' THR . 15.6 Cg_exo -44.26 76.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.791 1.661 . . . . 24.579999999999998 110.928 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 19' ' ' LYS . 34.2 m -172.02 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.436 -0.95 . . . . 34.82 108.436 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.5 129.62 29.91 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 21.460000000000001 109.505 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.74 -19.92 56.08 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 122.085 1.857 . . . . 13.859999999999999 112.099 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.679 -1.263 . . . . 0.0 109.551 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -32.95 74.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 108.44 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -62.51 -45.51 92.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 59.590000000000003 108.879 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -49.55 -45.2 47.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.12 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.58 84.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.135 -0.978 . . . . 0.0 108.811 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -70.4 -42.57 71.48 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.46 -0.775 . . . . 45.490000000000002 109.659 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.37 -36.05 76.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 34.969999999999999 111.06 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.77 -56.53 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.837 -1.164 . . . . 0.0 110.497 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 2.5 mt -59.78 -19.91 53.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.576 -1.328 . . . . 17.280000000000001 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -65.65 -27.58 68.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.135 -0.978 . . . . 24.109999999999999 108.919 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -90.11 3.81 52.24 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.316 -0.865 . . . . 44.07 110.431 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.7 mt -92.49 125.86 54.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.824 -1.172 . . . . 19.629999999999999 109.805 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.98 67.72 0.92 Allowed 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.802 1.668 . . . . 21.539999999999999 109.893 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 mm -79.43 150.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.7 mtpm? -54.19 -171.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.366 -0.834 . . . . 29.41 110.192 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' LYS . 16.7 mt-30 -50.78 -131.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.617 0.722 . . . . 0.0 111.447 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.14 49.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.242 -0.911 . . . . 15.27 110.933 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.8 -17.51 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -1.074 . . . . 8.7799999999999994 109.383 179.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.0 tp -107.88 130.9 54.97 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.48 -0.933 . . . . 7.1299999999999999 108.48 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.1 tp10 -141.58 169.27 17.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -0.988 . . . . 22.030000000000001 110.418 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 31.6 m-85 -131.92 109.96 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.606 -1.257 . . . . 16.329999999999998 107.606 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.0 t -94.67 104.01 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 6.5800000000000001 111.186 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -80.71 101.34 9.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.782 -0.822 . . . . 15.32 108.782 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.59 -7.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 10.92 110.198 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -100.49 46.93 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 21.719999999999999 108.804 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.03 20.25 0.31 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.025 -0.732 . . . . 22.449999999999999 109.025 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 9.0 t -144.51 -5.22 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 25.629999999999999 109.513 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 50' ' ' THR . 4.2 t-20 81.38 177.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.38 27.13 11.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.997 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.14 -60.69 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 18.870000000000001 110.41 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 81.6 m-20 -57.47 -29.51 64.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 45.210000000000001 111.022 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.13 -43.95 93.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.724 -1.235 . . . . 33.020000000000003 109.747 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.1 -53.67 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 9.8399999999999999 109.431 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.43 -43.17 83.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.839 -1.171 . . . . 17.84 107.839 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 26.3 m-20 -54.9 -34.93 63.58 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.345 -1.354 . . . . 18.84 107.345 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 1' ' ' ALA . 55.2 t80 -78.76 -47.3 17.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.878 -0.729 . . . . 12.99 109.245 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.76 -32.77 53.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.213 -1.032 . . . . 14.609999999999999 108.213 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.709 ' NE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -59.49 -55.59 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.879 -0.785 . . . . 40.450000000000003 108.879 179.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -67.45 -35.5 79.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.181 -0.95 . . . . 41.810000000000002 110.109 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.3 tp -64.88 -46.42 81.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.1 -1.0 . . . . 21.77 109.91 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.4 p -110.06 -58.5 2.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.47 -0.769 . . . . 11.380000000000001 109.481 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 150.01 -52.46 0.52 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.573 -1.411 . . . . 14.789999999999999 109.573 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 138.28 35.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -1.093 . . . . 17.809999999999999 110.261 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' N ' ' NE2' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -95.59 32.28 1.85 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.459 -0.941 . . . . 29.760000000000002 108.459 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 165.79 22.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 18.260000000000002 110.207 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 4.9 t -116.79 138.35 24.54 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.056 -1.09 . . . . 8.1999999999999993 108.056 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -80.66 -168.13 6.53 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 124.8 -0.917 . . . . 7.79 111.361 -0.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.539 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.68 90.75 2.03 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.852 -1.907 . . . . 26.050000000000001 105.852 177.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.23 155.58 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.737 0.779 . . . . 8.6799999999999997 111.551 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -144.12 89.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.818 -0.551 . . . . 14.07 110.921 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -71.72 110.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.084 -1.821 . . . . 9.3399999999999999 106.084 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.66 -153.34 52.5 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.729 -2.548 . . . . 12.42 106.729 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -84.15 -3.74 58.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.564 -1.551 . . . . 44.859999999999999 109.41 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.424 ' HB2' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -90.05 118.37 29.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.937 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -72.68 152.26 41.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.031 -1.043 . . . . 0.0 109.416 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -113.87 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -0.969 . . . . 20.449999999999999 109.336 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' HH22 ' A' ' 71' ' ' ARG . . . 132.51 -155.96 21.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.124 -1.19 . . . . 13.82 110.124 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.95 -147.16 22.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.201 -1.16 . . . . 12.42 110.201 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.56 -60.2 2.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.526 -0.985 . . . . 0.0 109.867 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 t -52.43 -25.84 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.286 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.19 -49.08 25.05 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.801 . . . . 27.059999999999999 109.333 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.5 tt -54.7 -59.23 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 15.31 110.145 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.41 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.16 -45.41 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.105 -178.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 -47.47 66.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.736 -1.228 . . . . 21.789999999999999 109.492 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.23 -36.54 77.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.903 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -60.77 -59.18 5.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 110.478 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.53 -24.19 67.37 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.432 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -82.55 -16.52 48.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.464 -0.773 . . . . 0.0 109.813 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 -9.88 56.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.819 -1.313 . . . . 25.640000000000001 109.819 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -67.7 -28.18 67.45 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -1.174 . . . . 50.259999999999998 108.809 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.32 -65.7 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 24.170000000000002 110.084 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.24 -30.38 37.78 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.43 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -62.86 -44.68 95.46 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.465 -0.939 . . . . 28.030000000000001 108.465 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.686 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -63.06 -34.11 76.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.662 -0.866 . . . . 40.960000000000001 108.662 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.11 -35.68 71.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 15.050000000000001 109.023 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -65.11 -56.9 10.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.608 -0.683 . . . . 0.0 111.574 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -46.01 -31.09 2.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 38.640000000000001 110.395 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.4 pt -104.45 -14.44 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.86 40.5 21.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.304 -1.118 . . . . 18.539999999999999 110.304 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.42 -8.06 59.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.239 . . . . 10.84 109.474 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.18 -178.99 4.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.561 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.685 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.485 -0.561 . . . . 18.329999999999998 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' A' ' 4' ' ' PHE . 66.7 mt-30 53.82 -99.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 29.77 110.037 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.97 -7.46 0.48 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 109.718 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.5 m-85 -62.17 -69.16 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 20.030000000000001 110.432 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -73.51 -40.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 12.91 110.443 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 68.4 m-80 -55.21 -29.94 58.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.067 -1.021 . . . . 28.329999999999998 109.497 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 m -75.29 -18.44 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -98.1 -44.03 6.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 111.212 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.26 129.18 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.174 . . . . 25.190000000000001 110.585 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.05 158.4 38.91 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.151 -1.055 . . . . 34.609999999999999 108.151 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.0 127.95 27.9 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.544 1.496 . . . . 11.720000000000001 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.12 28.16 46.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.753 -0.939 . . . . 10.24 110.753 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -143.14 136.88 28.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.969 -1.313 . . . . 25.359999999999999 109.933 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.79 134.4 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.386 -0.821 . . . . 10.890000000000001 109.392 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.15 143.0 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.437 -0.949 . . . . 15.82 108.437 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.7 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.405 -0.809 . . . . 8.9399999999999995 110.739 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.62 122.74 33.04 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.487 -1.301 . . . . 9.9299999999999997 107.487 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.6 pt -132.11 -174.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.104 0.954 . . . . 10.619999999999999 111.224 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mtmt -145.77 94.63 5.03 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.585 -1.635 . . . . 38.729999999999997 106.585 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.0 Cg_exo -46.49 82.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.561 1.508 . . . . 24.579999999999998 110.945 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 19' ' ' LYS . 14.7 m 178.95 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 34.82 108.41 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.96 121.88 54.42 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 21.460000000000001 109.711 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.04 -17.57 45.75 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.724 1.616 . . . . 13.859999999999999 111.778 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -68.87 -42.63 76.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.563 -1.335 . . . . 0.0 108.291 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -36.73 83.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -61.15 -39.37 89.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.8 -1.185 . . . . 59.590000000000003 107.8 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.69 -47.15 70.74 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.42 74.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.407 -0.808 . . . . 0.0 108.865 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 33' ' ' SER . 5.4 mt-30 -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.852 . . . . 45.490000000000002 109.745 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.3 mm-40 -69.82 -34.17 73.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 34.969999999999999 111.029 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.48 -55.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.544 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.5 mt -59.25 -24.13 62.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.671 -1.268 . . . . 17.280000000000001 109.696 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.2 p -63.85 -22.22 66.81 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.289 -1.004 . . . . 24.109999999999999 108.289 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -90.09 0.43 57.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.527 -0.733 . . . . 44.07 109.862 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 127.45 47.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 19.629999999999999 109.656 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.0 66.65 0.58 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.644 1.562 . . . . 21.539999999999999 109.777 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.07 148.15 6.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.9 mttp -54.55 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -0.826 . . . . 29.41 110.272 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' LYS . 17.0 mt-30 -51.1 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.641 0.734 . . . . 0.0 111.191 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.24 48.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.924 -0.87 . . . . 15.27 110.924 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -99.8 -17.36 17.71 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.129 -1.218 . . . . 8.7799999999999994 109.137 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -108.55 126.92 53.46 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.967 -1.123 . . . . 7.1299999999999999 107.967 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 23.2 tp10 -139.59 163.67 31.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.993 -1.067 . . . . 22.030000000000001 110.253 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.527 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.9 m-85 -126.32 110.84 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.677 -1.231 . . . . 16.329999999999998 107.677 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.61 107.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 6.5800000000000001 111.235 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' THR . 4.7 m-20 -82.59 99.61 9.65 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.469 -0.937 . . . . 15.32 108.469 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.2 pt -62.03 5.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 10.92 110.61 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ASP . 16.9 p -97.22 -25.53 15.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.089 -1.007 . . . . 21.719999999999999 109.812 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.91 23.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 22.449999999999999 109.943 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.543 ' C ' HD21 ' A' ' 51' ' ' ASN . 12.0 t -146.74 0.6 0.76 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 25.629999999999999 110.489 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 50' ' ' THR . 2.2 m-80 66.45 -177.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.227 -0.921 . . . . 0.0 109.245 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.58 29.92 16.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 108.8 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.85 -56.69 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 18.870000000000001 110.002 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 68.8 m-20 -57.02 -31.4 65.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 45.210000000000001 111.0 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.5 -45.13 92.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.752 -1.218 . . . . 33.020000000000003 109.739 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.86 -53.98 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.869 -1.144 . . . . 9.8399999999999999 109.677 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.26 -40.67 78.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.723 -1.214 . . . . 17.84 107.723 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 61.2 m-20 -54.96 -33.73 62.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.037 -1.468 . . . . 18.84 107.037 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -78.86 -48.72 14.15 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.058 -0.719 . . . . 12.99 109.058 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.3 mt -53.96 -33.21 56.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.141 -1.059 . . . . 14.609999999999999 108.141 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 6.9 tp60 -60.58 -57.68 11.68 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.165 -0.68 . . . . 40.450000000000003 109.165 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.09 -36.22 81.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.359 -0.838 . . . . 41.810000000000002 110.023 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 tp -65.38 -49.17 70.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.094 -1.004 . . . . 21.77 109.704 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 2.2 p -109.05 -67.2 1.0 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.74 . . . . 11.380000000000001 109.563 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 161.33 -49.07 0.36 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.258 -1.449 . . . . 14.789999999999999 110.874 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.662 ' CB ' HH12 ' A' ' 71' ' ' ARG . . . -97.81 136.95 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.304 . . . . 17.809999999999999 110.771 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.58 25.21 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.253 -1.388 . . . . 29.760000000000002 107.253 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.15 169.42 18.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.665 0.745 . . . . 18.260000000000002 110.254 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 2.9 t -120.0 135.09 24.1 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.02 -1.104 . . . . 8.1999999999999993 108.02 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -83.72 -164.69 3.61 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 124.868 -0.888 . . . . 7.79 110.797 -0.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.662 HH12 ' CB ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -152.41 93.47 1.8 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.036 -2.209 . . . . 26.050000000000001 105.036 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 73' ' ' PHE . 65.7 t -82.5 160.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.859 0.838 . . . . 8.6799999999999997 111.971 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' N ' ' CG1' ' A' ' 72' ' ' VAL . 83.9 m-85 -144.47 91.83 2.23 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 116.174 -0.467 . . . . 14.07 110.584 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 mm -71.73 104.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.881 -1.896 . . . . 9.3399999999999999 105.881 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.32 -149.64 51.11 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 106.101 -2.8 . . . . 12.42 106.101 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -84.77 -1.17 55.97 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.489 -1.595 . . . . 44.859999999999999 109.245 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' OD2' ' NH2' ' A' ' 97' ' ' ARG . 85.2 m-20 -89.5 111.76 22.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -72.97 147.67 44.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.89 -21.13 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.289 -0.882 . . . . 20.449999999999999 108.983 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.12 -149.42 18.87 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.18 -1.168 . . . . 13.82 110.18 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.52 -140.66 9.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.405 -1.078 . . . . 12.42 110.405 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -70.06 -65.61 0.7 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.729 -0.865 . . . . 0.0 110.334 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -50.83 -27.9 8.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.821 . . . . 0.0 109.692 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -73.92 -49.47 24.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.354 -0.841 . . . . 27.059999999999999 109.345 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.446 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 6.0 tt -56.01 -60.09 3.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 15.31 110.411 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' CG ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.59 -47.17 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 -178.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 t -49.46 -46.34 47.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.791 -1.193 . . . . 21.789999999999999 109.444 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.22 -39.11 75.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.878 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -60.58 -58.39 8.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.894 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.63 -24.75 65.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 109.102 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -79.97 -43.78 21.43 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.653 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.69 -9.96 30.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.393 -1.483 . . . . 25.640000000000001 109.393 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.58 -26.06 65.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -1.082 . . . . 50.259999999999998 108.911 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.52 -64.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 24.170000000000002 110.212 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.24 -30.82 40.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.32 -44.09 95.94 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.511 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 8.9 tpt180 -61.27 -35.49 77.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.411 -0.959 . . . . 40.960000000000001 108.411 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 98' ' ' LEU . 9.6 mp -70.6 -38.93 74.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.857 0.837 . . . . 15.050000000000001 108.82 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -65.55 -53.81 36.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.824 -0.548 . . . . 0.0 112.033 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -48.31 -32.17 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.78 -1.2 . . . . 38.640000000000001 110.42 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.2 pt -103.83 -14.4 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.572 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 78.99 45.4 9.06 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.283 -1.127 . . . . 18.539999999999999 110.283 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.56 -11.81 53.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -1.121 . . . . 10.84 109.187 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.57 -177.85 4.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.14 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.599 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.669 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.495 -0.557 . . . . 18.329999999999998 109.495 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 4' ' ' PHE . 25.1 tt0 51.54 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 29.77 110.138 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 1' ' ' ALA . 38.4 mt-10 -54.51 -11.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.051 -1.031 . . . . 0.0 109.163 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.3 m-85 -63.67 -69.49 0.27 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.476 -0.765 . . . . 20.030000000000001 110.619 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.64 -39.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 12.91 110.169 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.1 m-20 -55.75 -37.98 69.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.212 -0.93 . . . . 28.329999999999998 109.271 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -74.94 -12.03 60.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -97.21 -45.33 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 22.870000000000001 110.721 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.54 138.95 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.788 -1.195 . . . . 25.190000000000001 110.029 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.27 136.77 11.21 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 107.947 -1.131 . . . . 34.609999999999999 107.947 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -50.02 131.51 30.51 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 120.997 1.131 . . . . 11.720000000000001 109.699 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 20.64 70.06 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.209 -1.556 . . . . 10.24 109.209 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -137.82 132.98 33.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -1.06 . . . . 25.359999999999999 109.013 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.32 135.5 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.154 -0.966 . . . . 10.890000000000001 109.754 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.3 142.86 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.268 -1.012 . . . . 15.82 108.268 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -124.86 128.07 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 8.9399999999999995 111.201 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -94.74 114.69 26.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.352 -0.981 . . . . 9.9299999999999997 108.352 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.74 -172.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.537 1.161 . . . . 10.619999999999999 111.587 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -145.89 94.65 4.98 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 105.481 -2.044 . . . . 38.729999999999997 105.481 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.532 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.1 Cg_exo -49.21 79.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.392 1.394 . . . . 24.579999999999998 111.06 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.607 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.8 m -177.59 -32.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.539 -0.726 . . . . 34.82 109.442 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.77 124.68 45.09 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 21.460000000000001 109.6 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.78 -17.63 23.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.382 2.054 . . . . 13.859999999999999 113.164 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -69.91 -49.71 49.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.269 -1.52 . . . . 0.0 109.391 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.521 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -59.96 -33.08 71.45 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -61.13 -42.67 98.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.815 -0.809 . . . . 59.590000000000003 108.815 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.477 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 1.1 mtt-85 -54.52 -47.81 72.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.008 -1.058 . . . . 0.0 108.754 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -70.07 -41.81 73.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.36 -0.837 . . . . 45.490000000000002 109.435 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 42.5 mt-10 -72.19 -38.74 68.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.565 -0.709 . . . . 34.969999999999999 111.461 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -74.19 -55.69 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.813 -1.18 . . . . 0.0 110.093 -178.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -60.02 -20.08 56.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.538 -1.351 . . . . 17.280000000000001 109.649 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -65.73 -30.2 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.103 -0.998 . . . . 24.109999999999999 109.539 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 30' ' ' GLU . 2.9 mp0 -93.85 4.93 53.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 44.07 110.902 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.35 132.18 40.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.767 -1.208 . . . . 19.629999999999999 108.604 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.85 62.52 0.59 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.577 1.518 . . . . 21.539999999999999 110.258 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.3 mm -78.32 146.94 7.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.032 -1.043 . . . . 0.0 108.225 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 39' ' ' GLN . 18.6 mtpt -53.65 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.062 -1.024 . . . . 29.41 109.944 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 41' ' ' LEU . 26.9 mt-30 -52.29 -127.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.691 0.758 . . . . 0.0 112.363 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.81 48.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.102 -0.799 . . . . 15.27 111.102 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -99.66 -33.04 10.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.263 -1.14 . . . . 8.7799999999999994 108.81 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 tp -94.42 132.81 38.67 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.466 0.65 . . . . 7.1299999999999999 109.446 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.6 tp10 -142.01 174.05 10.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 22.030000000000001 109.515 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.475 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 46.7 m-85 -136.63 112.02 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.196 -1.409 . . . . 16.329999999999998 107.196 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.31 104.01 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 6.5800000000000001 111.775 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.6 m-20 -82.68 97.62 8.63 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.603 -0.888 . . . . 15.32 108.603 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.53 1.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 10.92 110.499 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.491 ' H ' ' C ' ' A' ' 46' ' ' ASP . 18.1 p -93.61 -17.26 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.027 -1.046 . . . . 21.719999999999999 108.635 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 7.27 5.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.49 -0.756 . . . . 22.449999999999999 109.546 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.0 t -142.31 -3.99 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 25.629999999999999 110.009 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 53' ' ' THR . 8.7 t30 66.55 -151.73 0.21 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 51.24 13.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.667 -1.271 . . . . 0.0 108.631 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 51' ' ' ASN . 4.3 p -41.59 -55.95 2.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.79 . . . . 18.870000000000001 110.733 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.9 m120 -52.31 -36.81 54.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 45.210000000000001 110.503 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -65.92 -45.01 83.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.06 . . . . 33.020000000000003 109.493 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -67.35 -52.55 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 9.8399999999999999 109.563 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -56.2 -43.74 78.78 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.231 -1.396 . . . . 17.84 107.231 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -55.5 -34.51 64.67 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.85 -1.537 . . . . 18.84 106.85 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -78.71 -48.81 14.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 120.245 -0.582 . . . . 12.99 109.506 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -51.95 -34.35 41.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.924 -1.139 . . . . 14.609999999999999 107.924 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' OE1' ' NH2' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -61.16 -58.2 9.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.304 0.573 . . . . 40.450000000000003 109.768 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -68.47 -35.65 77.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.177 -0.952 . . . . 41.810000000000002 110.861 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.94 -48.24 77.3 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 21.77 110.107 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -113.08 -61.79 1.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 11.380000000000001 109.423 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 160.9 -56.75 0.31 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.647 -1.381 . . . . 14.789999999999999 109.647 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.58 29.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -1.116 . . . . 17.809999999999999 109.296 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -108.95 20.85 17.96 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.026 -1.102 . . . . 29.760000000000002 108.026 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.01 165.63 17.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.346 -0.846 . . . . 18.260000000000002 109.524 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 2.6 t -105.6 131.08 22.06 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 8.1999999999999993 108.859 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 82' ' ' SER . 33.5 Cg_endo -84.65 -165.96 4.15 Favored 'Cis proline' 0 C--N 1.309 -1.548 0 CA-C-O 122.521 0.967 . . . . 7.79 111.674 -1.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -152.73 92.48 1.66 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.794 -2.299 . . . . 26.050000000000001 104.794 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.62 157.4 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.782 0.801 . . . . 8.6799999999999997 112.021 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -139.81 88.45 2.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.718 -0.614 . . . . 14.07 111.297 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.434 HD13 HG22 ' A' ' 74' ' ' ILE . 3.0 mm -71.93 113.88 9.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.921 -2.252 . . . . 9.3399999999999999 104.921 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.2 -154.52 29.18 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.796 -2.922 . . . . 12.42 105.796 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -83.01 0.34 45.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.218 -1.754 . . . . 44.859999999999999 108.622 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.46 110.01 19.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -74.35 142.33 45.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.675 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 1.9 pt -107.2 -22.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.979 -1.076 . . . . 20.449999999999999 109.166 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.28 19.05 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.212 -1.155 . . . . 13.82 110.212 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.79 -145.25 15.3 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.198 -1.161 . . . . 12.42 110.198 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.444 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 t -71.8 -60.53 2.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 t -51.38 -24.2 4.56 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.428 0.632 . . . . 0.0 109.483 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 3.5 t70 -76.73 -51.4 11.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.808 . . . . 27.059999999999999 109.394 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.2 tt -51.27 -58.91 4.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 15.31 109.975 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -50.2 -54.23 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.551 -0.718 . . . . 0.0 109.865 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' VAL . 74.3 m -44.68 -36.69 3.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.335 -0.853 . . . . 21.789999999999999 109.119 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.3 mt -80.83 -43.49 19.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.493 -0.754 . . . . 0.0 111.409 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.01 -56.2 23.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 111.018 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -26.0 64.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.742 -1.224 . . . . 0.0 108.911 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.8 m -79.18 -60.82 2.22 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.17 -7.93 6.01 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.061 -1.215 . . . . 25.640000000000001 110.061 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -70.12 -26.15 63.83 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.064 -1.256 . . . . 50.259999999999998 108.856 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 tp -60.08 -62.34 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.819 . . . . 24.170000000000002 110.717 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.12 -28.8 42.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.8 -49.48 68.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.317 -0.994 . . . . 28.030000000000001 108.317 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' NH1' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.22 -33.39 65.32 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.412 -1.329 . . . . 40.960000000000001 107.412 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.454 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.7 mp -72.51 -41.0 66.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.88 -0.785 . . . . 15.050000000000001 108.88 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -64.77 -52.07 58.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.731 -0.605 . . . . 0.0 111.693 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -34.1 27.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.836 -1.165 . . . . 38.640000000000001 111.007 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.9 pt -99.55 -18.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.63 -1.294 . . . . 0.0 109.097 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.6 40.95 7.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.605 -0.998 . . . . 18.539999999999999 110.605 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.75 -10.98 56.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.09 -1.241 . . . . 10.84 109.436 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.598 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.58 178.15 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.63 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.617 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.558 . . . . 18.329999999999998 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -79.31 -66.44 0.87 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 29.77 109.368 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -59.94 -14.32 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.422 -0.799 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.27 -75.74 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.178 -0.951 . . . . 20.030000000000001 110.483 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -74.24 -36.44 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 12.91 109.818 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.407 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 50.7 m-20 -56.14 -38.23 70.56 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 28.329999999999998 109.81 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.3 m -74.1 -12.46 60.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.095 -1.003 . . . . 0.0 109.86 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -97.63 -45.37 6.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 22.870000000000001 110.72 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.21 130.67 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.828 -1.17 . . . . 25.190000000000001 110.116 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.67 157.21 36.28 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.018 -1.104 . . . . 34.609999999999999 108.018 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.89 131.54 46.14 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.897 1.731 . . . . 11.720000000000001 111.588 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.74 21.76 68.08 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.488 -0.863 . . . . 10.24 111.073 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -140.11 132.76 28.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.972 -1.311 . . . . 25.359999999999999 109.415 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.74 133.75 41.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.401 -0.812 . . . . 10.890000000000001 109.404 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.93 142.9 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.673 -0.862 . . . . 15.82 108.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.9 t -125.91 126.8 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.202 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -94.18 116.91 29.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 9.9299999999999997 107.881 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 pt -127.82 -171.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 122.635 1.207 . . . . 10.619999999999999 111.527 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.5 mtmt -149.32 87.47 5.27 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 105.823 -1.918 . . . . 38.729999999999997 105.823 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' CG2' ' A' ' 21' ' ' THR . 16.7 Cg_exo -47.21 73.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.712 1.608 . . . . 24.579999999999998 110.861 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.8 p -161.88 -37.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.038 -1.097 . . . . 34.82 108.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.39 129.76 28.47 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 21.460000000000001 109.434 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -56.98 -24.55 57.99 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.404 2.07 . . . . 13.859999999999999 112.579 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.65 -41.64 87.9 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.38 -1.45 . . . . 0.0 108.76 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.654 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.12 -35.06 76.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.72 -1.215 . . . . 59.590000000000003 107.72 178.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.63 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -54.62 -47.98 72.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 179.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.58 76.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.316 -0.865 . . . . 0.0 108.841 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' OG ' ' A' ' 33' ' ' SER . 27.4 mt-30 -70.95 -41.66 70.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.467 -0.771 . . . . 45.490000000000002 109.75 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -71.31 -37.33 71.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 34.969999999999999 111.281 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.511 ' CG2' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.46 -58.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 110.525 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 ' H ' ' CG2' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -58.51 -22.75 56.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.623 -1.298 . . . . 17.280000000000001 109.945 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 5.7 m -64.92 -25.65 67.97 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -92.99 -0.82 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.81 . . . . 44.07 110.066 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.91 130.9 44.88 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.935 -1.103 . . . . 19.629999999999999 108.465 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.23 65.93 1.05 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.766 1.644 . . . . 21.539999999999999 110.592 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.6 mm -80.71 147.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.4 mttt -54.82 -166.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 29.41 110.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 1.7 mp0 -52.63 -131.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.834 0.826 . . . . 0.0 111.983 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.97 49.18 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.537 -1.025 . . . . 15.27 110.537 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -97.51 -30.44 12.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.307 -1.113 . . . . 8.7799999999999994 108.723 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.9 133.83 39.6 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.092 -0.707 . . . . 7.1299999999999999 109.092 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 22.1 tt0 -142.61 174.3 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 22.030000000000001 110.003 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.532 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 41.5 m-85 -136.98 110.68 8.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.438 -1.319 . . . . 16.329999999999998 107.438 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.11 104.77 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 6.5800000000000001 111.886 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.8 m-20 -81.44 102.53 10.58 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.512 -0.921 . . . . 15.32 108.512 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.5 pt -64.08 -2.13 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 10.92 111.54 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.25 -17.89 23.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.788 -1.195 . . . . 21.719999999999999 108.739 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 13.42 1.74 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.466 -0.771 . . . . 22.449999999999999 109.471 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.505 ' C ' HD21 ' A' ' 51' ' ' ASN . 14.5 t -142.81 -0.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 25.629999999999999 109.847 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.505 HD21 ' C ' ' A' ' 50' ' ' THR . 3.5 m-80 67.2 -171.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.21 31.37 18.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.833 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.519 ' H ' ' HG1' ' A' ' 53' ' ' THR . 0.6 OUTLIER -46.35 -53.71 10.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 18.870000000000001 109.806 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.2 m120 -54.94 -37.42 66.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 45.210000000000001 110.817 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.9 mp0 -62.1 -46.96 86.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.91 -1.119 . . . . 33.020000000000003 110.167 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.67 -54.75 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.784 -1.197 . . . . 9.8399999999999999 110.172 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -56.81 -41.11 77.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.523 -1.36 . . . . 17.84 107.705 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 6.0 m-20 -54.56 -33.93 60.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.959 -1.496 . . . . 18.84 106.959 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -79.67 -48.32 13.9 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.108 -0.637 . . . . 12.99 109.385 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.7 mt -52.69 -33.65 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.047 -1.033 . . . . 14.609999999999999 108.283 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.5 tp-100 -59.58 -54.85 41.78 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.321 0.581 . . . . 40.450000000000003 109.538 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.41 -42.27 83.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 41.810000000000002 110.347 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.7 tp -62.6 -47.23 84.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 21.77 110.562 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -108.94 -63.39 1.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.266 -0.896 . . . . 11.380000000000001 109.671 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.02 -38.97 1.02 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.399 -1.481 . . . . 14.789999999999999 109.399 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.32 140.29 32.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -1.151 . . . . 17.809999999999999 110.012 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -106.34 24.79 11.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.504 -0.924 . . . . 29.760000000000002 108.504 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.723 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.96 169.32 16.14 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.556 0.693 . . . . 18.260000000000002 110.909 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.629 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 10.9 t -110.9 133.36 21.27 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.291 -1.003 . . . . 8.1999999999999993 108.291 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 82' ' ' SER . 23.6 Cg_endo -86.74 -163.76 2.75 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 CA-C-O 122.617 1.007 . . . . 7.79 111.86 -1.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.723 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -145.04 95.72 2.73 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.489 -2.041 . . . . 26.050000000000001 105.489 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.4 t -85.54 156.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.366 -0.834 . . . . 8.6799999999999997 111.653 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.74 91.33 2.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.604 -0.685 . . . . 14.07 111.549 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 74' ' ' ILE . 3.4 mm -71.58 115.37 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.01 -2.218 . . . . 9.3399999999999999 105.01 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.45 -155.56 18.13 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 105.707 -2.957 . . . . 12.42 105.707 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.76 5.26 16.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.215 -1.756 . . . . 44.859999999999999 108.637 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 m-20 -89.52 115.04 26.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.387 -0.821 . . . . 0.0 110.793 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 t -77.41 141.92 39.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.306 -0.871 . . . . 0.0 109.678 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -109.64 -17.65 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.163 -0.961 . . . . 20.449999999999999 109.197 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.11 -160.19 21.3 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.071 -1.212 . . . . 13.82 110.071 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' CA ' HH21 ' A' ' 71' ' ' ARG . . . -89.26 -148.25 17.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.054 -1.218 . . . . 12.42 110.054 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 t -71.55 -60.37 2.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -1.005 . . . . 0.0 110.026 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 t -51.24 -25.38 5.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.192 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.38 -47.91 25.37 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.423 -0.798 . . . . 27.059999999999999 109.03 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -54.04 -59.41 4.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.457 -0.777 . . . . 15.31 110.015 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -51.38 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.371 -0.831 . . . . 0.0 110.309 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 9.0 m -46.82 -34.36 5.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.153 -0.967 . . . . 21.789999999999999 108.975 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.24 -38.94 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 111.734 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.417 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.5 OUTLIER -60.21 -59.19 5.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.08 -19.21 62.71 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.98 -1.075 . . . . 0.0 109.633 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.0 m -81.49 -45.5 15.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.062 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.77 -11.16 27.65 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.308 -1.117 . . . . 25.640000000000001 110.308 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -69.3 -25.5 64.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.279 . . . . 50.259999999999998 108.32 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.4 tp -59.91 -67.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.568 0.699 . . . . 24.170000000000002 110.848 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.452 ' C ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.32 -29.61 24.33 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -46.78 81.1 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.828 -1.175 . . . . 28.030000000000001 107.828 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -59.51 -34.12 72.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.897 -1.149 . . . . 40.960000000000001 107.897 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.4 mp -70.15 -40.48 74.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.612 -0.884 . . . . 15.050000000000001 108.612 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.32 -52.49 46.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.815 -0.553 . . . . 0.0 112.185 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -29.34 7.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.691 -1.255 . . . . 38.640000000000001 110.926 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.0 pt -102.7 -22.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.731 -1.231 . . . . 0.0 109.011 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.498 ' O ' ' CE ' ' A' ' 38' ' ' LYS . . . 90.0 47.54 3.86 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.387 -1.085 . . . . 18.539999999999999 110.387 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.15 -14.98 28.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.147 -1.208 . . . . 10.84 110.0 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -94.6 177.82 5.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.724 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.629 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.413 -0.588 . . . . 18.329999999999998 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -89.1 -72.95 0.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 29.77 111.384 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 2' ' ' GLN . 10.9 pt-20 -58.08 -23.65 55.48 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.302 -0.873 . . . . 0.0 111.672 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -61.93 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.791 -1.193 . . . . 20.030000000000001 111.482 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.36 -39.34 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.268 -0.895 . . . . 12.91 110.57 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 70.0 m-20 -54.38 -37.3 64.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 28.329999999999998 108.979 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.0 m -74.71 -11.23 60.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.376 -0.827 . . . . 0.0 109.192 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.44 -51.24 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 22.870000000000001 109.688 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -78.91 133.82 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 25.190000000000001 109.621 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 9' ' ' ILE . 6.6 mp0 -144.53 152.32 52.84 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.028 -1.101 . . . . 34.609999999999999 108.028 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.88 129.05 32.89 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.246 1.298 . . . . 11.720000000000001 109.243 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.53 22.83 78.11 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.349 -1.5 . . . . 10.24 109.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.77 128.56 42.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -1.064 . . . . 25.359999999999999 108.973 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -100.37 129.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.461 -0.774 . . . . 10.890000000000001 109.272 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.05 142.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.34 -0.985 . . . . 15.82 108.34 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.12 123.72 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 8.9399999999999995 111.055 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.05 117.35 29.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.403 ' CD1' HE21 ' A' ' 29' ' ' GLN . 16.5 pt -130.06 -172.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.578 1.18 . . . . 10.619999999999999 111.518 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' THR . 26.2 mtmt -150.2 85.58 5.42 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 105.841 -1.911 . . . . 38.729999999999997 105.841 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 21' ' ' THR . 18.4 Cg_exo -45.83 81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.483 1.456 . . . . 24.579999999999998 110.766 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' LYS . 32.6 m -173.67 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.169 -1.048 . . . . 34.82 108.169 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 127.08 36.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.799 . . . . 21.460000000000001 108.841 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.68 -22.69 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.192 1.928 . . . . 13.859999999999999 113.075 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -68.72 -42.35 77.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.284 -1.51 . . . . 0.0 108.96 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -37.2 79.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 26' ' ' ARG . 8.0 mmm-85 -62.21 -41.75 98.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.192 -0.67 . . . . 59.590000000000003 109.192 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -54.02 -49.5 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.12 -0.987 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.2 75.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.155 -0.966 . . . . 0.0 108.909 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.52 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 3.8 mm-40 -71.14 -42.28 69.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.361 -0.837 . . . . 45.490000000000002 109.723 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 33' ' ' SER . 48.4 mt-10 -70.89 -35.83 72.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.548 -0.72 . . . . 34.969999999999999 111.142 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.0 -56.45 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.927 -1.108 . . . . 0.0 110.798 -178.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -58.67 -23.91 60.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.457 -1.402 . . . . 17.280000000000001 109.891 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 2.5 p -63.28 -19.35 64.5 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.977 -1.077 . . . . 24.109999999999999 108.321 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -92.99 -4.38 52.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.539 -0.725 . . . . 44.07 110.071 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.5 mt -88.74 129.78 47.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.014 -1.054 . . . . 19.629999999999999 108.979 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.11 68.43 1.89 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.563 1.508 . . . . 21.539999999999999 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 37' ' ' ILE . 3.6 mm -80.44 142.42 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -57.3 156.25 7.85 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.231 -0.918 . . . . 29.41 110.076 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -58.31 141.56 50.71 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.478 0.656 . . . . 0.0 111.664 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.26 47.16 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.524 -0.735 . . . . 15.27 112.04 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.08 -35.1 9.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.75 -1.441 . . . . 8.7799999999999994 110.072 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 tp -93.54 134.91 35.32 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.485 -0.76 . . . . 7.1299999999999999 109.719 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -144.37 175.05 10.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 22.030000000000001 109.708 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.52 ' CD1' ' OE1' ' A' ' 29' ' ' GLN . 39.7 m-85 -137.63 109.06 6.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.078 -1.452 . . . . 16.329999999999998 107.078 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.26 106.43 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 6.5800000000000001 111.682 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -83.79 98.31 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.69 . . . . 15.32 109.3 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.93 -9.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 10.92 110.811 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -96.07 40.65 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.824 -1.176 . . . . 21.719999999999999 107.824 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.47 10.32 0.43 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.47 -0.892 . . . . 22.449999999999999 110.657 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 t -127.86 -3.38 5.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.329 -2.1 . . . . 25.629999999999999 105.329 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 71.88 -175.24 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.676 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER 54.64 18.44 2.05 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 52' ' ' HIS . 1.8 m -29.96 -56.58 0.18 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.443 -0.799 . . . . 18.870000000000001 110.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -59.26 -33.01 70.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.412 -0.805 . . . . 45.210000000000001 111.859 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' HIS . 61.5 mm-40 -60.61 -46.84 88.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.708 -1.245 . . . . 33.020000000000003 109.124 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' HA ' ' CB ' ' A' ' 1' ' ' ALA . 2.5 mp -63.29 -55.42 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 9.8399999999999999 109.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.67 -41.14 80.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 17.84 108.474 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.1 -35.61 59.81 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.84 -1.171 . . . . 18.84 107.84 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -80.0 -44.01 20.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.87 -0.789 . . . . 12.99 108.87 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.44 -37.02 46.54 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.517 -1.29 . . . . 14.609999999999999 107.517 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -61.23 -55.98 25.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.808 -0.812 . . . . 40.450000000000003 108.808 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.99 -37.22 83.82 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.4 -0.813 . . . . 41.810000000000002 110.127 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.94 -52.14 52.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 21.77 109.881 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.679 ' HG1' ' H ' ' A' ' 65' ' ' GLY . 1.4 p -109.72 -65.39 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.599 -0.688 . . . . 11.380000000000001 109.852 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.679 ' H ' ' HG1' ' A' ' 64' ' ' THR . . . 155.46 -42.18 0.58 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.703 -1.237 . . . . 14.789999999999999 110.042 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.94 139.4 33.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -1.173 . . . . 17.809999999999999 110.363 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.01 31.3 6.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.392 -0.966 . . . . 29.760000000000002 108.392 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.34 173.05 10.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.676 0.751 . . . . 18.260000000000002 111.295 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.597 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 6.1 t -113.11 129.14 24.83 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 107.669 -1.234 . . . . 8.1999999999999993 107.669 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -82.59 -166.13 4.74 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 CA-C-O 122.504 0.96 . . . . 7.79 112.02 -0.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -145.73 90.42 1.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 105.42 -2.067 . . . . 26.050000000000001 105.42 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.3 t -83.93 157.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 8.6799999999999997 112.355 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -145.14 89.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 14.07 111.111 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 74' ' ' ILE . 3.6 mm -71.13 116.41 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.006 -2.22 . . . . 9.3399999999999999 105.006 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.26 -158.88 16.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 105.867 -2.893 . . . . 12.42 105.867 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -80.96 2.98 24.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.197 -1.766 . . . . 44.859999999999999 108.787 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' CG ' HH21 ' A' ' 97' ' ' ARG . 17.2 m-20 -88.76 114.77 25.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.365 -0.835 . . . . 0.0 110.219 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -75.53 142.15 42.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 110.079 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -108.76 -20.64 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.174 -0.954 . . . . 20.449999999999999 108.822 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.07 -162.22 21.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.04 -1.224 . . . . 13.82 110.04 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.78 -148.27 12.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.137 -1.185 . . . . 12.42 110.137 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -70.53 -60.44 2.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.993 . . . . 0.0 110.04 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.8 t -50.61 -24.18 3.1 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.448 -0.783 . . . . 0.0 109.282 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.65 -49.13 16.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.424 -0.798 . . . . 27.059999999999999 109.283 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.468 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.4 tt -52.54 -59.88 3.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 15.31 110.043 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.78 -53.13 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.254 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.7 t -44.91 -36.0 3.11 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.119 -0.988 . . . . 21.789999999999999 109.246 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -81.66 -41.2 21.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.507 -0.746 . . . . 0.0 111.855 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -57.65 -57.68 11.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.81 -1.181 . . . . 0.0 110.63 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.602 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.91 -26.1 67.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.998 -1.064 . . . . 0.0 109.671 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.0 m -80.15 -24.26 40.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.01 -7.52 82.0 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.616 -0.994 . . . . 25.640000000000001 110.616 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.06 -26.15 63.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.934 -1.333 . . . . 50.259999999999998 108.392 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.13 -64.52 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.766 -0.583 . . . . 24.170000000000002 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 -29.61 40.85 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.21 -48.05 74.73 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.777 -1.194 . . . . 28.030000000000001 107.777 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.443 HH21 ' CG ' ' A' ' 77' ' ' ASP . 10.4 tpt180 -57.21 -32.71 66.78 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.681 -1.229 . . . . 40.960000000000001 107.681 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 98' ' ' LEU . 9.0 mp -72.43 -40.7 66.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.57 -0.9 . . . . 15.050000000000001 108.57 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.43 -53.41 48.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.661 -0.649 . . . . 0.0 111.647 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -33.57 15.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.747 -1.22 . . . . 38.640000000000001 110.714 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 pt -99.57 -17.43 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.672 -1.267 . . . . 0.0 109.006 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.5 42.57 8.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.216 -1.154 . . . . 18.539999999999999 110.216 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.7 -12.92 52.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 10.84 109.525 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.585 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.7 174.75 6.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.449 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.662 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.611 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.781 -0.452 . . . . 18.329999999999998 109.781 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' C ' ' O ' ' A' ' 1' ' ' ALA . 11.6 mt-30 30.06 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.825 -0.547 . . . . 29.77 111.339 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 1' ' ' ALA . 16.7 pt-20 -56.17 -12.14 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.14 -71.28 0.18 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.344 -0.847 . . . . 20.030000000000001 110.666 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.64 -40.92 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 12.91 110.559 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 11.7 m120 -54.78 -35.99 64.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.223 -0.923 . . . . 28.329999999999998 109.509 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.8 m -75.1 -12.83 60.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.156 -0.965 . . . . 0.0 109.437 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -96.78 -49.81 4.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 22.870000000000001 110.549 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 126.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 25.190000000000001 109.819 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 157.07 43.46 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.358 -0.979 . . . . 34.609999999999999 108.358 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.68 130.34 39.91 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.748 1.632 . . . . 11.720000000000001 111.299 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.93 24.38 60.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.952 -0.859 . . . . 10.24 110.952 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -143.28 135.36 26.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.326 . . . . 25.359999999999999 109.952 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.8 137.37 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.36 -0.837 . . . . 10.890000000000001 109.257 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.59 143.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 15.82 108.732 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.17 121.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.399 -0.813 . . . . 8.9399999999999995 110.535 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -89.97 123.31 33.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.504 -1.295 . . . . 9.9299999999999997 107.504 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.71 -172.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.447 1.117 . . . . 10.619999999999999 111.723 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.2 mtmt -144.02 96.67 5.42 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.236 -1.764 . . . . 38.729999999999997 106.236 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 11.2 Cg_exo -51.28 75.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.601 1.534 . . . . 24.579999999999998 110.586 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.9 m -170.68 -32.74 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.739 -0.837 . . . . 34.82 108.739 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.33 127.14 39.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 21.460000000000001 109.767 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.37 -12.09 19.0 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.213 1.942 . . . . 13.859999999999999 112.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' CG ' HG13 ' A' ' 106' ' ' GSH . 17.3 m-85 -72.25 -45.04 61.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.614 -1.304 . . . . 0.0 109.552 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -36.52 84.2 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.46 -33.29 69.59 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.671 -1.603 . . . . 59.590000000000003 106.671 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.13 -59.66 5.11 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.722 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.53 64.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.371 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.502 ' CD ' ' CD1' ' A' ' 44' ' ' PHE . 6.5 mm-40 -68.66 -32.91 73.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.224 -0.923 . . . . 45.490000000000002 108.841 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -71.63 -40.62 69.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 34.969999999999999 111.02 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 HG21 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -77.67 -59.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.896 -1.127 . . . . 0.0 111.017 -178.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' H ' HG21 ' A' ' 31' ' ' ILE . 4.9 mt -57.21 -22.66 42.45 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.806 -1.184 . . . . 17.280000000000001 110.215 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.0 m -66.56 -33.41 75.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.027 -1.045 . . . . 24.109999999999999 109.11 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.75 9.37 39.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 44.07 111.03 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 37' ' ' ILE . 14.4 mt -90.09 134.72 31.09 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.537 -1.352 . . . . 19.629999999999999 108.969 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.46 64.18 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 121.814 1.676 . . . . 21.539999999999999 110.231 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 mm -84.74 144.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.37 -0.831 . . . . 0.0 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -55.84 153.34 8.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.119 -0.988 . . . . 29.41 109.914 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -56.14 138.1 50.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 111.482 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.05 14.14 51.72 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.534 -0.729 . . . . 15.27 111.831 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.88 -21.74 14.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.825 -1.397 . . . . 8.7799999999999994 109.828 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -102.78 127.82 49.77 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 7.1299999999999999 109.387 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 44' ' ' PHE . 17.1 tp10 -142.77 164.69 29.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 22.030000000000001 109.85 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.502 ' CD1' ' CD ' ' A' ' 29' ' ' GLN . 14.1 m-85 -126.19 114.4 18.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.342 -1.355 . . . . 16.329999999999998 107.342 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -95.59 102.6 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 6.5800000000000001 111.553 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.24 102.98 9.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.695 -1.224 . . . . 15.32 107.695 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 pt -61.74 -1.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 10.92 111.434 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -93.11 -13.55 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.714 -1.241 . . . . 21.719999999999999 109.147 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 7.16 5.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 22.449999999999999 109.578 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 t -143.94 -0.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.157 -0.964 . . . . 25.629999999999999 109.936 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t30 68.51 -159.09 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 108.592 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.38 16.88 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.113 . . . . 0.0 108.537 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -41.8 -59.03 1.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.46 -0.775 . . . . 18.870000000000001 110.483 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.3 m-20 -53.48 -36.52 61.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 45.210000000000001 110.765 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.23 -45.37 84.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.976 -1.078 . . . . 33.020000000000003 110.213 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.51 -56.1 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.889 -1.132 . . . . 9.8399999999999999 109.771 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -55.85 -43.2 76.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.696 -1.224 . . . . 17.84 107.696 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 2.5 m-20 -55.93 -34.69 65.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.032 -1.469 . . . . 18.84 107.032 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -77.09 -46.1 24.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.823 -0.806 . . . . 12.99 108.823 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.1 mt -53.6 -36.26 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.762 -1.199 . . . . 14.609999999999999 107.762 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 21.1 tp60 -61.12 -57.07 14.05 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.957 -0.757 . . . . 40.450000000000003 108.957 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -65.9 -34.52 78.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.223 -0.923 . . . . 41.810000000000002 110.09 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.17 -52.75 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 21.77 109.89 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -109.88 -61.88 1.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.588 -0.695 . . . . 11.380000000000001 109.606 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 151.73 -37.85 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.682 -1.367 . . . . 14.789999999999999 109.682 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.62 130.57 47.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.243 -1.151 . . . . 17.809999999999999 110.622 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 37.15 1.54 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.174 -1.047 . . . . 29.760000000000002 108.174 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.77 168.91 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.052 0.93 . . . . 18.260000000000002 111.688 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.549 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 5.7 t -120.79 129.23 25.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.106 -1.442 . . . . 8.1999999999999993 107.106 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.94 -166.88 5.35 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 CA-C-O 122.425 0.927 . . . . 7.79 111.78 1.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.71 89.75 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.553 -2.017 . . . . 26.050000000000001 105.553 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.5 t -85.01 155.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.8 0.81 . . . . 8.6799999999999997 111.934 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -145.42 90.79 2.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 14.07 110.566 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.2 mp -72.01 112.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.731 -1.951 . . . . 9.3399999999999999 105.731 177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.85 -152.7 45.67 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.497 -2.641 . . . . 12.42 106.497 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -83.42 -0.67 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.534 -1.568 . . . . 44.859999999999999 109.09 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' HE ' ' A' ' 97' ' ' ARG . 7.4 m-20 -89.05 115.8 26.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.747 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 t -73.76 150.92 40.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.26 -26.82 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.194 -0.941 . . . . 20.449999999999999 109.592 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.91 -145.67 17.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.879 -1.288 . . . . 13.82 109.879 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.3 -144.18 10.93 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.998 -1.241 . . . . 12.42 109.998 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -71.03 -62.17 1.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.437 -1.037 . . . . 0.0 110.023 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -53.49 -25.53 16.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.446 -0.783 . . . . 0.0 109.572 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.38 -46.84 37.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.281 -0.887 . . . . 27.059999999999999 109.115 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.8 tt -54.55 -59.7 4.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.577 -0.702 . . . . 15.31 109.912 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -50.97 -48.72 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.796 . . . . 0.0 110.492 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 4.6 t -50.05 -43.44 51.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.833 -1.167 . . . . 21.789999999999999 109.292 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.2 -35.58 63.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.381 -0.824 . . . . 0.0 111.428 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -59.84 -61.47 2.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.87 -1.144 . . . . 0.0 110.274 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.581 ' NE2' ' HG ' ' A' ' 91' ' ' SER . 2.2 pp0? -62.07 -20.15 63.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 110.102 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.581 ' HG ' ' NE2' ' A' ' 90' ' ' GLN . 70.4 m -82.43 -22.77 35.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 109.668 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.92 66.33 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.437 -1.065 . . . . 25.640000000000001 110.437 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -68.49 -27.81 66.46 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.986 -1.303 . . . . 50.259999999999998 108.704 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.55 -64.64 0.87 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 24.170000000000002 110.311 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.83 -29.95 43.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.426 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.48 -47.06 83.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 28.030000000000001 108.357 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.649 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.46 -37.46 78.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.971 -1.122 . . . . 40.960000000000001 107.971 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.07 -34.47 68.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.518 -0.919 . . . . 15.050000000000001 108.518 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -64.92 -57.6 8.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.784 -0.572 . . . . 0.0 111.737 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.66 -34.17 7.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.907 -1.121 . . . . 38.640000000000001 110.665 -178.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.5 pt -100.29 -11.66 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.816 -1.178 . . . . 0.0 109.331 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.94 41.56 22.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.229 -1.148 . . . . 18.539999999999999 110.229 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.04 54.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -1.197 . . . . 10.84 109.243 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 pp -97.59 -174.22 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 109.558 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.635 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.456 -0.572 . . . . 18.329999999999998 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.445 ' N ' ' OE1' ' A' ' 2' ' ' GLN . 2.0 mm100 -83.22 -73.02 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 29.77 109.182 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' O ' ' OG ' ' A' ' 7' ' ' SER . 4.8 pt-20 -60.81 -6.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.625 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.7 m-85 -60.19 -74.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 20.030000000000001 110.617 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -73.26 -38.42 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 12.91 110.186 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 94.3 m-20 -55.98 -35.26 66.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.001 -1.062 . . . . 28.329999999999998 109.496 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 66.4 m -74.85 -13.07 60.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -97.4 -41.33 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 22.870000000000001 110.654 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.24 140.56 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.849 -1.157 . . . . 25.190000000000001 110.249 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -150.05 136.86 11.08 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.076 -1.083 . . . . 34.609999999999999 108.076 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.78 133.33 50.3 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 120.999 1.133 . . . . 11.720000000000001 109.739 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.66 18.44 73.18 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.081 -1.608 . . . . 10.24 109.081 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -137.88 135.31 36.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -1.078 . . . . 25.359999999999999 109.489 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.53 134.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.293 -0.879 . . . . 10.890000000000001 109.744 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.87 140.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.335 -0.987 . . . . 15.82 108.335 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.66 127.87 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.217 -0.927 . . . . 8.9399999999999995 111.177 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.49 121.35 34.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.064 -1.087 . . . . 9.9299999999999997 108.064 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.3 pt -131.34 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.331 1.062 . . . . 10.619999999999999 111.337 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 21' ' ' THR . 4.4 mtmp? -146.31 91.19 5.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -46.37 83.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.616 1.544 . . . . 24.579999999999998 110.484 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.4 m -177.78 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 34.82 108.395 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.85 125.74 41.1 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 21.460000000000001 109.765 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.24 -19.12 40.68 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.321 2.014 . . . . 13.859999999999999 112.605 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -69.9 -42.91 72.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.611 -1.306 . . . . 0.0 109.627 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.509 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -65.86 -34.29 77.8 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.654 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.07 -42.62 99.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.79 -0.819 . . . . 59.590000000000003 108.79 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.565 HH11 ' HG2' ' A' ' 27' ' ' ARG . 6.5 mtt-85 -53.57 -45.07 69.81 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.231 -0.918 . . . . 0.0 108.656 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -36.49 78.93 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 108.849 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 7.5 mt-30 -70.62 -44.02 68.08 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.694 0.759 . . . . 45.490000000000002 109.333 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -70.97 -36.47 72.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.652 -0.655 . . . . 34.969999999999999 111.177 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -75.52 -56.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.88 -1.138 . . . . 0.0 110.211 -178.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.9 mt -59.43 -21.3 59.79 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.757 -1.215 . . . . 17.280000000000001 109.254 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.654 -0.869 . . . . 24.109999999999999 108.654 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -92.82 -0.01 57.33 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.48 -0.762 . . . . 44.07 110.127 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.77 128.71 53.31 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.766 -1.209 . . . . 19.629999999999999 108.832 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.9 69.22 0.85 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.648 1.566 . . . . 21.539999999999999 109.417 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.4 mm -80.43 153.42 4.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.579 -0.701 . . . . 0.0 109.21 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -54.88 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.522 -0.736 . . . . 29.41 110.034 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.559 ' O ' ' O ' ' A' ' 38' ' ' LYS . 11.8 mt-30 -53.33 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.726 0.774 . . . . 0.0 111.036 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.85 54.67 0.75 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.079 -1.208 . . . . 15.27 110.079 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.13 -27.02 14.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.576 -0.955 . . . . 8.7799999999999994 109.3 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -97.09 131.73 43.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.762 -0.829 . . . . 7.1299999999999999 108.762 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 19.3 tt0 -141.23 173.07 11.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.85 . . . . 22.030000000000001 109.929 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 43.9 m-85 -135.35 111.75 9.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.349 -1.352 . . . . 16.329999999999998 107.349 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.74 104.9 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.872 . . . . 6.5800000000000001 111.971 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.8 m-20 -82.25 101.79 10.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.614 -0.884 . . . . 15.32 108.614 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 pt -61.97 -1.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 10.92 111.256 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' THR . 14.2 t -93.5 -17.06 23.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 21.719999999999999 109.303 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.0 12.82 1.23 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 22.449999999999999 109.52 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 7.3 t -140.81 -17.08 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 25.629999999999999 109.674 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 50' ' ' THR . 6.3 t-20 81.14 -175.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.451 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 58.49 24.18 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 108.873 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 52' ' ' HIS . 3.6 p -43.32 -51.93 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.805 . . . . 18.870000000000001 110.292 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -53.81 -35.4 61.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 45.210000000000001 110.144 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.03 -44.89 87.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.057 -1.027 . . . . 33.020000000000003 109.753 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.44 -53.9 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.019 . . . . 9.8399999999999999 109.647 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.53 -42.12 82.27 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.701 -1.222 . . . . 17.84 107.701 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.35 -33.67 63.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.067 -1.456 . . . . 18.84 107.067 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -77.35 -45.26 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.787 -0.82 . . . . 12.99 108.787 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 ' O ' ' OG1' ' A' ' 64' ' ' THR . 89.9 mt -55.49 -38.11 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.962 -1.125 . . . . 14.609999999999999 107.962 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 4.2 tp-100 -59.09 -49.29 78.43 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.522 0.677 . . . . 40.450000000000003 109.44 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -66.37 -54.22 27.05 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 41.810000000000002 110.65 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.81 -36.0 81.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 21.77 111.442 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 12.9 p -105.59 -68.38 0.87 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.021 -1.049 . . . . 11.380000000000001 109.812 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 144.26 -41.25 1.12 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.7 -1.76 . . . . 14.789999999999999 108.7 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.58 142.45 29.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.553 -0.969 . . . . 17.809999999999999 109.855 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -109.86 26.93 10.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 29.760000000000002 107.992 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.49 168.07 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.946 0.879 . . . . 18.260000000000002 111.238 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.639 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.7 t -113.22 132.39 22.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.309 -1.367 . . . . 8.1999999999999993 107.309 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -83.06 -167.52 5.64 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.616 1.007 . . . . 7.79 112.114 -0.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 91.77 2.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.716 -2.327 . . . . 26.050000000000001 104.716 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 73' ' ' PHE . 80.8 t -83.69 158.54 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.72 0.771 . . . . 8.6799999999999997 112.175 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.406 ' N ' ' CG1' ' A' ' 72' ' ' VAL . 65.6 m-85 -146.32 84.36 1.63 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.557 . . . . 14.07 111.55 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -70.7 114.43 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.885 -2.265 . . . . 9.3399999999999999 104.885 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -158.09 30.69 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 105.658 -2.977 . . . . 12.42 105.658 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -81.35 0.98 34.79 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.426 -1.632 . . . . 44.859999999999999 109.403 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -87.42 115.09 24.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 110.516 -179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -73.1 136.47 44.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' ILE . 2.8 pp -105.59 -7.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.159 -0.963 . . . . 20.449999999999999 109.281 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.34 -154.88 16.67 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.225 -1.15 . . . . 13.82 110.225 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 -141.52 12.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.34 -1.104 . . . . 12.42 110.34 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 p -71.42 -66.42 0.63 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.594 -0.944 . . . . 0.0 110.333 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 t -49.01 -29.39 4.83 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 109.358 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.56 -47.26 33.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.283 -0.886 . . . . 27.059999999999999 109.139 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 1.3 tt -54.58 -58.5 7.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 15.31 109.664 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -54.71 -49.0 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.383 -0.823 . . . . 0.0 110.526 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.535 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 6.5 m -45.29 -37.58 4.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.932 -1.105 . . . . 21.789999999999999 109.09 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.26 -38.77 34.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.453 -0.78 . . . . 0.0 111.84 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -59.95 -60.48 3.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.831 -1.168 . . . . 0.0 111.017 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 87' ' ' SER . 1.6 pp0? -58.65 -24.02 60.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 m -80.74 -57.0 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.69 -8.49 6.89 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.702 -1.359 . . . . 25.640000000000001 109.702 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -69.29 -26.42 64.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.313 -1.11 . . . . 50.259999999999998 108.566 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp -60.09 -65.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 24.170000000000002 110.599 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.61 -28.44 32.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.35 -47.85 77.79 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.442 -0.947 . . . . 28.030000000000001 108.442 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -58.18 -34.03 69.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.97 -1.122 . . . . 40.960000000000001 107.97 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -72.42 -40.82 66.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 15.050000000000001 109.292 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.97 -52.14 57.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.0 111.808 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -51.19 -33.14 26.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.819 -1.176 . . . . 38.640000000000001 111.114 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.1 pt -100.72 -14.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.0 43.49 7.56 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.354 -1.099 . . . . 18.539999999999999 110.354 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.25 -16.55 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.242 . . . . 10.84 109.839 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.4 179.11 5.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 109.771 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.685 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.639 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.241 0.543 . . . . 18.329999999999998 109.564 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.683 ' NE2' ' H ' ' A' ' 3' ' ' GLU . 2.4 pm0 -76.07 -53.14 8.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.04 -1.037 . . . . 29.77 109.68 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.683 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 11.1 pt-20 -64.21 -18.96 65.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.905 -1.122 . . . . 0.0 109.237 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.78 -71.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.506 -0.746 . . . . 20.030000000000001 110.613 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -72.63 -37.97 57.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 12.91 110.108 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 69.4 m-20 -55.39 -38.42 68.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.184 -0.947 . . . . 28.329999999999998 109.521 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -74.14 -11.9 60.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 42.6 mttm -97.55 -45.03 6.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 22.870000000000001 110.47 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.63 139.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 25.190000000000001 109.56 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -149.81 136.17 10.61 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.213 -1.032 . . . . 34.609999999999999 108.213 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.45 124.75 15.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 120.752 0.968 . . . . 11.720000000000001 109.628 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.62 55.18 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.368 -1.493 . . . . 10.24 109.368 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 8' ' ' LYS . 25.0 ttpt -137.29 135.67 37.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.335 -1.097 . . . . 25.359999999999999 109.409 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.96 132.9 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.829 . . . . 10.890000000000001 109.403 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.48 139.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 15.82 108.805 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.76 126.94 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 8.9399999999999995 110.794 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.08 120.01 33.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.604 -1.258 . . . . 9.9299999999999997 107.604 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.52 -174.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 122.615 1.198 . . . . 10.619999999999999 112.232 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mttm -141.54 95.09 7.29 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 105.558 -2.015 . . . . 38.729999999999997 105.558 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.523 ' O ' ' OG1' ' A' ' 21' ' ' THR . 14.0 Cg_exo -49.9 76.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.37 1.38 . . . . 24.579999999999998 110.834 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.656 ' N ' ' O ' ' A' ' 19' ' ' LYS . 87.8 m -172.0 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.228 -0.656 . . . . 34.82 109.228 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.79 124.64 47.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 21.460000000000001 110.266 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.12 -20.05 29.34 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.193 1.928 . . . . 13.859999999999999 112.872 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -66.9 -47.47 71.71 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.481 -1.387 . . . . 0.0 108.784 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -63.02 -36.22 82.85 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -60.59 -40.78 93.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.163 -1.051 . . . . 59.590000000000003 108.163 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -47.79 77.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.21 75.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.297 -0.877 . . . . 0.0 108.915 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.467 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 9.6 mt-30 -69.89 -40.98 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.59 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 68.8 mm-40 -69.33 -39.85 77.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.597 -0.689 . . . . 34.969999999999999 111.364 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.07 -55.93 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.882 -1.136 . . . . 0.0 110.947 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.447 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -56.75 -26.3 56.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.738 -1.226 . . . . 17.280000000000001 109.536 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.498 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.7 t -64.41 -26.94 68.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.16 -0.963 . . . . 24.109999999999999 109.02 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.553 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -92.03 0.31 57.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 44.07 110.288 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.65 133.54 37.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.763 -1.21 . . . . 19.629999999999999 108.319 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.24 62.99 0.7 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.578 1.519 . . . . 21.539999999999999 109.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 37' ' ' ILE . 3.0 mm -79.92 141.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -55.78 152.78 9.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.275 -0.891 . . . . 29.41 109.977 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 24.8 mp0 -57.08 141.15 46.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.436 0.636 . . . . 0.0 111.431 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.0 9.18 39.24 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.484 -0.76 . . . . 15.27 111.902 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -30.42 12.17 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.823 -1.399 . . . . 8.7799999999999994 109.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.58 131.76 42.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.518 -0.739 . . . . 7.1299999999999999 109.543 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -141.85 171.43 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 22.030000000000001 109.444 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CG ' ' OE1' ' A' ' 29' ' ' GLN . 39.3 m-85 -133.23 110.02 9.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.145 -1.428 . . . . 16.329999999999998 107.145 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.98 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.476 -0.765 . . . . 6.5800000000000001 111.434 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 48' ' ' THR . 3.8 m-20 -81.81 100.69 9.71 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.445 -0.946 . . . . 15.32 108.445 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.41 1.92 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 10.92 110.734 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 46' ' ' ASP . 17.5 p -95.83 -23.17 17.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 21.719999999999999 109.04 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.13 9.62 2.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 22.449999999999999 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 14.2 t -137.05 -7.69 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.841 . . . . 25.629999999999999 109.404 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.574 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 69.6 -163.81 0.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.497 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.3 OUTLIER 54.63 21.47 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.994 -1.066 . . . . 0.0 108.545 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -40.29 -59.91 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 18.870000000000001 110.739 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 7.9 m120 -54.18 -35.06 61.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 45.210000000000001 111.034 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.99 -46.36 88.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 33.020000000000003 109.963 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.01 -53.18 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.979 -1.076 . . . . 9.8399999999999999 109.518 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -56.53 -44.44 80.82 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.566 -1.272 . . . . 17.84 107.566 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 24.9 m-20 -53.61 -33.03 53.57 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.977 -1.49 . . . . 18.84 106.977 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -78.64 -48.56 14.83 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.94 -0.763 . . . . 12.99 108.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.7 mt -52.02 -36.4 50.02 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.524 -1.287 . . . . 14.609999999999999 107.524 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.9 tp60 -61.96 -55.31 30.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.794 -0.817 . . . . 40.450000000000003 108.794 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -39.19 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 41.810000000000002 109.678 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.2 tp -64.09 -45.62 87.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 21.77 109.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.636 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -117.64 -71.71 0.72 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.633 -0.667 . . . . 11.380000000000001 109.569 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.636 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 158.47 -34.26 0.5 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.317 -1.513 . . . . 14.789999999999999 109.317 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB1' HH21 ' A' ' 71' ' ' ARG . . . -95.93 137.13 35.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 17.809999999999999 110.019 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' O31' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -110.88 30.19 7.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.066 -1.087 . . . . 29.760000000000002 108.066 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.33 171.04 11.51 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.926 0.869 . . . . 18.260000000000002 111.501 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.64 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.3 t -115.26 132.12 23.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.494 -1.299 . . . . 8.1999999999999993 107.494 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.741 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 28.5 Cg_endo -81.04 -164.84 4.09 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 CA-C-O 122.032 0.763 . . . . 7.79 110.925 0.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.741 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -150.81 93.25 1.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.376 -2.083 . . . . 26.050000000000001 105.376 177.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.61 156.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.827 0.822 . . . . 8.6799999999999997 112.352 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.37 92.92 2.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.875 -0.516 . . . . 14.07 110.606 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.4 mm -72.43 113.74 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.832 -1.914 . . . . 9.3399999999999999 105.832 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.58 -145.62 42.26 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 106.622 -2.591 . . . . 12.42 106.622 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -87.56 -3.48 58.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.677 -1.484 . . . . 44.859999999999999 109.5 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.36 116.47 25.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.221 -0.924 . . . . 0.0 110.619 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -75.77 143.97 41.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.778 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -113.43 -18.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.189 -0.944 . . . . 20.449999999999999 109.335 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.43 -159.2 19.96 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.109 -1.196 . . . . 13.82 110.109 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' CA ' ' NH1' ' A' ' 71' ' ' ARG . . . -92.51 -143.7 12.98 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.391 -1.064 . . . . 12.42 110.655 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -71.33 -62.63 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -1.015 . . . . 0.0 110.383 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 t -51.0 -24.99 4.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.359 -0.838 . . . . 0.0 109.189 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -76.05 -45.52 33.81 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 27.059999999999999 109.219 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 3.0 tt -55.0 -58.41 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 15.31 109.829 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -52.06 -52.3 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 111.003 -178.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' VAL . 5.0 t -44.84 -38.99 4.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.059 -1.025 . . . . 21.789999999999999 109.251 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.84 -41.5 23.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.545 -0.722 . . . . 0.0 111.631 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -55.83 29.53 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.868 -1.145 . . . . 0.0 110.398 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -25.49 67.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.944 -1.098 . . . . 0.0 109.452 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.9 m -77.98 -62.22 1.74 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.419 -0.8 . . . . 0.0 109.024 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -9.25 5.53 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.09 -1.204 . . . . 25.640000000000001 110.09 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.22 -24.36 64.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.117 -1.225 . . . . 50.259999999999998 108.177 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.61 -67.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.638 -0.664 . . . . 24.170000000000002 110.47 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -51.58 -28.99 15.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.429 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.22 -49.18 70.69 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.074 -1.084 . . . . 28.030000000000001 108.074 178.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.489 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.68 -34.65 67.59 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.926 -1.139 . . . . 40.960000000000001 107.926 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD11 ' N ' ' A' ' 98' ' ' LEU . 8.3 mp -72.89 -38.52 66.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.479 -0.934 . . . . 15.050000000000001 108.479 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -64.49 -53.64 44.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.576 . . . . 0.0 111.555 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.87 23.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 38.640000000000001 110.76 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.58 -15.3 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.69 -1.256 . . . . 0.0 109.007 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.66 44.39 8.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.588 -1.005 . . . . 18.539999999999999 110.588 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.45 55.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -1.219 . . . . 10.84 109.87 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.553 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -95.79 -177.55 4.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.783 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.5 -179.895 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.64 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.516 -0.55 . . . . 18.329999999999998 109.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.53 -71.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 29.77 109.415 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.33 -11.31 4.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.26 -73.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 20.030000000000001 110.572 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -72.94 -37.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 12.91 109.884 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 18.0 m120 -55.73 -38.34 69.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.184 -0.948 . . . . 28.329999999999998 109.301 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 m -74.18 -10.03 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -95.96 -53.5 3.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 22.870000000000001 109.627 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.57 128.11 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.844 . . . . 25.190000000000001 110.067 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.36 155.67 39.45 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.072 -1.084 . . . . 34.609999999999999 108.072 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.56 130.06 38.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.895 1.73 . . . . 11.720000000000001 111.537 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.89 64.4 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.874 -0.89 . . . . 10.24 110.874 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -142.47 133.33 25.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.351 . . . . 25.359999999999999 109.928 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.23 136.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.890000000000001 109.037 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.79 144.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 15.82 108.55 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.66 126.88 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 8.9399999999999995 110.77 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -92.68 123.91 36.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 9.9299999999999997 107.571 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.92 -176.43 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.383 1.087 . . . . 10.619999999999999 111.342 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 21' ' ' THR . 14.6 mtmm -143.32 92.73 6.61 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.385 -1.709 . . . . 38.729999999999997 106.385 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' C ' ' OG1' ' A' ' 21' ' ' THR . 12.2 Cg_exo -47.79 82.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.629 1.553 . . . . 24.579999999999998 110.442 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 179.1 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.025 -0.731 . . . . 34.82 109.025 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 130.63 28.4 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 21.460000000000001 110.266 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -59.69 -20.33 57.77 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.393 2.062 . . . . 13.859999999999999 112.654 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.42 ' CG ' HG13 ' A' ' 106' ' ' GSH . 25.4 m-85 -70.37 -43.96 69.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.533 -1.355 . . . . 0.0 109.622 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -32.37 74.01 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.557 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.3 mmm-85 -64.04 -43.71 94.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.643 -0.873 . . . . 59.590000000000003 108.643 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 2.1 mtt-85 -51.75 -45.46 63.69 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.0 83.55 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -70.21 -42.15 72.71 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.43 -0.794 . . . . 45.490000000000002 109.296 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.74 -38.36 76.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.683 . . . . 34.969999999999999 111.078 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.81 -58.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.8 mt -57.71 -21.46 40.84 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.512 -1.367 . . . . 17.280000000000001 109.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -65.94 -24.96 66.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.052 -1.03 . . . . 24.109999999999999 108.769 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -91.32 1.38 57.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 44.07 110.191 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.48 126.78 55.19 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.903 -1.123 . . . . 19.629999999999999 109.163 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.55 67.64 0.76 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.773 1.648 . . . . 21.539999999999999 109.66 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.16 150.66 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.406 -0.809 . . . . 0.0 108.907 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 39' ' ' GLN . 30.0 mttm -53.47 -169.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.85 . . . . 29.41 110.309 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 38' ' ' LYS . 56.6 mm-40 -51.52 -127.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.529 0.681 . . . . 0.0 111.344 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.37 53.18 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.421 -1.072 . . . . 15.27 110.421 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -23.33 14.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -1.045 . . . . 8.7799999999999994 108.942 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -102.73 131.89 49.25 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.565 -0.902 . . . . 7.1299999999999999 108.565 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 25.9 tt0 -141.5 173.9 11.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.305 -0.872 . . . . 22.030000000000001 110.04 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 38.5 m-85 -135.22 109.84 8.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.57 -1.27 . . . . 16.329999999999998 107.57 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.58 103.49 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.096 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.98 101.5 9.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.219 -0.925 . . . . 15.32 108.731 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.3 -2.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.089 -1.007 . . . . 10.92 110.237 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 50' ' ' THR . 10.5 p -96.28 -29.79 13.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 21.719999999999999 109.346 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.55 18.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 22.449999999999999 109.273 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.519 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 10.7 t -140.5 -13.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -0.88 . . . . 25.629999999999999 109.91 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' CG ' ' N ' ' A' ' 52' ' ' HIS . 0.5 OUTLIER 78.7 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.545 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 2.4 m170 53.61 12.32 0.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.702 -1.249 . . . . 0.0 108.406 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -35.97 -67.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.718 -0.614 . . . . 18.870000000000001 111.077 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -53.96 -31.51 50.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.227 -0.921 . . . . 45.210000000000001 111.067 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' OE1' ' CE1' ' A' ' 52' ' ' HIS . 57.4 mt-10 -65.26 -46.61 79.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.041 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.44 -53.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.952 -1.092 . . . . 9.8399999999999999 109.453 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.493 HE22 ' HZ3' ' A' ' 19' ' ' LYS . 3.4 mt-30 -57.27 -43.43 83.08 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.824 -1.176 . . . . 17.84 107.824 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -54.78 -33.84 61.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.217 -1.401 . . . . 18.84 107.217 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -78.8 -49.21 13.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.969 -0.692 . . . . 12.99 109.136 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.06 -32.89 49.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.434 -0.951 . . . . 14.609999999999999 108.434 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 3.9 tp-100 -59.77 -53.89 52.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.675 -0.641 . . . . 40.450000000000003 109.385 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -66.92 -48.25 69.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 41.810000000000002 111.031 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.62 -39.02 92.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 21.77 110.554 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 10.5 p -106.49 -66.67 0.99 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.32 -0.862 . . . . 11.380000000000001 109.912 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 143.48 -42.15 1.1 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.694 -1.763 . . . . 14.789999999999999 108.694 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.22 136.62 38.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -1.02 . . . . 17.809999999999999 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 25.42 9.04 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.313 -0.995 . . . . 29.760000000000002 108.313 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.725 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -83.02 169.45 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.67 . . . . 18.260000000000002 110.354 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.589 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 10.9 t -113.67 138.53 22.68 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 107.916 -1.142 . . . . 8.1999999999999993 107.916 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 82' ' ' SER . 30.6 Cg_endo -84.95 -165.92 4.05 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 CA-C-O 122.299 0.875 . . . . 7.79 111.203 -0.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.725 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -143.41 92.77 2.4 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.131 -2.174 . . . . 26.050000000000001 105.131 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.2 t -83.63 156.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.877 . . . . 8.6799999999999997 111.387 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -146.22 92.05 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.635 -0.666 . . . . 14.07 111.105 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 74' ' ' ILE . 13.3 mm -72.97 106.32 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.598 -2.001 . . . . 9.3399999999999999 105.598 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.96 -152.1 46.81 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 105.793 -2.923 . . . . 12.42 105.793 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -81.76 4.06 23.46 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.388 -1.654 . . . . 44.859999999999999 108.507 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.664 ' CB ' HH21 ' A' ' 97' ' ' ARG . 23.6 m-20 -89.63 108.96 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.0 110.754 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 t -74.44 141.99 44.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.29 -13.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 20.449999999999999 109.443 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.96 -163.89 15.24 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.309 -1.117 . . . . 13.82 110.309 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 84' ' ' ASP . . . -86.58 -146.26 9.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.23 -1.148 . . . . 12.42 110.23 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 t -72.61 -59.7 2.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.553 -0.969 . . . . 0.0 110.049 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -50.24 -26.48 4.75 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 108.922 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 81' ' ' GLY . 16.7 m-20 -75.23 -47.81 26.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.526 -0.734 . . . . 27.059999999999999 109.09 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 1.7 tt -53.89 -59.15 5.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 15.31 109.776 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.603 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -52.35 -50.73 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 110.539 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.5 t -46.26 -41.54 13.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 21.789999999999999 109.869 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.85 -40.08 55.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 112.173 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -59.27 -59.5 5.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.646 -1.284 . . . . 0.0 110.858 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.603 ' OE1' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -57.96 -22.69 50.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.333 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 m -79.82 -60.09 2.48 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 109.119 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 -11.72 6.46 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.62 -1.392 . . . . 25.640000000000001 109.62 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' A' ' 96' ' ' THR . 36.7 tp10 -69.24 -25.58 64.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -1.163 . . . . 50.259999999999998 108.994 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.3 tp -58.48 -64.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.356 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -52.61 -27.41 16.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -63.57 -48.2 78.4 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.425 -0.91 . . . . 28.030000000000001 108.784 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.715 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.0 mmm180 -58.73 -34.28 71.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.052 . . . . 40.960000000000001 108.17 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.6 -39.68 73.65 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.805 -0.813 . . . . 15.050000000000001 108.805 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -66.03 -53.83 33.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.767 -0.583 . . . . 0.0 111.941 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.715 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -49.47 -33.36 14.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.207 . . . . 38.640000000000001 110.612 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.22 -13.23 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.697 -1.252 . . . . 0.0 109.331 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 46.42 8.91 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.549 -1.02 . . . . 18.539999999999999 110.549 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.07 -14.47 41.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -1.16 . . . . 10.84 109.586 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -95.48 174.61 6.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 109.951 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.649 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.63 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.489 -0.56 . . . . 18.329999999999998 109.489 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' PHE . 23.3 tt0 -90.14 -72.77 0.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 29.77 109.15 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' A' ' 7' ' ' SER . 10.2 pt-20 -58.37 -9.04 1.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.076 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 2' ' ' GLN . 2.0 m-85 -61.57 -72.91 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.78 . . . . 20.030000000000001 110.018 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.7 m -73.62 -40.32 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 12.91 110.126 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.463 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 73.8 m-20 -56.08 -27.23 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.201 -0.937 . . . . 28.329999999999998 110.399 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 24.9 m -74.71 -21.7 59.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.08 -1.012 . . . . 0.0 110.528 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -97.58 -45.36 6.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.973 -1.079 . . . . 22.870000000000001 111.293 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.39 129.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.014 -1.054 . . . . 25.190000000000001 110.123 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -146.79 153.05 45.91 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 34.609999999999999 108.664 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.03 122.86 12.56 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.218 1.279 . . . . 11.720000000000001 109.963 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.0 24.32 49.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.83 -1.308 . . . . 10.24 109.83 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -139.23 134.58 32.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -1.145 . . . . 25.359999999999999 109.232 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.02 137.36 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 10.890000000000001 110.11 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.51 153.06 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.499 -0.926 . . . . 15.82 108.499 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.94 121.65 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.234 -0.916 . . . . 8.9399999999999995 110.629 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.98 121.1 31.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.201 -1.407 . . . . 9.9299999999999997 107.201 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.2 pt -133.48 -168.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.472 1.129 . . . . 10.619999999999999 111.872 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.636 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.2 mtmt -145.59 96.65 4.75 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 106.205 -1.776 . . . . 38.729999999999997 106.205 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.51 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.4 Cg_exo -51.82 74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.379 1.386 . . . . 24.579999999999998 110.736 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.636 ' N ' ' O ' ' A' ' 19' ' ' LYS . 11.5 m -171.32 -32.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.919 -0.771 . . . . 34.82 108.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.22 128.57 34.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 21.460000000000001 110.074 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.82 -13.28 25.85 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.162 1.908 . . . . 13.859999999999999 112.118 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CG ' HG13 ' A' ' 106' ' ' GSH . 19.1 m-85 -71.34 -47.5 56.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.709 -1.244 . . . . 0.0 109.706 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -28.39 70.01 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.015 -1.053 . . . . 0.0 108.9 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -61.27 -42.64 98.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.29 -1.004 . . . . 59.590000000000003 108.29 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -54.24 -49.14 70.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.176 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -37.43 75.46 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.878 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.54 -42.15 71.59 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.333 -0.854 . . . . 45.490000000000002 109.618 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.77 -37.33 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.386 -0.821 . . . . 34.969999999999999 111.02 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.28 -57.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.99 -1.069 . . . . 0.0 110.197 -178.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -55.38 -24.62 30.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 17.280000000000001 109.394 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -65.28 -27.9 68.96 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.119 -0.988 . . . . 24.109999999999999 108.489 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -90.89 3.66 53.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.812 . . . . 44.07 110.286 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 37' ' ' ILE . 20.0 mt -91.83 131.5 35.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.795 -1.191 . . . . 19.629999999999999 109.257 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.88 64.61 0.43 Allowed 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.707 1.605 . . . . 21.539999999999999 110.31 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.8 mm -82.25 149.05 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 108.887 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.4 mmmt -53.22 -174.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 29.41 110.057 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 39' ' ' GLN . 4.3 mp0 -52.32 -121.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.674 -0.641 . . . . 0.0 111.123 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 48.31 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.402 -0.904 . . . . 15.27 110.866 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -18.26 16.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.241 -1.152 . . . . 8.7799999999999994 109.372 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -105.56 126.7 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 7.1299999999999999 108.83 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 36.7 tt0 -140.4 164.97 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 22.030000000000001 109.689 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.618 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 23.3 m-85 -126.45 114.91 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.593 -1.262 . . . . 16.329999999999998 107.593 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.87 102.06 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 6.5800000000000001 111.131 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 48' ' ' THR . 7.4 m-20 -80.44 100.06 8.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.478 -1.304 . . . . 15.32 107.478 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.6 pt -61.17 2.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 10.92 110.749 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 46' ' ' ASP . 5.1 t -94.88 -20.24 19.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.999 -1.063 . . . . 21.719999999999999 109.086 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.58 13.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 22.449999999999999 109.309 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.1 t -140.69 -14.71 0.94 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.22 -0.925 . . . . 25.629999999999999 109.902 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 50' ' ' THR . 1.1 m-20 78.97 -176.19 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.8 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.403 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER 57.76 30.16 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 109.089 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 p -44.69 -54.12 6.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 18.870000000000001 109.906 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.0 m-20 -54.15 -37.32 64.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 45.210000000000001 110.732 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -62.24 -46.58 88.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.112 . . . . 33.020000000000003 109.636 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.9 -55.7 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.969 -1.082 . . . . 9.8399999999999999 109.59 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -56.69 -40.45 75.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.694 -1.254 . . . . 17.84 107.878 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 22.9 m-20 -55.04 -32.53 61.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.015 -1.476 . . . . 18.84 107.015 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -78.8 -47.94 15.74 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.766 -0.827 . . . . 12.99 108.766 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.452 ' O ' ' OG1' ' A' ' 64' ' ' THR . 65.8 mt -54.53 -33.59 60.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.375 -0.972 . . . . 14.609999999999999 108.375 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.7 tp60 -59.25 -55.78 30.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.751 -0.593 . . . . 40.450000000000003 109.8 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.7 -50.42 62.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.028 -1.045 . . . . 41.810000000000002 111.106 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.06 -34.83 78.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.867 -1.146 . . . . 21.77 110.657 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.6 p -110.74 -70.44 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.306 -0.871 . . . . 11.380000000000001 109.915 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 147.04 -41.85 0.94 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.606 -1.798 . . . . 14.789999999999999 108.606 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.22 140.39 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.436 -1.037 . . . . 17.809999999999999 110.047 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' NH1' ' C3 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -109.85 24.43 13.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.192 -1.04 . . . . 29.760000000000002 108.192 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.95 174.1 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.923 0.868 . . . . 18.260000000000002 110.935 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.563 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 9.8 t -118.61 134.33 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.454 -1.313 . . . . 8.1999999999999993 107.454 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -80.7 -163.93 3.62 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 CA-C-O 122.245 0.852 . . . . 7.79 111.257 0.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 91.74 1.89 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.296 -2.113 . . . . 26.050000000000001 105.296 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.65 157.81 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.822 0.82 . . . . 8.6799999999999997 112.185 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -145.22 88.28 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.801 -0.562 . . . . 14.07 110.624 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.4 mp -71.0 109.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.469 -2.048 . . . . 9.3399999999999999 105.469 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.57 -154.64 52.1 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.036 -2.826 . . . . 12.42 106.036 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -84.51 0.2 50.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.354 -1.674 . . . . 44.859999999999999 108.934 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.7 114.91 25.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -71.69 149.45 45.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.366 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.0 -23.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.95 . . . . 20.449999999999999 109.342 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.64 -142.71 14.08 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.948 -1.261 . . . . 13.82 109.948 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -111.06 -144.19 9.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.898 -1.281 . . . . 12.42 109.898 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -71.04 -61.12 1.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -1.003 . . . . 0.0 109.801 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.9 t -52.99 -26.27 14.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.5 m-20 -73.53 -48.33 33.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.345 -0.847 . . . . 27.059999999999999 109.236 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.76 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.382 -0.824 . . . . 15.31 109.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.42 -49.43 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 0.0 110.015 -178.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -49.5 -41.32 40.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 21.789999999999999 109.357 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt -75.46 -36.67 60.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 111.253 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 -62.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.995 -1.066 . . . . 0.0 110.644 -178.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -61.19 -16.61 46.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.949 -1.095 . . . . 0.0 109.971 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.675 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 13.5 m -85.25 -18.61 33.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.891 . . . . 0.0 109.425 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.79 -13.49 52.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.891 -1.283 . . . . 25.640000000000001 109.891 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.55 -26.76 65.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.149 -1.207 . . . . 50.259999999999998 108.966 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.95 -63.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 24.170000000000002 110.157 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.1 -31.31 41.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.1 m -63.56 -43.99 95.46 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.696 -1.224 . . . . 28.030000000000001 107.696 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -60.0 -35.65 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.403 -0.962 . . . . 40.960000000000001 108.403 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 98' ' ' LEU . 9.9 mp -71.18 -40.23 71.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.445 -0.784 . . . . 15.050000000000001 109.237 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -65.08 -53.53 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 112.29 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -47.57 -31.54 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.728 -1.233 . . . . 38.640000000000001 110.503 -177.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 pt -104.17 -14.18 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.918 -1.114 . . . . 0.0 109.649 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.26 41.94 11.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.433 -1.067 . . . . 18.539999999999999 110.433 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.13 -12.32 53.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 10.84 109.561 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.62 -174.82 3.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.389 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.657 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 18.329999999999998 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 4' ' ' PHE . 52.5 mt-30 -138.6 -76.15 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 29.77 108.988 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -58.71 -5.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.6 m-85 -62.91 -70.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 20.030000000000001 110.25 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -73.1 -40.34 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 12.91 110.097 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 8.6 m-20 -54.79 -38.27 67.09 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.073 -1.017 . . . . 28.329999999999998 109.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -74.72 -12.35 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.212 -0.93 . . . . 0.0 109.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -97.24 -46.8 5.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.206 -0.934 . . . . 22.870000000000001 110.608 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.1 135.09 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.776 -1.202 . . . . 25.190000000000001 109.385 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.49 150.36 40.25 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.715 -0.846 . . . . 34.609999999999999 108.715 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.39 124.37 15.91 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.41 1.407 . . . . 11.720000000000001 110.021 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.08 28.45 45.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.764 -1.334 . . . . 10.24 109.764 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -140.91 137.22 32.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 25.359999999999999 109.761 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.63 135.05 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.382 -0.824 . . . . 10.890000000000001 109.643 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.42 141.39 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.048 . . . . 15.82 108.172 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 t -124.19 127.28 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 8.9399999999999995 111.078 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.84 121.04 34.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.24 -1.393 . . . . 9.9299999999999997 107.24 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.0 pt -131.14 -176.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.361 1.077 . . . . 10.619999999999999 111.254 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.5 mtmt -143.9 91.81 6.51 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.1 Cg_exo -47.18 78.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.892 1.728 . . . . 24.579999999999998 111.05 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' LYS . 88.2 m -174.1 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.852 -0.796 . . . . 34.82 108.852 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.75 130.04 29.95 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 21.460000000000001 109.857 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -57.94 -21.59 50.37 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.277 1.985 . . . . 13.859999999999999 112.209 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -70.43 -38.18 74.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.635 -1.291 . . . . 0.0 108.523 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER -66.73 -36.63 82.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -64.08 -40.53 96.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.918 -0.771 . . . . 59.590000000000003 108.918 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.9 OUTLIER -53.66 -48.84 69.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.433 -0.792 . . . . 0.0 109.291 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.52 72.98 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.372 -0.83 . . . . 0.0 109.161 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.626 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.57 -43.39 69.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.375 -0.828 . . . . 45.490000000000002 109.477 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 22.0 mm-40 -71.13 -35.78 71.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.554 -0.716 . . . . 34.969999999999999 111.256 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.48 -58.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 110.478 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 2.9 mt -58.99 -17.98 29.95 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.563 -1.336 . . . . 17.280000000000001 109.634 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.486 ' HG ' HE21 ' A' ' 34' ' ' GLN . 5.8 t -65.87 -29.93 70.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 24.109999999999999 109.037 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.486 HE21 ' HG ' ' A' ' 33' ' ' SER . 1.6 mp0 -91.72 5.88 48.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 44.07 110.49 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.9 mt -90.56 127.98 50.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.758 -1.213 . . . . 19.629999999999999 109.304 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.43 68.99 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.8 1.666 . . . . 21.539999999999999 109.94 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.6 mm -82.13 150.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.416 -0.802 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 39' ' ' GLN . 1.5 mmmm -54.68 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.466 -0.771 . . . . 29.41 110.392 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.599 ' O ' ' O ' ' A' ' 38' ' ' LYS . 91.1 mm-40 -52.61 -137.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.618 0.723 . . . . 0.0 110.884 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.27 52.82 0.09 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.107 -1.197 . . . . 15.27 110.107 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -98.52 -20.28 17.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -1.048 . . . . 8.7799999999999994 109.151 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.54 129.7 50.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.632 -0.877 . . . . 7.1299999999999999 108.632 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.9 tp10 -142.13 164.89 28.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.995 . . . . 22.030000000000001 109.955 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 56.5 m-85 -125.96 111.75 15.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.319 -1.363 . . . . 16.329999999999998 107.319 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -94.47 101.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 6.5800000000000001 111.305 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.16 101.42 9.65 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.873 . . . . 15.32 108.644 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.12 -6.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 10.92 109.251 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 p -96.92 43.08 1.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.332 -0.988 . . . . 21.719999999999999 108.332 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.14 14.09 0.45 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 22.449999999999999 107.801 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -139.49 -2.94 1.54 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.19 -1.041 . . . . 25.629999999999999 108.19 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.7 OUTLIER 70.21 -176.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.806 178.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.3 m80 53.61 18.06 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.007 -1.058 . . . . 0.0 108.552 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.501 ' H ' ' HG1' ' A' ' 53' ' ' THR . 0.2 OUTLIER -32.96 -55.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.403 0.621 . . . . 18.870000000000001 110.861 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -57.85 -33.3 68.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 45.210000000000001 111.275 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' HIS . 73.2 mm-40 -63.45 -43.7 96.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.829 -1.17 . . . . 33.020000000000003 109.925 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.8 -56.76 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.983 -1.073 . . . . 9.8399999999999999 109.581 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -54.9 -43.06 72.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.555 -1.276 . . . . 17.84 107.555 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.28 -33.61 65.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.41 -1.33 . . . . 18.84 107.41 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -76.6 -47.33 22.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 12.99 108.732 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 64' ' ' THR . 63.0 mt -54.78 -36.5 64.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.901 -1.148 . . . . 14.609999999999999 107.901 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 1.1 tp-100 -59.67 -52.37 65.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.266 0.555 . . . . 40.450000000000003 110.045 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.0 -51.0 66.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 41.810000000000002 110.839 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.94 -32.43 73.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.086 -1.009 . . . . 21.77 110.721 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.3 p -110.06 -74.05 0.66 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 11.380000000000001 109.53 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.22 -37.86 1.05 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.985 -1.646 . . . . 14.789999999999999 108.985 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.68 134.74 45.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -1.002 . . . . 17.809999999999999 109.908 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 32.5 4.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.538 -0.912 . . . . 29.760000000000002 108.538 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 167.72 19.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 18.260000000000002 110.294 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.54 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 11.9 t -113.55 134.5 21.98 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.288 -1.004 . . . . 8.1999999999999993 108.288 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.697 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 29.5 Cg_endo -86.08 -170.62 7.0 Favored 'Cis proline' 0 C--N 1.309 -1.513 0 C-N-CA 124.83 -0.904 . . . . 7.79 110.119 -0.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.716 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.08 102.78 4.94 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.54 -2.022 . . . . 26.050000000000001 105.54 176.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.07 159.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 8.6799999999999997 111.763 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -146.21 90.92 2.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.623 -0.673 . . . . 14.07 110.836 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.542 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -72.65 112.97 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.801 -1.926 . . . . 9.3399999999999999 105.801 177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.87 -152.47 39.55 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.401 -2.679 . . . . 12.42 106.401 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -83.37 -0.16 48.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.514 -1.58 . . . . 44.859999999999999 108.708 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.474 ' HB3' HH21 ' A' ' 97' ' ' ARG . 5.7 m-20 -89.45 115.05 26.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 0.0 110.599 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 t -73.71 150.71 41.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 109.449 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.98 -22.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 20.449999999999999 109.225 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.22 -146.75 18.39 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.581 -1.408 . . . . 13.82 109.581 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.19 -149.2 21.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.604 -1.398 . . . . 12.42 109.604 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.55 ' N ' ' O12' ' A' ' 106' ' ' GSH . 1.2 t -71.26 -59.47 2.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -1.181 . . . . 0.0 109.657 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -50.27 -27.31 5.85 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 -46.85 32.15 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.853 -0.795 . . . . 27.059999999999999 108.853 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -55.3 -59.78 4.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.581 -0.699 . . . . 15.31 110.353 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -49.08 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.419 -0.8 . . . . 0.0 110.472 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.33 36.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.875 -1.141 . . . . 21.789999999999999 109.564 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 mt -74.1 -38.04 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 111.988 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -60.3 -59.11 5.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -178.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -60.47 -24.45 65.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.003 -1.061 . . . . 0.0 109.664 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.0 m -80.76 -24.63 38.53 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.443 -0.786 . . . . 0.0 109.378 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.14 -9.61 76.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.32 -1.112 . . . . 25.640000000000001 110.32 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.71 -26.53 65.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.046 -1.267 . . . . 50.259999999999998 108.872 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 tp -59.53 -64.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 24.170000000000002 110.605 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.27 -31.12 42.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -63.67 -46.38 85.86 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 178.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.474 HH21 ' HB3' ' A' ' 77' ' ' ASP . 9.6 tpt180 -58.81 -38.32 78.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.294 -1.002 . . . . 40.960000000000001 108.294 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.32 -36.19 71.5 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.657 -0.868 . . . . 15.050000000000001 108.657 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -65.87 -54.65 23.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.706 -0.621 . . . . 0.0 111.974 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -50.21 -33.17 18.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.163 . . . . 38.640000000000001 110.908 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -100.12 -11.44 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.778 -1.201 . . . . 0.0 109.409 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.15 40.63 15.82 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.462 -1.055 . . . . 18.539999999999999 110.462 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.46 -20.49 29.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.136 -1.214 . . . . 10.84 109.3 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.18 -175.87 3.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.0 109.041 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.49 179.801 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.689 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.441 -0.577 . . . . 18.329999999999998 109.441 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 4' ' ' PHE . 48.7 tt0 -172.11 -82.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 29.77 109.409 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -8.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 108.617 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.1 m-85 -62.32 -68.28 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.406 -0.809 . . . . 20.030000000000001 110.214 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.68 -39.81 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 12.91 110.244 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.4 m120 -55.64 -34.96 65.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.12 -0.987 . . . . 28.329999999999998 109.043 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.4 m -74.63 -12.73 60.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -96.66 -48.32 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 22.870000000000001 109.848 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.51 132.06 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 25.190000000000001 109.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.91 157.25 34.38 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.132 -1.062 . . . . 34.609999999999999 108.132 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.28 130.62 36.43 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.708 1.605 . . . . 11.720000000000001 111.312 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.73 28.18 65.64 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 120.408 -0.901 . . . . 10.24 110.944 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -140.62 132.85 28.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.316 . . . . 25.359999999999999 109.7 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.36 136.86 31.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.379 -0.825 . . . . 10.890000000000001 109.263 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.67 142.37 23.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.564 -0.902 . . . . 15.82 108.564 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 45' ' ' VAL . 40.5 t -125.63 125.92 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 8.9399999999999995 110.968 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -93.79 121.89 35.7 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.903 -1.147 . . . . 9.9299999999999997 107.903 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.3 pt -131.07 -175.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.613 1.197 . . . . 10.619999999999999 111.839 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 21' ' ' THR . 39.2 mttm -140.92 97.39 7.11 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 105.166 -2.161 . . . . 38.729999999999997 105.166 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 21' ' ' THR . 10.3 Cg_exo -51.12 71.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.441 1.427 . . . . 24.579999999999998 110.895 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 19' ' ' LYS . 24.7 m -170.03 -32.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.185 -0.947 . . . . 34.82 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.32 133.17 24.19 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 21.460000000000001 109.882 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.46 -24.11 77.01 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 122.411 2.074 . . . . 13.859999999999999 112.991 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -67.23 -47.87 69.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.366 -1.458 . . . . 0.0 109.921 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -33.8 72.05 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -61.75 -42.24 98.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.548 -0.908 . . . . 59.590000000000003 108.548 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 27' ' ' ARG . 7.4 mtt-85 -56.15 -45.06 79.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 109.077 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.17 76.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.029 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' O ' ' OG ' ' A' ' 33' ' ' SER . 10.4 mt-30 -70.33 -41.16 73.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.488 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 26' ' ' ARG . 55.4 mm-40 -72.4 -39.08 68.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.614 -0.679 . . . . 34.969999999999999 111.64 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -72.91 -56.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.766 -1.209 . . . . 0.0 109.769 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.531 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -60.81 -19.01 58.81 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.577 -1.327 . . . . 17.280000000000001 109.536 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 3.5 m -66.54 -27.7 67.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.039 -1.038 . . . . 24.109999999999999 108.706 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 2.3 mp0 -91.53 -0.07 57.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 44.07 110.393 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.8 129.69 49.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.771 -1.206 . . . . 19.629999999999999 108.626 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.8 67.11 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.441 1.427 . . . . 21.539999999999999 109.451 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.9 mm -76.97 150.65 5.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.154 -0.966 . . . . 0.0 108.64 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' GLN . 6.9 mmmt -52.75 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 29.41 110.557 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' LYS . 90.5 mt-30 -52.03 -124.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.628 0.728 . . . . 0.0 111.88 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.25 48.62 1.17 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.425 -1.07 . . . . 15.27 110.425 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -33.92 12.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -1.094 . . . . 8.7799999999999994 109.201 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.0 tp -92.83 133.79 35.72 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.544 0.688 . . . . 7.1299999999999999 109.472 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.0 tt0 -143.57 174.05 11.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.471 -0.768 . . . . 22.030000000000001 109.055 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.518 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.7 m-85 -136.82 109.62 7.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.084 -1.45 . . . . 16.329999999999998 107.084 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 78.0 t -95.0 107.13 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 6.5800000000000001 111.967 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.5 m-20 -82.45 100.06 9.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.595 -0.891 . . . . 15.32 108.595 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.63 2.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 10.92 111.145 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -94.97 -31.0 13.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.873 -1.142 . . . . 21.719999999999999 108.395 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.47 22.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.48 -0.762 . . . . 22.449999999999999 109.658 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.1 t -141.22 -2.47 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.134 -0.978 . . . . 25.629999999999999 109.996 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 4.5 m-20 65.25 -168.6 0.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.492 -0.755 . . . . 0.0 109.994 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 51.37 19.14 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.68 -62.2 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.727 -0.608 . . . . 18.870000000000001 110.78 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.5 m120 -56.13 -36.74 68.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 45.210000000000001 110.805 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 1.1 mp0 -61.83 -44.57 96.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.937 -1.102 . . . . 33.020000000000003 109.912 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.32 -54.18 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.666 -1.271 . . . . 9.8399999999999999 109.627 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -56.91 -44.91 82.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.566 -1.334 . . . . 17.84 107.765 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.97 -34.72 57.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 18.84 107.284 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -78.36 -46.88 18.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.87 -0.732 . . . . 12.99 109.218 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.3 mt -52.59 -38.29 59.76 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.116 -1.068 . . . . 14.609999999999999 108.116 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -57.17 -55.54 33.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.641 -0.874 . . . . 40.450000000000003 108.641 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.08 -29.16 68.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.848 . . . . 41.810000000000002 109.585 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 2.0 tt -64.5 -68.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.951 . . . . 21.77 109.792 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -52.95 2.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.801 -0.562 . . . . 11.380000000000001 109.721 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 152.72 -42.93 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.051 -1.547 . . . . 14.789999999999999 111.128 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . . . -96.48 144.62 26.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.839 -1.389 . . . . 17.809999999999999 110.69 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.55 23.89 13.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.55 -0.907 . . . . 29.760000000000002 108.55 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.702 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.38 170.03 15.77 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 18.260000000000002 110.589 -178.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.68 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.7 t -111.18 132.44 21.73 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 107.839 -1.171 . . . . 8.1999999999999993 107.839 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HD2' ' H ' ' A' ' 82' ' ' SER . 27.8 Cg_endo -83.98 -168.32 5.97 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 CA-C-O 122.533 0.972 . . . . 7.79 112.15 -0.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.702 HH12 ' H ' ' A' ' 68' ' ' THR . 1.8 tpm_? -146.01 90.4 1.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.635 -1.987 . . . . 26.050000000000001 105.635 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.3 t -83.78 155.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.279 -0.888 . . . . 8.6799999999999997 111.794 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -142.69 91.77 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 14.07 111.535 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 74' ' ' ILE . 4.0 mm -72.02 114.3 10.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 105.249 -2.13 . . . . 9.3399999999999999 105.249 176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.38 -159.1 11.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.959 -2.856 . . . . 12.42 105.959 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -78.3 1.71 20.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.211 -1.758 . . . . 44.859999999999999 108.699 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.599 ' CB ' HH21 ' A' ' 97' ' ' ARG . 1.4 m-20 -88.43 112.09 22.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.735 . . . . 0.0 110.055 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 t -76.79 143.65 39.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.267 -0.896 . . . . 0.0 110.453 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -107.37 -21.41 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.028 . . . . 20.449999999999999 108.92 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.26 -146.63 18.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.218 -1.153 . . . . 13.82 110.218 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.91 -143.67 13.31 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.227 -1.149 . . . . 12.42 110.227 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.424 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.6 -61.73 1.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.517 -0.99 . . . . 0.0 109.964 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -52.73 -23.68 7.22 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.59 -0.694 . . . . 0.0 109.5 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.53 -51.55 12.67 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 27.059999999999999 109.272 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -50.92 -60.3 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 15.31 110.037 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -49.54 -51.93 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 110.066 -178.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 91' ' ' SER . 3.2 t -44.44 -37.7 3.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.229 -0.92 . . . . 21.789999999999999 108.953 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.2 mt -81.89 -40.96 21.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.53 -58.66 7.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.88 -1.137 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -24.83 66.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.004 -1.06 . . . . 0.0 109.411 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 87' ' ' SER . 50.2 m -79.87 -45.51 18.53 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.3 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.3 -9.22 26.69 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.377 -1.089 . . . . 25.640000000000001 110.377 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -69.69 -25.11 63.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.988 -1.301 . . . . 50.259999999999998 108.534 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.07 -63.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.479 0.657 . . . . 24.170000000000002 110.732 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.17 -28.26 39.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.448 -0.782 . . . . 0.0 108.915 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.4 -50.05 66.92 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.65 -0.82 . . . . 28.030000000000001 108.803 178.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.599 HH21 ' CB ' ' A' ' 77' ' ' ASP . 27.1 mtp180 -58.91 -31.05 68.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.912 -1.144 . . . . 40.960000000000001 107.912 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.4 mp -72.37 -40.49 67.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.051 -1.092 . . . . 15.050000000000001 108.051 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -64.9 -52.3 57.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.93 -0.481 . . . . 0.0 111.888 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -33.2 24.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.71 -1.244 . . . . 38.640000000000001 110.691 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.7 pt -99.76 -16.34 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.693 -1.255 . . . . 0.0 108.764 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.18 44.28 8.19 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.428 -1.069 . . . . 18.539999999999999 110.428 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.92 -13.85 46.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -1.155 . . . . 10.84 109.657 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.1 pt? -95.01 -175.61 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.504 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.68 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.352 0.596 . . . . 18.329999999999998 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.97 -79.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 29.77 109.127 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -59.43 -9.53 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.06 -69.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.414 -0.804 . . . . 20.030000000000001 111.218 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.9 m -73.27 -38.68 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 12.91 110.5 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 98.2 m-20 -55.73 -34.06 64.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.043 -1.036 . . . . 28.329999999999998 109.442 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.8 m -74.58 -13.83 60.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.022 -1.049 . . . . 0.0 110.001 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -97.42 -45.75 6.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.012 -1.055 . . . . 22.870000000000001 110.693 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.48 129.09 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.909 -1.12 . . . . 25.190000000000001 110.389 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.77 158.52 35.21 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 107.965 -1.124 . . . . 34.609999999999999 107.965 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -56.7 135.9 73.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.743 1.629 . . . . 11.720000000000001 111.418 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.81 27.64 68.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.75 -0.94 . . . . 10.24 110.75 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -142.6 131.85 23.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.347 . . . . 25.359999999999999 109.619 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.5 127.79 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.218 -0.926 . . . . 10.890000000000001 108.959 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.88 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.613 -0.884 . . . . 15.82 108.613 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -125.31 126.11 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.541 -0.724 . . . . 8.9399999999999995 111.259 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -92.67 119.1 31.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 pt -129.34 -173.79 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 122.311 1.053 . . . . 10.619999999999999 111.345 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -146.2 88.04 6.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.95 -1.871 . . . . 38.729999999999997 105.95 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' ' OG1' ' A' ' 21' ' ' THR . 17.7 Cg_exo -45.79 77.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.851 1.701 . . . . 24.579999999999998 110.834 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 19' ' ' LYS . 15.6 m -174.07 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.082 -1.081 . . . . 34.82 108.082 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 126.16 42.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 109.083 -0.71 . . . . 21.460000000000001 109.083 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.82 -24.6 56.83 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.069 1.846 . . . . 13.859999999999999 112.166 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -70.39 -38.18 74.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.799 -1.188 . . . . 0.0 108.782 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -36.35 84.02 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.581 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.5 mmm-85 -65.27 -42.93 92.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.962 -0.755 . . . . 59.590000000000003 108.962 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -50.14 -45.37 53.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 108.771 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.71 82.12 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.616 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 25.3 mt-30 -71.41 -45.77 61.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.791 . . . . 45.490000000000002 109.652 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -69.99 -34.41 73.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.524 -0.735 . . . . 34.969999999999999 110.787 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.93 -57.58 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 0.0 110.83 -178.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.57 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -59.49 -20.89 58.7 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.593 -1.317 . . . . 17.280000000000001 109.487 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 7.6 m -64.5 -22.29 66.92 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.142 -0.974 . . . . 24.109999999999999 108.415 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -93.02 -2.21 55.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.486 -0.759 . . . . 44.07 109.963 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.8 mt -88.7 130.38 45.33 Favored Pre-proline 0 N--CA 1.484 1.267 0 O-C-N 120.86 -1.15 . . . . 19.629999999999999 108.956 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 67.19 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.669 1.58 . . . . 21.539999999999999 109.875 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.49 149.56 5.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 108.685 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 39' ' ' GLN . 36.6 mttt -53.56 -168.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.345 -0.847 . . . . 29.41 110.29 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 21.8 mp0 -52.01 -123.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.6 0.714 . . . . 0.0 111.748 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 51.14 1.8 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.628 -0.989 . . . . 15.27 110.628 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.59 -27.31 14.07 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.549 -0.971 . . . . 8.7799999999999994 108.796 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.3 tp -97.25 130.87 44.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.606 -0.887 . . . . 7.1299999999999999 108.606 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 1.2 tp10 -140.62 172.97 11.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.442 -0.786 . . . . 22.030000000000001 109.874 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.458 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 35.9 m-85 -135.74 110.06 8.43 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.416 -1.327 . . . . 16.329999999999998 107.416 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.9 103.16 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 6.5800000000000001 111.676 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.3 m-20 -81.29 100.87 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.671 -0.863 . . . . 15.32 108.671 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.8 pt -63.69 -0.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.165 -0.96 . . . . 10.92 111.098 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 t -92.31 -14.34 28.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.717 -1.239 . . . . 21.719999999999999 108.965 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.54 8.04 4.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.789 . . . . 22.449999999999999 109.307 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -142.97 -0.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 25.629999999999999 109.797 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 53' ' ' THR . 13.3 t-20 67.38 -156.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.28 12.32 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.803 -1.186 . . . . 0.0 108.684 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -37.83 -62.89 0.51 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.524 -0.735 . . . . 18.870000000000001 110.892 -178.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -53.53 -32.57 51.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 45.210000000000001 110.481 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -65.67 -45.28 83.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.889 -1.132 . . . . 33.020000000000003 109.82 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.21 -50.29 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.922 -1.111 . . . . 9.8399999999999999 109.469 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -58.07 -42.38 85.4 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.275 -1.38 . . . . 17.84 107.275 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.09 -33.11 64.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.036 -1.468 . . . . 18.84 107.036 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -78.78 -51.82 9.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.98 -0.748 . . . . 12.99 108.98 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.44 -32.55 50.33 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.134 -1.061 . . . . 14.609999999999999 108.134 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.6 tp60 -59.13 -54.56 45.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.808 -0.557 . . . . 40.450000000000003 109.849 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -67.47 -49.61 62.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 41.810000000000002 110.878 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -65.28 -33.33 75.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.036 -1.04 . . . . 21.77 110.993 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.7 p -107.91 -66.75 1.01 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.162 -0.961 . . . . 11.380000000000001 109.47 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 141.96 -41.37 1.22 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.757 -1.737 . . . . 14.789999999999999 108.757 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.5 140.85 32.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 17.809999999999999 109.655 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 25.67 10.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.363 -0.977 . . . . 29.760000000000002 108.363 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.724 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -83.85 168.04 16.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.036 0.922 . . . . 18.260000000000002 111.471 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 14.7 t -112.54 134.79 21.54 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 107.725 -1.213 . . . . 8.1999999999999993 107.725 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 82' ' ' SER . 22.3 Cg_endo -85.62 -162.97 2.69 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 CA-C-O 122.512 0.963 . . . . 7.79 111.929 -0.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.724 HH12 ' H ' ' A' ' 68' ' ' THR . 1.5 tpm_? -144.94 97.38 3.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.271 -2.122 . . . . 26.050000000000001 105.271 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -86.87 157.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 8.6799999999999997 111.483 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -144.92 91.21 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 14.07 111.503 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 mm -72.37 112.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.343 -2.095 . . . . 9.3399999999999999 105.343 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 -153.13 36.03 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 105.476 -3.05 . . . . 12.42 105.476 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -83.65 2.82 35.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.219 -1.754 . . . . 44.859999999999999 108.67 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.647 ' CB ' HH21 ' A' ' 97' ' ' ARG . 5.5 m-20 -88.84 113.38 24.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 110.3 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.5 t -75.1 145.8 41.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 79' ' ' ILE . 2.6 pp -111.92 -16.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.264 -0.898 . . . . 20.449999999999999 109.334 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.92 -149.36 18.05 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.237 -1.145 . . . . 13.82 110.237 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.73 -147.52 20.93 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.096 -1.202 . . . . 12.42 110.096 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.418 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 t -71.78 -62.73 1.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.479 -1.012 . . . . 0.0 110.218 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.5 t -52.25 -24.46 7.37 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.71 -47.35 31.91 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.358 -0.839 . . . . 27.059999999999999 109.111 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.6 -59.39 4.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.728 . . . . 15.31 110.189 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -50.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 110.436 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 22.7 m -47.59 -36.86 11.34 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.03 -1.044 . . . . 21.789999999999999 109.049 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.0 mt -82.47 -37.81 24.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 0.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.42 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.47 -60.22 4.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.694 -1.254 . . . . 0.0 110.728 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.666 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.0 pp0? -61.42 -17.79 55.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.005 -1.059 . . . . 0.0 109.588 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.447 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 73.3 m -80.51 -63.47 1.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.72 -13.02 4.51 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.125 -1.19 . . . . 25.640000000000001 110.125 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.02 -29.65 67.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.15 -1.206 . . . . 50.259999999999998 108.535 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.08 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.574 -0.704 . . . . 24.170000000000002 111.051 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -28.62 52.92 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -48.92 73.07 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.616 -0.833 . . . . 28.030000000000001 108.816 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.647 HH21 ' CB ' ' A' ' 77' ' ' ASP . 29.0 mtp180 -60.46 -31.29 70.29 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.968 -1.123 . . . . 40.960000000000001 107.968 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.6 mp -71.75 -39.08 70.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.288 -1.004 . . . . 15.050000000000001 108.288 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -66.04 -54.15 29.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.919 -0.488 . . . . 0.0 111.913 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.65 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.786 -1.196 . . . . 38.640000000000001 110.947 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 pt -100.29 -14.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.625 -1.297 . . . . 0.0 109.07 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.35 44.13 8.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.291 -1.124 . . . . 18.539999999999999 110.291 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.27 38.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.236 . . . . 10.84 109.653 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.04 -179.97 5.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.577 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.597 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.621 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.378 -0.601 . . . . 18.329999999999998 109.378 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -76.63 -71.16 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.957 . . . . 29.77 109.99 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.3 pm0 -58.06 -10.16 1.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.879 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.48 -75.58 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 20.030000000000001 110.69 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -73.95 -35.67 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.97 . . . . 12.91 110.017 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -56.43 -35.56 67.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 109.377 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 66.8 m -75.0 -13.22 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.916 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -97.02 -47.74 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.124 -0.985 . . . . 22.870000000000001 110.349 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.5 133.38 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 25.190000000000001 110.385 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -151.25 160.06 32.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.903 -1.147 . . . . 34.609999999999999 107.903 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.77 130.27 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.754 1.636 . . . . 11.720000000000001 111.435 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.49 22.99 63.55 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 120.335 -0.936 . . . . 10.24 111.046 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -141.12 134.11 29.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.974 -1.309 . . . . 25.359999999999999 109.62 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.9 t -100.66 133.98 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.479 -0.763 . . . . 10.890000000000001 109.435 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.64 141.22 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.487 -0.931 . . . . 15.82 108.487 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' VAL . 25.3 t -122.74 124.14 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.824 . . . . 8.9399999999999995 111.307 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -91.61 120.51 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.588 -1.264 . . . . 9.9299999999999997 107.588 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -133.45 -170.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 122.667 1.223 . . . . 10.619999999999999 112.192 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.1 mtmt -146.57 96.43 4.45 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 105.707 -1.96 . . . . 38.729999999999997 105.707 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -50.68 82.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.282 1.321 . . . . 24.579999999999998 110.504 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -179.36 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 34.82 109.699 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.36 122.33 56.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.252 -0.905 . . . . 21.460000000000001 109.082 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -54.56 -10.89 2.67 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.34 2.027 . . . . 13.859999999999999 112.765 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.68 -49.98 23.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.422 -1.424 . . . . 0.0 110.186 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -26.76 68.03 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.667 -1.271 . . . . 0.0 107.896 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -62.97 -37.69 88.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.092 -1.077 . . . . 59.590000000000003 108.092 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -59.17 -50.51 73.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 108.991 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -36.8 74.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.312 -0.868 . . . . 0.0 109.003 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 5.5 mm-40 -69.39 -42.85 74.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 45.490000000000002 109.705 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.16 -38.16 69.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.493 -0.754 . . . . 34.969999999999999 110.876 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -75.93 -54.95 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.016 -1.053 . . . . 0.0 110.405 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.532 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -58.36 -22.6 54.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.322 -1.486 . . . . 17.280000000000001 108.726 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.8 m -65.39 -29.89 70.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.936 . . . . 24.109999999999999 108.585 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -89.1 0.46 56.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.779 . . . . 44.07 109.562 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 131.51 40.34 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.127 -0.983 . . . . 19.629999999999999 108.696 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.84 66.6 1.26 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.843 1.695 . . . . 21.539999999999999 110.418 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -81.05 146.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.98 -1.075 . . . . 0.0 108.492 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 39' ' ' GLN . 11.1 mtmt -54.39 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 29.41 110.96 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.55 ' O ' ' O ' ' A' ' 38' ' ' LYS . 52.7 mt-30 -52.42 -133.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.766 0.793 . . . . 0.0 111.784 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.51 50.24 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.336 -1.106 . . . . 15.27 110.336 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -97.04 -29.75 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 8.7799999999999994 108.726 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 132.02 40.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.978 -0.749 . . . . 7.1299999999999999 108.978 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 11.6 tp10 -143.47 169.43 17.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.434 -0.791 . . . . 22.030000000000001 109.387 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.2 m-85 -132.03 109.64 10.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.3 -1.37 . . . . 16.329999999999998 107.3 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 16' ' ' VAL . 57.2 t -93.47 103.2 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 6.5800000000000001 112.068 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -81.51 102.65 10.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 15.32 108.193 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 pt -62.94 0.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.364 -0.835 . . . . 10.92 111.765 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 50' ' ' THR . 9.0 t -95.93 -26.43 15.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.71 -1.244 . . . . 21.719999999999999 109.451 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 20.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 22.449999999999999 109.596 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 11.0 t -143.3 1.94 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.148 -0.97 . . . . 25.629999999999999 109.702 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.702 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.41 -176.51 0.18 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.702 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.26 20.89 10.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.666 -1.271 . . . . 0.0 108.391 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.31 -61.68 1.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 18.870000000000001 110.789 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.08 -32.7 68.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 45.210000000000001 111.218 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 4.7 mp0 -62.46 -44.36 96.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.101 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.68 -53.22 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.144 . . . . 9.8399999999999999 109.553 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.07 -44.94 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.609 -1.307 . . . . 17.84 107.511 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -55.7 -33.33 64.07 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.003 -1.48 . . . . 18.84 107.003 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.95 -47.75 17.85 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.937 -0.764 . . . . 12.99 108.937 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.4 mt -53.15 -35.02 59.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.882 -1.155 . . . . 14.609999999999999 107.882 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.1 tp60 -60.62 -54.74 41.71 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.228 0.537 . . . . 40.450000000000003 109.982 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -66.2 -45.3 81.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.966 -1.084 . . . . 41.810000000000002 110.693 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.99 -40.73 91.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.987 -1.071 . . . . 21.77 110.68 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.1 p -107.83 -65.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.786 . . . . 11.380000000000001 109.761 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.537 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 140.89 -38.49 1.55 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.786 -2.125 . . . . 14.789999999999999 107.786 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' HH21 ' A' ' 71' ' ' ARG . . . -98.21 138.33 35.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.682 -0.893 . . . . 17.809999999999999 109.813 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 38.37 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.206 -1.035 . . . . 29.760000000000002 108.206 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 166.78 14.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.245 1.021 . . . . 18.260000000000002 112.623 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.634 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 4.4 t -114.79 126.77 27.51 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 8.1999999999999993 107.22 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.722 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 35.4 Cg_endo -82.34 -173.93 12.53 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 CA-C-O 122.148 0.811 . . . . 7.79 111.222 1.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.727 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -140.94 98.7 3.44 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.215 -2.143 . . . . 26.050000000000001 105.215 176.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.2 t -89.4 157.95 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.745 0.783 . . . . 8.6799999999999997 112.6 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -146.5 88.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.839 -0.538 . . . . 14.07 111.329 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.2 mp -72.44 124.39 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 104.433 -2.432 . . . . 9.3399999999999999 104.433 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.26 -160.24 17.49 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 106.501 -2.64 . . . . 12.42 106.501 -176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -83.21 -1.95 54.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.395 -1.65 . . . . 44.859999999999999 109.984 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB2' HH21 ' A' ' 97' ' ' ARG . 4.2 m-20 -89.31 124.2 34.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.018 -1.051 . . . . 0.0 110.356 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 t -75.0 147.12 41.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 110.025 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -109.28 -21.09 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.681 -0.859 . . . . 20.449999999999999 108.681 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.99 -153.01 19.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.941 -1.264 . . . . 13.82 109.941 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.99 -147.02 21.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.966 -1.254 . . . . 12.42 109.966 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O11' ' A' ' 106' ' ' GSH . 1.3 t -69.71 -61.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -1.103 . . . . 0.0 109.863 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -51.06 -23.64 3.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.553 -0.717 . . . . 0.0 109.293 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.01 -47.38 25.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.451 -0.78 . . . . 27.059999999999999 109.016 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 4.7 tt -54.24 -60.03 3.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 15.31 109.834 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -50.27 -52.16 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.082 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.616 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 37.4 m -46.16 -35.92 5.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.143 -0.973 . . . . 21.789999999999999 108.899 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.8 mt -82.08 -40.05 22.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 111.615 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -58.71 -59.11 5.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.164 . . . . 0.0 110.777 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.3 pp0? -62.81 -19.74 64.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.927 -1.108 . . . . 0.0 109.768 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.552 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 70.7 m -83.86 -24.28 30.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.32 -9.54 76.57 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.106 -1.197 . . . . 25.640000000000001 110.106 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.128 -1.219 . . . . 50.259999999999998 108.21 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.6 -65.81 0.63 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.44 0.638 . . . . 24.170000000000002 110.887 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.01 -28.29 37.29 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.468 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.42 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -48.45 73.51 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.683 -0.858 . . . . 28.030000000000001 108.683 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.668 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.84 -33.87 72.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.762 -1.199 . . . . 40.960000000000001 107.762 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 98' ' ' LEU . 8.1 mp -70.1 -38.0 75.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.29 -1.004 . . . . 15.050000000000001 108.29 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -64.93 -58.03 7.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.917 -0.49 . . . . 0.0 111.635 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.39 -28.36 3.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.914 -1.116 . . . . 38.640000000000001 111.087 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -103.74 -19.8 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.709 -1.244 . . . . 0.0 109.214 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.39 41.89 7.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.38 -1.088 . . . . 18.539999999999999 110.38 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.78 -13.97 49.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -1.205 . . . . 10.84 109.437 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.07 -176.37 3.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 109.367 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.121 -0.987 . . . . 0.0 109.609 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.634 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.445 -0.576 . . . . 18.329999999999998 109.445 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -56.51 -43.19 79.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 29.77 109.268 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -62.18 -38.21 88.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.956 -1.09 . . . . 0.0 109.031 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -56.86 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 20.030000000000001 109.846 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 59' ' ' TYR . 14.9 m -73.14 -39.7 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.65 -0.656 . . . . 12.91 110.964 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -57.21 -34.26 68.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.797 -1.189 . . . . 28.329999999999998 109.973 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m -74.14 -13.59 60.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.021 -1.05 . . . . 0.0 109.426 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -96.98 -52.42 3.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 22.870000000000001 110.3 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.19 126.29 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 25.190000000000001 109.989 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.13 155.37 40.03 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.121 -1.066 . . . . 34.609999999999999 108.121 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.25 132.35 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.926 1.751 . . . . 11.720000000000001 111.411 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 22.75 64.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.767 -0.933 . . . . 10.24 110.767 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.77 135.1 27.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.875 -1.368 . . . . 25.359999999999999 110.121 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.15 135.42 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 10.890000000000001 108.99 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.33 141.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.39 -0.967 . . . . 15.82 108.39 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.386 -0.821 . . . . 8.9399999999999995 110.426 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -90.86 119.04 30.74 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.148 -1.427 . . . . 9.9299999999999997 107.148 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.32 -175.04 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.294 1.045 . . . . 10.619999999999999 111.178 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.76 ' O ' ' N ' ' A' ' 21' ' ' THR . 21.6 mtmt -146.19 88.65 6.21 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.459 -1.682 . . . . 38.729999999999997 106.459 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.457 ' O ' ' CG2' ' A' ' 21' ' ' THR . 12.9 Cg_exo -46.76 69.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.016 1.81 . . . . 24.579999999999998 110.921 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.76 ' N ' ' O ' ' A' ' 19' ' ' LYS . 20.8 p -162.3 -36.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.007 -1.108 . . . . 34.82 108.007 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 128.94 32.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 21.460000000000001 109.469 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.98 -20.2 43.88 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.056 1.837 . . . . 13.859999999999999 111.756 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.66 -40.89 72.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.677 -1.265 . . . . 0.0 108.518 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -36.48 83.67 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.553 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -65.14 -36.06 83.07 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.792 -0.818 . . . . 59.590000000000003 108.792 178.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.683 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -56.54 -50.67 71.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 109.243 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.03 67.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.24 -36.89 74.78 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.282 -0.886 . . . . 45.490000000000002 108.696 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 67.1 mm-40 -71.4 -39.69 70.97 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.811 -0.555 . . . . 34.969999999999999 111.4 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -77.15 -65.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.837 -1.165 . . . . 0.0 110.925 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' H ' HG21 ' A' ' 31' ' ' ILE . 3.1 mt -52.8 -22.77 5.75 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.853 -1.155 . . . . 17.280000000000001 110.191 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 5.0 p -66.64 -26.17 66.94 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.755 -1.215 . . . . 24.109999999999999 108.773 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -93.3 4.11 54.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.373 -0.829 . . . . 44.07 110.506 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 37' ' ' ILE . 16.5 mt -90.46 131.46 38.18 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.83 -1.168 . . . . 19.629999999999999 109.385 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -66.67 66.72 0.53 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.898 1.732 . . . . 21.539999999999999 110.132 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' LYS . 1.9 mm -81.67 153.37 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.214 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.2 mmmm -54.05 -168.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 29.41 110.028 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' LYS . 40.1 mt-30 -51.78 -134.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.6 0.714 . . . . 0.0 110.831 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.09 54.57 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.063 -1.215 . . . . 15.27 110.063 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.37 -17.69 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.402 -1.058 . . . . 8.7799999999999994 109.241 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.3 tp -105.54 130.33 53.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.64 -0.874 . . . . 7.1299999999999999 108.64 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' A' ' 44' ' ' PHE . 28.8 tt0 -139.37 173.51 11.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 22.030000000000001 110.17 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.511 ' H ' ' CG ' ' A' ' 43' ' ' GLU . 40.0 m-85 -134.58 110.82 9.58 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.782 -1.192 . . . . 16.329999999999998 107.782 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.3 t -96.19 104.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 6.5800000000000001 111.621 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.33 103.19 10.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.055 -1.091 . . . . 15.32 108.055 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.7 pt -62.41 -3.85 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 10.92 110.811 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -93.8 -15.83 24.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.286 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.04 10.8 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 22.449999999999999 109.467 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 15.3 t -142.86 -18.53 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.248 -0.907 . . . . 25.629999999999999 110.059 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 50' ' ' THR . 0.5 OUTLIER 84.33 -170.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.597 -0.689 . . . . 0.0 109.452 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER 56.17 24.21 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 108.792 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 8.7 p -42.84 -52.83 4.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 18.870000000000001 110.394 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.9 m-20 -52.63 -34.72 52.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 45.210000000000001 110.481 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -64.69 -45.09 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.129 . . . . 33.020000000000003 109.28 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.43 -50.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.05 -1.032 . . . . 9.8399999999999999 109.43 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.0 mt-30 -57.65 -39.54 77.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.5 -1.375 . . . . 17.84 107.447 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 11.8 m-20 -56.31 -32.56 64.74 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.189 -1.412 . . . . 18.84 107.189 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 5' ' ' VAL . 5.4 t80 -76.13 -51.56 11.95 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.064 -0.717 . . . . 12.99 109.064 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.493 ' O ' ' OG1' ' A' ' 64' ' ' THR . 22.5 mt -54.22 -32.06 54.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.059 -1.089 . . . . 14.609999999999999 108.059 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.3 tp-100 -63.2 -56.5 16.1 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.458 -0.777 . . . . 40.450000000000003 110.167 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -55.59 15.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 41.810000000000002 111.733 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -31.56 72.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.904 -1.122 . . . . 21.77 111.229 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.6 p -109.9 -63.32 1.39 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.974 -1.079 . . . . 11.380000000000001 109.81 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 140.73 -45.59 0.97 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.944 -1.662 . . . . 14.789999999999999 108.944 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.638 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.05 138.49 35.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.983 . . . . 17.809999999999999 109.261 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.939 ' HG2' HH11 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -107.64 26.43 10.29 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.912 -1.144 . . . . 29.760000000000002 107.912 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 173.26 12.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.743 -0.598 . . . . 18.260000000000002 109.588 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.564 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 12.5 t -117.79 137.64 24.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 8.1999999999999993 108.559 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.72 -165.73 3.98 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.678 -0.968 . . . . 7.79 110.585 -0.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.638 ' NH1' ' O ' ' A' ' 66' ' ' ALA . 1.8 tpt180 -148.46 98.08 2.84 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.848 -1.908 . . . . 26.050000000000001 105.848 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.16 159.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -0.87 . . . . 8.6799999999999997 111.219 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -145.34 94.9 2.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.7 -0.625 . . . . 14.07 110.783 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 74' ' ' ILE . 6.7 mm -72.92 105.59 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.775 -1.935 . . . . 9.3399999999999999 105.775 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.07 -147.25 48.96 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.723 -2.951 . . . . 12.42 105.723 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -84.37 3.44 35.89 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.477 -1.602 . . . . 44.859999999999999 108.791 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.652 ' CB ' HH21 ' A' ' 97' ' ' ARG . 74.7 m-20 -89.94 109.06 20.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.479 -0.763 . . . . 0.0 110.756 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 t -74.05 145.14 44.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 109.281 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -113.33 -22.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.205 -0.935 . . . . 20.449999999999999 109.33 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' HA2' HH21 ' A' ' 71' ' ' ARG . . . 134.62 -154.44 21.48 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.788 -1.325 . . . . 13.82 109.788 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -101.13 -142.85 13.19 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.005 -1.238 . . . . 12.42 110.005 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -71.67 -66.07 0.68 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.444 -1.033 . . . . 0.0 110.501 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t -51.65 -24.48 5.63 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -74.97 -47.95 26.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.373 -0.829 . . . . 27.059999999999999 109.369 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -55.03 -58.8 6.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.434 -0.791 . . . . 15.31 110.516 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -47.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.805 . . . . 0.0 110.664 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -43.25 47.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 21.789999999999999 109.172 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.9 mt -72.86 -41.08 65.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 111.984 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.4 -57.22 13.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.846 -1.159 . . . . 0.0 110.615 -177.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -25.45 67.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 109.323 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.5 m -82.58 -19.24 38.85 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.37 64.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.273 -1.131 . . . . 25.640000000000001 110.273 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.67 -25.35 65.66 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.143 -1.21 . . . . 50.259999999999998 109.152 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.62 -63.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 24.170000000000002 110.295 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -52.17 -27.36 14.15 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.456 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -62.71 -48.13 80.6 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.417 -0.913 . . . . 28.030000000000001 108.678 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.675 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.5 mmm180 -60.42 -32.91 71.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.036 . . . . 40.960000000000001 108.539 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 98' ' ' LEU . 8.4 mp -71.96 -39.43 69.35 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.399 -0.813 . . . . 15.050000000000001 109.243 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -65.74 -52.03 54.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.646 -0.658 . . . . 0.0 111.876 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.675 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -47.83 -34.2 8.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 38.640000000000001 110.404 -178.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.7 pt -101.98 -11.37 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.846 -1.159 . . . . 0.0 109.268 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 43.58 14.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.427 -1.069 . . . . 18.539999999999999 110.427 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.52 -17.18 34.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.162 -1.199 . . . . 10.84 109.67 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 3.8 pp -97.46 -177.48 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.631 -179.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.636 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 108.829 -0.804 . . . . 1.74 108.829 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 4' ' ' PHE . 18.9 mt-30 -107.38 -74.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 2.9100000000000001 109.375 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.4 pt-20 -56.03 -9.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.069 -1.019 . . . . 2.1800000000000002 108.819 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.5 m-85 -61.98 -72.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.58999999999999997 109.788 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.53 -36.32 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 1.1000000000000001 110.317 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 2' ' ' GLN . 6.1 m120 -58.37 -36.58 73.72 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.795 -1.19 . . . . 2.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 66.3 m -73.81 -13.35 60.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.92000000000000004 109.302 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -97.19 -48.65 5.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 1.8200000000000001 110.329 -179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.0 125.44 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.777 -1.202 . . . . 1.04 109.018 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.3 148.32 31.29 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.327 -0.99 . . . . 2.5699999999999998 108.327 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.21 135.93 30.92 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.196 1.931 . . . . 0.34000000000000002 111.741 -178.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.17 72.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.386 -1.085 . . . . 0.28000000000000003 110.386 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -144.11 140.05 29.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.022 -1.281 . . . . 2.1699999999999999 110.233 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.94 137.17 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 1.04 109.515 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.38 143.47 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 1.05 108.505 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.2 t -125.0 123.79 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 1.02 110.584 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -91.49 119.99 31.92 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.126 -1.435 . . . . 0.20000000000000001 107.126 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -131.28 -173.17 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.312 1.053 . . . . 1.04 111.676 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 27.1 mtmt -147.13 90.94 5.24 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 106.926 -1.509 . . . . 1.8700000000000001 106.926 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -45.9 75.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.507 1.472 . . . . 0.41999999999999998 110.383 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.2 m -169.21 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.927 -0.768 . . . . 1.8500000000000001 108.927 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.56 131.5 25.82 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.23000000000000001 110.266 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -60.04 -19.68 57.12 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 122.249 1.966 . . . . 0.37 112.054 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -70.22 -41.38 73.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.764 -1.21 . . . . 0.81000000000000005 109.026 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -33.71 76.66 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.36 -0.936 . . . . 1.4299999999999999 108.592 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.38 -45.43 93.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 108.779 179.483 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.64 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -49.22 -46.75 46.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.958 -1.088 . . . . 3.1899999999999999 109.589 -179.396 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.76 80.96 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.14 -1.024 . . . . 1.03 108.559 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -69.06 -46.62 67.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 1.9199999999999999 109.868 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -37.84 85.14 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.607 -0.683 . . . . 1.8700000000000001 111.231 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.5 -54.8 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.81 -1.181 . . . . 1.21 110.861 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' CG2' ' A' ' 31' ' ' ILE . 4.4 mt -58.18 -20.79 43.9 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.675 -1.266 . . . . 1.03 108.987 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -66.87 -28.08 68.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 1.8500000000000001 109.404 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -91.22 3.09 55.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 1.6499999999999999 109.896 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' ILE . 15.6 mt -91.5 127.01 52.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 1.0800000000000001 109.556 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.14 65.24 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.922 1.748 . . . . 0.29999999999999999 109.916 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.503 HG22 HD11 ' A' ' 37' ' ' ILE . 15.1 mm -78.45 146.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.574 -0.898 . . . . 1.04 108.574 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.1 mttt -52.59 -178.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -0.984 . . . . 2.3599999999999999 108.807 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.531 ' O ' ' O ' ' A' ' 38' ' ' LYS . 47.6 mt-30 -52.05 -123.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.994 -1.066 . . . . 3.3100000000000001 111.948 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.42 49.36 0.06 OUTLIER Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.439 -0.788 . . . . 0.88 111.534 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -105.05 -24.76 12.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.265 . . . . 1.05 109.395 179.136 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 37' ' ' ILE . 18.8 tp -102.58 131.4 49.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 1.05 109.086 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 161.9 36.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 2.0099999999999998 109.897 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -125.02 116.49 22.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.435 -1.32 . . . . 0.20000000000000001 107.435 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.71 105.31 17.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.446 -0.784 . . . . 1.0700000000000001 111.997 -177.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.75 100.43 8.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.011 -1.107 . . . . 1.1200000000000001 108.011 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 pt -61.96 -2.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 1.1200000000000001 111.589 -178.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 -22.11 18.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.705 -1.247 . . . . 1.8799999999999999 109.222 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.63 15.6 1.0 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 1.27 109.341 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 4.11 1.44 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.068 -1.02 . . . . 1.1100000000000001 109.976 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 65.98 -175.6 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 2.9700000000000002 109.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 53' ' ' THR . 6.0 m170 59.59 18.99 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 2.8700000000000001 109.754 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 53' ' ' THR . 0.0 OUTLIER -34.47 -65.14 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.542 -0.724 . . . . 1.24 110.377 -179.685 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 3.6 m-20 -54.73 -36.64 64.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 1.98 111.37 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.91 -45.45 92.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.641 -1.287 . . . . 2.1200000000000001 109.713 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.03 -51.94 54.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.998 -1.064 . . . . 1.0900000000000001 109.002 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.79 -42.94 85.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.784 -1.198 . . . . 0.63 107.774 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -56.35 -32.86 65.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.182 -1.414 . . . . 1.1200000000000001 107.182 178.129 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -79.03 -50.91 10.33 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.011 -0.737 . . . . 1.6699999999999999 109.011 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.9 mt -54.68 -28.1 45.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.007 -1.058 . . . . 1.04 108.221 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 7.2 tp60 -63.1 -56.44 16.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.709 . . . . 1.97 109.652 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -69.75 -38.05 76.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.447 -0.783 . . . . 2.9100000000000001 110.749 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.85 -40.52 95.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.125 -0.984 . . . . 1.5600000000000001 110.164 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.9 p -113.09 -70.8 0.79 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 109.266 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.85 -36.2 0.67 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.411 -1.476 . . . . 0.35999999999999999 109.411 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HB2' ' NH2' ' A' ' 71' ' ' ARG . . . -102.21 130.15 48.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 1.0900000000000001 110.292 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 25.36 5.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.565 -1.272 . . . . 2.1200000000000001 107.565 177.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.95 167.81 20.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.658 0.742 . . . . 1.04 110.04 -179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 8.4 t -115.72 136.92 22.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 1.04 107.438 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -78.46 -165.02 4.3 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 CA-C-O 122.562 0.984 . . . . 0.26000000000000001 111.871 -0.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -146.6 90.71 1.95 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.453 -2.054 . . . . 2.9199999999999999 105.453 177.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 73' ' ' PHE . 22.0 t -84.25 151.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 1.05 111.394 -176.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' N ' HG11 ' A' ' 72' ' ' VAL . 67.0 m-85 -141.85 92.25 2.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.797 -0.565 . . . . 0.23999999999999999 110.284 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.3 mm -71.65 107.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.576 -2.009 . . . . 1.22 105.576 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.84 -147.59 50.45 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.505 -2.638 . . . . 0.20999999999999999 106.505 -176.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.34 -4.89 59.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.539 -1.565 . . . . 2.4199999999999999 109.356 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.747 ' HB3' HH21 ' A' ' 97' ' ' ARG . 11.9 m-20 -89.03 117.22 27.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.096 -1.003 . . . . 1.26 110.76 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -74.31 151.68 39.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 1.03 110.092 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.47 -19.48 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 1.3 109.377 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.68 -150.38 19.51 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.176 -1.17 . . . . 0.31 110.176 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.07 -142.02 11.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.343 -1.103 . . . . 0.32000000000000001 110.343 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.78 -61.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.539 -0.977 . . . . 1.3 110.271 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -53.57 -27.61 27.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.457 -0.777 . . . . 0.93000000000000005 109.622 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.09 -45.64 56.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.306 -0.871 . . . . 1.6000000000000001 109.07 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 85' ' ' LEU . 6.2 tt -56.5 -64.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.629 -0.67 . . . . 1.0800000000000001 109.732 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.53 -47.52 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 1.04 110.11 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -48.43 47.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.905 -1.122 . . . . 1.3999999999999999 109.288 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.18 -31.89 62.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.27 -0.894 . . . . 1.05 111.553 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -61.36 -60.27 3.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.574 -1.328 . . . . 2.0600000000000001 109.372 -178.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -25.74 67.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 3.2200000000000002 110.514 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.8 m -79.61 -25.29 41.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.234 -0.917 . . . . 0.81999999999999995 110.783 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.48 -11.43 70.18 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.11 -1.196 . . . . 0.5 110.11 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.95 -31.26 70.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 1.95 108.567 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.86 -63.34 1.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.475 -0.766 . . . . 1.0800000000000001 110.638 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -54.95 -30.22 58.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.457 -0.942 . . . . 1.0800000000000001 108.457 -178.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.2 m -65.34 -41.55 93.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.989 -1.115 . . . . 1.1100000000000001 107.989 178.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.747 HH21 ' HB3' ' A' ' 77' ' ' ASP . 1.2 tpt180 -64.6 -34.84 79.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.332 -0.988 . . . . 3.0499999999999998 108.332 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 98' ' ' LEU . 7.4 mp -71.74 -32.93 68.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.409 -0.807 . . . . 1.1000000000000001 109.023 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -70.0 -57.26 5.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 2.2799999999999998 111.84 -178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -44.88 -30.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.688 -1.258 . . . . 0.40999999999999998 110.407 -177.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.6 pt -104.65 -15.76 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.949 -1.094 . . . . 1.05 108.885 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.3 43.56 10.45 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.346 -1.102 . . . . 0.17999999999999999 110.346 179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -13.38 49.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.068 -1.254 . . . . 0.98999999999999999 109.564 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 2.4 pt? -95.02 -175.32 3.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 1.73 109.326 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.943 -1.027 . . . . 2.2400000000000002 108.984 179.206 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GSH . . . . . 0.622 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.266 0.555 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.11 -71.18 0.15 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 20.030000000000001 110.153 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.6 m -73.18 -40.84 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.442 -0.786 . . . . 12.91 110.489 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 25.0 m-20 -55.98 -34.06 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 110.38 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.5 m -74.54 -18.33 60.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.922 -1.111 . . . . 0.0 110.349 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.578 ' CE ' HG21 ' A' ' 45' ' ' VAL . 5.2 mtpm? -98.0 -42.5 7.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.077 . . . . 22.870000000000001 111.442 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.34 126.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.728 -1.233 . . . . 25.190000000000001 109.696 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.61 159.07 35.1 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.956 -1.127 . . . . 34.609999999999999 107.956 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.09 136.56 61.63 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.789 1.659 . . . . 11.720000000000001 111.501 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.04 73.3 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.71 -0.956 . . . . 10.24 110.71 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -140.57 130.63 24.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.253 . . . . 25.359999999999999 109.536 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -101.54 133.81 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.46 -0.775 . . . . 10.890000000000001 109.876 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.36 137.48 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.277 -1.009 . . . . 15.82 108.277 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 18' ' ' ILE . 44.0 t -120.54 128.54 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.366 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' ' NZ ' ' A' ' 8' ' ' LYS . 80.8 m-85 -95.34 118.78 32.71 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.142 -1.058 . . . . 9.9299999999999997 108.142 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 16' ' ' VAL . 23.0 pt -130.25 -176.21 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.485 1.136 . . . . 10.619999999999999 111.42 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.4 mtmt -145.02 93.16 5.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.766 -1.938 . . . . 38.729999999999997 105.766 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -48.32 82.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.369 1.379 . . . . 24.579999999999998 110.577 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -177.78 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.047 -0.723 . . . . 34.82 109.047 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.12 126.81 38.77 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 21.460000000000001 109.099 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.18 -22.98 42.71 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.465 2.11 . . . . 13.859999999999999 113.061 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -67.89 -43.15 79.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.332 -1.48 . . . . 0.0 109.44 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.07 -38.14 89.99 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.41 -40.06 93.0 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.419 -0.956 . . . . 59.590000000000003 108.419 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.31 -45.2 68.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HG3' ' A' ' 70' ' ' PRO . . . -61.48 -35.8 78.69 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -70.38 -36.14 73.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.299 -0.876 . . . . 45.490000000000002 109.076 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -70.08 -41.69 73.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.761 -0.587 . . . . 34.969999999999999 111.14 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.85 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -72.58 -69.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.899 -1.126 . . . . 0.0 110.591 -178.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.85 ' H ' HG23 ' A' ' 31' ' ' ILE . 5.0 mt -51.64 -16.58 0.66 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.136 -0.978 . . . . 17.280000000000001 110.022 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.84 -29.78 68.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.012 -1.055 . . . . 24.109999999999999 108.292 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -93.41 1.65 56.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.481 -0.762 . . . . 44.07 110.617 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.73 HD12 HD23 ' A' ' 32' ' ' LEU . 18.1 mt -88.02 128.66 53.0 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.806 -1.184 . . . . 19.629999999999999 109.111 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -69.49 70.14 1.46 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.656 1.571 . . . . 21.539999999999999 109.73 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.2 mm -80.68 155.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.211 -0.931 . . . . 0.0 109.395 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.3 mmtp -54.36 -168.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.205 -0.935 . . . . 29.41 109.771 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 38' ' ' LYS . 71.0 mt-30 -54.76 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.692 0.758 . . . . 0.0 111.413 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 52.8 0.34 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.452 -1.059 . . . . 15.27 110.452 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.83 -32.46 11.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -1.109 . . . . 8.7799999999999994 109.158 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 tp -95.57 135.19 37.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.39 -0.596 . . . . 7.1299999999999999 109.39 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 26.2 tt0 -143.76 172.4 12.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 22.030000000000001 109.94 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 55.7 m-85 -133.06 111.0 10.6 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.272 -1.381 . . . . 16.329999999999998 107.272 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG21 ' CE ' ' A' ' 8' ' ' LYS . 53.0 t -96.16 106.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 6.5800000000000001 112.279 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 48' ' ' THR . 42.4 m-20 -83.54 98.08 9.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.872 -0.788 . . . . 15.32 108.872 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 pt -62.05 2.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 10.92 110.657 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 46' ' ' ASP . 1.8 p -96.55 -35.53 11.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.003 -1.061 . . . . 21.719999999999999 109.372 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.81 28.81 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 22.449999999999999 109.775 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 t -144.49 -3.55 0.81 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.047 -1.033 . . . . 25.629999999999999 110.145 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 5.4 t30 69.94 -179.14 0.23 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 109.159 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.458 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 1.3 m-70 53.98 27.22 7.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 108.563 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -43.07 -55.97 3.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.377 -0.827 . . . . 18.870000000000001 110.442 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -59.46 -32.69 70.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 45.210000000000001 111.225 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.6 mp0 -62.12 -44.55 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.786 -1.196 . . . . 33.020000000000003 110.256 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.87 -54.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.788 -1.195 . . . . 9.8399999999999999 109.628 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.63 -44.81 77.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.671 -1.233 . . . . 17.84 107.671 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -54.37 -34.41 61.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.937 -1.505 . . . . 18.84 106.937 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -78.26 -45.77 21.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.904 -0.776 . . . . 12.99 108.904 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.5 mt -53.75 -35.82 61.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.721 -1.215 . . . . 14.609999999999999 107.721 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 18.3 tp60 -60.47 -57.46 12.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.235 0.54 . . . . 40.450000000000003 109.66 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -67.48 -35.22 78.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 41.810000000000002 110.113 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.58 -48.64 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.948 . . . . 21.77 109.925 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -111.58 -63.9 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 11.380000000000001 109.468 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.45 -45.9 0.53 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.692 -1.242 . . . . 14.789999999999999 110.043 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.57 26.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -1.16 . . . . 17.809999999999999 110.283 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 31.21 6.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 29.760000000000002 109.132 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.45 167.58 16.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 18.260000000000002 111.056 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.14 133.88 21.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.956 -1.127 . . . . 8.1999999999999993 107.956 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 82' ' ' SER . 19.4 Cg_endo -81.04 -165.46 4.5 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.577 0.991 . . . . 7.79 111.918 -0.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.55 91.76 1.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 105.884 -1.895 . . . . 26.050000000000001 105.884 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 85' ' ' LEU . 96.3 t -85.3 157.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.288 -0.882 . . . . 8.6799999999999997 112.181 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.472 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.5 m-85 -143.91 90.45 2.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.677 -0.639 . . . . 14.07 111.262 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -71.91 115.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.132 -2.173 . . . . 9.3399999999999999 105.132 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.45 -153.12 32.87 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 105.85 -2.9 . . . . 12.42 105.85 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -83.77 0.18 48.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.31 -1.7 . . . . 44.859999999999999 109.436 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -89.52 118.81 29.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.256 -0.902 . . . . 0.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -76.35 142.67 41.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.79 -17.68 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.053 -1.029 . . . . 20.449999999999999 109.214 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 -157.61 21.8 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.303 -1.119 . . . . 13.82 110.303 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.78 -147.13 19.7 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.048 -1.221 . . . . 12.42 110.048 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.456 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.62 -61.11 1.92 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.492 -1.005 . . . . 0.0 109.688 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -51.02 -25.11 4.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.25 -49.31 19.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.496 -0.753 . . . . 27.059999999999999 109.183 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -54.02 -59.19 4.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 15.31 110.08 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.24 -51.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.7 m -45.67 -36.78 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 21.789999999999999 108.96 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.04 -41.92 27.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.508 -0.745 . . . . 0.0 111.344 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -58.13 -57.14 14.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.916 -1.115 . . . . 0.0 110.022 -178.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -26.59 68.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.361 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.9 m -81.88 -20.44 38.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.452 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.33 -8.03 73.14 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.512 -1.035 . . . . 25.640000000000001 110.512 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.88 -24.48 64.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.036 -1.273 . . . . 50.259999999999998 108.371 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 tp -61.74 -66.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.624 0.726 . . . . 24.170000000000002 110.899 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.499 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.06 -28.28 16.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.6 -48.11 76.11 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.143 -1.058 . . . . 28.030000000000001 108.143 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.83 -34.22 71.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.832 -1.173 . . . . 40.960000000000001 107.832 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.9 mp -70.92 -39.98 72.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.677 -0.86 . . . . 15.050000000000001 108.677 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.78 -55.66 21.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.83 -0.544 . . . . 0.0 111.599 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.31 -29.29 9.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.86 -1.15 . . . . 38.640000000000001 110.93 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.2 pt -101.28 -19.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.747 -1.22 . . . . 0.0 109.08 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.78 40.53 8.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.288 -1.125 . . . . 18.539999999999999 110.288 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.08 -13.54 50.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -1.21 . . . . 10.84 109.684 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.57 176.21 6.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.716 -179.792 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.58 -68.45 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.812 . . . . 20.030000000000001 110.664 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.43 -38.37 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 12.91 110.438 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 32.9 m120 -55.08 -37.56 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 28.329999999999998 109.483 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 m -75.11 -12.77 60.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.974 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -97.13 -46.05 6.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.109 -0.994 . . . . 22.870000000000001 110.865 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.82 136.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.852 -1.155 . . . . 25.190000000000001 109.906 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -146.92 153.28 45.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.766 -0.827 . . . . 34.609999999999999 108.766 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.14 131.71 44.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.644 1.562 . . . . 11.720000000000001 110.323 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.676 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 72.62 26.93 70.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.673 -1.371 . . . . 10.24 109.673 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -139.48 135.35 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -1.131 . . . . 25.359999999999999 109.363 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.63 135.6 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.304 -0.872 . . . . 10.890000000000001 109.92 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.49 141.9 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.847 -1.168 . . . . 15.82 107.847 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.68 124.79 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 8.9399999999999995 110.917 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -90.1 123.89 34.34 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.365 -1.346 . . . . 9.9299999999999997 107.365 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.4 pt -133.48 -176.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.19 0.995 . . . . 10.619999999999999 111.235 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.6 mtmt -145.02 93.49 5.52 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 106.455 -1.683 . . . . 38.729999999999997 106.455 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.485 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -46.87 80.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.691 1.594 . . . . 24.579999999999998 110.896 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.626 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.5 m -175.39 -37.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.794 -0.817 . . . . 34.82 108.794 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 128.97 31.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.283 -0.886 . . . . 21.460000000000001 110.018 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.67 -14.65 37.15 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.999 1.799 . . . . 13.859999999999999 112.158 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -69.05 -45.43 70.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.648 -1.282 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 108.94 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.535 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -64.45 -55.84 18.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.549 -0.719 . . . . 59.590000000000003 110.343 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 4.8 ptp180 -50.36 -35.68 29.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.548 -1.345 . . . . 0.0 109.118 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' ARG . . . -62.22 -36.82 83.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -71.66 -48.67 46.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.615 -0.678 . . . . 45.490000000000002 109.666 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.76 -31.42 70.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.563 -0.711 . . . . 34.969999999999999 111.023 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.593 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -78.31 -55.26 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.673 -1.267 . . . . 0.0 109.677 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.814 HD23 HD12 ' A' ' 35' ' ' LEU . 3.4 mt -59.89 -21.96 61.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.642 -1.286 . . . . 17.280000000000001 109.146 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -64.86 -26.7 68.44 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.523 -0.917 . . . . 24.109999999999999 108.523 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -90.95 3.17 55.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.553 -0.717 . . . . 44.07 110.38 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.814 HD12 HD23 ' A' ' 32' ' ' LEU . 17.0 mt -91.21 127.99 49.08 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.805 -1.184 . . . . 19.629999999999999 109.494 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -64.99 68.58 0.27 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 121.676 1.584 . . . . 21.539999999999999 109.663 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 35' ' ' LEU . 4.2 mm -82.98 151.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' O ' ' A' ' 39' ' ' GLN . 42.7 mmtt -53.41 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.265 -0.897 . . . . 29.41 109.854 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.613 ' O ' ' O ' ' A' ' 38' ' ' LYS . 6.1 mp0 -50.64 -128.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.645 0.736 . . . . 0.0 110.788 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 49.46 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 O-C-N 121.022 -1.049 . . . . 15.27 110.501 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.676 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -98.47 -13.83 20.34 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.229 -1.159 . . . . 8.7799999999999994 109.62 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -107.76 129.01 55.08 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.617 -0.883 . . . . 7.1299999999999999 108.617 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.54 165.39 27.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.063 -1.023 . . . . 22.030000000000001 110.443 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -128.39 112.98 15.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.759 -1.201 . . . . 16.329999999999998 107.759 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.6 106.92 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 6.5800000000000001 111.326 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.465 ' OD1' HD11 ' A' ' 18' ' ' ILE . 48.4 m-20 -81.99 101.98 10.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.53 -0.915 . . . . 15.32 108.53 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.26 -5.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.001 -1.062 . . . . 10.92 110.762 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 t -95.27 -23.15 17.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 21.719999999999999 109.432 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 18.33 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 22.449999999999999 109.613 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 11.2 t -144.39 -2.96 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.118 -0.989 . . . . 25.629999999999999 110.139 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.0 m-20 74.88 -176.97 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.071 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.426 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 55.62 27.57 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 108.724 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.84 -59.58 2.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 18.870000000000001 110.186 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -58.06 -28.69 64.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 45.210000000000001 110.964 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -64.34 -44.92 90.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.714 -1.241 . . . . 33.020000000000003 109.54 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.41 -53.73 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.919 -1.113 . . . . 9.8399999999999999 109.434 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.29 -41.46 75.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.663 -1.236 . . . . 17.84 107.663 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.86 -33.4 64.51 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.293 -1.373 . . . . 18.84 107.293 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -77.6 -47.62 18.91 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.871 -0.789 . . . . 12.99 108.871 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 69.6 mt -54.3 -36.11 63.34 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.211 -1.033 . . . . 14.609999999999999 108.211 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.5 tp60 -58.24 -51.54 69.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.758 -0.589 . . . . 40.450000000000003 109.551 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -66.44 -52.93 41.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.096 -1.003 . . . . 41.810000000000002 111.073 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.52 -31.76 73.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 21.77 110.813 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 19.2 p -112.35 -70.62 0.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.179 -0.95 . . . . 11.380000000000001 109.856 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 145.98 -43.09 0.92 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.001 -1.64 . . . . 14.789999999999999 109.001 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.67 131.64 44.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -1.045 . . . . 17.809999999999999 110.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 33.02 2.72 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 29.760000000000002 108.962 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 174.05 11.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.44 -0.787 . . . . 18.260000000000002 110.769 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.48 136.81 26.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.473 -0.936 . . . . 8.1999999999999993 108.473 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.738 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 41.5 Cg_endo -84.87 -173.63 10.52 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.897 -0.876 . . . . 7.79 109.867 0.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.738 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -136.52 102.69 5.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.375 -2.084 . . . . 26.050000000000001 105.375 176.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 73' ' ' PHE . 94.4 t -88.5 158.99 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.71 0.767 . . . . 8.6799999999999997 111.527 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.0 m-85 -145.3 87.37 1.8 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.769 -0.582 . . . . 14.07 110.62 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.36 107.94 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 105.926 -1.879 . . . . 9.3399999999999999 105.926 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.96 -154.53 53.09 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.492 -2.643 . . . . 12.42 106.492 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -82.89 -3.42 56.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.556 -1.556 . . . . 44.859999999999999 109.289 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.74 117.07 28.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 0.0 110.59 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.8 t -72.66 153.04 41.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.085 -1.01 . . . . 0.0 109.385 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.35 -29.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 20.449999999999999 109.614 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.67 -136.2 7.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.439 -1.465 . . . . 13.82 109.439 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -115.38 -145.77 8.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.473 -1.451 . . . . 12.42 109.473 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -71.44 -57.76 4.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 109.795 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -52.76 -27.59 18.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.496 -0.753 . . . . 0.0 109.242 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.64 -49.14 27.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -0.83 . . . . 27.059999999999999 109.085 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.2 tt -52.74 -60.94 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 15.31 109.554 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.85 -49.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.819 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 t -48.78 -48.5 41.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.803 -1.185 . . . . 21.789999999999999 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 94' ' ' LEU . 57.8 mt -70.01 -39.72 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 110.978 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.17 -57.55 12.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 110.728 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.45 -23.92 67.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.977 -1.077 . . . . 0.0 109.203 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -81.96 -22.01 36.9 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 109.506 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.19 -10.44 74.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.885 -1.286 . . . . 25.640000000000001 109.885 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.03 -31.43 71.09 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.197 . . . . 50.259999999999998 109.405 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.5 tp -57.88 -60.46 3.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 24.170000000000002 110.413 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.24 -32.32 62.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.601 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.97 -44.54 92.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.942 -1.133 . . . . 28.030000000000001 107.942 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 5.5 ttt180 -61.32 -37.39 83.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.23 -1.026 . . . . 40.960000000000001 108.23 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.52 -33.94 69.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.38 -0.97 . . . . 15.050000000000001 108.38 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -65.53 -56.56 11.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.827 -0.546 . . . . 0.0 111.572 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -48.18 -33.25 8.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 38.640000000000001 110.521 -178.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.9 pt -101.5 -9.35 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.97 42.01 31.13 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.399 -1.08 . . . . 18.539999999999999 110.399 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.38 -15.41 43.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -1.187 . . . . 10.84 109.189 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.6 pp -97.76 -172.99 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.736 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.84 -68.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.695 -0.628 . . . . 20.030000000000001 110.731 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -73.48 -40.04 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.355 -0.841 . . . . 12.91 110.365 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 17.6 m-20 -55.21 -37.46 67.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.982 -1.074 . . . . 28.329999999999998 109.104 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m -74.71 -12.68 60.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.97 -47.2 5.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 22.870000000000001 110.362 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.85 136.18 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.862 -1.148 . . . . 25.190000000000001 109.964 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -146.87 154.19 46.96 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.369 -0.975 . . . . 34.609999999999999 108.369 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.06 130.83 42.36 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.413 1.409 . . . . 11.720000000000001 109.97 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.01 64.67 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.785 -1.326 . . . . 10.24 109.785 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -138.9 132.77 30.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 25.359999999999999 109.401 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.1 t -102.68 127.54 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.253 -0.904 . . . . 10.890000000000001 109.4 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.29 140.7 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.507 -0.923 . . . . 15.82 108.507 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 18' ' ' ILE . 33.3 t -122.27 124.22 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.346 -0.846 . . . . 8.9399999999999995 111.088 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -92.51 116.33 28.89 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.192 . . . . 9.9299999999999997 107.783 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 16' ' ' VAL . 29.8 pt -127.65 -178.97 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.308 1.051 . . . . 10.619999999999999 111.47 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.7 mtmt -140.72 90.99 9.5 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 105.749 -1.945 . . . . 38.729999999999997 105.749 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.484 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.1 Cg_exo -47.14 80.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.718 1.612 . . . . 24.579999999999998 110.52 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 19' ' ' LYS . 17.9 m -175.68 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.571 -0.9 . . . . 34.82 108.571 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.3 124.24 47.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.374 -0.829 . . . . 21.460000000000001 109.66 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.28 -16.39 17.45 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 122.299 1.999 . . . . 13.859999999999999 112.901 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.34 -42.38 65.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.517 -1.364 . . . . 0.0 109.846 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -64.84 -31.72 73.08 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -61.5 -40.39 94.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.639 -0.875 . . . . 59.590000000000003 108.639 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.614 HH11 ' HG2' ' A' ' 27' ' ' ARG . 13.5 mtt-85 -54.28 -48.26 71.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 108.679 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.28 74.25 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.366 -0.834 . . . . 0.0 109.072 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -71.38 -45.74 62.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.817 . . . . 45.490000000000002 109.524 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 33' ' ' SER . 37.5 mt-10 -70.53 -32.86 70.48 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.599 -0.688 . . . . 34.969999999999999 110.927 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.636 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -79.4 -57.02 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.818 -1.176 . . . . 0.0 110.796 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.636 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -59.54 -22.02 61.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.632 -1.292 . . . . 17.280000000000001 109.818 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 8.9 p -64.51 -23.31 67.23 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.122 -0.986 . . . . 24.109999999999999 108.708 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -93.05 -1.28 56.71 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.442 -0.786 . . . . 44.07 110.048 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -88.63 128.7 51.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.864 -1.147 . . . . 19.629999999999999 108.996 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.06 67.9 0.94 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.685 1.59 . . . . 21.539999999999999 109.581 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm -80.14 148.97 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 39' ' ' GLN . 52.3 mttt -53.65 -167.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.553 -0.717 . . . . 29.41 110.271 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.7 mm100 -52.65 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.758 0.789 . . . . 0.0 111.519 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.5 51.65 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.533 -1.027 . . . . 15.27 110.533 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.55 -28.55 13.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.463 -1.022 . . . . 8.7799999999999994 108.636 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' HG21 ' A' ' 37' ' ' ILE . 59.6 tp -97.14 130.8 44.35 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.598 -0.89 . . . . 7.1299999999999999 108.598 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.2 tp10 -141.14 171.83 13.52 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 22.030000000000001 109.893 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.418 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 29.9 m-85 -134.34 109.0 8.51 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.23 -1.396 . . . . 16.329999999999998 107.23 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.26 102.41 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.543 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.09 97.34 7.5 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.628 -0.878 . . . . 15.32 108.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 56' ' ' ILE . 28.8 pt -61.98 1.61 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 10.92 110.831 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' ASP . 6.4 p -95.56 -28.19 14.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.021 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.23 19.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -0.808 . . . . 22.449999999999999 109.385 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.752 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 15.0 t -143.68 -0.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.945 . . . . 25.629999999999999 109.962 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 65.63 -172.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.581 ' NE2' ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 60.29 10.32 2.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 108.045 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.21 -68.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.802 -0.561 . . . . 18.870000000000001 111.515 -178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -55.72 -29.87 60.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 45.210000000000001 110.994 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.581 ' OE2' ' NE2' ' A' ' 52' ' ' HIS . 11.4 mt-10 -64.83 -42.11 95.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.781 -1.199 . . . . 33.020000000000003 109.738 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 47' ' ' ILE . 2.2 mp -67.5 -53.01 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.829 -1.169 . . . . 9.8399999999999999 109.167 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.04 -43.14 77.55 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.573 -1.269 . . . . 17.84 107.573 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -54.15 -34.02 59.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.021 -1.474 . . . . 18.84 107.021 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -78.51 -45.83 21.04 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 12.99 108.882 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.9 mt -53.45 -33.7 55.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.907 -1.146 . . . . 14.609999999999999 107.907 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 12.0 tp60 -60.84 -57.53 12.26 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.333 0.587 . . . . 40.450000000000003 109.441 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -67.49 -35.49 79.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 41.810000000000002 109.995 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.09 -48.15 74.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 21.77 109.982 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -110.82 -61.89 1.62 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.517 -0.74 . . . . 11.380000000000001 109.344 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.64 -49.36 0.49 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.883 -1.287 . . . . 14.789999999999999 109.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 140.68 31.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 17.809999999999999 110.537 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -101.45 37.74 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.272 -1.01 . . . . 29.760000000000002 108.272 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.42 165.34 17.27 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.158 0.98 . . . . 18.260000000000002 111.764 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.445 HG12 ' OG ' ' A' ' 25' ' ' SER . 3.2 t -115.08 130.87 23.87 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.2 -1.407 . . . . 8.1999999999999993 107.2 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 82' ' ' SER . 14.6 Cg_endo -77.03 -165.02 4.2 Favored 'Cis proline' 0 C--N 1.309 -1.522 0 CA-C-O 122.579 0.991 . . . . 7.79 112.328 0.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.534 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -151.03 89.92 1.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.543 -2.021 . . . . 26.050000000000001 105.543 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 79' ' ' ILE . 92.9 t -85.48 156.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.639 0.733 . . . . 8.6799999999999997 111.896 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.6 m-85 -144.06 91.25 2.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.751 -0.593 . . . . 14.07 111.04 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 mm -72.96 114.56 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 106.047 -1.835 . . . . 9.3399999999999999 106.047 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.74 -154.83 34.76 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.117 -2.793 . . . . 12.42 106.117 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.12 -1.06 51.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.452 -1.616 . . . . 44.859999999999999 109.271 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.14 118.66 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.273 -0.892 . . . . 0.0 110.407 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -75.47 150.15 38.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 72' ' ' VAL . 1.6 pp -114.66 -22.7 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.274 -0.891 . . . . 20.449999999999999 109.122 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.5 -128.91 4.48 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.128 -1.189 . . . . 13.82 110.128 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 -137.26 4.24 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.861 -1.296 . . . . 12.42 109.861 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -72.39 -63.99 1.04 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.49 -1.006 . . . . 0.0 110.119 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -53.51 -26.71 21.98 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 110.108 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 4.2 t0 -75.25 -46.43 33.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 27.059999999999999 109.199 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.1 tt -53.48 -59.16 4.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 15.31 109.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.25 -51.5 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.443 -0.786 . . . . 0.0 110.758 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -47.11 -39.12 12.68 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.903 -1.123 . . . . 21.789999999999999 109.203 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 mt -78.98 -41.8 28.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.495 -0.753 . . . . 0.0 112.124 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -57.24 13.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.579 -1.325 . . . . 0.0 110.625 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.2 -26.22 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.939 -1.101 . . . . 0.0 109.516 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.4 m -80.34 -21.29 42.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.7 -9.96 74.06 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.331 -1.107 . . . . 25.640000000000001 110.331 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -68.36 -29.19 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.003 -1.293 . . . . 50.259999999999998 108.397 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.9 tp -61.21 -63.87 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 24.170000000000002 110.792 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -52.68 -30.95 34.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -65.15 -49.26 70.54 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.148 -1.056 . . . . 28.030000000000001 108.148 178.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -55.86 -36.15 67.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.574 -1.269 . . . . 40.960000000000001 107.574 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.86 -37.34 67.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.664 -0.865 . . . . 15.050000000000001 108.664 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.11 -55.06 20.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.642 . . . . 0.0 111.566 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -48.84 -33.93 11.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.85 -1.156 . . . . 38.640000000000001 110.751 -178.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.95 -14.78 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.823 -1.173 . . . . 0.0 109.04 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.3 8.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.418 -1.073 . . . . 18.539999999999999 110.418 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.78 -19.14 29.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.279 . . . . 10.84 109.855 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -94.67 -175.42 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.711 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.223 0.535 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.18 -73.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 20.030000000000001 110.447 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.31 -37.4 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 12.91 110.059 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.412 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 26.2 m-20 -55.89 -37.09 68.39 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.106 -0.996 . . . . 28.329999999999998 109.582 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -74.5 -12.85 60.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -97.54 -44.33 6.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 110.755 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.33 137.66 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.821 -1.175 . . . . 25.190000000000001 109.611 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -147.83 137.83 12.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.331 -0.988 . . . . 34.609999999999999 108.331 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -51.66 129.21 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.067 1.178 . . . . 11.720000000000001 109.671 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 80.55 24.02 59.37 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.22 -1.552 . . . . 10.24 109.22 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -141.5 137.66 32.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -1.068 . . . . 25.359999999999999 109.402 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.53 137.28 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 10.890000000000001 109.843 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.62 144.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.224 -1.028 . . . . 15.82 108.224 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 18' ' ' ILE . 47.1 t -129.11 123.55 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 8.9399999999999995 111.132 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -90.73 122.61 33.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.533 -1.284 . . . . 9.9299999999999997 107.533 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' PRO . 18.7 pt -130.97 -170.67 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.337 1.065 . . . . 10.619999999999999 110.893 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 21' ' ' THR . 15.6 mtmm -149.24 91.16 4.54 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 105.983 -1.858 . . . . 38.729999999999997 105.983 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.3 Cg_exo -47.26 75.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.776 1.651 . . . . 24.579999999999998 111.004 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 19' ' ' LYS . 21.9 m -170.74 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.089 -0.708 . . . . 34.82 109.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.0 133.61 23.02 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.229 -0.92 . . . . 21.460000000000001 110.076 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.53 -24.96 77.14 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 122.156 1.904 . . . . 13.859999999999999 111.854 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.6 -37.94 73.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.867 -1.146 . . . . 0.0 109.242 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -39.87 91.83 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -61.63 -40.79 96.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.015 -0.735 . . . . 59.590000000000003 109.015 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.05 -47.43 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.13 74.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.181 -0.949 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.61 -44.66 64.03 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 45.490000000000002 110.038 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.602 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 41.8 mm-40 -70.19 -34.47 72.99 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.499 -0.751 . . . . 34.969999999999999 110.979 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -78.65 -57.43 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.782 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 35' ' ' LEU . 2.8 mt -60.55 -20.43 60.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.625 -1.297 . . . . 17.280000000000001 110.086 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.6 p -65.34 -26.49 68.05 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 109.026 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.602 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -90.45 4.57 50.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 44.07 110.616 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 32' ' ' LEU . 18.3 mt -91.45 128.51 46.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.776 -1.203 . . . . 19.629999999999999 109.638 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.35 65.37 0.72 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.872 1.714 . . . . 21.539999999999999 110.021 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.2 mm -78.88 153.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.291 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.0 mmmt -55.6 -169.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 29.41 109.424 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.581 ' O ' ' O ' ' A' ' 38' ' ' LYS . 14.3 mm100 -52.5 -129.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.445 -0.784 . . . . 0.0 111.086 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.53 48.57 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.834 -0.906 . . . . 15.27 110.834 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -97.68 -18.84 18.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.18 -1.188 . . . . 8.7799999999999994 109.344 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -107.4 130.09 54.85 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.585 -0.894 . . . . 7.1299999999999999 108.585 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -141.72 166.85 23.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 22.030000000000001 110.515 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -127.68 109.79 12.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.314 -1.365 . . . . 16.329999999999998 107.314 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -95.04 107.79 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 6.5800000000000001 111.36 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' HD11 ' A' ' 18' ' ' ILE . 69.9 m-20 -81.65 101.79 10.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.269 -1.012 . . . . 15.32 108.269 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.6 pt -63.33 -5.62 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 10.92 110.905 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 t -93.54 -13.59 27.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.845 -1.159 . . . . 21.719999999999999 109.405 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.93 11.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 22.449999999999999 109.443 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.5 t -142.63 -12.3 0.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 25.629999999999999 110.058 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 50' ' ' THR . 15.9 t30 82.71 -172.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.42 -0.8 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 1.6 m-70 57.59 30.27 18.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.126 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.2 p -45.02 -58.65 3.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 18.870000000000001 109.94 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -53.78 -33.94 57.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 45.210000000000001 110.712 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -63.62 -45.94 87.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.754 -1.216 . . . . 33.020000000000003 109.534 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.23 -52.67 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 9.8399999999999999 109.451 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.1 mt-30 -57.27 -40.56 77.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.67 -1.233 . . . . 17.84 107.67 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.71 -32.99 63.79 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.157 -1.423 . . . . 18.84 107.157 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -77.7 -46.37 22.08 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.934 -0.765 . . . . 12.99 108.934 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.76 -36.88 65.32 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.09 -1.078 . . . . 14.609999999999999 108.09 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.3 tp-100 -59.47 -52.57 65.03 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.759 -0.83 . . . . 40.450000000000003 108.759 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.73 -44.14 78.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 41.810000000000002 110.218 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.8 tp -64.1 -42.23 96.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 21.77 110.13 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.614 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 4.6 p -114.05 -74.02 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.438 -0.788 . . . . 11.380000000000001 109.702 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 157.8 -38.89 0.54 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.716 -1.354 . . . . 14.789999999999999 109.716 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.43 133.44 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -1.194 . . . . 17.809999999999999 110.208 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.9 21.65 14.29 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.885 -0.783 . . . . 29.760000000000002 108.885 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.88 171.57 15.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.529 -0.732 . . . . 18.260000000000002 110.316 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.26 138.39 24.23 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.636 -0.875 . . . . 8.1999999999999993 108.636 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HB3' HG22 ' A' ' 18' ' ' ILE . 14.8 Cg_endo -81.68 -167.75 6.06 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 124.854 -0.894 . . . . 7.79 110.95 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.0 92.98 2.54 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.966 -1.865 . . . . 26.050000000000001 105.966 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 85' ' ' LEU . 62.2 t -84.21 155.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.731 0.777 . . . . 8.6799999999999997 111.691 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.2 m-85 -143.03 88.51 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.861 -0.525 . . . . 14.07 110.639 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.29 109.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.987 -1.857 . . . . 9.3399999999999999 105.987 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.76 51.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 106.792 -2.523 . . . . 12.42 106.792 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -86.12 -5.3 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.538 -1.566 . . . . 44.859999999999999 109.152 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB3' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -89.04 116.42 27.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -72.31 152.76 41.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.33 -23.37 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 20.449999999999999 109.702 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.8 -148.76 19.53 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.747 -1.341 . . . . 13.82 109.747 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.535 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -102.12 -148.65 21.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.945 -1.262 . . . . 12.42 109.945 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -70.66 -58.23 3.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 t -53.19 -27.2 20.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.1 m-20 -73.66 -45.72 50.86 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 27.059999999999999 108.817 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -56.26 -60.9 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.539 -0.726 . . . . 15.31 109.952 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.66 -48.03 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.318 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.3 m -49.71 -45.92 49.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.704 -1.247 . . . . 21.789999999999999 109.494 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 mt -70.6 -38.65 74.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.452 ' NE2' HD23 ' A' ' 94' ' ' LEU . 12.4 tp60 -60.4 -58.51 8.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.176 -0.953 . . . . 0.0 110.489 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.89 -25.88 67.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.029 -1.044 . . . . 0.0 109.308 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.79 -15.32 52.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.69 -7.41 62.18 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.673 -1.371 . . . . 25.640000000000001 109.673 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.83 -27.92 66.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.203 -1.175 . . . . 50.259999999999998 109.016 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD23 ' NE2' ' A' ' 89' ' ' GLN . 30.0 tp -59.22 -63.76 1.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -0.847 . . . . 24.170000000000002 110.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.95 -30.24 45.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.502 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.55 -43.43 97.11 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.068 -1.086 . . . . 28.030000000000001 108.068 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.443 HH21 ' HB3' ' A' ' 77' ' ' ASP . 2.0 tpt180 -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.32 -0.992 . . . . 40.960000000000001 108.32 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 mp -71.62 -37.88 70.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.425 -0.797 . . . . 15.050000000000001 109.204 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.18 -56.81 12.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 111.856 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -46.82 -27.51 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.794 -1.191 . . . . 38.640000000000001 110.264 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.71 -17.81 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.723 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.86 39.37 13.68 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.25 -1.14 . . . . 18.539999999999999 110.25 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 -10.19 58.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.178 . . . . 10.84 109.638 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 104' ' ' LEU . 1.3 pt? -95.25 -176.98 3.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 109.964 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.597 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.583 0.706 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.25 -68.76 0.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.787 . . . . 20.030000000000001 110.678 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -72.94 -38.49 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.134 -0.979 . . . . 12.91 110.289 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 52.0 m-20 -55.1 -37.28 66.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.061 -1.024 . . . . 28.329999999999998 109.379 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 m -74.97 -12.7 60.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.743 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -97.16 -45.77 6.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 22.870000000000001 110.753 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.16 134.45 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.908 -1.12 . . . . 25.190000000000001 109.391 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -147.61 149.61 34.39 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 34.609999999999999 109.186 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.18 126.17 21.25 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.421 1.414 . . . . 11.720000000000001 110.024 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.7 21.34 61.93 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.607 -1.397 . . . . 10.24 109.607 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -137.64 134.01 34.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -1.058 . . . . 25.359999999999999 109.272 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.6 137.51 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.18 -0.95 . . . . 10.890000000000001 109.617 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.19 147.13 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.211 -1.033 . . . . 15.82 108.211 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.2 t -132.74 122.04 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.932 . . . . 8.9399999999999995 110.803 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -89.43 126.12 35.43 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.478 -1.304 . . . . 9.9299999999999997 107.478 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 70' ' ' PRO . 46.5 pt -133.74 -172.18 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.174 0.988 . . . . 10.619999999999999 111.319 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.744 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.6 mtmt -147.49 96.31 4.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.747 -1.575 . . . . 38.729999999999997 106.747 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 21' ' ' THR . 11.2 Cg_exo -49.22 66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.843 1.696 . . . . 24.579999999999998 111.147 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 19' ' ' LYS . 16.8 p -162.62 -35.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.984 -0.747 . . . . 34.82 108.984 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.13 128.47 35.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 21.460000000000001 110.072 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.25 -14.78 40.42 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 122.12 1.88 . . . . 13.859999999999999 111.996 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -70.54 -43.14 70.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.691 -1.256 . . . . 0.0 109.798 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -31.19 71.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.351 -0.843 . . . . 0.0 109.55 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.82 -47.74 83.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 59.590000000000003 109.544 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.664 HH11 ' HG3' ' A' ' 27' ' ' ARG . 2.4 mmm-85 -51.08 -41.29 59.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 0.0 108.803 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.33 82.75 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -71.57 -46.1 60.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 45.490000000000002 109.663 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.631 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 97.3 mt-10 -68.83 -34.6 75.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.518 -0.738 . . . . 34.969999999999999 110.916 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -76.8 -56.64 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.741 -1.225 . . . . 0.0 110.045 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.638 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -58.51 -20.85 49.49 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.667 -1.271 . . . . 17.280000000000001 109.14 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 m -65.22 -30.44 71.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.25 -0.906 . . . . 24.109999999999999 108.78 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -88.65 3.32 51.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 44.07 110.262 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 35' ' ' LEU . 18.1 mt -91.87 127.77 48.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.826 -1.171 . . . . 19.629999999999999 109.432 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.05 63.55 0.31 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.866 1.711 . . . . 21.539999999999999 110.485 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.1 mm -80.25 147.19 6.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.2 mttp -53.46 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 29.41 110.342 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' LYS . 33.1 mt-30 -49.81 -128.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 111.435 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.53 47.75 0.08 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.87 -0.892 . . . . 15.27 110.87 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -101.24 -15.33 17.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -1.207 . . . . 8.7799999999999994 109.193 179.134 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 37' ' ' ILE . 47.4 tp -110.18 128.73 55.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.404 -0.962 . . . . 7.1299999999999999 108.404 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.1 tt0 -141.32 169.8 16.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.067 . . . . 22.030000000000001 110.317 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.476 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.0 m-85 -133.12 112.87 12.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.048 -1.093 . . . . 16.329999999999998 108.048 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -95.9 102.09 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 6.5800000000000001 111.149 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.7 m-20 -80.19 100.2 8.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.234 -1.024 . . . . 15.32 108.234 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 pt -62.45 -0.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 10.92 110.196 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' ASP . 33.9 p -95.6 -27.03 15.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 21.719999999999999 109.597 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.48 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 22.449999999999999 109.484 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.477 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 14.7 t -145.17 -3.27 0.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 25.629999999999999 110.164 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.704 ' ND2' ' H ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 67.89 -162.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.048 -1.032 . . . . 0.0 108.526 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.704 ' H ' ' ND2' ' A' ' 51' ' ' ASN . 26.2 m-70 56.56 11.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.685 -1.26 . . . . 0.0 108.141 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.75 -69.22 0.11 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 18.870000000000001 111.36 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.1 m-20 -53.04 -31.28 40.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.062 -1.024 . . . . 45.210000000000001 110.895 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.8 -46.21 79.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.782 -1.199 . . . . 33.020000000000003 109.912 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.86 -52.3 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.748 -1.22 . . . . 9.8399999999999999 109.68 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.89 -41.64 82.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.63 -1.248 . . . . 17.84 107.63 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 9.9 m-20 -55.66 -34.23 64.8 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.279 -1.378 . . . . 18.84 107.279 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.15 -50.31 12.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.84 -0.744 . . . . 12.99 109.204 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.5 mt -52.42 -33.07 42.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.164 -1.05 . . . . 14.609999999999999 108.164 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.2 tp60 -60.42 -56.59 19.61 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.656 -0.653 . . . . 40.450000000000003 109.302 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -65.69 -41.19 92.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 41.810000000000002 109.867 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -65.72 -37.22 85.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 21.77 109.815 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.835 HG21 HH11 ' A' ' 71' ' ' ARG . 6.5 p -113.23 -63.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 11.380000000000001 109.555 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 61' ' ' GLN . . . 144.83 -49.21 0.69 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.007 -1.637 . . . . 14.789999999999999 109.007 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.22 44.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.047 . . . . 17.809999999999999 109.958 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.32 36.12 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.519 -0.919 . . . . 29.760000000000002 108.519 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.41 169.52 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.547 -0.721 . . . . 18.260000000000002 110.226 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.81 135.41 24.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.107 -1.072 . . . . 8.1999999999999993 108.107 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -81.98 -166.22 4.9 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 124.784 -0.923 . . . . 7.79 111.157 -0.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.835 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -143.03 91.18 2.26 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.789 -1.93 . . . . 26.050000000000001 105.789 177.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 79' ' ' ILE . 58.1 t -82.09 154.23 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 8.6799999999999997 111.211 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 72' ' ' VAL . 75.5 m-85 -143.47 88.67 2.02 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.397 -0.521 . . . . 14.07 110.2 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -71.6 101.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.024 -1.843 . . . . 9.3399999999999999 106.024 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.22 -149.85 39.68 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.345 -2.702 . . . . 12.42 106.345 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' CB ' ' NZ ' ' A' ' 76' ' ' LYS . 8.4 mtmp? -86.97 -6.78 58.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.568 -1.549 . . . . 44.859999999999999 109.474 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' HH21 ' A' ' 97' ' ' ARG . 3.0 m-20 -91.48 121.6 33.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 110.582 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -73.62 155.82 38.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 80' ' ' GLY . 2.8 pp -119.0 -16.61 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.233 -0.917 . . . . 20.449999999999999 109.69 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.572 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 136.23 -150.43 20.44 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.081 -1.207 . . . . 13.82 110.081 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.76 -145.3 11.81 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.955 -1.258 . . . . 12.42 109.955 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -70.89 -62.13 1.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.489 -1.007 . . . . 0.0 110.03 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 t -54.23 -26.43 28.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.349 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -73.88 -45.79 48.68 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -0.874 . . . . 27.059999999999999 109.007 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.6 tt -54.11 -59.66 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.41 -0.806 . . . . 15.31 109.7 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -54.09 -43.49 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 110.503 -178.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.619 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 18.8 m -55.27 -35.48 65.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 21.789999999999999 110.146 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.02 -34.35 32.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 0.0 111.258 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.41 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -62.23 -60.57 3.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.004 -1.06 . . . . 0.0 111.124 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.712 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.86 -17.42 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.859 -1.151 . . . . 0.0 109.523 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.544 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 40.4 m -80.26 -62.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.495 -0.753 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.77 4.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.401 -1.479 . . . . 25.640000000000001 109.401 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.37 -30.46 69.41 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.271 -1.135 . . . . 50.259999999999998 108.952 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.73 -64.18 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.431 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.01 -31.4 61.02 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.479 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.61 -45.44 90.34 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.422 -0.955 . . . . 28.030000000000001 108.422 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 77' ' ' ASP . 3.1 ttt180 -61.25 -34.99 76.06 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.273 -1.01 . . . . 40.960000000000001 108.273 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 102' ' ' GLY . 7.9 mp -70.93 -36.14 72.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.721 -0.844 . . . . 15.050000000000001 108.721 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -64.57 -57.5 8.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.782 -0.574 . . . . 0.0 111.346 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 96' ' ' THR . 1.1 pt20 -47.48 -31.72 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.895 -1.128 . . . . 38.640000000000001 110.349 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.86 -11.8 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.995 -1.066 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 73.75 44.51 31.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.507 -1.037 . . . . 18.539999999999999 110.507 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.42 -11.86 50.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -1.218 . . . . 10.84 109.484 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.72 -178.11 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 0.0 110.059 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.393 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -62.19 -72.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.391 -0.818 . . . . 20.030000000000001 110.248 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.84 -39.62 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 12.91 109.929 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 58.4 m-20 -55.6 -37.31 67.94 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 28.329999999999998 109.575 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -74.47 -13.02 60.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.97 -48.34 5.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 22.870000000000001 110.277 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 128.38 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.974 -1.079 . . . . 25.190000000000001 109.869 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -147.85 160.44 38.03 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.56 -0.904 . . . . 34.609999999999999 108.56 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.0 129.19 33.17 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.658 1.572 . . . . 11.720000000000001 111.165 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.54 29.94 50.82 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.865 -0.894 . . . . 10.24 110.865 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -144.8 136.21 25.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.88 -1.364 . . . . 25.359999999999999 110.074 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.24 133.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 10.890000000000001 109.38 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.68 144.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.347 -0.983 . . . . 15.82 108.347 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.42 124.46 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 8.9399999999999995 110.957 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -90.07 121.21 31.92 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.397 -1.334 . . . . 9.9299999999999997 107.397 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -130.7 -175.57 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.276 1.036 . . . . 10.619999999999999 111.2 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.7 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.9 mtmt -148.72 86.59 5.75 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.689 -1.597 . . . . 38.729999999999997 106.689 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.506 ' O ' ' OG1' ' A' ' 21' ' ' THR . 15.6 Cg_exo -44.26 76.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.791 1.661 . . . . 24.579999999999998 110.928 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 19' ' ' LYS . 34.2 m -172.02 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.436 -0.95 . . . . 34.82 108.436 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.5 129.62 29.91 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 21.460000000000001 109.505 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.74 -19.92 56.08 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 122.085 1.857 . . . . 13.859999999999999 112.099 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.679 -1.263 . . . . 0.0 109.551 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -32.95 74.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 108.44 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -62.51 -45.51 92.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 59.590000000000003 108.879 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -49.55 -45.2 47.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.12 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.58 84.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.135 -0.978 . . . . 0.0 108.811 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -70.4 -42.57 71.48 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.46 -0.775 . . . . 45.490000000000002 109.659 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.37 -36.05 76.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 34.969999999999999 111.06 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.77 -56.53 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.837 -1.164 . . . . 0.0 110.497 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD23 HD12 ' A' ' 35' ' ' LEU . 2.5 mt -59.78 -19.91 53.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.576 -1.328 . . . . 17.280000000000001 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -65.65 -27.58 68.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.135 -0.978 . . . . 24.109999999999999 108.919 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -90.11 3.81 52.24 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.316 -0.865 . . . . 44.07 110.431 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.712 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -92.49 125.86 54.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.824 -1.172 . . . . 19.629999999999999 109.805 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.98 67.72 0.92 Allowed 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.802 1.668 . . . . 21.539999999999999 109.893 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 mm -79.43 150.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.7 mtpm? -54.19 -171.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.366 -0.834 . . . . 29.41 110.192 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' LYS . 16.7 mt-30 -50.78 -131.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.617 0.722 . . . . 0.0 111.447 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.14 49.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.242 -0.911 . . . . 15.27 110.933 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.8 -17.51 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -1.074 . . . . 8.7799999999999994 109.383 179.268 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.0 tp -107.88 130.9 54.97 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.48 -0.933 . . . . 7.1299999999999999 108.48 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -141.58 169.27 17.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -0.988 . . . . 22.030000000000001 110.418 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -131.92 109.96 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.606 -1.257 . . . . 16.329999999999998 107.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.0 t -94.67 104.01 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 6.5800000000000001 111.186 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -80.71 101.34 9.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.782 -0.822 . . . . 15.32 108.782 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.59 -7.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 10.92 110.198 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -100.49 46.93 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 21.719999999999999 108.804 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.03 20.25 0.31 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.025 -0.732 . . . . 22.449999999999999 109.025 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 9.0 t -144.51 -5.22 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 25.629999999999999 109.513 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 50' ' ' THR . 4.2 t-20 81.38 177.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.38 27.13 11.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.997 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.14 -60.69 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 18.870000000000001 110.41 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 81.6 m-20 -57.47 -29.51 64.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 45.210000000000001 111.022 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.13 -43.95 93.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.724 -1.235 . . . . 33.020000000000003 109.747 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.1 -53.67 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 9.8399999999999999 109.431 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.43 -43.17 83.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.839 -1.171 . . . . 17.84 107.839 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 26.3 m-20 -54.9 -34.93 63.58 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.345 -1.354 . . . . 18.84 107.345 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -78.76 -47.3 17.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.878 -0.729 . . . . 12.99 109.245 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.76 -32.77 53.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.213 -1.032 . . . . 14.609999999999999 108.213 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 7.5 tp60 -59.49 -55.59 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.879 -0.785 . . . . 40.450000000000003 108.879 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -67.45 -35.5 79.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.181 -0.95 . . . . 41.810000000000002 110.109 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 73' ' ' PHE . 29.3 tp -64.88 -46.42 81.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.1 -1.0 . . . . 21.77 109.91 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.525 HG21 HH11 ' A' ' 71' ' ' ARG . 1.4 p -110.06 -58.5 2.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.47 -0.769 . . . . 11.380000000000001 109.481 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 150.01 -52.46 0.52 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.573 -1.411 . . . . 14.789999999999999 109.573 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 138.28 35.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -1.093 . . . . 17.809999999999999 110.261 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -95.59 32.28 1.85 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.459 -0.941 . . . . 29.760000000000002 108.459 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 165.79 22.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 18.260000000000002 110.207 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -116.79 138.35 24.54 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.056 -1.09 . . . . 8.1999999999999993 108.056 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -80.66 -168.13 6.53 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 124.8 -0.917 . . . . 7.79 111.361 -0.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.549 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.68 90.75 2.03 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.852 -1.907 . . . . 26.050000000000001 105.852 177.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.566 HG21 HD12 ' A' ' 85' ' ' LEU . 74.0 t -83.23 155.58 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.737 0.779 . . . . 8.6799999999999997 111.551 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CE2' HD23 ' A' ' 63' ' ' LEU . 79.6 m-85 -144.12 89.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.818 -0.551 . . . . 14.07 110.921 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -71.72 110.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.084 -1.821 . . . . 9.3399999999999999 106.084 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.66 -153.34 52.5 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.729 -2.548 . . . . 12.42 106.729 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -84.15 -3.74 58.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.564 -1.551 . . . . 44.859999999999999 109.41 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -90.05 118.37 29.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.937 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -72.68 152.26 41.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.031 -1.043 . . . . 0.0 109.416 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -113.87 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -0.969 . . . . 20.449999999999999 109.336 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.448 ' HA2' HH22 ' A' ' 71' ' ' ARG . . . 132.51 -155.96 21.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.124 -1.19 . . . . 13.82 110.124 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.95 -147.16 22.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.201 -1.16 . . . . 12.42 110.201 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -70.56 -60.2 2.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.526 -0.985 . . . . 0.0 109.867 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 t -52.43 -25.84 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.286 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.19 -49.08 25.05 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.801 . . . . 27.059999999999999 109.333 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.5 tt -54.7 -59.23 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 15.31 110.145 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.16 -45.41 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.105 -178.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 -47.47 66.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.736 -1.228 . . . . 21.789999999999999 109.492 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.23 -36.54 77.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.903 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -60.77 -59.18 5.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 110.478 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.53 -24.19 67.37 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.432 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -82.55 -16.52 48.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.464 -0.773 . . . . 0.0 109.813 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 -9.88 56.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.819 -1.313 . . . . 25.640000000000001 109.819 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -67.7 -28.18 67.45 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -1.174 . . . . 50.259999999999998 108.809 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.32 -65.7 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 24.170000000000002 110.084 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.24 -30.38 37.78 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.449 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -62.86 -44.68 95.46 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.465 -0.939 . . . . 28.030000000000001 108.465 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.707 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -63.06 -34.11 76.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.662 -0.866 . . . . 40.960000000000001 108.662 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.6 mp -71.11 -35.68 71.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 15.050000000000001 109.023 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -65.11 -56.9 10.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.608 -0.683 . . . . 0.0 111.574 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -46.01 -31.09 2.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 38.640000000000001 110.395 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.4 pt -104.45 -14.44 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.86 40.5 21.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.304 -1.118 . . . . 18.539999999999999 110.304 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.42 -8.06 59.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.239 . . . . 10.84 109.474 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.639 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.18 -178.99 4.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.561 179.724 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.254 0.55 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.17 -69.16 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 20.030000000000001 110.432 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 6' ' ' ASN . 2.5 m -73.51 -40.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 12.91 110.443 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 5' ' ' VAL . 68.4 m-80 -55.21 -29.94 58.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.067 -1.021 . . . . 28.329999999999998 109.497 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 m -75.29 -18.44 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -98.1 -44.03 6.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 111.212 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.26 129.18 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.174 . . . . 25.190000000000001 110.585 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.05 158.4 38.91 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.151 -1.055 . . . . 34.609999999999999 108.151 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.0 127.95 27.9 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.544 1.496 . . . . 11.720000000000001 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.12 28.16 46.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.753 -0.939 . . . . 10.24 110.753 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -143.14 136.88 28.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.969 -1.313 . . . . 25.359999999999999 109.933 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.79 134.4 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.386 -0.821 . . . . 10.890000000000001 109.392 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.15 143.0 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.437 -0.949 . . . . 15.82 108.437 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.7 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.405 -0.809 . . . . 8.9399999999999995 110.739 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.62 122.74 33.04 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.487 -1.301 . . . . 9.9299999999999997 107.487 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.6 pt -132.11 -174.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.104 0.954 . . . . 10.619999999999999 111.224 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mtmt -145.77 94.63 5.03 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.585 -1.635 . . . . 38.729999999999997 106.585 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.0 Cg_exo -46.49 82.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.561 1.508 . . . . 24.579999999999998 110.945 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 19' ' ' LYS . 14.7 m 178.95 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 34.82 108.41 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.96 121.88 54.42 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 21.460000000000001 109.711 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.04 -17.57 45.75 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.724 1.616 . . . . 13.859999999999999 111.778 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -68.87 -42.63 76.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.563 -1.335 . . . . 0.0 108.291 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -36.73 83.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -61.15 -39.37 89.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.8 -1.185 . . . . 59.590000000000003 107.8 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.69 -47.15 70.74 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.42 74.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.407 -0.808 . . . . 0.0 108.865 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 33' ' ' SER . 5.4 mt-30 -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.852 . . . . 45.490000000000002 109.745 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.3 mm-40 -69.82 -34.17 73.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 34.969999999999999 111.029 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.48 -55.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 35' ' ' LEU . 1.5 mt -59.25 -24.13 62.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.671 -1.268 . . . . 17.280000000000001 109.696 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.2 p -63.85 -22.22 66.81 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.289 -1.004 . . . . 24.109999999999999 108.289 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -90.09 0.43 57.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.527 -0.733 . . . . 44.07 109.862 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 32' ' ' LEU . 18.9 mt -92.96 127.45 47.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 19.629999999999999 109.656 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.0 66.65 0.58 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.644 1.562 . . . . 21.539999999999999 109.777 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -80.07 148.15 6.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.9 mttp -54.55 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -0.826 . . . . 29.41 110.272 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' LYS . 70.0 mt-30 -51.1 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.641 0.734 . . . . 0.0 111.191 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.24 48.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.924 -0.87 . . . . 15.27 110.924 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -99.8 -17.36 17.71 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.129 -1.218 . . . . 8.7799999999999994 109.137 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' A' ' 37' ' ' ILE . 54.1 tp -108.55 126.92 53.46 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.967 -1.123 . . . . 7.1299999999999999 107.967 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 23.2 tp10 -139.59 163.67 31.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.993 -1.067 . . . . 22.030000000000001 110.253 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.9 m-85 -126.32 110.84 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.677 -1.231 . . . . 16.329999999999998 107.677 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.61 107.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 6.5800000000000001 111.235 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' THR . 4.7 m-20 -82.59 99.61 9.65 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.469 -0.937 . . . . 15.32 108.469 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.2 pt -62.03 5.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 10.92 110.61 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . 16.9 p -97.22 -25.53 15.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.089 -1.007 . . . . 21.719999999999999 109.812 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.91 23.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 22.449999999999999 109.943 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 12.0 t -146.74 0.6 0.76 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 25.629999999999999 110.489 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 6.5 m120 66.45 -177.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.227 -0.921 . . . . 0.0 109.245 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.58 29.92 16.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 108.8 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.85 -56.69 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 18.870000000000001 110.002 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 68.8 m-20 -57.02 -31.4 65.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 45.210000000000001 111.0 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.5 -45.13 92.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.752 -1.218 . . . . 33.020000000000003 109.739 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.43 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.3 mp -66.86 -53.98 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.869 -1.144 . . . . 9.8399999999999999 109.677 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.26 -40.67 78.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.723 -1.214 . . . . 17.84 107.723 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 61.2 m-20 -54.96 -33.73 62.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.037 -1.468 . . . . 18.84 107.037 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -78.86 -48.72 14.15 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.058 -0.719 . . . . 12.99 109.058 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.3 mt -53.96 -33.21 56.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.141 -1.059 . . . . 14.609999999999999 108.141 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 6.9 tp60 -60.58 -57.68 11.68 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.165 -0.68 . . . . 40.450000000000003 109.165 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.09 -36.22 81.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.359 -0.838 . . . . 41.810000000000002 110.023 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 tp -65.38 -49.17 70.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.094 -1.004 . . . . 21.77 109.704 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 2.2 p -109.05 -67.2 1.0 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.74 . . . . 11.380000000000001 109.563 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 161.33 -49.07 0.36 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.258 -1.449 . . . . 14.789999999999999 110.874 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.849 ' HB3' HH12 ' A' ' 71' ' ' ARG . . . -97.81 136.95 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.304 . . . . 17.809999999999999 110.771 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.58 25.21 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.253 -1.388 . . . . 29.760000000000002 107.253 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.579 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -79.15 169.42 18.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.665 0.745 . . . . 18.260000000000002 110.254 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.0 135.09 24.1 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.02 -1.104 . . . . 8.1999999999999993 108.02 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -83.72 -164.69 3.61 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 124.868 -0.888 . . . . 7.79 110.797 -0.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.849 HH12 ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -152.41 93.47 1.8 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.036 -2.209 . . . . 26.050000000000001 105.036 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 73' ' ' PHE . 65.7 t -82.5 160.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.859 0.838 . . . . 8.6799999999999997 111.971 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.536 ' N ' HG12 ' A' ' 72' ' ' VAL . 83.9 m-85 -144.47 91.83 2.23 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 116.174 -0.467 . . . . 14.07 110.584 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 98' ' ' LEU . 8.3 mm -71.73 104.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.881 -1.896 . . . . 9.3399999999999999 105.881 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.32 -149.64 51.11 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 106.101 -2.8 . . . . 12.42 106.101 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -84.77 -1.17 55.97 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.489 -1.595 . . . . 44.859999999999999 109.245 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' OD2' ' NH2' ' A' ' 97' ' ' ARG . 85.2 m-20 -89.5 111.76 22.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -72.97 147.67 44.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.89 -21.13 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.289 -0.882 . . . . 20.449999999999999 108.983 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.12 -149.42 18.87 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.18 -1.168 . . . . 13.82 110.18 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.52 -140.66 9.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.405 -1.078 . . . . 12.42 110.405 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 86' ' ' VAL . 11.0 p -70.06 -65.61 0.7 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.729 -0.865 . . . . 0.0 110.334 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -50.83 -27.9 8.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.821 . . . . 0.0 109.692 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -73.92 -49.47 24.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.354 -0.841 . . . . 27.059999999999999 109.345 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.0 tt -56.01 -60.09 3.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 15.31 110.411 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -48.59 -47.17 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 -178.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 t -49.46 -46.34 47.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.791 -1.193 . . . . 21.789999999999999 109.444 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.22 -39.11 75.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.878 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -60.58 -58.39 8.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.894 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.63 -24.75 65.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 109.102 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -79.97 -43.78 21.43 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.653 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.69 -9.96 30.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.393 -1.483 . . . . 25.640000000000001 109.393 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.58 -26.06 65.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -1.082 . . . . 50.259999999999998 108.911 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.52 -64.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 24.170000000000002 110.212 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.24 -30.82 40.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.5 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.32 -44.09 95.94 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.511 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 8.9 tpt180 -61.27 -35.49 77.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.411 -0.959 . . . . 40.960000000000001 108.411 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.6 mp -70.6 -38.93 74.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.857 0.837 . . . . 15.050000000000001 108.82 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -65.55 -53.81 36.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.824 -0.548 . . . . 0.0 112.033 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -48.31 -32.17 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.78 -1.2 . . . . 38.640000000000001 110.42 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.2 pt -103.83 -14.4 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.572 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 78.99 45.4 9.06 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.283 -1.127 . . . . 18.539999999999999 110.283 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.56 -11.81 53.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -1.121 . . . . 10.84 109.187 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.57 -177.85 4.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.14 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.599 179.864 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -63.67 -69.49 0.27 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.476 -0.765 . . . . 20.030000000000001 110.619 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.64 -39.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 12.91 110.169 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.1 m-20 -55.75 -37.98 69.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.212 -0.93 . . . . 28.329999999999998 109.271 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -74.94 -12.03 60.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -97.21 -45.33 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 22.870000000000001 110.721 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.451 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.54 138.95 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.788 -1.195 . . . . 25.190000000000001 110.029 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -149.27 136.77 11.21 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 107.947 -1.131 . . . . 34.609999999999999 107.947 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -50.02 131.51 30.51 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 120.997 1.131 . . . . 11.720000000000001 109.699 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 20.64 70.06 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.209 -1.556 . . . . 10.24 109.209 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -137.82 132.98 33.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -1.06 . . . . 25.359999999999999 109.013 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.32 135.5 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.154 -0.966 . . . . 10.890000000000001 109.754 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.3 142.86 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.268 -1.012 . . . . 15.82 108.268 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 18' ' ' ILE . 39.0 t -124.86 128.07 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 8.9399999999999995 111.201 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -94.74 114.69 26.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.352 -0.981 . . . . 9.9299999999999997 108.352 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 25' ' ' SER . 41.6 pt -125.74 -172.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.537 1.161 . . . . 10.619999999999999 111.587 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -145.89 94.65 4.98 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 105.481 -2.044 . . . . 38.729999999999997 105.481 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.1 Cg_exo -49.21 79.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.392 1.394 . . . . 24.579999999999998 111.06 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.607 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.8 m -177.59 -32.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.539 -0.726 . . . . 34.82 109.442 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.77 124.68 45.09 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 21.460000000000001 109.6 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.78 -17.63 23.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.382 2.054 . . . . 13.859999999999999 113.164 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -69.91 -49.71 49.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.269 -1.52 . . . . 0.0 109.391 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -59.96 -33.08 71.45 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -61.13 -42.67 98.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.815 -0.809 . . . . 59.590000000000003 108.815 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 1.1 mtt-85 -54.52 -47.81 72.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.008 -1.058 . . . . 0.0 108.754 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 mt-30 -70.07 -41.81 73.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.36 -0.837 . . . . 45.490000000000002 109.435 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.599 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 42.5 mt-10 -72.19 -38.74 68.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.565 -0.709 . . . . 34.969999999999999 111.461 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -74.19 -55.69 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.813 -1.18 . . . . 0.0 110.093 -178.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.63 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -60.02 -20.08 56.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.538 -1.351 . . . . 17.280000000000001 109.649 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.1 m -65.73 -30.2 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.103 -0.998 . . . . 24.109999999999999 109.539 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 1.6 mp0 -93.85 4.93 53.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 44.07 110.902 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' OE1' ' A' ' 89' ' ' GLN . 21.6 mt -88.35 132.18 40.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.767 -1.208 . . . . 19.629999999999999 108.604 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.85 62.52 0.59 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.577 1.518 . . . . 21.539999999999999 110.258 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.3 mm -78.32 146.94 7.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.032 -1.043 . . . . 0.0 108.225 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 39' ' ' GLN . 18.6 mtpt -53.65 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.062 -1.024 . . . . 29.41 109.944 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 41' ' ' LEU . 26.9 mt-30 -52.29 -127.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.691 0.758 . . . . 0.0 112.363 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.81 48.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.102 -0.799 . . . . 15.27 111.102 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -99.66 -33.04 10.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.263 -1.14 . . . . 8.7799999999999994 108.81 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.6 tp -94.42 132.81 38.67 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.466 0.65 . . . . 7.1299999999999999 109.446 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.6 tp10 -142.01 174.05 10.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 22.030000000000001 109.515 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.463 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 46.7 m-85 -136.63 112.02 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.196 -1.409 . . . . 16.329999999999998 107.196 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.31 104.01 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 6.5800000000000001 111.775 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.6 m-20 -82.68 97.62 8.63 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.603 -0.888 . . . . 15.32 108.603 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.53 1.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 10.92 110.499 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 46' ' ' ASP . 18.1 p -93.61 -17.26 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.027 -1.046 . . . . 21.719999999999999 108.635 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 7.27 5.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.49 -0.756 . . . . 22.449999999999999 109.546 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.0 t -142.31 -3.99 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 25.629999999999999 110.009 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' C ' ' N ' ' A' ' 53' ' ' THR . 8.7 t30 66.55 -151.73 0.21 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.24 13.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.667 -1.271 . . . . 0.0 108.631 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 51' ' ' ASN . 4.3 p -41.59 -55.95 2.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.79 . . . . 18.870000000000001 110.733 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -52.31 -36.81 54.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 45.210000000000001 110.503 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -65.92 -45.01 83.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.06 . . . . 33.020000000000003 109.493 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -67.35 -52.55 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 9.8399999999999999 109.563 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 2.8 mt-30 -56.2 -43.74 78.78 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.231 -1.396 . . . . 17.84 107.231 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -55.5 -34.51 64.67 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.85 -1.537 . . . . 18.84 106.85 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -78.71 -48.81 14.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 120.245 -0.582 . . . . 12.99 109.506 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -51.95 -34.35 41.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.924 -1.139 . . . . 14.609999999999999 107.924 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.703 ' NE2' ' NH2' ' A' ' 67' ' ' ARG . 12.7 tp60 -61.16 -58.2 9.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.304 0.573 . . . . 40.450000000000003 109.768 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -68.47 -35.65 77.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.177 -0.952 . . . . 41.810000000000002 110.861 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.94 -48.24 77.3 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 21.77 110.107 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -113.08 -61.79 1.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 11.380000000000001 109.423 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 160.9 -56.75 0.31 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.647 -1.381 . . . . 14.789999999999999 109.647 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -99.07 143.58 29.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -1.116 . . . . 17.809999999999999 109.296 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.703 ' NH2' ' NE2' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -108.95 20.85 17.96 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.026 -1.102 . . . . 29.760000000000002 108.026 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.01 165.63 17.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.346 -0.846 . . . . 18.260000000000002 109.524 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG12 ' OG ' ' A' ' 25' ' ' SER . 2.6 t -105.6 131.08 22.06 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 8.1999999999999993 108.859 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 82' ' ' SER . 33.5 Cg_endo -84.65 -165.96 4.15 Favored 'Cis proline' 0 C--N 1.309 -1.548 0 CA-C-O 122.521 0.967 . . . . 7.79 111.674 -1.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.579 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 7.1 tpp180 -152.73 92.48 1.66 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.794 -2.299 . . . . 26.050000000000001 104.794 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 95.3 t -81.62 157.4 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.782 0.801 . . . . 8.6799999999999997 112.021 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.8 m-85 -139.81 88.45 2.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.718 -0.614 . . . . 14.07 111.297 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mm -71.93 113.88 9.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.921 -2.252 . . . . 9.3399999999999999 104.921 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.2 -154.52 29.18 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.796 -2.922 . . . . 12.42 105.796 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -83.01 0.34 45.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.218 -1.754 . . . . 44.859999999999999 108.622 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.46 110.01 19.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -74.35 142.33 45.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.675 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 1.9 pt -107.2 -22.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.979 -1.076 . . . . 20.449999999999999 109.166 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.28 19.05 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.212 -1.155 . . . . 13.82 110.212 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.79 -145.25 15.3 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.198 -1.161 . . . . 12.42 110.198 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.6 t -71.8 -60.53 2.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 t -51.38 -24.2 4.56 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.428 0.632 . . . . 0.0 109.483 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 3.5 t70 -76.73 -51.4 11.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.808 . . . . 27.059999999999999 109.394 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.2 tt -51.27 -58.91 4.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 15.31 109.975 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.2 -54.23 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.551 -0.718 . . . . 0.0 109.865 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' VAL . 74.3 m -44.68 -36.69 3.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.335 -0.853 . . . . 21.789999999999999 109.119 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 94' ' ' LEU . 32.3 mt -80.83 -43.49 19.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.493 -0.754 . . . . 0.0 111.409 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.456 ' OE1' HD11 ' A' ' 35' ' ' LEU . 22.9 tp60 -61.01 -56.2 23.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 111.018 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.54 -26.0 64.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.742 -1.224 . . . . 0.0 108.911 -179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.8 m -79.18 -60.82 2.22 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.17 -7.93 6.01 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.061 -1.215 . . . . 25.640000000000001 110.061 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -70.12 -26.15 63.83 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.064 -1.256 . . . . 50.259999999999998 108.856 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.3 tp -60.08 -62.34 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.819 . . . . 24.170000000000002 110.717 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.12 -28.8 42.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.8 -49.48 68.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.317 -0.994 . . . . 28.030000000000001 108.317 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.436 ' NH1' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.22 -33.39 65.32 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.412 -1.329 . . . . 40.960000000000001 107.412 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.51 -41.0 66.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.88 -0.785 . . . . 15.050000000000001 108.88 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -64.77 -52.07 58.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.731 -0.605 . . . . 0.0 111.693 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.96 -34.1 27.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.836 -1.165 . . . . 38.640000000000001 111.007 -177.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 101' ' ' ILE . 19.9 pt -99.55 -18.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.63 -1.294 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.6 40.95 7.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.605 -0.998 . . . . 18.539999999999999 110.605 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.75 -10.98 56.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.09 -1.241 . . . . 10.84 109.436 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.692 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.58 178.15 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.63 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.191 0.519 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.27 -75.74 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.178 -0.951 . . . . 20.030000000000001 110.483 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -74.24 -36.44 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 12.91 109.818 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.407 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 50.7 m-20 -56.14 -38.23 70.56 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 28.329999999999998 109.81 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.3 m -74.1 -12.46 60.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.095 -1.003 . . . . 0.0 109.86 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -97.63 -45.37 6.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 22.870000000000001 110.72 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.21 130.67 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.828 -1.17 . . . . 25.190000000000001 110.116 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.67 157.21 36.28 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.018 -1.104 . . . . 34.609999999999999 108.018 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.89 131.54 46.14 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.897 1.731 . . . . 11.720000000000001 111.588 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.74 21.76 68.08 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.488 -0.863 . . . . 10.24 111.073 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -140.11 132.76 28.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.972 -1.311 . . . . 25.359999999999999 109.415 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.74 133.75 41.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.401 -0.812 . . . . 10.890000000000001 109.404 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.93 142.9 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.673 -0.862 . . . . 15.82 108.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 18' ' ' ILE . 28.9 t -125.91 126.8 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.202 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -94.18 116.91 29.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 9.9299999999999997 107.881 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.8 pt -127.82 -171.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 122.635 1.207 . . . . 10.619999999999999 111.527 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.5 mtmt -149.32 87.47 5.27 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 105.823 -1.918 . . . . 38.729999999999997 105.823 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 21' ' ' THR . 16.7 Cg_exo -47.21 73.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.712 1.608 . . . . 24.579999999999998 110.861 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.8 p -161.88 -37.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.038 -1.097 . . . . 34.82 108.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.39 129.76 28.47 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 21.460000000000001 109.434 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -56.98 -24.55 57.99 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.404 2.07 . . . . 13.859999999999999 112.579 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.65 -41.64 87.9 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.38 -1.45 . . . . 0.0 108.76 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.664 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.12 -35.06 76.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.72 -1.215 . . . . 59.590000000000003 107.72 178.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -54.62 -47.98 72.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 179.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.58 76.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.316 -0.865 . . . . 0.0 108.841 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -70.95 -41.66 70.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.467 -0.771 . . . . 45.490000000000002 109.75 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -71.31 -37.33 71.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 34.969999999999999 111.281 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -76.46 -58.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 110.525 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -58.51 -22.75 56.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.623 -1.298 . . . . 17.280000000000001 109.945 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -64.92 -25.65 67.97 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 108.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -92.99 -0.82 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.81 . . . . 44.07 110.066 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 35' ' ' LEU . 21.1 mt -87.91 130.9 44.88 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.935 -1.103 . . . . 19.629999999999999 108.465 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.23 65.93 1.05 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.766 1.644 . . . . 21.539999999999999 110.592 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.6 mm -80.71 147.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.4 mttt -54.82 -166.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 29.41 110.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.642 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 1.7 mp0 -52.63 -131.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.834 0.826 . . . . 0.0 111.983 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.97 49.18 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.537 -1.025 . . . . 15.27 110.537 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -97.51 -30.44 12.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.307 -1.113 . . . . 8.7799999999999994 108.723 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -95.9 133.83 39.6 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.092 -0.707 . . . . 7.1299999999999999 109.092 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 22.1 tt0 -142.61 174.3 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 22.030000000000001 110.003 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 41.5 m-85 -136.98 110.68 8.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.438 -1.319 . . . . 16.329999999999998 107.438 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.11 104.77 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 6.5800000000000001 111.886 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.8 m-20 -81.44 102.53 10.58 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.512 -0.921 . . . . 15.32 108.512 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.5 pt -64.08 -2.13 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 10.92 111.54 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.25 -17.89 23.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.788 -1.195 . . . . 21.719999999999999 108.739 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 13.42 1.74 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.466 -0.771 . . . . 22.449999999999999 109.471 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.5 t -142.81 -0.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 25.629999999999999 109.847 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 67.2 -171.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.563 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.21 31.37 18.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.833 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -53.71 10.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 18.870000000000001 109.806 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 5.3 m-20 -54.94 -37.42 66.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 45.210000000000001 110.817 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.9 mp0 -62.1 -46.96 86.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.91 -1.119 . . . . 33.020000000000003 110.167 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.67 -54.75 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.784 -1.197 . . . . 9.8399999999999999 110.172 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -56.81 -41.11 77.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.523 -1.36 . . . . 17.84 107.705 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 6.0 m-20 -54.56 -33.93 60.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.959 -1.496 . . . . 18.84 106.959 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -79.67 -48.32 13.9 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.108 -0.637 . . . . 12.99 109.385 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.7 mt -52.69 -33.65 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.047 -1.033 . . . . 14.609999999999999 108.283 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.5 tp-100 -59.58 -54.85 41.78 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.321 0.581 . . . . 40.450000000000003 109.538 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.41 -42.27 83.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 41.810000000000002 110.347 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.7 tp -62.6 -47.23 84.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 21.77 110.562 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -108.94 -63.39 1.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.266 -0.896 . . . . 11.380000000000001 109.671 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.02 -38.97 1.02 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.399 -1.481 . . . . 14.789999999999999 109.399 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.32 140.29 32.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -1.151 . . . . 17.809999999999999 110.012 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 24.79 11.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.504 -0.924 . . . . 29.760000000000002 108.504 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.804 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.96 169.32 16.14 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.556 0.693 . . . . 18.260000000000002 110.909 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.9 133.36 21.27 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.291 -1.003 . . . . 8.1999999999999993 108.291 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.6 Cg_endo -86.74 -163.76 2.75 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 CA-C-O 122.617 1.007 . . . . 7.79 111.86 -1.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -145.04 95.72 2.73 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.489 -2.041 . . . . 26.050000000000001 105.489 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG21 HD12 ' A' ' 85' ' ' LEU . 94.4 t -85.54 156.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.366 -0.834 . . . . 8.6799999999999997 111.653 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' N ' HG12 ' A' ' 72' ' ' VAL . 78.4 m-85 -144.74 91.33 2.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.604 -0.685 . . . . 14.07 111.549 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.58 115.37 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.01 -2.218 . . . . 9.3399999999999999 105.01 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.45 -155.56 18.13 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 105.707 -2.957 . . . . 12.42 105.707 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.76 5.26 16.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.215 -1.756 . . . . 44.859999999999999 108.637 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 m-20 -89.52 115.04 26.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.387 -0.821 . . . . 0.0 110.793 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 t -77.41 141.92 39.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.306 -0.871 . . . . 0.0 109.678 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.2 pt -109.64 -17.65 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.163 -0.961 . . . . 20.449999999999999 109.197 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.11 -160.19 21.3 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.071 -1.212 . . . . 13.82 110.071 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' CA ' HH21 ' A' ' 71' ' ' ARG . . . -89.26 -148.25 17.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.054 -1.218 . . . . 12.42 110.054 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.55 -60.37 2.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -1.005 . . . . 0.0 110.026 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 t -51.24 -25.38 5.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.192 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.38 -47.91 25.37 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.423 -0.798 . . . . 27.059999999999999 109.03 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -54.04 -59.41 4.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.457 -0.777 . . . . 15.31 110.015 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.19 -51.38 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.371 -0.831 . . . . 0.0 110.309 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 9.0 m -46.82 -34.36 5.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.153 -0.967 . . . . 21.789999999999999 108.975 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.24 -38.94 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 111.734 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.417 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.5 OUTLIER -60.21 -59.19 5.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.08 -19.21 62.71 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.98 -1.075 . . . . 0.0 109.633 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.0 m -81.49 -45.5 15.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.062 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.77 -11.16 27.65 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.308 -1.117 . . . . 25.640000000000001 110.308 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -69.3 -25.5 64.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.279 . . . . 50.259999999999998 108.32 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.4 tp -59.91 -67.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.568 0.699 . . . . 24.170000000000002 110.848 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.32 -29.61 24.33 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -64.63 -46.78 81.1 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.828 -1.175 . . . . 28.030000000000001 107.828 178.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.485 ' NH1' HG22 ' A' ' 79' ' ' ILE . 7.1 ttt180 -59.51 -34.12 72.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.897 -1.149 . . . . 40.960000000000001 107.897 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . 10.4 mp -70.15 -40.48 74.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.612 -0.884 . . . . 15.050000000000001 108.612 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.32 -52.49 46.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.815 -0.553 . . . . 0.0 112.185 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -49.76 -29.34 7.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.691 -1.255 . . . . 38.640000000000001 110.926 -177.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.0 pt -102.7 -22.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.731 -1.231 . . . . 0.0 109.011 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.498 ' O ' ' CE ' ' A' ' 38' ' ' LYS . . . 90.0 47.54 3.86 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.387 -1.085 . . . . 18.539999999999999 110.387 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.15 -14.98 28.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.147 -1.208 . . . . 10.84 110.0 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.684 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -94.6 177.82 5.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.724 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -61.93 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.791 -1.193 . . . . 20.030000000000001 111.482 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.36 -39.34 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.268 -0.895 . . . . 12.91 110.57 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 70.0 m-20 -54.38 -37.3 64.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 28.329999999999998 108.979 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.0 m -74.71 -11.23 60.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.376 -0.827 . . . . 0.0 109.192 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.44 -51.24 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 22.870000000000001 109.688 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -78.91 133.82 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 25.190000000000001 109.621 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 9' ' ' ILE . 6.6 mp0 -144.53 152.32 52.84 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.028 -1.101 . . . . 34.609999999999999 108.028 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.88 129.05 32.89 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.246 1.298 . . . . 11.720000000000001 109.243 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.53 22.83 78.11 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.349 -1.5 . . . . 10.24 109.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.77 128.56 42.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -1.064 . . . . 25.359999999999999 108.973 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -100.37 129.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.461 -0.774 . . . . 10.890000000000001 109.272 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.05 142.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.34 -0.985 . . . . 15.82 108.34 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG12 HG23 ' A' ' 18' ' ' ILE . 40.5 t -124.12 123.72 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 8.9399999999999995 111.055 -177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.05 117.35 29.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 16' ' ' VAL . 16.5 pt -130.06 -172.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.578 1.18 . . . . 10.619999999999999 111.518 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' THR . 26.2 mtmt -150.2 85.58 5.42 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 105.841 -1.911 . . . . 38.729999999999997 105.841 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 21' ' ' THR . 18.4 Cg_exo -45.83 81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.483 1.456 . . . . 24.579999999999998 110.766 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' LYS . 32.6 m -173.67 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.169 -1.048 . . . . 34.82 108.169 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 127.08 36.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.799 . . . . 21.460000000000001 108.841 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.68 -22.69 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.192 1.928 . . . . 13.859999999999999 113.075 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -68.72 -42.35 77.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.284 -1.51 . . . . 0.0 108.96 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -37.2 79.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 26' ' ' ARG . 8.0 mmm-85 -62.21 -41.75 98.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.192 -0.67 . . . . 59.590000000000003 109.192 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -54.02 -49.5 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.12 -0.987 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.2 75.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.155 -0.966 . . . . 0.0 108.909 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.52 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 3.8 mm-40 -71.14 -42.28 69.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.361 -0.837 . . . . 45.490000000000002 109.723 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 33' ' ' SER . 48.4 mt-10 -70.89 -35.83 72.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.548 -0.72 . . . . 34.969999999999999 111.142 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.626 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.0 -56.45 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.927 -1.108 . . . . 0.0 110.798 -178.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -58.67 -23.91 60.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.457 -1.402 . . . . 17.280000000000001 109.891 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 2.5 p -63.28 -19.35 64.5 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.977 -1.077 . . . . 24.109999999999999 108.321 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -92.99 -4.38 52.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.539 -0.725 . . . . 44.07 110.071 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.715 HD12 HD23 ' A' ' 32' ' ' LEU . 21.5 mt -88.74 129.78 47.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.014 -1.054 . . . . 19.629999999999999 108.979 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.11 68.43 1.89 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.563 1.508 . . . . 21.539999999999999 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.6 mm -80.44 142.42 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -57.3 156.25 7.85 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.231 -0.918 . . . . 29.41 110.076 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -58.31 141.56 50.71 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.478 0.656 . . . . 0.0 111.664 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.26 47.16 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.524 -0.735 . . . . 15.27 112.04 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.08 -35.1 9.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.75 -1.441 . . . . 8.7799999999999994 110.072 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 37' ' ' ILE . 63.8 tp -93.54 134.91 35.32 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.485 -0.76 . . . . 7.1299999999999999 109.719 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -144.37 175.05 10.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 22.030000000000001 109.708 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.52 ' CD1' ' OE1' ' A' ' 29' ' ' GLN . 39.7 m-85 -137.63 109.06 6.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.078 -1.452 . . . . 16.329999999999998 107.078 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.26 106.43 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 6.5800000000000001 111.682 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' OD1' HD11 ' A' ' 18' ' ' ILE . 8.0 m-20 -83.79 98.31 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.69 . . . . 15.32 109.3 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.93 -9.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 10.92 110.811 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -96.07 40.65 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.824 -1.176 . . . . 21.719999999999999 107.824 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.47 10.32 0.43 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.47 -0.892 . . . . 22.449999999999999 110.657 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 t -127.86 -3.38 5.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.329 -2.1 . . . . 25.629999999999999 105.329 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 71.88 -175.24 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.676 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER 54.64 18.44 2.05 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 52' ' ' HIS . 1.8 m -29.96 -56.58 0.18 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.443 -0.799 . . . . 18.870000000000001 110.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 3.3 m-20 -59.26 -33.01 70.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.412 -0.805 . . . . 45.210000000000001 111.859 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' HIS . 61.5 mm-40 -60.61 -46.84 88.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.708 -1.245 . . . . 33.020000000000003 109.124 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.29 -55.42 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 9.8399999999999999 109.66 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.3 mt-30 -57.67 -41.14 80.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 17.84 108.474 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.1 -35.61 59.81 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.84 -1.171 . . . . 18.84 107.84 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -80.0 -44.01 20.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.87 -0.789 . . . . 12.99 108.87 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.44 -37.02 46.54 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.517 -1.29 . . . . 14.609999999999999 107.517 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.23 -55.98 25.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.808 -0.812 . . . . 40.450000000000003 108.808 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.99 -37.22 83.82 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.4 -0.813 . . . . 41.810000000000002 110.127 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.94 -52.14 52.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 21.77 109.881 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.4 p -109.72 -65.39 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.599 -0.688 . . . . 11.380000000000001 109.852 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.46 -42.18 0.58 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.703 -1.237 . . . . 14.789999999999999 110.042 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -96.94 139.4 33.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -1.173 . . . . 17.809999999999999 110.363 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.01 31.3 6.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.392 -0.966 . . . . 29.760000000000002 108.392 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.34 173.05 10.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.676 0.751 . . . . 18.260000000000002 111.295 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.11 129.14 24.83 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 107.669 -1.234 . . . . 8.1999999999999993 107.669 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.6 Cg_endo -82.59 -166.13 4.74 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 CA-C-O 122.504 0.96 . . . . 7.79 112.02 -0.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.518 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -145.73 90.42 1.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 105.42 -2.067 . . . . 26.050000000000001 105.42 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 73' ' ' PHE . 93.3 t -83.93 157.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 8.6799999999999997 112.355 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' N ' HG12 ' A' ' 72' ' ' VAL . 58.0 m-85 -145.14 89.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 14.07 111.111 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 101' ' ' ILE . 3.6 mm -71.13 116.41 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.006 -2.22 . . . . 9.3399999999999999 105.006 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.26 -158.88 16.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 105.867 -2.893 . . . . 12.42 105.867 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -80.96 2.98 24.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.197 -1.766 . . . . 44.859999999999999 108.787 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 97' ' ' ARG . 17.2 m-20 -88.76 114.77 25.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.365 -0.835 . . . . 0.0 110.219 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -75.53 142.15 42.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 110.079 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -108.76 -20.64 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.174 -0.954 . . . . 20.449999999999999 108.822 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.07 -162.22 21.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.04 -1.224 . . . . 13.82 110.04 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.78 -148.27 12.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.137 -1.185 . . . . 12.42 110.137 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -70.53 -60.44 2.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.993 . . . . 0.0 110.04 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.8 t -50.61 -24.18 3.1 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.448 -0.783 . . . . 0.0 109.282 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.65 -49.13 16.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.424 -0.798 . . . . 27.059999999999999 109.283 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.66 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.4 tt -52.54 -59.88 3.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 15.31 110.043 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.78 -53.13 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.254 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.7 t -44.91 -36.0 3.11 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.119 -0.988 . . . . 21.789999999999999 109.246 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 94' ' ' LEU . 41.6 mt -81.66 -41.2 21.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.507 -0.746 . . . . 0.0 111.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -57.65 -57.68 11.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.81 -1.181 . . . . 0.0 110.63 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.91 -26.1 67.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.998 -1.064 . . . . 0.0 109.671 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.0 m -80.15 -24.26 40.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.01 -7.52 82.0 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.616 -0.994 . . . . 25.640000000000001 110.616 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.06 -26.15 63.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.934 -1.333 . . . . 50.259999999999998 108.392 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.526 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.13 -64.52 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.766 -0.583 . . . . 24.170000000000002 110.777 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.77 -29.61 40.85 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.402 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.21 -48.05 74.73 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.777 -1.194 . . . . 28.030000000000001 107.777 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.463 HH21 ' CG ' ' A' ' 77' ' ' ASP . 10.4 tpt180 -57.21 -32.71 66.78 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.681 -1.229 . . . . 40.960000000000001 107.681 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -72.43 -40.7 66.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.57 -0.9 . . . . 15.050000000000001 108.57 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.43 -53.41 48.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.661 -0.649 . . . . 0.0 111.647 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -33.57 15.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.747 -1.22 . . . . 38.640000000000001 110.714 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 74' ' ' ILE . 15.0 pt -99.57 -17.43 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.672 -1.267 . . . . 0.0 109.006 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.5 42.57 8.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.216 -1.154 . . . . 18.539999999999999 110.216 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.7 -12.92 52.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 10.84 109.525 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.7 174.75 6.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.449 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.662 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.14 -71.28 0.18 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.344 -0.847 . . . . 20.030000000000001 110.666 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.64 -40.92 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 12.91 110.559 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 11.7 m120 -54.78 -35.99 64.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.223 -0.923 . . . . 28.329999999999998 109.509 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.8 m -75.1 -12.83 60.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.156 -0.965 . . . . 0.0 109.437 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -96.78 -49.81 4.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 22.870000000000001 110.549 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 126.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 25.190000000000001 109.819 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 157.07 43.46 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.358 -0.979 . . . . 34.609999999999999 108.358 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.68 130.34 39.91 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.748 1.632 . . . . 11.720000000000001 111.299 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.93 24.38 60.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.952 -0.859 . . . . 10.24 110.952 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -143.28 135.36 26.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.326 . . . . 25.359999999999999 109.952 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.8 137.37 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.36 -0.837 . . . . 10.890000000000001 109.257 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.59 143.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 15.82 108.732 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.17 121.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.399 -0.813 . . . . 8.9399999999999995 110.535 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -89.97 123.31 33.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.504 -1.295 . . . . 9.9299999999999997 107.504 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.7 pt -133.71 -172.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.447 1.117 . . . . 10.619999999999999 111.723 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.2 mtmt -144.02 96.67 5.42 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.236 -1.764 . . . . 38.729999999999997 106.236 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 11.2 Cg_exo -51.28 75.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.601 1.534 . . . . 24.579999999999998 110.586 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.9 m -170.68 -32.74 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.739 -0.837 . . . . 34.82 108.739 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.33 127.14 39.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 21.460000000000001 109.767 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.37 -12.09 19.0 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.213 1.942 . . . . 13.859999999999999 112.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -72.25 -45.04 61.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.614 -1.304 . . . . 0.0 109.552 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -36.52 84.2 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.46 -33.29 69.59 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.671 -1.603 . . . . 59.590000000000003 106.671 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.13 -59.66 5.11 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.722 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.53 64.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.371 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.502 ' CD ' ' CD1' ' A' ' 44' ' ' PHE . 6.5 mm-40 -68.66 -32.91 73.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.224 -0.923 . . . . 45.490000000000002 108.841 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -71.63 -40.62 69.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 34.969999999999999 111.02 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -77.67 -59.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.896 -1.127 . . . . 0.0 111.017 -178.431 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 35' ' ' LEU . 4.9 mt -57.21 -22.66 42.45 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.806 -1.184 . . . . 17.280000000000001 110.215 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -66.56 -33.41 75.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.027 -1.045 . . . . 24.109999999999999 109.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.75 9.37 39.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 44.07 111.03 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 32' ' ' LEU . 14.4 mt -90.09 134.72 31.09 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.537 -1.352 . . . . 19.629999999999999 108.969 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.46 64.18 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 121.814 1.676 . . . . 21.539999999999999 110.231 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.507 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.7 mm -84.74 144.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.37 -0.831 . . . . 0.0 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -55.84 153.34 8.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.119 -0.988 . . . . 29.41 109.914 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -56.14 138.1 50.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 111.482 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.05 14.14 51.72 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.534 -0.729 . . . . 15.27 111.831 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.88 -21.74 14.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.825 -1.397 . . . . 8.7799999999999994 109.828 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 37' ' ' ILE . 43.1 tp -102.78 127.82 49.77 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 7.1299999999999999 109.387 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 44' ' ' PHE . 17.1 tp10 -142.77 164.69 29.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 22.030000000000001 109.85 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.502 ' CD1' ' CD ' ' A' ' 29' ' ' GLN . 14.1 m-85 -126.19 114.4 18.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.342 -1.355 . . . . 16.329999999999998 107.342 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -95.59 102.6 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 6.5800000000000001 111.553 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.24 102.98 9.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.695 -1.224 . . . . 15.32 107.695 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 56' ' ' ILE . 21.5 pt -61.74 -1.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 10.92 111.434 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -93.11 -13.55 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.714 -1.241 . . . . 21.719999999999999 109.147 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 7.16 5.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 22.449999999999999 109.578 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 t -143.94 -0.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.157 -0.964 . . . . 25.629999999999999 109.936 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 68.51 -159.09 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 108.592 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.38 16.88 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.113 . . . . 0.0 108.537 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -41.8 -59.03 1.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.46 -0.775 . . . . 18.870000000000001 110.483 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.3 m-20 -53.48 -36.52 61.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 45.210000000000001 110.765 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.23 -45.37 84.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.976 -1.078 . . . . 33.020000000000003 110.213 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 47' ' ' ILE . 2.5 mp -65.51 -56.1 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.889 -1.132 . . . . 9.8399999999999999 109.771 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -55.85 -43.2 76.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.696 -1.224 . . . . 17.84 107.696 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 2.5 m-20 -55.93 -34.69 65.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.032 -1.469 . . . . 18.84 107.032 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -77.09 -46.1 24.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.823 -0.806 . . . . 12.99 108.823 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.1 mt -53.6 -36.26 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.762 -1.199 . . . . 14.609999999999999 107.762 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 21.1 tp60 -61.12 -57.07 14.05 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.957 -0.757 . . . . 40.450000000000003 108.957 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -65.9 -34.52 78.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.223 -0.923 . . . . 41.810000000000002 110.09 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.17 -52.75 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 21.77 109.89 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.565 HG21 HH11 ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.88 -61.88 1.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.588 -0.695 . . . . 11.380000000000001 109.606 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 151.73 -37.85 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.682 -1.367 . . . . 14.789999999999999 109.682 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.62 130.57 47.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.243 -1.151 . . . . 17.809999999999999 110.622 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 37.15 1.54 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.174 -1.047 . . . . 29.760000000000002 108.174 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.77 168.91 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.052 0.93 . . . . 18.260000000000002 111.688 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.79 129.23 25.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.106 -1.442 . . . . 8.1999999999999993 107.106 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.6 Cg_endo -75.94 -166.88 5.35 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 CA-C-O 122.425 0.927 . . . . 7.79 111.78 1.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.565 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -148.71 89.75 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.553 -2.017 . . . . 26.050000000000001 105.553 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 85' ' ' LEU . 82.5 t -85.01 155.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.8 0.81 . . . . 8.6799999999999997 111.934 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.428 ' N ' HG12 ' A' ' 72' ' ' VAL . 63.0 m-85 -145.42 90.79 2.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 14.07 110.566 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.01 112.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.731 -1.951 . . . . 9.3399999999999999 105.731 177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.85 -152.7 45.67 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.497 -2.641 . . . . 12.42 106.497 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -83.42 -0.67 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.534 -1.568 . . . . 44.859999999999999 109.09 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.541 ' CB ' ' HE ' ' A' ' 97' ' ' ARG . 7.4 m-20 -89.05 115.8 26.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.747 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 t -73.76 150.92 40.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.26 -26.82 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.194 -0.941 . . . . 20.449999999999999 109.592 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.91 -145.67 17.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.879 -1.288 . . . . 13.82 109.879 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.3 -144.18 10.93 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.998 -1.241 . . . . 12.42 109.998 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.03 -62.17 1.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.437 -1.037 . . . . 0.0 110.023 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -53.49 -25.53 16.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.446 -0.783 . . . . 0.0 109.572 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.38 -46.84 37.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.281 -0.887 . . . . 27.059999999999999 109.115 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.8 tt -54.55 -59.7 4.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.577 -0.702 . . . . 15.31 109.912 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -50.97 -48.72 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.796 . . . . 0.0 110.492 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 t -50.05 -43.44 51.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.833 -1.167 . . . . 21.789999999999999 109.292 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.2 -35.58 63.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.381 -0.824 . . . . 0.0 111.428 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -59.84 -61.47 2.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.87 -1.144 . . . . 0.0 110.274 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.536 ' NE2' ' C ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -62.07 -20.15 63.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 110.102 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.43 -22.77 35.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.92 66.33 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.437 -1.065 . . . . 25.640000000000001 110.437 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -68.49 -27.81 66.46 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.986 -1.303 . . . . 50.259999999999998 108.704 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.55 -64.64 0.87 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 24.170000000000002 110.311 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.575 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.83 -29.95 43.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.447 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.48 -47.06 83.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 28.030000000000001 108.357 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.657 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.46 -37.46 78.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.971 -1.122 . . . . 40.960000000000001 107.971 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.0 mp -72.07 -34.47 68.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.518 -0.919 . . . . 15.050000000000001 108.518 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -64.92 -57.6 8.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.784 -0.572 . . . . 0.0 111.737 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.66 -34.17 7.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.907 -1.121 . . . . 38.640000000000001 110.665 -178.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.5 pt -100.29 -11.66 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.816 -1.178 . . . . 0.0 109.331 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.94 41.56 22.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.229 -1.148 . . . . 18.539999999999999 110.229 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.04 54.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -1.197 . . . . 10.84 109.243 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 1.7 pp -97.59 -174.22 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 109.558 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.257 0.551 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.19 -74.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 20.030000000000001 110.617 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -73.26 -38.42 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 12.91 110.186 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 94.3 m-20 -55.98 -35.26 66.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.001 -1.062 . . . . 28.329999999999998 109.496 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -74.85 -13.07 60.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.906 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -97.4 -41.33 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 22.870000000000001 110.654 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -79.24 140.56 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.849 -1.157 . . . . 25.190000000000001 110.249 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -150.05 136.86 11.08 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.076 -1.083 . . . . 34.609999999999999 108.076 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.78 133.33 50.3 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 120.999 1.133 . . . . 11.720000000000001 109.739 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 79.66 18.44 73.18 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.081 -1.608 . . . . 10.24 109.081 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -137.88 135.31 36.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -1.078 . . . . 25.359999999999999 109.489 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.53 134.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.293 -0.879 . . . . 10.890000000000001 109.744 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.87 140.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.335 -0.987 . . . . 15.82 108.335 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.66 127.87 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.217 -0.927 . . . . 8.9399999999999995 111.177 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.49 121.35 34.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.064 -1.087 . . . . 9.9299999999999997 108.064 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.3 pt -131.34 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.331 1.062 . . . . 10.619999999999999 111.337 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 21' ' ' THR . 4.4 mtmp? -146.31 91.19 5.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.8 Cg_exo -46.37 83.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.616 1.544 . . . . 24.579999999999998 110.484 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.4 m -177.78 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 34.82 108.395 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.85 125.74 41.1 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 21.460000000000001 109.765 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.24 -19.12 40.68 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.321 2.014 . . . . 13.859999999999999 112.605 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -69.9 -42.91 72.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.611 -1.306 . . . . 0.0 109.627 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -65.86 -34.29 77.8 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.07 -42.62 99.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.79 -0.819 . . . . 59.590000000000003 108.79 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.6 HH11 ' HG2' ' A' ' 27' ' ' ARG . 6.5 mtt-85 -53.57 -45.07 69.81 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.231 -0.918 . . . . 0.0 108.656 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -36.49 78.93 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 108.849 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 7.5 mt-30 -70.62 -44.02 68.08 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.694 0.759 . . . . 45.490000000000002 109.333 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -70.97 -36.47 72.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.652 -0.655 . . . . 34.969999999999999 111.177 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.52 -56.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.88 -1.138 . . . . 0.0 110.211 -178.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.834 HD23 HD12 ' A' ' 35' ' ' LEU . 1.9 mt -59.43 -21.3 59.79 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.757 -1.215 . . . . 17.280000000000001 109.254 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.654 -0.869 . . . . 24.109999999999999 108.654 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -92.82 -0.01 57.33 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.48 -0.762 . . . . 44.07 110.127 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.834 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -87.77 128.71 53.31 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.766 -1.209 . . . . 19.629999999999999 108.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.9 69.22 0.85 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.648 1.566 . . . . 21.539999999999999 109.417 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.4 mm -80.43 153.42 4.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.579 -0.701 . . . . 0.0 109.21 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -54.88 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.522 -0.736 . . . . 29.41 110.034 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.559 ' O ' ' O ' ' A' ' 38' ' ' LYS . 11.8 mt-30 -53.33 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.726 0.774 . . . . 0.0 111.036 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.85 54.67 0.75 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.079 -1.208 . . . . 15.27 110.079 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.13 -27.02 14.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.576 -0.955 . . . . 8.7799999999999994 109.3 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -97.09 131.73 43.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.762 -0.829 . . . . 7.1299999999999999 108.762 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.3 tt0 -141.23 173.07 11.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.85 . . . . 22.030000000000001 109.929 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.504 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 43.9 m-85 -135.35 111.75 9.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.349 -1.352 . . . . 16.329999999999998 107.349 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.74 104.9 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.872 . . . . 6.5800000000000001 111.971 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.8 m-20 -82.25 101.79 10.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.614 -0.884 . . . . 15.32 108.614 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 56' ' ' ILE . 21.4 pt -61.97 -1.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 10.92 111.256 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 t -93.5 -17.06 23.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 21.719999999999999 109.303 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.0 12.82 1.23 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 22.449999999999999 109.52 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 7.3 t -140.81 -17.08 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 25.629999999999999 109.674 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 50' ' ' THR . 6.3 t-20 81.14 -175.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.451 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 58.49 24.18 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 108.873 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 52' ' ' HIS . 3.6 p -43.32 -51.93 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.805 . . . . 18.870000000000001 110.292 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -53.81 -35.4 61.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 45.210000000000001 110.144 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.03 -44.89 87.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.057 -1.027 . . . . 33.020000000000003 109.753 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.41 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.2 mp -66.44 -53.9 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.019 . . . . 9.8399999999999999 109.647 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.53 -42.12 82.27 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.701 -1.222 . . . . 17.84 107.701 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.35 -33.67 63.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.067 -1.456 . . . . 18.84 107.067 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -77.35 -45.26 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.787 -0.82 . . . . 12.99 108.787 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -55.49 -38.11 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.962 -1.125 . . . . 14.609999999999999 107.962 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 4.2 tp-100 -59.09 -49.29 78.43 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.522 0.677 . . . . 40.450000000000003 109.44 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -66.37 -54.22 27.05 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 41.810000000000002 110.65 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.81 -36.0 81.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 21.77 111.442 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 12.9 p -105.59 -68.38 0.87 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.021 -1.049 . . . . 11.380000000000001 109.812 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 144.26 -41.25 1.12 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.7 -1.76 . . . . 14.789999999999999 108.7 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.58 142.45 29.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.553 -0.969 . . . . 17.809999999999999 109.855 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.426 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -109.86 26.93 10.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 29.760000000000002 107.992 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.49 168.07 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.946 0.879 . . . . 18.260000000000002 111.238 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.22 132.39 22.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.309 -1.367 . . . . 8.1999999999999993 107.309 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 82' ' ' SER . 23.1 Cg_endo -83.06 -167.52 5.64 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.616 1.007 . . . . 7.79 112.114 -0.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 91.77 2.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.716 -2.327 . . . . 26.050000000000001 104.716 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 79' ' ' ILE . 80.8 t -83.69 158.54 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.72 0.771 . . . . 8.6799999999999997 112.175 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.484 ' N ' HG12 ' A' ' 72' ' ' VAL . 65.6 m-85 -146.32 84.36 1.63 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.557 . . . . 14.07 111.55 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -70.7 114.43 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.885 -2.265 . . . . 9.3399999999999999 104.885 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -158.09 30.69 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 105.658 -2.977 . . . . 12.42 105.658 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -81.35 0.98 34.79 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.426 -1.632 . . . . 44.859999999999999 109.403 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -87.42 115.09 24.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 110.516 -179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -73.1 136.47 44.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.684 ' C ' HD12 ' A' ' 79' ' ' ILE . 2.8 pp -105.59 -7.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.159 -0.963 . . . . 20.449999999999999 109.281 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 115.34 -154.88 16.67 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.225 -1.15 . . . . 13.82 110.225 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 -141.52 12.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.34 -1.104 . . . . 12.42 110.34 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.2 p -71.42 -66.42 0.63 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.594 -0.944 . . . . 0.0 110.333 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 t -49.01 -29.39 4.83 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 109.358 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.56 -47.26 33.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.283 -0.886 . . . . 27.059999999999999 109.139 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.3 tt -54.58 -58.5 7.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 15.31 109.664 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.71 -49.0 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.383 -0.823 . . . . 0.0 110.526 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.535 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 6.5 m -45.29 -37.58 4.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.932 -1.105 . . . . 21.789999999999999 109.09 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.26 -38.77 34.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.453 -0.78 . . . . 0.0 111.84 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -59.95 -60.48 3.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.831 -1.168 . . . . 0.0 111.017 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 87' ' ' SER . 1.6 pp0? -58.65 -24.02 60.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 m -80.74 -57.0 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.69 -8.49 6.89 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.702 -1.359 . . . . 25.640000000000001 109.702 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -69.29 -26.42 64.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.313 -1.11 . . . . 50.259999999999998 108.566 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp -60.09 -65.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 24.170000000000002 110.599 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.61 -28.44 32.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.35 -47.85 77.79 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.442 -0.947 . . . . 28.030000000000001 108.442 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -58.18 -34.03 69.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.97 -1.122 . . . . 40.960000000000001 107.97 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -72.42 -40.82 66.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 15.050000000000001 109.292 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.97 -52.14 57.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.0 111.808 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -51.19 -33.14 26.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.819 -1.176 . . . . 38.640000000000001 111.114 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.1 pt -100.72 -14.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.0 43.49 7.56 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.354 -1.099 . . . . 18.539999999999999 110.354 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.25 -16.55 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.242 . . . . 10.84 109.839 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.64 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.4 179.11 5.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 109.771 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.685 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.78 -71.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.506 -0.746 . . . . 20.030000000000001 110.613 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -72.63 -37.97 57.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 12.91 110.108 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 69.4 m-20 -55.39 -38.42 68.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.184 -0.947 . . . . 28.329999999999998 109.521 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -74.14 -11.9 60.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.507 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 42.6 mttm -97.55 -45.03 6.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 22.870000000000001 110.47 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.63 139.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 25.190000000000001 109.56 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -149.81 136.17 10.61 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.213 -1.032 . . . . 34.609999999999999 108.213 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.45 124.75 15.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 120.752 0.968 . . . . 11.720000000000001 109.628 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.62 55.18 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.368 -1.493 . . . . 10.24 109.368 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 8' ' ' LYS . 25.0 ttpt -137.29 135.67 37.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.335 -1.097 . . . . 25.359999999999999 109.409 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.96 132.9 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.829 . . . . 10.890000000000001 109.403 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.48 139.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 15.82 108.805 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 18' ' ' ILE . 40.0 t -121.76 126.94 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 8.9399999999999995 110.794 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.08 120.01 33.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.604 -1.258 . . . . 9.9299999999999997 107.604 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 16' ' ' VAL . 46.1 pt -132.52 -174.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 122.615 1.198 . . . . 10.619999999999999 112.232 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mttm -141.54 95.09 7.29 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 105.558 -2.015 . . . . 38.729999999999997 105.558 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 21' ' ' THR . 14.0 Cg_exo -49.9 76.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.37 1.38 . . . . 24.579999999999998 110.834 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.656 ' N ' ' O ' ' A' ' 19' ' ' LYS . 87.8 m -172.0 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.228 -0.656 . . . . 34.82 109.228 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.79 124.64 47.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 21.460000000000001 110.266 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.12 -20.05 29.34 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.193 1.928 . . . . 13.859999999999999 112.872 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -66.9 -47.47 71.71 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.481 -1.387 . . . . 0.0 108.784 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' HG12 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -63.02 -36.22 82.85 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -60.59 -40.78 93.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.163 -1.051 . . . . 59.590000000000003 108.163 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -47.79 77.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.21 75.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.297 -0.877 . . . . 0.0 108.915 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.615 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 8.9 mt-30 -69.89 -40.98 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.59 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 68.8 mm-40 -69.33 -39.85 77.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.597 -0.689 . . . . 34.969999999999999 111.364 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.07 -55.93 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.882 -1.136 . . . . 0.0 110.947 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.637 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -56.75 -26.3 56.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.738 -1.226 . . . . 17.280000000000001 109.536 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -64.41 -26.94 68.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.16 -0.963 . . . . 24.109999999999999 109.02 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 1.1 mp0 -92.03 0.31 57.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 44.07 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' ILE . 18.7 mt -87.65 133.54 37.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.763 -1.21 . . . . 19.629999999999999 108.319 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.24 62.99 0.7 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.578 1.519 . . . . 21.539999999999999 109.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.0 mm -79.92 141.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -55.78 152.78 9.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.275 -0.891 . . . . 29.41 109.977 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 24.8 mp0 -57.08 141.15 46.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.436 0.636 . . . . 0.0 111.431 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.0 9.18 39.24 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.484 -0.76 . . . . 15.27 111.902 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -30.42 12.17 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.823 -1.399 . . . . 8.7799999999999994 109.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.8 tp -96.58 131.76 42.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.518 -0.739 . . . . 7.1299999999999999 109.543 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -141.85 171.43 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 22.030000000000001 109.444 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.615 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 39.3 m-85 -133.23 110.02 9.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.145 -1.428 . . . . 16.329999999999998 107.145 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.98 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.476 -0.765 . . . . 6.5800000000000001 111.434 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 3.8 m-20 -81.81 100.69 9.71 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.445 -0.946 . . . . 15.32 108.445 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 28.6 pt -62.41 1.92 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 10.92 110.734 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 46' ' ' ASP . 17.5 p -95.83 -23.17 17.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 21.719999999999999 109.04 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.13 9.62 2.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 22.449999999999999 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.2 t -137.05 -7.69 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.841 . . . . 25.629999999999999 109.404 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.574 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 69.6 -163.81 0.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 1.5 m-70 54.63 21.47 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.994 -1.066 . . . . 0.0 108.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -40.29 -59.91 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 18.870000000000001 110.739 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 7.9 m120 -54.18 -35.06 61.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 45.210000000000001 111.034 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.99 -46.36 88.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 33.020000000000003 109.963 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.2 mp -66.01 -53.18 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.979 -1.076 . . . . 9.8399999999999999 109.518 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -56.53 -44.44 80.82 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.566 -1.272 . . . . 17.84 107.566 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 24.9 m-20 -53.61 -33.03 53.57 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.977 -1.49 . . . . 18.84 106.977 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -78.64 -48.56 14.83 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.94 -0.763 . . . . 12.99 108.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.7 mt -52.02 -36.4 50.02 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.524 -1.287 . . . . 14.609999999999999 107.524 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.9 tp60 -61.96 -55.31 30.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.794 -0.817 . . . . 40.450000000000003 108.794 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -66.82 -39.19 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 41.810000000000002 109.678 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.2 tp -64.09 -45.62 87.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 21.77 109.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.636 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -117.64 -71.71 0.72 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.633 -0.667 . . . . 11.380000000000001 109.569 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.636 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 158.47 -34.26 0.5 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.317 -1.513 . . . . 14.789999999999999 109.317 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -95.93 137.13 35.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 17.809999999999999 110.019 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.88 30.19 7.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.066 -1.087 . . . . 29.760000000000002 108.066 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.33 171.04 11.51 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.926 0.869 . . . . 18.260000000000002 111.501 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 ' OG ' ' A' ' 25' ' ' SER . 5.3 t -115.26 132.12 23.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.494 -1.299 . . . . 8.1999999999999993 107.494 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.741 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 28.5 Cg_endo -81.04 -164.84 4.09 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 CA-C-O 122.032 0.763 . . . . 7.79 110.925 0.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.741 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -150.81 93.25 1.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.376 -2.083 . . . . 26.050000000000001 105.376 177.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' A' ' 79' ' ' ILE . 94.1 t -85.61 156.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.827 0.822 . . . . 8.6799999999999997 112.352 -175.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.0 m-85 -145.37 92.92 2.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.875 -0.516 . . . . 14.07 110.606 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 98' ' ' LEU . 8.4 mm -72.43 113.74 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.832 -1.914 . . . . 9.3399999999999999 105.832 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.58 -145.62 42.26 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 106.622 -2.591 . . . . 12.42 106.622 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -87.56 -3.48 58.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.677 -1.484 . . . . 44.859999999999999 109.5 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.36 116.47 25.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.221 -0.924 . . . . 0.0 110.619 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -75.77 143.97 41.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.778 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.7 pp -113.43 -18.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.189 -0.944 . . . . 20.449999999999999 109.335 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.43 -159.2 19.96 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.109 -1.196 . . . . 13.82 110.109 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -92.51 -143.7 12.98 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.391 -1.064 . . . . 12.42 110.655 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.417 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 t -71.33 -62.63 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -1.015 . . . . 0.0 110.383 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 t -51.0 -24.99 4.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.359 -0.838 . . . . 0.0 109.189 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -76.05 -45.52 33.81 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 27.059999999999999 109.219 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.572 ' O ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt -55.0 -58.41 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 15.31 109.829 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -52.06 -52.3 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 111.003 -178.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' VAL . 5.0 t -44.84 -38.99 4.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.059 -1.025 . . . . 21.789999999999999 109.251 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.84 -41.5 23.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.545 -0.722 . . . . 0.0 111.631 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -55.83 29.53 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.868 -1.145 . . . . 0.0 110.398 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -62.1 -25.49 67.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.944 -1.098 . . . . 0.0 109.452 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.9 m -77.98 -62.22 1.74 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.419 -0.8 . . . . 0.0 109.024 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -9.25 5.53 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.09 -1.204 . . . . 25.640000000000001 110.09 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.22 -24.36 64.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.117 -1.225 . . . . 50.259999999999998 108.177 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.61 -67.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.638 -0.664 . . . . 24.170000000000002 110.47 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -51.58 -28.99 15.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.22 -49.18 70.69 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.074 -1.084 . . . . 28.030000000000001 108.074 178.202 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.5 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.68 -34.65 67.59 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.926 -1.139 . . . . 40.960000000000001 107.926 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 74' ' ' ILE . 8.3 mp -72.89 -38.52 66.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.479 -0.934 . . . . 15.050000000000001 108.479 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -64.49 -53.64 44.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.576 . . . . 0.0 111.555 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.14 -34.87 23.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 38.640000000000001 110.76 -178.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.58 -15.3 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.69 -1.256 . . . . 0.0 109.007 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.66 44.39 8.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.588 -1.005 . . . . 18.539999999999999 110.588 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.45 55.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -1.219 . . . . 10.84 109.87 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.649 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -95.79 -177.55 4.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.783 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.5 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.205 0.526 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.26 -73.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 20.030000000000001 110.572 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -72.94 -37.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 12.91 109.884 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 18.0 m120 -55.73 -38.34 69.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.184 -0.948 . . . . 28.329999999999998 109.301 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 m -74.18 -10.03 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -95.96 -53.5 3.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 22.870000000000001 109.627 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -79.57 128.11 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.844 . . . . 25.190000000000001 110.067 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HA ' ' HZ3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.36 155.67 39.45 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.072 -1.084 . . . . 34.609999999999999 108.072 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.56 130.06 38.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.895 1.73 . . . . 11.720000000000001 111.537 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.89 64.4 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.874 -0.89 . . . . 10.24 110.874 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -142.47 133.33 25.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.351 . . . . 25.359999999999999 109.928 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.23 136.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.890000000000001 109.037 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.79 144.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 15.82 108.55 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.66 126.88 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 8.9399999999999995 110.77 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -92.68 123.91 36.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 9.9299999999999997 107.571 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.92 -176.43 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.383 1.087 . . . . 10.619999999999999 111.342 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 21' ' ' THR . 14.6 mtmm -143.32 92.73 6.61 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.385 -1.709 . . . . 38.729999999999997 106.385 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' C ' ' OG1' ' A' ' 21' ' ' THR . 12.2 Cg_exo -47.79 82.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.629 1.553 . . . . 24.579999999999998 110.442 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 179.1 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.025 -0.731 . . . . 34.82 109.025 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 130.63 28.4 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 21.460000000000001 110.266 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -59.69 -20.33 57.77 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.393 2.062 . . . . 13.859999999999999 112.654 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -70.37 -43.96 69.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.533 -1.355 . . . . 0.0 109.622 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -32.37 74.01 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.3 mmm-85 -64.04 -43.71 94.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.643 -0.873 . . . . 59.590000000000003 108.643 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 2.1 mtt-85 -51.75 -45.46 63.69 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.0 83.55 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -70.21 -42.15 72.71 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.43 -0.794 . . . . 45.490000000000002 109.296 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.74 -38.36 76.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.683 . . . . 34.969999999999999 111.078 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.81 -58.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 35' ' ' LEU . 1.8 mt -57.71 -21.46 40.84 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.512 -1.367 . . . . 17.280000000000001 109.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -65.94 -24.96 66.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.052 -1.03 . . . . 24.109999999999999 108.769 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -91.32 1.38 57.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 44.07 110.191 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -90.48 126.78 55.19 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.903 -1.123 . . . . 19.629999999999999 109.163 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.55 67.64 0.76 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.773 1.648 . . . . 21.539999999999999 109.66 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.16 150.66 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.406 -0.809 . . . . 0.0 108.907 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 39' ' ' GLN . 30.0 mttm -53.47 -169.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.85 . . . . 29.41 110.309 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 38' ' ' LYS . 56.6 mm-40 -51.52 -127.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.529 0.681 . . . . 0.0 111.344 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.37 53.18 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.421 -1.072 . . . . 15.27 110.421 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -101.08 -23.33 14.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -1.045 . . . . 8.7799999999999994 108.942 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.0 tp -102.73 131.89 49.25 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.565 -0.902 . . . . 7.1299999999999999 108.565 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 25.9 tt0 -141.5 173.9 11.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.305 -0.872 . . . . 22.030000000000001 110.04 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.512 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 38.5 m-85 -135.22 109.84 8.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.57 -1.27 . . . . 16.329999999999998 107.57 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.58 103.49 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.096 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.98 101.5 9.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.219 -0.925 . . . . 15.32 108.731 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.3 -2.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.089 -1.007 . . . . 10.92 110.237 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' THR . 10.5 p -96.28 -29.79 13.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 21.719999999999999 109.346 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.55 18.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 22.449999999999999 109.273 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.519 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 10.7 t -140.5 -13.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -0.88 . . . . 25.629999999999999 109.91 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' CG ' ' N ' ' A' ' 52' ' ' HIS . 0.5 OUTLIER 78.7 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.545 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 2.4 m170 53.61 12.32 0.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.702 -1.249 . . . . 0.0 108.406 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -35.97 -67.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.718 -0.614 . . . . 18.870000000000001 111.077 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -53.96 -31.51 50.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.227 -0.921 . . . . 45.210000000000001 111.067 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' OE1' ' CE1' ' A' ' 52' ' ' HIS . 57.4 mt-10 -65.26 -46.61 79.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.041 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.44 -53.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.952 -1.092 . . . . 9.8399999999999999 109.453 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -57.27 -43.43 83.08 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.824 -1.176 . . . . 17.84 107.824 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -54.78 -33.84 61.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.217 -1.401 . . . . 18.84 107.217 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -78.8 -49.21 13.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.969 -0.692 . . . . 12.99 109.136 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.06 -32.89 49.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.434 -0.951 . . . . 14.609999999999999 108.434 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.677 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.7 tp60 -59.77 -53.89 52.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.675 -0.641 . . . . 40.450000000000003 109.385 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -66.92 -48.25 69.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 41.810000000000002 111.031 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.62 -39.02 92.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 21.77 110.554 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 10.5 p -106.49 -66.67 0.99 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.32 -0.862 . . . . 11.380000000000001 109.912 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 143.48 -42.15 1.1 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.694 -1.763 . . . . 14.789999999999999 108.694 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.22 136.62 38.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -1.02 . . . . 17.809999999999999 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -102.44 25.42 9.04 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.313 -0.995 . . . . 29.760000000000002 108.313 179.06 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.805 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -83.02 169.45 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.67 . . . . 18.260000000000002 110.354 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.49 HG21 ' NZ ' ' A' ' 19' ' ' LYS . 10.9 t -113.67 138.53 22.68 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 107.916 -1.142 . . . . 8.1999999999999993 107.916 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 82' ' ' SER . 30.6 Cg_endo -84.95 -165.92 4.05 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 CA-C-O 122.299 0.875 . . . . 7.79 111.203 -0.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.805 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -143.41 92.77 2.4 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.131 -2.174 . . . . 26.050000000000001 105.131 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 79' ' ' ILE . 77.2 t -83.63 156.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.877 . . . . 8.6799999999999997 111.387 -176.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' N ' HG12 ' A' ' 72' ' ' VAL . 74.3 m-85 -146.22 92.05 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.635 -0.666 . . . . 14.07 111.105 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -72.97 106.32 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.598 -2.001 . . . . 9.3399999999999999 105.598 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.96 -152.1 46.81 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 105.793 -2.923 . . . . 12.42 105.793 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HZ3' ' HA ' ' A' ' 10' ' ' GLN . 31.8 mttm -81.76 4.06 23.46 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.388 -1.654 . . . . 44.859999999999999 108.507 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.683 ' CB ' HH21 ' A' ' 97' ' ' ARG . 23.6 m-20 -89.63 108.96 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.0 110.754 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 t -74.44 141.99 44.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.8 pp -111.29 -13.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 20.449999999999999 109.443 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.96 -163.89 15.24 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.309 -1.117 . . . . 13.82 110.309 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 84' ' ' ASP . . . -86.58 -146.26 9.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.23 -1.148 . . . . 12.42 110.23 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -72.61 -59.7 2.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.553 -0.969 . . . . 0.0 110.049 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -50.24 -26.48 4.75 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 108.922 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 81' ' ' GLY . 16.7 m-20 -75.23 -47.81 26.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.526 -0.734 . . . . 27.059999999999999 109.09 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 tt -53.89 -59.15 5.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 15.31 109.776 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.603 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -52.35 -50.73 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 110.539 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.5 t -46.26 -41.54 13.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 21.789999999999999 109.869 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.85 -40.08 55.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 112.173 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -59.27 -59.5 5.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.646 -1.284 . . . . 0.0 110.858 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -57.96 -22.69 50.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.333 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 m -79.82 -60.09 2.48 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 109.119 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 -11.72 6.46 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.62 -1.392 . . . . 25.640000000000001 109.62 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 96' ' ' THR . 36.7 tp10 -69.24 -25.58 64.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -1.163 . . . . 50.259999999999998 108.994 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.3 tp -58.48 -64.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.356 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -52.61 -27.41 16.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -63.57 -48.2 78.4 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.425 -0.91 . . . . 28.030000000000001 108.784 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.683 HH21 ' CB ' ' A' ' 77' ' ' ASP . 22.0 mmm180 -58.73 -34.28 71.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.052 . . . . 40.960000000000001 108.17 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 mp -70.6 -39.68 73.65 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.805 -0.813 . . . . 15.050000000000001 108.805 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -66.03 -53.83 33.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.767 -0.583 . . . . 0.0 111.941 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -49.47 -33.36 14.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.207 . . . . 38.640000000000001 110.612 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.22 -13.23 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.697 -1.252 . . . . 0.0 109.331 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 46.42 8.91 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.549 -1.02 . . . . 18.539999999999999 110.549 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.07 -14.47 41.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -1.16 . . . . 10.84 109.586 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.659 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -95.48 174.61 6.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 109.951 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.649 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.57 -72.91 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.78 . . . . 20.030000000000001 110.018 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.7 m -73.62 -40.32 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 12.91 110.126 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.463 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 73.8 m-20 -56.08 -27.23 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.201 -0.937 . . . . 28.329999999999998 110.399 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 m -74.71 -21.7 59.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.08 -1.012 . . . . 0.0 110.528 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -97.58 -45.36 6.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.973 -1.079 . . . . 22.870000000000001 111.293 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.39 129.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.014 -1.054 . . . . 25.190000000000001 110.123 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -146.79 153.05 45.91 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 34.609999999999999 108.664 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.03 122.86 12.56 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.218 1.279 . . . . 11.720000000000001 109.963 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 84.0 24.32 49.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.83 -1.308 . . . . 10.24 109.83 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -139.23 134.58 32.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -1.145 . . . . 25.359999999999999 109.232 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.02 137.36 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 10.890000000000001 110.11 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -145.51 153.06 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.499 -0.926 . . . . 15.82 108.499 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.94 121.65 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.234 -0.916 . . . . 8.9399999999999995 110.629 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.98 121.1 31.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.201 -1.407 . . . . 9.9299999999999997 107.201 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 70' ' ' PRO . 34.2 pt -133.48 -168.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.472 1.129 . . . . 10.619999999999999 111.872 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.636 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.2 mtmt -145.59 96.65 4.75 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 106.205 -1.776 . . . . 38.729999999999997 106.205 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.496 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.4 Cg_exo -51.82 74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.379 1.386 . . . . 24.579999999999998 110.736 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.636 ' N ' ' O ' ' A' ' 19' ' ' LYS . 11.5 m -171.32 -32.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.919 -0.771 . . . . 34.82 108.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.22 128.57 34.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 21.460000000000001 110.074 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.82 -13.28 25.85 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.162 1.908 . . . . 13.859999999999999 112.118 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -71.34 -47.5 56.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.709 -1.244 . . . . 0.0 109.706 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -28.39 70.01 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.015 -1.053 . . . . 0.0 108.9 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -61.27 -42.64 98.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.29 -1.004 . . . . 59.590000000000003 108.29 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -54.24 -49.14 70.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.176 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -37.43 75.46 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.878 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 4.6 mt-30 -70.54 -42.15 71.59 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.333 -0.854 . . . . 45.490000000000002 109.618 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.77 -37.33 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.386 -0.821 . . . . 34.969999999999999 111.02 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.681 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.28 -57.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.99 -1.069 . . . . 0.0 110.197 -178.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.663 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -55.38 -24.62 30.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 17.280000000000001 109.394 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -65.28 -27.9 68.96 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.119 -0.988 . . . . 24.109999999999999 108.489 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -90.89 3.66 53.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.812 . . . . 44.07 110.286 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 35' ' ' LEU . 20.0 mt -91.83 131.5 35.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.795 -1.191 . . . . 19.629999999999999 109.257 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.88 64.61 0.43 Allowed 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.707 1.605 . . . . 21.539999999999999 110.31 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.8 mm -82.25 149.05 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 108.887 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.4 mmmt -53.22 -174.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 29.41 110.057 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.563 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 24.1 mp0 -52.32 -121.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.674 -0.641 . . . . 0.0 111.123 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 48.31 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.402 -0.904 . . . . 15.27 110.866 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -100.81 -18.26 16.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.241 -1.152 . . . . 8.7799999999999994 109.372 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -105.56 126.7 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 7.1299999999999999 108.83 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 36.7 tt0 -140.4 164.97 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 22.030000000000001 109.689 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.487 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 23.3 m-85 -126.45 114.91 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.593 -1.262 . . . . 16.329999999999998 107.593 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.87 102.06 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 6.5800000000000001 111.131 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 48' ' ' THR . 7.4 m-20 -80.44 100.06 8.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.478 -1.304 . . . . 15.32 107.478 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CG2' HG21 ' A' ' 56' ' ' ILE . 14.6 pt -61.17 2.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 10.92 110.749 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 46' ' ' ASP . 5.1 t -94.88 -20.24 19.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.999 -1.063 . . . . 21.719999999999999 109.086 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.58 13.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 22.449999999999999 109.309 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.1 t -140.69 -14.71 0.94 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.22 -0.925 . . . . 25.629999999999999 109.902 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 50' ' ' THR . 1.1 m-20 78.97 -176.19 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.8 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.403 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER 57.76 30.16 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 109.089 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 p -44.69 -54.12 6.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 18.870000000000001 109.906 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.0 m-20 -54.15 -37.32 64.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 45.210000000000001 110.732 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -62.24 -46.58 88.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.112 . . . . 33.020000000000003 109.636 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.7 mp -65.9 -55.7 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.969 -1.082 . . . . 9.8399999999999999 109.59 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -56.69 -40.45 75.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.694 -1.254 . . . . 17.84 107.878 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 22.9 m-20 -55.04 -32.53 61.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.015 -1.476 . . . . 18.84 107.015 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -78.8 -47.94 15.74 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.766 -0.827 . . . . 12.99 108.766 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -54.53 -33.59 60.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.375 -0.972 . . . . 14.609999999999999 108.375 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.638 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.2 tp-100 -59.25 -55.78 30.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.751 -0.593 . . . . 40.450000000000003 109.8 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.7 -50.42 62.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.028 -1.045 . . . . 41.810000000000002 111.106 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.06 -34.83 78.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.867 -1.146 . . . . 21.77 110.657 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.6 p -110.74 -70.44 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.306 -0.871 . . . . 11.380000000000001 109.915 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.638 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 147.04 -41.85 0.94 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.606 -1.798 . . . . 14.789999999999999 108.606 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.22 140.39 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.436 -1.037 . . . . 17.809999999999999 110.047 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -109.85 24.43 13.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.192 -1.04 . . . . 29.760000000000002 108.192 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.95 174.1 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.923 0.868 . . . . 18.260000000000002 110.935 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.61 134.33 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.454 -1.313 . . . . 8.1999999999999993 107.454 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -80.7 -163.93 3.62 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 CA-C-O 122.245 0.852 . . . . 7.79 111.257 0.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 91.74 1.89 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.296 -2.113 . . . . 26.050000000000001 105.296 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 85' ' ' LEU . 92.2 t -84.65 157.81 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.822 0.82 . . . . 8.6799999999999997 112.185 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 72' ' ' VAL . 57.6 m-85 -145.22 88.28 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.801 -0.562 . . . . 14.07 110.624 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.598 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.0 109.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.469 -2.048 . . . . 9.3399999999999999 105.469 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.57 -154.64 52.1 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.036 -2.826 . . . . 12.42 106.036 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -84.51 0.2 50.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.354 -1.674 . . . . 44.859999999999999 108.934 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.7 114.91 25.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -71.69 149.45 45.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.366 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.0 -23.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.95 . . . . 20.449999999999999 109.342 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.64 -142.71 14.08 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.948 -1.261 . . . . 13.82 109.948 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -111.06 -144.19 9.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.898 -1.281 . . . . 12.42 109.898 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -71.04 -61.12 1.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -1.003 . . . . 0.0 109.801 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.9 t -52.99 -26.27 14.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.5 m-20 -73.53 -48.33 33.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.345 -0.847 . . . . 27.059999999999999 109.236 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.76 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.382 -0.824 . . . . 15.31 109.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.42 -49.43 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 0.0 110.015 -178.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -49.5 -41.32 40.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 21.789999999999999 109.357 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt -75.46 -36.67 60.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 111.253 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 -62.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.995 -1.066 . . . . 0.0 110.644 -178.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -61.19 -16.61 46.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.949 -1.095 . . . . 0.0 109.971 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.675 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 13.5 m -85.25 -18.61 33.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.891 . . . . 0.0 109.425 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.79 -13.49 52.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.891 -1.283 . . . . 25.640000000000001 109.891 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.55 -26.76 65.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.149 -1.207 . . . . 50.259999999999998 108.966 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.95 -63.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 24.170000000000002 110.157 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.1 -31.31 41.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.1 m -63.56 -43.99 95.46 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.696 -1.224 . . . . 28.030000000000001 107.696 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -60.0 -35.65 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.403 -0.962 . . . . 40.960000000000001 108.403 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.9 mp -71.18 -40.23 71.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.445 -0.784 . . . . 15.050000000000001 109.237 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -65.08 -53.53 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 112.29 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -47.57 -31.54 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.728 -1.233 . . . . 38.640000000000001 110.503 -177.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 pt -104.17 -14.18 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.918 -1.114 . . . . 0.0 109.649 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.26 41.94 11.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.433 -1.067 . . . . 18.539999999999999 110.433 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.13 -12.32 53.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 10.84 109.561 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.62 -174.82 3.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.389 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.91 -70.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 20.030000000000001 110.25 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -73.1 -40.34 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 12.91 110.097 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 8.6 m-20 -54.79 -38.27 67.09 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.073 -1.017 . . . . 28.329999999999998 109.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -74.72 -12.35 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.212 -0.93 . . . . 0.0 109.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -97.24 -46.8 5.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.206 -0.934 . . . . 22.870000000000001 110.608 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.1 135.09 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.776 -1.202 . . . . 25.190000000000001 109.385 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.49 150.36 40.25 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.715 -0.846 . . . . 34.609999999999999 108.715 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.39 124.37 15.91 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.41 1.407 . . . . 11.720000000000001 110.021 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.08 28.45 45.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.764 -1.334 . . . . 10.24 109.764 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -140.91 137.22 32.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 25.359999999999999 109.761 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.63 135.05 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.382 -0.824 . . . . 10.890000000000001 109.643 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.42 141.39 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.048 . . . . 15.82 108.172 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 t -124.19 127.28 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 8.9399999999999995 111.078 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.84 121.04 34.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.24 -1.393 . . . . 9.9299999999999997 107.24 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 70' ' ' PRO . 28.0 pt -131.14 -176.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.361 1.077 . . . . 10.619999999999999 111.254 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.5 mtmt -143.9 91.81 6.51 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.1 Cg_exo -47.18 78.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.892 1.728 . . . . 24.579999999999998 111.05 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' LYS . 88.2 m -174.1 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.852 -0.796 . . . . 34.82 108.852 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.75 130.04 29.95 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 21.460000000000001 109.857 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -57.94 -21.59 50.37 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.277 1.985 . . . . 13.859999999999999 112.209 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -70.43 -38.18 74.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.635 -1.291 . . . . 0.0 108.523 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -36.63 82.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.672 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -64.08 -40.53 96.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.918 -0.771 . . . . 59.590000000000003 108.918 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.9 OUTLIER -53.66 -48.84 69.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.433 -0.792 . . . . 0.0 109.291 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.52 72.98 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.372 -0.83 . . . . 0.0 109.161 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 4.1 mt-30 -70.57 -43.39 69.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.375 -0.828 . . . . 45.490000000000002 109.477 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.6 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 22.0 mm-40 -71.13 -35.78 71.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.554 -0.716 . . . . 34.969999999999999 111.256 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.48 -58.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 110.478 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.826 HD23 HD12 ' A' ' 35' ' ' LEU . 2.9 mt -58.99 -17.98 29.95 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.563 -1.336 . . . . 17.280000000000001 109.634 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 t -65.87 -29.93 70.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 24.109999999999999 109.037 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.6 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 1.2 mp0 -91.72 5.88 48.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 44.07 110.49 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.826 HD12 HD23 ' A' ' 32' ' ' LEU . 15.9 mt -90.56 127.98 50.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.758 -1.213 . . . . 19.629999999999999 109.304 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.43 68.99 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.8 1.666 . . . . 21.539999999999999 109.94 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.6 mm -82.13 150.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.416 -0.802 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 39' ' ' GLN . 1.5 mmmm -54.68 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.466 -0.771 . . . . 29.41 110.392 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.599 ' O ' ' O ' ' A' ' 38' ' ' LYS . 91.1 mm-40 -52.61 -137.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.618 0.723 . . . . 0.0 110.884 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.27 52.82 0.09 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.107 -1.197 . . . . 15.27 110.107 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -98.52 -20.28 17.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -1.048 . . . . 8.7799999999999994 109.151 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -103.54 129.7 50.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.632 -0.877 . . . . 7.1299999999999999 108.632 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.9 tp10 -142.13 164.89 28.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.995 . . . . 22.030000000000001 109.955 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.481 ' CG ' ' OE1' ' A' ' 29' ' ' GLN . 56.5 m-85 -125.96 111.75 15.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.319 -1.363 . . . . 16.329999999999998 107.319 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -94.47 101.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 6.5800000000000001 111.305 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.16 101.42 9.65 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.873 . . . . 15.32 108.644 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.12 -6.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 10.92 109.251 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 p -96.92 43.08 1.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.332 -0.988 . . . . 21.719999999999999 108.332 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.14 14.09 0.45 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 22.449999999999999 107.801 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -139.49 -2.94 1.54 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.19 -1.041 . . . . 25.629999999999999 108.19 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.7 OUTLIER 70.21 -176.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.806 178.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.3 m80 53.61 18.06 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.007 -1.058 . . . . 0.0 108.552 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -32.96 -55.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.403 0.621 . . . . 18.870000000000001 110.861 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -57.85 -33.3 68.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 45.210000000000001 111.275 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' HIS . 73.2 mm-40 -63.45 -43.7 96.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.829 -1.17 . . . . 33.020000000000003 109.925 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.8 -56.76 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.983 -1.073 . . . . 9.8399999999999999 109.581 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -54.9 -43.06 72.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.555 -1.276 . . . . 17.84 107.555 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.28 -33.61 65.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.41 -1.33 . . . . 18.84 107.41 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -76.6 -47.33 22.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 12.99 108.732 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.0 mt -54.78 -36.5 64.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.901 -1.148 . . . . 14.609999999999999 107.901 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 18.2 tp60 -59.67 -52.37 65.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.266 0.555 . . . . 40.450000000000003 110.045 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.0 -51.0 66.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 41.810000000000002 110.839 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.94 -32.43 73.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.086 -1.009 . . . . 21.77 110.721 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.3 p -110.06 -74.05 0.66 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 11.380000000000001 109.53 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.22 -37.86 1.05 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.985 -1.646 . . . . 14.789999999999999 108.985 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -102.68 134.74 45.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -1.002 . . . . 17.809999999999999 109.908 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -105.44 32.5 4.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.538 -0.912 . . . . 29.760000000000002 108.538 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 167.72 19.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 18.260000000000002 110.294 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.55 134.5 21.98 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.288 -1.004 . . . . 8.1999999999999993 108.288 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.5 Cg_endo -86.08 -170.62 7.0 Favored 'Cis proline' 0 C--N 1.309 -1.513 0 C-N-CA 124.83 -0.904 . . . . 7.79 110.119 -0.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.732 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.08 102.78 4.94 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.54 -2.022 . . . . 26.050000000000001 105.54 176.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 85' ' ' LEU . 98.1 t -90.07 159.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 8.6799999999999997 111.763 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.8 m-85 -146.21 90.92 2.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.623 -0.673 . . . . 14.07 110.836 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -72.65 112.97 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.801 -1.926 . . . . 9.3399999999999999 105.801 177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.87 -152.47 39.55 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.401 -2.679 . . . . 12.42 106.401 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -83.37 -0.16 48.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.514 -1.58 . . . . 44.859999999999999 108.708 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' HB3' HH21 ' A' ' 97' ' ' ARG . 5.7 m-20 -89.45 115.05 26.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 0.0 110.599 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 t -73.71 150.71 41.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 109.449 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.98 -22.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 20.449999999999999 109.225 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.22 -146.75 18.39 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.581 -1.408 . . . . 13.82 109.581 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -102.19 -149.2 21.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.604 -1.398 . . . . 12.42 109.604 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -71.26 -59.47 2.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -1.181 . . . . 0.0 109.657 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -50.27 -27.31 5.85 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 -46.85 32.15 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.853 -0.795 . . . . 27.059999999999999 108.853 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 72' ' ' VAL . 5.0 tt -55.3 -59.78 4.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.581 -0.699 . . . . 15.31 110.353 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.53 -49.08 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.419 -0.8 . . . . 0.0 110.472 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.33 36.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.875 -1.141 . . . . 21.789999999999999 109.564 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 mt -74.1 -38.04 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 111.988 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.419 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -60.3 -59.11 5.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -178.141 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -60.47 -24.45 65.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.003 -1.061 . . . . 0.0 109.664 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.0 m -80.76 -24.63 38.53 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.443 -0.786 . . . . 0.0 109.378 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.14 -9.61 76.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.32 -1.112 . . . . 25.640000000000001 110.32 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.71 -26.53 65.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.046 -1.267 . . . . 50.259999999999998 108.872 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 tp -59.53 -64.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 24.170000000000002 110.605 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.27 -31.12 42.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -63.67 -46.38 85.86 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 178.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' A' ' 77' ' ' ASP . 9.6 tpt180 -58.81 -38.32 78.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.294 -1.002 . . . . 40.960000000000001 108.294 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.32 -36.19 71.5 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.657 -0.868 . . . . 15.050000000000001 108.657 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -65.87 -54.65 23.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.706 -0.621 . . . . 0.0 111.974 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -50.21 -33.17 18.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.163 . . . . 38.640000000000001 110.908 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -100.12 -11.44 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.778 -1.201 . . . . 0.0 109.409 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.15 40.63 15.82 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.462 -1.055 . . . . 18.539999999999999 110.462 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.46 -20.49 29.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.136 -1.214 . . . . 10.84 109.3 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.3 pp -96.18 -175.87 3.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 104' ' ' LEU . 49.0 mt-30 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.49 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.32 -68.28 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.406 -0.809 . . . . 20.030000000000001 110.214 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.68 -39.81 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 12.91 110.244 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 6.8 m-20 -55.64 -34.96 65.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.12 -0.987 . . . . 28.329999999999998 109.043 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.4 m -74.63 -12.73 60.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -96.66 -48.32 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 22.870000000000001 109.848 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.51 132.06 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 25.190000000000001 109.635 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.91 157.25 34.38 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.132 -1.062 . . . . 34.609999999999999 108.132 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.28 130.62 36.43 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.708 1.605 . . . . 11.720000000000001 111.312 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.73 28.18 65.64 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 120.408 -0.901 . . . . 10.24 110.944 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -140.62 132.85 28.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.316 . . . . 25.359999999999999 109.7 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.36 136.86 31.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.379 -0.825 . . . . 10.890000000000001 109.263 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.67 142.37 23.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.564 -0.902 . . . . 15.82 108.564 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 45' ' ' VAL . 40.5 t -125.63 125.92 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 8.9399999999999995 110.968 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -93.79 121.89 35.7 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.903 -1.147 . . . . 9.9299999999999997 107.903 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.3 pt -131.07 -175.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.613 1.197 . . . . 10.619999999999999 111.839 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 21' ' ' THR . 39.2 mttm -140.92 97.39 7.11 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 105.166 -2.161 . . . . 38.729999999999997 105.166 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 21' ' ' THR . 10.3 Cg_exo -51.12 71.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.441 1.427 . . . . 24.579999999999998 110.895 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 19' ' ' LYS . 24.7 m -170.03 -32.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.185 -0.947 . . . . 34.82 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.32 133.17 24.19 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 21.460000000000001 109.882 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.46 -24.11 77.01 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 122.411 2.074 . . . . 13.859999999999999 112.991 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -67.23 -47.87 69.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.366 -1.458 . . . . 0.0 109.921 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -33.8 72.05 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -61.75 -42.24 98.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.548 -0.908 . . . . 59.590000000000003 108.548 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 27' ' ' ARG . 7.4 mtt-85 -56.15 -45.06 79.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 109.077 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.17 76.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.029 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -70.33 -41.16 73.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.488 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.603 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 55.4 mm-40 -72.4 -39.08 68.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.614 -0.679 . . . . 34.969999999999999 111.64 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.676 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.91 -56.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.766 -1.209 . . . . 0.0 109.769 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.659 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -60.81 -19.01 58.81 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.577 -1.327 . . . . 17.280000000000001 109.536 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -66.54 -27.7 67.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.039 -1.038 . . . . 24.109999999999999 108.706 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -91.53 -0.07 57.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 44.07 110.393 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 32' ' ' LEU . 15.7 mt -87.8 129.69 49.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.771 -1.206 . . . . 19.629999999999999 108.626 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.8 67.11 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.441 1.427 . . . . 21.539999999999999 109.451 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.9 mm -76.97 150.65 5.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.154 -0.966 . . . . 0.0 108.64 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' GLN . 6.9 mmmt -52.75 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 29.41 110.557 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' LYS . 90.5 mt-30 -52.03 -124.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.628 0.728 . . . . 0.0 111.88 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.25 48.62 1.17 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.425 -1.07 . . . . 15.27 110.425 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -33.92 12.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -1.094 . . . . 8.7799999999999994 109.201 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 37' ' ' ILE . 66.0 tp -92.83 133.79 35.72 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.544 0.688 . . . . 7.1299999999999999 109.472 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.0 tt0 -143.57 174.05 11.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.471 -0.768 . . . . 22.030000000000001 109.055 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.518 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.7 m-85 -136.82 109.62 7.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.084 -1.45 . . . . 16.329999999999998 107.084 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 16' ' ' VAL . 78.0 t -95.0 107.13 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 6.5800000000000001 111.967 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.5 m-20 -82.45 100.06 9.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.595 -0.891 . . . . 15.32 108.595 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.63 2.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 10.92 111.145 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -94.97 -31.0 13.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.873 -1.142 . . . . 21.719999999999999 108.395 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.47 22.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.48 -0.762 . . . . 22.449999999999999 109.658 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.1 t -141.22 -2.47 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.134 -0.978 . . . . 25.629999999999999 109.996 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 4.5 m-20 65.25 -168.6 0.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.492 -0.755 . . . . 0.0 109.994 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 51.37 19.14 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.481 HG22 ' NZ ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -35.68 -62.2 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.727 -0.608 . . . . 18.870000000000001 110.78 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.5 m120 -56.13 -36.74 68.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 45.210000000000001 110.805 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 1.1 mp0 -61.83 -44.57 96.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.937 -1.102 . . . . 33.020000000000003 109.912 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.32 -54.18 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.666 -1.271 . . . . 9.8399999999999999 109.627 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -56.91 -44.91 82.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.566 -1.334 . . . . 17.84 107.765 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.97 -34.72 57.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 18.84 107.284 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -78.36 -46.88 18.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.87 -0.732 . . . . 12.99 109.218 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.3 mt -52.59 -38.29 59.76 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.116 -1.068 . . . . 14.609999999999999 108.116 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 15.1 tp60 -57.17 -55.54 33.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.641 -0.874 . . . . 40.450000000000003 108.641 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.08 -29.16 68.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.848 . . . . 41.810000000000002 109.585 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 63' ' ' LEU . 2.0 tt -64.5 -68.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.951 . . . . 21.77 109.792 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -52.95 2.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.801 -0.562 . . . . 11.380000000000001 109.721 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' A' ' 61' ' ' GLN . . . 152.72 -42.93 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.051 -1.547 . . . . 14.789999999999999 111.128 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . . . -96.48 144.62 26.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.839 -1.389 . . . . 17.809999999999999 110.69 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.55 23.89 13.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.55 -0.907 . . . . 29.760000000000002 108.55 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.754 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.38 170.03 15.77 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 18.260000000000002 110.589 -178.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.18 132.44 21.73 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 107.839 -1.171 . . . . 8.1999999999999993 107.839 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 82' ' ' SER . 27.8 Cg_endo -83.98 -168.32 5.97 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 CA-C-O 122.533 0.972 . . . . 7.79 112.15 -0.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.754 HH12 ' H ' ' A' ' 68' ' ' THR . 1.8 tpm_? -146.01 90.4 1.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.635 -1.987 . . . . 26.050000000000001 105.635 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 73' ' ' PHE . 88.3 t -83.78 155.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.279 -0.888 . . . . 8.6799999999999997 111.794 -176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' N ' HG12 ' A' ' 72' ' ' VAL . 81.8 m-85 -142.69 91.77 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 14.07 111.535 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.0 mm -72.02 114.3 10.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 105.249 -2.13 . . . . 9.3399999999999999 105.249 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.38 -159.1 11.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.959 -2.856 . . . . 12.42 105.959 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -78.3 1.71 20.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.211 -1.758 . . . . 44.859999999999999 108.699 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.616 ' CB ' HH21 ' A' ' 97' ' ' ARG . 1.4 m-20 -88.43 112.09 22.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.735 . . . . 0.0 110.055 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 t -76.79 143.65 39.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.267 -0.896 . . . . 0.0 110.453 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.8 pt -107.37 -21.41 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.028 . . . . 20.449999999999999 108.92 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.26 -146.63 18.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.218 -1.153 . . . . 13.82 110.218 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.91 -143.67 13.31 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.227 -1.149 . . . . 12.42 110.227 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.6 -61.73 1.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.517 -0.99 . . . . 0.0 109.964 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -52.73 -23.68 7.22 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.59 -0.694 . . . . 0.0 109.5 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.53 -51.55 12.67 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 27.059999999999999 109.272 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -50.92 -60.3 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 15.31 110.037 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.54 -51.93 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 110.066 -178.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 86' ' ' VAL . 3.2 t -44.44 -37.7 3.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.229 -0.92 . . . . 21.789999999999999 108.953 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' HD13 ' A' ' 94' ' ' LEU . 42.2 mt -81.89 -40.96 21.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 111.507 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.53 -58.66 7.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.88 -1.137 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -24.83 66.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.004 -1.06 . . . . 0.0 109.411 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.2 m -79.87 -45.51 18.53 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.3 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.3 -9.22 26.69 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.377 -1.089 . . . . 25.640000000000001 110.377 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' HG21 ' A' ' 96' ' ' THR . 8.5 tp10 -69.69 -25.11 63.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.988 -1.301 . . . . 50.259999999999998 108.534 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.8 tp -60.07 -63.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.479 0.657 . . . . 24.170000000000002 110.732 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.17 -28.26 39.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.448 -0.782 . . . . 0.0 108.915 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.4 -50.05 66.92 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.65 -0.82 . . . . 28.030000000000001 108.803 178.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.616 HH21 ' CB ' ' A' ' 77' ' ' ASP . 27.1 mtp180 -58.91 -31.05 68.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.912 -1.144 . . . . 40.960000000000001 107.912 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.37 -40.49 67.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.051 -1.092 . . . . 15.050000000000001 108.051 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -64.9 -52.3 57.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.93 -0.481 . . . . 0.0 111.888 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -33.2 24.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.71 -1.244 . . . . 38.640000000000001 110.691 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 101' ' ' ILE . 18.7 pt -99.76 -16.34 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.693 -1.255 . . . . 0.0 108.764 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.18 44.28 8.19 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.428 -1.069 . . . . 18.539999999999999 110.428 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.92 -13.85 46.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -1.155 . . . . 10.84 109.657 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.1 pt? -95.01 -175.61 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.504 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.06 -69.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.414 -0.804 . . . . 20.030000000000001 111.218 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.9 m -73.27 -38.68 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 12.91 110.5 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 98.2 m-20 -55.73 -34.06 64.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.043 -1.036 . . . . 28.329999999999998 109.442 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.8 m -74.58 -13.83 60.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.022 -1.049 . . . . 0.0 110.001 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -97.42 -45.75 6.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.012 -1.055 . . . . 22.870000000000001 110.693 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.48 129.09 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.909 -1.12 . . . . 25.190000000000001 110.389 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.77 158.52 35.21 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 107.965 -1.124 . . . . 34.609999999999999 107.965 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -56.7 135.9 73.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.743 1.629 . . . . 11.720000000000001 111.418 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.81 27.64 68.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.75 -0.94 . . . . 10.24 110.75 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -142.6 131.85 23.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.347 . . . . 25.359999999999999 109.619 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.5 127.79 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.218 -0.926 . . . . 10.890000000000001 108.959 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.88 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.613 -0.884 . . . . 15.82 108.613 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 18' ' ' ILE . 32.7 t -125.31 126.11 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.541 -0.724 . . . . 8.9399999999999995 111.259 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -92.67 119.1 31.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.3 pt -129.34 -173.79 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 122.311 1.053 . . . . 10.619999999999999 111.345 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -146.2 88.04 6.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.95 -1.871 . . . . 38.729999999999997 105.95 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.544 ' O ' ' OG1' ' A' ' 21' ' ' THR . 17.7 Cg_exo -45.79 77.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.851 1.701 . . . . 24.579999999999998 110.834 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 19' ' ' LYS . 15.6 m -174.07 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.082 -1.081 . . . . 34.82 108.082 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 126.16 42.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 109.083 -0.71 . . . . 21.460000000000001 109.083 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.82 -24.6 56.83 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.069 1.846 . . . . 13.859999999999999 112.166 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -70.39 -38.18 74.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.799 -1.188 . . . . 0.0 108.782 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -36.35 84.02 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.593 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.5 mmm-85 -65.27 -42.93 92.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.962 -0.755 . . . . 59.590000000000003 108.962 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -50.14 -45.37 53.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 108.771 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.71 82.12 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.616 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.41 -45.77 61.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.791 . . . . 45.490000000000002 109.652 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -69.99 -34.41 73.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.524 -0.735 . . . . 34.969999999999999 110.787 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.93 -57.58 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 0.0 110.83 -178.336 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.694 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -59.49 -20.89 58.7 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.593 -1.317 . . . . 17.280000000000001 109.487 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 m -64.5 -22.29 66.92 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.142 -0.974 . . . . 24.109999999999999 108.415 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -93.02 -2.21 55.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.486 -0.759 . . . . 44.07 109.963 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 HD23 ' A' ' 32' ' ' LEU . 18.8 mt -88.7 130.38 45.33 Favored Pre-proline 0 N--CA 1.484 1.267 0 O-C-N 120.86 -1.15 . . . . 19.629999999999999 108.956 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 67.19 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.669 1.58 . . . . 21.539999999999999 109.875 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.49 149.56 5.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 108.685 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 39' ' ' GLN . 36.6 mttt -53.56 -168.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.345 -0.847 . . . . 29.41 110.29 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.597 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 21.8 mp0 -52.01 -123.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.6 0.714 . . . . 0.0 111.748 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 51.14 1.8 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.628 -0.989 . . . . 15.27 110.628 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.59 -27.31 14.07 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.549 -0.971 . . . . 8.7799999999999994 108.796 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HB2' HG21 ' A' ' 37' ' ' ILE . 55.3 tp -97.25 130.87 44.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.606 -0.887 . . . . 7.1299999999999999 108.606 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 1.2 tp10 -140.62 172.97 11.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.442 -0.786 . . . . 22.030000000000001 109.874 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 35.9 m-85 -135.74 110.06 8.43 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.416 -1.327 . . . . 16.329999999999998 107.416 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.9 103.16 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 6.5800000000000001 111.676 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.3 m-20 -81.29 100.87 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.671 -0.863 . . . . 15.32 108.671 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 56' ' ' ILE . 25.8 pt -63.69 -0.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.165 -0.96 . . . . 10.92 111.098 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 t -92.31 -14.34 28.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.717 -1.239 . . . . 21.719999999999999 108.965 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.54 8.04 4.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.789 . . . . 22.449999999999999 109.307 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -142.97 -0.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 25.629999999999999 109.797 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' C ' ' N ' ' A' ' 53' ' ' THR . 13.3 t-20 67.38 -156.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.28 12.32 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.803 -1.186 . . . . 0.0 108.684 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -37.83 -62.89 0.51 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.524 -0.735 . . . . 18.870000000000001 110.892 -178.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -53.53 -32.57 51.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 45.210000000000001 110.481 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -65.67 -45.28 83.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.889 -1.132 . . . . 33.020000000000003 109.82 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 47' ' ' ILE . 2.4 mp -67.21 -50.29 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.922 -1.111 . . . . 9.8399999999999999 109.469 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -58.07 -42.38 85.4 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.275 -1.38 . . . . 17.84 107.275 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.09 -33.11 64.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.036 -1.468 . . . . 18.84 107.036 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -78.78 -51.82 9.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.98 -0.748 . . . . 12.99 108.98 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.44 -32.55 50.33 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.134 -1.061 . . . . 14.609999999999999 108.134 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.6 tp60 -59.13 -54.56 45.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.808 -0.557 . . . . 40.450000000000003 109.849 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -67.47 -49.61 62.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 41.810000000000002 110.878 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -65.28 -33.33 75.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.036 -1.04 . . . . 21.77 110.993 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.7 p -107.91 -66.75 1.01 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.162 -0.961 . . . . 11.380000000000001 109.47 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 141.96 -41.37 1.22 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.757 -1.737 . . . . 14.789999999999999 108.757 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.5 140.85 32.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 17.809999999999999 109.655 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -106.15 25.67 10.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.363 -0.977 . . . . 29.760000000000002 108.363 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.82 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -83.85 168.04 16.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.036 0.922 . . . . 18.260000000000002 111.471 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.54 134.79 21.54 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 107.725 -1.213 . . . . 8.1999999999999993 107.725 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB3' HG22 ' A' ' 18' ' ' ILE . 22.3 Cg_endo -85.62 -162.97 2.69 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 CA-C-O 122.512 0.963 . . . . 7.79 111.929 -0.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.82 HH12 ' H ' ' A' ' 68' ' ' THR . 1.5 tpm_? -144.94 97.38 3.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.271 -2.122 . . . . 26.050000000000001 105.271 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 85' ' ' LEU . 99.3 t -86.87 157.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 8.6799999999999997 111.483 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.461 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.4 m-85 -144.92 91.21 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 14.07 111.503 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 mm -72.37 112.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.343 -2.095 . . . . 9.3399999999999999 105.343 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 -153.13 36.03 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 105.476 -3.05 . . . . 12.42 105.476 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -83.65 2.82 35.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.219 -1.754 . . . . 44.859999999999999 108.67 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.661 ' CB ' HH21 ' A' ' 97' ' ' ARG . 5.5 m-20 -88.84 113.38 24.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 110.3 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.5 t -75.1 145.8 41.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.6 pp -111.92 -16.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.264 -0.898 . . . . 20.449999999999999 109.334 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.92 -149.36 18.05 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.237 -1.145 . . . . 13.82 110.237 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.73 -147.52 20.93 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.096 -1.202 . . . . 12.42 110.096 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 t -71.78 -62.73 1.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.479 -1.012 . . . . 0.0 110.218 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.5 t -52.25 -24.46 7.37 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.71 -47.35 31.91 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.358 -0.839 . . . . 27.059999999999999 109.111 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.6 -59.39 4.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.728 . . . . 15.31 110.189 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -51.5 -50.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 110.436 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.51 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 22.7 m -47.59 -36.86 11.34 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.03 -1.044 . . . . 21.789999999999999 109.049 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.0 mt -82.47 -37.81 24.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 0.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.42 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.47 -60.22 4.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.694 -1.254 . . . . 0.0 110.728 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.529 ' NE2' ' C ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.42 -17.79 55.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.005 -1.059 . . . . 0.0 109.588 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -80.51 -63.47 1.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.72 -13.02 4.51 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.125 -1.19 . . . . 25.640000000000001 110.125 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.02 -29.65 67.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.15 -1.206 . . . . 50.259999999999998 108.535 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.08 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.574 -0.704 . . . . 24.170000000000002 111.051 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -54.97 -28.62 52.92 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -64.64 -48.92 73.07 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.616 -0.833 . . . . 28.030000000000001 108.816 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.661 HH21 ' CB ' ' A' ' 77' ' ' ASP . 29.0 mtp180 -60.46 -31.29 70.29 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.968 -1.123 . . . . 40.960000000000001 107.968 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.75 -39.08 70.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.288 -1.004 . . . . 15.050000000000001 108.288 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -66.04 -54.15 29.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.919 -0.488 . . . . 0.0 111.913 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -49.73 -32.65 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.786 -1.196 . . . . 38.640000000000001 110.947 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 pt -100.29 -14.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.625 -1.297 . . . . 0.0 109.07 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.35 44.13 8.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.291 -1.124 . . . . 18.539999999999999 110.291 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.27 38.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.236 . . . . 10.84 109.653 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.04 -179.97 5.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.577 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.597 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.187 0.518 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.48 -75.58 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 20.030000000000001 110.69 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -73.95 -35.67 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.97 . . . . 12.91 110.017 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -56.43 -35.56 67.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 109.377 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -75.0 -13.22 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.916 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -97.02 -47.74 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.124 -0.985 . . . . 22.870000000000001 110.349 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -79.5 133.38 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 25.190000000000001 110.385 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -151.25 160.06 32.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.903 -1.147 . . . . 34.609999999999999 107.903 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.77 130.27 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.754 1.636 . . . . 11.720000000000001 111.435 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.49 22.99 63.55 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 120.335 -0.936 . . . . 10.24 111.046 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -141.12 134.11 29.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.974 -1.309 . . . . 25.359999999999999 109.62 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.9 t -100.66 133.98 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.479 -0.763 . . . . 10.890000000000001 109.435 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.64 141.22 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.487 -0.931 . . . . 15.82 108.487 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.74 124.14 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.824 . . . . 8.9399999999999995 111.307 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -91.61 120.51 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.588 -1.264 . . . . 9.9299999999999997 107.588 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.453 HG22 ' HB3' ' A' ' 70' ' ' PRO . 43.7 pt -133.45 -170.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 122.667 1.223 . . . . 10.619999999999999 112.192 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.1 mtmt -146.57 96.43 4.45 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 105.707 -1.96 . . . . 38.729999999999997 105.707 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -50.68 82.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.282 1.321 . . . . 24.579999999999998 110.504 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -179.36 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 34.82 109.699 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.36 122.33 56.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.252 -0.905 . . . . 21.460000000000001 109.082 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -54.56 -10.89 2.67 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.34 2.027 . . . . 13.859999999999999 112.765 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.68 -49.98 23.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.422 -1.424 . . . . 0.0 110.186 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -26.76 68.03 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.667 -1.271 . . . . 0.0 107.896 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -62.97 -37.69 88.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.092 -1.077 . . . . 59.590000000000003 108.092 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -59.17 -50.51 73.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 108.991 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -36.8 74.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.312 -0.868 . . . . 0.0 109.003 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 5.5 mm-40 -69.39 -42.85 74.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 45.490000000000002 109.705 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.16 -38.16 69.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.493 -0.754 . . . . 34.969999999999999 110.876 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.633 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.93 -54.95 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.016 -1.053 . . . . 0.0 110.405 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.607 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -58.36 -22.6 54.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.322 -1.486 . . . . 17.280000000000001 108.726 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -65.39 -29.89 70.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.936 . . . . 24.109999999999999 108.585 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -89.1 0.46 56.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.779 . . . . 44.07 109.562 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 ' OE1' ' A' ' 89' ' ' GLN . 25.4 mt -89.3 131.51 40.34 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.127 -0.983 . . . . 19.629999999999999 108.696 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.84 66.6 1.26 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.843 1.695 . . . . 21.539999999999999 110.418 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -81.05 146.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.98 -1.075 . . . . 0.0 108.492 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 39' ' ' GLN . 11.1 mtmt -54.39 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 29.41 110.96 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.55 ' O ' ' O ' ' A' ' 38' ' ' LYS . 52.7 mt-30 -52.42 -133.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.766 0.793 . . . . 0.0 111.784 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.51 50.24 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.336 -1.106 . . . . 15.27 110.336 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -97.04 -29.75 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 8.7799999999999994 108.726 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 37' ' ' ILE . 62.3 tp -94.98 132.02 40.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.978 -0.749 . . . . 7.1299999999999999 108.978 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 11.6 tp10 -143.47 169.43 17.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.434 -0.791 . . . . 22.030000000000001 109.387 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.2 m-85 -132.03 109.64 10.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.3 -1.37 . . . . 16.329999999999998 107.3 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.47 103.2 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 6.5800000000000001 112.068 -176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -81.51 102.65 10.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 15.32 108.193 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 pt -62.94 0.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.364 -0.835 . . . . 10.92 111.765 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -95.93 -26.43 15.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.71 -1.244 . . . . 21.719999999999999 109.451 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 20.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 22.449999999999999 109.596 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.711 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 11.0 t -143.3 1.94 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.148 -0.97 . . . . 25.629999999999999 109.702 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.711 ' ND2' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 65.41 -176.51 0.18 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.548 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.26 20.89 10.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.666 -1.271 . . . . 0.0 108.391 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.31 -61.68 1.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 18.870000000000001 110.789 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.08 -32.7 68.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 45.210000000000001 111.218 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 4.7 mp0 -62.46 -44.36 96.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.101 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.68 -53.22 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.144 . . . . 9.8399999999999999 109.553 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.07 -44.94 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.609 -1.307 . . . . 17.84 107.511 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -55.7 -33.33 64.07 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.003 -1.48 . . . . 18.84 107.003 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.95 -47.75 17.85 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.937 -0.764 . . . . 12.99 108.937 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.4 mt -53.15 -35.02 59.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.882 -1.155 . . . . 14.609999999999999 107.882 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.1 tp60 -60.62 -54.74 41.71 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.228 0.537 . . . . 40.450000000000003 109.982 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -66.2 -45.3 81.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.966 -1.084 . . . . 41.810000000000002 110.693 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.99 -40.73 91.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.987 -1.071 . . . . 21.77 110.68 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.1 p -107.83 -65.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.786 . . . . 11.380000000000001 109.761 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 140.89 -38.49 1.55 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.786 -2.125 . . . . 14.789999999999999 107.786 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.21 138.33 35.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.682 -0.893 . . . . 17.809999999999999 109.813 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -112.52 38.37 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.206 -1.035 . . . . 29.760000000000002 108.206 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 166.78 14.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.245 1.021 . . . . 18.260000000000002 112.623 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.79 126.77 27.51 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 8.1999999999999993 107.22 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.722 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 35.4 Cg_endo -82.34 -173.93 12.53 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 CA-C-O 122.148 0.811 . . . . 7.79 111.222 1.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.737 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -140.94 98.7 3.44 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.215 -2.143 . . . . 26.050000000000001 105.215 176.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 73' ' ' PHE . 67.2 t -89.4 157.95 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.745 0.783 . . . . 8.6799999999999997 112.6 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.9 m-85 -146.5 88.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.839 -0.538 . . . . 14.07 111.329 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.44 124.39 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 104.433 -2.432 . . . . 9.3399999999999999 104.433 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.26 -160.24 17.49 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 106.501 -2.64 . . . . 12.42 106.501 -176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -83.21 -1.95 54.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.395 -1.65 . . . . 44.859999999999999 109.984 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' HB2' HH21 ' A' ' 97' ' ' ARG . 4.2 m-20 -89.31 124.2 34.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.018 -1.051 . . . . 0.0 110.356 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 t -75.0 147.12 41.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 110.025 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -109.28 -21.09 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.681 -0.859 . . . . 20.449999999999999 108.681 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.99 -153.01 19.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.941 -1.264 . . . . 13.82 109.941 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.99 -147.02 21.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.966 -1.254 . . . . 12.42 109.966 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -69.71 -61.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -1.103 . . . . 0.0 109.863 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -51.06 -23.64 3.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.553 -0.717 . . . . 0.0 109.293 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.01 -47.38 25.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.451 -0.78 . . . . 27.059999999999999 109.016 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.7 tt -54.24 -60.03 3.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 15.31 109.834 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.27 -52.16 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.082 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 37.4 m -46.16 -35.92 5.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.143 -0.973 . . . . 21.789999999999999 108.899 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 94' ' ' LEU . 71.8 mt -82.08 -40.05 22.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 111.615 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.707 ' OE1' HD11 ' A' ' 35' ' ' LEU . 25.2 tp60 -58.71 -59.11 5.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.164 . . . . 0.0 110.777 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.81 -19.74 64.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.927 -1.108 . . . . 0.0 109.768 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.7 m -83.86 -24.28 30.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.32 -9.54 76.57 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.106 -1.197 . . . . 25.640000000000001 110.106 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.128 -1.219 . . . . 50.259999999999998 108.21 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.6 -65.81 0.63 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.44 0.638 . . . . 24.170000000000002 110.887 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.01 -28.29 37.29 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.468 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -48.45 73.51 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.683 -0.858 . . . . 28.030000000000001 108.683 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.688 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.84 -33.87 72.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.762 -1.199 . . . . 40.960000000000001 107.762 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.1 -38.0 75.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.29 -1.004 . . . . 15.050000000000001 108.29 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -64.93 -58.03 7.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.917 -0.49 . . . . 0.0 111.635 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.39 -28.36 3.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.914 -1.116 . . . . 38.640000000000001 111.087 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -103.74 -19.8 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.709 -1.244 . . . . 0.0 109.214 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.39 41.89 7.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.38 -1.088 . . . . 18.539999999999999 110.38 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.78 -13.97 49.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -1.205 . . . . 10.84 109.437 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.07 -176.37 3.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 109.367 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.121 -0.987 . . . . 0.0 109.609 179.867 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -56.86 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 20.030000000000001 109.846 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.8 HG21 ' CZ ' ' A' ' 59' ' ' TYR . 14.9 m -73.14 -39.7 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.65 -0.656 . . . . 12.91 110.964 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.502 ' N ' HG23 ' A' ' 5' ' ' VAL . 93.8 m-20 -57.21 -34.26 68.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.797 -1.189 . . . . 28.329999999999998 109.973 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m -74.14 -13.59 60.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.021 -1.05 . . . . 0.0 109.426 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -96.98 -52.42 3.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 22.870000000000001 110.3 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.19 126.29 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 25.190000000000001 109.989 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -149.13 155.37 40.03 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.121 -1.066 . . . . 34.609999999999999 108.121 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.25 132.35 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.926 1.751 . . . . 11.720000000000001 111.411 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 22.75 64.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.767 -0.933 . . . . 10.24 110.767 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.77 135.1 27.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.875 -1.368 . . . . 25.359999999999999 110.121 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.15 135.42 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 10.890000000000001 108.99 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.33 141.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.39 -0.967 . . . . 15.82 108.39 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 18' ' ' ILE . 21.8 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.386 -0.821 . . . . 8.9399999999999995 110.426 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -90.86 119.04 30.74 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.148 -1.427 . . . . 9.9299999999999997 107.148 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.7 pt -130.32 -175.04 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.294 1.045 . . . . 10.619999999999999 111.178 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.76 ' O ' ' N ' ' A' ' 21' ' ' THR . 21.6 mtmt -146.19 88.65 6.21 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.459 -1.682 . . . . 38.729999999999997 106.459 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 21' ' ' THR . 12.9 Cg_exo -46.76 69.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.016 1.81 . . . . 24.579999999999998 110.921 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.76 ' N ' ' O ' ' A' ' 19' ' ' LYS . 20.8 p -162.3 -36.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.007 -1.108 . . . . 34.82 108.007 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 128.94 32.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 21.460000000000001 109.469 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.98 -20.2 43.88 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.056 1.837 . . . . 13.859999999999999 111.756 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.66 -40.89 72.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.677 -1.265 . . . . 0.0 108.518 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -36.48 83.67 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.556 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -65.14 -36.06 83.07 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.792 -0.818 . . . . 59.590000000000003 108.792 178.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.72 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -56.54 -50.67 71.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 109.243 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . . . -56.94 -34.03 67.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.24 -36.89 74.78 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.282 -0.886 . . . . 45.490000000000002 108.696 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 67.1 mm-40 -71.4 -39.69 70.97 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.811 -0.555 . . . . 34.969999999999999 111.4 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -77.15 -65.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.837 -1.165 . . . . 0.0 110.925 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.648 ' H ' HG23 ' A' ' 31' ' ' ILE . 3.1 mt -52.8 -22.77 5.75 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.853 -1.155 . . . . 17.280000000000001 110.191 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 5.0 p -66.64 -26.17 66.94 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.755 -1.215 . . . . 24.109999999999999 108.773 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -93.3 4.11 54.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.373 -0.829 . . . . 44.07 110.506 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 32' ' ' LEU . 16.5 mt -90.46 131.46 38.18 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.83 -1.168 . . . . 19.629999999999999 109.385 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -66.67 66.72 0.53 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.898 1.732 . . . . 21.539999999999999 110.132 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' LYS . 1.9 mm -81.67 153.37 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.214 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.2 mmmm -54.05 -168.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 29.41 110.028 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' LYS . 40.1 mt-30 -51.78 -134.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.6 0.714 . . . . 0.0 110.831 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.09 54.57 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.063 -1.215 . . . . 15.27 110.063 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.37 -17.69 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.402 -1.058 . . . . 8.7799999999999994 109.241 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.3 tp -105.54 130.33 53.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.64 -0.874 . . . . 7.1299999999999999 108.64 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 28.8 tt0 -139.37 173.51 11.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 22.030000000000001 110.17 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.486 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 40.0 m-85 -134.58 110.82 9.58 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.782 -1.192 . . . . 16.329999999999998 107.782 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.3 t -96.19 104.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 6.5800000000000001 111.621 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' HD11 ' A' ' 18' ' ' ILE . 13.5 m-20 -81.33 103.19 10.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.055 -1.091 . . . . 15.32 108.055 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.7 pt -62.41 -3.85 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 10.92 110.811 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -93.8 -15.83 24.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.286 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.04 10.8 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 22.449999999999999 109.467 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 15.3 t -142.86 -18.53 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.248 -0.907 . . . . 25.629999999999999 110.059 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 50' ' ' THR . 0.5 OUTLIER 84.33 -170.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.597 -0.689 . . . . 0.0 109.452 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER 56.17 24.21 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 108.792 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 8.7 p -42.84 -52.83 4.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 18.870000000000001 110.394 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.9 m-20 -52.63 -34.72 52.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 45.210000000000001 110.481 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -64.69 -45.09 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.129 . . . . 33.020000000000003 109.28 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.43 -50.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.05 -1.032 . . . . 9.8399999999999999 109.43 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.0 mt-30 -57.65 -39.54 77.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.5 -1.375 . . . . 17.84 107.447 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 11.8 m-20 -56.31 -32.56 64.74 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.189 -1.412 . . . . 18.84 107.189 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 5.4 t80 -76.13 -51.56 11.95 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.064 -0.717 . . . . 12.99 109.064 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 22.5 mt -54.22 -32.06 54.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.059 -1.089 . . . . 14.609999999999999 108.059 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.3 tp-100 -63.2 -56.5 16.1 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.458 -0.777 . . . . 40.450000000000003 110.167 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -55.59 15.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 41.810000000000002 111.733 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -31.56 72.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.904 -1.122 . . . . 21.77 111.229 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.6 p -109.9 -63.32 1.39 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.974 -1.079 . . . . 11.380000000000001 109.81 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 140.73 -45.59 0.97 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.944 -1.662 . . . . 14.789999999999999 108.944 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' NH1' ' A' ' 71' ' ' ARG . . . -98.05 138.49 35.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.983 . . . . 17.809999999999999 109.261 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.967 ' HG2' HH11 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -107.64 26.43 10.29 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.912 -1.144 . . . . 29.760000000000002 107.912 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 173.26 12.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.743 -0.598 . . . . 18.260000000000002 109.588 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.5 t -117.79 137.64 24.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 8.1999999999999993 108.559 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.0 Cg_endo -84.72 -165.73 3.98 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.678 -0.968 . . . . 7.79 110.585 -0.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.877 ' NH1' ' HB3' ' A' ' 66' ' ' ALA . 1.8 tpt180 -148.46 98.08 2.84 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.848 -1.908 . . . . 26.050000000000001 105.848 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 85' ' ' LEU . 93.5 t -84.16 159.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -0.87 . . . . 8.6799999999999997 111.219 -176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 72' ' ' VAL . 77.4 m-85 -145.34 94.9 2.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.7 -0.625 . . . . 14.07 110.783 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 101' ' ' ILE . 6.7 mm -72.92 105.59 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.775 -1.935 . . . . 9.3399999999999999 105.775 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.07 -147.25 48.96 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.723 -2.951 . . . . 12.42 105.723 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -84.37 3.44 35.89 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.477 -1.602 . . . . 44.859999999999999 108.791 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.672 ' CB ' HH21 ' A' ' 97' ' ' ARG . 74.7 m-20 -89.94 109.06 20.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.479 -0.763 . . . . 0.0 110.756 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 t -74.05 145.14 44.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 109.281 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -113.33 -22.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.205 -0.935 . . . . 20.449999999999999 109.33 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA2' HH21 ' A' ' 71' ' ' ARG . . . 134.62 -154.44 21.48 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.788 -1.325 . . . . 13.82 109.788 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -101.13 -142.85 13.19 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.005 -1.238 . . . . 12.42 110.005 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.67 -66.07 0.68 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.444 -1.033 . . . . 0.0 110.501 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t -51.65 -24.48 5.63 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.571 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -74.97 -47.95 26.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.373 -0.829 . . . . 27.059999999999999 109.369 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.685 HD12 HG21 ' A' ' 72' ' ' VAL . 5.6 tt -55.03 -58.8 6.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.434 -0.791 . . . . 15.31 110.516 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -48.93 -47.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.805 . . . . 0.0 110.664 -178.084 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -43.25 47.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 21.789999999999999 109.172 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.9 mt -72.86 -41.08 65.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 111.984 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.4 -57.22 13.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.846 -1.159 . . . . 0.0 110.615 -177.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -25.45 67.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 109.323 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.5 m -82.58 -19.24 38.85 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.37 64.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.273 -1.131 . . . . 25.640000000000001 110.273 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 96' ' ' THR . 23.7 tt0 -67.67 -25.35 65.66 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.143 -1.21 . . . . 50.259999999999998 109.152 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.62 -63.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 24.170000000000002 110.295 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -52.17 -27.36 14.15 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.474 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.475 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -62.71 -48.13 80.6 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.417 -0.913 . . . . 28.030000000000001 108.678 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.672 HH21 ' CB ' ' A' ' 77' ' ' ASP . 22.5 mmm180 -60.42 -32.91 71.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.036 . . . . 40.960000000000001 108.539 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.4 mp -71.96 -39.43 69.35 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.399 -0.813 . . . . 15.050000000000001 109.243 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -65.74 -52.03 54.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.646 -0.658 . . . . 0.0 111.876 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.83 -34.2 8.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 38.640000000000001 110.404 -178.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 74' ' ' ILE . 17.7 pt -101.98 -11.37 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.846 -1.159 . . . . 0.0 109.268 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 43.58 14.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.427 -1.069 . . . . 18.539999999999999 110.427 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.52 -17.18 34.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.162 -1.199 . . . . 10.84 109.67 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 3.8 pp -97.46 -177.48 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.631 -179.95 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.819 -0.808 . . . . 2.1800000000000002 108.819 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.98 -72.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.5 109.788 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.53 -36.32 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.27000000000000002 110.317 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -58.37 -36.58 73.72 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.795 -1.19 . . . . 1.22 109.655 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -73.81 -13.35 60.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.37 109.302 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -97.19 -48.65 5.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 1.3 110.329 -179.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.0 125.44 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.777 -1.202 . . . . 0.32000000000000001 109.018 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.3 148.32 31.29 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.327 -0.99 . . . . 2.0899999999999999 108.327 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.21 135.93 30.92 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.196 1.931 . . . . 0.27000000000000002 111.741 -178.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.17 72.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.386 -1.085 . . . . 0.23999999999999999 110.386 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -144.11 140.05 29.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.022 -1.281 . . . . 1.5900000000000001 110.233 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.94 137.17 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.12 109.515 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.38 143.47 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.14999999999999999 108.505 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 18' ' ' ILE . 57.2 t -125.0 123.79 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.12 110.584 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -91.49 119.99 31.92 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.126 -1.435 . . . . 0.16 107.126 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 16' ' ' VAL . 37.3 pt -131.28 -173.17 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.312 1.053 . . . . 0.19 111.676 -177.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 27.1 mtmt -147.13 90.94 5.24 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 106.926 -1.509 . . . . 1.24 106.926 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -45.9 75.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.507 1.472 . . . . 0.37 110.383 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.2 m -169.21 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.927 -0.768 . . . . 1.1799999999999999 108.927 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.56 131.5 25.82 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.23000000000000001 110.266 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -60.04 -19.68 57.12 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 122.249 1.966 . . . . 0.32000000000000001 112.054 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -70.22 -41.38 73.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.764 -1.21 . . . . 0.29999999999999999 109.026 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -33.71 76.66 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.36 -0.936 . . . . 1.1000000000000001 108.592 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.38 -45.43 93.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 2.71 108.779 179.483 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -49.22 -46.75 46.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.958 -1.088 . . . . 2.4399999999999999 109.589 -179.396 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.76 80.96 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.14 -1.024 . . . . 0.22 108.559 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -69.06 -46.62 67.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 1.26 109.868 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -37.84 85.14 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.607 -0.683 . . . . 1.8700000000000001 111.231 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.657 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -77.5 -54.8 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.81 -1.181 . . . . 0.53000000000000003 110.861 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 35' ' ' LEU . 4.4 mt -58.18 -20.79 43.9 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.675 -1.266 . . . . 0.17999999999999999 108.987 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -66.87 -28.08 68.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 1.3100000000000001 109.404 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -91.22 3.09 55.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 1.5800000000000001 109.896 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 32' ' ' LEU . 15.6 mt -91.5 127.01 52.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.28999999999999998 109.556 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.14 65.24 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.922 1.748 . . . . 0.27000000000000002 109.916 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 42' ' ' LEU . 15.1 mm -78.45 146.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.574 -0.898 . . . . 0.25 108.574 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.1 mttt -52.59 -178.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -0.984 . . . . 1.79 108.807 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 41' ' ' LEU . 47.6 mt-30 -52.05 -123.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.994 -1.066 . . . . 2.5499999999999998 111.948 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.42 49.36 0.06 OUTLIER Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.439 -0.788 . . . . 0.37 111.534 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -105.05 -24.76 12.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.265 . . . . 0.28000000000000003 109.395 179.136 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 37' ' ' ILE . 18.8 tp -102.58 131.4 49.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.16 109.086 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 161.9 36.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 2.0099999999999998 109.897 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -125.02 116.49 22.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.435 -1.32 . . . . 0.16 107.435 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.71 105.31 17.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.446 -0.784 . . . . 0.17000000000000001 111.997 -177.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 18' ' ' ILE . 26.0 m-20 -80.75 100.43 8.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.011 -1.107 . . . . 1.1200000000000001 108.011 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 pt -61.96 -2.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.25 111.589 -178.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 -22.11 18.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.705 -1.247 . . . . 1.24 109.222 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.63 15.6 1.0 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.56999999999999995 109.341 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 4.11 1.44 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.068 -1.02 . . . . 0.59999999999999998 109.976 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 65.98 -175.6 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 2.4100000000000001 109.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 53' ' ' THR . 6.0 m170 59.59 18.99 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 2.21 109.754 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -34.47 -65.14 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.542 -0.724 . . . . 0.89000000000000001 110.377 -179.685 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 3.6 m-20 -54.73 -36.64 64.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 1.21 111.37 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.91 -45.45 92.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.641 -1.287 . . . . 2.1200000000000001 109.713 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.03 -51.94 54.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.998 -1.064 . . . . 0.22 109.002 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.79 -42.94 85.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.784 -1.198 . . . . 0.46000000000000002 107.774 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -56.35 -32.86 65.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.182 -1.414 . . . . 1.1200000000000001 107.182 178.129 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -79.03 -50.91 10.33 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.011 -0.737 . . . . 1.21 109.011 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.9 mt -54.68 -28.1 45.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.007 -1.058 . . . . 0.25 108.221 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 7.2 tp60 -63.1 -56.44 16.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.709 . . . . 1.3600000000000001 109.652 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -69.75 -38.05 76.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.447 -0.783 . . . . 2.2599999999999998 110.749 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.85 -40.52 95.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.125 -0.984 . . . . 0.93000000000000005 110.164 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.9 p -113.09 -70.8 0.79 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.308 -0.87 . . . . 0.70999999999999996 109.266 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.85 -36.2 0.67 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.411 -1.476 . . . . 0.33000000000000002 109.411 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -102.21 130.15 48.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.35999999999999999 110.292 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 25.36 5.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.565 -1.272 . . . . 1.6299999999999999 107.565 177.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.406 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -79.95 167.81 20.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.658 0.742 . . . . 0.33000000000000002 110.04 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.72 136.92 22.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.23000000000000001 107.438 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -78.46 -165.02 4.3 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 CA-C-O 122.562 0.984 . . . . 0.22 111.871 -0.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -146.6 90.71 1.95 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.453 -2.054 . . . . 2.1800000000000002 105.453 177.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 22.0 t -84.25 151.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.12 111.394 -176.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.85 92.25 2.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.797 -0.565 . . . . 0.20000000000000001 110.284 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 ' N ' ' A' ' 74' ' ' ILE . 3.3 mm -71.65 107.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.576 -2.009 . . . . 0.53000000000000003 105.576 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.84 -147.59 50.45 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.505 -2.638 . . . . 0.17999999999999999 106.505 -176.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.34 -4.89 59.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.539 -1.565 . . . . 1.8799999999999999 109.356 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' HH21 ' A' ' 97' ' ' ARG . 11.9 m-20 -89.03 117.22 27.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.096 -1.003 . . . . 1.26 110.76 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -74.31 151.68 39.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.28000000000000003 110.092 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.47 -19.48 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.51000000000000001 109.377 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.68 -150.38 19.51 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.176 -1.17 . . . . 0.31 110.176 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.07 -142.02 11.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.343 -1.103 . . . . 0.22 110.343 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -71.78 -61.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.539 -0.977 . . . . 0.68000000000000005 110.271 -179.108 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -53.57 -27.61 27.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.457 -0.777 . . . . 0.33000000000000002 109.622 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.09 -45.64 56.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.306 -0.871 . . . . 1.6000000000000001 109.07 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.2 tt -56.5 -64.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.629 -0.67 . . . . 0.22 109.732 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -45.53 -47.52 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.23999999999999999 110.11 -178.458 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -48.43 47.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.905 -1.122 . . . . 0.92000000000000004 109.288 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.18 -31.89 62.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.27 -0.894 . . . . 0.20000000000000001 111.553 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -61.36 -60.27 3.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.574 -1.328 . . . . 2.0600000000000001 109.372 -178.991 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -25.74 67.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 2.46 110.514 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.8 m -79.61 -25.29 41.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.234 -0.917 . . . . 0.57999999999999996 110.783 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.48 -11.43 70.18 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.11 -1.196 . . . . 0.28999999999999998 110.11 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.95 -31.26 70.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 1.95 108.567 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.86 -63.34 1.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.475 -0.766 . . . . 0.29999999999999999 110.638 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -54.95 -30.22 58.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.457 -0.942 . . . . 0.27000000000000002 108.457 -178.682 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.2 m -65.34 -41.55 93.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.989 -1.115 . . . . 0.29999999999999999 107.989 178.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.798 HH21 ' HB3' ' A' ' 77' ' ' ASP . 1.2 tpt180 -64.6 -34.84 79.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.332 -0.988 . . . . 2.3300000000000001 108.332 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.74 -32.93 68.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.409 -0.807 . . . . 0.25 109.023 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -70.0 -57.26 5.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 1.77 111.84 -178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -44.88 -30.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.688 -1.258 . . . . 0.34999999999999998 110.407 -177.78 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.6 pt -104.65 -15.76 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.949 -1.094 . . . . 0.27000000000000002 108.885 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.3 43.56 10.45 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.346 -1.102 . . . . 0.16 110.346 179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -13.38 49.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.068 -1.254 . . . . 0.17999999999999999 109.564 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 104' ' ' LEU . 2.4 pt? -95.02 -175.32 3.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 109.326 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.943 -1.027 . . . . 1.8799999999999999 108.984 179.206 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.515 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.475 -0.565 . . . . 18.329999999999998 109.475 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -111.84 -75.26 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 29.77 109.23 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.4 -10.15 2.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.11 -71.18 0.15 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 20.030000000000001 110.153 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.6 m -73.18 -40.84 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.442 -0.786 . . . . 12.91 110.489 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 25.0 m-20 -55.98 -34.06 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 110.38 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.5 m -74.54 -18.33 60.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.922 -1.111 . . . . 0.0 110.349 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.578 ' CE ' HG21 ' A' ' 45' ' ' VAL . 5.2 mtpm? -98.0 -42.5 7.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.077 . . . . 22.870000000000001 111.442 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.34 126.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.728 -1.233 . . . . 25.190000000000001 109.696 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.61 159.07 35.1 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.956 -1.127 . . . . 34.609999999999999 107.956 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.09 136.56 61.63 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.789 1.659 . . . . 11.720000000000001 111.501 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.04 73.3 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.71 -0.956 . . . . 10.24 110.71 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -140.57 130.63 24.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.253 . . . . 25.359999999999999 109.536 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -101.54 133.81 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.46 -0.775 . . . . 10.890000000000001 109.876 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.36 137.48 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.277 -1.009 . . . . 15.82 108.277 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 18' ' ' ILE . 44.0 t -120.54 128.54 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.366 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' ' NZ ' ' A' ' 8' ' ' LYS . 80.8 m-85 -95.34 118.78 32.71 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.142 -1.058 . . . . 9.9299999999999997 108.142 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 16' ' ' VAL . 23.0 pt -130.25 -176.21 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.485 1.136 . . . . 10.619999999999999 111.42 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.4 mtmt -145.02 93.16 5.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.766 -1.938 . . . . 38.729999999999997 105.766 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -48.32 82.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.369 1.379 . . . . 24.579999999999998 110.577 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -177.78 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.047 -0.723 . . . . 34.82 109.047 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.12 126.81 38.77 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 21.460000000000001 109.099 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.18 -22.98 42.71 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.465 2.11 . . . . 13.859999999999999 113.061 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -67.89 -43.15 79.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.332 -1.48 . . . . 0.0 109.44 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.07 -38.14 89.99 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.41 -40.06 93.0 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.419 -0.956 . . . . 59.590000000000003 108.419 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.31 -45.2 68.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HG3' ' A' ' 70' ' ' PRO . . . -61.48 -35.8 78.69 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -70.38 -36.14 73.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.299 -0.876 . . . . 45.490000000000002 109.076 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -70.08 -41.69 73.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.761 -0.587 . . . . 34.969999999999999 111.14 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.85 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -72.58 -69.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.899 -1.126 . . . . 0.0 110.591 -178.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.85 ' H ' HG23 ' A' ' 31' ' ' ILE . 5.0 mt -51.64 -16.58 0.66 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.136 -0.978 . . . . 17.280000000000001 110.022 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.84 -29.78 68.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.012 -1.055 . . . . 24.109999999999999 108.292 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -93.41 1.65 56.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.481 -0.762 . . . . 44.07 110.617 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.73 HD12 HD23 ' A' ' 32' ' ' LEU . 18.1 mt -88.02 128.66 53.0 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.806 -1.184 . . . . 19.629999999999999 109.111 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -69.49 70.14 1.46 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.656 1.571 . . . . 21.539999999999999 109.73 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.2 mm -80.68 155.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.211 -0.931 . . . . 0.0 109.395 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.3 mmtp -54.36 -168.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.205 -0.935 . . . . 29.41 109.771 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 38' ' ' LYS . 71.0 mt-30 -54.76 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.692 0.758 . . . . 0.0 111.413 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 52.8 0.34 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.452 -1.059 . . . . 15.27 110.452 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.83 -32.46 11.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -1.109 . . . . 8.7799999999999994 109.158 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 tp -95.57 135.19 37.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.39 -0.596 . . . . 7.1299999999999999 109.39 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 26.2 tt0 -143.76 172.4 12.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 22.030000000000001 109.94 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 55.7 m-85 -133.06 111.0 10.6 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.272 -1.381 . . . . 16.329999999999998 107.272 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG21 ' CE ' ' A' ' 8' ' ' LYS . 53.0 t -96.16 106.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 6.5800000000000001 112.279 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 48' ' ' THR . 42.4 m-20 -83.54 98.08 9.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.872 -0.788 . . . . 15.32 108.872 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 pt -62.05 2.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 10.92 110.657 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 46' ' ' ASP . 1.8 p -96.55 -35.53 11.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.003 -1.061 . . . . 21.719999999999999 109.372 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.81 28.81 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 22.449999999999999 109.775 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 t -144.49 -3.55 0.81 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.047 -1.033 . . . . 25.629999999999999 110.145 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 5.4 t30 69.94 -179.14 0.23 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 109.159 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.458 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 1.3 m-70 53.98 27.22 7.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 108.563 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -43.07 -55.97 3.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.377 -0.827 . . . . 18.870000000000001 110.442 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -59.46 -32.69 70.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 45.210000000000001 111.225 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.6 mp0 -62.12 -44.55 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.786 -1.196 . . . . 33.020000000000003 110.256 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.87 -54.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.788 -1.195 . . . . 9.8399999999999999 109.628 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.63 -44.81 77.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.671 -1.233 . . . . 17.84 107.671 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -54.37 -34.41 61.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.937 -1.505 . . . . 18.84 106.937 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 1' ' ' ALA . 33.5 t80 -78.26 -45.77 21.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.904 -0.776 . . . . 12.99 108.904 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.5 mt -53.75 -35.82 61.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.721 -1.215 . . . . 14.609999999999999 107.721 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 18.3 tp60 -60.47 -57.46 12.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.235 0.54 . . . . 40.450000000000003 109.66 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -67.48 -35.22 78.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 41.810000000000002 110.113 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.58 -48.64 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.948 . . . . 21.77 109.925 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -111.58 -63.9 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 11.380000000000001 109.468 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.45 -45.9 0.53 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.692 -1.242 . . . . 14.789999999999999 110.043 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.57 26.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -1.16 . . . . 17.809999999999999 110.283 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -110.94 31.21 6.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 29.760000000000002 109.132 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.45 167.58 16.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 18.260000000000002 111.056 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.683 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.2 t -111.14 133.88 21.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.956 -1.127 . . . . 8.1999999999999993 107.956 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 82' ' ' SER . 19.4 Cg_endo -81.04 -165.46 4.5 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.577 0.991 . . . . 7.79 111.918 -0.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.55 91.76 1.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 105.884 -1.895 . . . . 26.050000000000001 105.884 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 85' ' ' LEU . 96.3 t -85.3 157.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.288 -0.882 . . . . 8.6799999999999997 112.181 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.5 m-85 -143.91 90.45 2.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.677 -0.639 . . . . 14.07 111.262 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -71.91 115.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.132 -2.173 . . . . 9.3399999999999999 105.132 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.45 -153.12 32.87 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 105.85 -2.9 . . . . 12.42 105.85 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -83.77 0.18 48.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.31 -1.7 . . . . 44.859999999999999 109.436 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -89.52 118.81 29.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.256 -0.902 . . . . 0.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -76.35 142.67 41.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.79 -17.68 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.053 -1.029 . . . . 20.449999999999999 109.214 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 -157.61 21.8 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.303 -1.119 . . . . 13.82 110.303 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.78 -147.13 19.7 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.048 -1.221 . . . . 12.42 110.048 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.456 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.62 -61.11 1.92 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.492 -1.005 . . . . 0.0 109.688 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -51.02 -25.11 4.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.25 -49.31 19.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.496 -0.753 . . . . 27.059999999999999 109.183 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -54.02 -59.19 4.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 15.31 110.08 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.24 -51.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.7 m -45.67 -36.78 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 21.789999999999999 108.96 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.04 -41.92 27.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.508 -0.745 . . . . 0.0 111.344 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -58.13 -57.14 14.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.916 -1.115 . . . . 0.0 110.022 -178.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -26.59 68.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.361 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.9 m -81.88 -20.44 38.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.452 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.33 -8.03 73.14 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.512 -1.035 . . . . 25.640000000000001 110.512 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.88 -24.48 64.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.036 -1.273 . . . . 50.259999999999998 108.371 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 tp -61.74 -66.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.624 0.726 . . . . 24.170000000000002 110.899 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.499 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.06 -28.28 16.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.6 -48.11 76.11 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.143 -1.058 . . . . 28.030000000000001 108.143 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.83 -34.22 71.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.832 -1.173 . . . . 40.960000000000001 107.832 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.9 mp -70.92 -39.98 72.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.677 -0.86 . . . . 15.050000000000001 108.677 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.78 -55.66 21.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.83 -0.544 . . . . 0.0 111.599 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.31 -29.29 9.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.86 -1.15 . . . . 38.640000000000001 110.93 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.2 pt -101.28 -19.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.747 -1.22 . . . . 0.0 109.08 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.78 40.53 8.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.288 -1.125 . . . . 18.539999999999999 110.288 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.08 -13.54 50.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -1.21 . . . . 10.84 109.684 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.57 176.21 6.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.716 -179.792 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.683 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.438 -0.578 . . . . 18.329999999999998 109.438 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 4' ' ' PHE . 47.3 tt0 -166.24 -83.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 29.77 109.096 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.84 -6.99 0.88 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.135 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.7 m-85 -62.58 -68.45 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.812 . . . . 20.030000000000001 110.664 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.43 -38.37 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 12.91 110.438 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 71.2 m-80 -55.08 -37.56 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 28.329999999999998 109.483 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 m -75.11 -12.77 60.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.974 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -97.13 -46.05 6.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.109 -0.994 . . . . 22.870000000000001 110.865 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.82 136.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.852 -1.155 . . . . 25.190000000000001 109.906 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -146.92 153.28 45.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.766 -0.827 . . . . 34.609999999999999 108.766 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.14 131.71 44.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.644 1.562 . . . . 11.720000000000001 110.323 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.676 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 72.62 26.93 70.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.673 -1.371 . . . . 10.24 109.673 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -139.48 135.35 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -1.131 . . . . 25.359999999999999 109.363 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.63 135.6 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.304 -0.872 . . . . 10.890000000000001 109.92 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.49 141.9 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.847 -1.168 . . . . 15.82 107.847 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.68 124.79 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 8.9399999999999995 110.917 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -90.1 123.89 34.34 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.365 -1.346 . . . . 9.9299999999999997 107.365 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.4 pt -133.48 -176.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.19 0.995 . . . . 10.619999999999999 111.235 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.6 mtmt -145.02 93.49 5.52 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 106.455 -1.683 . . . . 38.729999999999997 106.455 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.485 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -46.87 80.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.691 1.594 . . . . 24.579999999999998 110.896 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.626 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.5 m -175.39 -37.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.794 -0.817 . . . . 34.82 108.794 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 128.97 31.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.283 -0.886 . . . . 21.460000000000001 110.018 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.67 -14.65 37.15 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.999 1.799 . . . . 13.859999999999999 112.158 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -69.05 -45.43 70.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.648 -1.282 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 108.94 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.535 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -64.45 -55.84 18.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.549 -0.719 . . . . 59.590000000000003 110.343 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 4.8 ptp180 -50.36 -35.68 29.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.548 -1.345 . . . . 0.0 109.118 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' ARG . . . -62.22 -36.82 83.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -71.66 -48.67 46.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.615 -0.678 . . . . 45.490000000000002 109.666 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.76 -31.42 70.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.563 -0.711 . . . . 34.969999999999999 111.023 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.593 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -78.31 -55.26 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.673 -1.267 . . . . 0.0 109.677 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.814 HD23 HD12 ' A' ' 35' ' ' LEU . 3.4 mt -59.89 -21.96 61.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.642 -1.286 . . . . 17.280000000000001 109.146 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -64.86 -26.7 68.44 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.523 -0.917 . . . . 24.109999999999999 108.523 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -90.95 3.17 55.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.553 -0.717 . . . . 44.07 110.38 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.814 HD12 HD23 ' A' ' 32' ' ' LEU . 17.0 mt -91.21 127.99 49.08 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.805 -1.184 . . . . 19.629999999999999 109.494 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -64.99 68.58 0.27 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 121.676 1.584 . . . . 21.539999999999999 109.663 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 35' ' ' LEU . 4.2 mm -82.98 151.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' O ' ' A' ' 39' ' ' GLN . 42.7 mmtt -53.41 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.265 -0.897 . . . . 29.41 109.854 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.613 ' O ' ' O ' ' A' ' 38' ' ' LYS . 6.1 mp0 -50.64 -128.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.645 0.736 . . . . 0.0 110.788 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 49.46 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 O-C-N 121.022 -1.049 . . . . 15.27 110.501 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.676 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -98.47 -13.83 20.34 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.229 -1.159 . . . . 8.7799999999999994 109.62 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -107.76 129.01 55.08 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.617 -0.883 . . . . 7.1299999999999999 108.617 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.54 165.39 27.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.063 -1.023 . . . . 22.030000000000001 110.443 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -128.39 112.98 15.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.759 -1.201 . . . . 16.329999999999998 107.759 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.6 106.92 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 6.5800000000000001 111.326 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.465 ' OD1' HD11 ' A' ' 18' ' ' ILE . 48.4 m-20 -81.99 101.98 10.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.53 -0.915 . . . . 15.32 108.53 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.26 -5.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.001 -1.062 . . . . 10.92 110.762 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 t -95.27 -23.15 17.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 21.719999999999999 109.432 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 18.33 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 22.449999999999999 109.613 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 11.2 t -144.39 -2.96 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.118 -0.989 . . . . 25.629999999999999 110.139 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.0 m-20 74.88 -176.97 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.071 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.426 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 55.62 27.57 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 108.724 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.84 -59.58 2.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 18.870000000000001 110.186 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -58.06 -28.69 64.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 45.210000000000001 110.964 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -64.34 -44.92 90.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.714 -1.241 . . . . 33.020000000000003 109.54 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.41 -53.73 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.919 -1.113 . . . . 9.8399999999999999 109.434 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.29 -41.46 75.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.663 -1.236 . . . . 17.84 107.663 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.86 -33.4 64.51 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.293 -1.373 . . . . 18.84 107.293 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -77.6 -47.62 18.91 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.871 -0.789 . . . . 12.99 108.871 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 69.6 mt -54.3 -36.11 63.34 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.211 -1.033 . . . . 14.609999999999999 108.211 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.5 tp60 -58.24 -51.54 69.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.758 -0.589 . . . . 40.450000000000003 109.551 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -66.44 -52.93 41.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.096 -1.003 . . . . 41.810000000000002 111.073 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.52 -31.76 73.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 21.77 110.813 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 19.2 p -112.35 -70.62 0.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.179 -0.95 . . . . 11.380000000000001 109.856 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 145.98 -43.09 0.92 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.001 -1.64 . . . . 14.789999999999999 109.001 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.67 131.64 44.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -1.045 . . . . 17.809999999999999 110.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 33.02 2.72 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 29.760000000000002 108.962 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 174.05 11.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.44 -0.787 . . . . 18.260000000000002 110.769 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.1 t -122.48 136.81 26.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.473 -0.936 . . . . 8.1999999999999993 108.473 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.738 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 41.5 Cg_endo -84.87 -173.63 10.52 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.897 -0.876 . . . . 7.79 109.867 0.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.738 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -136.52 102.69 5.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.375 -2.084 . . . . 26.050000000000001 105.375 176.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 73' ' ' PHE . 94.4 t -88.5 158.99 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.71 0.767 . . . . 8.6799999999999997 111.527 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.0 m-85 -145.3 87.37 1.8 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.769 -0.582 . . . . 14.07 110.62 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.36 107.94 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 105.926 -1.879 . . . . 9.3399999999999999 105.926 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.96 -154.53 53.09 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.492 -2.643 . . . . 12.42 106.492 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -82.89 -3.42 56.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.556 -1.556 . . . . 44.859999999999999 109.289 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.74 117.07 28.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 0.0 110.59 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.8 t -72.66 153.04 41.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.085 -1.01 . . . . 0.0 109.385 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.35 -29.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 20.449999999999999 109.614 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.67 -136.2 7.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.439 -1.465 . . . . 13.82 109.439 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -115.38 -145.77 8.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.473 -1.451 . . . . 12.42 109.473 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -71.44 -57.76 4.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 109.795 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -52.76 -27.59 18.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.496 -0.753 . . . . 0.0 109.242 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.64 -49.14 27.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -0.83 . . . . 27.059999999999999 109.085 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.2 tt -52.74 -60.94 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 15.31 109.554 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.85 -49.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.819 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 t -48.78 -48.5 41.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.803 -1.185 . . . . 21.789999999999999 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 94' ' ' LEU . 57.8 mt -70.01 -39.72 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 110.978 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.17 -57.55 12.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 110.728 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.45 -23.92 67.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.977 -1.077 . . . . 0.0 109.203 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -81.96 -22.01 36.9 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 109.506 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.19 -10.44 74.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.885 -1.286 . . . . 25.640000000000001 109.885 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.03 -31.43 71.09 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.197 . . . . 50.259999999999998 109.405 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.5 tp -57.88 -60.46 3.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 24.170000000000002 110.413 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.24 -32.32 62.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.601 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.97 -44.54 92.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.942 -1.133 . . . . 28.030000000000001 107.942 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 5.5 ttt180 -61.32 -37.39 83.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.23 -1.026 . . . . 40.960000000000001 108.23 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.52 -33.94 69.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.38 -0.97 . . . . 15.050000000000001 108.38 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -65.53 -56.56 11.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.827 -0.546 . . . . 0.0 111.572 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -48.18 -33.25 8.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 38.640000000000001 110.521 -178.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.9 pt -101.5 -9.35 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.97 42.01 31.13 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.399 -1.08 . . . . 18.539999999999999 110.399 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.38 -15.41 43.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -1.187 . . . . 10.84 109.189 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.6 pp -97.76 -172.99 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.736 -179.839 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.659 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.317 0.579 . . . . 18.329999999999998 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 4' ' ' PHE . 1.3 pt20 -151.78 -77.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 29.77 108.778 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.43 -7.6 0.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.4 m-85 -61.84 -68.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.695 -0.628 . . . . 20.030000000000001 110.731 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -73.48 -40.04 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.355 -0.841 . . . . 12.91 110.365 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 17.6 m-20 -55.21 -37.46 67.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.982 -1.074 . . . . 28.329999999999998 109.104 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m -74.71 -12.68 60.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.97 -47.2 5.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 22.870000000000001 110.362 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.85 136.18 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.862 -1.148 . . . . 25.190000000000001 109.964 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -146.87 154.19 46.96 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.369 -0.975 . . . . 34.609999999999999 108.369 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.06 130.83 42.36 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.413 1.409 . . . . 11.720000000000001 109.97 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.01 64.67 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.785 -1.326 . . . . 10.24 109.785 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -138.9 132.77 30.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 25.359999999999999 109.401 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.1 t -102.68 127.54 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.253 -0.904 . . . . 10.890000000000001 109.4 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.29 140.7 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.507 -0.923 . . . . 15.82 108.507 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 18' ' ' ILE . 33.3 t -122.27 124.22 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.346 -0.846 . . . . 8.9399999999999995 111.088 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -92.51 116.33 28.89 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.192 . . . . 9.9299999999999997 107.783 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 16' ' ' VAL . 29.8 pt -127.65 -178.97 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.308 1.051 . . . . 10.619999999999999 111.47 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.7 mtmt -140.72 90.99 9.5 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 105.749 -1.945 . . . . 38.729999999999997 105.749 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.1 Cg_exo -47.14 80.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.718 1.612 . . . . 24.579999999999998 110.52 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 19' ' ' LYS . 17.9 m -175.68 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.571 -0.9 . . . . 34.82 108.571 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.3 124.24 47.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.374 -0.829 . . . . 21.460000000000001 109.66 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.28 -16.39 17.45 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 122.299 1.999 . . . . 13.859999999999999 112.901 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.34 -42.38 65.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.517 -1.364 . . . . 0.0 109.846 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -64.84 -31.72 73.08 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -61.5 -40.39 94.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.639 -0.875 . . . . 59.590000000000003 108.639 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.614 HH11 ' HG2' ' A' ' 27' ' ' ARG . 13.5 mtt-85 -54.28 -48.26 71.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 108.679 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.28 74.25 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.366 -0.834 . . . . 0.0 109.072 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -71.38 -45.74 62.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.817 . . . . 45.490000000000002 109.524 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 33' ' ' SER . 37.5 mt-10 -70.53 -32.86 70.48 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.599 -0.688 . . . . 34.969999999999999 110.927 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.636 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -79.4 -57.02 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.818 -1.176 . . . . 0.0 110.796 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.636 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -59.54 -22.02 61.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.632 -1.292 . . . . 17.280000000000001 109.818 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 8.9 p -64.51 -23.31 67.23 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.122 -0.986 . . . . 24.109999999999999 108.708 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -93.05 -1.28 56.71 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.442 -0.786 . . . . 44.07 110.048 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -88.63 128.7 51.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.864 -1.147 . . . . 19.629999999999999 108.996 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.06 67.9 0.94 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.685 1.59 . . . . 21.539999999999999 109.581 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm -80.14 148.97 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 39' ' ' GLN . 52.3 mttt -53.65 -167.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.553 -0.717 . . . . 29.41 110.271 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.7 mm100 -52.65 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.758 0.789 . . . . 0.0 111.519 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.5 51.65 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.533 -1.027 . . . . 15.27 110.533 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.55 -28.55 13.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.463 -1.022 . . . . 8.7799999999999994 108.636 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' HG21 ' A' ' 37' ' ' ILE . 59.6 tp -97.14 130.8 44.35 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.598 -0.89 . . . . 7.1299999999999999 108.598 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.2 tp10 -141.14 171.83 13.52 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 22.030000000000001 109.893 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.418 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 29.9 m-85 -134.34 109.0 8.51 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.23 -1.396 . . . . 16.329999999999998 107.23 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.26 102.41 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.543 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.09 97.34 7.5 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.628 -0.878 . . . . 15.32 108.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 56' ' ' ILE . 28.8 pt -61.98 1.61 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 10.92 110.831 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' ASP . 6.4 p -95.56 -28.19 14.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.021 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.23 19.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -0.808 . . . . 22.449999999999999 109.385 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.752 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 15.0 t -143.68 -0.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.945 . . . . 25.629999999999999 109.962 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 65.63 -172.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.581 ' NE2' ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 60.29 10.32 2.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 108.045 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.21 -68.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.802 -0.561 . . . . 18.870000000000001 111.515 -178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -55.72 -29.87 60.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 45.210000000000001 110.994 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.581 ' OE2' ' NE2' ' A' ' 52' ' ' HIS . 11.4 mt-10 -64.83 -42.11 95.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.781 -1.199 . . . . 33.020000000000003 109.738 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 47' ' ' ILE . 2.2 mp -67.5 -53.01 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.829 -1.169 . . . . 9.8399999999999999 109.167 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.04 -43.14 77.55 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.573 -1.269 . . . . 17.84 107.573 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -54.15 -34.02 59.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.021 -1.474 . . . . 18.84 107.021 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -78.51 -45.83 21.04 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 12.99 108.882 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.9 mt -53.45 -33.7 55.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.907 -1.146 . . . . 14.609999999999999 107.907 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 12.0 tp60 -60.84 -57.53 12.26 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.333 0.587 . . . . 40.450000000000003 109.441 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -67.49 -35.49 79.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 41.810000000000002 109.995 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.09 -48.15 74.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 21.77 109.982 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -110.82 -61.89 1.62 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.517 -0.74 . . . . 11.380000000000001 109.344 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.64 -49.36 0.49 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.883 -1.287 . . . . 14.789999999999999 109.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 140.68 31.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 17.809999999999999 110.537 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -101.45 37.74 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.272 -1.01 . . . . 29.760000000000002 108.272 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.448 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -85.42 165.34 17.27 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.158 0.98 . . . . 18.260000000000002 111.764 -178.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.626 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.2 t -115.08 130.87 23.87 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.2 -1.407 . . . . 8.1999999999999993 107.2 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 82' ' ' SER . 14.6 Cg_endo -77.03 -165.02 4.2 Favored 'Cis proline' 0 C--N 1.309 -1.522 0 CA-C-O 122.579 0.991 . . . . 7.79 112.328 0.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.534 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -151.03 89.92 1.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.543 -2.021 . . . . 26.050000000000001 105.543 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 79' ' ' ILE . 92.9 t -85.48 156.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.639 0.733 . . . . 8.6799999999999997 111.896 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.6 m-85 -144.06 91.25 2.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.751 -0.593 . . . . 14.07 111.04 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 mm -72.96 114.56 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 106.047 -1.835 . . . . 9.3399999999999999 106.047 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.74 -154.83 34.76 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.117 -2.793 . . . . 12.42 106.117 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.12 -1.06 51.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.452 -1.616 . . . . 44.859999999999999 109.271 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.14 118.66 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.273 -0.892 . . . . 0.0 110.407 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -75.47 150.15 38.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 72' ' ' VAL . 1.6 pp -114.66 -22.7 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.274 -0.891 . . . . 20.449999999999999 109.122 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.5 -128.91 4.48 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.128 -1.189 . . . . 13.82 110.128 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 -137.26 4.24 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.861 -1.296 . . . . 12.42 109.861 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -72.39 -63.99 1.04 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.49 -1.006 . . . . 0.0 110.119 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -53.51 -26.71 21.98 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 110.108 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 4.2 t0 -75.25 -46.43 33.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 27.059999999999999 109.199 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.1 tt -53.48 -59.16 4.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 15.31 109.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.25 -51.5 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.443 -0.786 . . . . 0.0 110.758 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -47.11 -39.12 12.68 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.903 -1.123 . . . . 21.789999999999999 109.203 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 mt -78.98 -41.8 28.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.495 -0.753 . . . . 0.0 112.124 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -57.24 13.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.579 -1.325 . . . . 0.0 110.625 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.2 -26.22 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.939 -1.101 . . . . 0.0 109.516 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.4 m -80.34 -21.29 42.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.7 -9.96 74.06 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.331 -1.107 . . . . 25.640000000000001 110.331 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -68.36 -29.19 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.003 -1.293 . . . . 50.259999999999998 108.397 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.9 tp -61.21 -63.87 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 24.170000000000002 110.792 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -52.68 -30.95 34.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -65.15 -49.26 70.54 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.148 -1.056 . . . . 28.030000000000001 108.148 178.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -55.86 -36.15 67.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.574 -1.269 . . . . 40.960000000000001 107.574 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.86 -37.34 67.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.664 -0.865 . . . . 15.050000000000001 108.664 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.11 -55.06 20.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.642 . . . . 0.0 111.566 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -48.84 -33.93 11.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.85 -1.156 . . . . 38.640000000000001 110.751 -178.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.95 -14.78 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.823 -1.173 . . . . 0.0 109.04 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.3 8.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.418 -1.073 . . . . 18.539999999999999 110.418 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.78 -19.14 29.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.279 . . . . 10.84 109.855 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -94.67 -175.42 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.711 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.626 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.476 -0.564 . . . . 18.329999999999998 109.476 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.34 -70.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 29.77 109.405 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.43 -11.76 4.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.757 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.18 -73.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 20.030000000000001 110.447 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.31 -37.4 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 12.91 110.059 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.412 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 26.2 m-20 -55.89 -37.09 68.39 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.106 -0.996 . . . . 28.329999999999998 109.582 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -74.5 -12.85 60.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -97.54 -44.33 6.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 110.755 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.33 137.66 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.821 -1.175 . . . . 25.190000000000001 109.611 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -147.83 137.83 12.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.331 -0.988 . . . . 34.609999999999999 108.331 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -51.66 129.21 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.067 1.178 . . . . 11.720000000000001 109.671 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 80.55 24.02 59.37 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.22 -1.552 . . . . 10.24 109.22 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -141.5 137.66 32.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -1.068 . . . . 25.359999999999999 109.402 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.53 137.28 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 10.890000000000001 109.843 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.62 144.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.224 -1.028 . . . . 15.82 108.224 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 18' ' ' ILE . 47.1 t -129.11 123.55 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 8.9399999999999995 111.132 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -90.73 122.61 33.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.533 -1.284 . . . . 9.9299999999999997 107.533 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' PRO . 18.7 pt -130.97 -170.67 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.337 1.065 . . . . 10.619999999999999 110.893 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 21' ' ' THR . 15.6 mtmm -149.24 91.16 4.54 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 105.983 -1.858 . . . . 38.729999999999997 105.983 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.3 Cg_exo -47.26 75.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.776 1.651 . . . . 24.579999999999998 111.004 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 19' ' ' LYS . 21.9 m -170.74 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.089 -0.708 . . . . 34.82 109.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.0 133.61 23.02 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.229 -0.92 . . . . 21.460000000000001 110.076 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.53 -24.96 77.14 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 122.156 1.904 . . . . 13.859999999999999 111.854 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.6 -37.94 73.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.867 -1.146 . . . . 0.0 109.242 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -39.87 91.83 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -61.63 -40.79 96.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.015 -0.735 . . . . 59.590000000000003 109.015 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.05 -47.43 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.13 74.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.181 -0.949 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.61 -44.66 64.03 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 45.490000000000002 110.038 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.602 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 41.8 mm-40 -70.19 -34.47 72.99 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.499 -0.751 . . . . 34.969999999999999 110.979 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -78.65 -57.43 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.782 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 35' ' ' LEU . 2.8 mt -60.55 -20.43 60.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.625 -1.297 . . . . 17.280000000000001 110.086 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.6 p -65.34 -26.49 68.05 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 109.026 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.602 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -90.45 4.57 50.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 44.07 110.616 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 32' ' ' LEU . 18.3 mt -91.45 128.51 46.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.776 -1.203 . . . . 19.629999999999999 109.638 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.35 65.37 0.72 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.872 1.714 . . . . 21.539999999999999 110.021 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.2 mm -78.88 153.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.291 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.0 mmmt -55.6 -169.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 29.41 109.424 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.581 ' O ' ' O ' ' A' ' 38' ' ' LYS . 14.3 mm100 -52.5 -129.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.445 -0.784 . . . . 0.0 111.086 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.53 48.57 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.834 -0.906 . . . . 15.27 110.834 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -97.68 -18.84 18.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.18 -1.188 . . . . 8.7799999999999994 109.344 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -107.4 130.09 54.85 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.585 -0.894 . . . . 7.1299999999999999 108.585 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -141.72 166.85 23.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 22.030000000000001 110.515 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -127.68 109.79 12.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.314 -1.365 . . . . 16.329999999999998 107.314 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -95.04 107.79 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 6.5800000000000001 111.36 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' HD11 ' A' ' 18' ' ' ILE . 69.9 m-20 -81.65 101.79 10.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.269 -1.012 . . . . 15.32 108.269 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.6 pt -63.33 -5.62 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 10.92 110.905 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 t -93.54 -13.59 27.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.845 -1.159 . . . . 21.719999999999999 109.405 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.93 11.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 22.449999999999999 109.443 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.5 t -142.63 -12.3 0.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 25.629999999999999 110.058 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 50' ' ' THR . 15.9 t30 82.71 -172.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.42 -0.8 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 1.6 m-70 57.59 30.27 18.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.126 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.2 p -45.02 -58.65 3.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 18.870000000000001 109.94 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -53.78 -33.94 57.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 45.210000000000001 110.712 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -63.62 -45.94 87.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.754 -1.216 . . . . 33.020000000000003 109.534 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.23 -52.67 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 9.8399999999999999 109.451 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.1 mt-30 -57.27 -40.56 77.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.67 -1.233 . . . . 17.84 107.67 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.71 -32.99 63.79 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.157 -1.423 . . . . 18.84 107.157 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -77.7 -46.37 22.08 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.934 -0.765 . . . . 12.99 108.934 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.76 -36.88 65.32 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.09 -1.078 . . . . 14.609999999999999 108.09 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.3 tp-100 -59.47 -52.57 65.03 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.759 -0.83 . . . . 40.450000000000003 108.759 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.73 -44.14 78.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 41.810000000000002 110.218 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.8 tp -64.1 -42.23 96.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 21.77 110.13 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.614 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 4.6 p -114.05 -74.02 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.438 -0.788 . . . . 11.380000000000001 109.702 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 157.8 -38.89 0.54 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.716 -1.354 . . . . 14.789999999999999 109.716 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.43 133.44 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -1.194 . . . . 17.809999999999999 110.208 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.9 21.65 14.29 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.885 -0.783 . . . . 29.760000000000002 108.885 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.88 171.57 15.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.529 -0.732 . . . . 18.260000000000002 110.316 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.49 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 19.4 t -116.26 138.39 24.23 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.636 -0.875 . . . . 8.1999999999999993 108.636 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HB3' HG22 ' A' ' 18' ' ' ILE . 14.8 Cg_endo -81.68 -167.75 6.06 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 124.854 -0.894 . . . . 7.79 110.95 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.0 92.98 2.54 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.966 -1.865 . . . . 26.050000000000001 105.966 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 85' ' ' LEU . 62.2 t -84.21 155.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.731 0.777 . . . . 8.6799999999999997 111.691 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.2 m-85 -143.03 88.51 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.861 -0.525 . . . . 14.07 110.639 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.29 109.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.987 -1.857 . . . . 9.3399999999999999 105.987 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.76 51.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 106.792 -2.523 . . . . 12.42 106.792 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -86.12 -5.3 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.538 -1.566 . . . . 44.859999999999999 109.152 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB3' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -89.04 116.42 27.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -72.31 152.76 41.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.33 -23.37 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 20.449999999999999 109.702 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.8 -148.76 19.53 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.747 -1.341 . . . . 13.82 109.747 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.535 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -102.12 -148.65 21.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.945 -1.262 . . . . 12.42 109.945 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -70.66 -58.23 3.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 t -53.19 -27.2 20.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.1 m-20 -73.66 -45.72 50.86 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 27.059999999999999 108.817 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -56.26 -60.9 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.539 -0.726 . . . . 15.31 109.952 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.66 -48.03 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.318 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.3 m -49.71 -45.92 49.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.704 -1.247 . . . . 21.789999999999999 109.494 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 mt -70.6 -38.65 74.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.452 ' NE2' HD23 ' A' ' 94' ' ' LEU . 12.4 tp60 -60.4 -58.51 8.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.176 -0.953 . . . . 0.0 110.489 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.89 -25.88 67.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.029 -1.044 . . . . 0.0 109.308 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.79 -15.32 52.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.69 -7.41 62.18 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.673 -1.371 . . . . 25.640000000000001 109.673 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.83 -27.92 66.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.203 -1.175 . . . . 50.259999999999998 109.016 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD23 ' NE2' ' A' ' 89' ' ' GLN . 30.0 tp -59.22 -63.76 1.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -0.847 . . . . 24.170000000000002 110.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.95 -30.24 45.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.502 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.55 -43.43 97.11 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.068 -1.086 . . . . 28.030000000000001 108.068 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.443 HH21 ' HB3' ' A' ' 77' ' ' ASP . 2.0 tpt180 -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.32 -0.992 . . . . 40.960000000000001 108.32 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 mp -71.62 -37.88 70.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.425 -0.797 . . . . 15.050000000000001 109.204 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.18 -56.81 12.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 111.856 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -46.82 -27.51 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.794 -1.191 . . . . 38.640000000000001 110.264 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.71 -17.81 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.723 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.86 39.37 13.68 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.25 -1.14 . . . . 18.539999999999999 110.25 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 -10.19 58.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.178 . . . . 10.84 109.638 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 104' ' ' LEU . 1.3 pt? -95.25 -176.98 3.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 109.964 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.597 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.622 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.375 -0.602 . . . . 18.329999999999998 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.39 -74.36 0.34 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 29.77 108.919 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -58.59 -10.48 2.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.76 . . . . 0.0 109.098 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.25 -68.76 0.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.787 . . . . 20.030000000000001 110.678 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -72.94 -38.49 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.134 -0.979 . . . . 12.91 110.289 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 52.0 m-20 -55.1 -37.28 66.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.061 -1.024 . . . . 28.329999999999998 109.379 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 m -74.97 -12.7 60.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.743 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -97.16 -45.77 6.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 22.870000000000001 110.753 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.16 134.45 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.908 -1.12 . . . . 25.190000000000001 109.391 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -147.61 149.61 34.39 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 34.609999999999999 109.186 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.18 126.17 21.25 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.421 1.414 . . . . 11.720000000000001 110.024 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.7 21.34 61.93 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.607 -1.397 . . . . 10.24 109.607 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -137.64 134.01 34.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -1.058 . . . . 25.359999999999999 109.272 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.6 137.51 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.18 -0.95 . . . . 10.890000000000001 109.617 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.19 147.13 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.211 -1.033 . . . . 15.82 108.211 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.2 t -132.74 122.04 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.932 . . . . 8.9399999999999995 110.803 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -89.43 126.12 35.43 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.478 -1.304 . . . . 9.9299999999999997 107.478 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 70' ' ' PRO . 46.5 pt -133.74 -172.18 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.174 0.988 . . . . 10.619999999999999 111.319 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.744 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.6 mtmt -147.49 96.31 4.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.747 -1.575 . . . . 38.729999999999997 106.747 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 21' ' ' THR . 11.2 Cg_exo -49.22 66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.843 1.696 . . . . 24.579999999999998 111.147 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 19' ' ' LYS . 16.8 p -162.62 -35.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.984 -0.747 . . . . 34.82 108.984 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.13 128.47 35.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 21.460000000000001 110.072 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.25 -14.78 40.42 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 122.12 1.88 . . . . 13.859999999999999 111.996 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -70.54 -43.14 70.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.691 -1.256 . . . . 0.0 109.798 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -31.19 71.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.351 -0.843 . . . . 0.0 109.55 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.82 -47.74 83.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 59.590000000000003 109.544 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.664 HH11 ' HG3' ' A' ' 27' ' ' ARG . 2.4 mmm-85 -51.08 -41.29 59.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 0.0 108.803 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.33 82.75 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -71.57 -46.1 60.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 45.490000000000002 109.663 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.631 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 97.3 mt-10 -68.83 -34.6 75.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.518 -0.738 . . . . 34.969999999999999 110.916 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -76.8 -56.64 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.741 -1.225 . . . . 0.0 110.045 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.638 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -58.51 -20.85 49.49 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.667 -1.271 . . . . 17.280000000000001 109.14 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 m -65.22 -30.44 71.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.25 -0.906 . . . . 24.109999999999999 108.78 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -88.65 3.32 51.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 44.07 110.262 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 35' ' ' LEU . 18.1 mt -91.87 127.77 48.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.826 -1.171 . . . . 19.629999999999999 109.432 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.05 63.55 0.31 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.866 1.711 . . . . 21.539999999999999 110.485 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.1 mm -80.25 147.19 6.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.2 mttp -53.46 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 29.41 110.342 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' LYS . 33.1 mt-30 -49.81 -128.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 111.435 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.53 47.75 0.08 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.87 -0.892 . . . . 15.27 110.87 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -101.24 -15.33 17.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -1.207 . . . . 8.7799999999999994 109.193 179.134 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 37' ' ' ILE . 47.4 tp -110.18 128.73 55.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.404 -0.962 . . . . 7.1299999999999999 108.404 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.1 tt0 -141.32 169.8 16.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.067 . . . . 22.030000000000001 110.317 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.476 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.0 m-85 -133.12 112.87 12.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.048 -1.093 . . . . 16.329999999999998 108.048 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -95.9 102.09 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 6.5800000000000001 111.149 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.7 m-20 -80.19 100.2 8.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.234 -1.024 . . . . 15.32 108.234 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 pt -62.45 -0.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 10.92 110.196 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' ASP . 33.9 p -95.6 -27.03 15.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 21.719999999999999 109.597 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.48 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 22.449999999999999 109.484 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.477 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 14.7 t -145.17 -3.27 0.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 25.629999999999999 110.164 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.704 ' ND2' ' H ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 67.89 -162.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.048 -1.032 . . . . 0.0 108.526 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.704 ' H ' ' ND2' ' A' ' 51' ' ' ASN . 26.2 m-70 56.56 11.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.685 -1.26 . . . . 0.0 108.141 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.75 -69.22 0.11 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 18.870000000000001 111.36 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.1 m-20 -53.04 -31.28 40.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.062 -1.024 . . . . 45.210000000000001 110.895 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.8 -46.21 79.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.782 -1.199 . . . . 33.020000000000003 109.912 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.86 -52.3 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.748 -1.22 . . . . 9.8399999999999999 109.68 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.89 -41.64 82.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.63 -1.248 . . . . 17.84 107.63 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 9.9 m-20 -55.66 -34.23 64.8 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.279 -1.378 . . . . 18.84 107.279 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 1' ' ' ALA . 58.8 t80 -78.15 -50.31 12.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.84 -0.744 . . . . 12.99 109.204 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.5 mt -52.42 -33.07 42.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.164 -1.05 . . . . 14.609999999999999 108.164 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.2 tp60 -60.42 -56.59 19.61 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.656 -0.653 . . . . 40.450000000000003 109.302 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -65.69 -41.19 92.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 41.810000000000002 109.867 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -65.72 -37.22 85.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 21.77 109.815 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.835 HG21 HH11 ' A' ' 71' ' ' ARG . 6.5 p -113.23 -63.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 11.380000000000001 109.555 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 61' ' ' GLN . . . 144.83 -49.21 0.69 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.007 -1.637 . . . . 14.789999999999999 109.007 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.22 44.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.047 . . . . 17.809999999999999 109.958 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.32 36.12 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.519 -0.919 . . . . 29.760000000000002 108.519 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.41 169.52 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.547 -0.721 . . . . 18.260000000000002 110.226 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 3.3 t -120.81 135.41 24.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.107 -1.072 . . . . 8.1999999999999993 108.107 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -81.98 -166.22 4.9 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 124.784 -0.923 . . . . 7.79 111.157 -0.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.835 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -143.03 91.18 2.26 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.789 -1.93 . . . . 26.050000000000001 105.789 177.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 79' ' ' ILE . 58.1 t -82.09 154.23 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 8.6799999999999997 111.211 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 72' ' ' VAL . 75.5 m-85 -143.47 88.67 2.02 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.397 -0.521 . . . . 14.07 110.2 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -71.6 101.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.024 -1.843 . . . . 9.3399999999999999 106.024 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.22 -149.85 39.68 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.345 -2.702 . . . . 12.42 106.345 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' CB ' ' NZ ' ' A' ' 76' ' ' LYS . 8.4 mtmp? -86.97 -6.78 58.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.568 -1.549 . . . . 44.859999999999999 109.474 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' HH21 ' A' ' 97' ' ' ARG . 3.0 m-20 -91.48 121.6 33.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 110.582 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -73.62 155.82 38.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 80' ' ' GLY . 2.8 pp -119.0 -16.61 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.233 -0.917 . . . . 20.449999999999999 109.69 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.572 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 136.23 -150.43 20.44 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.081 -1.207 . . . . 13.82 110.081 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.76 -145.3 11.81 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.955 -1.258 . . . . 12.42 109.955 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -70.89 -62.13 1.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.489 -1.007 . . . . 0.0 110.03 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 t -54.23 -26.43 28.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.349 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -73.88 -45.79 48.68 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -0.874 . . . . 27.059999999999999 109.007 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.6 tt -54.11 -59.66 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.41 -0.806 . . . . 15.31 109.7 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -54.09 -43.49 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 110.503 -178.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.619 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 18.8 m -55.27 -35.48 65.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 21.789999999999999 110.146 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.02 -34.35 32.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 0.0 111.258 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -62.23 -60.57 3.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.004 -1.06 . . . . 0.0 111.124 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.712 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.86 -17.42 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.859 -1.151 . . . . 0.0 109.523 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.544 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 40.4 m -80.26 -62.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.495 -0.753 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.77 4.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.401 -1.479 . . . . 25.640000000000001 109.401 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.37 -30.46 69.41 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.271 -1.135 . . . . 50.259999999999998 108.952 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.73 -64.18 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.431 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.01 -31.4 61.02 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.479 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.61 -45.44 90.34 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.422 -0.955 . . . . 28.030000000000001 108.422 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 77' ' ' ASP . 3.1 ttt180 -61.25 -34.99 76.06 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.273 -1.01 . . . . 40.960000000000001 108.273 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 102' ' ' GLY . 7.9 mp -70.93 -36.14 72.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.721 -0.844 . . . . 15.050000000000001 108.721 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -64.57 -57.5 8.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.782 -0.574 . . . . 0.0 111.346 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 96' ' ' THR . 1.1 pt20 -47.48 -31.72 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.895 -1.128 . . . . 38.640000000000001 110.349 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.86 -11.8 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.995 -1.066 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 73.75 44.51 31.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.507 -1.037 . . . . 18.539999999999999 110.507 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.42 -11.86 50.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -1.218 . . . . 10.84 109.484 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.72 -178.11 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 0.0 110.059 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.393 179.81 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.698 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.535 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.563 -0.532 . . . . 18.329999999999998 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.4 -74.02 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 29.77 109.119 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.62 -8.26 1.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.056 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.8 m-85 -62.19 -72.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.391 -0.818 . . . . 20.030000000000001 110.248 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.84 -39.62 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 12.91 109.929 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 58.4 m-20 -55.6 -37.31 67.94 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 28.329999999999998 109.575 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -74.47 -13.02 60.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.97 -48.34 5.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 22.870000000000001 110.277 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 128.38 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.974 -1.079 . . . . 25.190000000000001 109.869 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -147.85 160.44 38.03 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.56 -0.904 . . . . 34.609999999999999 108.56 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.0 129.19 33.17 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.658 1.572 . . . . 11.720000000000001 111.165 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.54 29.94 50.82 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.865 -0.894 . . . . 10.24 110.865 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -144.8 136.21 25.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.88 -1.364 . . . . 25.359999999999999 110.074 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.24 133.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 10.890000000000001 109.38 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.68 144.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.347 -0.983 . . . . 15.82 108.347 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.42 124.46 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 8.9399999999999995 110.957 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -90.07 121.21 31.92 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.397 -1.334 . . . . 9.9299999999999997 107.397 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -130.7 -175.57 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.276 1.036 . . . . 10.619999999999999 111.2 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.7 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.9 mtmt -148.72 86.59 5.75 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.689 -1.597 . . . . 38.729999999999997 106.689 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' O ' ' OG1' ' A' ' 21' ' ' THR . 15.6 Cg_exo -44.26 76.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.791 1.661 . . . . 24.579999999999998 110.928 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 19' ' ' LYS . 34.2 m -172.02 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.436 -0.95 . . . . 34.82 108.436 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.5 129.62 29.91 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 21.460000000000001 109.505 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.74 -19.92 56.08 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 122.085 1.857 . . . . 13.859999999999999 112.099 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.679 -1.263 . . . . 0.0 109.551 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -32.95 74.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 108.44 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -62.51 -45.51 92.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 59.590000000000003 108.879 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -49.55 -45.2 47.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.12 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.58 84.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.135 -0.978 . . . . 0.0 108.811 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -70.4 -42.57 71.48 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.46 -0.775 . . . . 45.490000000000002 109.659 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.37 -36.05 76.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 34.969999999999999 111.06 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.77 -56.53 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.837 -1.164 . . . . 0.0 110.497 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD23 HD12 ' A' ' 35' ' ' LEU . 2.5 mt -59.78 -19.91 53.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.576 -1.328 . . . . 17.280000000000001 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -65.65 -27.58 68.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.135 -0.978 . . . . 24.109999999999999 108.919 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -90.11 3.81 52.24 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.316 -0.865 . . . . 44.07 110.431 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.712 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -92.49 125.86 54.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.824 -1.172 . . . . 19.629999999999999 109.805 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.98 67.72 0.92 Allowed 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.802 1.668 . . . . 21.539999999999999 109.893 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 mm -79.43 150.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.7 mtpm? -54.19 -171.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.366 -0.834 . . . . 29.41 110.192 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' LYS . 16.7 mt-30 -50.78 -131.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.617 0.722 . . . . 0.0 111.447 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.14 49.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.242 -0.911 . . . . 15.27 110.933 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.8 -17.51 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -1.074 . . . . 8.7799999999999994 109.383 179.268 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.0 tp -107.88 130.9 54.97 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.48 -0.933 . . . . 7.1299999999999999 108.48 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -141.58 169.27 17.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -0.988 . . . . 22.030000000000001 110.418 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -131.92 109.96 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.606 -1.257 . . . . 16.329999999999998 107.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.0 t -94.67 104.01 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 6.5800000000000001 111.186 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -80.71 101.34 9.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.782 -0.822 . . . . 15.32 108.782 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.59 -7.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 10.92 110.198 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -100.49 46.93 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 21.719999999999999 108.804 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.03 20.25 0.31 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.025 -0.732 . . . . 22.449999999999999 109.025 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 9.0 t -144.51 -5.22 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 25.629999999999999 109.513 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 50' ' ' THR . 4.2 t-20 81.38 177.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.38 27.13 11.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.997 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.14 -60.69 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 18.870000000000001 110.41 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 81.6 m-20 -57.47 -29.51 64.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 45.210000000000001 111.022 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.13 -43.95 93.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.724 -1.235 . . . . 33.020000000000003 109.747 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.1 -53.67 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 9.8399999999999999 109.431 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.43 -43.17 83.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.839 -1.171 . . . . 17.84 107.839 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 26.3 m-20 -54.9 -34.93 63.58 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.345 -1.354 . . . . 18.84 107.345 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 1' ' ' ALA . 55.2 t80 -78.76 -47.3 17.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.878 -0.729 . . . . 12.99 109.245 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.76 -32.77 53.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.213 -1.032 . . . . 14.609999999999999 108.213 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 7.5 tp60 -59.49 -55.59 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.879 -0.785 . . . . 40.450000000000003 108.879 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -67.45 -35.5 79.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.181 -0.95 . . . . 41.810000000000002 110.109 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 73' ' ' PHE . 29.3 tp -64.88 -46.42 81.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.1 -1.0 . . . . 21.77 109.91 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.525 HG21 HH11 ' A' ' 71' ' ' ARG . 1.4 p -110.06 -58.5 2.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.47 -0.769 . . . . 11.380000000000001 109.481 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 150.01 -52.46 0.52 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.573 -1.411 . . . . 14.789999999999999 109.573 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 138.28 35.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -1.093 . . . . 17.809999999999999 110.261 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -95.59 32.28 1.85 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.459 -0.941 . . . . 29.760000000000002 108.459 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 165.79 22.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 18.260000000000002 110.207 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 4.9 t -116.79 138.35 24.54 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.056 -1.09 . . . . 8.1999999999999993 108.056 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -80.66 -168.13 6.53 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 124.8 -0.917 . . . . 7.79 111.361 -0.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.549 ' HG3' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.68 90.75 2.03 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.852 -1.907 . . . . 26.050000000000001 105.852 177.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.566 HG21 HD12 ' A' ' 85' ' ' LEU . 74.0 t -83.23 155.58 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.737 0.779 . . . . 8.6799999999999997 111.551 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CE2' HD23 ' A' ' 63' ' ' LEU . 79.6 m-85 -144.12 89.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.818 -0.551 . . . . 14.07 110.921 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -71.72 110.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.084 -1.821 . . . . 9.3399999999999999 106.084 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.66 -153.34 52.5 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.729 -2.548 . . . . 12.42 106.729 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -84.15 -3.74 58.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.564 -1.551 . . . . 44.859999999999999 109.41 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -90.05 118.37 29.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.937 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -72.68 152.26 41.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.031 -1.043 . . . . 0.0 109.416 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -113.87 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -0.969 . . . . 20.449999999999999 109.336 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' HA2' HH22 ' A' ' 71' ' ' ARG . . . 132.51 -155.96 21.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.124 -1.19 . . . . 13.82 110.124 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.95 -147.16 22.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.201 -1.16 . . . . 12.42 110.201 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -70.56 -60.2 2.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.526 -0.985 . . . . 0.0 109.867 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 t -52.43 -25.84 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.286 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.19 -49.08 25.05 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.801 . . . . 27.059999999999999 109.333 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.5 tt -54.7 -59.23 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 15.31 110.145 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.16 -45.41 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.105 -178.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 -47.47 66.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.736 -1.228 . . . . 21.789999999999999 109.492 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.23 -36.54 77.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.903 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -60.77 -59.18 5.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 110.478 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.53 -24.19 67.37 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.432 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -82.55 -16.52 48.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.464 -0.773 . . . . 0.0 109.813 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 -9.88 56.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.819 -1.313 . . . . 25.640000000000001 109.819 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -67.7 -28.18 67.45 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -1.174 . . . . 50.259999999999998 108.809 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.32 -65.7 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 24.170000000000002 110.084 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.24 -30.38 37.78 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.449 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -62.86 -44.68 95.46 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.465 -0.939 . . . . 28.030000000000001 108.465 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.707 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -63.06 -34.11 76.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.662 -0.866 . . . . 40.960000000000001 108.662 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.6 mp -71.11 -35.68 71.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 15.050000000000001 109.023 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -65.11 -56.9 10.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.608 -0.683 . . . . 0.0 111.574 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -46.01 -31.09 2.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 38.640000000000001 110.395 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.4 pt -104.45 -14.44 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.86 40.5 21.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.304 -1.118 . . . . 18.539999999999999 110.304 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.42 -8.06 59.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.239 . . . . 10.84 109.474 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.639 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.18 -178.99 4.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.561 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.685 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.485 -0.561 . . . . 18.329999999999998 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 4' ' ' PHE . 66.7 mt-30 53.82 -99.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 29.77 110.037 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.97 -7.46 0.48 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 109.718 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.5 m-85 -62.17 -69.16 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 20.030000000000001 110.432 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 6' ' ' ASN . 2.5 m -73.51 -40.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 12.91 110.443 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 5' ' ' VAL . 68.4 m-80 -55.21 -29.94 58.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.067 -1.021 . . . . 28.329999999999998 109.497 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 m -75.29 -18.44 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -98.1 -44.03 6.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 22.870000000000001 111.212 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.26 129.18 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.174 . . . . 25.190000000000001 110.585 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.05 158.4 38.91 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.151 -1.055 . . . . 34.609999999999999 108.151 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.0 127.95 27.9 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.544 1.496 . . . . 11.720000000000001 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.12 28.16 46.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.753 -0.939 . . . . 10.24 110.753 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -143.14 136.88 28.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.969 -1.313 . . . . 25.359999999999999 109.933 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.79 134.4 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.386 -0.821 . . . . 10.890000000000001 109.392 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.15 143.0 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.437 -0.949 . . . . 15.82 108.437 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.7 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.405 -0.809 . . . . 8.9399999999999995 110.739 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.62 122.74 33.04 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.487 -1.301 . . . . 9.9299999999999997 107.487 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.6 pt -132.11 -174.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.104 0.954 . . . . 10.619999999999999 111.224 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mtmt -145.77 94.63 5.03 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.585 -1.635 . . . . 38.729999999999997 106.585 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.0 Cg_exo -46.49 82.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.561 1.508 . . . . 24.579999999999998 110.945 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 19' ' ' LYS . 14.7 m 178.95 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 34.82 108.41 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.96 121.88 54.42 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 21.460000000000001 109.711 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.04 -17.57 45.75 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.724 1.616 . . . . 13.859999999999999 111.778 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -68.87 -42.63 76.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.563 -1.335 . . . . 0.0 108.291 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -36.73 83.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -61.15 -39.37 89.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.8 -1.185 . . . . 59.590000000000003 107.8 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.69 -47.15 70.74 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.42 74.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.407 -0.808 . . . . 0.0 108.865 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 33' ' ' SER . 5.4 mt-30 -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.852 . . . . 45.490000000000002 109.745 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.3 mm-40 -69.82 -34.17 73.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 34.969999999999999 111.029 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.48 -55.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 35' ' ' LEU . 1.5 mt -59.25 -24.13 62.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.671 -1.268 . . . . 17.280000000000001 109.696 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.2 p -63.85 -22.22 66.81 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.289 -1.004 . . . . 24.109999999999999 108.289 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -90.09 0.43 57.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.527 -0.733 . . . . 44.07 109.862 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 32' ' ' LEU . 18.9 mt -92.96 127.45 47.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 19.629999999999999 109.656 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.0 66.65 0.58 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.644 1.562 . . . . 21.539999999999999 109.777 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -80.07 148.15 6.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.9 mttp -54.55 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -0.826 . . . . 29.41 110.272 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' LYS . 70.0 mt-30 -51.1 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.641 0.734 . . . . 0.0 111.191 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.24 48.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.924 -0.87 . . . . 15.27 110.924 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -99.8 -17.36 17.71 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.129 -1.218 . . . . 8.7799999999999994 109.137 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' A' ' 37' ' ' ILE . 54.1 tp -108.55 126.92 53.46 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.967 -1.123 . . . . 7.1299999999999999 107.967 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 23.2 tp10 -139.59 163.67 31.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.993 -1.067 . . . . 22.030000000000001 110.253 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.9 m-85 -126.32 110.84 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.677 -1.231 . . . . 16.329999999999998 107.677 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.61 107.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 6.5800000000000001 111.235 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' THR . 4.7 m-20 -82.59 99.61 9.65 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.469 -0.937 . . . . 15.32 108.469 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.2 pt -62.03 5.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 10.92 110.61 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . 16.9 p -97.22 -25.53 15.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.089 -1.007 . . . . 21.719999999999999 109.812 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.91 23.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 22.449999999999999 109.943 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 12.0 t -146.74 0.6 0.76 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 25.629999999999999 110.489 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 6.5 m120 66.45 -177.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.227 -0.921 . . . . 0.0 109.245 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.58 29.92 16.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 108.8 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.85 -56.69 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 18.870000000000001 110.002 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 68.8 m-20 -57.02 -31.4 65.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 45.210000000000001 111.0 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.5 -45.13 92.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.752 -1.218 . . . . 33.020000000000003 109.739 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.43 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.3 mp -66.86 -53.98 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.869 -1.144 . . . . 9.8399999999999999 109.677 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.26 -40.67 78.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.723 -1.214 . . . . 17.84 107.723 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 61.2 m-20 -54.96 -33.73 62.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.037 -1.468 . . . . 18.84 107.037 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -78.86 -48.72 14.15 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.058 -0.719 . . . . 12.99 109.058 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.3 mt -53.96 -33.21 56.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.141 -1.059 . . . . 14.609999999999999 108.141 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 6.9 tp60 -60.58 -57.68 11.68 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.165 -0.68 . . . . 40.450000000000003 109.165 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.09 -36.22 81.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.359 -0.838 . . . . 41.810000000000002 110.023 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 tp -65.38 -49.17 70.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.094 -1.004 . . . . 21.77 109.704 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 2.2 p -109.05 -67.2 1.0 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.74 . . . . 11.380000000000001 109.563 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 161.33 -49.07 0.36 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.258 -1.449 . . . . 14.789999999999999 110.874 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.849 ' HB3' HH12 ' A' ' 71' ' ' ARG . . . -97.81 136.95 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.304 . . . . 17.809999999999999 110.771 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.58 25.21 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.253 -1.388 . . . . 29.760000000000002 107.253 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.579 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -79.15 169.42 18.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.665 0.745 . . . . 18.260000000000002 110.254 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 2.9 t -120.0 135.09 24.1 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.02 -1.104 . . . . 8.1999999999999993 108.02 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -83.72 -164.69 3.61 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 124.868 -0.888 . . . . 7.79 110.797 -0.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.849 HH12 ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -152.41 93.47 1.8 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.036 -2.209 . . . . 26.050000000000001 105.036 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 73' ' ' PHE . 65.7 t -82.5 160.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.859 0.838 . . . . 8.6799999999999997 111.971 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.536 ' N ' HG12 ' A' ' 72' ' ' VAL . 83.9 m-85 -144.47 91.83 2.23 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 116.174 -0.467 . . . . 14.07 110.584 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 98' ' ' LEU . 8.3 mm -71.73 104.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.881 -1.896 . . . . 9.3399999999999999 105.881 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.32 -149.64 51.11 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 106.101 -2.8 . . . . 12.42 106.101 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -84.77 -1.17 55.97 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.489 -1.595 . . . . 44.859999999999999 109.245 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' OD2' ' NH2' ' A' ' 97' ' ' ARG . 85.2 m-20 -89.5 111.76 22.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -72.97 147.67 44.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.89 -21.13 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.289 -0.882 . . . . 20.449999999999999 108.983 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.12 -149.42 18.87 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.18 -1.168 . . . . 13.82 110.18 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.52 -140.66 9.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.405 -1.078 . . . . 12.42 110.405 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 86' ' ' VAL . 11.0 p -70.06 -65.61 0.7 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.729 -0.865 . . . . 0.0 110.334 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -50.83 -27.9 8.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.821 . . . . 0.0 109.692 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -73.92 -49.47 24.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.354 -0.841 . . . . 27.059999999999999 109.345 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.0 tt -56.01 -60.09 3.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 15.31 110.411 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -48.59 -47.17 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 -178.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 t -49.46 -46.34 47.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.791 -1.193 . . . . 21.789999999999999 109.444 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.22 -39.11 75.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.878 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -60.58 -58.39 8.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.894 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.63 -24.75 65.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 109.102 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -79.97 -43.78 21.43 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.653 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.69 -9.96 30.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.393 -1.483 . . . . 25.640000000000001 109.393 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.58 -26.06 65.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -1.082 . . . . 50.259999999999998 108.911 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.52 -64.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 24.170000000000002 110.212 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.24 -30.82 40.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.5 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.32 -44.09 95.94 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.511 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 8.9 tpt180 -61.27 -35.49 77.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.411 -0.959 . . . . 40.960000000000001 108.411 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.6 mp -70.6 -38.93 74.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.857 0.837 . . . . 15.050000000000001 108.82 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -65.55 -53.81 36.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.824 -0.548 . . . . 0.0 112.033 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -48.31 -32.17 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.78 -1.2 . . . . 38.640000000000001 110.42 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.2 pt -103.83 -14.4 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.572 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 78.99 45.4 9.06 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.283 -1.127 . . . . 18.539999999999999 110.283 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.56 -11.81 53.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -1.121 . . . . 10.84 109.187 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.57 -177.85 4.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.14 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.599 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.669 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.495 -0.557 . . . . 18.329999999999998 109.495 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 4' ' ' PHE . 25.1 tt0 51.54 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 29.77 110.138 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 1' ' ' ALA . 38.4 mt-10 -54.51 -11.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.051 -1.031 . . . . 0.0 109.163 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.3 m-85 -63.67 -69.49 0.27 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.476 -0.765 . . . . 20.030000000000001 110.619 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.64 -39.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 12.91 110.169 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.1 m-20 -55.75 -37.98 69.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.212 -0.93 . . . . 28.329999999999998 109.271 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -74.94 -12.03 60.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -97.21 -45.33 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 22.870000000000001 110.721 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.451 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.54 138.95 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.788 -1.195 . . . . 25.190000000000001 110.029 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -149.27 136.77 11.21 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 107.947 -1.131 . . . . 34.609999999999999 107.947 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -50.02 131.51 30.51 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 120.997 1.131 . . . . 11.720000000000001 109.699 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 20.64 70.06 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.209 -1.556 . . . . 10.24 109.209 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -137.82 132.98 33.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -1.06 . . . . 25.359999999999999 109.013 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.32 135.5 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.154 -0.966 . . . . 10.890000000000001 109.754 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.3 142.86 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.268 -1.012 . . . . 15.82 108.268 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 18' ' ' ILE . 39.0 t -124.86 128.07 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 8.9399999999999995 111.201 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -94.74 114.69 26.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.352 -0.981 . . . . 9.9299999999999997 108.352 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 25' ' ' SER . 41.6 pt -125.74 -172.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.537 1.161 . . . . 10.619999999999999 111.587 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -145.89 94.65 4.98 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 105.481 -2.044 . . . . 38.729999999999997 105.481 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.1 Cg_exo -49.21 79.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.392 1.394 . . . . 24.579999999999998 111.06 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.607 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.8 m -177.59 -32.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.539 -0.726 . . . . 34.82 109.442 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.77 124.68 45.09 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 21.460000000000001 109.6 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.78 -17.63 23.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.382 2.054 . . . . 13.859999999999999 113.164 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CG ' HG12 ' A' ' 106' ' ' GSH . 26.4 m-85 -69.91 -49.71 49.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.269 -1.52 . . . . 0.0 109.391 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -59.96 -33.08 71.45 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -61.13 -42.67 98.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.815 -0.809 . . . . 59.590000000000003 108.815 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 1.1 mtt-85 -54.52 -47.81 72.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.008 -1.058 . . . . 0.0 108.754 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 mt-30 -70.07 -41.81 73.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.36 -0.837 . . . . 45.490000000000002 109.435 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.599 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 42.5 mt-10 -72.19 -38.74 68.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.565 -0.709 . . . . 34.969999999999999 111.461 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -74.19 -55.69 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.813 -1.18 . . . . 0.0 110.093 -178.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.63 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -60.02 -20.08 56.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.538 -1.351 . . . . 17.280000000000001 109.649 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.1 m -65.73 -30.2 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.103 -0.998 . . . . 24.109999999999999 109.539 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 1.6 mp0 -93.85 4.93 53.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 44.07 110.902 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' OE1' ' A' ' 89' ' ' GLN . 21.6 mt -88.35 132.18 40.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.767 -1.208 . . . . 19.629999999999999 108.604 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.85 62.52 0.59 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.577 1.518 . . . . 21.539999999999999 110.258 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.3 mm -78.32 146.94 7.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.032 -1.043 . . . . 0.0 108.225 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 39' ' ' GLN . 18.6 mtpt -53.65 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.062 -1.024 . . . . 29.41 109.944 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 41' ' ' LEU . 26.9 mt-30 -52.29 -127.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.691 0.758 . . . . 0.0 112.363 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.81 48.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.102 -0.799 . . . . 15.27 111.102 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -99.66 -33.04 10.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.263 -1.14 . . . . 8.7799999999999994 108.81 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.6 tp -94.42 132.81 38.67 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.466 0.65 . . . . 7.1299999999999999 109.446 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.6 tp10 -142.01 174.05 10.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 22.030000000000001 109.515 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.463 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 46.7 m-85 -136.63 112.02 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.196 -1.409 . . . . 16.329999999999998 107.196 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.31 104.01 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 6.5800000000000001 111.775 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.6 m-20 -82.68 97.62 8.63 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.603 -0.888 . . . . 15.32 108.603 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.53 1.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 10.92 110.499 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 46' ' ' ASP . 18.1 p -93.61 -17.26 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.027 -1.046 . . . . 21.719999999999999 108.635 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 7.27 5.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.49 -0.756 . . . . 22.449999999999999 109.546 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.0 t -142.31 -3.99 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 25.629999999999999 110.009 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' C ' ' N ' ' A' ' 53' ' ' THR . 8.7 t30 66.55 -151.73 0.21 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.24 13.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.667 -1.271 . . . . 0.0 108.631 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 51' ' ' ASN . 4.3 p -41.59 -55.95 2.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.79 . . . . 18.870000000000001 110.733 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -52.31 -36.81 54.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 45.210000000000001 110.503 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -65.92 -45.01 83.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.06 . . . . 33.020000000000003 109.493 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -67.35 -52.55 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 9.8399999999999999 109.563 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 2.8 mt-30 -56.2 -43.74 78.78 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.231 -1.396 . . . . 17.84 107.231 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -55.5 -34.51 64.67 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.85 -1.537 . . . . 18.84 106.85 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -78.71 -48.81 14.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 120.245 -0.582 . . . . 12.99 109.506 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -51.95 -34.35 41.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.924 -1.139 . . . . 14.609999999999999 107.924 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.703 ' NE2' ' NH2' ' A' ' 67' ' ' ARG . 12.7 tp60 -61.16 -58.2 9.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.304 0.573 . . . . 40.450000000000003 109.768 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -68.47 -35.65 77.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.177 -0.952 . . . . 41.810000000000002 110.861 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.94 -48.24 77.3 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 21.77 110.107 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -113.08 -61.79 1.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 11.380000000000001 109.423 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 160.9 -56.75 0.31 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.647 -1.381 . . . . 14.789999999999999 109.647 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -99.07 143.58 29.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -1.116 . . . . 17.809999999999999 109.296 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.703 ' NH2' ' NE2' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -108.95 20.85 17.96 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.026 -1.102 . . . . 29.760000000000002 108.026 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.424 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.2 OUTLIER -68.01 165.63 17.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.346 -0.846 . . . . 18.260000000000002 109.524 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 2.6 t -105.6 131.08 22.06 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 8.1999999999999993 108.859 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 82' ' ' SER . 33.5 Cg_endo -84.65 -165.96 4.15 Favored 'Cis proline' 0 C--N 1.309 -1.548 0 CA-C-O 122.521 0.967 . . . . 7.79 111.674 -1.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.579 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 7.1 tpp180 -152.73 92.48 1.66 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.794 -2.299 . . . . 26.050000000000001 104.794 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 95.3 t -81.62 157.4 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.782 0.801 . . . . 8.6799999999999997 112.021 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.8 m-85 -139.81 88.45 2.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.718 -0.614 . . . . 14.07 111.297 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mm -71.93 113.88 9.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.921 -2.252 . . . . 9.3399999999999999 104.921 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.2 -154.52 29.18 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.796 -2.922 . . . . 12.42 105.796 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -83.01 0.34 45.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.218 -1.754 . . . . 44.859999999999999 108.622 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.46 110.01 19.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -74.35 142.33 45.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.675 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 1.9 pt -107.2 -22.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.979 -1.076 . . . . 20.449999999999999 109.166 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.28 19.05 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.212 -1.155 . . . . 13.82 110.212 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.79 -145.25 15.3 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.198 -1.161 . . . . 12.42 110.198 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.6 t -71.8 -60.53 2.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 t -51.38 -24.2 4.56 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.428 0.632 . . . . 0.0 109.483 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 3.5 t70 -76.73 -51.4 11.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.808 . . . . 27.059999999999999 109.394 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.2 tt -51.27 -58.91 4.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 15.31 109.975 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.2 -54.23 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.551 -0.718 . . . . 0.0 109.865 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' VAL . 74.3 m -44.68 -36.69 3.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.335 -0.853 . . . . 21.789999999999999 109.119 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 94' ' ' LEU . 32.3 mt -80.83 -43.49 19.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.493 -0.754 . . . . 0.0 111.409 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.456 ' OE1' HD11 ' A' ' 35' ' ' LEU . 22.9 tp60 -61.01 -56.2 23.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 111.018 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.54 -26.0 64.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.742 -1.224 . . . . 0.0 108.911 -179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.8 m -79.18 -60.82 2.22 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.17 -7.93 6.01 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.061 -1.215 . . . . 25.640000000000001 110.061 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -70.12 -26.15 63.83 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.064 -1.256 . . . . 50.259999999999998 108.856 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.3 tp -60.08 -62.34 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.819 . . . . 24.170000000000002 110.717 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.12 -28.8 42.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.8 -49.48 68.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.317 -0.994 . . . . 28.030000000000001 108.317 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.436 ' NH1' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.22 -33.39 65.32 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.412 -1.329 . . . . 40.960000000000001 107.412 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.51 -41.0 66.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.88 -0.785 . . . . 15.050000000000001 108.88 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -64.77 -52.07 58.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.731 -0.605 . . . . 0.0 111.693 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.96 -34.1 27.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.836 -1.165 . . . . 38.640000000000001 111.007 -177.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 101' ' ' ILE . 19.9 pt -99.55 -18.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.63 -1.294 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.6 40.95 7.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.605 -0.998 . . . . 18.539999999999999 110.605 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.75 -10.98 56.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.09 -1.241 . . . . 10.84 109.436 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.692 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.58 178.15 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.63 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.617 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.558 . . . . 18.329999999999998 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -79.31 -66.44 0.87 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 29.77 109.368 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -59.94 -14.32 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.422 -0.799 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.27 -75.74 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.178 -0.951 . . . . 20.030000000000001 110.483 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -74.24 -36.44 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 12.91 109.818 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.407 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 50.7 m-20 -56.14 -38.23 70.56 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 28.329999999999998 109.81 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.3 m -74.1 -12.46 60.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.095 -1.003 . . . . 0.0 109.86 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -97.63 -45.37 6.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 22.870000000000001 110.72 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.21 130.67 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.828 -1.17 . . . . 25.190000000000001 110.116 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.67 157.21 36.28 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.018 -1.104 . . . . 34.609999999999999 108.018 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.89 131.54 46.14 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.897 1.731 . . . . 11.720000000000001 111.588 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.74 21.76 68.08 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.488 -0.863 . . . . 10.24 111.073 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -140.11 132.76 28.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.972 -1.311 . . . . 25.359999999999999 109.415 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.74 133.75 41.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.401 -0.812 . . . . 10.890000000000001 109.404 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.93 142.9 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.673 -0.862 . . . . 15.82 108.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 18' ' ' ILE . 28.9 t -125.91 126.8 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 8.9399999999999995 111.202 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -94.18 116.91 29.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 9.9299999999999997 107.881 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.8 pt -127.82 -171.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 122.635 1.207 . . . . 10.619999999999999 111.527 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.5 mtmt -149.32 87.47 5.27 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 105.823 -1.918 . . . . 38.729999999999997 105.823 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 21' ' ' THR . 16.7 Cg_exo -47.21 73.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.712 1.608 . . . . 24.579999999999998 110.861 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.8 p -161.88 -37.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.038 -1.097 . . . . 34.82 108.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.39 129.76 28.47 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 21.460000000000001 109.434 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -56.98 -24.55 57.99 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.404 2.07 . . . . 13.859999999999999 112.579 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.65 -41.64 87.9 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.38 -1.45 . . . . 0.0 108.76 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.664 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.12 -35.06 76.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.72 -1.215 . . . . 59.590000000000003 107.72 178.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -54.62 -47.98 72.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 179.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.58 76.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.316 -0.865 . . . . 0.0 108.841 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -70.95 -41.66 70.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.467 -0.771 . . . . 45.490000000000002 109.75 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -71.31 -37.33 71.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 34.969999999999999 111.281 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -76.46 -58.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 110.525 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -58.51 -22.75 56.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.623 -1.298 . . . . 17.280000000000001 109.945 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -64.92 -25.65 67.97 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.049 -1.032 . . . . 24.109999999999999 108.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -92.99 -0.82 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.81 . . . . 44.07 110.066 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 35' ' ' LEU . 21.1 mt -87.91 130.9 44.88 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.935 -1.103 . . . . 19.629999999999999 108.465 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.23 65.93 1.05 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.766 1.644 . . . . 21.539999999999999 110.592 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.6 mm -80.71 147.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.4 mttt -54.82 -166.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 29.41 110.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.642 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 1.7 mp0 -52.63 -131.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.834 0.826 . . . . 0.0 111.983 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.97 49.18 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.537 -1.025 . . . . 15.27 110.537 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -97.51 -30.44 12.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.307 -1.113 . . . . 8.7799999999999994 108.723 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -95.9 133.83 39.6 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.092 -0.707 . . . . 7.1299999999999999 109.092 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 22.1 tt0 -142.61 174.3 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 22.030000000000001 110.003 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 41.5 m-85 -136.98 110.68 8.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.438 -1.319 . . . . 16.329999999999998 107.438 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.11 104.77 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 6.5800000000000001 111.886 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.8 m-20 -81.44 102.53 10.58 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.512 -0.921 . . . . 15.32 108.512 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.5 pt -64.08 -2.13 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 10.92 111.54 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.25 -17.89 23.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.788 -1.195 . . . . 21.719999999999999 108.739 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 13.42 1.74 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.466 -0.771 . . . . 22.449999999999999 109.471 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.5 t -142.81 -0.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 25.629999999999999 109.847 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 67.2 -171.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.563 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.21 31.37 18.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.833 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -53.71 10.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 18.870000000000001 109.806 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 5.3 m-20 -54.94 -37.42 66.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 45.210000000000001 110.817 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.9 mp0 -62.1 -46.96 86.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.91 -1.119 . . . . 33.020000000000003 110.167 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.67 -54.75 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.784 -1.197 . . . . 9.8399999999999999 110.172 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -56.81 -41.11 77.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.523 -1.36 . . . . 17.84 107.705 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 6.0 m-20 -54.56 -33.93 60.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.959 -1.496 . . . . 18.84 106.959 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -79.67 -48.32 13.9 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.108 -0.637 . . . . 12.99 109.385 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.7 mt -52.69 -33.65 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.047 -1.033 . . . . 14.609999999999999 108.283 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.5 tp-100 -59.58 -54.85 41.78 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.321 0.581 . . . . 40.450000000000003 109.538 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.41 -42.27 83.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 41.810000000000002 110.347 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.7 tp -62.6 -47.23 84.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 21.77 110.562 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -108.94 -63.39 1.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.266 -0.896 . . . . 11.380000000000001 109.671 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.02 -38.97 1.02 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.399 -1.481 . . . . 14.789999999999999 109.399 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.32 140.29 32.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -1.151 . . . . 17.809999999999999 110.012 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -106.34 24.79 11.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.504 -0.924 . . . . 29.760000000000002 108.504 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.804 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.96 169.32 16.14 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.556 0.693 . . . . 18.260000000000002 110.909 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.629 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 10.9 t -110.9 133.36 21.27 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.291 -1.003 . . . . 8.1999999999999993 108.291 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.6 Cg_endo -86.74 -163.76 2.75 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 CA-C-O 122.617 1.007 . . . . 7.79 111.86 -1.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -145.04 95.72 2.73 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.489 -2.041 . . . . 26.050000000000001 105.489 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG21 HD12 ' A' ' 85' ' ' LEU . 94.4 t -85.54 156.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.366 -0.834 . . . . 8.6799999999999997 111.653 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' N ' HG12 ' A' ' 72' ' ' VAL . 78.4 m-85 -144.74 91.33 2.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.604 -0.685 . . . . 14.07 111.549 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.58 115.37 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.01 -2.218 . . . . 9.3399999999999999 105.01 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.45 -155.56 18.13 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 105.707 -2.957 . . . . 12.42 105.707 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.76 5.26 16.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.215 -1.756 . . . . 44.859999999999999 108.637 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 m-20 -89.52 115.04 26.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.387 -0.821 . . . . 0.0 110.793 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 t -77.41 141.92 39.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.306 -0.871 . . . . 0.0 109.678 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.2 pt -109.64 -17.65 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.163 -0.961 . . . . 20.449999999999999 109.197 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.11 -160.19 21.3 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.071 -1.212 . . . . 13.82 110.071 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' CA ' HH21 ' A' ' 71' ' ' ARG . . . -89.26 -148.25 17.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.054 -1.218 . . . . 12.42 110.054 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.55 -60.37 2.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -1.005 . . . . 0.0 110.026 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 t -51.24 -25.38 5.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.192 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.38 -47.91 25.37 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.423 -0.798 . . . . 27.059999999999999 109.03 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -54.04 -59.41 4.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.457 -0.777 . . . . 15.31 110.015 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.19 -51.38 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.371 -0.831 . . . . 0.0 110.309 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 9.0 m -46.82 -34.36 5.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.153 -0.967 . . . . 21.789999999999999 108.975 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.24 -38.94 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 111.734 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.417 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.5 OUTLIER -60.21 -59.19 5.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.08 -19.21 62.71 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.98 -1.075 . . . . 0.0 109.633 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.0 m -81.49 -45.5 15.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.062 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.77 -11.16 27.65 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.308 -1.117 . . . . 25.640000000000001 110.308 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -69.3 -25.5 64.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.279 . . . . 50.259999999999998 108.32 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.4 tp -59.91 -67.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.568 0.699 . . . . 24.170000000000002 110.848 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.32 -29.61 24.33 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -64.63 -46.78 81.1 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.828 -1.175 . . . . 28.030000000000001 107.828 178.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.485 ' NH1' HG22 ' A' ' 79' ' ' ILE . 7.1 ttt180 -59.51 -34.12 72.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.897 -1.149 . . . . 40.960000000000001 107.897 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . 10.4 mp -70.15 -40.48 74.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.612 -0.884 . . . . 15.050000000000001 108.612 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.32 -52.49 46.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.815 -0.553 . . . . 0.0 112.185 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -49.76 -29.34 7.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.691 -1.255 . . . . 38.640000000000001 110.926 -177.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.0 pt -102.7 -22.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.731 -1.231 . . . . 0.0 109.011 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.498 ' O ' ' CE ' ' A' ' 38' ' ' LYS . . . 90.0 47.54 3.86 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.387 -1.085 . . . . 18.539999999999999 110.387 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.15 -14.98 28.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.147 -1.208 . . . . 10.84 110.0 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.684 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -94.6 177.82 5.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.724 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.629 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.413 -0.588 . . . . 18.329999999999998 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' N ' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -89.1 -72.95 0.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 29.77 111.384 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 2' ' ' GLN . 10.9 pt-20 -58.08 -23.65 55.48 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.302 -0.873 . . . . 0.0 111.672 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -61.93 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.791 -1.193 . . . . 20.030000000000001 111.482 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.36 -39.34 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.268 -0.895 . . . . 12.91 110.57 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 70.0 m-20 -54.38 -37.3 64.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 28.329999999999998 108.979 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.0 m -74.71 -11.23 60.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.376 -0.827 . . . . 0.0 109.192 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.44 -51.24 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 22.870000000000001 109.688 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -78.91 133.82 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 25.190000000000001 109.621 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 9' ' ' ILE . 6.6 mp0 -144.53 152.32 52.84 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.028 -1.101 . . . . 34.609999999999999 108.028 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.88 129.05 32.89 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.246 1.298 . . . . 11.720000000000001 109.243 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.53 22.83 78.11 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.349 -1.5 . . . . 10.24 109.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.77 128.56 42.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -1.064 . . . . 25.359999999999999 108.973 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -100.37 129.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.461 -0.774 . . . . 10.890000000000001 109.272 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.05 142.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.34 -0.985 . . . . 15.82 108.34 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG12 HG23 ' A' ' 18' ' ' ILE . 40.5 t -124.12 123.72 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 8.9399999999999995 111.055 -177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.05 117.35 29.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 16' ' ' VAL . 16.5 pt -130.06 -172.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.578 1.18 . . . . 10.619999999999999 111.518 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' THR . 26.2 mtmt -150.2 85.58 5.42 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 105.841 -1.911 . . . . 38.729999999999997 105.841 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 21' ' ' THR . 18.4 Cg_exo -45.83 81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.483 1.456 . . . . 24.579999999999998 110.766 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' LYS . 32.6 m -173.67 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.169 -1.048 . . . . 34.82 108.169 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 127.08 36.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.799 . . . . 21.460000000000001 108.841 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.68 -22.69 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.192 1.928 . . . . 13.859999999999999 113.075 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' CG ' HG12 ' A' ' 106' ' ' GSH . 29.3 m-85 -68.72 -42.35 77.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.284 -1.51 . . . . 0.0 108.96 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -37.2 79.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 26' ' ' ARG . 8.0 mmm-85 -62.21 -41.75 98.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.192 -0.67 . . . . 59.590000000000003 109.192 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -54.02 -49.5 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.12 -0.987 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.2 75.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.155 -0.966 . . . . 0.0 108.909 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.52 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 3.8 mm-40 -71.14 -42.28 69.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.361 -0.837 . . . . 45.490000000000002 109.723 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 33' ' ' SER . 48.4 mt-10 -70.89 -35.83 72.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.548 -0.72 . . . . 34.969999999999999 111.142 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.626 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.0 -56.45 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.927 -1.108 . . . . 0.0 110.798 -178.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -58.67 -23.91 60.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.457 -1.402 . . . . 17.280000000000001 109.891 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 2.5 p -63.28 -19.35 64.5 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.977 -1.077 . . . . 24.109999999999999 108.321 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -92.99 -4.38 52.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.539 -0.725 . . . . 44.07 110.071 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.715 HD12 HD23 ' A' ' 32' ' ' LEU . 21.5 mt -88.74 129.78 47.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.014 -1.054 . . . . 19.629999999999999 108.979 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.11 68.43 1.89 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.563 1.508 . . . . 21.539999999999999 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.6 mm -80.44 142.42 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -57.3 156.25 7.85 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.231 -0.918 . . . . 29.41 110.076 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -58.31 141.56 50.71 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.478 0.656 . . . . 0.0 111.664 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.26 47.16 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.524 -0.735 . . . . 15.27 112.04 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.08 -35.1 9.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.75 -1.441 . . . . 8.7799999999999994 110.072 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 37' ' ' ILE . 63.8 tp -93.54 134.91 35.32 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.485 -0.76 . . . . 7.1299999999999999 109.719 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -144.37 175.05 10.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 22.030000000000001 109.708 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.52 ' CD1' ' OE1' ' A' ' 29' ' ' GLN . 39.7 m-85 -137.63 109.06 6.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.078 -1.452 . . . . 16.329999999999998 107.078 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.26 106.43 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 6.5800000000000001 111.682 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' OD1' HD11 ' A' ' 18' ' ' ILE . 8.0 m-20 -83.79 98.31 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.69 . . . . 15.32 109.3 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.93 -9.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 10.92 110.811 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -96.07 40.65 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.824 -1.176 . . . . 21.719999999999999 107.824 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.47 10.32 0.43 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.47 -0.892 . . . . 22.449999999999999 110.657 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 t -127.86 -3.38 5.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.329 -2.1 . . . . 25.629999999999999 105.329 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 71.88 -175.24 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.676 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER 54.64 18.44 2.05 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 52' ' ' HIS . 1.8 m -29.96 -56.58 0.18 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.443 -0.799 . . . . 18.870000000000001 110.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 3.3 m-20 -59.26 -33.01 70.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.412 -0.805 . . . . 45.210000000000001 111.859 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' HIS . 61.5 mm-40 -60.61 -46.84 88.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.708 -1.245 . . . . 33.020000000000003 109.124 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' HA ' ' CB ' ' A' ' 1' ' ' ALA . 2.5 mp -63.29 -55.42 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 9.8399999999999999 109.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.3 mt-30 -57.67 -41.14 80.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 17.84 108.474 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.1 -35.61 59.81 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.84 -1.171 . . . . 18.84 107.84 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -80.0 -44.01 20.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.87 -0.789 . . . . 12.99 108.87 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.44 -37.02 46.54 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.517 -1.29 . . . . 14.609999999999999 107.517 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -61.23 -55.98 25.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.808 -0.812 . . . . 40.450000000000003 108.808 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.99 -37.22 83.82 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.4 -0.813 . . . . 41.810000000000002 110.127 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.94 -52.14 52.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 21.77 109.881 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.4 p -109.72 -65.39 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.599 -0.688 . . . . 11.380000000000001 109.852 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.46 -42.18 0.58 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.703 -1.237 . . . . 14.789999999999999 110.042 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -96.94 139.4 33.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -1.173 . . . . 17.809999999999999 110.363 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.01 31.3 6.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.392 -0.966 . . . . 29.760000000000002 108.392 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.34 173.05 10.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.676 0.751 . . . . 18.260000000000002 111.295 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.597 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 6.1 t -113.11 129.14 24.83 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 107.669 -1.234 . . . . 8.1999999999999993 107.669 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.6 Cg_endo -82.59 -166.13 4.74 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 CA-C-O 122.504 0.96 . . . . 7.79 112.02 -0.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.518 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -145.73 90.42 1.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 105.42 -2.067 . . . . 26.050000000000001 105.42 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 73' ' ' PHE . 93.3 t -83.93 157.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 8.6799999999999997 112.355 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' N ' HG12 ' A' ' 72' ' ' VAL . 58.0 m-85 -145.14 89.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 14.07 111.111 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 101' ' ' ILE . 3.6 mm -71.13 116.41 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.006 -2.22 . . . . 9.3399999999999999 105.006 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.26 -158.88 16.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 105.867 -2.893 . . . . 12.42 105.867 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -80.96 2.98 24.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.197 -1.766 . . . . 44.859999999999999 108.787 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 97' ' ' ARG . 17.2 m-20 -88.76 114.77 25.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.365 -0.835 . . . . 0.0 110.219 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -75.53 142.15 42.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 110.079 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -108.76 -20.64 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.174 -0.954 . . . . 20.449999999999999 108.822 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.07 -162.22 21.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.04 -1.224 . . . . 13.82 110.04 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.78 -148.27 12.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.137 -1.185 . . . . 12.42 110.137 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -70.53 -60.44 2.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.993 . . . . 0.0 110.04 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.8 t -50.61 -24.18 3.1 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.448 -0.783 . . . . 0.0 109.282 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.65 -49.13 16.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.424 -0.798 . . . . 27.059999999999999 109.283 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.66 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.4 tt -52.54 -59.88 3.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 15.31 110.043 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.78 -53.13 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.254 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.7 t -44.91 -36.0 3.11 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.119 -0.988 . . . . 21.789999999999999 109.246 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 94' ' ' LEU . 41.6 mt -81.66 -41.2 21.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.507 -0.746 . . . . 0.0 111.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -57.65 -57.68 11.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.81 -1.181 . . . . 0.0 110.63 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.91 -26.1 67.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.998 -1.064 . . . . 0.0 109.671 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.0 m -80.15 -24.26 40.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.01 -7.52 82.0 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.616 -0.994 . . . . 25.640000000000001 110.616 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.06 -26.15 63.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.934 -1.333 . . . . 50.259999999999998 108.392 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.526 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.13 -64.52 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.766 -0.583 . . . . 24.170000000000002 110.777 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.77 -29.61 40.85 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.402 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.21 -48.05 74.73 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.777 -1.194 . . . . 28.030000000000001 107.777 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.463 HH21 ' CG ' ' A' ' 77' ' ' ASP . 10.4 tpt180 -57.21 -32.71 66.78 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.681 -1.229 . . . . 40.960000000000001 107.681 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -72.43 -40.7 66.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.57 -0.9 . . . . 15.050000000000001 108.57 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.43 -53.41 48.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.661 -0.649 . . . . 0.0 111.647 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -33.57 15.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.747 -1.22 . . . . 38.640000000000001 110.714 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 74' ' ' ILE . 15.0 pt -99.57 -17.43 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.672 -1.267 . . . . 0.0 109.006 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.5 42.57 8.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.216 -1.154 . . . . 18.539999999999999 110.216 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.7 -12.92 52.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 10.84 109.525 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.7 174.75 6.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.449 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.662 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.611 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.781 -0.452 . . . . 18.329999999999998 109.781 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' C ' ' O ' ' A' ' 1' ' ' ALA . 38.0 mt-30 30.06 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.825 -0.547 . . . . 29.77 111.339 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 1' ' ' ALA . 16.7 pt-20 -56.17 -12.14 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.14 -71.28 0.18 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.344 -0.847 . . . . 20.030000000000001 110.666 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.64 -40.92 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 12.91 110.559 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 11.7 m120 -54.78 -35.99 64.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.223 -0.923 . . . . 28.329999999999998 109.509 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.8 m -75.1 -12.83 60.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.156 -0.965 . . . . 0.0 109.437 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -96.78 -49.81 4.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 22.870000000000001 110.549 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 126.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 25.190000000000001 109.819 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 157.07 43.46 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.358 -0.979 . . . . 34.609999999999999 108.358 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.68 130.34 39.91 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.748 1.632 . . . . 11.720000000000001 111.299 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.93 24.38 60.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.952 -0.859 . . . . 10.24 110.952 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -143.28 135.36 26.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.326 . . . . 25.359999999999999 109.952 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.8 137.37 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.36 -0.837 . . . . 10.890000000000001 109.257 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.59 143.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 15.82 108.732 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.17 121.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.399 -0.813 . . . . 8.9399999999999995 110.535 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -89.97 123.31 33.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.504 -1.295 . . . . 9.9299999999999997 107.504 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.7 pt -133.71 -172.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.447 1.117 . . . . 10.619999999999999 111.723 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.2 mtmt -144.02 96.67 5.42 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.236 -1.764 . . . . 38.729999999999997 106.236 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 11.2 Cg_exo -51.28 75.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.601 1.534 . . . . 24.579999999999998 110.586 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.9 m -170.68 -32.74 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.739 -0.837 . . . . 34.82 108.739 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.33 127.14 39.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 21.460000000000001 109.767 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.37 -12.09 19.0 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.213 1.942 . . . . 13.859999999999999 112.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CG ' HG12 ' A' ' 106' ' ' GSH . 17.3 m-85 -72.25 -45.04 61.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.614 -1.304 . . . . 0.0 109.552 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -36.52 84.2 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.46 -33.29 69.59 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.671 -1.603 . . . . 59.590000000000003 106.671 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.13 -59.66 5.11 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.722 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.53 64.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.371 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.502 ' CD ' ' CD1' ' A' ' 44' ' ' PHE . 6.5 mm-40 -68.66 -32.91 73.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.224 -0.923 . . . . 45.490000000000002 108.841 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -71.63 -40.62 69.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 34.969999999999999 111.02 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -77.67 -59.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.896 -1.127 . . . . 0.0 111.017 -178.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 35' ' ' LEU . 4.9 mt -57.21 -22.66 42.45 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.806 -1.184 . . . . 17.280000000000001 110.215 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -66.56 -33.41 75.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.027 -1.045 . . . . 24.109999999999999 109.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.75 9.37 39.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 44.07 111.03 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 32' ' ' LEU . 14.4 mt -90.09 134.72 31.09 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.537 -1.352 . . . . 19.629999999999999 108.969 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.46 64.18 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 121.814 1.676 . . . . 21.539999999999999 110.231 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.507 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.7 mm -84.74 144.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.37 -0.831 . . . . 0.0 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -55.84 153.34 8.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.119 -0.988 . . . . 29.41 109.914 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -56.14 138.1 50.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 111.482 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.05 14.14 51.72 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.534 -0.729 . . . . 15.27 111.831 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.88 -21.74 14.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.825 -1.397 . . . . 8.7799999999999994 109.828 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 37' ' ' ILE . 43.1 tp -102.78 127.82 49.77 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 7.1299999999999999 109.387 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 44' ' ' PHE . 17.1 tp10 -142.77 164.69 29.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 22.030000000000001 109.85 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.502 ' CD1' ' CD ' ' A' ' 29' ' ' GLN . 14.1 m-85 -126.19 114.4 18.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.342 -1.355 . . . . 16.329999999999998 107.342 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -95.59 102.6 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 6.5800000000000001 111.553 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.24 102.98 9.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.695 -1.224 . . . . 15.32 107.695 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 56' ' ' ILE . 21.5 pt -61.74 -1.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 10.92 111.434 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -93.11 -13.55 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.714 -1.241 . . . . 21.719999999999999 109.147 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 7.16 5.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 22.449999999999999 109.578 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 t -143.94 -0.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.157 -0.964 . . . . 25.629999999999999 109.936 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 68.51 -159.09 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 108.592 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.38 16.88 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.113 . . . . 0.0 108.537 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -41.8 -59.03 1.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.46 -0.775 . . . . 18.870000000000001 110.483 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.3 m-20 -53.48 -36.52 61.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 45.210000000000001 110.765 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.23 -45.37 84.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.976 -1.078 . . . . 33.020000000000003 110.213 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 47' ' ' ILE . 2.5 mp -65.51 -56.1 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.889 -1.132 . . . . 9.8399999999999999 109.771 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -55.85 -43.2 76.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.696 -1.224 . . . . 17.84 107.696 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 2.5 m-20 -55.93 -34.69 65.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.032 -1.469 . . . . 18.84 107.032 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -77.09 -46.1 24.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.823 -0.806 . . . . 12.99 108.823 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.1 mt -53.6 -36.26 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.762 -1.199 . . . . 14.609999999999999 107.762 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 21.1 tp60 -61.12 -57.07 14.05 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.957 -0.757 . . . . 40.450000000000003 108.957 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -65.9 -34.52 78.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.223 -0.923 . . . . 41.810000000000002 110.09 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.17 -52.75 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 21.77 109.89 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.565 HG21 HH11 ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.88 -61.88 1.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.588 -0.695 . . . . 11.380000000000001 109.606 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 151.73 -37.85 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.682 -1.367 . . . . 14.789999999999999 109.682 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.62 130.57 47.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.243 -1.151 . . . . 17.809999999999999 110.622 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 37.15 1.54 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.174 -1.047 . . . . 29.760000000000002 108.174 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.479 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -83.77 168.91 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.052 0.93 . . . . 18.260000000000002 111.688 -177.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.549 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 5.7 t -120.79 129.23 25.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.106 -1.442 . . . . 8.1999999999999993 107.106 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.6 Cg_endo -75.94 -166.88 5.35 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 CA-C-O 122.425 0.927 . . . . 7.79 111.78 1.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.565 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -148.71 89.75 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.553 -2.017 . . . . 26.050000000000001 105.553 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 85' ' ' LEU . 82.5 t -85.01 155.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.8 0.81 . . . . 8.6799999999999997 111.934 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.428 ' N ' HG12 ' A' ' 72' ' ' VAL . 63.0 m-85 -145.42 90.79 2.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 14.07 110.566 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.01 112.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.731 -1.951 . . . . 9.3399999999999999 105.731 177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.85 -152.7 45.67 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.497 -2.641 . . . . 12.42 106.497 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -83.42 -0.67 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.534 -1.568 . . . . 44.859999999999999 109.09 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.541 ' CB ' ' HE ' ' A' ' 97' ' ' ARG . 7.4 m-20 -89.05 115.8 26.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.747 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 t -73.76 150.92 40.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.26 -26.82 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.194 -0.941 . . . . 20.449999999999999 109.592 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.91 -145.67 17.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.879 -1.288 . . . . 13.82 109.879 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.3 -144.18 10.93 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.998 -1.241 . . . . 12.42 109.998 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.03 -62.17 1.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.437 -1.037 . . . . 0.0 110.023 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -53.49 -25.53 16.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.446 -0.783 . . . . 0.0 109.572 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.38 -46.84 37.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.281 -0.887 . . . . 27.059999999999999 109.115 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.8 tt -54.55 -59.7 4.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.577 -0.702 . . . . 15.31 109.912 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -50.97 -48.72 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.796 . . . . 0.0 110.492 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 t -50.05 -43.44 51.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.833 -1.167 . . . . 21.789999999999999 109.292 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.2 -35.58 63.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.381 -0.824 . . . . 0.0 111.428 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -59.84 -61.47 2.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.87 -1.144 . . . . 0.0 110.274 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' NE2' ' C ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -62.07 -20.15 63.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 110.102 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.43 -22.77 35.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.92 66.33 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.437 -1.065 . . . . 25.640000000000001 110.437 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -68.49 -27.81 66.46 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.986 -1.303 . . . . 50.259999999999998 108.704 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.55 -64.64 0.87 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 24.170000000000002 110.311 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.83 -29.95 43.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.447 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.48 -47.06 83.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 28.030000000000001 108.357 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.657 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.46 -37.46 78.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.971 -1.122 . . . . 40.960000000000001 107.971 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.0 mp -72.07 -34.47 68.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.518 -0.919 . . . . 15.050000000000001 108.518 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -64.92 -57.6 8.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.784 -0.572 . . . . 0.0 111.737 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.66 -34.17 7.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.907 -1.121 . . . . 38.640000000000001 110.665 -178.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.5 pt -100.29 -11.66 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.816 -1.178 . . . . 0.0 109.331 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.94 41.56 22.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.229 -1.148 . . . . 18.539999999999999 110.229 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.04 54.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -1.197 . . . . 10.84 109.243 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 1.7 pp -97.59 -174.22 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 109.558 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.635 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.456 -0.572 . . . . 18.329999999999998 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.445 ' N ' ' OE1' ' A' ' 2' ' ' GLN . 2.0 mm100 -83.22 -73.02 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 29.77 109.182 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.81 -6.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.625 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.19 -74.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 20.030000000000001 110.617 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -73.26 -38.42 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 12.91 110.186 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 94.3 m-20 -55.98 -35.26 66.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.001 -1.062 . . . . 28.329999999999998 109.496 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -74.85 -13.07 60.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.906 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -97.4 -41.33 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 22.870000000000001 110.654 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -79.24 140.56 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.849 -1.157 . . . . 25.190000000000001 110.249 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -150.05 136.86 11.08 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.076 -1.083 . . . . 34.609999999999999 108.076 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.78 133.33 50.3 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 120.999 1.133 . . . . 11.720000000000001 109.739 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 79.66 18.44 73.18 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.081 -1.608 . . . . 10.24 109.081 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -137.88 135.31 36.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -1.078 . . . . 25.359999999999999 109.489 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.53 134.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.293 -0.879 . . . . 10.890000000000001 109.744 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.87 140.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.335 -0.987 . . . . 15.82 108.335 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.66 127.87 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.217 -0.927 . . . . 8.9399999999999995 111.177 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.49 121.35 34.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.064 -1.087 . . . . 9.9299999999999997 108.064 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.3 pt -131.34 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.331 1.062 . . . . 10.619999999999999 111.337 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 21' ' ' THR . 4.4 mtmp? -146.31 91.19 5.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.8 Cg_exo -46.37 83.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.616 1.544 . . . . 24.579999999999998 110.484 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.4 m -177.78 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 34.82 108.395 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.85 125.74 41.1 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 21.460000000000001 109.765 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.24 -19.12 40.68 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.321 2.014 . . . . 13.859999999999999 112.605 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -69.9 -42.91 72.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.611 -1.306 . . . . 0.0 109.627 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -65.86 -34.29 77.8 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.07 -42.62 99.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.79 -0.819 . . . . 59.590000000000003 108.79 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.6 HH11 ' HG2' ' A' ' 27' ' ' ARG . 6.5 mtt-85 -53.57 -45.07 69.81 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.231 -0.918 . . . . 0.0 108.656 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -36.49 78.93 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 108.849 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 7.5 mt-30 -70.62 -44.02 68.08 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.694 0.759 . . . . 45.490000000000002 109.333 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -70.97 -36.47 72.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.652 -0.655 . . . . 34.969999999999999 111.177 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.52 -56.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.88 -1.138 . . . . 0.0 110.211 -178.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.834 HD23 HD12 ' A' ' 35' ' ' LEU . 1.9 mt -59.43 -21.3 59.79 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.757 -1.215 . . . . 17.280000000000001 109.254 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.654 -0.869 . . . . 24.109999999999999 108.654 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -92.82 -0.01 57.33 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.48 -0.762 . . . . 44.07 110.127 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.834 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -87.77 128.71 53.31 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.766 -1.209 . . . . 19.629999999999999 108.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.9 69.22 0.85 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.648 1.566 . . . . 21.539999999999999 109.417 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.4 mm -80.43 153.42 4.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.579 -0.701 . . . . 0.0 109.21 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -54.88 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.522 -0.736 . . . . 29.41 110.034 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.559 ' O ' ' O ' ' A' ' 38' ' ' LYS . 11.8 mt-30 -53.33 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.726 0.774 . . . . 0.0 111.036 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.85 54.67 0.75 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.079 -1.208 . . . . 15.27 110.079 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.13 -27.02 14.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.576 -0.955 . . . . 8.7799999999999994 109.3 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -97.09 131.73 43.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.762 -0.829 . . . . 7.1299999999999999 108.762 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.3 tt0 -141.23 173.07 11.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.85 . . . . 22.030000000000001 109.929 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.504 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 43.9 m-85 -135.35 111.75 9.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.349 -1.352 . . . . 16.329999999999998 107.349 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.74 104.9 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.872 . . . . 6.5800000000000001 111.971 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.8 m-20 -82.25 101.79 10.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.614 -0.884 . . . . 15.32 108.614 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 56' ' ' ILE . 21.4 pt -61.97 -1.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 10.92 111.256 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 t -93.5 -17.06 23.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 21.719999999999999 109.303 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.0 12.82 1.23 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 22.449999999999999 109.52 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 7.3 t -140.81 -17.08 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 25.629999999999999 109.674 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 50' ' ' THR . 6.3 t-20 81.14 -175.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.451 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 58.49 24.18 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 108.873 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 52' ' ' HIS . 3.6 p -43.32 -51.93 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.805 . . . . 18.870000000000001 110.292 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -53.81 -35.4 61.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 45.210000000000001 110.144 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.03 -44.89 87.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.057 -1.027 . . . . 33.020000000000003 109.753 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.41 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.2 mp -66.44 -53.9 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.019 . . . . 9.8399999999999999 109.647 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.53 -42.12 82.27 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.701 -1.222 . . . . 17.84 107.701 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.35 -33.67 63.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.067 -1.456 . . . . 18.84 107.067 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -77.35 -45.26 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.787 -0.82 . . . . 12.99 108.787 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -55.49 -38.11 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.962 -1.125 . . . . 14.609999999999999 107.962 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 4.2 tp-100 -59.09 -49.29 78.43 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.522 0.677 . . . . 40.450000000000003 109.44 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -66.37 -54.22 27.05 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 41.810000000000002 110.65 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.81 -36.0 81.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 21.77 111.442 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 12.9 p -105.59 -68.38 0.87 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.021 -1.049 . . . . 11.380000000000001 109.812 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 144.26 -41.25 1.12 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.7 -1.76 . . . . 14.789999999999999 108.7 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.58 142.45 29.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.553 -0.969 . . . . 17.809999999999999 109.855 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.426 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -109.86 26.93 10.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 29.760000000000002 107.992 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.49 168.07 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.946 0.879 . . . . 18.260000000000002 111.238 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.639 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.7 t -113.22 132.39 22.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.309 -1.367 . . . . 8.1999999999999993 107.309 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 82' ' ' SER . 23.1 Cg_endo -83.06 -167.52 5.64 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.616 1.007 . . . . 7.79 112.114 -0.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 91.77 2.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.716 -2.327 . . . . 26.050000000000001 104.716 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 79' ' ' ILE . 80.8 t -83.69 158.54 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.72 0.771 . . . . 8.6799999999999997 112.175 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.484 ' N ' HG12 ' A' ' 72' ' ' VAL . 65.6 m-85 -146.32 84.36 1.63 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.557 . . . . 14.07 111.55 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -70.7 114.43 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.885 -2.265 . . . . 9.3399999999999999 104.885 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -158.09 30.69 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 105.658 -2.977 . . . . 12.42 105.658 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -81.35 0.98 34.79 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.426 -1.632 . . . . 44.859999999999999 109.403 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -87.42 115.09 24.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 110.516 -179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -73.1 136.47 44.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.684 ' C ' HD12 ' A' ' 79' ' ' ILE . 2.8 pp -105.59 -7.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.159 -0.963 . . . . 20.449999999999999 109.281 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 115.34 -154.88 16.67 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.225 -1.15 . . . . 13.82 110.225 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 -141.52 12.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.34 -1.104 . . . . 12.42 110.34 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.2 p -71.42 -66.42 0.63 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.594 -0.944 . . . . 0.0 110.333 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 t -49.01 -29.39 4.83 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 109.358 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.56 -47.26 33.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.283 -0.886 . . . . 27.059999999999999 109.139 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.3 tt -54.58 -58.5 7.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 15.31 109.664 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.71 -49.0 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.383 -0.823 . . . . 0.0 110.526 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.535 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 6.5 m -45.29 -37.58 4.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.932 -1.105 . . . . 21.789999999999999 109.09 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.26 -38.77 34.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.453 -0.78 . . . . 0.0 111.84 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -59.95 -60.48 3.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.831 -1.168 . . . . 0.0 111.017 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 87' ' ' SER . 1.6 pp0? -58.65 -24.02 60.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 m -80.74 -57.0 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.69 -8.49 6.89 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.702 -1.359 . . . . 25.640000000000001 109.702 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -69.29 -26.42 64.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.313 -1.11 . . . . 50.259999999999998 108.566 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp -60.09 -65.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 24.170000000000002 110.599 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.61 -28.44 32.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.35 -47.85 77.79 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.442 -0.947 . . . . 28.030000000000001 108.442 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -58.18 -34.03 69.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.97 -1.122 . . . . 40.960000000000001 107.97 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -72.42 -40.82 66.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 15.050000000000001 109.292 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.97 -52.14 57.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.0 111.808 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -51.19 -33.14 26.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.819 -1.176 . . . . 38.640000000000001 111.114 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.1 pt -100.72 -14.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.0 43.49 7.56 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.354 -1.099 . . . . 18.539999999999999 110.354 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.25 -16.55 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.242 . . . . 10.84 109.839 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.64 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.4 179.11 5.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 109.771 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.685 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.639 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.241 0.543 . . . . 18.329999999999998 109.564 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.721 ' NE2' ' H ' ' A' ' 3' ' ' GLU . 2.4 pm0 -76.07 -53.14 8.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.04 -1.037 . . . . 29.77 109.68 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.721 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 11.1 pt-20 -64.21 -18.96 65.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.905 -1.122 . . . . 0.0 109.237 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.78 -71.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.506 -0.746 . . . . 20.030000000000001 110.613 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -72.63 -37.97 57.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 12.91 110.108 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 69.4 m-20 -55.39 -38.42 68.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.184 -0.947 . . . . 28.329999999999998 109.521 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -74.14 -11.9 60.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.507 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 42.6 mttm -97.55 -45.03 6.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 22.870000000000001 110.47 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.63 139.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 25.190000000000001 109.56 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -149.81 136.17 10.61 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.213 -1.032 . . . . 34.609999999999999 108.213 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.45 124.75 15.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 120.752 0.968 . . . . 11.720000000000001 109.628 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.62 55.18 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.368 -1.493 . . . . 10.24 109.368 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 8' ' ' LYS . 25.0 ttpt -137.29 135.67 37.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.335 -1.097 . . . . 25.359999999999999 109.409 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.96 132.9 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.829 . . . . 10.890000000000001 109.403 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.48 139.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 15.82 108.805 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 18' ' ' ILE . 40.0 t -121.76 126.94 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 8.9399999999999995 110.794 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.08 120.01 33.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.604 -1.258 . . . . 9.9299999999999997 107.604 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 16' ' ' VAL . 46.1 pt -132.52 -174.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 122.615 1.198 . . . . 10.619999999999999 112.232 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mttm -141.54 95.09 7.29 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 105.558 -2.015 . . . . 38.729999999999997 105.558 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 21' ' ' THR . 14.0 Cg_exo -49.9 76.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.37 1.38 . . . . 24.579999999999998 110.834 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.656 ' N ' ' O ' ' A' ' 19' ' ' LYS . 87.8 m -172.0 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.228 -0.656 . . . . 34.82 109.228 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.79 124.64 47.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 21.460000000000001 110.266 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.12 -20.05 29.34 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.193 1.928 . . . . 13.859999999999999 112.872 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -66.9 -47.47 71.71 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.481 -1.387 . . . . 0.0 108.784 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' HG12 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -63.02 -36.22 82.85 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -60.59 -40.78 93.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.163 -1.051 . . . . 59.590000000000003 108.163 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -47.79 77.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.21 75.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.297 -0.877 . . . . 0.0 108.915 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.615 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 8.9 mt-30 -69.89 -40.98 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.59 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 68.8 mm-40 -69.33 -39.85 77.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.597 -0.689 . . . . 34.969999999999999 111.364 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.07 -55.93 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.882 -1.136 . . . . 0.0 110.947 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.637 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -56.75 -26.3 56.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.738 -1.226 . . . . 17.280000000000001 109.536 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -64.41 -26.94 68.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.16 -0.963 . . . . 24.109999999999999 109.02 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 1.1 mp0 -92.03 0.31 57.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 44.07 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' ILE . 18.7 mt -87.65 133.54 37.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.763 -1.21 . . . . 19.629999999999999 108.319 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.24 62.99 0.7 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.578 1.519 . . . . 21.539999999999999 109.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.0 mm -79.92 141.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -55.78 152.78 9.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.275 -0.891 . . . . 29.41 109.977 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 24.8 mp0 -57.08 141.15 46.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.436 0.636 . . . . 0.0 111.431 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.0 9.18 39.24 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.484 -0.76 . . . . 15.27 111.902 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -30.42 12.17 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.823 -1.399 . . . . 8.7799999999999994 109.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.8 tp -96.58 131.76 42.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.518 -0.739 . . . . 7.1299999999999999 109.543 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -141.85 171.43 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 22.030000000000001 109.444 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.615 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 39.3 m-85 -133.23 110.02 9.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.145 -1.428 . . . . 16.329999999999998 107.145 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.98 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.476 -0.765 . . . . 6.5800000000000001 111.434 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 3.8 m-20 -81.81 100.69 9.71 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.445 -0.946 . . . . 15.32 108.445 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 28.6 pt -62.41 1.92 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 10.92 110.734 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 46' ' ' ASP . 17.5 p -95.83 -23.17 17.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 21.719999999999999 109.04 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.13 9.62 2.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 22.449999999999999 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.2 t -137.05 -7.69 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.841 . . . . 25.629999999999999 109.404 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.574 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 69.6 -163.81 0.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 1.5 m-70 54.63 21.47 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.994 -1.066 . . . . 0.0 108.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -40.29 -59.91 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 18.870000000000001 110.739 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 7.9 m120 -54.18 -35.06 61.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 45.210000000000001 111.034 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.99 -46.36 88.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 33.020000000000003 109.963 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.2 mp -66.01 -53.18 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.979 -1.076 . . . . 9.8399999999999999 109.518 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -56.53 -44.44 80.82 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.566 -1.272 . . . . 17.84 107.566 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 24.9 m-20 -53.61 -33.03 53.57 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.977 -1.49 . . . . 18.84 106.977 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -78.64 -48.56 14.83 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.94 -0.763 . . . . 12.99 108.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.7 mt -52.02 -36.4 50.02 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.524 -1.287 . . . . 14.609999999999999 107.524 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.9 tp60 -61.96 -55.31 30.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.794 -0.817 . . . . 40.450000000000003 108.794 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -66.82 -39.19 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 41.810000000000002 109.678 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.2 tp -64.09 -45.62 87.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 21.77 109.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.636 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -117.64 -71.71 0.72 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.633 -0.667 . . . . 11.380000000000001 109.569 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.636 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 158.47 -34.26 0.5 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.317 -1.513 . . . . 14.789999999999999 109.317 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -95.93 137.13 35.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 17.809999999999999 110.019 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' O31' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -110.88 30.19 7.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.066 -1.087 . . . . 29.760000000000002 108.066 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.33 171.04 11.51 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.926 0.869 . . . . 18.260000000000002 111.501 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.64 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.3 t -115.26 132.12 23.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.494 -1.299 . . . . 8.1999999999999993 107.494 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.741 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 28.5 Cg_endo -81.04 -164.84 4.09 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 CA-C-O 122.032 0.763 . . . . 7.79 110.925 0.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.741 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -150.81 93.25 1.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.376 -2.083 . . . . 26.050000000000001 105.376 177.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' A' ' 79' ' ' ILE . 94.1 t -85.61 156.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.827 0.822 . . . . 8.6799999999999997 112.352 -175.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.0 m-85 -145.37 92.92 2.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.875 -0.516 . . . . 14.07 110.606 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 98' ' ' LEU . 8.4 mm -72.43 113.74 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.832 -1.914 . . . . 9.3399999999999999 105.832 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.58 -145.62 42.26 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 106.622 -2.591 . . . . 12.42 106.622 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -87.56 -3.48 58.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.677 -1.484 . . . . 44.859999999999999 109.5 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.36 116.47 25.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.221 -0.924 . . . . 0.0 110.619 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -75.77 143.97 41.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.778 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.7 pp -113.43 -18.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.189 -0.944 . . . . 20.449999999999999 109.335 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.43 -159.2 19.96 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.109 -1.196 . . . . 13.82 110.109 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -92.51 -143.7 12.98 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.391 -1.064 . . . . 12.42 110.655 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.417 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 t -71.33 -62.63 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -1.015 . . . . 0.0 110.383 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 t -51.0 -24.99 4.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.359 -0.838 . . . . 0.0 109.189 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -76.05 -45.52 33.81 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 27.059999999999999 109.219 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.572 ' O ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt -55.0 -58.41 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 15.31 109.829 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -52.06 -52.3 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 111.003 -178.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' VAL . 5.0 t -44.84 -38.99 4.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.059 -1.025 . . . . 21.789999999999999 109.251 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.84 -41.5 23.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.545 -0.722 . . . . 0.0 111.631 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -55.83 29.53 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.868 -1.145 . . . . 0.0 110.398 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -62.1 -25.49 67.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.944 -1.098 . . . . 0.0 109.452 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.9 m -77.98 -62.22 1.74 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.419 -0.8 . . . . 0.0 109.024 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -9.25 5.53 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.09 -1.204 . . . . 25.640000000000001 110.09 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.22 -24.36 64.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.117 -1.225 . . . . 50.259999999999998 108.177 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.61 -67.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.638 -0.664 . . . . 24.170000000000002 110.47 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -51.58 -28.99 15.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.22 -49.18 70.69 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.074 -1.084 . . . . 28.030000000000001 108.074 178.202 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.5 HH11 ' CG ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.68 -34.65 67.59 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.926 -1.139 . . . . 40.960000000000001 107.926 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 74' ' ' ILE . 8.3 mp -72.89 -38.52 66.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.479 -0.934 . . . . 15.050000000000001 108.479 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -64.49 -53.64 44.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.576 . . . . 0.0 111.555 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.14 -34.87 23.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 38.640000000000001 110.76 -178.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.58 -15.3 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.69 -1.256 . . . . 0.0 109.007 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.66 44.39 8.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.588 -1.005 . . . . 18.539999999999999 110.588 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.45 55.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -1.219 . . . . 10.84 109.87 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.649 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -95.79 -177.55 4.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.783 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.5 -179.895 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.64 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.516 -0.55 . . . . 18.329999999999998 109.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.53 -71.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 29.77 109.415 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.33 -11.31 4.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.26 -73.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 20.030000000000001 110.572 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -72.94 -37.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 12.91 109.884 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 55.5 m-80 -55.73 -38.34 69.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.184 -0.948 . . . . 28.329999999999998 109.301 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 m -74.18 -10.03 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -95.96 -53.5 3.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 22.870000000000001 109.627 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -79.57 128.11 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.844 . . . . 25.190000000000001 110.067 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HA ' ' HZ3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.36 155.67 39.45 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.072 -1.084 . . . . 34.609999999999999 108.072 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.56 130.06 38.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.895 1.73 . . . . 11.720000000000001 111.537 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.89 64.4 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.874 -0.89 . . . . 10.24 110.874 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -142.47 133.33 25.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.351 . . . . 25.359999999999999 109.928 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.23 136.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.890000000000001 109.037 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.79 144.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 15.82 108.55 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.66 126.88 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 8.9399999999999995 110.77 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -92.68 123.91 36.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 9.9299999999999997 107.571 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.92 -176.43 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.383 1.087 . . . . 10.619999999999999 111.342 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 21' ' ' THR . 14.6 mtmm -143.32 92.73 6.61 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.385 -1.709 . . . . 38.729999999999997 106.385 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' C ' ' OG1' ' A' ' 21' ' ' THR . 12.2 Cg_exo -47.79 82.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.629 1.553 . . . . 24.579999999999998 110.442 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 179.1 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.025 -0.731 . . . . 34.82 109.025 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 130.63 28.4 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 21.460000000000001 110.266 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -59.69 -20.33 57.77 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.393 2.062 . . . . 13.859999999999999 112.654 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 106' ' ' GSH . 25.4 m-85 -70.37 -43.96 69.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.533 -1.355 . . . . 0.0 109.622 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -32.37 74.01 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.3 mmm-85 -64.04 -43.71 94.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.643 -0.873 . . . . 59.590000000000003 108.643 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 2.1 mtt-85 -51.75 -45.46 63.69 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.0 83.55 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -70.21 -42.15 72.71 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.43 -0.794 . . . . 45.490000000000002 109.296 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.74 -38.36 76.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.683 . . . . 34.969999999999999 111.078 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.81 -58.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 35' ' ' LEU . 1.8 mt -57.71 -21.46 40.84 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.512 -1.367 . . . . 17.280000000000001 109.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -65.94 -24.96 66.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.052 -1.03 . . . . 24.109999999999999 108.769 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -91.32 1.38 57.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 44.07 110.191 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -90.48 126.78 55.19 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.903 -1.123 . . . . 19.629999999999999 109.163 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.55 67.64 0.76 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.773 1.648 . . . . 21.539999999999999 109.66 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.16 150.66 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.406 -0.809 . . . . 0.0 108.907 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 39' ' ' GLN . 30.0 mttm -53.47 -169.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.85 . . . . 29.41 110.309 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 38' ' ' LYS . 56.6 mm-40 -51.52 -127.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.529 0.681 . . . . 0.0 111.344 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.37 53.18 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.421 -1.072 . . . . 15.27 110.421 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -101.08 -23.33 14.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -1.045 . . . . 8.7799999999999994 108.942 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.0 tp -102.73 131.89 49.25 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.565 -0.902 . . . . 7.1299999999999999 108.565 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 25.9 tt0 -141.5 173.9 11.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.305 -0.872 . . . . 22.030000000000001 110.04 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.512 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 38.5 m-85 -135.22 109.84 8.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.57 -1.27 . . . . 16.329999999999998 107.57 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.58 103.49 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 6.5800000000000001 111.096 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.98 101.5 9.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.219 -0.925 . . . . 15.32 108.731 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.3 -2.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.089 -1.007 . . . . 10.92 110.237 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' THR . 10.5 p -96.28 -29.79 13.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 21.719999999999999 109.346 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.55 18.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 22.449999999999999 109.273 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.519 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 10.7 t -140.5 -13.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -0.88 . . . . 25.629999999999999 109.91 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' CG ' ' N ' ' A' ' 52' ' ' HIS . 0.5 OUTLIER 78.7 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.545 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 2.4 m170 53.61 12.32 0.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.702 -1.249 . . . . 0.0 108.406 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -35.97 -67.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.718 -0.614 . . . . 18.870000000000001 111.077 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -53.96 -31.51 50.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.227 -0.921 . . . . 45.210000000000001 111.067 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' OE1' ' CE1' ' A' ' 52' ' ' HIS . 57.4 mt-10 -65.26 -46.61 79.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.041 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.44 -53.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.952 -1.092 . . . . 9.8399999999999999 109.453 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -57.27 -43.43 83.08 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.824 -1.176 . . . . 17.84 107.824 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -54.78 -33.84 61.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.217 -1.401 . . . . 18.84 107.217 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -78.8 -49.21 13.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.969 -0.692 . . . . 12.99 109.136 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.06 -32.89 49.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.434 -0.951 . . . . 14.609999999999999 108.434 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.677 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.7 tp60 -59.77 -53.89 52.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.675 -0.641 . . . . 40.450000000000003 109.385 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -66.92 -48.25 69.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 41.810000000000002 111.031 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.62 -39.02 92.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 21.77 110.554 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 10.5 p -106.49 -66.67 0.99 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.32 -0.862 . . . . 11.380000000000001 109.912 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 143.48 -42.15 1.1 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.694 -1.763 . . . . 14.789999999999999 108.694 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.22 136.62 38.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -1.02 . . . . 17.809999999999999 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -102.44 25.42 9.04 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.313 -0.995 . . . . 29.760000000000002 108.313 179.06 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.805 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -83.02 169.45 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.67 . . . . 18.260000000000002 110.354 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.589 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 10.9 t -113.67 138.53 22.68 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 107.916 -1.142 . . . . 8.1999999999999993 107.916 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 82' ' ' SER . 30.6 Cg_endo -84.95 -165.92 4.05 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 CA-C-O 122.299 0.875 . . . . 7.79 111.203 -0.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.805 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -143.41 92.77 2.4 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.131 -2.174 . . . . 26.050000000000001 105.131 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 79' ' ' ILE . 77.2 t -83.63 156.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.877 . . . . 8.6799999999999997 111.387 -176.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' N ' HG12 ' A' ' 72' ' ' VAL . 74.3 m-85 -146.22 92.05 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.635 -0.666 . . . . 14.07 111.105 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -72.97 106.32 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.598 -2.001 . . . . 9.3399999999999999 105.598 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.96 -152.1 46.81 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 105.793 -2.923 . . . . 12.42 105.793 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HZ3' ' HA ' ' A' ' 10' ' ' GLN . 31.8 mttm -81.76 4.06 23.46 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.388 -1.654 . . . . 44.859999999999999 108.507 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.683 ' CB ' HH21 ' A' ' 97' ' ' ARG . 23.6 m-20 -89.63 108.96 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.0 110.754 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 t -74.44 141.99 44.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.8 pp -111.29 -13.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 20.449999999999999 109.443 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.96 -163.89 15.24 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.309 -1.117 . . . . 13.82 110.309 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 84' ' ' ASP . . . -86.58 -146.26 9.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.23 -1.148 . . . . 12.42 110.23 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -72.61 -59.7 2.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.553 -0.969 . . . . 0.0 110.049 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -50.24 -26.48 4.75 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 108.922 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 81' ' ' GLY . 16.7 m-20 -75.23 -47.81 26.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.526 -0.734 . . . . 27.059999999999999 109.09 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 tt -53.89 -59.15 5.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 15.31 109.776 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.603 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -52.35 -50.73 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 110.539 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.5 t -46.26 -41.54 13.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 21.789999999999999 109.869 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.85 -40.08 55.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 112.173 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -59.27 -59.5 5.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.646 -1.284 . . . . 0.0 110.858 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -57.96 -22.69 50.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.333 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 m -79.82 -60.09 2.48 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 109.119 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 -11.72 6.46 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.62 -1.392 . . . . 25.640000000000001 109.62 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 96' ' ' THR . 36.7 tp10 -69.24 -25.58 64.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -1.163 . . . . 50.259999999999998 108.994 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.3 tp -58.48 -64.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.861 . . . . 24.170000000000002 110.356 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -52.61 -27.41 16.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -63.57 -48.2 78.4 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.425 -0.91 . . . . 28.030000000000001 108.784 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.683 HH21 ' CB ' ' A' ' 77' ' ' ASP . 22.0 mmm180 -58.73 -34.28 71.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.052 . . . . 40.960000000000001 108.17 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 mp -70.6 -39.68 73.65 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.805 -0.813 . . . . 15.050000000000001 108.805 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -66.03 -53.83 33.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.767 -0.583 . . . . 0.0 111.941 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -49.47 -33.36 14.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.207 . . . . 38.640000000000001 110.612 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.22 -13.23 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.697 -1.252 . . . . 0.0 109.331 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 46.42 8.91 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.549 -1.02 . . . . 18.539999999999999 110.549 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.07 -14.47 41.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -1.16 . . . . 10.84 109.586 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.659 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -95.48 174.61 6.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 109.951 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.649 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.63 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.489 -0.56 . . . . 18.329999999999998 109.489 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -90.14 -72.77 0.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 29.77 109.15 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.37 -9.04 1.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.57 -72.91 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.78 . . . . 20.030000000000001 110.018 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.7 m -73.62 -40.32 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 12.91 110.126 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.463 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 73.8 m-20 -56.08 -27.23 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.201 -0.937 . . . . 28.329999999999998 110.399 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 m -74.71 -21.7 59.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.08 -1.012 . . . . 0.0 110.528 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -97.58 -45.36 6.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.973 -1.079 . . . . 22.870000000000001 111.293 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.39 129.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.014 -1.054 . . . . 25.190000000000001 110.123 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -146.79 153.05 45.91 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 34.609999999999999 108.664 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.03 122.86 12.56 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.218 1.279 . . . . 11.720000000000001 109.963 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 84.0 24.32 49.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.83 -1.308 . . . . 10.24 109.83 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -139.23 134.58 32.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -1.145 . . . . 25.359999999999999 109.232 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.02 137.36 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 10.890000000000001 110.11 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -145.51 153.06 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.499 -0.926 . . . . 15.82 108.499 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.94 121.65 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.234 -0.916 . . . . 8.9399999999999995 110.629 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.98 121.1 31.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.201 -1.407 . . . . 9.9299999999999997 107.201 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 70' ' ' PRO . 34.2 pt -133.48 -168.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.472 1.129 . . . . 10.619999999999999 111.872 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.636 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.2 mtmt -145.59 96.65 4.75 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 106.205 -1.776 . . . . 38.729999999999997 106.205 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.4 Cg_exo -51.82 74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.379 1.386 . . . . 24.579999999999998 110.736 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.636 ' N ' ' O ' ' A' ' 19' ' ' LYS . 11.5 m -171.32 -32.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.919 -0.771 . . . . 34.82 108.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.22 128.57 34.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 21.460000000000001 110.074 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.82 -13.28 25.85 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.162 1.908 . . . . 13.859999999999999 112.118 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CG ' HG12 ' A' ' 106' ' ' GSH . 19.1 m-85 -71.34 -47.5 56.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.709 -1.244 . . . . 0.0 109.706 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -28.39 70.01 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.015 -1.053 . . . . 0.0 108.9 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -61.27 -42.64 98.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.29 -1.004 . . . . 59.590000000000003 108.29 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -54.24 -49.14 70.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.176 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -37.43 75.46 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.878 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 4.6 mt-30 -70.54 -42.15 71.59 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.333 -0.854 . . . . 45.490000000000002 109.618 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.77 -37.33 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.386 -0.821 . . . . 34.969999999999999 111.02 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.681 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.28 -57.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.99 -1.069 . . . . 0.0 110.197 -178.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.663 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -55.38 -24.62 30.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 17.280000000000001 109.394 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -65.28 -27.9 68.96 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.119 -0.988 . . . . 24.109999999999999 108.489 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -90.89 3.66 53.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.812 . . . . 44.07 110.286 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 35' ' ' LEU . 20.0 mt -91.83 131.5 35.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.795 -1.191 . . . . 19.629999999999999 109.257 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.88 64.61 0.43 Allowed 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.707 1.605 . . . . 21.539999999999999 110.31 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.8 mm -82.25 149.05 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 108.887 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.4 mmmt -53.22 -174.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 29.41 110.057 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.563 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 24.1 mp0 -52.32 -121.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.674 -0.641 . . . . 0.0 111.123 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 48.31 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.402 -0.904 . . . . 15.27 110.866 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -100.81 -18.26 16.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.241 -1.152 . . . . 8.7799999999999994 109.372 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -105.56 126.7 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 7.1299999999999999 108.83 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 36.7 tt0 -140.4 164.97 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 22.030000000000001 109.689 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.487 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 23.3 m-85 -126.45 114.91 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.593 -1.262 . . . . 16.329999999999998 107.593 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.87 102.06 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 6.5800000000000001 111.131 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 48' ' ' THR . 7.4 m-20 -80.44 100.06 8.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.478 -1.304 . . . . 15.32 107.478 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CG2' HG21 ' A' ' 56' ' ' ILE . 14.6 pt -61.17 2.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 10.92 110.749 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 46' ' ' ASP . 5.1 t -94.88 -20.24 19.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.999 -1.063 . . . . 21.719999999999999 109.086 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.58 13.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 22.449999999999999 109.309 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.1 t -140.69 -14.71 0.94 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.22 -0.925 . . . . 25.629999999999999 109.902 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 50' ' ' THR . 1.1 m-20 78.97 -176.19 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.8 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.403 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER 57.76 30.16 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 109.089 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 p -44.69 -54.12 6.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 18.870000000000001 109.906 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.0 m-20 -54.15 -37.32 64.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 45.210000000000001 110.732 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -62.24 -46.58 88.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.112 . . . . 33.020000000000003 109.636 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.7 mp -65.9 -55.7 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.969 -1.082 . . . . 9.8399999999999999 109.59 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -56.69 -40.45 75.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.694 -1.254 . . . . 17.84 107.878 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 22.9 m-20 -55.04 -32.53 61.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.015 -1.476 . . . . 18.84 107.015 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -78.8 -47.94 15.74 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.766 -0.827 . . . . 12.99 108.766 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -54.53 -33.59 60.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.375 -0.972 . . . . 14.609999999999999 108.375 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.638 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.2 tp-100 -59.25 -55.78 30.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.751 -0.593 . . . . 40.450000000000003 109.8 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.7 -50.42 62.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.028 -1.045 . . . . 41.810000000000002 111.106 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.06 -34.83 78.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.867 -1.146 . . . . 21.77 110.657 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.6 p -110.74 -70.44 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.306 -0.871 . . . . 11.380000000000001 109.915 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.638 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 147.04 -41.85 0.94 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.606 -1.798 . . . . 14.789999999999999 108.606 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.22 140.39 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.436 -1.037 . . . . 17.809999999999999 110.047 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' NH1' ' C3 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -109.85 24.43 13.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.192 -1.04 . . . . 29.760000000000002 108.192 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.95 174.1 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.923 0.868 . . . . 18.260000000000002 110.935 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.563 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 9.8 t -118.61 134.33 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.454 -1.313 . . . . 8.1999999999999993 107.454 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -80.7 -163.93 3.62 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 CA-C-O 122.245 0.852 . . . . 7.79 111.257 0.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 91.74 1.89 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.296 -2.113 . . . . 26.050000000000001 105.296 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 85' ' ' LEU . 92.2 t -84.65 157.81 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.822 0.82 . . . . 8.6799999999999997 112.185 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 72' ' ' VAL . 57.6 m-85 -145.22 88.28 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.801 -0.562 . . . . 14.07 110.624 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.598 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.0 109.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.469 -2.048 . . . . 9.3399999999999999 105.469 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.57 -154.64 52.1 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.036 -2.826 . . . . 12.42 106.036 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -84.51 0.2 50.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.354 -1.674 . . . . 44.859999999999999 108.934 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.7 114.91 25.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -71.69 149.45 45.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.366 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.0 -23.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.95 . . . . 20.449999999999999 109.342 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.64 -142.71 14.08 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.948 -1.261 . . . . 13.82 109.948 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -111.06 -144.19 9.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.898 -1.281 . . . . 12.42 109.898 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -71.04 -61.12 1.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -1.003 . . . . 0.0 109.801 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.9 t -52.99 -26.27 14.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.5 m-20 -73.53 -48.33 33.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.345 -0.847 . . . . 27.059999999999999 109.236 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.76 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.382 -0.824 . . . . 15.31 109.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.42 -49.43 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 0.0 110.015 -178.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -49.5 -41.32 40.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 21.789999999999999 109.357 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt -75.46 -36.67 60.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 111.253 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.403 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 -62.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.995 -1.066 . . . . 0.0 110.644 -178.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -61.19 -16.61 46.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.949 -1.095 . . . . 0.0 109.971 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.675 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 13.5 m -85.25 -18.61 33.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.891 . . . . 0.0 109.425 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.79 -13.49 52.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.891 -1.283 . . . . 25.640000000000001 109.891 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.55 -26.76 65.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.149 -1.207 . . . . 50.259999999999998 108.966 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.95 -63.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 24.170000000000002 110.157 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.1 -31.31 41.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.1 m -63.56 -43.99 95.46 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.696 -1.224 . . . . 28.030000000000001 107.696 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -60.0 -35.65 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.403 -0.962 . . . . 40.960000000000001 108.403 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.9 mp -71.18 -40.23 71.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.445 -0.784 . . . . 15.050000000000001 109.237 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -65.08 -53.53 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 112.29 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -47.57 -31.54 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.728 -1.233 . . . . 38.640000000000001 110.503 -177.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 pt -104.17 -14.18 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.918 -1.114 . . . . 0.0 109.649 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.26 41.94 11.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.433 -1.067 . . . . 18.539999999999999 110.433 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.13 -12.32 53.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 10.84 109.561 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.62 -174.82 3.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.389 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.657 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 18.329999999999998 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' C ' ' H ' ' A' ' 4' ' ' PHE . 52.5 mt-30 -138.6 -76.15 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 29.77 108.988 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -58.71 -5.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.6 m-85 -62.91 -70.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 20.030000000000001 110.25 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -73.1 -40.34 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 12.91 110.097 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 8.6 m-20 -54.79 -38.27 67.09 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.073 -1.017 . . . . 28.329999999999998 109.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -74.72 -12.35 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.212 -0.93 . . . . 0.0 109.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -97.24 -46.8 5.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.206 -0.934 . . . . 22.870000000000001 110.608 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.1 135.09 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.776 -1.202 . . . . 25.190000000000001 109.385 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.49 150.36 40.25 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.715 -0.846 . . . . 34.609999999999999 108.715 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.39 124.37 15.91 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.41 1.407 . . . . 11.720000000000001 110.021 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.08 28.45 45.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.764 -1.334 . . . . 10.24 109.764 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -140.91 137.22 32.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 25.359999999999999 109.761 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.63 135.05 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.382 -0.824 . . . . 10.890000000000001 109.643 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.42 141.39 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.048 . . . . 15.82 108.172 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 t -124.19 127.28 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 8.9399999999999995 111.078 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.84 121.04 34.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.24 -1.393 . . . . 9.9299999999999997 107.24 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 70' ' ' PRO . 28.0 pt -131.14 -176.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.361 1.077 . . . . 10.619999999999999 111.254 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.5 mtmt -143.9 91.81 6.51 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.077 -1.823 . . . . 38.729999999999997 106.077 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.1 Cg_exo -47.18 78.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.892 1.728 . . . . 24.579999999999998 111.05 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' LYS . 88.2 m -174.1 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.852 -0.796 . . . . 34.82 108.852 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.75 130.04 29.95 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 21.460000000000001 109.857 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -57.94 -21.59 50.37 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.277 1.985 . . . . 13.859999999999999 112.209 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -70.43 -38.18 74.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.635 -1.291 . . . . 0.0 108.523 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -36.63 82.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.672 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -64.08 -40.53 96.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.918 -0.771 . . . . 59.590000000000003 108.918 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.9 OUTLIER -53.66 -48.84 69.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.433 -0.792 . . . . 0.0 109.291 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.52 72.98 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.372 -0.83 . . . . 0.0 109.161 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 4.1 mt-30 -70.57 -43.39 69.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.375 -0.828 . . . . 45.490000000000002 109.477 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.6 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 22.0 mm-40 -71.13 -35.78 71.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.554 -0.716 . . . . 34.969999999999999 111.256 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.48 -58.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 110.478 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.826 HD23 HD12 ' A' ' 35' ' ' LEU . 2.9 mt -58.99 -17.98 29.95 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.563 -1.336 . . . . 17.280000000000001 109.634 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 t -65.87 -29.93 70.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 24.109999999999999 109.037 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.6 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 1.2 mp0 -91.72 5.88 48.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 44.07 110.49 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.826 HD12 HD23 ' A' ' 32' ' ' LEU . 15.9 mt -90.56 127.98 50.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.758 -1.213 . . . . 19.629999999999999 109.304 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.43 68.99 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.8 1.666 . . . . 21.539999999999999 109.94 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.6 mm -82.13 150.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.416 -0.802 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 39' ' ' GLN . 1.5 mmmm -54.68 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.466 -0.771 . . . . 29.41 110.392 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.599 ' O ' ' O ' ' A' ' 38' ' ' LYS . 91.1 mm-40 -52.61 -137.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.618 0.723 . . . . 0.0 110.884 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.27 52.82 0.09 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.107 -1.197 . . . . 15.27 110.107 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -98.52 -20.28 17.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -1.048 . . . . 8.7799999999999994 109.151 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -103.54 129.7 50.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.632 -0.877 . . . . 7.1299999999999999 108.632 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.9 tp10 -142.13 164.89 28.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.995 . . . . 22.030000000000001 109.955 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.481 ' CG ' ' OE1' ' A' ' 29' ' ' GLN . 56.5 m-85 -125.96 111.75 15.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.319 -1.363 . . . . 16.329999999999998 107.319 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -94.47 101.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 6.5800000000000001 111.305 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.16 101.42 9.65 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.873 . . . . 15.32 108.644 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.12 -6.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 10.92 109.251 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 p -96.92 43.08 1.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.332 -0.988 . . . . 21.719999999999999 108.332 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.14 14.09 0.45 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 22.449999999999999 107.801 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -139.49 -2.94 1.54 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.19 -1.041 . . . . 25.629999999999999 108.19 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.7 OUTLIER 70.21 -176.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.806 178.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.3 m80 53.61 18.06 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.007 -1.058 . . . . 0.0 108.552 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -32.96 -55.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.403 0.621 . . . . 18.870000000000001 110.861 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -57.85 -33.3 68.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 45.210000000000001 111.275 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' HIS . 73.2 mm-40 -63.45 -43.7 96.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.829 -1.17 . . . . 33.020000000000003 109.925 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.8 -56.76 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.983 -1.073 . . . . 9.8399999999999999 109.581 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -54.9 -43.06 72.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.555 -1.276 . . . . 17.84 107.555 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.28 -33.61 65.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.41 -1.33 . . . . 18.84 107.41 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -76.6 -47.33 22.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 12.99 108.732 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.0 mt -54.78 -36.5 64.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.901 -1.148 . . . . 14.609999999999999 107.901 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 18.2 tp60 -59.67 -52.37 65.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.266 0.555 . . . . 40.450000000000003 110.045 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.0 -51.0 66.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 41.810000000000002 110.839 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.94 -32.43 73.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.086 -1.009 . . . . 21.77 110.721 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.3 p -110.06 -74.05 0.66 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 11.380000000000001 109.53 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.22 -37.86 1.05 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.985 -1.646 . . . . 14.789999999999999 108.985 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -102.68 134.74 45.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -1.002 . . . . 17.809999999999999 109.908 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -105.44 32.5 4.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.538 -0.912 . . . . 29.760000000000002 108.538 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 167.72 19.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 18.260000000000002 110.294 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.54 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 11.9 t -113.55 134.5 21.98 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.288 -1.004 . . . . 8.1999999999999993 108.288 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.5 Cg_endo -86.08 -170.62 7.0 Favored 'Cis proline' 0 C--N 1.309 -1.513 0 C-N-CA 124.83 -0.904 . . . . 7.79 110.119 -0.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.732 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.08 102.78 4.94 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.54 -2.022 . . . . 26.050000000000001 105.54 176.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 85' ' ' LEU . 98.1 t -90.07 159.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 8.6799999999999997 111.763 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.8 m-85 -146.21 90.92 2.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.623 -0.673 . . . . 14.07 110.836 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -72.65 112.97 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.801 -1.926 . . . . 9.3399999999999999 105.801 177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.87 -152.47 39.55 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.401 -2.679 . . . . 12.42 106.401 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -83.37 -0.16 48.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.514 -1.58 . . . . 44.859999999999999 108.708 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' HB3' HH21 ' A' ' 97' ' ' ARG . 5.7 m-20 -89.45 115.05 26.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 0.0 110.599 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 t -73.71 150.71 41.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 109.449 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.98 -22.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 20.449999999999999 109.225 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.22 -146.75 18.39 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.581 -1.408 . . . . 13.82 109.581 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -102.19 -149.2 21.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.604 -1.398 . . . . 12.42 109.604 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.55 ' N ' ' O12' ' A' ' 106' ' ' GSH . 1.2 t -71.26 -59.47 2.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -1.181 . . . . 0.0 109.657 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -50.27 -27.31 5.85 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 -46.85 32.15 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.853 -0.795 . . . . 27.059999999999999 108.853 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 72' ' ' VAL . 5.0 tt -55.3 -59.78 4.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.581 -0.699 . . . . 15.31 110.353 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.53 -49.08 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.419 -0.8 . . . . 0.0 110.472 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.33 36.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.875 -1.141 . . . . 21.789999999999999 109.564 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 mt -74.1 -38.04 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 111.988 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -60.3 -59.11 5.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -178.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -60.47 -24.45 65.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.003 -1.061 . . . . 0.0 109.664 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.0 m -80.76 -24.63 38.53 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.443 -0.786 . . . . 0.0 109.378 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.14 -9.61 76.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.32 -1.112 . . . . 25.640000000000001 110.32 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.71 -26.53 65.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.046 -1.267 . . . . 50.259999999999998 108.872 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 tp -59.53 -64.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 24.170000000000002 110.605 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.27 -31.12 42.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -63.67 -46.38 85.86 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.974 -1.121 . . . . 28.030000000000001 107.974 178.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' A' ' 77' ' ' ASP . 9.6 tpt180 -58.81 -38.32 78.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.294 -1.002 . . . . 40.960000000000001 108.294 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.32 -36.19 71.5 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.657 -0.868 . . . . 15.050000000000001 108.657 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -65.87 -54.65 23.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.706 -0.621 . . . . 0.0 111.974 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -50.21 -33.17 18.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.163 . . . . 38.640000000000001 110.908 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -100.12 -11.44 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.778 -1.201 . . . . 0.0 109.409 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.15 40.63 15.82 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.462 -1.055 . . . . 18.539999999999999 110.462 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.46 -20.49 29.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.136 -1.214 . . . . 10.84 109.3 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.3 pp -96.18 -175.87 3.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 104' ' ' LEU . 49.0 mt-30 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.49 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.689 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.441 -0.577 . . . . 18.329999999999998 109.441 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.423 ' C ' ' N ' ' A' ' 4' ' ' PHE . 48.7 tt0 -172.11 -82.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 29.77 109.409 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -8.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 108.617 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' C ' ' A' ' 2' ' ' GLN . 1.1 m-85 -62.32 -68.28 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.406 -0.809 . . . . 20.030000000000001 110.214 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.68 -39.81 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 12.91 110.244 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.4 m120 -55.64 -34.96 65.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.12 -0.987 . . . . 28.329999999999998 109.043 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.4 m -74.63 -12.73 60.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -96.66 -48.32 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 22.870000000000001 109.848 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.51 132.06 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 25.190000000000001 109.635 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.91 157.25 34.38 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.132 -1.062 . . . . 34.609999999999999 108.132 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.28 130.62 36.43 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.708 1.605 . . . . 11.720000000000001 111.312 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.73 28.18 65.64 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 120.408 -0.901 . . . . 10.24 110.944 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -140.62 132.85 28.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.316 . . . . 25.359999999999999 109.7 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.36 136.86 31.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.379 -0.825 . . . . 10.890000000000001 109.263 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.67 142.37 23.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.564 -0.902 . . . . 15.82 108.564 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 45' ' ' VAL . 40.5 t -125.63 125.92 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 8.9399999999999995 110.968 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -93.79 121.89 35.7 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.903 -1.147 . . . . 9.9299999999999997 107.903 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.3 pt -131.07 -175.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.613 1.197 . . . . 10.619999999999999 111.839 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 21' ' ' THR . 39.2 mttm -140.92 97.39 7.11 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 105.166 -2.161 . . . . 38.729999999999997 105.166 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 21' ' ' THR . 10.3 Cg_exo -51.12 71.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.441 1.427 . . . . 24.579999999999998 110.895 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 19' ' ' LYS . 24.7 m -170.03 -32.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.185 -0.947 . . . . 34.82 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.32 133.17 24.19 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 21.460000000000001 109.882 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.46 -24.11 77.01 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 122.411 2.074 . . . . 13.859999999999999 112.991 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -67.23 -47.87 69.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.366 -1.458 . . . . 0.0 109.921 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -33.8 72.05 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -61.75 -42.24 98.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.548 -0.908 . . . . 59.590000000000003 108.548 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 27' ' ' ARG . 7.4 mtt-85 -56.15 -45.06 79.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 109.077 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.17 76.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.029 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -70.33 -41.16 73.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.466 -0.771 . . . . 45.490000000000002 109.488 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.603 ' O ' ' NE2' ' A' ' 34' ' ' GLN . 55.4 mm-40 -72.4 -39.08 68.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.614 -0.679 . . . . 34.969999999999999 111.64 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.676 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.91 -56.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.766 -1.209 . . . . 0.0 109.769 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.659 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -60.81 -19.01 58.81 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.577 -1.327 . . . . 17.280000000000001 109.536 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -66.54 -27.7 67.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.039 -1.038 . . . . 24.109999999999999 108.706 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.603 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -91.53 -0.07 57.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 44.07 110.393 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 32' ' ' LEU . 15.7 mt -87.8 129.69 49.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.771 -1.206 . . . . 19.629999999999999 108.626 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.8 67.11 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.441 1.427 . . . . 21.539999999999999 109.451 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.9 mm -76.97 150.65 5.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.154 -0.966 . . . . 0.0 108.64 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' GLN . 6.9 mmmt -52.75 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 29.41 110.557 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' LYS . 90.5 mt-30 -52.03 -124.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.628 0.728 . . . . 0.0 111.88 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.25 48.62 1.17 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.425 -1.07 . . . . 15.27 110.425 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -33.92 12.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -1.094 . . . . 8.7799999999999994 109.201 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 37' ' ' ILE . 66.0 tp -92.83 133.79 35.72 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.544 0.688 . . . . 7.1299999999999999 109.472 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.0 tt0 -143.57 174.05 11.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.471 -0.768 . . . . 22.030000000000001 109.055 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.518 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.7 m-85 -136.82 109.62 7.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.084 -1.45 . . . . 16.329999999999998 107.084 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 16' ' ' VAL . 78.0 t -95.0 107.13 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 6.5800000000000001 111.967 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.5 m-20 -82.45 100.06 9.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.595 -0.891 . . . . 15.32 108.595 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.63 2.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 10.92 111.145 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -94.97 -31.0 13.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.873 -1.142 . . . . 21.719999999999999 108.395 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.47 22.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.48 -0.762 . . . . 22.449999999999999 109.658 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.1 t -141.22 -2.47 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.134 -0.978 . . . . 25.629999999999999 109.996 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 4.5 m-20 65.25 -168.6 0.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.492 -0.755 . . . . 0.0 109.994 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 51.37 19.14 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.481 HG22 ' NZ ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -35.68 -62.2 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.727 -0.608 . . . . 18.870000000000001 110.78 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.5 m120 -56.13 -36.74 68.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 45.210000000000001 110.805 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 1.1 mp0 -61.83 -44.57 96.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.937 -1.102 . . . . 33.020000000000003 109.912 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.32 -54.18 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.666 -1.271 . . . . 9.8399999999999999 109.627 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -56.91 -44.91 82.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.566 -1.334 . . . . 17.84 107.765 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.97 -34.72 57.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 18.84 107.284 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -78.36 -46.88 18.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.87 -0.732 . . . . 12.99 109.218 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.3 mt -52.59 -38.29 59.76 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.116 -1.068 . . . . 14.609999999999999 108.116 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 15.1 tp60 -57.17 -55.54 33.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.641 -0.874 . . . . 40.450000000000003 108.641 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.08 -29.16 68.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.848 . . . . 41.810000000000002 109.585 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 63' ' ' LEU . 2.0 tt -64.5 -68.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.951 . . . . 21.77 109.792 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -52.95 2.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.801 -0.562 . . . . 11.380000000000001 109.721 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' A' ' 61' ' ' GLN . . . 152.72 -42.93 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.051 -1.547 . . . . 14.789999999999999 111.128 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . . . -96.48 144.62 26.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.839 -1.389 . . . . 17.809999999999999 110.69 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.55 23.89 13.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.55 -0.907 . . . . 29.760000000000002 108.55 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.754 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.38 170.03 15.77 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 18.260000000000002 110.589 -178.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.68 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.7 t -111.18 132.44 21.73 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 107.839 -1.171 . . . . 8.1999999999999993 107.839 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 82' ' ' SER . 27.8 Cg_endo -83.98 -168.32 5.97 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 CA-C-O 122.533 0.972 . . . . 7.79 112.15 -0.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.754 HH12 ' H ' ' A' ' 68' ' ' THR . 1.8 tpm_? -146.01 90.4 1.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.635 -1.987 . . . . 26.050000000000001 105.635 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 73' ' ' PHE . 88.3 t -83.78 155.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.279 -0.888 . . . . 8.6799999999999997 111.794 -176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' N ' HG12 ' A' ' 72' ' ' VAL . 81.8 m-85 -142.69 91.77 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 14.07 111.535 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.0 mm -72.02 114.3 10.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 105.249 -2.13 . . . . 9.3399999999999999 105.249 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.38 -159.1 11.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.959 -2.856 . . . . 12.42 105.959 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -78.3 1.71 20.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.211 -1.758 . . . . 44.859999999999999 108.699 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.616 ' CB ' HH21 ' A' ' 97' ' ' ARG . 1.4 m-20 -88.43 112.09 22.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.735 . . . . 0.0 110.055 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 t -76.79 143.65 39.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.267 -0.896 . . . . 0.0 110.453 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.8 pt -107.37 -21.41 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.028 . . . . 20.449999999999999 108.92 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.26 -146.63 18.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.218 -1.153 . . . . 13.82 110.218 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.91 -143.67 13.31 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.227 -1.149 . . . . 12.42 110.227 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.6 -61.73 1.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.517 -0.99 . . . . 0.0 109.964 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -52.73 -23.68 7.22 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.59 -0.694 . . . . 0.0 109.5 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.53 -51.55 12.67 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 27.059999999999999 109.272 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -50.92 -60.3 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 15.31 110.037 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.54 -51.93 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 110.066 -178.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 86' ' ' VAL . 3.2 t -44.44 -37.7 3.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.229 -0.92 . . . . 21.789999999999999 108.953 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' HD13 ' A' ' 94' ' ' LEU . 42.2 mt -81.89 -40.96 21.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 111.507 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.53 -58.66 7.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.88 -1.137 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -24.83 66.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.004 -1.06 . . . . 0.0 109.411 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.2 m -79.87 -45.51 18.53 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.3 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.3 -9.22 26.69 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.377 -1.089 . . . . 25.640000000000001 110.377 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' HG21 ' A' ' 96' ' ' THR . 8.5 tp10 -69.69 -25.11 63.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.988 -1.301 . . . . 50.259999999999998 108.534 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.8 tp -60.07 -63.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.479 0.657 . . . . 24.170000000000002 110.732 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.17 -28.26 39.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.448 -0.782 . . . . 0.0 108.915 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.4 -50.05 66.92 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.65 -0.82 . . . . 28.030000000000001 108.803 178.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.616 HH21 ' CB ' ' A' ' 77' ' ' ASP . 27.1 mtp180 -58.91 -31.05 68.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.912 -1.144 . . . . 40.960000000000001 107.912 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.37 -40.49 67.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.051 -1.092 . . . . 15.050000000000001 108.051 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -64.9 -52.3 57.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.93 -0.481 . . . . 0.0 111.888 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -33.2 24.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.71 -1.244 . . . . 38.640000000000001 110.691 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 101' ' ' ILE . 18.7 pt -99.76 -16.34 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.693 -1.255 . . . . 0.0 108.764 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.18 44.28 8.19 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.428 -1.069 . . . . 18.539999999999999 110.428 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.92 -13.85 46.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -1.155 . . . . 10.84 109.657 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.1 pt? -95.01 -175.61 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.504 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.68 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.352 0.596 . . . . 18.329999999999998 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -159.97 -79.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 29.77 109.127 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -59.43 -9.53 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.06 -69.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.414 -0.804 . . . . 20.030000000000001 111.218 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.9 m -73.27 -38.68 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 12.91 110.5 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 98.2 m-20 -55.73 -34.06 64.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.043 -1.036 . . . . 28.329999999999998 109.442 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.8 m -74.58 -13.83 60.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.022 -1.049 . . . . 0.0 110.001 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -97.42 -45.75 6.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.012 -1.055 . . . . 22.870000000000001 110.693 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.48 129.09 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.909 -1.12 . . . . 25.190000000000001 110.389 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.77 158.52 35.21 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 107.965 -1.124 . . . . 34.609999999999999 107.965 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -56.7 135.9 73.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.743 1.629 . . . . 11.720000000000001 111.418 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.81 27.64 68.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.75 -0.94 . . . . 10.24 110.75 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -142.6 131.85 23.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.347 . . . . 25.359999999999999 109.619 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.5 127.79 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.218 -0.926 . . . . 10.890000000000001 108.959 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.88 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.613 -0.884 . . . . 15.82 108.613 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 18' ' ' ILE . 32.7 t -125.31 126.11 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.541 -0.724 . . . . 8.9399999999999995 111.259 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -92.67 119.1 31.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.574 -1.269 . . . . 9.9299999999999997 107.574 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.3 pt -129.34 -173.79 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 122.311 1.053 . . . . 10.619999999999999 111.345 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -146.2 88.04 6.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.95 -1.871 . . . . 38.729999999999997 105.95 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.544 ' O ' ' OG1' ' A' ' 21' ' ' THR . 17.7 Cg_exo -45.79 77.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.851 1.701 . . . . 24.579999999999998 110.834 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 19' ' ' LYS . 15.6 m -174.07 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.082 -1.081 . . . . 34.82 108.082 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 126.16 42.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 109.083 -0.71 . . . . 21.460000000000001 109.083 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.82 -24.6 56.83 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.069 1.846 . . . . 13.859999999999999 112.166 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -70.39 -38.18 74.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.799 -1.188 . . . . 0.0 108.782 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -36.35 84.02 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.593 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.5 mmm-85 -65.27 -42.93 92.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.962 -0.755 . . . . 59.590000000000003 108.962 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -50.14 -45.37 53.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 108.771 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.71 82.12 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.616 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.41 -45.77 61.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.791 . . . . 45.490000000000002 109.652 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -69.99 -34.41 73.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.524 -0.735 . . . . 34.969999999999999 110.787 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.93 -57.58 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 0.0 110.83 -178.336 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.694 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -59.49 -20.89 58.7 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.593 -1.317 . . . . 17.280000000000001 109.487 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 m -64.5 -22.29 66.92 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.142 -0.974 . . . . 24.109999999999999 108.415 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -93.02 -2.21 55.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.486 -0.759 . . . . 44.07 109.963 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 HD23 ' A' ' 32' ' ' LEU . 18.8 mt -88.7 130.38 45.33 Favored Pre-proline 0 N--CA 1.484 1.267 0 O-C-N 120.86 -1.15 . . . . 19.629999999999999 108.956 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 67.19 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.669 1.58 . . . . 21.539999999999999 109.875 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.49 149.56 5.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 108.685 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 39' ' ' GLN . 36.6 mttt -53.56 -168.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.345 -0.847 . . . . 29.41 110.29 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.597 ' H ' ' CD ' ' A' ' 39' ' ' GLN . 21.8 mp0 -52.01 -123.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.6 0.714 . . . . 0.0 111.748 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 51.14 1.8 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.628 -0.989 . . . . 15.27 110.628 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.59 -27.31 14.07 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.549 -0.971 . . . . 8.7799999999999994 108.796 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HB2' HG21 ' A' ' 37' ' ' ILE . 55.3 tp -97.25 130.87 44.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.606 -0.887 . . . . 7.1299999999999999 108.606 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 1.2 tp10 -140.62 172.97 11.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.442 -0.786 . . . . 22.030000000000001 109.874 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 35.9 m-85 -135.74 110.06 8.43 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.416 -1.327 . . . . 16.329999999999998 107.416 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.9 103.16 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 6.5800000000000001 111.676 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 1.3 m-20 -81.29 100.87 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.671 -0.863 . . . . 15.32 108.671 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 56' ' ' ILE . 25.8 pt -63.69 -0.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.165 -0.96 . . . . 10.92 111.098 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 t -92.31 -14.34 28.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.717 -1.239 . . . . 21.719999999999999 108.965 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.54 8.04 4.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.789 . . . . 22.449999999999999 109.307 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -142.97 -0.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 25.629999999999999 109.797 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' C ' ' N ' ' A' ' 53' ' ' THR . 13.3 t-20 67.38 -156.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.28 12.32 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.803 -1.186 . . . . 0.0 108.684 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -37.83 -62.89 0.51 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.524 -0.735 . . . . 18.870000000000001 110.892 -178.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -53.53 -32.57 51.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 45.210000000000001 110.481 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -65.67 -45.28 83.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.889 -1.132 . . . . 33.020000000000003 109.82 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 47' ' ' ILE . 2.4 mp -67.21 -50.29 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.922 -1.111 . . . . 9.8399999999999999 109.469 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -58.07 -42.38 85.4 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.275 -1.38 . . . . 17.84 107.275 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.09 -33.11 64.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.036 -1.468 . . . . 18.84 107.036 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -78.78 -51.82 9.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.98 -0.748 . . . . 12.99 108.98 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.44 -32.55 50.33 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.134 -1.061 . . . . 14.609999999999999 108.134 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.6 tp60 -59.13 -54.56 45.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.808 -0.557 . . . . 40.450000000000003 109.849 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -67.47 -49.61 62.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 41.810000000000002 110.878 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -65.28 -33.33 75.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.036 -1.04 . . . . 21.77 110.993 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.7 p -107.91 -66.75 1.01 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.162 -0.961 . . . . 11.380000000000001 109.47 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 141.96 -41.37 1.22 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.757 -1.737 . . . . 14.789999999999999 108.757 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.5 140.85 32.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 17.809999999999999 109.655 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -106.15 25.67 10.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.363 -0.977 . . . . 29.760000000000002 108.363 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.82 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -83.85 168.04 16.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.036 0.922 . . . . 18.260000000000002 111.471 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 14.7 t -112.54 134.79 21.54 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 107.725 -1.213 . . . . 8.1999999999999993 107.725 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB3' HG22 ' A' ' 18' ' ' ILE . 22.3 Cg_endo -85.62 -162.97 2.69 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 CA-C-O 122.512 0.963 . . . . 7.79 111.929 -0.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.82 HH12 ' H ' ' A' ' 68' ' ' THR . 1.5 tpm_? -144.94 97.38 3.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.271 -2.122 . . . . 26.050000000000001 105.271 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 85' ' ' LEU . 99.3 t -86.87 157.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 8.6799999999999997 111.483 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.461 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.4 m-85 -144.92 91.21 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 14.07 111.503 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 mm -72.37 112.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.343 -2.095 . . . . 9.3399999999999999 105.343 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 -153.13 36.03 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 105.476 -3.05 . . . . 12.42 105.476 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -83.65 2.82 35.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.219 -1.754 . . . . 44.859999999999999 108.67 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.661 ' CB ' HH21 ' A' ' 97' ' ' ARG . 5.5 m-20 -88.84 113.38 24.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 110.3 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.5 t -75.1 145.8 41.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.6 pp -111.92 -16.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.264 -0.898 . . . . 20.449999999999999 109.334 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.92 -149.36 18.05 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.237 -1.145 . . . . 13.82 110.237 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.73 -147.52 20.93 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.096 -1.202 . . . . 12.42 110.096 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 t -71.78 -62.73 1.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.479 -1.012 . . . . 0.0 110.218 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.5 t -52.25 -24.46 7.37 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.71 -47.35 31.91 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.358 -0.839 . . . . 27.059999999999999 109.111 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.6 -59.39 4.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.728 . . . . 15.31 110.189 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -51.5 -50.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 110.436 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.51 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 22.7 m -47.59 -36.86 11.34 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.03 -1.044 . . . . 21.789999999999999 109.049 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.0 mt -82.47 -37.81 24.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 0.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.42 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.47 -60.22 4.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.694 -1.254 . . . . 0.0 110.728 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.529 ' NE2' ' C ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.42 -17.79 55.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.005 -1.059 . . . . 0.0 109.588 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -80.51 -63.47 1.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.72 -13.02 4.51 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.125 -1.19 . . . . 25.640000000000001 110.125 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.02 -29.65 67.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.15 -1.206 . . . . 50.259999999999998 108.535 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.08 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.574 -0.704 . . . . 24.170000000000002 111.051 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -54.97 -28.62 52.92 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -64.64 -48.92 73.07 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.616 -0.833 . . . . 28.030000000000001 108.816 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.661 HH21 ' CB ' ' A' ' 77' ' ' ASP . 29.0 mtp180 -60.46 -31.29 70.29 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.968 -1.123 . . . . 40.960000000000001 107.968 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.75 -39.08 70.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.288 -1.004 . . . . 15.050000000000001 108.288 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -66.04 -54.15 29.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.919 -0.488 . . . . 0.0 111.913 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -49.73 -32.65 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.786 -1.196 . . . . 38.640000000000001 110.947 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 pt -100.29 -14.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.625 -1.297 . . . . 0.0 109.07 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.35 44.13 8.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.291 -1.124 . . . . 18.539999999999999 110.291 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.27 38.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.236 . . . . 10.84 109.653 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.04 -179.97 5.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.577 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.597 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.621 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.378 -0.601 . . . . 18.329999999999998 109.378 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -76.63 -71.16 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.957 . . . . 29.77 109.99 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.658 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.3 pm0 -58.06 -10.16 1.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.879 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.48 -75.58 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 20.030000000000001 110.69 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -73.95 -35.67 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.97 . . . . 12.91 110.017 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -56.43 -35.56 67.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.183 -0.948 . . . . 28.329999999999998 109.377 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -75.0 -13.22 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.916 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -97.02 -47.74 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.124 -0.985 . . . . 22.870000000000001 110.349 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -79.5 133.38 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 25.190000000000001 110.385 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -151.25 160.06 32.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.903 -1.147 . . . . 34.609999999999999 107.903 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.77 130.27 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.754 1.636 . . . . 11.720000000000001 111.435 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.49 22.99 63.55 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 120.335 -0.936 . . . . 10.24 111.046 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -141.12 134.11 29.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.974 -1.309 . . . . 25.359999999999999 109.62 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.9 t -100.66 133.98 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.479 -0.763 . . . . 10.890000000000001 109.435 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.64 141.22 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.487 -0.931 . . . . 15.82 108.487 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.74 124.14 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.824 . . . . 8.9399999999999995 111.307 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -91.61 120.51 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.588 -1.264 . . . . 9.9299999999999997 107.588 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.453 HG22 ' HB3' ' A' ' 70' ' ' PRO . 43.7 pt -133.45 -170.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 122.667 1.223 . . . . 10.619999999999999 112.192 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.1 mtmt -146.57 96.43 4.45 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 105.707 -1.96 . . . . 38.729999999999997 105.707 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -50.68 82.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.282 1.321 . . . . 24.579999999999998 110.504 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -179.36 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 34.82 109.699 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.36 122.33 56.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.252 -0.905 . . . . 21.460000000000001 109.082 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -54.56 -10.89 2.67 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.34 2.027 . . . . 13.859999999999999 112.765 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CG ' HG12 ' A' ' 106' ' ' GSH . 22.2 m-85 -73.68 -49.98 23.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.422 -1.424 . . . . 0.0 110.186 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -26.76 68.03 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.667 -1.271 . . . . 0.0 107.896 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -62.97 -37.69 88.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.092 -1.077 . . . . 59.590000000000003 108.092 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -59.17 -50.51 73.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 108.991 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -36.8 74.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.312 -0.868 . . . . 0.0 109.003 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 5.5 mm-40 -69.39 -42.85 74.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 45.490000000000002 109.705 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.16 -38.16 69.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.493 -0.754 . . . . 34.969999999999999 110.876 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.633 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.93 -54.95 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.016 -1.053 . . . . 0.0 110.405 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.607 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -58.36 -22.6 54.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.322 -1.486 . . . . 17.280000000000001 108.726 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -65.39 -29.89 70.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.936 . . . . 24.109999999999999 108.585 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -89.1 0.46 56.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.779 . . . . 44.07 109.562 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 ' OE1' ' A' ' 89' ' ' GLN . 25.4 mt -89.3 131.51 40.34 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.127 -0.983 . . . . 19.629999999999999 108.696 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.84 66.6 1.26 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.843 1.695 . . . . 21.539999999999999 110.418 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -81.05 146.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.98 -1.075 . . . . 0.0 108.492 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 39' ' ' GLN . 11.1 mtmt -54.39 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 29.41 110.96 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.55 ' O ' ' O ' ' A' ' 38' ' ' LYS . 52.7 mt-30 -52.42 -133.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.766 0.793 . . . . 0.0 111.784 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.51 50.24 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.336 -1.106 . . . . 15.27 110.336 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -97.04 -29.75 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 8.7799999999999994 108.726 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 37' ' ' ILE . 62.3 tp -94.98 132.02 40.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.978 -0.749 . . . . 7.1299999999999999 108.978 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 11.6 tp10 -143.47 169.43 17.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.434 -0.791 . . . . 22.030000000000001 109.387 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.2 m-85 -132.03 109.64 10.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.3 -1.37 . . . . 16.329999999999998 107.3 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.47 103.2 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 6.5800000000000001 112.068 -176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 4.0 m-20 -81.51 102.65 10.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 15.32 108.193 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 pt -62.94 0.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.364 -0.835 . . . . 10.92 111.765 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -95.93 -26.43 15.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.71 -1.244 . . . . 21.719999999999999 109.451 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 20.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 22.449999999999999 109.596 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.711 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 11.0 t -143.3 1.94 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.148 -0.97 . . . . 25.629999999999999 109.702 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.711 ' ND2' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 65.41 -176.51 0.18 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.548 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.26 20.89 10.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.666 -1.271 . . . . 0.0 108.391 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.31 -61.68 1.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 18.870000000000001 110.789 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.08 -32.7 68.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 45.210000000000001 111.218 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 4.7 mp0 -62.46 -44.36 96.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.86 -1.15 . . . . 33.020000000000003 110.101 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.68 -53.22 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.144 . . . . 9.8399999999999999 109.553 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.07 -44.94 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.609 -1.307 . . . . 17.84 107.511 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -55.7 -33.33 64.07 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.003 -1.48 . . . . 18.84 107.003 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.95 -47.75 17.85 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.937 -0.764 . . . . 12.99 108.937 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.4 mt -53.15 -35.02 59.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.882 -1.155 . . . . 14.609999999999999 107.882 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.1 tp60 -60.62 -54.74 41.71 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.228 0.537 . . . . 40.450000000000003 109.982 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -66.2 -45.3 81.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.966 -1.084 . . . . 41.810000000000002 110.693 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.99 -40.73 91.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.987 -1.071 . . . . 21.77 110.68 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.1 p -107.83 -65.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.786 . . . . 11.380000000000001 109.761 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 140.89 -38.49 1.55 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.786 -2.125 . . . . 14.789999999999999 107.786 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.21 138.33 35.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.682 -0.893 . . . . 17.809999999999999 109.813 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -112.52 38.37 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.206 -1.035 . . . . 29.760000000000002 108.206 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.461 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -88.29 166.78 14.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.245 1.021 . . . . 18.260000000000002 112.623 -177.314 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.634 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 4.4 t -114.79 126.77 27.51 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 8.1999999999999993 107.22 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.722 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 35.4 Cg_endo -82.34 -173.93 12.53 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 CA-C-O 122.148 0.811 . . . . 7.79 111.222 1.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.737 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -140.94 98.7 3.44 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.215 -2.143 . . . . 26.050000000000001 105.215 176.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 73' ' ' PHE . 67.2 t -89.4 157.95 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.745 0.783 . . . . 8.6799999999999997 112.6 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.9 m-85 -146.5 88.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.839 -0.538 . . . . 14.07 111.329 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.44 124.39 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 104.433 -2.432 . . . . 9.3399999999999999 104.433 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.26 -160.24 17.49 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 106.501 -2.64 . . . . 12.42 106.501 -176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -83.21 -1.95 54.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.395 -1.65 . . . . 44.859999999999999 109.984 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' HB2' HH21 ' A' ' 97' ' ' ARG . 4.2 m-20 -89.31 124.2 34.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.018 -1.051 . . . . 0.0 110.356 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 t -75.0 147.12 41.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 110.025 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -109.28 -21.09 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.681 -0.859 . . . . 20.449999999999999 108.681 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.99 -153.01 19.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.941 -1.264 . . . . 13.82 109.941 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.99 -147.02 21.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.966 -1.254 . . . . 12.42 109.966 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O11' ' A' ' 106' ' ' GSH . 1.3 t -69.71 -61.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -1.103 . . . . 0.0 109.863 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -51.06 -23.64 3.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.553 -0.717 . . . . 0.0 109.293 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.01 -47.38 25.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.451 -0.78 . . . . 27.059999999999999 109.016 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.7 tt -54.24 -60.03 3.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 15.31 109.834 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.27 -52.16 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.082 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 37.4 m -46.16 -35.92 5.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.143 -0.973 . . . . 21.789999999999999 108.899 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 94' ' ' LEU . 71.8 mt -82.08 -40.05 22.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 111.615 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.707 ' OE1' HD11 ' A' ' 35' ' ' LEU . 25.2 tp60 -58.71 -59.11 5.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.164 . . . . 0.0 110.777 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.81 -19.74 64.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.927 -1.108 . . . . 0.0 109.768 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.7 m -83.86 -24.28 30.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.32 -9.54 76.57 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.106 -1.197 . . . . 25.640000000000001 110.106 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.128 -1.219 . . . . 50.259999999999998 108.21 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.6 -65.81 0.63 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.44 0.638 . . . . 24.170000000000002 110.887 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.01 -28.29 37.29 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.468 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -48.45 73.51 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.683 -0.858 . . . . 28.030000000000001 108.683 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.688 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.84 -33.87 72.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.762 -1.199 . . . . 40.960000000000001 107.762 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.1 -38.0 75.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.29 -1.004 . . . . 15.050000000000001 108.29 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -64.93 -58.03 7.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.917 -0.49 . . . . 0.0 111.635 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.39 -28.36 3.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.914 -1.116 . . . . 38.640000000000001 111.087 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -103.74 -19.8 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.709 -1.244 . . . . 0.0 109.214 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.39 41.89 7.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.38 -1.088 . . . . 18.539999999999999 110.38 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.78 -13.97 49.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -1.205 . . . . 10.84 109.437 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.07 -176.37 3.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 109.367 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.121 -0.987 . . . . 0.0 109.609 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.634 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.445 -0.576 . . . . 18.329999999999998 109.445 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.417 ' H ' ' HG2' ' A' ' 2' ' ' GLN . 6.6 pt20 -56.51 -43.19 79.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 29.77 109.268 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -62.18 -38.21 88.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.956 -1.09 . . . . 0.0 109.031 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -56.86 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 20.030000000000001 109.846 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.8 HG21 ' CZ ' ' A' ' 59' ' ' TYR . 14.9 m -73.14 -39.7 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.65 -0.656 . . . . 12.91 110.964 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.502 ' N ' HG23 ' A' ' 5' ' ' VAL . 12.0 m120 -57.21 -34.26 68.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.797 -1.189 . . . . 28.329999999999998 109.973 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m -74.14 -13.59 60.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.021 -1.05 . . . . 0.0 109.426 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -96.98 -52.42 3.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 22.870000000000001 110.3 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.19 126.29 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 25.190000000000001 109.989 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -149.13 155.37 40.03 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.121 -1.066 . . . . 34.609999999999999 108.121 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.25 132.35 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.926 1.751 . . . . 11.720000000000001 111.411 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 22.75 64.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.767 -0.933 . . . . 10.24 110.767 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.77 135.1 27.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.875 -1.368 . . . . 25.359999999999999 110.121 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.15 135.42 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 10.890000000000001 108.99 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.33 141.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.39 -0.967 . . . . 15.82 108.39 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 18' ' ' ILE . 21.8 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.386 -0.821 . . . . 8.9399999999999995 110.426 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -90.86 119.04 30.74 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.148 -1.427 . . . . 9.9299999999999997 107.148 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.7 pt -130.32 -175.04 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.294 1.045 . . . . 10.619999999999999 111.178 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.76 ' O ' ' N ' ' A' ' 21' ' ' THR . 21.6 mtmt -146.19 88.65 6.21 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.459 -1.682 . . . . 38.729999999999997 106.459 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 21' ' ' THR . 12.9 Cg_exo -46.76 69.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.016 1.81 . . . . 24.579999999999998 110.921 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.76 ' N ' ' O ' ' A' ' 19' ' ' LYS . 20.8 p -162.3 -36.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.007 -1.108 . . . . 34.82 108.007 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 128.94 32.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 21.460000000000001 109.469 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.98 -20.2 43.88 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.056 1.837 . . . . 13.859999999999999 111.756 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.66 -40.89 72.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.677 -1.265 . . . . 0.0 108.518 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -36.48 83.67 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.556 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -65.14 -36.06 83.07 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.792 -0.818 . . . . 59.590000000000003 108.792 178.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.72 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -56.54 -50.67 71.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 109.243 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . . . -56.94 -34.03 67.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.24 -36.89 74.78 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.282 -0.886 . . . . 45.490000000000002 108.696 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 67.1 mm-40 -71.4 -39.69 70.97 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.811 -0.555 . . . . 34.969999999999999 111.4 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -77.15 -65.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.837 -1.165 . . . . 0.0 110.925 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.648 ' H ' HG23 ' A' ' 31' ' ' ILE . 3.1 mt -52.8 -22.77 5.75 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.853 -1.155 . . . . 17.280000000000001 110.191 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 5.0 p -66.64 -26.17 66.94 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.755 -1.215 . . . . 24.109999999999999 108.773 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -93.3 4.11 54.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.373 -0.829 . . . . 44.07 110.506 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 32' ' ' LEU . 16.5 mt -90.46 131.46 38.18 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.83 -1.168 . . . . 19.629999999999999 109.385 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -66.67 66.72 0.53 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.898 1.732 . . . . 21.539999999999999 110.132 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' LYS . 1.9 mm -81.67 153.37 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.214 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.2 mmmm -54.05 -168.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 29.41 110.028 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' LYS . 40.1 mt-30 -51.78 -134.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.6 0.714 . . . . 0.0 110.831 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.09 54.57 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.063 -1.215 . . . . 15.27 110.063 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.37 -17.69 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.402 -1.058 . . . . 8.7799999999999994 109.241 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.3 tp -105.54 130.33 53.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.64 -0.874 . . . . 7.1299999999999999 108.64 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 28.8 tt0 -139.37 173.51 11.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 22.030000000000001 110.17 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.486 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 40.0 m-85 -134.58 110.82 9.58 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.782 -1.192 . . . . 16.329999999999998 107.782 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.3 t -96.19 104.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 6.5800000000000001 111.621 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' HD11 ' A' ' 18' ' ' ILE . 13.5 m-20 -81.33 103.19 10.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.055 -1.091 . . . . 15.32 108.055 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.7 pt -62.41 -3.85 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 10.92 110.811 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -93.8 -15.83 24.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.954 -1.091 . . . . 21.719999999999999 109.286 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.04 10.8 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 22.449999999999999 109.467 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 15.3 t -142.86 -18.53 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.248 -0.907 . . . . 25.629999999999999 110.059 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 50' ' ' THR . 0.5 OUTLIER 84.33 -170.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.597 -0.689 . . . . 0.0 109.452 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER 56.17 24.21 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 108.792 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 8.7 p -42.84 -52.83 4.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 18.870000000000001 110.394 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.9 m-20 -52.63 -34.72 52.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 45.210000000000001 110.481 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -64.69 -45.09 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.129 . . . . 33.020000000000003 109.28 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.43 -50.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.05 -1.032 . . . . 9.8399999999999999 109.43 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.0 mt-30 -57.65 -39.54 77.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.5 -1.375 . . . . 17.84 107.447 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 11.8 m-20 -56.31 -32.56 64.74 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.189 -1.412 . . . . 18.84 107.189 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 5.4 t80 -76.13 -51.56 11.95 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.064 -0.717 . . . . 12.99 109.064 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 22.5 mt -54.22 -32.06 54.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.059 -1.089 . . . . 14.609999999999999 108.059 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.3 tp-100 -63.2 -56.5 16.1 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.458 -0.777 . . . . 40.450000000000003 110.167 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -55.59 15.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 41.810000000000002 111.733 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -31.56 72.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.904 -1.122 . . . . 21.77 111.229 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.6 p -109.9 -63.32 1.39 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.974 -1.079 . . . . 11.380000000000001 109.81 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 140.73 -45.59 0.97 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.944 -1.662 . . . . 14.789999999999999 108.944 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' NH1' ' A' ' 71' ' ' ARG . . . -98.05 138.49 35.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.983 . . . . 17.809999999999999 109.261 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.967 ' HG2' HH11 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -107.64 26.43 10.29 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.912 -1.144 . . . . 29.760000000000002 107.912 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 173.26 12.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.743 -0.598 . . . . 18.260000000000002 109.588 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.564 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 12.5 t -117.79 137.64 24.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 8.1999999999999993 108.559 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.0 Cg_endo -84.72 -165.73 3.98 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.678 -0.968 . . . . 7.79 110.585 -0.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.877 ' NH1' ' HB3' ' A' ' 66' ' ' ALA . 1.8 tpt180 -148.46 98.08 2.84 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.848 -1.908 . . . . 26.050000000000001 105.848 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 85' ' ' LEU . 93.5 t -84.16 159.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -0.87 . . . . 8.6799999999999997 111.219 -176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 72' ' ' VAL . 77.4 m-85 -145.34 94.9 2.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.7 -0.625 . . . . 14.07 110.783 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 101' ' ' ILE . 6.7 mm -72.92 105.59 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.775 -1.935 . . . . 9.3399999999999999 105.775 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.07 -147.25 48.96 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.723 -2.951 . . . . 12.42 105.723 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -84.37 3.44 35.89 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.477 -1.602 . . . . 44.859999999999999 108.791 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.672 ' CB ' HH21 ' A' ' 97' ' ' ARG . 74.7 m-20 -89.94 109.06 20.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.479 -0.763 . . . . 0.0 110.756 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 t -74.05 145.14 44.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 109.281 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -113.33 -22.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.205 -0.935 . . . . 20.449999999999999 109.33 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA2' HH21 ' A' ' 71' ' ' ARG . . . 134.62 -154.44 21.48 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.788 -1.325 . . . . 13.82 109.788 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -101.13 -142.85 13.19 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.005 -1.238 . . . . 12.42 110.005 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.67 -66.07 0.68 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.444 -1.033 . . . . 0.0 110.501 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t -51.65 -24.48 5.63 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.571 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -74.97 -47.95 26.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.373 -0.829 . . . . 27.059999999999999 109.369 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.685 HD12 HG21 ' A' ' 72' ' ' VAL . 5.6 tt -55.03 -58.8 6.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.434 -0.791 . . . . 15.31 110.516 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -48.93 -47.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.805 . . . . 0.0 110.664 -178.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -43.25 47.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 21.789999999999999 109.172 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.9 mt -72.86 -41.08 65.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 111.984 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.4 -57.22 13.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.846 -1.159 . . . . 0.0 110.615 -177.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -25.45 67.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 109.323 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.5 m -82.58 -19.24 38.85 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.37 64.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.273 -1.131 . . . . 25.640000000000001 110.273 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 96' ' ' THR . 23.7 tt0 -67.67 -25.35 65.66 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.143 -1.21 . . . . 50.259999999999998 109.152 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.62 -63.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 24.170000000000002 110.295 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -52.17 -27.36 14.15 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.475 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -62.71 -48.13 80.6 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.417 -0.913 . . . . 28.030000000000001 108.678 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.672 HH21 ' CB ' ' A' ' 77' ' ' ASP . 22.5 mmm180 -60.42 -32.91 71.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.036 . . . . 40.960000000000001 108.539 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.4 mp -71.96 -39.43 69.35 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.399 -0.813 . . . . 15.050000000000001 109.243 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -65.74 -52.03 54.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.646 -0.658 . . . . 0.0 111.876 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.83 -34.2 8.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 38.640000000000001 110.404 -178.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 74' ' ' ILE . 17.7 pt -101.98 -11.37 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.846 -1.159 . . . . 0.0 109.268 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 43.58 14.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.427 -1.069 . . . . 18.539999999999999 110.427 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.52 -17.18 34.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.162 -1.199 . . . . 10.84 109.67 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 3.8 pp -97.46 -177.48 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.631 -179.95 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.636 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 108.829 -0.804 . . . . 1.72 108.829 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' C ' ' N ' ' A' ' 4' ' ' PHE . 18.9 mt-30 -107.38 -74.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 2.48 109.375 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 1.4 pt-20 -56.03 -9.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.069 -1.019 . . . . 2.1800000000000002 108.819 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' N ' ' C ' ' A' ' 2' ' ' GLN . 1.5 m-85 -61.98 -72.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.5 109.788 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.53 -36.32 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.27000000000000002 110.317 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 2' ' ' GLN . 6.1 m120 -58.37 -36.58 73.72 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.795 -1.19 . . . . 1.22 109.655 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -73.81 -13.35 60.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.37 109.302 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -97.19 -48.65 5.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 1.3 110.329 -179.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.0 125.44 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.777 -1.202 . . . . 0.32000000000000001 109.018 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.3 148.32 31.29 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.327 -0.99 . . . . 2.0899999999999999 108.327 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.21 135.93 30.92 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.196 1.931 . . . . 0.27000000000000002 111.741 -178.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.17 72.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.386 -1.085 . . . . 0.23999999999999999 110.386 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -144.11 140.05 29.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.022 -1.281 . . . . 1.5900000000000001 110.233 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.94 137.17 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.12 109.515 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.38 143.47 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.14999999999999999 108.505 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 18' ' ' ILE . 57.2 t -125.0 123.79 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.12 110.584 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -91.49 119.99 31.92 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.126 -1.435 . . . . 0.16 107.126 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 16' ' ' VAL . 37.3 pt -131.28 -173.17 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.312 1.053 . . . . 0.19 111.676 -177.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 27.1 mtmt -147.13 90.94 5.24 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 106.926 -1.509 . . . . 1.24 106.926 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -45.9 75.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.507 1.472 . . . . 0.37 110.383 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.2 m -169.21 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.927 -0.768 . . . . 1.1799999999999999 108.927 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.56 131.5 25.82 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.23000000000000001 110.266 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -60.04 -19.68 57.12 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 122.249 1.966 . . . . 0.32000000000000001 112.054 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -70.22 -41.38 73.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.764 -1.21 . . . . 0.29999999999999999 109.026 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -33.71 76.66 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.36 -0.936 . . . . 1.1000000000000001 108.592 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.38 -45.43 93.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 2.71 108.779 179.483 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -49.22 -46.75 46.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.958 -1.088 . . . . 2.4399999999999999 109.589 -179.396 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.76 80.96 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.14 -1.024 . . . . 0.22 108.559 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -69.06 -46.62 67.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 1.26 109.868 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -37.84 85.14 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.607 -0.683 . . . . 1.8700000000000001 111.231 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.657 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -77.5 -54.8 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.81 -1.181 . . . . 0.53000000000000003 110.861 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 35' ' ' LEU . 4.4 mt -58.18 -20.79 43.9 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.675 -1.266 . . . . 0.17999999999999999 108.987 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -66.87 -28.08 68.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 1.3100000000000001 109.404 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -91.22 3.09 55.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 1.5800000000000001 109.896 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 32' ' ' LEU . 15.6 mt -91.5 127.01 52.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.28999999999999998 109.556 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.14 65.24 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.922 1.748 . . . . 0.27000000000000002 109.916 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 42' ' ' LEU . 15.1 mm -78.45 146.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.574 -0.898 . . . . 0.25 108.574 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.1 mttt -52.59 -178.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -0.984 . . . . 1.79 108.807 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 41' ' ' LEU . 47.6 mt-30 -52.05 -123.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.994 -1.066 . . . . 2.5499999999999998 111.948 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.42 49.36 0.06 OUTLIER Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.439 -0.788 . . . . 0.37 111.534 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -105.05 -24.76 12.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.265 . . . . 0.28000000000000003 109.395 179.136 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 37' ' ' ILE . 18.8 tp -102.58 131.4 49.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.16 109.086 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 161.9 36.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 2.0099999999999998 109.897 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -125.02 116.49 22.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.435 -1.32 . . . . 0.16 107.435 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.71 105.31 17.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.446 -0.784 . . . . 0.17000000000000001 111.997 -177.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 18' ' ' ILE . 26.0 m-20 -80.75 100.43 8.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.011 -1.107 . . . . 1.1200000000000001 108.011 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 pt -61.96 -2.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.25 111.589 -178.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 -22.11 18.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.705 -1.247 . . . . 1.24 109.222 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.63 15.6 1.0 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.56999999999999995 109.341 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 4.11 1.44 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.068 -1.02 . . . . 0.59999999999999998 109.976 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 65.98 -175.6 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 2.4100000000000001 109.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 53' ' ' THR . 6.0 m170 59.59 18.99 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 2.21 109.754 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -34.47 -65.14 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.542 -0.724 . . . . 0.89000000000000001 110.377 -179.685 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 3.6 m-20 -54.73 -36.64 64.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 1.21 111.37 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.91 -45.45 92.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.641 -1.287 . . . . 2.1200000000000001 109.713 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.03 -51.94 54.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.998 -1.064 . . . . 0.22 109.002 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.79 -42.94 85.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.784 -1.198 . . . . 0.46000000000000002 107.774 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -56.35 -32.86 65.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.182 -1.414 . . . . 1.1200000000000001 107.182 178.129 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -79.03 -50.91 10.33 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.011 -0.737 . . . . 1.21 109.011 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.9 mt -54.68 -28.1 45.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.007 -1.058 . . . . 0.25 108.221 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 7.2 tp60 -63.1 -56.44 16.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.709 . . . . 1.3600000000000001 109.652 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -69.75 -38.05 76.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.447 -0.783 . . . . 2.2599999999999998 110.749 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.85 -40.52 95.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.125 -0.984 . . . . 0.93000000000000005 110.164 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.9 p -113.09 -70.8 0.79 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.308 -0.87 . . . . 0.70999999999999996 109.266 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.85 -36.2 0.67 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.411 -1.476 . . . . 0.33000000000000002 109.411 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -102.21 130.15 48.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.35999999999999999 110.292 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 25.36 5.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.565 -1.272 . . . . 1.6299999999999999 107.565 177.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.605 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -79.95 167.81 20.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.658 0.742 . . . . 0.33000000000000002 110.04 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 8.4 t -115.72 136.92 22.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.23000000000000001 107.438 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -78.46 -165.02 4.3 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 CA-C-O 122.562 0.984 . . . . 0.22 111.871 -0.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -146.6 90.71 1.95 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.453 -2.054 . . . . 2.1800000000000002 105.453 177.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 22.0 t -84.25 151.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.12 111.394 -176.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.85 92.25 2.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.797 -0.565 . . . . 0.20000000000000001 110.284 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 ' N ' ' A' ' 74' ' ' ILE . 3.3 mm -71.65 107.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.576 -2.009 . . . . 0.53000000000000003 105.576 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.84 -147.59 50.45 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.505 -2.638 . . . . 0.17999999999999999 106.505 -176.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.34 -4.89 59.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.539 -1.565 . . . . 1.8799999999999999 109.356 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' HH21 ' A' ' 97' ' ' ARG . 11.9 m-20 -89.03 117.22 27.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.096 -1.003 . . . . 1.26 110.76 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -74.31 151.68 39.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.28000000000000003 110.092 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.47 -19.48 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.51000000000000001 109.377 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.68 -150.38 19.51 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.176 -1.17 . . . . 0.31 110.176 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.07 -142.02 11.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.343 -1.103 . . . . 0.22 110.343 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -71.78 -61.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.539 -0.977 . . . . 0.68000000000000005 110.271 -179.108 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -53.57 -27.61 27.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.457 -0.777 . . . . 0.33000000000000002 109.622 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.09 -45.64 56.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.306 -0.871 . . . . 1.6000000000000001 109.07 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.2 tt -56.5 -64.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.629 -0.67 . . . . 0.22 109.732 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -45.53 -47.52 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.23999999999999999 110.11 -178.458 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -48.43 47.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.905 -1.122 . . . . 0.92000000000000004 109.288 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.18 -31.89 62.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.27 -0.894 . . . . 0.20000000000000001 111.553 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CD ' ' C ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -61.36 -60.27 3.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.574 -1.328 . . . . 2.0600000000000001 109.372 -178.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -25.74 67.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 2.46 110.514 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.8 m -79.61 -25.29 41.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.234 -0.917 . . . . 0.57999999999999996 110.783 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.48 -11.43 70.18 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.11 -1.196 . . . . 0.28999999999999998 110.11 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.95 -31.26 70.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 1.95 108.567 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.86 -63.34 1.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.475 -0.766 . . . . 0.29999999999999999 110.638 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -54.95 -30.22 58.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.457 -0.942 . . . . 0.27000000000000002 108.457 -178.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.2 m -65.34 -41.55 93.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.989 -1.115 . . . . 0.29999999999999999 107.989 178.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.798 HH21 ' HB3' ' A' ' 77' ' ' ASP . 1.2 tpt180 -64.6 -34.84 79.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.332 -0.988 . . . . 2.3300000000000001 108.332 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.74 -32.93 68.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.409 -0.807 . . . . 0.25 109.023 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -70.0 -57.26 5.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 1.77 111.84 -178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -44.88 -30.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.688 -1.258 . . . . 0.34999999999999998 110.407 -177.78 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.6 pt -104.65 -15.76 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.949 -1.094 . . . . 0.27000000000000002 108.885 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.3 43.56 10.45 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.346 -1.102 . . . . 0.16 110.346 179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -13.38 49.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.068 -1.254 . . . . 0.17999999999999999 109.564 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 104' ' ' LEU . 2.4 pt? -95.02 -175.32 3.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 109.326 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.943 -1.027 . . . . 1.8799999999999999 108.984 179.206 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GSH . . . . . 0.622 ' SG2' ' CD1' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.266 0.555 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.11 -71.18 0.15 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 20.03 110.153 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.6 m -73.18 -40.84 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.442 -0.786 . . . . 12.91 110.489 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.8 m120 -55.98 -34.06 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.183 -0.948 . . . . 28.33 110.38 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.5 m -74.54 -18.33 60.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.922 -1.111 . . . . 0.0 110.349 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.578 ' CE ' HG21 ' A' ' 45' ' ' VAL . 5.2 mtpm? -98.0 -42.5 7.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.077 . . . . 22.87 111.442 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.34 126.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.728 -1.233 . . . . 25.19 109.696 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.61 159.07 35.1 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.956 -1.127 . . . . 34.61 107.956 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.09 136.56 61.63 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.789 1.659 . . . . 11.72 111.501 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.04 73.3 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.71 -0.956 . . . . 10.24 110.71 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -140.57 130.63 24.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.253 . . . . 25.36 109.536 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -101.54 133.81 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.46 -0.775 . . . . 10.89 109.876 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.36 137.48 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.277 -1.009 . . . . 15.82 108.277 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 18' ' ' ILE . 44.0 t -120.54 128.54 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 8.94 111.366 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' ' NZ ' ' A' ' 8' ' ' LYS . 80.8 m-85 -95.34 118.78 32.71 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.142 -1.058 . . . . 9.93 108.142 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 16' ' ' VAL . 23.0 pt -130.25 -176.21 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.485 1.136 . . . . 10.62 111.42 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.4 mtmt -145.02 93.16 5.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.766 -1.938 . . . . 38.73 105.766 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -48.32 82.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.369 1.379 . . . . 24.58 110.577 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -177.78 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.047 -0.723 . . . . 34.82 109.047 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.12 126.81 38.77 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 21.46 109.099 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.18 -22.98 42.71 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.465 2.11 . . . . 13.86 113.061 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -67.89 -43.15 79.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.332 -1.48 . . . . 0.0 109.44 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.07 -38.14 89.99 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.41 -40.06 93.0 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.419 -0.956 . . . . 59.59 108.419 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.31 -45.2 68.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HG3' ' A' ' 70' ' ' PRO . . . -61.48 -35.8 78.69 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.38 -36.14 73.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.299 -0.876 . . . . 45.49 109.076 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -70.08 -41.69 73.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.761 -0.587 . . . . 34.97 111.14 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.85 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -72.58 -69.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.899 -1.126 . . . . 0.0 110.591 -178.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.85 ' H ' HG23 ' A' ' 31' ' ' ILE . 5.0 mt -51.64 -16.58 0.66 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.136 -0.978 . . . . 17.28 110.022 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.84 -29.78 68.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.012 -1.055 . . . . 24.11 108.292 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -93.41 1.65 56.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.481 -0.762 . . . . 44.07 110.617 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.73 HD12 HD23 ' A' ' 32' ' ' LEU . 18.1 mt -88.02 128.66 53.0 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.806 -1.184 . . . . 19.63 109.111 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -69.49 70.14 1.46 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.656 1.571 . . . . 21.54 109.73 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.2 mm -80.68 155.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.211 -0.931 . . . . 0.0 109.395 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.3 mmtp -54.36 -168.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.205 -0.935 . . . . 29.41 109.771 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 38' ' ' LYS . 71.0 mt-30 -54.76 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.692 0.758 . . . . 0.0 111.413 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 52.8 0.34 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.452 -1.059 . . . . 15.27 110.452 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.83 -32.46 11.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -1.109 . . . . 8.78 109.158 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 tp -95.57 135.19 37.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.39 -0.596 . . . . 7.13 109.39 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 26.2 tt0 -143.76 172.4 12.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 22.03 109.94 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 55.7 m-85 -133.06 111.0 10.6 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.272 -1.381 . . . . 16.33 107.272 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG21 ' CE ' ' A' ' 8' ' ' LYS . 53.0 t -96.16 106.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 6.58 112.279 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 48' ' ' THR . 42.4 m-20 -83.54 98.08 9.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.872 -0.788 . . . . 15.32 108.872 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 pt -62.05 2.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 10.92 110.657 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 46' ' ' ASP . 1.8 p -96.55 -35.53 11.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.003 -1.061 . . . . 21.72 109.372 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.81 28.81 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 22.45 109.775 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 t -144.49 -3.55 0.81 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.047 -1.033 . . . . 25.63 110.145 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.716 HD22 ' CD2' ' A' ' 52' ' ' HIS . 5.4 t30 69.94 -179.14 0.23 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 109.159 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.716 ' CD2' HD22 ' A' ' 51' ' ' ASN . 0.1 OUTLIER 53.98 27.22 7.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 108.563 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -43.07 -55.97 3.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.377 -0.827 . . . . 18.87 110.442 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -59.46 -32.69 70.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 45.21 111.225 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.6 mp0 -62.12 -44.55 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.786 -1.196 . . . . 33.02 110.256 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.87 -54.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.788 -1.195 . . . . 9.84 109.628 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.63 -44.81 77.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.671 -1.233 . . . . 17.84 107.671 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -54.37 -34.41 61.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.937 -1.505 . . . . 18.84 106.937 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -78.26 -45.77 21.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.904 -0.776 . . . . 12.99 108.904 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.5 mt -53.75 -35.82 61.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.721 -1.215 . . . . 14.61 107.721 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 18.3 tp60 -60.47 -57.46 12.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.235 0.54 . . . . 40.45 109.66 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -67.48 -35.22 78.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 41.81 110.113 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.58 -48.64 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.948 . . . . 21.77 109.925 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -111.58 -63.9 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 11.38 109.468 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.45 -45.9 0.53 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.692 -1.242 . . . . 14.79 110.043 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.57 26.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -1.16 . . . . 17.81 110.283 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 31.21 6.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 29.76 109.132 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.45 167.58 16.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 18.26 111.056 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.14 133.88 21.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.956 -1.127 . . . . 8.2 107.956 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 82' ' ' SER . 19.4 Cg_endo -81.04 -165.46 4.5 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.577 0.991 . . . . 7.79 111.918 -0.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.55 91.76 1.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 105.884 -1.895 . . . . 26.05 105.884 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 85' ' ' LEU . 96.3 t -85.3 157.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.288 -0.882 . . . . 8.68 112.181 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.472 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.5 m-85 -143.91 90.45 2.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.677 -0.639 . . . . 14.07 111.262 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -71.91 115.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.132 -2.173 . . . . 9.34 105.132 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.45 -153.12 32.87 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 105.85 -2.9 . . . . 12.42 105.85 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -83.77 0.18 48.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.31 -1.7 . . . . 44.86 109.436 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -89.52 118.81 29.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.256 -0.902 . . . . 0.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -76.35 142.67 41.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.79 -17.68 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.053 -1.029 . . . . 20.45 109.214 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 -157.61 21.8 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.303 -1.119 . . . . 13.82 110.303 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.78 -147.13 19.7 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.048 -1.221 . . . . 12.42 110.048 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.456 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.62 -61.11 1.92 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.492 -1.005 . . . . 0.0 109.688 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -51.02 -25.11 4.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.25 -49.31 19.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.496 -0.753 . . . . 27.06 109.183 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -54.02 -59.19 4.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 15.31 110.08 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.24 -51.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.7 m -45.67 -36.78 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 21.79 108.96 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.04 -41.92 27.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.508 -0.745 . . . . 0.0 111.344 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -58.13 -57.14 14.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.916 -1.115 . . . . 0.0 110.022 -178.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.9 -26.59 68.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.361 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.9 m -81.88 -20.44 38.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.452 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.33 -8.03 73.14 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.512 -1.035 . . . . 25.64 110.512 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.88 -24.48 64.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.036 -1.273 . . . . 50.26 108.371 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 tp -61.74 -66.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.624 0.726 . . . . 24.17 110.899 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.499 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.06 -28.28 16.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.6 -48.11 76.11 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.143 -1.058 . . . . 28.03 108.143 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.83 -34.22 71.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.832 -1.173 . . . . 40.96 107.832 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.9 mp -70.92 -39.98 72.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.677 -0.86 . . . . 15.05 108.677 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.78 -55.66 21.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.83 -0.544 . . . . 0.0 111.599 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.31 -29.29 9.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.86 -1.15 . . . . 38.64 110.93 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.2 pt -101.28 -19.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.747 -1.22 . . . . 0.0 109.08 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.78 40.53 8.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.288 -1.125 . . . . 18.54 110.288 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.08 -13.54 50.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -1.21 . . . . 10.84 109.684 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.57 176.21 6.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.716 -179.792 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.58 -68.45 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.812 . . . . 20.03 110.664 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.43 -38.37 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 12.91 110.438 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 32.9 m120 -55.08 -37.56 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 28.33 109.483 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 m -75.11 -12.77 60.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.974 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -97.13 -46.05 6.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.109 -0.994 . . . . 22.87 110.865 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.82 136.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.852 -1.155 . . . . 25.19 109.906 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -146.92 153.28 45.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.766 -0.827 . . . . 34.61 108.766 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.14 131.71 44.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.644 1.562 . . . . 11.72 110.323 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.676 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 72.62 26.93 70.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.673 -1.371 . . . . 10.24 109.673 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -139.48 135.35 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -1.131 . . . . 25.36 109.363 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.63 135.6 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.304 -0.872 . . . . 10.89 109.92 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.49 141.9 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.847 -1.168 . . . . 15.82 107.847 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.68 124.79 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 8.94 110.917 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -90.1 123.89 34.34 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.365 -1.346 . . . . 9.93 107.365 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.4 pt -133.48 -176.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.19 0.995 . . . . 10.62 111.235 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.6 mtmt -145.02 93.49 5.52 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 106.455 -1.683 . . . . 38.73 106.455 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.485 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -46.87 80.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.691 1.594 . . . . 24.58 110.896 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.626 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.5 m -175.39 -37.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.794 -0.817 . . . . 34.82 108.794 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 128.97 31.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.283 -0.886 . . . . 21.46 110.018 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.67 -14.65 37.15 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.999 1.799 . . . . 13.86 112.158 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -69.05 -45.43 70.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.648 -1.282 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 108.94 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.535 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -64.45 -55.84 18.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.549 -0.719 . . . . 59.59 110.343 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 4.8 ptp180 -50.36 -35.68 29.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.548 -1.345 . . . . 0.0 109.118 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' ARG . . . -62.22 -36.82 83.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -71.66 -48.67 46.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.615 -0.678 . . . . 45.49 109.666 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.76 -31.42 70.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.563 -0.711 . . . . 34.97 111.023 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -78.31 -55.26 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.673 -1.267 . . . . 0.0 109.677 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.814 HD23 HD12 ' A' ' 35' ' ' LEU . 3.4 mt -59.89 -21.96 61.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.642 -1.286 . . . . 17.28 109.146 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -64.86 -26.7 68.44 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.523 -0.917 . . . . 24.11 108.523 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -90.95 3.17 55.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.553 -0.717 . . . . 44.07 110.38 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.814 HD12 HD23 ' A' ' 32' ' ' LEU . 17.0 mt -91.21 127.99 49.08 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.805 -1.184 . . . . 19.63 109.494 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -64.99 68.58 0.27 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 121.676 1.584 . . . . 21.54 109.663 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 35' ' ' LEU . 4.2 mm -82.98 151.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' O ' ' A' ' 39' ' ' GLN . 42.7 mmtt -53.41 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.265 -0.897 . . . . 29.41 109.854 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.613 ' O ' ' O ' ' A' ' 38' ' ' LYS . 6.1 mp0 -50.64 -128.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.645 0.736 . . . . 0.0 110.788 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 49.46 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 O-C-N 121.022 -1.049 . . . . 15.27 110.501 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.676 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -98.47 -13.83 20.34 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.229 -1.159 . . . . 8.78 109.62 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -107.76 129.01 55.08 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.617 -0.883 . . . . 7.13 108.617 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.54 165.39 27.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.063 -1.023 . . . . 22.03 110.443 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -128.39 112.98 15.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.759 -1.201 . . . . 16.33 107.759 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.6 106.92 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 6.58 111.326 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.465 ' OD1' HD11 ' A' ' 18' ' ' ILE . 48.4 m-20 -81.99 101.98 10.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.53 -0.915 . . . . 15.32 108.53 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.26 -5.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.001 -1.062 . . . . 10.92 110.762 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 t -95.27 -23.15 17.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 21.72 109.432 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 18.33 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 22.45 109.613 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 11.2 t -144.39 -2.96 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.118 -0.989 . . . . 25.63 110.139 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.0 m-20 74.88 -176.97 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.071 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.426 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 55.62 27.57 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 108.724 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.84 -59.58 2.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 18.87 110.186 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -58.06 -28.69 64.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 45.21 110.964 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -64.34 -44.92 90.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.714 -1.241 . . . . 33.02 109.54 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.41 -53.73 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.919 -1.113 . . . . 9.84 109.434 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.29 -41.46 75.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.663 -1.236 . . . . 17.84 107.663 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.86 -33.4 64.51 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.293 -1.373 . . . . 18.84 107.293 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -77.6 -47.62 18.91 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.871 -0.789 . . . . 12.99 108.871 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 69.6 mt -54.3 -36.11 63.34 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.211 -1.033 . . . . 14.61 108.211 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.5 tp60 -58.24 -51.54 69.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.758 -0.589 . . . . 40.45 109.551 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -66.44 -52.93 41.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.096 -1.003 . . . . 41.81 111.073 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.52 -31.76 73.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 21.77 110.813 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 19.2 p -112.35 -70.62 0.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.179 -0.95 . . . . 11.38 109.856 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 145.98 -43.09 0.92 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.001 -1.64 . . . . 14.79 109.001 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.67 131.64 44.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -1.045 . . . . 17.81 110.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 33.02 2.72 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 29.76 108.962 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 174.05 11.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.44 -0.787 . . . . 18.26 110.769 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.48 136.81 26.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.473 -0.936 . . . . 8.2 108.473 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.738 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 41.5 Cg_endo -84.87 -173.63 10.52 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.897 -0.876 . . . . 7.79 109.867 0.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.738 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -136.52 102.69 5.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.375 -2.084 . . . . 26.05 105.375 176.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 73' ' ' PHE . 94.4 t -88.5 158.99 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.71 0.767 . . . . 8.68 111.527 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.0 m-85 -145.3 87.37 1.8 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.769 -0.582 . . . . 14.07 110.62 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.36 107.94 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 105.926 -1.879 . . . . 9.34 105.926 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.96 -154.53 53.09 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.492 -2.643 . . . . 12.42 106.492 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -82.89 -3.42 56.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.556 -1.556 . . . . 44.86 109.289 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.74 117.07 28.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 0.0 110.59 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.8 t -72.66 153.04 41.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.085 -1.01 . . . . 0.0 109.385 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.35 -29.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 20.45 109.614 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.67 -136.2 7.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.439 -1.465 . . . . 13.82 109.439 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -115.38 -145.77 8.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.473 -1.451 . . . . 12.42 109.473 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -71.44 -57.76 4.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 109.795 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -52.76 -27.59 18.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.496 -0.753 . . . . 0.0 109.242 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.64 -49.14 27.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -0.83 . . . . 27.06 109.085 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.2 tt -52.74 -60.94 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 15.31 109.554 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.85 -49.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.819 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 t -48.78 -48.5 41.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.803 -1.185 . . . . 21.79 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 94' ' ' LEU . 57.8 mt -70.01 -39.72 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 110.978 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.17 -57.55 12.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 110.728 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.45 -23.92 67.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.977 -1.077 . . . . 0.0 109.203 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -81.96 -22.01 36.9 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 109.506 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.19 -10.44 74.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.885 -1.286 . . . . 25.64 109.885 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.03 -31.43 71.09 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.197 . . . . 50.26 109.405 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.5 tp -57.88 -60.46 3.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 24.17 110.413 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.24 -32.32 62.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.601 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.97 -44.54 92.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.942 -1.133 . . . . 28.03 107.942 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 5.5 ttt180 -61.32 -37.39 83.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.23 -1.026 . . . . 40.96 108.23 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.52 -33.94 69.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.38 -0.97 . . . . 15.05 108.38 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -65.53 -56.56 11.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.827 -0.546 . . . . 0.0 111.572 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -48.18 -33.25 8.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 38.64 110.521 -178.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.9 pt -101.5 -9.35 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.97 42.01 31.13 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.399 -1.08 . . . . 18.54 110.399 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.38 -15.41 43.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -1.187 . . . . 10.84 109.189 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.6 pp -97.76 -172.99 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.736 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.84 -68.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.695 -0.628 . . . . 20.03 110.731 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -73.48 -40.04 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.355 -0.841 . . . . 12.91 110.365 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 17.6 m-20 -55.21 -37.46 67.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.982 -1.074 . . . . 28.33 109.104 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m -74.71 -12.68 60.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.97 -47.2 5.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 22.87 110.362 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.85 136.18 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.862 -1.148 . . . . 25.19 109.964 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -146.87 154.19 46.96 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.369 -0.975 . . . . 34.61 108.369 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.06 130.83 42.36 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.413 1.409 . . . . 11.72 109.97 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.01 64.67 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.785 -1.326 . . . . 10.24 109.785 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -138.9 132.77 30.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 25.36 109.401 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.1 t -102.68 127.54 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.253 -0.904 . . . . 10.89 109.4 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.29 140.7 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.507 -0.923 . . . . 15.82 108.507 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 18' ' ' ILE . 33.3 t -122.27 124.22 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.346 -0.846 . . . . 8.94 111.088 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -92.51 116.33 28.89 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.192 . . . . 9.93 107.783 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 16' ' ' VAL . 29.8 pt -127.65 -178.97 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.308 1.051 . . . . 10.62 111.47 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.7 mtmt -140.72 90.99 9.5 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 105.749 -1.945 . . . . 38.73 105.749 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.484 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.1 Cg_exo -47.14 80.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.718 1.612 . . . . 24.58 110.52 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 19' ' ' LYS . 17.9 m -175.68 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.571 -0.9 . . . . 34.82 108.571 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.3 124.24 47.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.374 -0.829 . . . . 21.46 109.66 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.28 -16.39 17.45 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 122.299 1.999 . . . . 13.86 112.901 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.34 -42.38 65.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.517 -1.364 . . . . 0.0 109.846 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -64.84 -31.72 73.08 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -61.5 -40.39 94.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.639 -0.875 . . . . 59.59 108.639 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.614 HH11 ' HG2' ' A' ' 27' ' ' ARG . 13.5 mtt-85 -54.28 -48.26 71.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 108.679 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.28 74.25 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.366 -0.834 . . . . 0.0 109.072 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -71.38 -45.74 62.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.817 . . . . 45.49 109.524 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 33' ' ' SER . 37.5 mt-10 -70.53 -32.86 70.48 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.599 -0.688 . . . . 34.97 110.927 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -79.4 -57.02 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.818 -1.176 . . . . 0.0 110.796 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.636 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -59.54 -22.02 61.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.632 -1.292 . . . . 17.28 109.818 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 8.9 p -64.51 -23.31 67.23 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.122 -0.986 . . . . 24.11 108.708 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -93.05 -1.28 56.71 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.442 -0.786 . . . . 44.07 110.048 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -88.63 128.7 51.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.864 -1.147 . . . . 19.63 108.996 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.06 67.9 0.94 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.685 1.59 . . . . 21.54 109.581 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm -80.14 148.97 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 39' ' ' GLN . 52.3 mttt -53.65 -167.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.553 -0.717 . . . . 29.41 110.271 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.7 mm100 -52.65 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.758 0.789 . . . . 0.0 111.519 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.5 51.65 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.533 -1.027 . . . . 15.27 110.533 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.55 -28.55 13.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.463 -1.022 . . . . 8.78 108.636 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' HG21 ' A' ' 37' ' ' ILE . 59.6 tp -97.14 130.8 44.35 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.598 -0.89 . . . . 7.13 108.598 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.2 tp10 -141.14 171.83 13.52 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 22.03 109.893 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.418 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 29.9 m-85 -134.34 109.0 8.51 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.23 -1.396 . . . . 16.33 107.23 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.26 102.41 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 6.58 111.543 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.09 97.34 7.5 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.628 -0.878 . . . . 15.32 108.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 56' ' ' ILE . 28.8 pt -61.98 1.61 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 10.92 110.831 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' ASP . 6.4 p -95.56 -28.19 14.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 21.72 109.021 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.23 19.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -0.808 . . . . 22.45 109.385 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 15.0 t -143.68 -0.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.945 . . . . 25.63 109.962 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.63 -172.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.712 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.29 10.32 2.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 108.045 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.21 -68.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.802 -0.561 . . . . 18.87 111.515 -178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 54' ' ' ASN . 2.2 m120 -55.72 -29.87 60.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 45.21 110.994 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.581 ' OE2' ' NE2' ' A' ' 52' ' ' HIS . 11.4 mt-10 -64.83 -42.11 95.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.781 -1.199 . . . . 33.02 109.738 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 47' ' ' ILE . 2.2 mp -67.5 -53.01 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.829 -1.169 . . . . 9.84 109.167 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.04 -43.14 77.55 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.573 -1.269 . . . . 17.84 107.573 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -54.15 -34.02 59.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.021 -1.474 . . . . 18.84 107.021 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -78.51 -45.83 21.04 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 12.99 108.882 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.9 mt -53.45 -33.7 55.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.907 -1.146 . . . . 14.61 107.907 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 12.0 tp60 -60.84 -57.53 12.26 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.333 0.587 . . . . 40.45 109.441 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -67.49 -35.49 79.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 41.81 109.995 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.09 -48.15 74.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 21.77 109.982 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -110.82 -61.89 1.62 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.517 -0.74 . . . . 11.38 109.344 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.64 -49.36 0.49 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.883 -1.287 . . . . 14.79 109.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 140.68 31.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 17.81 110.537 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -101.45 37.74 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.272 -1.01 . . . . 29.76 108.272 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.42 165.34 17.27 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.158 0.98 . . . . 18.26 111.764 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.445 HG12 ' OG ' ' A' ' 25' ' ' SER . 3.2 t -115.08 130.87 23.87 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.2 -1.407 . . . . 8.2 107.2 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 82' ' ' SER . 14.6 Cg_endo -77.03 -165.02 4.2 Favored 'Cis proline' 0 C--N 1.309 -1.522 0 CA-C-O 122.579 0.991 . . . . 7.79 112.328 0.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.534 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -151.03 89.92 1.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.543 -2.021 . . . . 26.05 105.543 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 79' ' ' ILE . 92.9 t -85.48 156.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.639 0.733 . . . . 8.68 111.896 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.6 m-85 -144.06 91.25 2.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.751 -0.593 . . . . 14.07 111.04 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 mm -72.96 114.56 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 106.047 -1.835 . . . . 9.34 106.047 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.74 -154.83 34.76 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.117 -2.793 . . . . 12.42 106.117 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.12 -1.06 51.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.452 -1.616 . . . . 44.86 109.271 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.14 118.66 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.273 -0.892 . . . . 0.0 110.407 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -75.47 150.15 38.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 72' ' ' VAL . 1.6 pp -114.66 -22.7 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.274 -0.891 . . . . 20.45 109.122 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.5 -128.91 4.48 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.128 -1.189 . . . . 13.82 110.128 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 -137.26 4.24 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.861 -1.296 . . . . 12.42 109.861 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -72.39 -63.99 1.04 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.49 -1.006 . . . . 0.0 110.119 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -53.51 -26.71 21.98 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 110.108 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 4.2 t0 -75.25 -46.43 33.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 27.06 109.199 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.1 tt -53.48 -59.16 4.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 15.31 109.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.25 -51.5 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.443 -0.786 . . . . 0.0 110.758 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -47.11 -39.12 12.68 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.903 -1.123 . . . . 21.79 109.203 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 mt -78.98 -41.8 28.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.495 -0.753 . . . . 0.0 112.124 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -57.24 13.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.579 -1.325 . . . . 0.0 110.625 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.2 -26.22 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.939 -1.101 . . . . 0.0 109.516 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.4 m -80.34 -21.29 42.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.7 -9.96 74.06 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.331 -1.107 . . . . 25.64 110.331 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -68.36 -29.19 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.003 -1.293 . . . . 50.26 108.397 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.9 tp -61.21 -63.87 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 24.17 110.792 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -52.68 -30.95 34.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -65.15 -49.26 70.54 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.148 -1.056 . . . . 28.03 108.148 178.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -55.86 -36.15 67.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.574 -1.269 . . . . 40.96 107.574 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.86 -37.34 67.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.664 -0.865 . . . . 15.05 108.664 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.11 -55.06 20.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.642 . . . . 0.0 111.566 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -48.84 -33.93 11.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.85 -1.156 . . . . 38.64 110.751 -178.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.95 -14.78 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.823 -1.173 . . . . 0.0 109.04 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.3 8.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.418 -1.073 . . . . 18.54 110.418 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.78 -19.14 29.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.279 . . . . 10.84 109.855 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -94.67 -175.42 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.711 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.223 0.535 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.18 -73.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 20.03 110.447 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 HD22 ' A' ' 6' ' ' ASN . 2.4 m -73.31 -37.4 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 12.91 110.059 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.49 HD22 HG23 ' A' ' 5' ' ' VAL . 1.9 m120 -55.89 -37.09 68.39 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.106 -0.996 . . . . 28.33 109.582 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -74.5 -12.85 60.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -97.54 -44.33 6.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 22.87 110.755 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.33 137.66 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.821 -1.175 . . . . 25.19 109.611 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -147.83 137.83 12.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.331 -0.988 . . . . 34.61 108.331 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -51.66 129.21 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.067 1.178 . . . . 11.72 109.671 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 80.55 24.02 59.37 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.22 -1.552 . . . . 10.24 109.22 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -141.5 137.66 32.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -1.068 . . . . 25.36 109.402 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.53 137.28 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 10.89 109.843 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.62 144.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.224 -1.028 . . . . 15.82 108.224 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 18' ' ' ILE . 47.1 t -129.11 123.55 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 8.94 111.132 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -90.73 122.61 33.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.533 -1.284 . . . . 9.93 107.533 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' PRO . 18.7 pt -130.97 -170.67 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.337 1.065 . . . . 10.62 110.893 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 21' ' ' THR . 15.6 mtmm -149.24 91.16 4.54 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 105.983 -1.858 . . . . 38.73 105.983 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.3 Cg_exo -47.26 75.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.776 1.651 . . . . 24.58 111.004 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 19' ' ' LYS . 21.9 m -170.74 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.089 -0.708 . . . . 34.82 109.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.0 133.61 23.02 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.229 -0.92 . . . . 21.46 110.076 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.53 -24.96 77.14 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 122.156 1.904 . . . . 13.86 111.854 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.6 -37.94 73.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.867 -1.146 . . . . 0.0 109.242 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -39.87 91.83 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -61.63 -40.79 96.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.015 -0.735 . . . . 59.59 109.015 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.05 -47.43 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.13 74.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.181 -0.949 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.61 -44.66 64.03 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 45.49 110.038 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.8 mm-40 -70.19 -34.47 72.99 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.499 -0.751 . . . . 34.97 110.979 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -78.65 -57.43 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.782 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 35' ' ' LEU . 2.8 mt -60.55 -20.43 60.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.625 -1.297 . . . . 17.28 110.086 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.542 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.6 p -65.34 -26.49 68.05 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.049 -1.032 . . . . 24.11 109.026 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.617 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -90.45 4.57 50.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 44.07 110.616 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 32' ' ' LEU . 18.3 mt -91.45 128.51 46.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.776 -1.203 . . . . 19.63 109.638 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.35 65.37 0.72 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.872 1.714 . . . . 21.54 110.021 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.2 mm -78.88 153.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.291 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.0 mmmt -55.6 -169.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 29.41 109.424 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.581 ' O ' ' O ' ' A' ' 38' ' ' LYS . 23.3 mm-40 -52.5 -129.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.445 -0.784 . . . . 0.0 111.086 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.53 48.57 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.834 -0.906 . . . . 15.27 110.834 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -97.68 -18.84 18.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.18 -1.188 . . . . 8.78 109.344 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -107.4 130.09 54.85 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.585 -0.894 . . . . 7.13 108.585 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -141.72 166.85 23.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 22.03 110.515 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -127.68 109.79 12.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.314 -1.365 . . . . 16.33 107.314 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -95.04 107.79 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 6.58 111.36 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' HD11 ' A' ' 18' ' ' ILE . 69.9 m-20 -81.65 101.79 10.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.269 -1.012 . . . . 15.32 108.269 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.6 pt -63.33 -5.62 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 10.92 110.905 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 t -93.54 -13.59 27.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.845 -1.159 . . . . 21.72 109.405 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.93 11.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 22.45 109.443 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.5 t -142.63 -12.3 0.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 25.63 110.058 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.6 t-20 82.71 -172.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.42 -0.8 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 57.59 30.27 18.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.126 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.2 p -45.02 -58.65 3.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 18.87 109.94 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.6 m120 -53.78 -33.94 57.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 45.21 110.712 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -63.62 -45.94 87.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.754 -1.216 . . . . 33.02 109.534 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.23 -52.67 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 9.84 109.451 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.1 mt-30 -57.27 -40.56 77.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.67 -1.233 . . . . 17.84 107.67 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.71 -32.99 63.79 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.157 -1.423 . . . . 18.84 107.157 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -77.7 -46.37 22.08 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.934 -0.765 . . . . 12.99 108.934 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.76 -36.88 65.32 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.09 -1.078 . . . . 14.61 108.09 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.3 tp-100 -59.47 -52.57 65.03 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.759 -0.83 . . . . 40.45 108.759 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.73 -44.14 78.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 41.81 110.218 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.8 tp -64.1 -42.23 96.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 21.77 110.13 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.614 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 4.6 p -114.05 -74.02 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.438 -0.788 . . . . 11.38 109.702 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 157.8 -38.89 0.54 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.716 -1.354 . . . . 14.79 109.716 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.43 133.44 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -1.194 . . . . 17.81 110.208 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.9 21.65 14.29 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.885 -0.783 . . . . 29.76 108.885 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.88 171.57 15.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.529 -0.732 . . . . 18.26 110.316 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.26 138.39 24.23 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.636 -0.875 . . . . 8.2 108.636 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HB3' HG22 ' A' ' 18' ' ' ILE . 14.8 Cg_endo -81.68 -167.75 6.06 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 124.854 -0.894 . . . . 7.79 110.95 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.0 92.98 2.54 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.966 -1.865 . . . . 26.05 105.966 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 85' ' ' LEU . 62.2 t -84.21 155.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.731 0.777 . . . . 8.68 111.691 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.2 m-85 -143.03 88.51 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.861 -0.525 . . . . 14.07 110.639 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.29 109.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.987 -1.857 . . . . 9.34 105.987 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.76 51.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 106.792 -2.523 . . . . 12.42 106.792 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -86.12 -5.3 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.538 -1.566 . . . . 44.86 109.152 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB3' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -89.04 116.42 27.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -72.31 152.76 41.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.33 -23.37 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 20.45 109.702 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.8 -148.76 19.53 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.747 -1.341 . . . . 13.82 109.747 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.535 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -102.12 -148.65 21.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.945 -1.262 . . . . 12.42 109.945 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -70.66 -58.23 3.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 t -53.19 -27.2 20.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.1 m-20 -73.66 -45.72 50.86 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 27.06 108.817 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -56.26 -60.9 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.539 -0.726 . . . . 15.31 109.952 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.66 -48.03 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.318 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.3 m -49.71 -45.92 49.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.704 -1.247 . . . . 21.79 109.494 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 mt -70.6 -38.65 74.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.452 ' NE2' HD23 ' A' ' 94' ' ' LEU . 12.4 tp60 -60.4 -58.51 8.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.176 -0.953 . . . . 0.0 110.489 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.89 -25.88 67.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.029 -1.044 . . . . 0.0 109.308 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.79 -15.32 52.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.69 -7.41 62.18 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.673 -1.371 . . . . 25.64 109.673 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.83 -27.92 66.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.203 -1.175 . . . . 50.26 109.016 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD23 ' NE2' ' A' ' 89' ' ' GLN . 30.0 tp -59.22 -63.76 1.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -0.847 . . . . 24.17 110.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.95 -30.24 45.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.502 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.55 -43.43 97.11 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.068 -1.086 . . . . 28.03 108.068 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.443 HH21 ' HB3' ' A' ' 77' ' ' ASP . 2.0 tpt180 -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.32 -0.992 . . . . 40.96 108.32 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 mp -71.62 -37.88 70.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.425 -0.797 . . . . 15.05 109.204 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.18 -56.81 12.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 111.856 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -46.82 -27.51 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.794 -1.191 . . . . 38.64 110.264 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.71 -17.81 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.723 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.86 39.37 13.68 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.25 -1.14 . . . . 18.54 110.25 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 -10.19 58.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.178 . . . . 10.84 109.638 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' H ' HD23 ' A' ' 104' ' ' LEU . 1.3 pt? -95.25 -176.98 3.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 109.964 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.597 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.583 0.706 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.25 -68.76 0.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.787 . . . . 20.03 110.678 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -72.94 -38.49 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.134 -0.979 . . . . 12.91 110.289 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 7.5 m120 -55.1 -37.28 66.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.061 -1.024 . . . . 28.33 109.379 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 m -74.97 -12.7 60.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.743 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -97.16 -45.77 6.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 22.87 110.753 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.16 134.45 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.908 -1.12 . . . . 25.19 109.391 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -147.61 149.61 34.39 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 34.61 109.186 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.18 126.17 21.25 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.421 1.414 . . . . 11.72 110.024 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.7 21.34 61.93 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.607 -1.397 . . . . 10.24 109.607 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -137.64 134.01 34.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -1.058 . . . . 25.36 109.272 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.6 137.51 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.18 -0.95 . . . . 10.89 109.617 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.19 147.13 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.211 -1.033 . . . . 15.82 108.211 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.2 t -132.74 122.04 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.932 . . . . 8.94 110.803 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -89.43 126.12 35.43 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.478 -1.304 . . . . 9.93 107.478 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 70' ' ' PRO . 46.5 pt -133.74 -172.18 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.174 0.988 . . . . 10.62 111.319 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.744 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.6 mtmt -147.49 96.31 4.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.747 -1.575 . . . . 38.73 106.747 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 21' ' ' THR . 11.2 Cg_exo -49.22 66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.843 1.696 . . . . 24.58 111.147 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 19' ' ' LYS . 16.8 p -162.62 -35.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.984 -0.747 . . . . 34.82 108.984 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.13 128.47 35.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 21.46 110.072 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.25 -14.78 40.42 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 122.12 1.88 . . . . 13.86 111.996 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -70.54 -43.14 70.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.691 -1.256 . . . . 0.0 109.798 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -31.19 71.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.351 -0.843 . . . . 0.0 109.55 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.82 -47.74 83.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 59.59 109.544 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.664 HH11 ' HG3' ' A' ' 27' ' ' ARG . 2.4 mmm-85 -51.08 -41.29 59.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 0.0 108.803 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.33 82.75 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -71.57 -46.1 60.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 45.49 109.663 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 97.3 mt-10 -68.83 -34.6 75.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.518 -0.738 . . . . 34.97 110.916 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -76.8 -56.64 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.741 -1.225 . . . . 0.0 110.045 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.638 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -58.51 -20.85 49.49 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.667 -1.271 . . . . 17.28 109.14 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.428 ' HB2' HE22 ' A' ' 34' ' ' GLN . 8.9 m -65.22 -30.44 71.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.25 -0.906 . . . . 24.11 108.78 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.519 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -88.65 3.32 51.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 44.07 110.262 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 35' ' ' LEU . 18.1 mt -91.87 127.77 48.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.826 -1.171 . . . . 19.63 109.432 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.05 63.55 0.31 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.866 1.711 . . . . 21.54 110.485 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.1 mm -80.25 147.19 6.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.2 mttp -53.46 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 29.41 110.342 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' LYS . 33.1 mt-30 -49.81 -128.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 111.435 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.53 47.75 0.08 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.87 -0.892 . . . . 15.27 110.87 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -101.24 -15.33 17.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -1.207 . . . . 8.78 109.193 179.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 37' ' ' ILE . 47.4 tp -110.18 128.73 55.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.404 -0.962 . . . . 7.13 108.404 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.1 tt0 -141.32 169.8 16.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.067 . . . . 22.03 110.317 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.476 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.0 m-85 -133.12 112.87 12.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.048 -1.093 . . . . 16.33 108.048 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -95.9 102.09 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 6.58 111.149 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 2.7 m-20 -80.19 100.2 8.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.234 -1.024 . . . . 15.32 108.234 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 pt -62.45 -0.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 10.92 110.196 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' ASP . 33.9 p -95.6 -27.03 15.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 21.72 109.597 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.48 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 22.45 109.484 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.477 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 14.7 t -145.17 -3.27 0.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 25.63 110.164 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.707 HD21 ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 67.89 -162.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.048 -1.032 . . . . 0.0 108.526 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' HD21 ' A' ' 51' ' ' ASN . 20.1 m170 56.56 11.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.685 -1.26 . . . . 0.0 108.141 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.75 -69.22 0.11 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 18.87 111.36 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.1 m-20 -53.04 -31.28 40.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.062 -1.024 . . . . 45.21 110.895 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.8 -46.21 79.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.782 -1.199 . . . . 33.02 109.912 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.86 -52.3 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.748 -1.22 . . . . 9.84 109.68 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.89 -41.64 82.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.63 -1.248 . . . . 17.84 107.63 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 9.9 m-20 -55.66 -34.23 64.8 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.279 -1.378 . . . . 18.84 107.279 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.15 -50.31 12.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.84 -0.744 . . . . 12.99 109.204 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.5 mt -52.42 -33.07 42.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.164 -1.05 . . . . 14.61 108.164 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.2 tp60 -60.42 -56.59 19.61 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.656 -0.653 . . . . 40.45 109.302 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -65.69 -41.19 92.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 41.81 109.867 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -65.72 -37.22 85.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 21.77 109.815 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.835 HG21 HH11 ' A' ' 71' ' ' ARG . 6.5 p -113.23 -63.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 11.38 109.555 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 61' ' ' GLN . . . 144.83 -49.21 0.69 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.007 -1.637 . . . . 14.79 109.007 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.22 44.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.047 . . . . 17.81 109.958 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.32 36.12 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.519 -0.919 . . . . 29.76 108.519 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.41 169.52 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.547 -0.721 . . . . 18.26 110.226 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.81 135.41 24.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.107 -1.072 . . . . 8.2 108.107 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -81.98 -166.22 4.9 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 124.784 -0.923 . . . . 7.79 111.157 -0.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.835 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -143.03 91.18 2.26 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.789 -1.93 . . . . 26.05 105.789 177.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 79' ' ' ILE . 58.1 t -82.09 154.23 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 8.68 111.211 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 72' ' ' VAL . 75.5 m-85 -143.47 88.67 2.02 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.397 -0.521 . . . . 14.07 110.2 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -71.6 101.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.024 -1.843 . . . . 9.34 106.024 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.22 -149.85 39.68 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.345 -2.702 . . . . 12.42 106.345 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 8.4 mtmp? -86.97 -6.78 58.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.568 -1.549 . . . . 44.86 109.474 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' HH21 ' A' ' 97' ' ' ARG . 3.0 m-20 -91.48 121.6 33.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 110.582 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -73.62 155.82 38.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 80' ' ' GLY . 2.8 pp -119.0 -16.61 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.233 -0.917 . . . . 20.45 109.69 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.572 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 136.23 -150.43 20.44 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.081 -1.207 . . . . 13.82 110.081 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.76 -145.3 11.81 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.955 -1.258 . . . . 12.42 109.955 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -70.89 -62.13 1.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.489 -1.007 . . . . 0.0 110.03 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 t -54.23 -26.43 28.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.349 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -73.88 -45.79 48.68 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -0.874 . . . . 27.06 109.007 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.6 tt -54.11 -59.66 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.41 -0.806 . . . . 15.31 109.7 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -54.09 -43.49 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 110.503 -178.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.619 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 18.8 m -55.27 -35.48 65.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 21.79 110.146 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.02 -34.35 32.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 0.0 111.258 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.41 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -62.23 -60.57 3.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.004 -1.06 . . . . 0.0 111.124 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.712 ' OE1' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.86 -17.42 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.859 -1.151 . . . . 0.0 109.523 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.544 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 40.4 m -80.26 -62.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.495 -0.753 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.77 4.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.401 -1.479 . . . . 25.64 109.401 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.37 -30.46 69.41 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.271 -1.135 . . . . 50.26 108.952 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.73 -64.18 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 24.17 110.431 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.01 -31.4 61.02 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.479 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.61 -45.44 90.34 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.422 -0.955 . . . . 28.03 108.422 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 77' ' ' ASP . 3.1 ttt180 -61.25 -34.99 76.06 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.273 -1.01 . . . . 40.96 108.273 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 102' ' ' GLY . 7.9 mp -70.93 -36.14 72.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.721 -0.844 . . . . 15.05 108.721 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -64.57 -57.5 8.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.782 -0.574 . . . . 0.0 111.346 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 96' ' ' THR . 1.1 pt20 -47.48 -31.72 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.895 -1.128 . . . . 38.64 110.349 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.86 -11.8 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.995 -1.066 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 73.75 44.51 31.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.507 -1.037 . . . . 18.54 110.507 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.42 -11.86 50.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -1.218 . . . . 10.84 109.484 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.72 -178.11 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 0.0 110.059 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.393 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -62.19 -72.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.391 -0.818 . . . . 20.03 110.248 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.84 -39.62 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 12.91 109.929 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 3.3 m120 -55.6 -37.31 67.94 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 28.33 109.575 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -74.47 -13.02 60.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.97 -48.34 5.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 22.87 110.277 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 128.38 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.974 -1.079 . . . . 25.19 109.869 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -147.85 160.44 38.03 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.56 -0.904 . . . . 34.61 108.56 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.0 129.19 33.17 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.658 1.572 . . . . 11.72 111.165 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.54 29.94 50.82 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.865 -0.894 . . . . 10.24 110.865 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -144.8 136.21 25.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.88 -1.364 . . . . 25.36 110.074 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.24 133.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 10.89 109.38 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.68 144.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.347 -0.983 . . . . 15.82 108.347 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.42 124.46 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 8.94 110.957 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -90.07 121.21 31.92 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.397 -1.334 . . . . 9.93 107.397 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -130.7 -175.57 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.276 1.036 . . . . 10.62 111.2 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.7 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.9 mtmt -148.72 86.59 5.75 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.689 -1.597 . . . . 38.73 106.689 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.506 ' O ' ' OG1' ' A' ' 21' ' ' THR . 15.6 Cg_exo -44.26 76.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.791 1.661 . . . . 24.58 110.928 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 19' ' ' LYS . 34.2 m -172.02 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.436 -0.95 . . . . 34.82 108.436 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.5 129.62 29.91 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 21.46 109.505 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.74 -19.92 56.08 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 122.085 1.857 . . . . 13.86 112.099 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.679 -1.263 . . . . 0.0 109.551 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -32.95 74.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 108.44 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -62.51 -45.51 92.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 59.59 108.879 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -49.55 -45.2 47.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.12 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.58 84.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.135 -0.978 . . . . 0.0 108.811 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -70.4 -42.57 71.48 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.46 -0.775 . . . . 45.49 109.659 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.37 -36.05 76.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 34.97 111.06 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.77 -56.53 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.837 -1.164 . . . . 0.0 110.497 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD23 HD12 ' A' ' 35' ' ' LEU . 2.5 mt -59.78 -19.91 53.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.576 -1.328 . . . . 17.28 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -65.65 -27.58 68.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.135 -0.978 . . . . 24.11 108.919 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -90.11 3.81 52.24 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.316 -0.865 . . . . 44.07 110.431 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.712 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -92.49 125.86 54.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.824 -1.172 . . . . 19.63 109.805 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.98 67.72 0.92 Allowed 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.802 1.668 . . . . 21.54 109.893 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 mm -79.43 150.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.7 mtpm? -54.19 -171.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.366 -0.834 . . . . 29.41 110.192 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' LYS . 16.7 mt-30 -50.78 -131.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.617 0.722 . . . . 0.0 111.447 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.14 49.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.242 -0.911 . . . . 15.27 110.933 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.8 -17.51 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -1.074 . . . . 8.78 109.383 179.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.0 tp -107.88 130.9 54.97 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.48 -0.933 . . . . 7.13 108.48 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -141.58 169.27 17.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -0.988 . . . . 22.03 110.418 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -131.92 109.96 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.606 -1.257 . . . . 16.33 107.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.0 t -94.67 104.01 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 6.58 111.186 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -80.71 101.34 9.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.782 -0.822 . . . . 15.32 108.782 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.59 -7.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 10.92 110.198 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -100.49 46.93 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 21.72 108.804 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.03 20.25 0.31 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.025 -0.732 . . . . 22.45 109.025 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 9.0 t -144.51 -5.22 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 25.63 109.513 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 50' ' ' THR . 4.2 t-20 81.38 177.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.38 27.13 11.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.997 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.14 -60.69 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 18.87 110.41 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 81.6 m-20 -57.47 -29.51 64.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 45.21 111.022 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.13 -43.95 93.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.724 -1.235 . . . . 33.02 109.747 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.1 -53.67 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 9.84 109.431 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.43 -43.17 83.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.839 -1.171 . . . . 17.84 107.839 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 26.3 m-20 -54.9 -34.93 63.58 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.345 -1.354 . . . . 18.84 107.345 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -78.76 -47.3 17.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.878 -0.729 . . . . 12.99 109.245 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.76 -32.77 53.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.213 -1.032 . . . . 14.61 108.213 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.721 HE22 ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -59.49 -55.59 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.879 -0.785 . . . . 40.45 108.879 179.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -67.45 -35.5 79.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.181 -0.95 . . . . 41.81 110.109 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 73' ' ' PHE . 29.3 tp -64.88 -46.42 81.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.1 -1.0 . . . . 21.77 109.91 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.525 HG21 HH11 ' A' ' 71' ' ' ARG . 1.4 p -110.06 -58.5 2.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.47 -0.769 . . . . 11.38 109.481 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 150.01 -52.46 0.52 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.573 -1.411 . . . . 14.79 109.573 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 138.28 35.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -1.093 . . . . 17.81 110.261 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.721 ' N ' HE22 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -95.59 32.28 1.85 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.459 -0.941 . . . . 29.76 108.459 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 165.79 22.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 18.26 110.207 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -116.79 138.35 24.54 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.056 -1.09 . . . . 8.2 108.056 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -80.66 -168.13 6.53 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 124.8 -0.917 . . . . 7.79 111.361 -0.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.549 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.68 90.75 2.03 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.852 -1.907 . . . . 26.05 105.852 177.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.566 HG21 HD12 ' A' ' 85' ' ' LEU . 74.0 t -83.23 155.58 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.737 0.779 . . . . 8.68 111.551 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CE2' HD23 ' A' ' 63' ' ' LEU . 79.6 m-85 -144.12 89.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.818 -0.551 . . . . 14.07 110.921 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -71.72 110.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.084 -1.821 . . . . 9.34 106.084 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.66 -153.34 52.5 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.729 -2.548 . . . . 12.42 106.729 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -84.15 -3.74 58.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.564 -1.551 . . . . 44.86 109.41 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -90.05 118.37 29.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.937 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -72.68 152.26 41.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.031 -1.043 . . . . 0.0 109.416 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -113.87 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -0.969 . . . . 20.45 109.336 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.448 ' HA2' HH22 ' A' ' 71' ' ' ARG . . . 132.51 -155.96 21.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.124 -1.19 . . . . 13.82 110.124 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.95 -147.16 22.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.201 -1.16 . . . . 12.42 110.201 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -70.56 -60.2 2.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.526 -0.985 . . . . 0.0 109.867 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 t -52.43 -25.84 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.286 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.19 -49.08 25.05 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.801 . . . . 27.06 109.333 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.5 tt -54.7 -59.23 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 15.31 110.145 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.16 -45.41 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.105 -178.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 -47.47 66.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.736 -1.228 . . . . 21.79 109.492 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.23 -36.54 77.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.903 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -60.77 -59.18 5.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 110.478 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.53 -24.19 67.37 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.432 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -82.55 -16.52 48.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.464 -0.773 . . . . 0.0 109.813 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 -9.88 56.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.819 -1.313 . . . . 25.64 109.819 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -67.7 -28.18 67.45 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -1.174 . . . . 50.26 108.809 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.32 -65.7 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 24.17 110.084 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.24 -30.38 37.78 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.449 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -62.86 -44.68 95.46 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.465 -0.939 . . . . 28.03 108.465 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.707 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -63.06 -34.11 76.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.662 -0.866 . . . . 40.96 108.662 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.6 mp -71.11 -35.68 71.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 15.05 109.023 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -65.11 -56.9 10.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.608 -0.683 . . . . 0.0 111.574 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -46.01 -31.09 2.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 38.64 110.395 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.4 pt -104.45 -14.44 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.86 40.5 21.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.304 -1.118 . . . . 18.54 110.304 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.42 -8.06 59.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.239 . . . . 10.84 109.474 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.639 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.18 -178.99 4.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.561 179.724 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.254 0.55 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.17 -69.16 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 20.03 110.432 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 6' ' ' ASN . 2.5 m -73.51 -40.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 12.91 110.443 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 5' ' ' VAL . 68.4 m-80 -55.21 -29.94 58.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.067 -1.021 . . . . 28.33 109.497 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 m -75.29 -18.44 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -98.1 -44.03 6.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 22.87 111.212 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.26 129.18 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.174 . . . . 25.19 110.585 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.05 158.4 38.91 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.151 -1.055 . . . . 34.61 108.151 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.0 127.95 27.9 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.544 1.496 . . . . 11.72 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.12 28.16 46.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.753 -0.939 . . . . 10.24 110.753 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -143.14 136.88 28.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.969 -1.313 . . . . 25.36 109.933 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.79 134.4 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.386 -0.821 . . . . 10.89 109.392 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.15 143.0 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.437 -0.949 . . . . 15.82 108.437 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.7 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.405 -0.809 . . . . 8.94 110.739 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.62 122.74 33.04 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.487 -1.301 . . . . 9.93 107.487 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.6 pt -132.11 -174.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.104 0.954 . . . . 10.62 111.224 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mtmt -145.77 94.63 5.03 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.585 -1.635 . . . . 38.73 106.585 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.0 Cg_exo -46.49 82.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.561 1.508 . . . . 24.58 110.945 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 19' ' ' LYS . 14.7 m 178.95 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 34.82 108.41 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.96 121.88 54.42 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 21.46 109.711 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.04 -17.57 45.75 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.724 1.616 . . . . 13.86 111.778 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -68.87 -42.63 76.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.563 -1.335 . . . . 0.0 108.291 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -36.73 83.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -61.15 -39.37 89.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.8 -1.185 . . . . 59.59 107.8 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.69 -47.15 70.74 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.42 74.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.407 -0.808 . . . . 0.0 108.865 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 33' ' ' SER . 5.4 mt-30 -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.852 . . . . 45.49 109.745 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.3 mm-40 -69.82 -34.17 73.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 34.97 111.029 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.48 -55.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 35' ' ' LEU . 1.5 mt -59.25 -24.13 62.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.671 -1.268 . . . . 17.28 109.696 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.2 p -63.85 -22.22 66.81 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.289 -1.004 . . . . 24.11 108.289 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -90.09 0.43 57.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.527 -0.733 . . . . 44.07 109.862 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 32' ' ' LEU . 18.9 mt -92.96 127.45 47.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 19.63 109.656 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.0 66.65 0.58 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.644 1.562 . . . . 21.54 109.777 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -80.07 148.15 6.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.9 mttp -54.55 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -0.826 . . . . 29.41 110.272 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' LYS . 17.0 mt-30 -51.1 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.641 0.734 . . . . 0.0 111.191 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.24 48.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.924 -0.87 . . . . 15.27 110.924 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -99.8 -17.36 17.71 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.129 -1.218 . . . . 8.78 109.137 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' A' ' 37' ' ' ILE . 54.1 tp -108.55 126.92 53.46 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.967 -1.123 . . . . 7.13 107.967 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 23.2 tp10 -139.59 163.67 31.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.993 -1.067 . . . . 22.03 110.253 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.9 m-85 -126.32 110.84 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.677 -1.231 . . . . 16.33 107.677 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.61 107.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 6.58 111.235 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' THR . 4.7 m-20 -82.59 99.61 9.65 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.469 -0.937 . . . . 15.32 108.469 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.2 pt -62.03 5.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 10.92 110.61 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . 16.9 p -97.22 -25.53 15.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.089 -1.007 . . . . 21.72 109.812 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.91 23.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 22.45 109.943 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.575 ' C ' HD22 ' A' ' 51' ' ' ASN . 12.0 t -146.74 0.6 0.76 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 25.63 110.489 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.575 HD22 ' C ' ' A' ' 50' ' ' THR . 2.2 m-80 66.45 -177.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.227 -0.921 . . . . 0.0 109.245 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.58 29.92 16.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 108.8 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.85 -56.69 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 18.87 110.002 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 68.8 m-20 -57.02 -31.4 65.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 45.21 111.0 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.5 -45.13 92.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.752 -1.218 . . . . 33.02 109.739 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.3 mp -66.86 -53.98 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.869 -1.144 . . . . 9.84 109.677 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.26 -40.67 78.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.723 -1.214 . . . . 17.84 107.723 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 61.2 m-20 -54.96 -33.73 62.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.037 -1.468 . . . . 18.84 107.037 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -78.86 -48.72 14.15 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.058 -0.719 . . . . 12.99 109.058 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.3 mt -53.96 -33.21 56.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.141 -1.059 . . . . 14.61 108.141 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 6.9 tp60 -60.58 -57.68 11.68 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.165 -0.68 . . . . 40.45 109.165 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.09 -36.22 81.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.359 -0.838 . . . . 41.81 110.023 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 tp -65.38 -49.17 70.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.094 -1.004 . . . . 21.77 109.704 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 2.2 p -109.05 -67.2 1.0 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.74 . . . . 11.38 109.563 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 161.33 -49.07 0.36 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.258 -1.449 . . . . 14.79 110.874 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.849 ' HB3' HH12 ' A' ' 71' ' ' ARG . . . -97.81 136.95 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.304 . . . . 17.81 110.771 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.58 25.21 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.253 -1.388 . . . . 29.76 107.253 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.579 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -79.15 169.42 18.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.665 0.745 . . . . 18.26 110.254 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.0 135.09 24.1 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.02 -1.104 . . . . 8.2 108.02 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -83.72 -164.69 3.61 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 124.868 -0.888 . . . . 7.79 110.797 -0.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.849 HH12 ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -152.41 93.47 1.8 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.036 -2.209 . . . . 26.05 105.036 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 73' ' ' PHE . 65.7 t -82.5 160.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.859 0.838 . . . . 8.68 111.971 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.536 ' N ' HG12 ' A' ' 72' ' ' VAL . 83.9 m-85 -144.47 91.83 2.23 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 116.174 -0.467 . . . . 14.07 110.584 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 98' ' ' LEU . 8.3 mm -71.73 104.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.881 -1.896 . . . . 9.34 105.881 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.32 -149.64 51.11 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 106.101 -2.8 . . . . 12.42 106.101 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -84.77 -1.17 55.97 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.489 -1.595 . . . . 44.86 109.245 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' OD2' ' NH2' ' A' ' 97' ' ' ARG . 85.2 m-20 -89.5 111.76 22.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -72.97 147.67 44.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.89 -21.13 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.289 -0.882 . . . . 20.45 108.983 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.12 -149.42 18.87 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.18 -1.168 . . . . 13.82 110.18 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.52 -140.66 9.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.405 -1.078 . . . . 12.42 110.405 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 86' ' ' VAL . 11.0 p -70.06 -65.61 0.7 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.729 -0.865 . . . . 0.0 110.334 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -50.83 -27.9 8.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.821 . . . . 0.0 109.692 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -73.92 -49.47 24.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.354 -0.841 . . . . 27.06 109.345 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.0 tt -56.01 -60.09 3.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 15.31 110.411 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -48.59 -47.17 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 -178.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 t -49.46 -46.34 47.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.791 -1.193 . . . . 21.79 109.444 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.22 -39.11 75.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.878 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -60.58 -58.39 8.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.894 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.63 -24.75 65.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 109.102 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -79.97 -43.78 21.43 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.653 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.69 -9.96 30.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.393 -1.483 . . . . 25.64 109.393 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.58 -26.06 65.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -1.082 . . . . 50.26 108.911 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.52 -64.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 24.17 110.212 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.24 -30.82 40.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.5 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.32 -44.09 95.94 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.974 -1.121 . . . . 28.03 107.974 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.511 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 8.9 tpt180 -61.27 -35.49 77.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.411 -0.959 . . . . 40.96 108.411 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.6 mp -70.6 -38.93 74.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.857 0.837 . . . . 15.05 108.82 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -65.55 -53.81 36.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.824 -0.548 . . . . 0.0 112.033 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -48.31 -32.17 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.78 -1.2 . . . . 38.64 110.42 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.2 pt -103.83 -14.4 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.572 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 78.99 45.4 9.06 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.283 -1.127 . . . . 18.54 110.283 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.56 -11.81 53.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -1.121 . . . . 10.84 109.187 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.57 -177.85 4.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.14 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.599 179.864 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -63.67 -69.49 0.27 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.476 -0.765 . . . . 20.03 110.619 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.64 -39.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 12.91 110.169 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.1 m-20 -55.75 -37.98 69.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.212 -0.93 . . . . 28.33 109.271 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -74.94 -12.03 60.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -97.21 -45.33 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 22.87 110.721 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.451 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.54 138.95 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.788 -1.195 . . . . 25.19 110.029 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.27 136.77 11.21 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 107.947 -1.131 . . . . 34.61 107.947 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -50.02 131.51 30.51 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 120.997 1.131 . . . . 11.72 109.699 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 20.64 70.06 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.209 -1.556 . . . . 10.24 109.209 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -137.82 132.98 33.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -1.06 . . . . 25.36 109.013 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.32 135.5 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.154 -0.966 . . . . 10.89 109.754 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.3 142.86 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.268 -1.012 . . . . 15.82 108.268 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 18' ' ' ILE . 39.0 t -124.86 128.07 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 8.94 111.201 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -94.74 114.69 26.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.352 -0.981 . . . . 9.93 108.352 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 25' ' ' SER . 41.6 pt -125.74 -172.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.537 1.161 . . . . 10.62 111.587 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -145.89 94.65 4.98 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 105.481 -2.044 . . . . 38.73 105.481 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.1 Cg_exo -49.21 79.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.392 1.394 . . . . 24.58 111.06 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.607 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.8 m -177.59 -32.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.539 -0.726 . . . . 34.82 109.442 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.77 124.68 45.09 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 21.46 109.6 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.78 -17.63 23.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.382 2.054 . . . . 13.86 113.164 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -69.91 -49.71 49.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.269 -1.52 . . . . 0.0 109.391 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -59.96 -33.08 71.45 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -61.13 -42.67 98.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.815 -0.809 . . . . 59.59 108.815 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 1.1 mtt-85 -54.52 -47.81 72.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.008 -1.058 . . . . 0.0 108.754 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 mt-30 -70.07 -41.81 73.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.36 -0.837 . . . . 45.49 109.435 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 42.5 mt-10 -72.19 -38.74 68.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.565 -0.709 . . . . 34.97 111.461 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -74.19 -55.69 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.813 -1.18 . . . . 0.0 110.093 -178.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.63 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -60.02 -20.08 56.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.538 -1.351 . . . . 17.28 109.649 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.1 m -65.73 -30.2 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.103 -0.998 . . . . 24.11 109.539 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 30' ' ' GLU . 2.9 mp0 -93.85 4.93 53.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 44.07 110.902 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' OE1' ' A' ' 89' ' ' GLN . 21.6 mt -88.35 132.18 40.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.767 -1.208 . . . . 19.63 108.604 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.85 62.52 0.59 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.577 1.518 . . . . 21.54 110.258 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.3 mm -78.32 146.94 7.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.032 -1.043 . . . . 0.0 108.225 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 39' ' ' GLN . 18.6 mtpt -53.65 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.062 -1.024 . . . . 29.41 109.944 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 41' ' ' LEU . 26.9 mt-30 -52.29 -127.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.691 0.758 . . . . 0.0 112.363 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.81 48.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.102 -0.799 . . . . 15.27 111.102 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -99.66 -33.04 10.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.263 -1.14 . . . . 8.78 108.81 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.6 tp -94.42 132.81 38.67 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.466 0.65 . . . . 7.13 109.446 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.6 tp10 -142.01 174.05 10.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 22.03 109.515 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.463 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 46.7 m-85 -136.63 112.02 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.196 -1.409 . . . . 16.33 107.196 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.31 104.01 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 6.58 111.775 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 2.6 m-20 -82.68 97.62 8.63 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.603 -0.888 . . . . 15.32 108.603 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.53 1.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 10.92 110.499 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 46' ' ' ASP . 18.1 p -93.61 -17.26 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.027 -1.046 . . . . 21.72 108.635 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 7.27 5.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.49 -0.756 . . . . 22.45 109.546 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.0 t -142.31 -3.99 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 25.63 110.009 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' C ' ' N ' ' A' ' 53' ' ' THR . 8.7 t30 66.55 -151.73 0.21 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 51.24 13.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.667 -1.271 . . . . 0.0 108.631 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 51' ' ' ASN . 4.3 p -41.59 -55.95 2.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.79 . . . . 18.87 110.733 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.9 m120 -52.31 -36.81 54.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 45.21 110.503 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -65.92 -45.01 83.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.06 . . . . 33.02 109.493 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -67.35 -52.55 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 9.84 109.563 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 2.8 mt-30 -56.2 -43.74 78.78 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.231 -1.396 . . . . 17.84 107.231 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -55.5 -34.51 64.67 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.85 -1.537 . . . . 18.84 106.85 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -78.71 -48.81 14.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 120.245 -0.582 . . . . 12.99 109.506 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -51.95 -34.35 41.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.924 -1.139 . . . . 14.61 107.924 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' OE1' ' NH2' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -61.16 -58.2 9.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.304 0.573 . . . . 40.45 109.768 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -68.47 -35.65 77.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.177 -0.952 . . . . 41.81 110.861 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.94 -48.24 77.3 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 21.77 110.107 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -113.08 -61.79 1.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 11.38 109.423 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 160.9 -56.75 0.31 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.647 -1.381 . . . . 14.79 109.647 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -99.07 143.58 29.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -1.116 . . . . 17.81 109.296 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -108.95 20.85 17.96 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.026 -1.102 . . . . 29.76 108.026 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.01 165.63 17.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.346 -0.846 . . . . 18.26 109.524 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG12 ' OG ' ' A' ' 25' ' ' SER . 2.6 t -105.6 131.08 22.06 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 8.2 108.859 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 82' ' ' SER . 33.5 Cg_endo -84.65 -165.96 4.15 Favored 'Cis proline' 0 C--N 1.309 -1.548 0 CA-C-O 122.521 0.967 . . . . 7.79 111.674 -1.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.579 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 7.1 tpp180 -152.73 92.48 1.66 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.794 -2.299 . . . . 26.05 104.794 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 95.3 t -81.62 157.4 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.782 0.801 . . . . 8.68 112.021 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.8 m-85 -139.81 88.45 2.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.718 -0.614 . . . . 14.07 111.297 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mm -71.93 113.88 9.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.921 -2.252 . . . . 9.34 104.921 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.2 -154.52 29.18 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.796 -2.922 . . . . 12.42 105.796 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -83.01 0.34 45.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.218 -1.754 . . . . 44.86 108.622 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.46 110.01 19.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -74.35 142.33 45.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.675 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 1.9 pt -107.2 -22.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.979 -1.076 . . . . 20.45 109.166 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.28 19.05 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.212 -1.155 . . . . 13.82 110.212 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.79 -145.25 15.3 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.198 -1.161 . . . . 12.42 110.198 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.6 t -71.8 -60.53 2.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 t -51.38 -24.2 4.56 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.428 0.632 . . . . 0.0 109.483 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 3.5 t70 -76.73 -51.4 11.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.808 . . . . 27.06 109.394 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.2 tt -51.27 -58.91 4.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 15.31 109.975 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.2 -54.23 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.551 -0.718 . . . . 0.0 109.865 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' VAL . 74.3 m -44.68 -36.69 3.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.335 -0.853 . . . . 21.79 109.119 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 94' ' ' LEU . 32.3 mt -80.83 -43.49 19.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.493 -0.754 . . . . 0.0 111.409 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.456 ' OE1' HD11 ' A' ' 35' ' ' LEU . 22.9 tp60 -61.01 -56.2 23.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 111.018 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.54 -26.0 64.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.742 -1.224 . . . . 0.0 108.911 -179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.8 m -79.18 -60.82 2.22 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.17 -7.93 6.01 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.061 -1.215 . . . . 25.64 110.061 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -70.12 -26.15 63.83 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.064 -1.256 . . . . 50.26 108.856 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.3 tp -60.08 -62.34 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.819 . . . . 24.17 110.717 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.12 -28.8 42.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.8 -49.48 68.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.317 -0.994 . . . . 28.03 108.317 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.436 ' NH1' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.22 -33.39 65.32 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.412 -1.329 . . . . 40.96 107.412 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.51 -41.0 66.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.88 -0.785 . . . . 15.05 108.88 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -64.77 -52.07 58.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.731 -0.605 . . . . 0.0 111.693 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.96 -34.1 27.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.836 -1.165 . . . . 38.64 111.007 -177.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 101' ' ' ILE . 19.9 pt -99.55 -18.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.63 -1.294 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.6 40.95 7.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.605 -0.998 . . . . 18.54 110.605 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.75 -10.98 56.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.09 -1.241 . . . . 10.84 109.436 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.692 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.58 178.15 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.417 HE21 ' HG2' ' A' ' 38' ' ' LYS . 7.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.63 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.191 0.519 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.27 -75.74 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.178 -0.951 . . . . 20.03 110.483 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -74.24 -36.44 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 12.91 109.818 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.407 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 50.7 m-20 -56.14 -38.23 70.56 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 28.33 109.81 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.3 m -74.1 -12.46 60.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.095 -1.003 . . . . 0.0 109.86 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -97.63 -45.37 6.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 22.87 110.72 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.21 130.67 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.828 -1.17 . . . . 25.19 110.116 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.67 157.21 36.28 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.018 -1.104 . . . . 34.61 108.018 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.89 131.54 46.14 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.897 1.731 . . . . 11.72 111.588 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.74 21.76 68.08 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.488 -0.863 . . . . 10.24 111.073 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -140.11 132.76 28.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.972 -1.311 . . . . 25.36 109.415 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.74 133.75 41.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.401 -0.812 . . . . 10.89 109.404 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.93 142.9 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.673 -0.862 . . . . 15.82 108.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 18' ' ' ILE . 28.9 t -125.91 126.8 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 8.94 111.202 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -94.18 116.91 29.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 9.93 107.881 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.8 pt -127.82 -171.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 122.635 1.207 . . . . 10.62 111.527 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.5 mtmt -149.32 87.47 5.27 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 105.823 -1.918 . . . . 38.73 105.823 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 21' ' ' THR . 16.7 Cg_exo -47.21 73.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.712 1.608 . . . . 24.58 110.861 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.8 p -161.88 -37.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.038 -1.097 . . . . 34.82 108.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.39 129.76 28.47 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 21.46 109.434 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -56.98 -24.55 57.99 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.404 2.07 . . . . 13.86 112.579 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.65 -41.64 87.9 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.38 -1.45 . . . . 0.0 108.76 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.664 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.12 -35.06 76.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.72 -1.215 . . . . 59.59 107.72 178.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -54.62 -47.98 72.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 179.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.58 76.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.316 -0.865 . . . . 0.0 108.841 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -70.95 -41.66 70.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.467 -0.771 . . . . 45.49 109.75 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -71.31 -37.33 71.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 34.97 111.281 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -76.46 -58.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 110.525 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -58.51 -22.75 56.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.623 -1.298 . . . . 17.28 109.945 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -64.92 -25.65 67.97 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.049 -1.032 . . . . 24.11 108.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -92.99 -0.82 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.81 . . . . 44.07 110.066 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 35' ' ' LEU . 21.1 mt -87.91 130.9 44.88 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.935 -1.103 . . . . 19.63 108.465 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.23 65.93 1.05 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.766 1.644 . . . . 21.54 110.592 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.6 mm -80.71 147.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.4 mttt -54.82 -166.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 29.41 110.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.642 ' CD ' ' H ' ' A' ' 39' ' ' GLN . 1.7 mp0 -52.63 -131.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.834 0.826 . . . . 0.0 111.983 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.97 49.18 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.537 -1.025 . . . . 15.27 110.537 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -97.51 -30.44 12.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.307 -1.113 . . . . 8.78 108.723 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -95.9 133.83 39.6 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.092 -0.707 . . . . 7.13 109.092 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 22.1 tt0 -142.61 174.3 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 22.03 110.003 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 41.5 m-85 -136.98 110.68 8.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.438 -1.319 . . . . 16.33 107.438 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.11 104.77 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 6.58 111.886 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.8 m-20 -81.44 102.53 10.58 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.512 -0.921 . . . . 15.32 108.512 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.5 pt -64.08 -2.13 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 10.92 111.54 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.25 -17.89 23.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.788 -1.195 . . . . 21.72 108.739 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 13.42 1.74 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.466 -0.771 . . . . 22.45 109.471 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.529 ' C ' HD22 ' A' ' 51' ' ' ASN . 14.5 t -142.81 -0.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 25.63 109.847 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.529 HD22 ' C ' ' A' ' 50' ' ' THR . 3.5 m-80 67.2 -171.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.21 31.37 18.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.833 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -53.71 10.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 18.87 109.806 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.2 m120 -54.94 -37.42 66.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 45.21 110.817 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.9 mp0 -62.1 -46.96 86.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.91 -1.119 . . . . 33.02 110.167 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.67 -54.75 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.784 -1.197 . . . . 9.84 110.172 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -56.81 -41.11 77.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.523 -1.36 . . . . 17.84 107.705 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 6.0 m-20 -54.56 -33.93 60.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.959 -1.496 . . . . 18.84 106.959 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -79.67 -48.32 13.9 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.108 -0.637 . . . . 12.99 109.385 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.7 mt -52.69 -33.65 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.047 -1.033 . . . . 14.61 108.283 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.5 tp-100 -59.58 -54.85 41.78 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.321 0.581 . . . . 40.45 109.538 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.41 -42.27 83.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 41.81 110.347 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.7 tp -62.6 -47.23 84.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 21.77 110.562 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -108.94 -63.39 1.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.266 -0.896 . . . . 11.38 109.671 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.02 -38.97 1.02 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.399 -1.481 . . . . 14.79 109.399 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.32 140.29 32.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -1.151 . . . . 17.81 110.012 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 24.79 11.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.504 -0.924 . . . . 29.76 108.504 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.804 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.96 169.32 16.14 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.556 0.693 . . . . 18.26 110.909 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.9 133.36 21.27 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.291 -1.003 . . . . 8.2 108.291 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.6 Cg_endo -86.74 -163.76 2.75 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 CA-C-O 122.617 1.007 . . . . 7.79 111.86 -1.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -145.04 95.72 2.73 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.489 -2.041 . . . . 26.05 105.489 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG21 HD12 ' A' ' 85' ' ' LEU . 94.4 t -85.54 156.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.366 -0.834 . . . . 8.68 111.653 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' N ' HG12 ' A' ' 72' ' ' VAL . 78.4 m-85 -144.74 91.33 2.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.604 -0.685 . . . . 14.07 111.549 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.58 115.37 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.01 -2.218 . . . . 9.34 105.01 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.45 -155.56 18.13 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 105.707 -2.957 . . . . 12.42 105.707 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.76 5.26 16.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.215 -1.756 . . . . 44.86 108.637 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 m-20 -89.52 115.04 26.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.387 -0.821 . . . . 0.0 110.793 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 t -77.41 141.92 39.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.306 -0.871 . . . . 0.0 109.678 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.2 pt -109.64 -17.65 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.163 -0.961 . . . . 20.45 109.197 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.11 -160.19 21.3 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.071 -1.212 . . . . 13.82 110.071 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' CA ' HH21 ' A' ' 71' ' ' ARG . . . -89.26 -148.25 17.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.054 -1.218 . . . . 12.42 110.054 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.55 -60.37 2.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -1.005 . . . . 0.0 110.026 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 t -51.24 -25.38 5.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.192 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.38 -47.91 25.37 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.423 -0.798 . . . . 27.06 109.03 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -54.04 -59.41 4.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.457 -0.777 . . . . 15.31 110.015 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.19 -51.38 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.371 -0.831 . . . . 0.0 110.309 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 9.0 m -46.82 -34.36 5.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.153 -0.967 . . . . 21.79 108.975 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.24 -38.94 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 111.734 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.417 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.5 OUTLIER -60.21 -59.19 5.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.08 -19.21 62.71 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.98 -1.075 . . . . 0.0 109.633 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.0 m -81.49 -45.5 15.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.062 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.77 -11.16 27.65 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.308 -1.117 . . . . 25.64 110.308 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -69.3 -25.5 64.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.279 . . . . 50.26 108.32 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.4 tp -59.91 -67.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.568 0.699 . . . . 24.17 110.848 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.32 -29.61 24.33 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -64.63 -46.78 81.1 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.828 -1.175 . . . . 28.03 107.828 178.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.485 ' NH1' HG22 ' A' ' 79' ' ' ILE . 7.1 ttt180 -59.51 -34.12 72.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.897 -1.149 . . . . 40.96 107.897 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . 10.4 mp -70.15 -40.48 74.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.612 -0.884 . . . . 15.05 108.612 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.32 -52.49 46.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.815 -0.553 . . . . 0.0 112.185 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -49.76 -29.34 7.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.691 -1.255 . . . . 38.64 110.926 -177.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.0 pt -102.7 -22.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.731 -1.231 . . . . 0.0 109.011 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.498 ' O ' ' CE ' ' A' ' 38' ' ' LYS . . . 90.0 47.54 3.86 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.387 -1.085 . . . . 18.54 110.387 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.15 -14.98 28.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.147 -1.208 . . . . 10.84 110.0 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.684 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -94.6 177.82 5.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.724 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -61.93 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.791 -1.193 . . . . 20.03 111.482 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.36 -39.34 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.268 -0.895 . . . . 12.91 110.57 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 70.0 m-20 -54.38 -37.3 64.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 28.33 108.979 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.0 m -74.71 -11.23 60.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.376 -0.827 . . . . 0.0 109.192 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.44 -51.24 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 22.87 109.688 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -78.91 133.82 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 25.19 109.621 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 9' ' ' ILE . 6.6 mp0 -144.53 152.32 52.84 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.028 -1.101 . . . . 34.61 108.028 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.88 129.05 32.89 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.246 1.298 . . . . 11.72 109.243 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.53 22.83 78.11 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.349 -1.5 . . . . 10.24 109.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.77 128.56 42.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -1.064 . . . . 25.36 108.973 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -100.37 129.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.461 -0.774 . . . . 10.89 109.272 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.05 142.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.34 -0.985 . . . . 15.82 108.34 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG12 HG23 ' A' ' 18' ' ' ILE . 40.5 t -124.12 123.72 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 8.94 111.055 -177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.05 117.35 29.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 9.93 107.574 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 16' ' ' VAL . 16.5 pt -130.06 -172.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.578 1.18 . . . . 10.62 111.518 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' THR . 26.2 mtmt -150.2 85.58 5.42 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 105.841 -1.911 . . . . 38.73 105.841 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 21' ' ' THR . 18.4 Cg_exo -45.83 81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.483 1.456 . . . . 24.58 110.766 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' LYS . 32.6 m -173.67 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.169 -1.048 . . . . 34.82 108.169 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 127.08 36.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.799 . . . . 21.46 108.841 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.68 -22.69 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.192 1.928 . . . . 13.86 113.075 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -68.72 -42.35 77.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.284 -1.51 . . . . 0.0 108.96 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -37.2 79.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 26' ' ' ARG . 8.0 mmm-85 -62.21 -41.75 98.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.192 -0.67 . . . . 59.59 109.192 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -54.02 -49.5 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.12 -0.987 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.2 75.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.155 -0.966 . . . . 0.0 108.909 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.52 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 3.8 mm-40 -71.14 -42.28 69.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.361 -0.837 . . . . 45.49 109.723 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 33' ' ' SER . 48.4 mt-10 -70.89 -35.83 72.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.548 -0.72 . . . . 34.97 111.142 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.626 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.0 -56.45 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.927 -1.108 . . . . 0.0 110.798 -178.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -58.67 -23.91 60.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.457 -1.402 . . . . 17.28 109.891 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 2.5 p -63.28 -19.35 64.5 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.977 -1.077 . . . . 24.11 108.321 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -92.99 -4.38 52.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.539 -0.725 . . . . 44.07 110.071 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.715 HD12 HD23 ' A' ' 32' ' ' LEU . 21.5 mt -88.74 129.78 47.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.014 -1.054 . . . . 19.63 108.979 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.11 68.43 1.89 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.563 1.508 . . . . 21.54 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.6 mm -80.44 142.42 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -57.3 156.25 7.85 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.231 -0.918 . . . . 29.41 110.076 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -58.31 141.56 50.71 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.478 0.656 . . . . 0.0 111.664 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.26 47.16 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.524 -0.735 . . . . 15.27 112.04 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.08 -35.1 9.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.75 -1.441 . . . . 8.78 110.072 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 37' ' ' ILE . 63.8 tp -93.54 134.91 35.32 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.485 -0.76 . . . . 7.13 109.719 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -144.37 175.05 10.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 22.03 109.708 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.52 ' CD1' ' OE1' ' A' ' 29' ' ' GLN . 39.7 m-85 -137.63 109.06 6.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.078 -1.452 . . . . 16.33 107.078 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.26 106.43 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 6.58 111.682 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' OD1' HD11 ' A' ' 18' ' ' ILE . 8.0 m-20 -83.79 98.31 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.69 . . . . 15.32 109.3 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.93 -9.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 10.92 110.811 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -96.07 40.65 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.824 -1.176 . . . . 21.72 107.824 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.47 10.32 0.43 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.47 -0.892 . . . . 22.45 110.657 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 t -127.86 -3.38 5.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.329 -2.1 . . . . 25.63 105.329 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 71.88 -175.24 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.676 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER 54.64 18.44 2.05 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 52' ' ' HIS . 1.8 m -29.96 -56.58 0.18 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.443 -0.799 . . . . 18.87 110.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -59.26 -33.01 70.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.412 -0.805 . . . . 45.21 111.859 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' HIS . 61.5 mm-40 -60.61 -46.84 88.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.708 -1.245 . . . . 33.02 109.124 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.29 -55.42 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 9.84 109.66 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.3 mt-30 -57.67 -41.14 80.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 17.84 108.474 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.1 -35.61 59.81 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.84 -1.171 . . . . 18.84 107.84 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -80.0 -44.01 20.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.87 -0.789 . . . . 12.99 108.87 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.44 -37.02 46.54 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.517 -1.29 . . . . 14.61 107.517 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -61.23 -55.98 25.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.808 -0.812 . . . . 40.45 108.808 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.99 -37.22 83.82 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.4 -0.813 . . . . 41.81 110.127 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.94 -52.14 52.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 21.77 109.881 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.4 p -109.72 -65.39 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.599 -0.688 . . . . 11.38 109.852 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.46 -42.18 0.58 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.703 -1.237 . . . . 14.79 110.042 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -96.94 139.4 33.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -1.173 . . . . 17.81 110.363 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.01 31.3 6.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.392 -0.966 . . . . 29.76 108.392 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.34 173.05 10.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.676 0.751 . . . . 18.26 111.295 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.11 129.14 24.83 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 107.669 -1.234 . . . . 8.2 107.669 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.6 Cg_endo -82.59 -166.13 4.74 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 CA-C-O 122.504 0.96 . . . . 7.79 112.02 -0.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.518 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -145.73 90.42 1.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 105.42 -2.067 . . . . 26.05 105.42 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 73' ' ' PHE . 93.3 t -83.93 157.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 8.68 112.355 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' N ' HG12 ' A' ' 72' ' ' VAL . 58.0 m-85 -145.14 89.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 14.07 111.111 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 101' ' ' ILE . 3.6 mm -71.13 116.41 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.006 -2.22 . . . . 9.34 105.006 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.26 -158.88 16.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 105.867 -2.893 . . . . 12.42 105.867 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -80.96 2.98 24.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.197 -1.766 . . . . 44.86 108.787 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 97' ' ' ARG . 17.2 m-20 -88.76 114.77 25.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.365 -0.835 . . . . 0.0 110.219 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -75.53 142.15 42.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 110.079 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -108.76 -20.64 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.174 -0.954 . . . . 20.45 108.822 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.07 -162.22 21.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.04 -1.224 . . . . 13.82 110.04 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.78 -148.27 12.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.137 -1.185 . . . . 12.42 110.137 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -70.53 -60.44 2.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.993 . . . . 0.0 110.04 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.8 t -50.61 -24.18 3.1 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.448 -0.783 . . . . 0.0 109.282 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.65 -49.13 16.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.424 -0.798 . . . . 27.06 109.283 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.66 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.4 tt -52.54 -59.88 3.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 15.31 110.043 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.78 -53.13 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.254 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.7 t -44.91 -36.0 3.11 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.119 -0.988 . . . . 21.79 109.246 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 94' ' ' LEU . 41.6 mt -81.66 -41.2 21.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.507 -0.746 . . . . 0.0 111.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -57.65 -57.68 11.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.81 -1.181 . . . . 0.0 110.63 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.91 -26.1 67.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.998 -1.064 . . . . 0.0 109.671 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.0 m -80.15 -24.26 40.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.01 -7.52 82.0 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.616 -0.994 . . . . 25.64 110.616 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.06 -26.15 63.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.934 -1.333 . . . . 50.26 108.392 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.526 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.13 -64.52 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.766 -0.583 . . . . 24.17 110.777 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.77 -29.61 40.85 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.402 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.21 -48.05 74.73 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.777 -1.194 . . . . 28.03 107.777 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.463 HH21 ' CG ' ' A' ' 77' ' ' ASP . 10.4 tpt180 -57.21 -32.71 66.78 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.681 -1.229 . . . . 40.96 107.681 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -72.43 -40.7 66.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.57 -0.9 . . . . 15.05 108.57 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.43 -53.41 48.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.661 -0.649 . . . . 0.0 111.647 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -33.57 15.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.747 -1.22 . . . . 38.64 110.714 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 74' ' ' ILE . 15.0 pt -99.57 -17.43 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.672 -1.267 . . . . 0.0 109.006 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.5 42.57 8.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.216 -1.154 . . . . 18.54 110.216 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.7 -12.92 52.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 10.84 109.525 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.7 174.75 6.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.449 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.662 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.14 -71.28 0.18 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.344 -0.847 . . . . 20.03 110.666 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.64 -40.92 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 12.91 110.559 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 11.7 m120 -54.78 -35.99 64.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.223 -0.923 . . . . 28.33 109.509 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.8 m -75.1 -12.83 60.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.156 -0.965 . . . . 0.0 109.437 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -96.78 -49.81 4.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 22.87 110.549 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 126.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 25.19 109.819 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 157.07 43.46 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.358 -0.979 . . . . 34.61 108.358 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.68 130.34 39.91 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.748 1.632 . . . . 11.72 111.299 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.93 24.38 60.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.952 -0.859 . . . . 10.24 110.952 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -143.28 135.36 26.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.326 . . . . 25.36 109.952 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.8 137.37 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.36 -0.837 . . . . 10.89 109.257 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.59 143.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 15.82 108.732 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.17 121.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.399 -0.813 . . . . 8.94 110.535 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -89.97 123.31 33.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.504 -1.295 . . . . 9.93 107.504 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.7 pt -133.71 -172.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.447 1.117 . . . . 10.62 111.723 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.2 mtmt -144.02 96.67 5.42 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.236 -1.764 . . . . 38.73 106.236 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 11.2 Cg_exo -51.28 75.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.601 1.534 . . . . 24.58 110.586 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.9 m -170.68 -32.74 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.739 -0.837 . . . . 34.82 108.739 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.33 127.14 39.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 21.46 109.767 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.37 -12.09 19.0 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.213 1.942 . . . . 13.86 112.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -72.25 -45.04 61.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.614 -1.304 . . . . 0.0 109.552 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -36.52 84.2 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.46 -33.29 69.59 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.671 -1.603 . . . . 59.59 106.671 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.13 -59.66 5.11 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.722 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.53 64.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.371 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.502 ' CD ' ' CD1' ' A' ' 44' ' ' PHE . 6.5 mm-40 -68.66 -32.91 73.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.224 -0.923 . . . . 45.49 108.841 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -71.63 -40.62 69.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 34.97 111.02 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -77.67 -59.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.896 -1.127 . . . . 0.0 111.017 -178.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 35' ' ' LEU . 4.9 mt -57.21 -22.66 42.45 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.806 -1.184 . . . . 17.28 110.215 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -66.56 -33.41 75.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.027 -1.045 . . . . 24.11 109.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.75 9.37 39.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 44.07 111.03 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 32' ' ' LEU . 14.4 mt -90.09 134.72 31.09 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.537 -1.352 . . . . 19.63 108.969 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.46 64.18 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 121.814 1.676 . . . . 21.54 110.231 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.507 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.7 mm -84.74 144.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.37 -0.831 . . . . 0.0 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -55.84 153.34 8.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.119 -0.988 . . . . 29.41 109.914 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -56.14 138.1 50.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 111.482 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.05 14.14 51.72 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.534 -0.729 . . . . 15.27 111.831 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.88 -21.74 14.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.825 -1.397 . . . . 8.78 109.828 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 37' ' ' ILE . 43.1 tp -102.78 127.82 49.77 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 7.13 109.387 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 44' ' ' PHE . 17.1 tp10 -142.77 164.69 29.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 22.03 109.85 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.502 ' CD1' ' CD ' ' A' ' 29' ' ' GLN . 14.1 m-85 -126.19 114.4 18.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.342 -1.355 . . . . 16.33 107.342 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -95.59 102.6 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 6.58 111.553 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.24 102.98 9.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.695 -1.224 . . . . 15.32 107.695 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 56' ' ' ILE . 21.5 pt -61.74 -1.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 10.92 111.434 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -93.11 -13.55 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.714 -1.241 . . . . 21.72 109.147 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 7.16 5.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 22.45 109.578 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 t -143.94 -0.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.157 -0.964 . . . . 25.63 109.936 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t30 68.51 -159.09 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 108.592 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.38 16.88 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.113 . . . . 0.0 108.537 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -41.8 -59.03 1.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.46 -0.775 . . . . 18.87 110.483 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.3 m-20 -53.48 -36.52 61.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 45.21 110.765 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.23 -45.37 84.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.976 -1.078 . . . . 33.02 110.213 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 47' ' ' ILE . 2.5 mp -65.51 -56.1 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.889 -1.132 . . . . 9.84 109.771 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -55.85 -43.2 76.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.696 -1.224 . . . . 17.84 107.696 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 2.5 m-20 -55.93 -34.69 65.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.032 -1.469 . . . . 18.84 107.032 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -77.09 -46.1 24.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.823 -0.806 . . . . 12.99 108.823 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.1 mt -53.6 -36.26 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.762 -1.199 . . . . 14.61 107.762 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 21.1 tp60 -61.12 -57.07 14.05 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.957 -0.757 . . . . 40.45 108.957 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -65.9 -34.52 78.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.223 -0.923 . . . . 41.81 110.09 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.17 -52.75 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 21.77 109.89 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.565 HG21 HH11 ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.88 -61.88 1.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.588 -0.695 . . . . 11.38 109.606 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 151.73 -37.85 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.682 -1.367 . . . . 14.79 109.682 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.62 130.57 47.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.243 -1.151 . . . . 17.81 110.622 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 37.15 1.54 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.174 -1.047 . . . . 29.76 108.174 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.77 168.91 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.052 0.93 . . . . 18.26 111.688 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.79 129.23 25.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.106 -1.442 . . . . 8.2 107.106 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.6 Cg_endo -75.94 -166.88 5.35 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 CA-C-O 122.425 0.927 . . . . 7.79 111.78 1.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.565 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -148.71 89.75 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.553 -2.017 . . . . 26.05 105.553 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 85' ' ' LEU . 82.5 t -85.01 155.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.8 0.81 . . . . 8.68 111.934 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.428 ' N ' HG12 ' A' ' 72' ' ' VAL . 63.0 m-85 -145.42 90.79 2.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 14.07 110.566 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.01 112.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.731 -1.951 . . . . 9.34 105.731 177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.85 -152.7 45.67 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.497 -2.641 . . . . 12.42 106.497 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -83.42 -0.67 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.534 -1.568 . . . . 44.86 109.09 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.541 ' CB ' ' HE ' ' A' ' 97' ' ' ARG . 7.4 m-20 -89.05 115.8 26.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.747 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 t -73.76 150.92 40.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.26 -26.82 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.194 -0.941 . . . . 20.45 109.592 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.91 -145.67 17.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.879 -1.288 . . . . 13.82 109.879 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.3 -144.18 10.93 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.998 -1.241 . . . . 12.42 109.998 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.03 -62.17 1.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.437 -1.037 . . . . 0.0 110.023 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -53.49 -25.53 16.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.446 -0.783 . . . . 0.0 109.572 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.38 -46.84 37.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.281 -0.887 . . . . 27.06 109.115 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.8 tt -54.55 -59.7 4.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.577 -0.702 . . . . 15.31 109.912 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -50.97 -48.72 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.796 . . . . 0.0 110.492 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 4.6 t -50.05 -43.44 51.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.833 -1.167 . . . . 21.79 109.292 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.2 -35.58 63.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.381 -0.824 . . . . 0.0 111.428 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -59.84 -61.47 2.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.87 -1.144 . . . . 0.0 110.274 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 87' ' ' SER . 2.2 pp0? -62.07 -20.15 63.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 110.102 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.43 -22.77 35.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.92 66.33 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.437 -1.065 . . . . 25.64 110.437 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -68.49 -27.81 66.46 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.986 -1.303 . . . . 50.26 108.704 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.55 -64.64 0.87 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 24.17 110.311 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.575 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.83 -29.95 43.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.447 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.48 -47.06 83.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 28.03 108.357 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.46 -37.46 78.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.971 -1.122 . . . . 40.96 107.971 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.0 mp -72.07 -34.47 68.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.518 -0.919 . . . . 15.05 108.518 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -64.92 -57.6 8.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.784 -0.572 . . . . 0.0 111.737 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.66 -34.17 7.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.907 -1.121 . . . . 38.64 110.665 -178.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.5 pt -100.29 -11.66 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.816 -1.178 . . . . 0.0 109.331 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.94 41.56 22.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.229 -1.148 . . . . 18.54 110.229 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.04 54.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -1.197 . . . . 10.84 109.243 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 1.7 pp -97.59 -174.22 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 109.558 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.257 0.551 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.19 -74.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 20.03 110.617 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -73.26 -38.42 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 12.91 110.186 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 94.3 m-20 -55.98 -35.26 66.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.001 -1.062 . . . . 28.33 109.496 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -74.85 -13.07 60.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.906 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -97.4 -41.33 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 22.87 110.654 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -79.24 140.56 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.849 -1.157 . . . . 25.19 110.249 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -150.05 136.86 11.08 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.076 -1.083 . . . . 34.61 108.076 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.78 133.33 50.3 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 120.999 1.133 . . . . 11.72 109.739 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 79.66 18.44 73.18 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.081 -1.608 . . . . 10.24 109.081 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -137.88 135.31 36.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -1.078 . . . . 25.36 109.489 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.53 134.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.293 -0.879 . . . . 10.89 109.744 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.87 140.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.335 -0.987 . . . . 15.82 108.335 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.66 127.87 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.217 -0.927 . . . . 8.94 111.177 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.49 121.35 34.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.064 -1.087 . . . . 9.93 108.064 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.3 pt -131.34 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.331 1.062 . . . . 10.62 111.337 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 21' ' ' THR . 4.4 mtmp? -146.31 91.19 5.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 106.077 -1.823 . . . . 38.73 106.077 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.8 Cg_exo -46.37 83.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.616 1.544 . . . . 24.58 110.484 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.4 m -177.78 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 34.82 108.395 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.85 125.74 41.1 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 21.46 109.765 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.24 -19.12 40.68 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.321 2.014 . . . . 13.86 112.605 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -69.9 -42.91 72.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.611 -1.306 . . . . 0.0 109.627 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -65.86 -34.29 77.8 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.07 -42.62 99.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.79 -0.819 . . . . 59.59 108.79 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.6 HH11 ' HG2' ' A' ' 27' ' ' ARG . 6.5 mtt-85 -53.57 -45.07 69.81 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.231 -0.918 . . . . 0.0 108.656 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -36.49 78.93 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 108.849 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 7.5 mt-30 -70.62 -44.02 68.08 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.694 0.759 . . . . 45.49 109.333 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -70.97 -36.47 72.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.652 -0.655 . . . . 34.97 111.177 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.52 -56.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.88 -1.138 . . . . 0.0 110.211 -178.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.834 HD23 HD12 ' A' ' 35' ' ' LEU . 1.9 mt -59.43 -21.3 59.79 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.757 -1.215 . . . . 17.28 109.254 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.654 -0.869 . . . . 24.11 108.654 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -92.82 -0.01 57.33 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.48 -0.762 . . . . 44.07 110.127 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.834 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -87.77 128.71 53.31 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.766 -1.209 . . . . 19.63 108.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.9 69.22 0.85 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.648 1.566 . . . . 21.54 109.417 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.4 mm -80.43 153.42 4.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.579 -0.701 . . . . 0.0 109.21 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -54.88 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.522 -0.736 . . . . 29.41 110.034 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.559 ' O ' ' O ' ' A' ' 38' ' ' LYS . 11.8 mt-30 -53.33 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.726 0.774 . . . . 0.0 111.036 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.85 54.67 0.75 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.079 -1.208 . . . . 15.27 110.079 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.13 -27.02 14.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.576 -0.955 . . . . 8.78 109.3 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -97.09 131.73 43.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.762 -0.829 . . . . 7.13 108.762 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.3 tt0 -141.23 173.07 11.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.85 . . . . 22.03 109.929 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.504 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 43.9 m-85 -135.35 111.75 9.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.349 -1.352 . . . . 16.33 107.349 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.74 104.9 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.872 . . . . 6.58 111.971 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.8 m-20 -82.25 101.79 10.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.614 -0.884 . . . . 15.32 108.614 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 56' ' ' ILE . 21.4 pt -61.97 -1.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 10.92 111.256 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 t -93.5 -17.06 23.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 21.72 109.303 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.0 12.82 1.23 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 22.45 109.52 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 7.3 t -140.81 -17.08 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 25.63 109.674 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 50' ' ' THR . 6.3 t-20 81.14 -175.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.451 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 58.49 24.18 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 108.873 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 52' ' ' HIS . 3.6 p -43.32 -51.93 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.805 . . . . 18.87 110.292 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -53.81 -35.4 61.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 45.21 110.144 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.03 -44.89 87.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.057 -1.027 . . . . 33.02 109.753 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.41 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.2 mp -66.44 -53.9 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.019 . . . . 9.84 109.647 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.53 -42.12 82.27 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.701 -1.222 . . . . 17.84 107.701 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.35 -33.67 63.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.067 -1.456 . . . . 18.84 107.067 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -77.35 -45.26 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.787 -0.82 . . . . 12.99 108.787 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -55.49 -38.11 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.962 -1.125 . . . . 14.61 107.962 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 4.2 tp-100 -59.09 -49.29 78.43 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.522 0.677 . . . . 40.45 109.44 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -66.37 -54.22 27.05 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 41.81 110.65 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.81 -36.0 81.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 21.77 111.442 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 12.9 p -105.59 -68.38 0.87 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.021 -1.049 . . . . 11.38 109.812 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 144.26 -41.25 1.12 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.7 -1.76 . . . . 14.79 108.7 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.58 142.45 29.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.553 -0.969 . . . . 17.81 109.855 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.426 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -109.86 26.93 10.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 29.76 107.992 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.49 168.07 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.946 0.879 . . . . 18.26 111.238 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.22 132.39 22.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.309 -1.367 . . . . 8.2 107.309 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 82' ' ' SER . 23.1 Cg_endo -83.06 -167.52 5.64 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.616 1.007 . . . . 7.79 112.114 -0.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 91.77 2.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.716 -2.327 . . . . 26.05 104.716 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 79' ' ' ILE . 80.8 t -83.69 158.54 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.72 0.771 . . . . 8.68 112.175 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.484 ' N ' HG12 ' A' ' 72' ' ' VAL . 65.6 m-85 -146.32 84.36 1.63 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.557 . . . . 14.07 111.55 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -70.7 114.43 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.885 -2.265 . . . . 9.34 104.885 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -158.09 30.69 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 105.658 -2.977 . . . . 12.42 105.658 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -81.35 0.98 34.79 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.426 -1.632 . . . . 44.86 109.403 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -87.42 115.09 24.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 110.516 -179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -73.1 136.47 44.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.684 ' C ' HD12 ' A' ' 79' ' ' ILE . 2.8 pp -105.59 -7.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.159 -0.963 . . . . 20.45 109.281 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 115.34 -154.88 16.67 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.225 -1.15 . . . . 13.82 110.225 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 -141.52 12.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.34 -1.104 . . . . 12.42 110.34 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.2 p -71.42 -66.42 0.63 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.594 -0.944 . . . . 0.0 110.333 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 t -49.01 -29.39 4.83 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 109.358 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.56 -47.26 33.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.283 -0.886 . . . . 27.06 109.139 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.3 tt -54.58 -58.5 7.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 15.31 109.664 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.71 -49.0 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.383 -0.823 . . . . 0.0 110.526 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.535 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 6.5 m -45.29 -37.58 4.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.932 -1.105 . . . . 21.79 109.09 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.26 -38.77 34.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.453 -0.78 . . . . 0.0 111.84 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -59.95 -60.48 3.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.831 -1.168 . . . . 0.0 111.017 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 87' ' ' SER . 1.6 pp0? -58.65 -24.02 60.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 m -80.74 -57.0 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.69 -8.49 6.89 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.702 -1.359 . . . . 25.64 109.702 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -69.29 -26.42 64.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.313 -1.11 . . . . 50.26 108.566 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp -60.09 -65.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 24.17 110.599 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.61 -28.44 32.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.35 -47.85 77.79 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.442 -0.947 . . . . 28.03 108.442 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' CG ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -58.18 -34.03 69.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.97 -1.122 . . . . 40.96 107.97 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -72.42 -40.82 66.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 15.05 109.292 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.97 -52.14 57.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.0 111.808 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -51.19 -33.14 26.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.819 -1.176 . . . . 38.64 111.114 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.1 pt -100.72 -14.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.0 43.49 7.56 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.354 -1.099 . . . . 18.54 110.354 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.25 -16.55 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.242 . . . . 10.84 109.839 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.64 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.4 179.11 5.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 109.771 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.685 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.78 -71.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.506 -0.746 . . . . 20.03 110.613 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -72.63 -37.97 57.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 12.91 110.108 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 69.4 m-20 -55.39 -38.42 68.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.184 -0.947 . . . . 28.33 109.521 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -74.14 -11.9 60.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.507 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 42.6 mttm -97.55 -45.03 6.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 22.87 110.47 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.63 139.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 25.19 109.56 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -149.81 136.17 10.61 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.213 -1.032 . . . . 34.61 108.213 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.45 124.75 15.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 120.752 0.968 . . . . 11.72 109.628 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.62 55.18 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.368 -1.493 . . . . 10.24 109.368 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 8' ' ' LYS . 25.0 ttpt -137.29 135.67 37.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.335 -1.097 . . . . 25.36 109.409 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.96 132.9 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.829 . . . . 10.89 109.403 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.48 139.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 15.82 108.805 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 18' ' ' ILE . 40.0 t -121.76 126.94 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 8.94 110.794 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.08 120.01 33.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.604 -1.258 . . . . 9.93 107.604 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 16' ' ' VAL . 46.1 pt -132.52 -174.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 122.615 1.198 . . . . 10.62 112.232 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mttm -141.54 95.09 7.29 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 105.558 -2.015 . . . . 38.73 105.558 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 21' ' ' THR . 14.0 Cg_exo -49.9 76.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.37 1.38 . . . . 24.58 110.834 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.656 ' N ' ' O ' ' A' ' 19' ' ' LYS . 87.8 m -172.0 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.228 -0.656 . . . . 34.82 109.228 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.79 124.64 47.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 21.46 110.266 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.12 -20.05 29.34 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.193 1.928 . . . . 13.86 112.872 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -66.9 -47.47 71.71 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.481 -1.387 . . . . 0.0 108.784 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' HG12 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -63.02 -36.22 82.85 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -60.59 -40.78 93.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.163 -1.051 . . . . 59.59 108.163 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -47.79 77.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.21 75.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.297 -0.877 . . . . 0.0 108.915 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.467 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 9.6 mt-30 -69.89 -40.98 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 45.49 109.59 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 68.8 mm-40 -69.33 -39.85 77.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.597 -0.689 . . . . 34.97 111.364 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.07 -55.93 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.882 -1.136 . . . . 0.0 110.947 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.637 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -56.75 -26.3 56.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.738 -1.226 . . . . 17.28 109.536 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.527 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.7 t -64.41 -26.94 68.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.16 -0.963 . . . . 24.11 109.02 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.553 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -92.03 0.31 57.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 44.07 110.288 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' ILE . 18.7 mt -87.65 133.54 37.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.763 -1.21 . . . . 19.63 108.319 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.24 62.99 0.7 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.578 1.519 . . . . 21.54 109.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.0 mm -79.92 141.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -55.78 152.78 9.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.275 -0.891 . . . . 29.41 109.977 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 39' ' ' GLN . 24.8 mp0 -57.08 141.15 46.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.436 0.636 . . . . 0.0 111.431 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.0 9.18 39.24 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.484 -0.76 . . . . 15.27 111.902 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -30.42 12.17 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.823 -1.399 . . . . 8.78 109.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.8 tp -96.58 131.76 42.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.518 -0.739 . . . . 7.13 109.543 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -141.85 171.43 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 22.03 109.444 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CG ' ' OE1' ' A' ' 29' ' ' GLN . 39.3 m-85 -133.23 110.02 9.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.145 -1.428 . . . . 16.33 107.145 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.98 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.476 -0.765 . . . . 6.58 111.434 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 3.8 m-20 -81.81 100.69 9.71 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.445 -0.946 . . . . 15.32 108.445 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 28.6 pt -62.41 1.92 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 10.92 110.734 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 46' ' ' ASP . 17.5 p -95.83 -23.17 17.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 21.72 109.04 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.13 9.62 2.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 22.45 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 14.2 t -137.05 -7.69 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.841 . . . . 25.63 109.404 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.574 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 69.6 -163.81 0.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.497 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.3 OUTLIER 54.63 21.47 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.994 -1.066 . . . . 0.0 108.545 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -40.29 -59.91 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 18.87 110.739 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 7.9 m120 -54.18 -35.06 61.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 45.21 111.034 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.99 -46.36 88.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 33.02 109.963 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -66.01 -53.18 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.979 -1.076 . . . . 9.84 109.518 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -56.53 -44.44 80.82 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.566 -1.272 . . . . 17.84 107.566 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 24.9 m-20 -53.61 -33.03 53.57 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.977 -1.49 . . . . 18.84 106.977 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -78.64 -48.56 14.83 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.94 -0.763 . . . . 12.99 108.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.7 mt -52.02 -36.4 50.02 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.524 -1.287 . . . . 14.61 107.524 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.9 tp60 -61.96 -55.31 30.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.794 -0.817 . . . . 40.45 108.794 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -39.19 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 41.81 109.678 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.2 tp -64.09 -45.62 87.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 21.77 109.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.636 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -117.64 -71.71 0.72 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.633 -0.667 . . . . 11.38 109.569 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.636 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 158.47 -34.26 0.5 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.317 -1.513 . . . . 14.79 109.317 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -95.93 137.13 35.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 17.81 110.019 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.88 30.19 7.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.066 -1.087 . . . . 29.76 108.066 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.33 171.04 11.51 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.926 0.869 . . . . 18.26 111.501 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 ' OG ' ' A' ' 25' ' ' SER . 5.3 t -115.26 132.12 23.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.494 -1.299 . . . . 8.2 107.494 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.741 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 28.5 Cg_endo -81.04 -164.84 4.09 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 CA-C-O 122.032 0.763 . . . . 7.79 110.925 0.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.741 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -150.81 93.25 1.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.376 -2.083 . . . . 26.05 105.376 177.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' A' ' 79' ' ' ILE . 94.1 t -85.61 156.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.827 0.822 . . . . 8.68 112.352 -175.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.0 m-85 -145.37 92.92 2.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.875 -0.516 . . . . 14.07 110.606 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 98' ' ' LEU . 8.4 mm -72.43 113.74 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.832 -1.914 . . . . 9.34 105.832 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.58 -145.62 42.26 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 106.622 -2.591 . . . . 12.42 106.622 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -87.56 -3.48 58.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.677 -1.484 . . . . 44.86 109.5 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.36 116.47 25.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.221 -0.924 . . . . 0.0 110.619 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -75.77 143.97 41.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.778 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.7 pp -113.43 -18.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.189 -0.944 . . . . 20.45 109.335 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.43 -159.2 19.96 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.109 -1.196 . . . . 13.82 110.109 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -92.51 -143.7 12.98 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.391 -1.064 . . . . 12.42 110.655 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.417 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 t -71.33 -62.63 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -1.015 . . . . 0.0 110.383 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 t -51.0 -24.99 4.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.359 -0.838 . . . . 0.0 109.189 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -76.05 -45.52 33.81 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 27.06 109.219 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.572 ' O ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt -55.0 -58.41 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 15.31 109.829 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -52.06 -52.3 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 111.003 -178.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' VAL . 5.0 t -44.84 -38.99 4.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.059 -1.025 . . . . 21.79 109.251 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.84 -41.5 23.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.545 -0.722 . . . . 0.0 111.631 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -55.83 29.53 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.868 -1.145 . . . . 0.0 110.398 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -62.1 -25.49 67.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.944 -1.098 . . . . 0.0 109.452 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.9 m -77.98 -62.22 1.74 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.419 -0.8 . . . . 0.0 109.024 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -9.25 5.53 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.09 -1.204 . . . . 25.64 110.09 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.22 -24.36 64.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.117 -1.225 . . . . 50.26 108.177 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.61 -67.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.638 -0.664 . . . . 24.17 110.47 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -51.58 -28.99 15.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.22 -49.18 70.69 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.074 -1.084 . . . . 28.03 108.074 178.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.5 ' CG ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.68 -34.65 67.59 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.926 -1.139 . . . . 40.96 107.926 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 74' ' ' ILE . 8.3 mp -72.89 -38.52 66.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.479 -0.934 . . . . 15.05 108.479 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -64.49 -53.64 44.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.576 . . . . 0.0 111.555 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.14 -34.87 23.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 38.64 110.76 -178.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.58 -15.3 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.69 -1.256 . . . . 0.0 109.007 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.66 44.39 8.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.588 -1.005 . . . . 18.54 110.588 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.45 55.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -1.219 . . . . 10.84 109.87 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.649 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -95.79 -177.55 4.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.783 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.5 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.205 0.526 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.26 -73.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 20.03 110.572 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -72.94 -37.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 12.91 109.884 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 18.0 m120 -55.73 -38.34 69.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.184 -0.948 . . . . 28.33 109.301 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 m -74.18 -10.03 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -95.96 -53.5 3.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 22.87 109.627 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -79.57 128.11 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.844 . . . . 25.19 110.067 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HA ' ' HZ3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.36 155.67 39.45 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.072 -1.084 . . . . 34.61 108.072 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.56 130.06 38.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.895 1.73 . . . . 11.72 111.537 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.89 64.4 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.874 -0.89 . . . . 10.24 110.874 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -142.47 133.33 25.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.351 . . . . 25.36 109.928 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.23 136.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.89 109.037 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.79 144.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 15.82 108.55 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.66 126.88 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 8.94 110.77 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -92.68 123.91 36.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 9.93 107.571 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.92 -176.43 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.383 1.087 . . . . 10.62 111.342 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 21' ' ' THR . 14.6 mtmm -143.32 92.73 6.61 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.385 -1.709 . . . . 38.73 106.385 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' C ' ' OG1' ' A' ' 21' ' ' THR . 12.2 Cg_exo -47.79 82.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.629 1.553 . . . . 24.58 110.442 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 179.1 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.025 -0.731 . . . . 34.82 109.025 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 130.63 28.4 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 21.46 110.266 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -59.69 -20.33 57.77 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.393 2.062 . . . . 13.86 112.654 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -70.37 -43.96 69.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.533 -1.355 . . . . 0.0 109.622 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -32.37 74.01 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.3 mmm-85 -64.04 -43.71 94.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.643 -0.873 . . . . 59.59 108.643 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 2.1 mtt-85 -51.75 -45.46 63.69 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.0 83.55 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -70.21 -42.15 72.71 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.43 -0.794 . . . . 45.49 109.296 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.74 -38.36 76.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.683 . . . . 34.97 111.078 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.81 -58.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 35' ' ' LEU . 1.8 mt -57.71 -21.46 40.84 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.512 -1.367 . . . . 17.28 109.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -65.94 -24.96 66.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.052 -1.03 . . . . 24.11 108.769 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -91.32 1.38 57.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 44.07 110.191 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -90.48 126.78 55.19 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.903 -1.123 . . . . 19.63 109.163 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.55 67.64 0.76 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.773 1.648 . . . . 21.54 109.66 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.16 150.66 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.406 -0.809 . . . . 0.0 108.907 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 39' ' ' GLN . 30.0 mttm -53.47 -169.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.85 . . . . 29.41 110.309 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 38' ' ' LYS . 56.6 mm-40 -51.52 -127.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.529 0.681 . . . . 0.0 111.344 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.37 53.18 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.421 -1.072 . . . . 15.27 110.421 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -101.08 -23.33 14.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -1.045 . . . . 8.78 108.942 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.0 tp -102.73 131.89 49.25 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.565 -0.902 . . . . 7.13 108.565 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 25.9 tt0 -141.5 173.9 11.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.305 -0.872 . . . . 22.03 110.04 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.512 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 38.5 m-85 -135.22 109.84 8.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.57 -1.27 . . . . 16.33 107.57 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.58 103.49 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 6.58 111.096 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.98 101.5 9.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.219 -0.925 . . . . 15.32 108.731 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.3 -2.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.089 -1.007 . . . . 10.92 110.237 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' THR . 10.5 p -96.28 -29.79 13.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 21.72 109.346 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.55 18.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 22.45 109.273 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.519 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 10.7 t -140.5 -13.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -0.88 . . . . 25.63 109.91 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' CG ' ' N ' ' A' ' 52' ' ' HIS . 0.5 OUTLIER 78.7 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.545 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 2.4 m170 53.61 12.32 0.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.702 -1.249 . . . . 0.0 108.406 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -35.97 -67.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.718 -0.614 . . . . 18.87 111.077 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -53.96 -31.51 50.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.227 -0.921 . . . . 45.21 111.067 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' OE1' ' CE1' ' A' ' 52' ' ' HIS . 57.4 mt-10 -65.26 -46.61 79.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.15 . . . . 33.02 110.041 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.44 -53.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.952 -1.092 . . . . 9.84 109.453 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.27 -43.43 83.08 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.824 -1.176 . . . . 17.84 107.824 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -54.78 -33.84 61.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.217 -1.401 . . . . 18.84 107.217 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -78.8 -49.21 13.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.969 -0.692 . . . . 12.99 109.136 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.06 -32.89 49.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.434 -0.951 . . . . 14.61 108.434 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 3.9 tp-100 -59.77 -53.89 52.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.675 -0.641 . . . . 40.45 109.385 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -66.92 -48.25 69.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 41.81 111.031 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.62 -39.02 92.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 21.77 110.554 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 10.5 p -106.49 -66.67 0.99 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.32 -0.862 . . . . 11.38 109.912 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 143.48 -42.15 1.1 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.694 -1.763 . . . . 14.79 108.694 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.22 136.62 38.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -1.02 . . . . 17.81 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -102.44 25.42 9.04 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.313 -0.995 . . . . 29.76 108.313 179.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.805 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -83.02 169.45 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.67 . . . . 18.26 110.354 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.571 ' CG2' ' HZ1' ' A' ' 19' ' ' LYS . 10.9 t -113.67 138.53 22.68 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 107.916 -1.142 . . . . 8.2 107.916 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 82' ' ' SER . 30.6 Cg_endo -84.95 -165.92 4.05 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 CA-C-O 122.299 0.875 . . . . 7.79 111.203 -0.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.805 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -143.41 92.77 2.4 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.131 -2.174 . . . . 26.05 105.131 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 79' ' ' ILE . 77.2 t -83.63 156.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.877 . . . . 8.68 111.387 -176.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' N ' HG12 ' A' ' 72' ' ' VAL . 74.3 m-85 -146.22 92.05 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.635 -0.666 . . . . 14.07 111.105 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -72.97 106.32 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.598 -2.001 . . . . 9.34 105.598 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.96 -152.1 46.81 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 105.793 -2.923 . . . . 12.42 105.793 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HZ3' ' HA ' ' A' ' 10' ' ' GLN . 31.8 mttm -81.76 4.06 23.46 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.388 -1.654 . . . . 44.86 108.507 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.683 ' CB ' HH21 ' A' ' 97' ' ' ARG . 23.6 m-20 -89.63 108.96 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.0 110.754 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 t -74.44 141.99 44.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.8 pp -111.29 -13.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 20.45 109.443 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.96 -163.89 15.24 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.309 -1.117 . . . . 13.82 110.309 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 84' ' ' ASP . . . -86.58 -146.26 9.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.23 -1.148 . . . . 12.42 110.23 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -72.61 -59.7 2.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.553 -0.969 . . . . 0.0 110.049 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -50.24 -26.48 4.75 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 108.922 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 81' ' ' GLY . 16.7 m-20 -75.23 -47.81 26.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.526 -0.734 . . . . 27.06 109.09 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 tt -53.89 -59.15 5.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 15.31 109.776 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.603 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -52.35 -50.73 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 110.539 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.5 t -46.26 -41.54 13.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 21.79 109.869 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.85 -40.08 55.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 112.173 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -59.27 -59.5 5.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.646 -1.284 . . . . 0.0 110.858 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -57.96 -22.69 50.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.333 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 m -79.82 -60.09 2.48 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 109.119 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 -11.72 6.46 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.62 -1.392 . . . . 25.64 109.62 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 96' ' ' THR . 36.7 tp10 -69.24 -25.58 64.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -1.163 . . . . 50.26 108.994 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.3 tp -58.48 -64.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.861 . . . . 24.17 110.356 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -52.61 -27.41 16.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -63.57 -48.2 78.4 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.425 -0.91 . . . . 28.03 108.784 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.743 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.0 mmm180 -58.73 -34.28 71.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.052 . . . . 40.96 108.17 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 mp -70.6 -39.68 73.65 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.805 -0.813 . . . . 15.05 108.805 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -66.03 -53.83 33.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.767 -0.583 . . . . 0.0 111.941 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.743 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -49.47 -33.36 14.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.207 . . . . 38.64 110.612 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.22 -13.23 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.697 -1.252 . . . . 0.0 109.331 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 46.42 8.91 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.549 -1.02 . . . . 18.54 110.549 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.07 -14.47 41.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -1.16 . . . . 10.84 109.586 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.659 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -95.48 174.61 6.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 109.951 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.649 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.57 -72.91 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.78 . . . . 20.03 110.018 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.7 m -73.62 -40.32 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 12.91 110.126 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.463 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 73.8 m-20 -56.08 -27.23 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.201 -0.937 . . . . 28.33 110.399 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 m -74.71 -21.7 59.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.08 -1.012 . . . . 0.0 110.528 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -97.58 -45.36 6.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.973 -1.079 . . . . 22.87 111.293 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.39 129.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.014 -1.054 . . . . 25.19 110.123 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -146.79 153.05 45.91 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 34.61 108.664 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.03 122.86 12.56 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.218 1.279 . . . . 11.72 109.963 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 84.0 24.32 49.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.83 -1.308 . . . . 10.24 109.83 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -139.23 134.58 32.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -1.145 . . . . 25.36 109.232 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.02 137.36 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 10.89 110.11 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -145.51 153.06 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.499 -0.926 . . . . 15.82 108.499 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.94 121.65 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.234 -0.916 . . . . 8.94 110.629 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.98 121.1 31.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.201 -1.407 . . . . 9.93 107.201 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 70' ' ' PRO . 34.2 pt -133.48 -168.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.472 1.129 . . . . 10.62 111.872 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.636 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.2 mtmt -145.59 96.65 4.75 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 106.205 -1.776 . . . . 38.73 106.205 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.496 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.4 Cg_exo -51.82 74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.379 1.386 . . . . 24.58 110.736 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.636 ' N ' ' O ' ' A' ' 19' ' ' LYS . 11.5 m -171.32 -32.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.919 -0.771 . . . . 34.82 108.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.22 128.57 34.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 21.46 110.074 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.82 -13.28 25.85 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.162 1.908 . . . . 13.86 112.118 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -71.34 -47.5 56.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.709 -1.244 . . . . 0.0 109.706 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -28.39 70.01 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.015 -1.053 . . . . 0.0 108.9 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -61.27 -42.64 98.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.29 -1.004 . . . . 59.59 108.29 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -54.24 -49.14 70.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.176 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -37.43 75.46 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.878 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.54 -42.15 71.59 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.333 -0.854 . . . . 45.49 109.618 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.77 -37.33 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.386 -0.821 . . . . 34.97 111.02 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.681 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.28 -57.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.99 -1.069 . . . . 0.0 110.197 -178.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.663 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -55.38 -24.62 30.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 17.28 109.394 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -65.28 -27.9 68.96 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.119 -0.988 . . . . 24.11 108.489 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -90.89 3.66 53.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.812 . . . . 44.07 110.286 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 35' ' ' LEU . 20.0 mt -91.83 131.5 35.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.795 -1.191 . . . . 19.63 109.257 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.88 64.61 0.43 Allowed 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.707 1.605 . . . . 21.54 110.31 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.8 mm -82.25 149.05 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 108.887 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.4 mmmt -53.22 -174.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 29.41 110.057 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.604 ' NE2' ' H ' ' A' ' 39' ' ' GLN . 4.3 mp0 -52.32 -121.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.674 -0.641 . . . . 0.0 111.123 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 48.31 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.402 -0.904 . . . . 15.27 110.866 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -100.81 -18.26 16.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.241 -1.152 . . . . 8.78 109.372 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -105.56 126.7 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 7.13 108.83 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 36.7 tt0 -140.4 164.97 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 22.03 109.689 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.618 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 23.3 m-85 -126.45 114.91 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.593 -1.262 . . . . 16.33 107.593 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.87 102.06 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 6.58 111.131 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 48' ' ' THR . 7.4 m-20 -80.44 100.06 8.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.478 -1.304 . . . . 15.32 107.478 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CG2' HG21 ' A' ' 56' ' ' ILE . 14.6 pt -61.17 2.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 10.92 110.749 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 46' ' ' ASP . 5.1 t -94.88 -20.24 19.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.999 -1.063 . . . . 21.72 109.086 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.58 13.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 22.45 109.309 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.1 t -140.69 -14.71 0.94 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.22 -0.925 . . . . 25.63 109.902 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 50' ' ' THR . 1.1 m-20 78.97 -176.19 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.8 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.403 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER 57.76 30.16 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 109.089 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 p -44.69 -54.12 6.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 18.87 109.906 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.0 m-20 -54.15 -37.32 64.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 45.21 110.732 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -62.24 -46.58 88.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.112 . . . . 33.02 109.636 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.7 mp -65.9 -55.7 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.969 -1.082 . . . . 9.84 109.59 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -56.69 -40.45 75.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.694 -1.254 . . . . 17.84 107.878 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 22.9 m-20 -55.04 -32.53 61.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.015 -1.476 . . . . 18.84 107.015 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -78.8 -47.94 15.74 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.766 -0.827 . . . . 12.99 108.766 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -54.53 -33.59 60.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.375 -0.972 . . . . 14.61 108.375 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.7 tp60 -59.25 -55.78 30.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.751 -0.593 . . . . 40.45 109.8 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.7 -50.42 62.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.028 -1.045 . . . . 41.81 111.106 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.06 -34.83 78.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.867 -1.146 . . . . 21.77 110.657 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.6 p -110.74 -70.44 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.306 -0.871 . . . . 11.38 109.915 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 147.04 -41.85 0.94 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.606 -1.798 . . . . 14.79 108.606 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.22 140.39 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.436 -1.037 . . . . 17.81 110.047 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -109.85 24.43 13.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.192 -1.04 . . . . 29.76 108.192 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.95 174.1 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.923 0.868 . . . . 18.26 110.935 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.61 134.33 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.454 -1.313 . . . . 8.2 107.454 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -80.7 -163.93 3.62 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 CA-C-O 122.245 0.852 . . . . 7.79 111.257 0.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 91.74 1.89 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.296 -2.113 . . . . 26.05 105.296 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 85' ' ' LEU . 92.2 t -84.65 157.81 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.822 0.82 . . . . 8.68 112.185 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 72' ' ' VAL . 57.6 m-85 -145.22 88.28 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.801 -0.562 . . . . 14.07 110.624 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.598 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.0 109.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.469 -2.048 . . . . 9.34 105.469 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.57 -154.64 52.1 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.036 -2.826 . . . . 12.42 106.036 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -84.51 0.2 50.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.354 -1.674 . . . . 44.86 108.934 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.7 114.91 25.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -71.69 149.45 45.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.366 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.0 -23.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.95 . . . . 20.45 109.342 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.64 -142.71 14.08 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.948 -1.261 . . . . 13.82 109.948 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -111.06 -144.19 9.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.898 -1.281 . . . . 12.42 109.898 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -71.04 -61.12 1.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -1.003 . . . . 0.0 109.801 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.9 t -52.99 -26.27 14.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.5 m-20 -73.53 -48.33 33.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.345 -0.847 . . . . 27.06 109.236 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.76 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.382 -0.824 . . . . 15.31 109.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.42 -49.43 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 0.0 110.015 -178.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -49.5 -41.32 40.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 21.79 109.357 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt -75.46 -36.67 60.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 111.253 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.403 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 -62.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.995 -1.066 . . . . 0.0 110.644 -178.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -61.19 -16.61 46.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.949 -1.095 . . . . 0.0 109.971 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.675 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 13.5 m -85.25 -18.61 33.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.891 . . . . 0.0 109.425 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.79 -13.49 52.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.891 -1.283 . . . . 25.64 109.891 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.55 -26.76 65.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.149 -1.207 . . . . 50.26 108.966 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.95 -63.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 24.17 110.157 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.1 -31.31 41.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.1 m -63.56 -43.99 95.46 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.696 -1.224 . . . . 28.03 107.696 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -60.0 -35.65 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.403 -0.962 . . . . 40.96 108.403 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.9 mp -71.18 -40.23 71.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.445 -0.784 . . . . 15.05 109.237 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -65.08 -53.53 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 112.29 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -47.57 -31.54 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.728 -1.233 . . . . 38.64 110.503 -177.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 pt -104.17 -14.18 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.918 -1.114 . . . . 0.0 109.649 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.26 41.94 11.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.433 -1.067 . . . . 18.54 110.433 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.13 -12.32 53.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 10.84 109.561 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.62 -174.82 3.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.389 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.91 -70.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 20.03 110.25 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -73.1 -40.34 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 12.91 110.097 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 8.6 m-20 -54.79 -38.27 67.09 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.073 -1.017 . . . . 28.33 109.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -74.72 -12.35 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.212 -0.93 . . . . 0.0 109.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -97.24 -46.8 5.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.206 -0.934 . . . . 22.87 110.608 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.1 135.09 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.776 -1.202 . . . . 25.19 109.385 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.49 150.36 40.25 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.715 -0.846 . . . . 34.61 108.715 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.39 124.37 15.91 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.41 1.407 . . . . 11.72 110.021 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.08 28.45 45.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.764 -1.334 . . . . 10.24 109.764 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -140.91 137.22 32.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 25.36 109.761 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.63 135.05 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.382 -0.824 . . . . 10.89 109.643 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.42 141.39 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.048 . . . . 15.82 108.172 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 t -124.19 127.28 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 8.94 111.078 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.84 121.04 34.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.24 -1.393 . . . . 9.93 107.24 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 70' ' ' PRO . 28.0 pt -131.14 -176.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.361 1.077 . . . . 10.62 111.254 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.5 mtmt -143.9 91.81 6.51 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.077 -1.823 . . . . 38.73 106.077 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.1 Cg_exo -47.18 78.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.892 1.728 . . . . 24.58 111.05 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' LYS . 88.2 m -174.1 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.852 -0.796 . . . . 34.82 108.852 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.75 130.04 29.95 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 21.46 109.857 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -57.94 -21.59 50.37 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.277 1.985 . . . . 13.86 112.209 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -70.43 -38.18 74.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.635 -1.291 . . . . 0.0 108.523 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -36.63 82.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.672 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -64.08 -40.53 96.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.918 -0.771 . . . . 59.59 108.918 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.9 OUTLIER -53.66 -48.84 69.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.433 -0.792 . . . . 0.0 109.291 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.52 72.98 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.372 -0.83 . . . . 0.0 109.161 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.626 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.57 -43.39 69.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.375 -0.828 . . . . 45.49 109.477 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 22.0 mm-40 -71.13 -35.78 71.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.554 -0.716 . . . . 34.97 111.256 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.48 -58.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 110.478 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.826 HD23 HD12 ' A' ' 35' ' ' LEU . 2.9 mt -58.99 -17.98 29.95 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.563 -1.336 . . . . 17.28 109.634 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 t -65.87 -29.93 70.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 24.11 109.037 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 30' ' ' GLU . 1.6 mp0 -91.72 5.88 48.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 44.07 110.49 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.826 HD12 HD23 ' A' ' 32' ' ' LEU . 15.9 mt -90.56 127.98 50.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.758 -1.213 . . . . 19.63 109.304 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.43 68.99 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.8 1.666 . . . . 21.54 109.94 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.6 mm -82.13 150.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.416 -0.802 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 39' ' ' GLN . 1.5 mmmm -54.68 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.466 -0.771 . . . . 29.41 110.392 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.599 ' O ' ' O ' ' A' ' 38' ' ' LYS . 91.1 mm-40 -52.61 -137.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.618 0.723 . . . . 0.0 110.884 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.27 52.82 0.09 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.107 -1.197 . . . . 15.27 110.107 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -98.52 -20.28 17.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -1.048 . . . . 8.78 109.151 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -103.54 129.7 50.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.632 -0.877 . . . . 7.13 108.632 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.9 tp10 -142.13 164.89 28.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.995 . . . . 22.03 109.955 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 56.5 m-85 -125.96 111.75 15.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.319 -1.363 . . . . 16.33 107.319 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -94.47 101.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 6.58 111.305 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.16 101.42 9.65 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.873 . . . . 15.32 108.644 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.12 -6.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 10.92 109.251 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 p -96.92 43.08 1.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.332 -0.988 . . . . 21.72 108.332 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.14 14.09 0.45 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 22.45 107.801 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -139.49 -2.94 1.54 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.19 -1.041 . . . . 25.63 108.19 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.7 OUTLIER 70.21 -176.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.806 178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.3 m80 53.61 18.06 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.007 -1.058 . . . . 0.0 108.552 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -32.96 -55.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.403 0.621 . . . . 18.87 110.861 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -57.85 -33.3 68.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 45.21 111.275 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' HIS . 73.2 mm-40 -63.45 -43.7 96.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.829 -1.17 . . . . 33.02 109.925 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.8 -56.76 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.983 -1.073 . . . . 9.84 109.581 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -54.9 -43.06 72.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.555 -1.276 . . . . 17.84 107.555 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.28 -33.61 65.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.41 -1.33 . . . . 18.84 107.41 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -76.6 -47.33 22.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 12.99 108.732 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.0 mt -54.78 -36.5 64.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.901 -1.148 . . . . 14.61 107.901 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 1.1 tp-100 -59.67 -52.37 65.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.266 0.555 . . . . 40.45 110.045 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.0 -51.0 66.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 41.81 110.839 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.94 -32.43 73.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.086 -1.009 . . . . 21.77 110.721 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.3 p -110.06 -74.05 0.66 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 11.38 109.53 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.22 -37.86 1.05 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.985 -1.646 . . . . 14.79 108.985 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -102.68 134.74 45.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -1.002 . . . . 17.81 109.908 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -105.44 32.5 4.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.538 -0.912 . . . . 29.76 108.538 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 167.72 19.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 18.26 110.294 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.55 134.5 21.98 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.288 -1.004 . . . . 8.2 108.288 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.5 Cg_endo -86.08 -170.62 7.0 Favored 'Cis proline' 0 C--N 1.309 -1.513 0 C-N-CA 124.83 -0.904 . . . . 7.79 110.119 -0.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.732 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.08 102.78 4.94 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.54 -2.022 . . . . 26.05 105.54 176.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 85' ' ' LEU . 98.1 t -90.07 159.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 8.68 111.763 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.8 m-85 -146.21 90.92 2.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.623 -0.673 . . . . 14.07 110.836 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -72.65 112.97 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.801 -1.926 . . . . 9.34 105.801 177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.87 -152.47 39.55 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.401 -2.679 . . . . 12.42 106.401 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -83.37 -0.16 48.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.514 -1.58 . . . . 44.86 108.708 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' HB3' HH21 ' A' ' 97' ' ' ARG . 5.7 m-20 -89.45 115.05 26.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 0.0 110.599 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 t -73.71 150.71 41.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 109.449 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.98 -22.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 20.45 109.225 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.22 -146.75 18.39 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.581 -1.408 . . . . 13.82 109.581 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -102.19 -149.2 21.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.604 -1.398 . . . . 12.42 109.604 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -71.26 -59.47 2.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -1.181 . . . . 0.0 109.657 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -50.27 -27.31 5.85 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 -46.85 32.15 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.853 -0.795 . . . . 27.06 108.853 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 72' ' ' VAL . 5.0 tt -55.3 -59.78 4.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.581 -0.699 . . . . 15.31 110.353 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.53 -49.08 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.419 -0.8 . . . . 0.0 110.472 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.33 36.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.875 -1.141 . . . . 21.79 109.564 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 mt -74.1 -38.04 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 111.988 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.419 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -60.3 -59.11 5.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -178.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -60.47 -24.45 65.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.003 -1.061 . . . . 0.0 109.664 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.0 m -80.76 -24.63 38.53 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.443 -0.786 . . . . 0.0 109.378 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.14 -9.61 76.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.32 -1.112 . . . . 25.64 110.32 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.71 -26.53 65.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.046 -1.267 . . . . 50.26 108.872 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 tp -59.53 -64.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 24.17 110.605 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.27 -31.12 42.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -63.67 -46.38 85.86 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.974 -1.121 . . . . 28.03 107.974 178.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' A' ' 77' ' ' ASP . 9.6 tpt180 -58.81 -38.32 78.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.294 -1.002 . . . . 40.96 108.294 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.32 -36.19 71.5 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.657 -0.868 . . . . 15.05 108.657 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -65.87 -54.65 23.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.706 -0.621 . . . . 0.0 111.974 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -50.21 -33.17 18.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.163 . . . . 38.64 110.908 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -100.12 -11.44 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.778 -1.201 . . . . 0.0 109.409 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.15 40.63 15.82 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.462 -1.055 . . . . 18.54 110.462 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.46 -20.49 29.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.136 -1.214 . . . . 10.84 109.3 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.3 pp -96.18 -175.87 3.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 104' ' ' LEU . 49.0 mt-30 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.49 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.32 -68.28 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.406 -0.809 . . . . 20.03 110.214 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.68 -39.81 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 12.91 110.244 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.4 m120 -55.64 -34.96 65.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.12 -0.987 . . . . 28.33 109.043 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.4 m -74.63 -12.73 60.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -96.66 -48.32 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 22.87 109.848 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.51 132.06 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 25.19 109.635 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.91 157.25 34.38 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.132 -1.062 . . . . 34.61 108.132 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.28 130.62 36.43 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.708 1.605 . . . . 11.72 111.312 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.73 28.18 65.64 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 120.408 -0.901 . . . . 10.24 110.944 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -140.62 132.85 28.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.316 . . . . 25.36 109.7 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.36 136.86 31.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.379 -0.825 . . . . 10.89 109.263 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.67 142.37 23.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.564 -0.902 . . . . 15.82 108.564 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 45' ' ' VAL . 40.5 t -125.63 125.92 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 8.94 110.968 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -93.79 121.89 35.7 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.903 -1.147 . . . . 9.93 107.903 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.3 pt -131.07 -175.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.613 1.197 . . . . 10.62 111.839 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 21' ' ' THR . 39.2 mttm -140.92 97.39 7.11 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 105.166 -2.161 . . . . 38.73 105.166 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 21' ' ' THR . 10.3 Cg_exo -51.12 71.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.441 1.427 . . . . 24.58 110.895 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 19' ' ' LYS . 24.7 m -170.03 -32.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.185 -0.947 . . . . 34.82 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.32 133.17 24.19 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 21.46 109.882 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.46 -24.11 77.01 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 122.411 2.074 . . . . 13.86 112.991 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -67.23 -47.87 69.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.366 -1.458 . . . . 0.0 109.921 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -33.8 72.05 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -61.75 -42.24 98.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.548 -0.908 . . . . 59.59 108.548 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 27' ' ' ARG . 7.4 mtt-85 -56.15 -45.06 79.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 109.077 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.17 76.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.029 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -70.33 -41.16 73.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.466 -0.771 . . . . 45.49 109.488 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 26' ' ' ARG . 55.4 mm-40 -72.4 -39.08 68.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.614 -0.679 . . . . 34.97 111.64 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.676 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.91 -56.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.766 -1.209 . . . . 0.0 109.769 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.659 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -60.81 -19.01 58.81 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.577 -1.327 . . . . 17.28 109.536 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -66.54 -27.7 67.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.039 -1.038 . . . . 24.11 108.706 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 2.3 mp0 -91.53 -0.07 57.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 44.07 110.393 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 32' ' ' LEU . 15.7 mt -87.8 129.69 49.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.771 -1.206 . . . . 19.63 108.626 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.8 67.11 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.441 1.427 . . . . 21.54 109.451 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.9 mm -76.97 150.65 5.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.154 -0.966 . . . . 0.0 108.64 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' GLN . 6.9 mmmt -52.75 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 29.41 110.557 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' LYS . 90.5 mt-30 -52.03 -124.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.628 0.728 . . . . 0.0 111.88 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.25 48.62 1.17 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.425 -1.07 . . . . 15.27 110.425 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -33.92 12.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -1.094 . . . . 8.78 109.201 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 37' ' ' ILE . 66.0 tp -92.83 133.79 35.72 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.544 0.688 . . . . 7.13 109.472 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.0 tt0 -143.57 174.05 11.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.471 -0.768 . . . . 22.03 109.055 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.518 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.7 m-85 -136.82 109.62 7.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.084 -1.45 . . . . 16.33 107.084 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 16' ' ' VAL . 78.0 t -95.0 107.13 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 6.58 111.967 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.5 m-20 -82.45 100.06 9.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.595 -0.891 . . . . 15.32 108.595 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.63 2.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 10.92 111.145 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -94.97 -31.0 13.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.873 -1.142 . . . . 21.72 108.395 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.47 22.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.48 -0.762 . . . . 22.45 109.658 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.1 t -141.22 -2.47 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.134 -0.978 . . . . 25.63 109.996 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 4.5 m-20 65.25 -168.6 0.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.492 -0.755 . . . . 0.0 109.994 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 51.37 19.14 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.481 HG22 ' NZ ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -35.68 -62.2 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.727 -0.608 . . . . 18.87 110.78 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.5 m120 -56.13 -36.74 68.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 45.21 110.805 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 1.1 mp0 -61.83 -44.57 96.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.937 -1.102 . . . . 33.02 109.912 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.32 -54.18 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.666 -1.271 . . . . 9.84 109.627 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -56.91 -44.91 82.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.566 -1.334 . . . . 17.84 107.765 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.97 -34.72 57.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 18.84 107.284 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -78.36 -46.88 18.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.87 -0.732 . . . . 12.99 109.218 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.3 mt -52.59 -38.29 59.76 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.116 -1.068 . . . . 14.61 108.116 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -57.17 -55.54 33.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.641 -0.874 . . . . 40.45 108.641 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.08 -29.16 68.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.848 . . . . 41.81 109.585 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 63' ' ' LEU . 2.0 tt -64.5 -68.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.951 . . . . 21.77 109.792 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -52.95 2.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.801 -0.562 . . . . 11.38 109.721 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.432 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 152.72 -42.93 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.051 -1.547 . . . . 14.79 111.128 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . . . -96.48 144.62 26.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.839 -1.389 . . . . 17.81 110.69 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.55 23.89 13.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.55 -0.907 . . . . 29.76 108.55 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.754 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.38 170.03 15.77 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 18.26 110.589 -178.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.18 132.44 21.73 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 107.839 -1.171 . . . . 8.2 107.839 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 82' ' ' SER . 27.8 Cg_endo -83.98 -168.32 5.97 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 CA-C-O 122.533 0.972 . . . . 7.79 112.15 -0.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.754 HH12 ' H ' ' A' ' 68' ' ' THR . 1.8 tpm_? -146.01 90.4 1.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.635 -1.987 . . . . 26.05 105.635 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 73' ' ' PHE . 88.3 t -83.78 155.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.279 -0.888 . . . . 8.68 111.794 -176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' N ' HG12 ' A' ' 72' ' ' VAL . 81.8 m-85 -142.69 91.77 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 14.07 111.535 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.0 mm -72.02 114.3 10.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 105.249 -2.13 . . . . 9.34 105.249 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.38 -159.1 11.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.959 -2.856 . . . . 12.42 105.959 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -78.3 1.71 20.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.211 -1.758 . . . . 44.86 108.699 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.616 ' CB ' HH21 ' A' ' 97' ' ' ARG . 1.4 m-20 -88.43 112.09 22.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.735 . . . . 0.0 110.055 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 t -76.79 143.65 39.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.267 -0.896 . . . . 0.0 110.453 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.8 pt -107.37 -21.41 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.028 . . . . 20.45 108.92 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.26 -146.63 18.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.218 -1.153 . . . . 13.82 110.218 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.91 -143.67 13.31 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.227 -1.149 . . . . 12.42 110.227 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.6 -61.73 1.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.517 -0.99 . . . . 0.0 109.964 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -52.73 -23.68 7.22 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.59 -0.694 . . . . 0.0 109.5 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.53 -51.55 12.67 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 27.06 109.272 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -50.92 -60.3 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 15.31 110.037 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.54 -51.93 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 110.066 -178.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 86' ' ' VAL . 3.2 t -44.44 -37.7 3.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.229 -0.92 . . . . 21.79 108.953 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' HD13 ' A' ' 94' ' ' LEU . 42.2 mt -81.89 -40.96 21.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 111.507 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.53 -58.66 7.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.88 -1.137 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -24.83 66.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.004 -1.06 . . . . 0.0 109.411 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.2 m -79.87 -45.51 18.53 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.3 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.3 -9.22 26.69 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.377 -1.089 . . . . 25.64 110.377 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' HG21 ' A' ' 96' ' ' THR . 8.5 tp10 -69.69 -25.11 63.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.988 -1.301 . . . . 50.26 108.534 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.8 tp -60.07 -63.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.479 0.657 . . . . 24.17 110.732 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.17 -28.26 39.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.448 -0.782 . . . . 0.0 108.915 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.4 -50.05 66.92 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.65 -0.82 . . . . 28.03 108.803 178.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.616 HH21 ' CB ' ' A' ' 77' ' ' ASP . 27.1 mtp180 -58.91 -31.05 68.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.912 -1.144 . . . . 40.96 107.912 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.37 -40.49 67.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.051 -1.092 . . . . 15.05 108.051 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -64.9 -52.3 57.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.93 -0.481 . . . . 0.0 111.888 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -33.2 24.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.71 -1.244 . . . . 38.64 110.691 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 101' ' ' ILE . 18.7 pt -99.76 -16.34 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.693 -1.255 . . . . 0.0 108.764 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.18 44.28 8.19 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.428 -1.069 . . . . 18.54 110.428 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.92 -13.85 46.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -1.155 . . . . 10.84 109.657 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.1 pt? -95.01 -175.61 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.504 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.06 -69.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.414 -0.804 . . . . 20.03 111.218 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.9 m -73.27 -38.68 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 12.91 110.5 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 98.2 m-20 -55.73 -34.06 64.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.043 -1.036 . . . . 28.33 109.442 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.8 m -74.58 -13.83 60.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.022 -1.049 . . . . 0.0 110.001 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -97.42 -45.75 6.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.012 -1.055 . . . . 22.87 110.693 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.48 129.09 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.909 -1.12 . . . . 25.19 110.389 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.77 158.52 35.21 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 107.965 -1.124 . . . . 34.61 107.965 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -56.7 135.9 73.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.743 1.629 . . . . 11.72 111.418 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.81 27.64 68.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.75 -0.94 . . . . 10.24 110.75 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -142.6 131.85 23.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.347 . . . . 25.36 109.619 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.5 127.79 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.218 -0.926 . . . . 10.89 108.959 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.88 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.613 -0.884 . . . . 15.82 108.613 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 18' ' ' ILE . 32.7 t -125.31 126.11 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.541 -0.724 . . . . 8.94 111.259 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -92.67 119.1 31.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.574 -1.269 . . . . 9.93 107.574 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.3 pt -129.34 -173.79 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 122.311 1.053 . . . . 10.62 111.345 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -146.2 88.04 6.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.95 -1.871 . . . . 38.73 105.95 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.544 ' O ' ' OG1' ' A' ' 21' ' ' THR . 17.7 Cg_exo -45.79 77.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.851 1.701 . . . . 24.58 110.834 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 19' ' ' LYS . 15.6 m -174.07 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.082 -1.081 . . . . 34.82 108.082 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 126.16 42.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 109.083 -0.71 . . . . 21.46 109.083 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.82 -24.6 56.83 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.069 1.846 . . . . 13.86 112.166 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -70.39 -38.18 74.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.799 -1.188 . . . . 0.0 108.782 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -36.35 84.02 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.593 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.5 mmm-85 -65.27 -42.93 92.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.962 -0.755 . . . . 59.59 108.962 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -50.14 -45.37 53.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 108.771 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.71 82.12 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.616 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -71.41 -45.77 61.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.791 . . . . 45.49 109.652 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -69.99 -34.41 73.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.524 -0.735 . . . . 34.97 110.787 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.93 -57.58 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 0.0 110.83 -178.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.694 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -59.49 -20.89 58.7 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.593 -1.317 . . . . 17.28 109.487 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 m -64.5 -22.29 66.92 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.142 -0.974 . . . . 24.11 108.415 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -93.02 -2.21 55.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.486 -0.759 . . . . 44.07 109.963 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 HD23 ' A' ' 32' ' ' LEU . 18.8 mt -88.7 130.38 45.33 Favored Pre-proline 0 N--CA 1.484 1.267 0 O-C-N 120.86 -1.15 . . . . 19.63 108.956 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 67.19 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.669 1.58 . . . . 21.54 109.875 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.49 149.56 5.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 108.685 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 39' ' ' GLN . 36.6 mttt -53.56 -168.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.345 -0.847 . . . . 29.41 110.29 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.597 ' CD ' ' H ' ' A' ' 39' ' ' GLN . 21.8 mp0 -52.01 -123.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.6 0.714 . . . . 0.0 111.748 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 51.14 1.8 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.628 -0.989 . . . . 15.27 110.628 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.59 -27.31 14.07 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.549 -0.971 . . . . 8.78 108.796 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HB2' HG21 ' A' ' 37' ' ' ILE . 55.3 tp -97.25 130.87 44.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.606 -0.887 . . . . 7.13 108.606 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 1.2 tp10 -140.62 172.97 11.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.442 -0.786 . . . . 22.03 109.874 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 35.9 m-85 -135.74 110.06 8.43 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.416 -1.327 . . . . 16.33 107.416 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.9 103.16 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 6.58 111.676 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.3 m-20 -81.29 100.87 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.671 -0.863 . . . . 15.32 108.671 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 56' ' ' ILE . 25.8 pt -63.69 -0.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.165 -0.96 . . . . 10.92 111.098 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 t -92.31 -14.34 28.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.717 -1.239 . . . . 21.72 108.965 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.54 8.04 4.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.789 . . . . 22.45 109.307 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -142.97 -0.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 25.63 109.797 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' C ' ' N ' ' A' ' 53' ' ' THR . 13.3 t-20 67.38 -156.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.28 12.32 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.803 -1.186 . . . . 0.0 108.684 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -37.83 -62.89 0.51 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.524 -0.735 . . . . 18.87 110.892 -178.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -53.53 -32.57 51.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 45.21 110.481 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -65.67 -45.28 83.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.889 -1.132 . . . . 33.02 109.82 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 47' ' ' ILE . 2.4 mp -67.21 -50.29 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.922 -1.111 . . . . 9.84 109.469 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -58.07 -42.38 85.4 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.275 -1.38 . . . . 17.84 107.275 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.09 -33.11 64.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.036 -1.468 . . . . 18.84 107.036 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -78.78 -51.82 9.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.98 -0.748 . . . . 12.99 108.98 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.44 -32.55 50.33 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.134 -1.061 . . . . 14.61 108.134 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.6 tp60 -59.13 -54.56 45.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.808 -0.557 . . . . 40.45 109.849 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -67.47 -49.61 62.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 41.81 110.878 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -65.28 -33.33 75.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.036 -1.04 . . . . 21.77 110.993 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.7 p -107.91 -66.75 1.01 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.162 -0.961 . . . . 11.38 109.47 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 141.96 -41.37 1.22 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.757 -1.737 . . . . 14.79 108.757 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.5 140.85 32.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 17.81 109.655 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -106.15 25.67 10.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.363 -0.977 . . . . 29.76 108.363 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.82 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -83.85 168.04 16.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.036 0.922 . . . . 18.26 111.471 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.54 134.79 21.54 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 107.725 -1.213 . . . . 8.2 107.725 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB3' HG22 ' A' ' 18' ' ' ILE . 22.3 Cg_endo -85.62 -162.97 2.69 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 CA-C-O 122.512 0.963 . . . . 7.79 111.929 -0.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.82 HH12 ' H ' ' A' ' 68' ' ' THR . 1.5 tpm_? -144.94 97.38 3.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.271 -2.122 . . . . 26.05 105.271 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 85' ' ' LEU . 99.3 t -86.87 157.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 8.68 111.483 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.461 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.4 m-85 -144.92 91.21 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 14.07 111.503 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 mm -72.37 112.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.343 -2.095 . . . . 9.34 105.343 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 -153.13 36.03 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 105.476 -3.05 . . . . 12.42 105.476 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -83.65 2.82 35.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.219 -1.754 . . . . 44.86 108.67 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.661 ' CB ' HH21 ' A' ' 97' ' ' ARG . 5.5 m-20 -88.84 113.38 24.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 110.3 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.5 t -75.1 145.8 41.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.6 pp -111.92 -16.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.264 -0.898 . . . . 20.45 109.334 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.92 -149.36 18.05 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.237 -1.145 . . . . 13.82 110.237 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.73 -147.52 20.93 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.096 -1.202 . . . . 12.42 110.096 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 t -71.78 -62.73 1.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.479 -1.012 . . . . 0.0 110.218 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.5 t -52.25 -24.46 7.37 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.71 -47.35 31.91 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.358 -0.839 . . . . 27.06 109.111 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.6 -59.39 4.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.728 . . . . 15.31 110.189 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -51.5 -50.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 110.436 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 22.7 m -47.59 -36.86 11.34 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.03 -1.044 . . . . 21.79 109.049 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.0 mt -82.47 -37.81 24.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 0.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.42 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.47 -60.22 4.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.694 -1.254 . . . . 0.0 110.728 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.666 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.0 pp0? -61.42 -17.79 55.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.005 -1.059 . . . . 0.0 109.588 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.447 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 73.3 m -80.51 -63.47 1.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.72 -13.02 4.51 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.125 -1.19 . . . . 25.64 110.125 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.02 -29.65 67.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.15 -1.206 . . . . 50.26 108.535 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.08 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.574 -0.704 . . . . 24.17 111.051 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -54.97 -28.62 52.92 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -64.64 -48.92 73.07 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.616 -0.833 . . . . 28.03 108.816 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.661 HH21 ' CB ' ' A' ' 77' ' ' ASP . 29.0 mtp180 -60.46 -31.29 70.29 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.968 -1.123 . . . . 40.96 107.968 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.75 -39.08 70.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.288 -1.004 . . . . 15.05 108.288 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -66.04 -54.15 29.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.919 -0.488 . . . . 0.0 111.913 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -49.73 -32.65 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.786 -1.196 . . . . 38.64 110.947 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 pt -100.29 -14.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.625 -1.297 . . . . 0.0 109.07 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.35 44.13 8.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.291 -1.124 . . . . 18.54 110.291 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.27 38.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.236 . . . . 10.84 109.653 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.04 -179.97 5.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.577 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.597 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.187 0.518 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.48 -75.58 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 20.03 110.69 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -73.95 -35.67 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.97 . . . . 12.91 110.017 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -56.43 -35.56 67.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.183 -0.948 . . . . 28.33 109.377 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -75.0 -13.22 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.916 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -97.02 -47.74 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.124 -0.985 . . . . 22.87 110.349 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -79.5 133.38 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 25.19 110.385 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -151.25 160.06 32.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.903 -1.147 . . . . 34.61 107.903 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.77 130.27 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.754 1.636 . . . . 11.72 111.435 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.49 22.99 63.55 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 120.335 -0.936 . . . . 10.24 111.046 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -141.12 134.11 29.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.974 -1.309 . . . . 25.36 109.62 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.9 t -100.66 133.98 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.479 -0.763 . . . . 10.89 109.435 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.64 141.22 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.487 -0.931 . . . . 15.82 108.487 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.74 124.14 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.824 . . . . 8.94 111.307 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -91.61 120.51 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.588 -1.264 . . . . 9.93 107.588 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.453 HG22 ' HB3' ' A' ' 70' ' ' PRO . 43.7 pt -133.45 -170.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 122.667 1.223 . . . . 10.62 112.192 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.1 mtmt -146.57 96.43 4.45 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 105.707 -1.96 . . . . 38.73 105.707 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -50.68 82.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.282 1.321 . . . . 24.58 110.504 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -179.36 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 34.82 109.699 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.36 122.33 56.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.252 -0.905 . . . . 21.46 109.082 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -54.56 -10.89 2.67 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.34 2.027 . . . . 13.86 112.765 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -73.68 -49.98 23.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.422 -1.424 . . . . 0.0 110.186 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -26.76 68.03 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.667 -1.271 . . . . 0.0 107.896 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -62.97 -37.69 88.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.092 -1.077 . . . . 59.59 108.092 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -59.17 -50.51 73.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 108.991 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -36.8 74.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.312 -0.868 . . . . 0.0 109.003 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 5.5 mm-40 -69.39 -42.85 74.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 45.49 109.705 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.16 -38.16 69.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.493 -0.754 . . . . 34.97 110.876 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.93 -54.95 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.016 -1.053 . . . . 0.0 110.405 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.607 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -58.36 -22.6 54.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.322 -1.486 . . . . 17.28 108.726 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -65.39 -29.89 70.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.936 . . . . 24.11 108.585 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -89.1 0.46 56.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.779 . . . . 44.07 109.562 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 ' OE1' ' A' ' 89' ' ' GLN . 25.4 mt -89.3 131.51 40.34 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.127 -0.983 . . . . 19.63 108.696 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.84 66.6 1.26 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.843 1.695 . . . . 21.54 110.418 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -81.05 146.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.98 -1.075 . . . . 0.0 108.492 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 39' ' ' GLN . 11.1 mtmt -54.39 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 29.41 110.96 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.55 ' O ' ' O ' ' A' ' 38' ' ' LYS . 52.7 mt-30 -52.42 -133.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.766 0.793 . . . . 0.0 111.784 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.51 50.24 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.336 -1.106 . . . . 15.27 110.336 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -97.04 -29.75 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 8.78 108.726 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 37' ' ' ILE . 62.3 tp -94.98 132.02 40.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.978 -0.749 . . . . 7.13 108.978 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 11.6 tp10 -143.47 169.43 17.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.434 -0.791 . . . . 22.03 109.387 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.2 m-85 -132.03 109.64 10.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.3 -1.37 . . . . 16.33 107.3 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.47 103.2 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 6.58 112.068 -176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.0 m-20 -81.51 102.65 10.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 15.32 108.193 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 pt -62.94 0.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.364 -0.835 . . . . 10.92 111.765 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -95.93 -26.43 15.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.71 -1.244 . . . . 21.72 109.451 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 20.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 22.45 109.596 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 11.0 t -143.3 1.94 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.148 -0.97 . . . . 25.63 109.702 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.702 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.41 -176.51 0.18 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.702 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.26 20.89 10.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.666 -1.271 . . . . 0.0 108.391 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.31 -61.68 1.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 18.87 110.789 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.08 -32.7 68.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 45.21 111.218 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 4.7 mp0 -62.46 -44.36 96.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.86 -1.15 . . . . 33.02 110.101 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.68 -53.22 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.144 . . . . 9.84 109.553 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.07 -44.94 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.609 -1.307 . . . . 17.84 107.511 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -55.7 -33.33 64.07 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.003 -1.48 . . . . 18.84 107.003 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.95 -47.75 17.85 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.937 -0.764 . . . . 12.99 108.937 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.4 mt -53.15 -35.02 59.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.882 -1.155 . . . . 14.61 107.882 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.1 tp60 -60.62 -54.74 41.71 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.228 0.537 . . . . 40.45 109.982 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -66.2 -45.3 81.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.966 -1.084 . . . . 41.81 110.693 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.99 -40.73 91.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.987 -1.071 . . . . 21.77 110.68 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.1 p -107.83 -65.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.786 . . . . 11.38 109.761 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 140.89 -38.49 1.55 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.786 -2.125 . . . . 14.79 107.786 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.21 138.33 35.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.682 -0.893 . . . . 17.81 109.813 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -112.52 38.37 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.206 -1.035 . . . . 29.76 108.206 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 166.78 14.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.245 1.021 . . . . 18.26 112.623 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.79 126.77 27.51 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 8.2 107.22 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.722 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 35.4 Cg_endo -82.34 -173.93 12.53 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 CA-C-O 122.148 0.811 . . . . 7.79 111.222 1.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.737 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -140.94 98.7 3.44 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.215 -2.143 . . . . 26.05 105.215 176.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 73' ' ' PHE . 67.2 t -89.4 157.95 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.745 0.783 . . . . 8.68 112.6 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.9 m-85 -146.5 88.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.839 -0.538 . . . . 14.07 111.329 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.44 124.39 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 104.433 -2.432 . . . . 9.34 104.433 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.26 -160.24 17.49 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 106.501 -2.64 . . . . 12.42 106.501 -176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -83.21 -1.95 54.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.395 -1.65 . . . . 44.86 109.984 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' HB2' HH21 ' A' ' 97' ' ' ARG . 4.2 m-20 -89.31 124.2 34.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.018 -1.051 . . . . 0.0 110.356 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 t -75.0 147.12 41.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 110.025 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -109.28 -21.09 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.681 -0.859 . . . . 20.45 108.681 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.99 -153.01 19.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.941 -1.264 . . . . 13.82 109.941 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.99 -147.02 21.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.966 -1.254 . . . . 12.42 109.966 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -69.71 -61.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -1.103 . . . . 0.0 109.863 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -51.06 -23.64 3.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.553 -0.717 . . . . 0.0 109.293 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.01 -47.38 25.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.451 -0.78 . . . . 27.06 109.016 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.7 tt -54.24 -60.03 3.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 15.31 109.834 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.27 -52.16 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.082 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.616 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 37.4 m -46.16 -35.92 5.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.143 -0.973 . . . . 21.79 108.899 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 94' ' ' LEU . 71.8 mt -82.08 -40.05 22.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 111.615 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.707 ' OE1' HD11 ' A' ' 35' ' ' LEU . 25.2 tp60 -58.71 -59.11 5.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.164 . . . . 0.0 110.777 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.3 pp0? -62.81 -19.74 64.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.927 -1.108 . . . . 0.0 109.768 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.552 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 70.7 m -83.86 -24.28 30.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.32 -9.54 76.57 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.106 -1.197 . . . . 25.64 110.106 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.128 -1.219 . . . . 50.26 108.21 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.6 -65.81 0.63 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.44 0.638 . . . . 24.17 110.887 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.01 -28.29 37.29 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -48.45 73.51 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.683 -0.858 . . . . 28.03 108.683 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.688 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.84 -33.87 72.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.762 -1.199 . . . . 40.96 107.762 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.1 -38.0 75.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.29 -1.004 . . . . 15.05 108.29 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -64.93 -58.03 7.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.917 -0.49 . . . . 0.0 111.635 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.39 -28.36 3.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.914 -1.116 . . . . 38.64 111.087 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -103.74 -19.8 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.709 -1.244 . . . . 0.0 109.214 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.39 41.89 7.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.38 -1.088 . . . . 18.54 110.38 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.78 -13.97 49.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -1.205 . . . . 10.84 109.437 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.07 -176.37 3.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 109.367 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.121 -0.987 . . . . 0.0 109.609 179.867 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -56.86 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 20.03 109.846 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.8 HG21 ' CZ ' ' A' ' 59' ' ' TYR . 14.9 m -73.14 -39.7 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.65 -0.656 . . . . 12.91 110.964 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.502 ' N ' HG23 ' A' ' 5' ' ' VAL . 12.0 m120 -57.21 -34.26 68.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.797 -1.189 . . . . 28.33 109.973 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m -74.14 -13.59 60.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.021 -1.05 . . . . 0.0 109.426 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -96.98 -52.42 3.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 22.87 110.3 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.19 126.29 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 25.19 109.989 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.13 155.37 40.03 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.121 -1.066 . . . . 34.61 108.121 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.25 132.35 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.926 1.751 . . . . 11.72 111.411 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 22.75 64.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.767 -0.933 . . . . 10.24 110.767 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.77 135.1 27.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.875 -1.368 . . . . 25.36 110.121 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.15 135.42 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 10.89 108.99 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.33 141.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.39 -0.967 . . . . 15.82 108.39 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 18' ' ' ILE . 21.8 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.386 -0.821 . . . . 8.94 110.426 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -90.86 119.04 30.74 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.148 -1.427 . . . . 9.93 107.148 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.7 pt -130.32 -175.04 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.294 1.045 . . . . 10.62 111.178 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.76 ' O ' ' N ' ' A' ' 21' ' ' THR . 21.6 mtmt -146.19 88.65 6.21 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.459 -1.682 . . . . 38.73 106.459 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 21' ' ' THR . 12.9 Cg_exo -46.76 69.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.016 1.81 . . . . 24.58 110.921 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.76 ' N ' ' O ' ' A' ' 19' ' ' LYS . 20.8 p -162.3 -36.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.007 -1.108 . . . . 34.82 108.007 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 128.94 32.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 21.46 109.469 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.98 -20.2 43.88 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.056 1.837 . . . . 13.86 111.756 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.66 -40.89 72.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.677 -1.265 . . . . 0.0 108.518 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -36.48 83.67 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.556 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -65.14 -36.06 83.07 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.792 -0.818 . . . . 59.59 108.792 178.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.72 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -56.54 -50.67 71.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 109.243 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . . . -56.94 -34.03 67.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.24 -36.89 74.78 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.282 -0.886 . . . . 45.49 108.696 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 67.1 mm-40 -71.4 -39.69 70.97 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.811 -0.555 . . . . 34.97 111.4 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -77.15 -65.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.837 -1.165 . . . . 0.0 110.925 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.648 ' H ' HG23 ' A' ' 31' ' ' ILE . 3.1 mt -52.8 -22.77 5.75 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.853 -1.155 . . . . 17.28 110.191 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 5.0 p -66.64 -26.17 66.94 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.755 -1.215 . . . . 24.11 108.773 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -93.3 4.11 54.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.373 -0.829 . . . . 44.07 110.506 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 32' ' ' LEU . 16.5 mt -90.46 131.46 38.18 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.83 -1.168 . . . . 19.63 109.385 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -66.67 66.72 0.53 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.898 1.732 . . . . 21.54 110.132 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' LYS . 1.9 mm -81.67 153.37 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.214 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.2 mmmm -54.05 -168.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 29.41 110.028 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' LYS . 40.1 mt-30 -51.78 -134.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.6 0.714 . . . . 0.0 110.831 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.09 54.57 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.063 -1.215 . . . . 15.27 110.063 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.37 -17.69 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.402 -1.058 . . . . 8.78 109.241 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.3 tp -105.54 130.33 53.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.64 -0.874 . . . . 7.13 108.64 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 28.8 tt0 -139.37 173.51 11.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 22.03 110.17 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.486 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 40.0 m-85 -134.58 110.82 9.58 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.782 -1.192 . . . . 16.33 107.782 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.3 t -96.19 104.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 6.58 111.621 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' HD11 ' A' ' 18' ' ' ILE . 13.5 m-20 -81.33 103.19 10.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.055 -1.091 . . . . 15.32 108.055 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.7 pt -62.41 -3.85 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 10.92 110.811 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -93.8 -15.83 24.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.954 -1.091 . . . . 21.72 109.286 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.04 10.8 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 22.45 109.467 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.3 t -142.86 -18.53 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.248 -0.907 . . . . 25.63 110.059 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 50' ' ' THR . 0.5 OUTLIER 84.33 -170.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.597 -0.689 . . . . 0.0 109.452 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER 56.17 24.21 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 108.792 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 8.7 p -42.84 -52.83 4.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 18.87 110.394 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.9 m-20 -52.63 -34.72 52.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 45.21 110.481 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -64.69 -45.09 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.129 . . . . 33.02 109.28 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.43 -50.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.05 -1.032 . . . . 9.84 109.43 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.0 mt-30 -57.65 -39.54 77.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.5 -1.375 . . . . 17.84 107.447 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 11.8 m-20 -56.31 -32.56 64.74 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.189 -1.412 . . . . 18.84 107.189 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 5.4 t80 -76.13 -51.56 11.95 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.064 -0.717 . . . . 12.99 109.064 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 22.5 mt -54.22 -32.06 54.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.059 -1.089 . . . . 14.61 108.059 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.3 tp-100 -63.2 -56.5 16.1 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.458 -0.777 . . . . 40.45 110.167 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -55.59 15.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 41.81 111.733 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -31.56 72.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.904 -1.122 . . . . 21.77 111.229 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.6 p -109.9 -63.32 1.39 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.974 -1.079 . . . . 11.38 109.81 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 140.73 -45.59 0.97 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.944 -1.662 . . . . 14.79 108.944 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' NH1' ' A' ' 71' ' ' ARG . . . -98.05 138.49 35.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.983 . . . . 17.81 109.261 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.967 HH11 ' HG2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -107.64 26.43 10.29 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.912 -1.144 . . . . 29.76 107.912 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 173.26 12.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.743 -0.598 . . . . 18.26 109.588 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.5 t -117.79 137.64 24.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 8.2 108.559 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.0 Cg_endo -84.72 -165.73 3.98 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.678 -0.968 . . . . 7.79 110.585 -0.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.877 ' NH1' ' HB3' ' A' ' 66' ' ' ALA . 1.8 tpt180 -148.46 98.08 2.84 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.848 -1.908 . . . . 26.05 105.848 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 85' ' ' LEU . 93.5 t -84.16 159.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -0.87 . . . . 8.68 111.219 -176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 72' ' ' VAL . 77.4 m-85 -145.34 94.9 2.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.7 -0.625 . . . . 14.07 110.783 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 101' ' ' ILE . 6.7 mm -72.92 105.59 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.775 -1.935 . . . . 9.34 105.775 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.07 -147.25 48.96 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.723 -2.951 . . . . 12.42 105.723 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -84.37 3.44 35.89 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.477 -1.602 . . . . 44.86 108.791 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.672 ' CB ' HH21 ' A' ' 97' ' ' ARG . 74.7 m-20 -89.94 109.06 20.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.479 -0.763 . . . . 0.0 110.756 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 t -74.05 145.14 44.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 109.281 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -113.33 -22.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.205 -0.935 . . . . 20.45 109.33 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA2' HH21 ' A' ' 71' ' ' ARG . . . 134.62 -154.44 21.48 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.788 -1.325 . . . . 13.82 109.788 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -101.13 -142.85 13.19 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.005 -1.238 . . . . 12.42 110.005 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.67 -66.07 0.68 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.444 -1.033 . . . . 0.0 110.501 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t -51.65 -24.48 5.63 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.571 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -74.97 -47.95 26.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.373 -0.829 . . . . 27.06 109.369 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.685 HD12 HG21 ' A' ' 72' ' ' VAL . 5.6 tt -55.03 -58.8 6.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.434 -0.791 . . . . 15.31 110.516 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -48.93 -47.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.805 . . . . 0.0 110.664 -178.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -43.25 47.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 21.79 109.172 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.9 mt -72.86 -41.08 65.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 111.984 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.4 -57.22 13.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.846 -1.159 . . . . 0.0 110.615 -177.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -25.45 67.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 109.323 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.5 m -82.58 -19.24 38.85 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.37 64.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.273 -1.131 . . . . 25.64 110.273 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 96' ' ' THR . 23.7 tt0 -67.67 -25.35 65.66 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.143 -1.21 . . . . 50.26 109.152 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.62 -63.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 24.17 110.295 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -52.17 -27.36 14.15 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.475 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -62.71 -48.13 80.6 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.417 -0.913 . . . . 28.03 108.678 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.702 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.5 mmm180 -60.42 -32.91 71.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.036 . . . . 40.96 108.539 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.4 mp -71.96 -39.43 69.35 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.399 -0.813 . . . . 15.05 109.243 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -65.74 -52.03 54.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.646 -0.658 . . . . 0.0 111.876 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.702 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -47.83 -34.2 8.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 38.64 110.404 -178.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 74' ' ' ILE . 17.7 pt -101.98 -11.37 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.846 -1.159 . . . . 0.0 109.268 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 43.58 14.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.427 -1.069 . . . . 18.54 110.427 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.52 -17.18 34.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.162 -1.199 . . . . 10.84 109.67 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 3.8 pp -97.46 -177.48 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.631 -179.95 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.819 -0.808 . . . . 2.18 108.819 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.98 -72.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.5 109.788 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.53 -36.32 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.27 110.317 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -58.37 -36.58 73.72 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.795 -1.19 . . . . 1.22 109.655 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -73.81 -13.35 60.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.37 109.302 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -97.19 -48.65 5.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 1.3 110.329 -179.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.0 125.44 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.777 -1.202 . . . . 0.32 109.018 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.3 148.32 31.29 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.327 -0.99 . . . . 2.09 108.327 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.21 135.93 30.92 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.196 1.931 . . . . 0.27 111.741 -178.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.17 72.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.386 -1.085 . . . . 0.24 110.386 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -144.11 140.05 29.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.022 -1.281 . . . . 1.59 110.233 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.94 137.17 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.12 109.515 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.38 143.47 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.15 108.505 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 18' ' ' ILE . 57.2 t -125.0 123.79 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.12 110.584 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -91.49 119.99 31.92 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.126 -1.435 . . . . 0.16 107.126 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 16' ' ' VAL . 37.3 pt -131.28 -173.17 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.312 1.053 . . . . 0.19 111.676 -177.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 27.1 mtmt -147.13 90.94 5.24 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 106.926 -1.509 . . . . 1.24 106.926 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -45.9 75.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.507 1.472 . . . . 0.37 110.383 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.2 m -169.21 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.927 -0.768 . . . . 1.18 108.927 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.56 131.5 25.82 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.23 110.266 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -60.04 -19.68 57.12 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 122.249 1.966 . . . . 0.32 112.054 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -70.22 -41.38 73.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.764 -1.21 . . . . 0.3 109.026 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -33.71 76.66 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.36 -0.936 . . . . 1.1 108.592 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.38 -45.43 93.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 2.71 108.779 179.483 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -49.22 -46.75 46.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.958 -1.088 . . . . 2.44 109.589 -179.396 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.76 80.96 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.14 -1.024 . . . . 0.22 108.559 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -69.06 -46.62 67.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 1.26 109.868 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -37.84 85.14 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.607 -0.683 . . . . 1.87 111.231 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -77.5 -54.8 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.81 -1.181 . . . . 0.53 110.861 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 35' ' ' LEU . 4.4 mt -58.18 -20.79 43.9 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.675 -1.266 . . . . 0.18 108.987 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -66.87 -28.08 68.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 1.31 109.404 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -91.22 3.09 55.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 1.58 109.896 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 32' ' ' LEU . 15.6 mt -91.5 127.01 52.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.29 109.556 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.14 65.24 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.922 1.748 . . . . 0.27 109.916 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 42' ' ' LEU . 15.1 mm -78.45 146.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.574 -0.898 . . . . 0.25 108.574 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.1 mttt -52.59 -178.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -0.984 . . . . 1.79 108.807 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 41' ' ' LEU . 47.6 mt-30 -52.05 -123.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.994 -1.066 . . . . 2.55 111.948 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.42 49.36 0.06 OUTLIER Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.439 -0.788 . . . . 0.37 111.534 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -105.05 -24.76 12.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.265 . . . . 0.28 109.395 179.136 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 37' ' ' ILE . 18.8 tp -102.58 131.4 49.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.16 109.086 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 161.9 36.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 2.01 109.897 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -125.02 116.49 22.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.435 -1.32 . . . . 0.16 107.435 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.71 105.31 17.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.446 -0.784 . . . . 0.17 111.997 -177.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 18' ' ' ILE . 26.0 m-20 -80.75 100.43 8.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.011 -1.107 . . . . 1.12 108.011 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 pt -61.96 -2.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.25 111.589 -178.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 -22.11 18.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.705 -1.247 . . . . 1.24 109.222 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.63 15.6 1.0 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.57 109.341 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 4.11 1.44 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.068 -1.02 . . . . 0.6 109.976 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 65.98 -175.6 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 2.41 109.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 53' ' ' THR . 6.0 m170 59.59 18.99 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 2.21 109.754 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -34.47 -65.14 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.542 -0.724 . . . . 0.89 110.377 -179.685 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 3.6 m-20 -54.73 -36.64 64.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 1.21 111.37 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.91 -45.45 92.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.641 -1.287 . . . . 2.12 109.713 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.03 -51.94 54.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.998 -1.064 . . . . 0.22 109.002 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.79 -42.94 85.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.784 -1.198 . . . . 0.46 107.774 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -56.35 -32.86 65.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.182 -1.414 . . . . 1.12 107.182 178.129 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -79.03 -50.91 10.33 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.011 -0.737 . . . . 1.21 109.011 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.9 mt -54.68 -28.1 45.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.007 -1.058 . . . . 0.25 108.221 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 7.2 tp60 -63.1 -56.44 16.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.709 . . . . 1.36 109.652 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -69.75 -38.05 76.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.447 -0.783 . . . . 2.26 110.749 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.85 -40.52 95.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.125 -0.984 . . . . 0.93 110.164 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.9 p -113.09 -70.8 0.79 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.308 -0.87 . . . . 0.71 109.266 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.85 -36.2 0.67 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.411 -1.476 . . . . 0.33 109.411 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -102.21 130.15 48.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.36 110.292 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 25.36 5.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.565 -1.272 . . . . 1.63 107.565 177.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.406 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -79.95 167.81 20.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.658 0.742 . . . . 0.33 110.04 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.72 136.92 22.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.23 107.438 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -78.46 -165.02 4.3 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 CA-C-O 122.562 0.984 . . . . 0.22 111.871 -0.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -146.6 90.71 1.95 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.453 -2.054 . . . . 2.18 105.453 177.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 22.0 t -84.25 151.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.12 111.394 -176.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.85 92.25 2.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.797 -0.565 . . . . 0.2 110.284 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 74' ' ' ILE . 3.3 mm -71.65 107.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.576 -2.009 . . . . 0.53 105.576 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.84 -147.59 50.45 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.505 -2.638 . . . . 0.18 106.505 -176.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.34 -4.89 59.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.539 -1.565 . . . . 1.88 109.356 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' HH21 ' A' ' 97' ' ' ARG . 11.9 m-20 -89.03 117.22 27.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.096 -1.003 . . . . 1.26 110.76 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -74.31 151.68 39.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.28 110.092 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.47 -19.48 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.51 109.377 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.68 -150.38 19.51 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.176 -1.17 . . . . 0.31 110.176 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.07 -142.02 11.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.343 -1.103 . . . . 0.22 110.343 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -71.78 -61.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.539 -0.977 . . . . 0.68 110.271 -179.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -53.57 -27.61 27.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.457 -0.777 . . . . 0.33 109.622 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.09 -45.64 56.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.306 -0.871 . . . . 1.6 109.07 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.2 tt -56.5 -64.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.629 -0.67 . . . . 0.22 109.732 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -45.53 -47.52 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.24 110.11 -178.458 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -48.43 47.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.905 -1.122 . . . . 0.92 109.288 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.18 -31.89 62.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.27 -0.894 . . . . 0.2 111.553 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -61.36 -60.27 3.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.574 -1.328 . . . . 2.06 109.372 -178.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -25.74 67.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 2.46 110.514 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.8 m -79.61 -25.29 41.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.234 -0.917 . . . . 0.58 110.783 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.48 -11.43 70.18 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.11 -1.196 . . . . 0.29 110.11 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.95 -31.26 70.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 1.95 108.567 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.86 -63.34 1.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.475 -0.766 . . . . 0.3 110.638 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -54.95 -30.22 58.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.457 -0.942 . . . . 0.27 108.457 -178.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.2 m -65.34 -41.55 93.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.989 -1.115 . . . . 0.3 107.989 178.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.798 HH21 ' HB3' ' A' ' 77' ' ' ASP . 1.2 tpt180 -64.6 -34.84 79.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.332 -0.988 . . . . 2.33 108.332 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.74 -32.93 68.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.409 -0.807 . . . . 0.25 109.023 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -70.0 -57.26 5.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 1.77 111.84 -178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -44.88 -30.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.688 -1.258 . . . . 0.35 110.407 -177.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.6 pt -104.65 -15.76 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.949 -1.094 . . . . 0.27 108.885 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.3 43.56 10.45 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.346 -1.102 . . . . 0.16 110.346 179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -13.38 49.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.068 -1.254 . . . . 0.18 109.564 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.725 ' H ' HD23 ' A' ' 104' ' ' LEU . 2.4 pt? -95.02 -175.32 3.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 1.14 109.326 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.943 -1.027 . . . . 1.88 108.984 179.206 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.515 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.475 -0.565 . . . . 18.33 109.475 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -111.84 -75.26 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 29.77 109.23 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.4 -10.15 2.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -61.11 -71.18 0.15 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 20.03 110.153 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.6 m -73.18 -40.84 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.442 -0.786 . . . . 12.91 110.489 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.8 m120 -55.98 -34.06 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.183 -0.948 . . . . 28.33 110.38 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.5 m -74.54 -18.33 60.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.922 -1.111 . . . . 0.0 110.349 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.578 ' CE ' HG21 ' A' ' 45' ' ' VAL . 5.2 mtpm? -98.0 -42.5 7.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.077 . . . . 22.87 111.442 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.34 126.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.728 -1.233 . . . . 25.19 109.696 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.61 159.07 35.1 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.956 -1.127 . . . . 34.61 107.956 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.09 136.56 61.63 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.789 1.659 . . . . 11.72 111.501 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.04 73.3 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.71 -0.956 . . . . 10.24 110.71 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -140.57 130.63 24.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.253 . . . . 25.36 109.536 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -101.54 133.81 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.46 -0.775 . . . . 10.89 109.876 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.36 137.48 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.277 -1.009 . . . . 15.82 108.277 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 18' ' ' ILE . 44.0 t -120.54 128.54 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 8.94 111.366 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' ' NZ ' ' A' ' 8' ' ' LYS . 80.8 m-85 -95.34 118.78 32.71 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.142 -1.058 . . . . 9.93 108.142 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 16' ' ' VAL . 23.0 pt -130.25 -176.21 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.485 1.136 . . . . 10.62 111.42 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.4 mtmt -145.02 93.16 5.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.766 -1.938 . . . . 38.73 105.766 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -48.32 82.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.369 1.379 . . . . 24.58 110.577 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -177.78 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.047 -0.723 . . . . 34.82 109.047 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.12 126.81 38.77 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 21.46 109.099 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.18 -22.98 42.71 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.465 2.11 . . . . 13.86 113.061 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -67.89 -43.15 79.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.332 -1.48 . . . . 0.0 109.44 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.07 -38.14 89.99 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.41 -40.06 93.0 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.419 -0.956 . . . . 59.59 108.419 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.31 -45.2 68.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB2' ' HG3' ' A' ' 70' ' ' PRO . . . -61.48 -35.8 78.69 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.38 -36.14 73.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.299 -0.876 . . . . 45.49 109.076 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -70.08 -41.69 73.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.761 -0.587 . . . . 34.97 111.14 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.85 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -72.58 -69.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.899 -1.126 . . . . 0.0 110.591 -178.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.85 ' H ' HG23 ' A' ' 31' ' ' ILE . 5.0 mt -51.64 -16.58 0.66 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.136 -0.978 . . . . 17.28 110.022 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.84 -29.78 68.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.012 -1.055 . . . . 24.11 108.292 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -93.41 1.65 56.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.481 -0.762 . . . . 44.07 110.617 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.73 HD12 HD23 ' A' ' 32' ' ' LEU . 18.1 mt -88.02 128.66 53.0 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.806 -1.184 . . . . 19.63 109.111 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -69.49 70.14 1.46 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.656 1.571 . . . . 21.54 109.73 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.2 mm -80.68 155.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.211 -0.931 . . . . 0.0 109.395 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.3 mmtp -54.36 -168.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.205 -0.935 . . . . 29.41 109.771 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 38' ' ' LYS . 71.0 mt-30 -54.76 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.692 0.758 . . . . 0.0 111.413 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 52.8 0.34 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.452 -1.059 . . . . 15.27 110.452 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.83 -32.46 11.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -1.109 . . . . 8.78 109.158 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 tp -95.57 135.19 37.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.39 -0.596 . . . . 7.13 109.39 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 26.2 tt0 -143.76 172.4 12.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 22.03 109.94 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 55.7 m-85 -133.06 111.0 10.6 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.272 -1.381 . . . . 16.33 107.272 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG21 ' CE ' ' A' ' 8' ' ' LYS . 53.0 t -96.16 106.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 6.58 112.279 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 48' ' ' THR . 42.4 m-20 -83.54 98.08 9.38 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.872 -0.788 . . . . 15.32 108.872 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 pt -62.05 2.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 10.92 110.657 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 46' ' ' ASP . 1.8 p -96.55 -35.53 11.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.003 -1.061 . . . . 21.72 109.372 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.81 28.81 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 22.45 109.775 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 t -144.49 -3.55 0.81 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.047 -1.033 . . . . 25.63 110.145 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.716 HD22 ' CD2' ' A' ' 52' ' ' HIS . 5.4 t30 69.94 -179.14 0.23 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 109.159 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.716 ' CD2' HD22 ' A' ' 51' ' ' ASN . 0.1 OUTLIER 53.98 27.22 7.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 108.563 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -43.07 -55.97 3.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.377 -0.827 . . . . 18.87 110.442 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -59.46 -32.69 70.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 45.21 111.225 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.6 mp0 -62.12 -44.55 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.786 -1.196 . . . . 33.02 110.256 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.87 -54.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.788 -1.195 . . . . 9.84 109.628 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.63 -44.81 77.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.671 -1.233 . . . . 17.84 107.671 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -54.37 -34.41 61.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.937 -1.505 . . . . 18.84 106.937 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 1' ' ' ALA . 33.5 t80 -78.26 -45.77 21.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.904 -0.776 . . . . 12.99 108.904 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.5 mt -53.75 -35.82 61.66 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.721 -1.215 . . . . 14.61 107.721 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 18.3 tp60 -60.47 -57.46 12.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.235 0.54 . . . . 40.45 109.66 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -67.48 -35.22 78.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 41.81 110.113 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.58 -48.64 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.948 . . . . 21.77 109.925 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -111.58 -63.9 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.519 -0.738 . . . . 11.38 109.468 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.45 -45.9 0.53 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.692 -1.242 . . . . 14.79 110.043 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.57 26.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -1.16 . . . . 17.81 110.283 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -110.94 31.21 6.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 29.76 109.132 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.45 167.58 16.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 18.26 111.056 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.683 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.2 t -111.14 133.88 21.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.956 -1.127 . . . . 8.2 107.956 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 82' ' ' SER . 19.4 Cg_endo -81.04 -165.46 4.5 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.577 0.991 . . . . 7.79 111.918 -0.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.55 91.76 1.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 105.884 -1.895 . . . . 26.05 105.884 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 85' ' ' LEU . 96.3 t -85.3 157.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.288 -0.882 . . . . 8.68 112.181 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.5 m-85 -143.91 90.45 2.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.677 -0.639 . . . . 14.07 111.262 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -71.91 115.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.132 -2.173 . . . . 9.34 105.132 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.45 -153.12 32.87 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 105.85 -2.9 . . . . 12.42 105.85 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -83.77 0.18 48.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.31 -1.7 . . . . 44.86 109.436 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -89.52 118.81 29.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.256 -0.902 . . . . 0.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -76.35 142.67 41.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.79 -17.68 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.053 -1.029 . . . . 20.45 109.214 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 -157.61 21.8 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.303 -1.119 . . . . 13.82 110.303 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.78 -147.13 19.7 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.048 -1.221 . . . . 12.42 110.048 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.456 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.62 -61.11 1.92 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.492 -1.005 . . . . 0.0 109.688 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -51.02 -25.11 4.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.25 -49.31 19.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.496 -0.753 . . . . 27.06 109.183 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.6 tt -54.02 -59.19 4.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 15.31 110.08 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.24 -51.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.7 m -45.67 -36.78 5.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 21.79 108.96 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.04 -41.92 27.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.508 -0.745 . . . . 0.0 111.344 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -58.13 -57.14 14.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.916 -1.115 . . . . 0.0 110.022 -178.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.9 -26.59 68.25 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.361 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.9 m -81.88 -20.44 38.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.452 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.33 -8.03 73.14 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.512 -1.035 . . . . 25.64 110.512 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.88 -24.48 64.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.036 -1.273 . . . . 50.26 108.371 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 tp -61.74 -66.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.624 0.726 . . . . 24.17 110.899 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.499 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.06 -28.28 16.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.6 -48.11 76.11 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.143 -1.058 . . . . 28.03 108.143 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -58.83 -34.22 71.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.832 -1.173 . . . . 40.96 107.832 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.9 mp -70.92 -39.98 72.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.677 -0.86 . . . . 15.05 108.677 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.78 -55.66 21.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.83 -0.544 . . . . 0.0 111.599 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.31 -29.29 9.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.86 -1.15 . . . . 38.64 110.93 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.2 pt -101.28 -19.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.747 -1.22 . . . . 0.0 109.08 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.78 40.53 8.77 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.288 -1.125 . . . . 18.54 110.288 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.08 -13.54 50.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -1.21 . . . . 10.84 109.684 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.57 176.21 6.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.716 -179.792 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.683 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.438 -0.578 . . . . 18.33 109.438 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 4' ' ' PHE . 47.3 tt0 -166.24 -83.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 29.77 109.096 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.84 -6.99 0.88 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.135 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.7 m-85 -62.58 -68.45 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.812 . . . . 20.03 110.664 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.43 -38.37 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 12.91 110.438 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 32.9 m120 -55.08 -37.56 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 28.33 109.483 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 m -75.11 -12.77 60.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.974 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -97.13 -46.05 6.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.109 -0.994 . . . . 22.87 110.865 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.82 136.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.852 -1.155 . . . . 25.19 109.906 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -146.92 153.28 45.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.766 -0.827 . . . . 34.61 108.766 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.14 131.71 44.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.644 1.562 . . . . 11.72 110.323 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.676 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 72.62 26.93 70.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.673 -1.371 . . . . 10.24 109.673 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -139.48 135.35 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -1.131 . . . . 25.36 109.363 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.63 135.6 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.304 -0.872 . . . . 10.89 109.92 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.49 141.9 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.847 -1.168 . . . . 15.82 107.847 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -125.68 124.79 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 8.94 110.917 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -90.1 123.89 34.34 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.365 -1.346 . . . . 9.93 107.365 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.4 pt -133.48 -176.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.19 0.995 . . . . 10.62 111.235 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.6 mtmt -145.02 93.49 5.52 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 106.455 -1.683 . . . . 38.73 106.455 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.485 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -46.87 80.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.691 1.594 . . . . 24.58 110.896 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.626 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.5 m -175.39 -37.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.794 -0.817 . . . . 34.82 108.794 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 128.97 31.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.283 -0.886 . . . . 21.46 110.018 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.67 -14.65 37.15 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.999 1.799 . . . . 13.86 112.158 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -69.05 -45.43 70.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.648 -1.282 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 108.94 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.535 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -64.45 -55.84 18.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.549 -0.719 . . . . 59.59 110.343 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 4.8 ptp180 -50.36 -35.68 29.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.548 -1.345 . . . . 0.0 109.118 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' ARG . . . -62.22 -36.82 83.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -71.66 -48.67 46.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.615 -0.678 . . . . 45.49 109.666 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.76 -31.42 70.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.563 -0.711 . . . . 34.97 111.023 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -78.31 -55.26 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.673 -1.267 . . . . 0.0 109.677 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.814 HD23 HD12 ' A' ' 35' ' ' LEU . 3.4 mt -59.89 -21.96 61.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.642 -1.286 . . . . 17.28 109.146 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -64.86 -26.7 68.44 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.523 -0.917 . . . . 24.11 108.523 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -90.95 3.17 55.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.553 -0.717 . . . . 44.07 110.38 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.814 HD12 HD23 ' A' ' 32' ' ' LEU . 17.0 mt -91.21 127.99 49.08 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.805 -1.184 . . . . 19.63 109.494 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -64.99 68.58 0.27 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 121.676 1.584 . . . . 21.54 109.663 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 35' ' ' LEU . 4.2 mm -82.98 151.89 3.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' O ' ' A' ' 39' ' ' GLN . 42.7 mmtt -53.41 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.265 -0.897 . . . . 29.41 109.854 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.613 ' O ' ' O ' ' A' ' 38' ' ' LYS . 6.1 mp0 -50.64 -128.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.645 0.736 . . . . 0.0 110.788 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.51 49.46 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 O-C-N 121.022 -1.049 . . . . 15.27 110.501 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.676 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -98.47 -13.83 20.34 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.229 -1.159 . . . . 8.78 109.62 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -107.76 129.01 55.08 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.617 -0.883 . . . . 7.13 108.617 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.54 165.39 27.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.063 -1.023 . . . . 22.03 110.443 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -128.39 112.98 15.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.759 -1.201 . . . . 16.33 107.759 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.6 106.92 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 6.58 111.326 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.465 ' OD1' HD11 ' A' ' 18' ' ' ILE . 48.4 m-20 -81.99 101.98 10.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.53 -0.915 . . . . 15.32 108.53 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.26 -5.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.001 -1.062 . . . . 10.92 110.762 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 t -95.27 -23.15 17.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 21.72 109.432 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 18.33 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 22.45 109.613 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 11.2 t -144.39 -2.96 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.118 -0.989 . . . . 25.63 110.139 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.0 m-20 74.88 -176.97 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.071 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.426 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 55.62 27.57 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 108.724 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.84 -59.58 2.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 18.87 110.186 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -58.06 -28.69 64.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 45.21 110.964 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -64.34 -44.92 90.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.714 -1.241 . . . . 33.02 109.54 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.41 -53.73 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.919 -1.113 . . . . 9.84 109.434 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.29 -41.46 75.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.663 -1.236 . . . . 17.84 107.663 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.86 -33.4 64.51 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.293 -1.373 . . . . 18.84 107.293 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -77.6 -47.62 18.91 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.871 -0.789 . . . . 12.99 108.871 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 69.6 mt -54.3 -36.11 63.34 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.211 -1.033 . . . . 14.61 108.211 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.5 tp60 -58.24 -51.54 69.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.758 -0.589 . . . . 40.45 109.551 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -66.44 -52.93 41.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.096 -1.003 . . . . 41.81 111.073 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.52 -31.76 73.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 21.77 110.813 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 19.2 p -112.35 -70.62 0.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.179 -0.95 . . . . 11.38 109.856 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 145.98 -43.09 0.92 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.001 -1.64 . . . . 14.79 109.001 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.67 131.64 44.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.423 -1.045 . . . . 17.81 110.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 33.02 2.72 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 29.76 108.962 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 174.05 11.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.44 -0.787 . . . . 18.26 110.769 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.1 t -122.48 136.81 26.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.473 -0.936 . . . . 8.2 108.473 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.738 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 41.5 Cg_endo -84.87 -173.63 10.52 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.897 -0.876 . . . . 7.79 109.867 0.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.738 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -136.52 102.69 5.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.375 -2.084 . . . . 26.05 105.375 176.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 73' ' ' PHE . 94.4 t -88.5 158.99 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.71 0.767 . . . . 8.68 111.527 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.0 m-85 -145.3 87.37 1.8 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.769 -0.582 . . . . 14.07 110.62 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.36 107.94 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 105.926 -1.879 . . . . 9.34 105.926 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.96 -154.53 53.09 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.492 -2.643 . . . . 12.42 106.492 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -82.89 -3.42 56.92 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.556 -1.556 . . . . 44.86 109.289 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.74 117.07 28.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 0.0 110.59 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.8 t -72.66 153.04 41.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.085 -1.01 . . . . 0.0 109.385 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.35 -29.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 20.45 109.614 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.67 -136.2 7.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.439 -1.465 . . . . 13.82 109.439 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -115.38 -145.77 8.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.473 -1.451 . . . . 12.42 109.473 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -71.44 -57.76 4.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 109.795 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -52.76 -27.59 18.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.496 -0.753 . . . . 0.0 109.242 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.64 -49.14 27.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -0.83 . . . . 27.06 109.085 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.2 tt -52.74 -60.94 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 15.31 109.554 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.85 -49.29 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.819 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 t -48.78 -48.5 41.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.803 -1.185 . . . . 21.79 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB2' HD13 ' A' ' 94' ' ' LEU . 57.8 mt -70.01 -39.72 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 0.0 110.978 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.17 -57.55 12.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 110.728 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.45 -23.92 67.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.977 -1.077 . . . . 0.0 109.203 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -81.96 -22.01 36.9 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 109.506 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.19 -10.44 74.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.885 -1.286 . . . . 25.64 109.885 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.03 -31.43 71.09 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.197 . . . . 50.26 109.405 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.5 tp -57.88 -60.46 3.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 24.17 110.413 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.24 -32.32 62.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.601 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.97 -44.54 92.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.942 -1.133 . . . . 28.03 107.942 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 5.5 ttt180 -61.32 -37.39 83.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.23 -1.026 . . . . 40.96 108.23 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.52 -33.94 69.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.38 -0.97 . . . . 15.05 108.38 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -65.53 -56.56 11.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.827 -0.546 . . . . 0.0 111.572 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -48.18 -33.25 8.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 38.64 110.521 -178.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.9 pt -101.5 -9.35 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.97 42.01 31.13 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.399 -1.08 . . . . 18.54 110.399 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.38 -15.41 43.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -1.187 . . . . 10.84 109.189 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.6 pp -97.76 -172.99 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.736 -179.839 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.659 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.317 0.579 . . . . 18.33 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 4' ' ' PHE . 1.3 pt20 -151.78 -77.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 29.77 108.778 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.43 -7.6 0.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.4 m-85 -61.84 -68.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.695 -0.628 . . . . 20.03 110.731 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -73.48 -40.04 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.355 -0.841 . . . . 12.91 110.365 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 17.6 m-20 -55.21 -37.46 67.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.982 -1.074 . . . . 28.33 109.104 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m -74.71 -12.68 60.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.97 -47.2 5.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 22.87 110.362 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.85 136.18 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.862 -1.148 . . . . 25.19 109.964 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -146.87 154.19 46.96 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.369 -0.975 . . . . 34.61 108.369 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.06 130.83 42.36 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.413 1.409 . . . . 11.72 109.97 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.01 64.67 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.785 -1.326 . . . . 10.24 109.785 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -138.9 132.77 30.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 25.36 109.401 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.1 t -102.68 127.54 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.253 -0.904 . . . . 10.89 109.4 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.29 140.7 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.507 -0.923 . . . . 15.82 108.507 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 18' ' ' ILE . 33.3 t -122.27 124.22 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.346 -0.846 . . . . 8.94 111.088 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -92.51 116.33 28.89 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.192 . . . . 9.93 107.783 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 16' ' ' VAL . 29.8 pt -127.65 -178.97 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.308 1.051 . . . . 10.62 111.47 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 21' ' ' THR . 23.7 mtmt -140.72 90.99 9.5 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 105.749 -1.945 . . . . 38.73 105.749 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.1 Cg_exo -47.14 80.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.718 1.612 . . . . 24.58 110.52 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 19' ' ' LYS . 17.9 m -175.68 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.571 -0.9 . . . . 34.82 108.571 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.3 124.24 47.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.374 -0.829 . . . . 21.46 109.66 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.28 -16.39 17.45 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 122.299 1.999 . . . . 13.86 112.901 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.34 -42.38 65.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.517 -1.364 . . . . 0.0 109.846 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -64.84 -31.72 73.08 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -61.5 -40.39 94.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.639 -0.875 . . . . 59.59 108.639 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.614 HH11 ' HG2' ' A' ' 27' ' ' ARG . 13.5 mtt-85 -54.28 -48.26 71.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 108.679 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.28 74.25 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.366 -0.834 . . . . 0.0 109.072 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -71.38 -45.74 62.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.817 . . . . 45.49 109.524 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' OG ' ' A' ' 33' ' ' SER . 37.5 mt-10 -70.53 -32.86 70.48 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.599 -0.688 . . . . 34.97 110.927 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -79.4 -57.02 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.818 -1.176 . . . . 0.0 110.796 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.636 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -59.54 -22.02 61.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.632 -1.292 . . . . 17.28 109.818 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 8.9 p -64.51 -23.31 67.23 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.122 -0.986 . . . . 24.11 108.708 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -93.05 -1.28 56.71 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.442 -0.786 . . . . 44.07 110.048 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -88.63 128.7 51.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.864 -1.147 . . . . 19.63 108.996 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.06 67.9 0.94 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.685 1.59 . . . . 21.54 109.581 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm -80.14 148.97 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 39' ' ' GLN . 52.3 mttt -53.65 -167.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.553 -0.717 . . . . 29.41 110.271 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.7 mm100 -52.65 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.758 0.789 . . . . 0.0 111.519 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.5 51.65 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.533 -1.027 . . . . 15.27 110.533 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.55 -28.55 13.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.463 -1.022 . . . . 8.78 108.636 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' HG21 ' A' ' 37' ' ' ILE . 59.6 tp -97.14 130.8 44.35 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.598 -0.89 . . . . 7.13 108.598 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.2 tp10 -141.14 171.83 13.52 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 22.03 109.893 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.418 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 29.9 m-85 -134.34 109.0 8.51 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.23 -1.396 . . . . 16.33 107.23 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.26 102.41 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 6.58 111.543 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.09 97.34 7.5 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.628 -0.878 . . . . 15.32 108.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 56' ' ' ILE . 28.8 pt -61.98 1.61 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 10.92 110.831 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' ASP . 6.4 p -95.56 -28.19 14.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 21.72 109.021 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.23 19.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -0.808 . . . . 22.45 109.385 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 15.0 t -143.68 -0.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.945 . . . . 25.63 109.962 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.63 -172.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.712 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.29 10.32 2.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 108.045 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.21 -68.86 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.802 -0.561 . . . . 18.87 111.515 -178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 54' ' ' ASN . 2.2 m120 -55.72 -29.87 60.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 45.21 110.994 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.581 ' OE2' ' NE2' ' A' ' 52' ' ' HIS . 11.4 mt-10 -64.83 -42.11 95.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.781 -1.199 . . . . 33.02 109.738 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 47' ' ' ILE . 2.2 mp -67.5 -53.01 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.829 -1.169 . . . . 9.84 109.167 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.04 -43.14 77.55 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.573 -1.269 . . . . 17.84 107.573 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -54.15 -34.02 59.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.021 -1.474 . . . . 18.84 107.021 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -78.51 -45.83 21.04 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 12.99 108.882 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.9 mt -53.45 -33.7 55.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.907 -1.146 . . . . 14.61 107.907 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' O ' ' A' ' 65' ' ' GLY . 12.0 tp60 -60.84 -57.53 12.26 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.333 0.587 . . . . 40.45 109.441 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -67.49 -35.49 79.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 41.81 109.995 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.09 -48.15 74.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 21.77 109.982 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -110.82 -61.89 1.62 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.517 -0.74 . . . . 11.38 109.344 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.64 -49.36 0.49 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.883 -1.287 . . . . 14.79 109.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 140.68 31.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 17.81 110.537 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -101.45 37.74 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.272 -1.01 . . . . 29.76 108.272 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.448 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -85.42 165.34 17.27 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.158 0.98 . . . . 18.26 111.764 -178.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.626 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.2 t -115.08 130.87 23.87 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.2 -1.407 . . . . 8.2 107.2 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 82' ' ' SER . 14.6 Cg_endo -77.03 -165.02 4.2 Favored 'Cis proline' 0 C--N 1.309 -1.522 0 CA-C-O 122.579 0.991 . . . . 7.79 112.328 0.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.534 ' NH1' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -151.03 89.92 1.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.543 -2.021 . . . . 26.05 105.543 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 79' ' ' ILE . 92.9 t -85.48 156.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.639 0.733 . . . . 8.68 111.896 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.6 m-85 -144.06 91.25 2.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.751 -0.593 . . . . 14.07 111.04 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 mm -72.96 114.56 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 106.047 -1.835 . . . . 9.34 106.047 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.74 -154.83 34.76 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.117 -2.793 . . . . 12.42 106.117 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.12 -1.06 51.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.452 -1.616 . . . . 44.86 109.271 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.14 118.66 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.273 -0.892 . . . . 0.0 110.407 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.4 t -75.47 150.15 38.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 72' ' ' VAL . 1.6 pp -114.66 -22.7 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.274 -0.891 . . . . 20.45 109.122 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.5 -128.91 4.48 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.128 -1.189 . . . . 13.82 110.128 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 -137.26 4.24 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.861 -1.296 . . . . 12.42 109.861 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -72.39 -63.99 1.04 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.49 -1.006 . . . . 0.0 110.119 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -53.51 -26.71 21.98 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 110.108 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 4.2 t0 -75.25 -46.43 33.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 27.06 109.199 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.1 tt -53.48 -59.16 4.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 15.31 109.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.25 -51.5 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.443 -0.786 . . . . 0.0 110.758 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -47.11 -39.12 12.68 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.903 -1.123 . . . . 21.79 109.203 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 mt -78.98 -41.8 28.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.495 -0.753 . . . . 0.0 112.124 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -57.24 13.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.579 -1.325 . . . . 0.0 110.625 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.2 -26.22 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.939 -1.101 . . . . 0.0 109.516 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.4 m -80.34 -21.29 42.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.7 -9.96 74.06 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.331 -1.107 . . . . 25.64 110.331 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -68.36 -29.19 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.003 -1.293 . . . . 50.26 108.397 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.9 tp -61.21 -63.87 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 24.17 110.792 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -52.68 -30.95 34.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -65.15 -49.26 70.54 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.148 -1.056 . . . . 28.03 108.148 178.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -55.86 -36.15 67.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.574 -1.269 . . . . 40.96 107.574 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.86 -37.34 67.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.664 -0.865 . . . . 15.05 108.664 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.11 -55.06 20.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.642 . . . . 0.0 111.566 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -48.84 -33.93 11.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.85 -1.156 . . . . 38.64 110.751 -178.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.95 -14.78 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.823 -1.173 . . . . 0.0 109.04 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.3 8.76 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.418 -1.073 . . . . 18.54 110.418 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.78 -19.14 29.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.279 . . . . 10.84 109.855 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -94.67 -175.42 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.711 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.626 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.476 -0.564 . . . . 18.33 109.476 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.34 -70.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 29.77 109.405 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.43 -11.76 4.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.757 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -62.18 -73.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 20.03 110.447 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 HD22 ' A' ' 6' ' ' ASN . 2.4 m -73.31 -37.4 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 12.91 110.059 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.49 HD22 HG23 ' A' ' 5' ' ' VAL . 1.9 m120 -55.89 -37.09 68.39 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.106 -0.996 . . . . 28.33 109.582 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.2 m -74.5 -12.85 60.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -97.54 -44.33 6.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 22.87 110.755 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -78.33 137.66 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.821 -1.175 . . . . 25.19 109.611 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -147.83 137.83 12.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.331 -0.988 . . . . 34.61 108.331 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -51.66 129.21 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.067 1.178 . . . . 11.72 109.671 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 80.55 24.02 59.37 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.22 -1.552 . . . . 10.24 109.22 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -141.5 137.66 32.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -1.068 . . . . 25.36 109.402 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.53 137.28 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 10.89 109.843 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.62 144.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.224 -1.028 . . . . 15.82 108.224 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 18' ' ' ILE . 47.1 t -129.11 123.55 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 8.94 111.132 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -90.73 122.61 33.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.533 -1.284 . . . . 9.93 107.533 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' PRO . 18.7 pt -130.97 -170.67 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.337 1.065 . . . . 10.62 110.893 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 21' ' ' THR . 15.6 mtmm -149.24 91.16 4.54 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 105.983 -1.858 . . . . 38.73 105.983 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.3 Cg_exo -47.26 75.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.776 1.651 . . . . 24.58 111.004 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 19' ' ' LYS . 21.9 m -170.74 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.089 -0.708 . . . . 34.82 109.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.0 133.61 23.02 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.229 -0.92 . . . . 21.46 110.076 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.53 -24.96 77.14 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 122.156 1.904 . . . . 13.86 111.854 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -70.6 -37.94 73.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.867 -1.146 . . . . 0.0 109.242 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -39.87 91.83 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -61.63 -40.79 96.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.015 -0.735 . . . . 59.59 109.015 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.05 -47.43 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.13 74.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.181 -0.949 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -71.61 -44.66 64.03 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 45.49 110.038 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.8 mm-40 -70.19 -34.47 72.99 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.499 -0.751 . . . . 34.97 110.979 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -78.65 -57.43 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.782 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 35' ' ' LEU . 2.8 mt -60.55 -20.43 60.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.625 -1.297 . . . . 17.28 110.086 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.542 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.6 p -65.34 -26.49 68.05 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.049 -1.032 . . . . 24.11 109.026 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.617 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -90.45 4.57 50.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 44.07 110.616 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 32' ' ' LEU . 18.3 mt -91.45 128.51 46.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.776 -1.203 . . . . 19.63 109.638 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.35 65.37 0.72 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.872 1.714 . . . . 21.54 110.021 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.2 mm -78.88 153.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.291 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.0 mmmt -55.6 -169.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 29.41 109.424 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.581 ' O ' ' O ' ' A' ' 38' ' ' LYS . 23.3 mm-40 -52.5 -129.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.445 -0.784 . . . . 0.0 111.086 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.53 48.57 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.834 -0.906 . . . . 15.27 110.834 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -97.68 -18.84 18.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.18 -1.188 . . . . 8.78 109.344 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -107.4 130.09 54.85 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.585 -0.894 . . . . 7.13 108.585 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -141.72 166.85 23.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 22.03 110.515 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -127.68 109.79 12.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.314 -1.365 . . . . 16.33 107.314 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -95.04 107.79 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 6.58 111.36 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' HD11 ' A' ' 18' ' ' ILE . 69.9 m-20 -81.65 101.79 10.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.269 -1.012 . . . . 15.32 108.269 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.6 pt -63.33 -5.62 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 10.92 110.905 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 t -93.54 -13.59 27.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.845 -1.159 . . . . 21.72 109.405 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.93 11.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 22.45 109.443 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.5 t -142.63 -12.3 0.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 25.63 110.058 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 50' ' ' THR . 2.6 t-20 82.71 -172.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.42 -0.8 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 57.59 30.27 18.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.126 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.2 p -45.02 -58.65 3.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 18.87 109.94 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.6 m120 -53.78 -33.94 57.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 45.21 110.712 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -63.62 -45.94 87.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.754 -1.216 . . . . 33.02 109.534 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.23 -52.67 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 9.84 109.451 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.1 mt-30 -57.27 -40.56 77.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.67 -1.233 . . . . 17.84 107.67 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.71 -32.99 63.79 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.157 -1.423 . . . . 18.84 107.157 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -77.7 -46.37 22.08 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.934 -0.765 . . . . 12.99 108.934 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.76 -36.88 65.32 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.09 -1.078 . . . . 14.61 108.09 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.3 tp-100 -59.47 -52.57 65.03 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.759 -0.83 . . . . 40.45 108.759 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.73 -44.14 78.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 41.81 110.218 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.8 tp -64.1 -42.23 96.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 21.77 110.13 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.614 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 4.6 p -114.05 -74.02 0.64 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.438 -0.788 . . . . 11.38 109.702 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 157.8 -38.89 0.54 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.716 -1.354 . . . . 14.79 109.716 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.43 133.44 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -1.194 . . . . 17.81 110.208 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.9 21.65 14.29 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.885 -0.783 . . . . 29.76 108.885 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.88 171.57 15.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.529 -0.732 . . . . 18.26 110.316 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.49 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 19.4 t -116.26 138.39 24.23 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.636 -0.875 . . . . 8.2 108.636 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HB3' HG22 ' A' ' 18' ' ' ILE . 14.8 Cg_endo -81.68 -167.75 6.06 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 124.854 -0.894 . . . . 7.79 110.95 -1.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.0 92.98 2.54 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.966 -1.865 . . . . 26.05 105.966 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 85' ' ' LEU . 62.2 t -84.21 155.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.731 0.777 . . . . 8.68 111.691 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 72' ' ' VAL . 61.2 m-85 -143.03 88.51 2.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.861 -0.525 . . . . 14.07 110.639 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.29 109.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.987 -1.857 . . . . 9.34 105.987 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.76 51.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 106.792 -2.523 . . . . 12.42 106.792 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -86.12 -5.3 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.538 -1.566 . . . . 44.86 109.152 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB3' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -89.04 116.42 27.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -72.31 152.76 41.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.33 -23.37 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 20.45 109.702 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.8 -148.76 19.53 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.747 -1.341 . . . . 13.82 109.747 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.535 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -102.12 -148.65 21.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.945 -1.262 . . . . 12.42 109.945 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -70.66 -58.23 3.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -1.108 . . . . 0.0 109.555 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 t -53.19 -27.2 20.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.1 m-20 -73.66 -45.72 50.86 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 27.06 108.817 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -56.26 -60.9 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.539 -0.726 . . . . 15.31 109.952 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.66 -48.03 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.318 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.3 m -49.71 -45.92 49.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.704 -1.247 . . . . 21.79 109.494 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 mt -70.6 -38.65 74.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.452 ' NE2' HD23 ' A' ' 94' ' ' LEU . 12.4 tp60 -60.4 -58.51 8.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.176 -0.953 . . . . 0.0 110.489 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.89 -25.88 67.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.029 -1.044 . . . . 0.0 109.308 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.79 -15.32 52.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.486 -0.759 . . . . 0.0 109.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.69 -7.41 62.18 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.673 -1.371 . . . . 25.64 109.673 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.83 -27.92 66.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.203 -1.175 . . . . 50.26 109.016 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD23 ' NE2' ' A' ' 89' ' ' GLN . 30.0 tp -59.22 -63.76 1.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -0.847 . . . . 24.17 110.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.95 -30.24 45.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.502 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -63.55 -43.43 97.11 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.068 -1.086 . . . . 28.03 108.068 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.443 HH21 ' HB3' ' A' ' 77' ' ' ASP . 2.0 tpt180 -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.32 -0.992 . . . . 40.96 108.32 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 mp -71.62 -37.88 70.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.425 -0.797 . . . . 15.05 109.204 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.18 -56.81 12.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.583 -0.698 . . . . 0.0 111.856 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -46.82 -27.51 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.794 -1.191 . . . . 38.64 110.264 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.71 -17.81 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.03 -1.044 . . . . 0.0 109.723 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.86 39.37 13.68 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.25 -1.14 . . . . 18.54 110.25 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 -10.19 58.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -1.178 . . . . 10.84 109.638 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' H ' HD23 ' A' ' 104' ' ' LEU . 1.3 pt? -95.25 -176.98 3.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 109.964 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.597 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.622 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.375 -0.602 . . . . 18.33 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.39 -74.36 0.34 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 29.77 108.919 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -58.59 -10.48 2.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.76 . . . . 0.0 109.098 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.25 -68.76 0.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.787 . . . . 20.03 110.678 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -72.94 -38.49 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.134 -0.979 . . . . 12.91 110.289 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 7.5 m120 -55.1 -37.28 66.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.061 -1.024 . . . . 28.33 109.379 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 m -74.97 -12.7 60.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.743 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -97.16 -45.77 6.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 22.87 110.753 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.16 134.45 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.908 -1.12 . . . . 25.19 109.391 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -147.61 149.61 34.39 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 34.61 109.186 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.18 126.17 21.25 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.421 1.414 . . . . 11.72 110.024 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.7 21.34 61.93 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.607 -1.397 . . . . 10.24 109.607 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -137.64 134.01 34.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -1.058 . . . . 25.36 109.272 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.6 137.51 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.18 -0.95 . . . . 10.89 109.617 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.19 147.13 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.211 -1.033 . . . . 15.82 108.211 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.2 t -132.74 122.04 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.932 . . . . 8.94 110.803 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -89.43 126.12 35.43 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.478 -1.304 . . . . 9.93 107.478 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 70' ' ' PRO . 46.5 pt -133.74 -172.18 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.174 0.988 . . . . 10.62 111.319 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.744 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.6 mtmt -147.49 96.31 4.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.747 -1.575 . . . . 38.73 106.747 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 21' ' ' THR . 11.2 Cg_exo -49.22 66.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.843 1.696 . . . . 24.58 111.147 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 19' ' ' LYS . 16.8 p -162.62 -35.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.984 -0.747 . . . . 34.82 108.984 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.13 128.47 35.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 21.46 110.072 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.25 -14.78 40.42 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 122.12 1.88 . . . . 13.86 111.996 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -70.54 -43.14 70.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.691 -1.256 . . . . 0.0 109.798 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -31.19 71.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.351 -0.843 . . . . 0.0 109.55 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.82 -47.74 83.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 59.59 109.544 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.664 HH11 ' HG3' ' A' ' 27' ' ' ARG . 2.4 mmm-85 -51.08 -41.29 59.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 0.0 108.803 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.33 82.75 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -71.57 -46.1 60.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 45.49 109.663 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 97.3 mt-10 -68.83 -34.6 75.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.518 -0.738 . . . . 34.97 110.916 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -76.8 -56.64 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.741 -1.225 . . . . 0.0 110.045 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.638 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -58.51 -20.85 49.49 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.667 -1.271 . . . . 17.28 109.14 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.428 ' HB2' HE22 ' A' ' 34' ' ' GLN . 8.9 m -65.22 -30.44 71.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.25 -0.906 . . . . 24.11 108.78 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.519 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -88.65 3.32 51.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 44.07 110.262 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 35' ' ' LEU . 18.1 mt -91.87 127.77 48.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.826 -1.171 . . . . 19.63 109.432 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.05 63.55 0.31 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.866 1.711 . . . . 21.54 110.485 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.1 mm -80.25 147.19 6.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.2 mttp -53.46 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 29.41 110.342 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.595 ' O ' ' O ' ' A' ' 38' ' ' LYS . 33.1 mt-30 -49.81 -128.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 111.435 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.53 47.75 0.08 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.87 -0.892 . . . . 15.27 110.87 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -101.24 -15.33 17.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -1.207 . . . . 8.78 109.193 179.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 37' ' ' ILE . 47.4 tp -110.18 128.73 55.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.404 -0.962 . . . . 7.13 108.404 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.1 tt0 -141.32 169.8 16.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.067 . . . . 22.03 110.317 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.476 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.0 m-85 -133.12 112.87 12.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.048 -1.093 . . . . 16.33 108.048 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -95.9 102.09 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 6.58 111.149 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 2.7 m-20 -80.19 100.2 8.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.234 -1.024 . . . . 15.32 108.234 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 pt -62.45 -0.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 10.92 110.196 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' ASP . 33.9 p -95.6 -27.03 15.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 21.72 109.597 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.48 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 22.45 109.484 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.477 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 14.7 t -145.17 -3.27 0.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 25.63 110.164 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.707 HD21 ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 67.89 -162.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.048 -1.032 . . . . 0.0 108.526 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' HD21 ' A' ' 51' ' ' ASN . 20.1 m170 56.56 11.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.685 -1.26 . . . . 0.0 108.141 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -35.75 -69.22 0.11 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 18.87 111.36 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.1 m-20 -53.04 -31.28 40.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.062 -1.024 . . . . 45.21 110.895 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.8 -46.21 79.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.782 -1.199 . . . . 33.02 109.912 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.86 -52.3 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.748 -1.22 . . . . 9.84 109.68 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.89 -41.64 82.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.63 -1.248 . . . . 17.84 107.63 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 9.9 m-20 -55.66 -34.23 64.8 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.279 -1.378 . . . . 18.84 107.279 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 1' ' ' ALA . 58.8 t80 -78.15 -50.31 12.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.84 -0.744 . . . . 12.99 109.204 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.5 mt -52.42 -33.07 42.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.164 -1.05 . . . . 14.61 108.164 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.2 tp60 -60.42 -56.59 19.61 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.656 -0.653 . . . . 40.45 109.302 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -65.69 -41.19 92.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 41.81 109.867 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -65.72 -37.22 85.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 21.77 109.815 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.835 HG21 HH11 ' A' ' 71' ' ' ARG . 6.5 p -113.23 -63.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 11.38 109.555 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 61' ' ' GLN . . . 144.83 -49.21 0.69 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.007 -1.637 . . . . 14.79 109.007 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.22 44.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.047 . . . . 17.81 109.958 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.32 36.12 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.519 -0.919 . . . . 29.76 108.519 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.41 169.52 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.547 -0.721 . . . . 18.26 110.226 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 3.3 t -120.81 135.41 24.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.107 -1.072 . . . . 8.2 108.107 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -81.98 -166.22 4.9 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 124.784 -0.923 . . . . 7.79 111.157 -0.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.835 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -143.03 91.18 2.26 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.789 -1.93 . . . . 26.05 105.789 177.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 79' ' ' ILE . 58.1 t -82.09 154.23 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 8.68 111.211 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 72' ' ' VAL . 75.5 m-85 -143.47 88.67 2.02 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.397 -0.521 . . . . 14.07 110.2 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -71.6 101.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.024 -1.843 . . . . 9.34 106.024 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.22 -149.85 39.68 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.345 -2.702 . . . . 12.42 106.345 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 8.4 mtmp? -86.97 -6.78 58.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.568 -1.549 . . . . 44.86 109.474 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' HH21 ' A' ' 97' ' ' ARG . 3.0 m-20 -91.48 121.6 33.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 110.582 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -73.62 155.82 38.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 80' ' ' GLY . 2.8 pp -119.0 -16.61 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.233 -0.917 . . . . 20.45 109.69 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.572 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 136.23 -150.43 20.44 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.081 -1.207 . . . . 13.82 110.081 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.76 -145.3 11.81 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.955 -1.258 . . . . 12.42 109.955 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -70.89 -62.13 1.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.489 -1.007 . . . . 0.0 110.03 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 t -54.23 -26.43 28.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.349 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -73.88 -45.79 48.68 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -0.874 . . . . 27.06 109.007 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.6 tt -54.11 -59.66 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.41 -0.806 . . . . 15.31 109.7 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -54.09 -43.49 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 110.503 -178.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.619 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 18.8 m -55.27 -35.48 65.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 21.79 110.146 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.02 -34.35 32.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 0.0 111.258 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -62.23 -60.57 3.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.004 -1.06 . . . . 0.0 111.124 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.712 ' OE1' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.86 -17.42 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.859 -1.151 . . . . 0.0 109.523 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.544 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 40.4 m -80.26 -62.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.495 -0.753 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.77 4.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.401 -1.479 . . . . 25.64 109.401 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.37 -30.46 69.41 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.271 -1.135 . . . . 50.26 108.952 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.73 -64.18 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 24.17 110.431 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -55.01 -31.4 61.02 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.479 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.61 -45.44 90.34 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.422 -0.955 . . . . 28.03 108.422 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 77' ' ' ASP . 3.1 ttt180 -61.25 -34.99 76.06 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.273 -1.01 . . . . 40.96 108.273 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 102' ' ' GLY . 7.9 mp -70.93 -36.14 72.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.721 -0.844 . . . . 15.05 108.721 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -64.57 -57.5 8.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.782 -0.574 . . . . 0.0 111.346 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 96' ' ' THR . 1.1 pt20 -47.48 -31.72 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.895 -1.128 . . . . 38.64 110.349 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.3 pt -103.86 -11.8 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.995 -1.066 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 73.75 44.51 31.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.507 -1.037 . . . . 18.54 110.507 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.42 -11.86 50.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -1.218 . . . . 10.84 109.484 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.72 -178.11 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 0.0 110.059 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.393 179.81 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.698 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.535 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.563 -0.532 . . . . 18.33 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 10.6 mp0 -132.4 -74.02 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 29.77 109.119 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -58.62 -8.26 1.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.056 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.8 m-85 -62.19 -72.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.391 -0.818 . . . . 20.03 110.248 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.4 m -73.84 -39.62 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 12.91 109.929 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 3.3 m120 -55.6 -37.31 67.94 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 28.33 109.575 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -74.47 -13.02 60.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.97 -48.34 5.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 22.87 110.277 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 128.38 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.974 -1.079 . . . . 25.19 109.869 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -147.85 160.44 38.03 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.56 -0.904 . . . . 34.61 108.56 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.0 129.19 33.17 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.658 1.572 . . . . 11.72 111.165 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.54 29.94 50.82 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.865 -0.894 . . . . 10.24 110.865 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -144.8 136.21 25.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.88 -1.364 . . . . 25.36 110.074 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.24 133.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 10.89 109.38 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.68 144.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.347 -0.983 . . . . 15.82 108.347 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.42 124.46 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 8.94 110.957 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -90.07 121.21 31.92 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.397 -1.334 . . . . 9.93 107.397 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 pt -130.7 -175.57 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.276 1.036 . . . . 10.62 111.2 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.7 ' O ' ' N ' ' A' ' 21' ' ' THR . 18.9 mtmt -148.72 86.59 5.75 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 106.689 -1.597 . . . . 38.73 106.689 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' O ' ' OG1' ' A' ' 21' ' ' THR . 15.6 Cg_exo -44.26 76.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.791 1.661 . . . . 24.58 110.928 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 19' ' ' LYS . 34.2 m -172.02 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.436 -0.95 . . . . 34.82 108.436 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.5 129.62 29.91 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 21.46 109.505 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.74 -19.92 56.08 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 122.085 1.857 . . . . 13.86 112.099 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.679 -1.263 . . . . 0.0 109.551 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -32.95 74.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 108.44 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -62.51 -45.51 92.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 59.59 108.879 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -49.55 -45.2 47.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.12 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.58 84.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.135 -0.978 . . . . 0.0 108.811 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -70.4 -42.57 71.48 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.46 -0.775 . . . . 45.49 109.659 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.37 -36.05 76.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 34.97 111.06 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.638 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -78.77 -56.53 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.837 -1.164 . . . . 0.0 110.497 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD23 HD12 ' A' ' 35' ' ' LEU . 2.5 mt -59.78 -19.91 53.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.576 -1.328 . . . . 17.28 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -65.65 -27.58 68.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.135 -0.978 . . . . 24.11 108.919 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -90.11 3.81 52.24 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.316 -0.865 . . . . 44.07 110.431 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.712 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -92.49 125.86 54.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.824 -1.172 . . . . 19.63 109.805 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.98 67.72 0.92 Allowed 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.802 1.668 . . . . 21.54 109.893 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 mm -79.43 150.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.7 mtpm? -54.19 -171.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.366 -0.834 . . . . 29.41 110.192 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' LYS . 16.7 mt-30 -50.78 -131.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.617 0.722 . . . . 0.0 111.447 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.14 49.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.242 -0.911 . . . . 15.27 110.933 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.8 -17.51 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -1.074 . . . . 8.78 109.383 179.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.0 tp -107.88 130.9 54.97 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.48 -0.933 . . . . 7.13 108.48 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -141.58 169.27 17.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -0.988 . . . . 22.03 110.418 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -131.92 109.96 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.606 -1.257 . . . . 16.33 107.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.0 t -94.67 104.01 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 6.58 111.186 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -80.71 101.34 9.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.782 -0.822 . . . . 15.32 108.782 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 pt -63.59 -7.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 10.92 110.198 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -100.49 46.93 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 21.72 108.804 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.03 20.25 0.31 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.025 -0.732 . . . . 22.45 109.025 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 9.0 t -144.51 -5.22 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 25.63 109.513 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 50' ' ' THR . 4.2 t-20 81.38 177.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.38 27.13 11.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.106 -0.997 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.14 -60.69 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 18.87 110.41 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 81.6 m-20 -57.47 -29.51 64.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 45.21 111.022 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.13 -43.95 93.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.724 -1.235 . . . . 33.02 109.747 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -66.1 -53.67 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 9.84 109.431 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.43 -43.17 83.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.839 -1.171 . . . . 17.84 107.839 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 26.3 m-20 -54.9 -34.93 63.58 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.345 -1.354 . . . . 18.84 107.345 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 1' ' ' ALA . 55.2 t80 -78.76 -47.3 17.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.878 -0.729 . . . . 12.99 109.245 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.76 -32.77 53.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.213 -1.032 . . . . 14.61 108.213 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.721 HE22 ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -59.49 -55.59 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.879 -0.785 . . . . 40.45 108.879 179.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -67.45 -35.5 79.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.181 -0.95 . . . . 41.81 110.109 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 73' ' ' PHE . 29.3 tp -64.88 -46.42 81.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.1 -1.0 . . . . 21.77 109.91 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.525 HG21 HH11 ' A' ' 71' ' ' ARG . 1.4 p -110.06 -58.5 2.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.47 -0.769 . . . . 11.38 109.481 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 150.01 -52.46 0.52 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.573 -1.411 . . . . 14.79 109.573 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 138.28 35.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -1.093 . . . . 17.81 110.261 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.721 ' N ' HE22 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -95.59 32.28 1.85 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.459 -0.941 . . . . 29.76 108.459 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 165.79 22.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 18.26 110.207 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 4.9 t -116.79 138.35 24.54 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.056 -1.09 . . . . 8.2 108.056 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -80.66 -168.13 6.53 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 124.8 -0.917 . . . . 7.79 111.361 -0.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.549 ' NH1' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.68 90.75 2.03 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.852 -1.907 . . . . 26.05 105.852 177.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.566 HG21 HD12 ' A' ' 85' ' ' LEU . 74.0 t -83.23 155.58 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.737 0.779 . . . . 8.68 111.551 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CE2' HD23 ' A' ' 63' ' ' LEU . 79.6 m-85 -144.12 89.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.818 -0.551 . . . . 14.07 110.921 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -71.72 110.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.084 -1.821 . . . . 9.34 106.084 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.66 -153.34 52.5 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.729 -2.548 . . . . 12.42 106.729 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -84.15 -3.74 58.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.564 -1.551 . . . . 44.86 109.41 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' HH21 ' A' ' 97' ' ' ARG . 1.2 m-20 -90.05 118.37 29.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.937 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -72.68 152.26 41.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.031 -1.043 . . . . 0.0 109.416 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -113.87 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -0.969 . . . . 20.45 109.336 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' HA2' HH22 ' A' ' 71' ' ' ARG . . . 132.51 -155.96 21.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.124 -1.19 . . . . 13.82 110.124 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.95 -147.16 22.25 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.201 -1.16 . . . . 12.42 110.201 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -70.56 -60.2 2.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.526 -0.985 . . . . 0.0 109.867 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 t -52.43 -25.84 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.286 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.19 -49.08 25.05 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.801 . . . . 27.06 109.333 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.5 tt -54.7 -59.23 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 15.31 110.145 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.16 -45.41 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.105 -178.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 -47.47 66.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.736 -1.228 . . . . 21.79 109.492 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.23 -36.54 77.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.903 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -60.77 -59.18 5.79 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 110.478 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -62.53 -24.19 67.37 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.432 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -82.55 -16.52 48.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.464 -0.773 . . . . 0.0 109.813 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 -9.88 56.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.819 -1.313 . . . . 25.64 109.819 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -67.7 -28.18 67.45 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -1.174 . . . . 50.26 108.809 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.32 -65.7 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 24.17 110.084 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.24 -30.38 37.78 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.449 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -62.86 -44.68 95.46 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.465 -0.939 . . . . 28.03 108.465 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.707 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -63.06 -34.11 76.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.662 -0.866 . . . . 40.96 108.662 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.6 mp -71.11 -35.68 71.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 15.05 109.023 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -65.11 -56.9 10.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.608 -0.683 . . . . 0.0 111.574 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -46.01 -31.09 2.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 38.64 110.395 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.4 pt -104.45 -14.44 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.86 40.5 21.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.304 -1.118 . . . . 18.54 110.304 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.42 -8.06 59.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.239 . . . . 10.84 109.474 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.639 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.18 -178.99 4.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.561 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.685 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.485 -0.561 . . . . 18.33 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 4' ' ' PHE . 66.7 mt-30 53.82 -99.14 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 29.77 110.037 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.97 -7.46 0.48 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 109.718 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.5 m-85 -62.17 -69.16 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 20.03 110.432 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 6' ' ' ASN . 2.5 m -73.51 -40.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 12.91 110.443 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 5' ' ' VAL . 68.4 m-80 -55.21 -29.94 58.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.067 -1.021 . . . . 28.33 109.497 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 m -75.29 -18.44 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -98.1 -44.03 6.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 22.87 111.212 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.26 129.18 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.174 . . . . 25.19 110.585 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.05 158.4 38.91 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.151 -1.055 . . . . 34.61 108.151 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.0 127.95 27.9 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.544 1.496 . . . . 11.72 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.12 28.16 46.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.753 -0.939 . . . . 10.24 110.753 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -143.14 136.88 28.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.969 -1.313 . . . . 25.36 109.933 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.79 134.4 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.386 -0.821 . . . . 10.89 109.392 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.15 143.0 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.437 -0.949 . . . . 15.82 108.437 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.7 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.405 -0.809 . . . . 8.94 110.739 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.62 122.74 33.04 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.487 -1.301 . . . . 9.93 107.487 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.6 pt -132.11 -174.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.104 0.954 . . . . 10.62 111.224 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mtmt -145.77 94.63 5.03 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.585 -1.635 . . . . 38.73 106.585 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.0 Cg_exo -46.49 82.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.561 1.508 . . . . 24.58 110.945 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 19' ' ' LYS . 14.7 m 178.95 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 34.82 108.41 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.96 121.88 54.42 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 21.46 109.711 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.04 -17.57 45.75 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.724 1.616 . . . . 13.86 111.778 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -68.87 -42.63 76.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.563 -1.335 . . . . 0.0 108.291 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -36.73 83.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -61.15 -39.37 89.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.8 -1.185 . . . . 59.59 107.8 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -53.69 -47.15 70.74 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.42 74.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.407 -0.808 . . . . 0.0 108.865 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 33' ' ' SER . 5.4 mt-30 -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.338 -0.852 . . . . 45.49 109.745 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' A' ' 33' ' ' SER . 41.3 mm-40 -69.82 -34.17 73.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 34.97 111.029 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.48 -55.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 35' ' ' LEU . 1.5 mt -59.25 -24.13 62.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.671 -1.268 . . . . 17.28 109.696 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 1.2 p -63.85 -22.22 66.81 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.289 -1.004 . . . . 24.11 108.289 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -90.09 0.43 57.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.527 -0.733 . . . . 44.07 109.862 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 32' ' ' LEU . 18.9 mt -92.96 127.45 47.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 19.63 109.656 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.0 66.65 0.58 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.644 1.562 . . . . 21.54 109.777 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -80.07 148.15 6.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.9 mttp -54.55 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -0.826 . . . . 29.41 110.272 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 38' ' ' LYS . 17.0 mt-30 -51.1 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.641 0.734 . . . . 0.0 111.191 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.24 48.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.924 -0.87 . . . . 15.27 110.924 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -99.8 -17.36 17.71 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.129 -1.218 . . . . 8.78 109.137 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' A' ' 37' ' ' ILE . 54.1 tp -108.55 126.92 53.46 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.967 -1.123 . . . . 7.13 107.967 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 23.2 tp10 -139.59 163.67 31.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.993 -1.067 . . . . 22.03 110.253 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.9 m-85 -126.32 110.84 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.677 -1.231 . . . . 16.33 107.677 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.61 107.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 6.58 111.235 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' THR . 4.7 m-20 -82.59 99.61 9.65 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.469 -0.937 . . . . 15.32 108.469 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.2 pt -62.03 5.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 10.92 110.61 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . 16.9 p -97.22 -25.53 15.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.089 -1.007 . . . . 21.72 109.812 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.91 23.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 22.45 109.943 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.575 ' C ' HD22 ' A' ' 51' ' ' ASN . 12.0 t -146.74 0.6 0.76 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.967 -1.083 . . . . 25.63 110.489 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.575 HD22 ' C ' ' A' ' 50' ' ' THR . 2.2 m-80 66.45 -177.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.227 -0.921 . . . . 0.0 109.245 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER 56.58 29.92 16.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 108.8 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.85 -56.69 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 18.87 110.002 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 68.8 m-20 -57.02 -31.4 65.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 45.21 111.0 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.5 -45.13 92.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.752 -1.218 . . . . 33.02 109.739 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.3 mp -66.86 -53.98 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.869 -1.144 . . . . 9.84 109.677 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.26 -40.67 78.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.723 -1.214 . . . . 17.84 107.723 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 61.2 m-20 -54.96 -33.73 62.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.037 -1.468 . . . . 18.84 107.037 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -78.86 -48.72 14.15 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.058 -0.719 . . . . 12.99 109.058 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.3 mt -53.96 -33.21 56.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.141 -1.059 . . . . 14.61 108.141 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 67' ' ' ARG . 6.9 tp60 -60.58 -57.68 11.68 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.165 -0.68 . . . . 40.45 109.165 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.09 -36.22 81.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.359 -0.838 . . . . 41.81 110.023 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 tp -65.38 -49.17 70.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.094 -1.004 . . . . 21.77 109.704 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 2.2 p -109.05 -67.2 1.0 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.74 . . . . 11.38 109.563 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 161.33 -49.07 0.36 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.258 -1.449 . . . . 14.79 110.874 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.849 ' HB3' HH12 ' A' ' 71' ' ' ARG . . . -97.81 136.95 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.304 . . . . 17.81 110.771 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -93.58 25.21 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.253 -1.388 . . . . 29.76 107.253 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.579 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -79.15 169.42 18.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.665 0.745 . . . . 18.26 110.254 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 2.9 t -120.0 135.09 24.1 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.02 -1.104 . . . . 8.2 108.02 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -83.72 -164.69 3.61 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 124.868 -0.888 . . . . 7.79 110.797 -0.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.849 HH12 ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -152.41 93.47 1.8 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.036 -2.209 . . . . 26.05 105.036 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 73' ' ' PHE . 65.7 t -82.5 160.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.859 0.838 . . . . 8.68 111.971 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.536 ' N ' HG12 ' A' ' 72' ' ' VAL . 83.9 m-85 -144.47 91.83 2.23 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 116.174 -0.467 . . . . 14.07 110.584 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 98' ' ' LEU . 8.3 mm -71.73 104.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.881 -1.896 . . . . 9.34 105.881 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.32 -149.64 51.11 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 106.101 -2.8 . . . . 12.42 106.101 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -84.77 -1.17 55.97 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.489 -1.595 . . . . 44.86 109.245 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' OD2' ' NH2' ' A' ' 97' ' ' ARG . 85.2 m-20 -89.5 111.76 22.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -72.97 147.67 44.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.89 -21.13 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.289 -0.882 . . . . 20.45 108.983 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.12 -149.42 18.87 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.18 -1.168 . . . . 13.82 110.18 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -107.52 -140.66 9.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.405 -1.078 . . . . 12.42 110.405 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 86' ' ' VAL . 11.0 p -70.06 -65.61 0.7 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.729 -0.865 . . . . 0.0 110.334 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -50.83 -27.9 8.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.821 . . . . 0.0 109.692 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -73.92 -49.47 24.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.354 -0.841 . . . . 27.06 109.345 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.0 tt -56.01 -60.09 3.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 15.31 110.411 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -48.59 -47.17 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 -178.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 t -49.46 -46.34 47.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.791 -1.193 . . . . 21.79 109.444 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.22 -39.11 75.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.878 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -60.58 -58.39 8.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.894 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.63 -24.75 65.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 0.0 109.102 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -79.97 -43.78 21.43 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.653 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.69 -9.96 30.14 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.393 -1.483 . . . . 25.64 109.393 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.58 -26.06 65.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -1.082 . . . . 50.26 108.911 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.52 -64.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 24.17 110.212 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.24 -30.82 40.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.5 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.32 -44.09 95.94 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.974 -1.121 . . . . 28.03 107.974 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.511 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 8.9 tpt180 -61.27 -35.49 77.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.411 -0.959 . . . . 40.96 108.411 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.6 mp -70.6 -38.93 74.04 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.857 0.837 . . . . 15.05 108.82 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -65.55 -53.81 36.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.824 -0.548 . . . . 0.0 112.033 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -48.31 -32.17 7.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.78 -1.2 . . . . 38.64 110.42 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.2 pt -103.83 -14.4 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.572 ' O ' ' NZ ' ' A' ' 38' ' ' LYS . . . 78.99 45.4 9.06 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.283 -1.127 . . . . 18.54 110.283 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.56 -11.81 53.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -1.121 . . . . 10.84 109.187 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.57 -177.85 4.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.14 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.599 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.669 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.495 -0.557 . . . . 18.33 109.495 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 4' ' ' PHE . 25.1 tt0 51.54 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 29.77 110.138 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 1' ' ' ALA . 38.4 mt-10 -54.51 -11.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.051 -1.031 . . . . 0.0 109.163 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.3 m-85 -63.67 -69.49 0.27 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.476 -0.765 . . . . 20.03 110.619 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.64 -39.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 12.91 110.169 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.1 m-20 -55.75 -37.98 69.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.212 -0.93 . . . . 28.33 109.271 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -74.94 -12.03 60.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -97.21 -45.33 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.219 -0.925 . . . . 22.87 110.721 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.451 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.54 138.95 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.788 -1.195 . . . . 25.19 110.029 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.27 136.77 11.21 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 107.947 -1.131 . . . . 34.61 107.947 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -50.02 131.51 30.51 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 120.997 1.131 . . . . 11.72 109.699 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 20.64 70.06 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.209 -1.556 . . . . 10.24 109.209 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -137.82 132.98 33.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -1.06 . . . . 25.36 109.013 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.32 135.5 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.154 -0.966 . . . . 10.89 109.754 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.3 142.86 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.268 -1.012 . . . . 15.82 108.268 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 18' ' ' ILE . 39.0 t -124.86 128.07 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 8.94 111.201 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -94.74 114.69 26.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.352 -0.981 . . . . 9.93 108.352 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 25' ' ' SER . 41.6 pt -125.74 -172.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.537 1.161 . . . . 10.62 111.587 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -145.89 94.65 4.98 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 105.481 -2.044 . . . . 38.73 105.481 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.1 Cg_exo -49.21 79.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.392 1.394 . . . . 24.58 111.06 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.607 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.8 m -177.59 -32.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.539 -0.726 . . . . 34.82 109.442 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.77 124.68 45.09 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 21.46 109.6 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.78 -17.63 23.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.382 2.054 . . . . 13.86 113.164 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CG ' HG12 ' A' ' 106' ' ' GSH . 26.4 m-85 -69.91 -49.71 49.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.269 -1.52 . . . . 0.0 109.391 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -59.96 -33.08 71.45 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -61.13 -42.67 98.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.815 -0.809 . . . . 59.59 108.815 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 1.1 mtt-85 -54.52 -47.81 72.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.008 -1.058 . . . . 0.0 108.754 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 mt-30 -70.07 -41.81 73.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.36 -0.837 . . . . 45.49 109.435 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 42.5 mt-10 -72.19 -38.74 68.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.565 -0.709 . . . . 34.97 111.461 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -74.19 -55.69 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.813 -1.18 . . . . 0.0 110.093 -178.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.63 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -60.02 -20.08 56.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.538 -1.351 . . . . 17.28 109.649 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 29' ' ' GLN . 4.1 m -65.73 -30.2 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.103 -0.998 . . . . 24.11 109.539 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 30' ' ' GLU . 2.9 mp0 -93.85 4.93 53.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 44.07 110.902 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' OE1' ' A' ' 89' ' ' GLN . 21.6 mt -88.35 132.18 40.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.767 -1.208 . . . . 19.63 108.604 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.85 62.52 0.59 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.577 1.518 . . . . 21.54 110.258 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.3 mm -78.32 146.94 7.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.032 -1.043 . . . . 0.0 108.225 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 39' ' ' GLN . 18.6 mtpt -53.65 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.062 -1.024 . . . . 29.41 109.944 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 41' ' ' LEU . 26.9 mt-30 -52.29 -127.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.691 0.758 . . . . 0.0 112.363 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.81 48.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.102 -0.799 . . . . 15.27 111.102 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -99.66 -33.04 10.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.263 -1.14 . . . . 8.78 108.81 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.6 tp -94.42 132.81 38.67 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.466 0.65 . . . . 7.13 109.446 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 2.6 tp10 -142.01 174.05 10.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 22.03 109.515 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.463 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 46.7 m-85 -136.63 112.02 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.196 -1.409 . . . . 16.33 107.196 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.31 104.01 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 6.58 111.775 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 2.6 m-20 -82.68 97.62 8.63 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.603 -0.888 . . . . 15.32 108.603 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.5 pt -61.53 1.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 10.92 110.499 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 46' ' ' ASP . 18.1 p -93.61 -17.26 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.027 -1.046 . . . . 21.72 108.635 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.67 7.27 5.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.49 -0.756 . . . . 22.45 109.546 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.0 t -142.31 -3.99 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 25.63 110.009 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' C ' ' N ' ' A' ' 53' ' ' THR . 8.7 t30 66.55 -151.73 0.21 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 51.24 13.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.667 -1.271 . . . . 0.0 108.631 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 51' ' ' ASN . 4.3 p -41.59 -55.95 2.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.79 . . . . 18.87 110.733 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.9 m120 -52.31 -36.81 54.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 45.21 110.503 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -65.92 -45.01 83.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.06 . . . . 33.02 109.493 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -67.35 -52.55 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 9.84 109.563 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 2.8 mt-30 -56.2 -43.74 78.78 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.231 -1.396 . . . . 17.84 107.231 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -55.5 -34.51 64.67 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.85 -1.537 . . . . 18.84 106.85 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -78.71 -48.81 14.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 120.245 -0.582 . . . . 12.99 109.506 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -51.95 -34.35 41.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.924 -1.139 . . . . 14.61 107.924 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' OE1' ' NH2' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -61.16 -58.2 9.32 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.304 0.573 . . . . 40.45 109.768 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -68.47 -35.65 77.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.177 -0.952 . . . . 41.81 110.861 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.94 -48.24 77.3 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 21.77 110.107 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -113.08 -61.79 1.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 11.38 109.423 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 160.9 -56.75 0.31 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.647 -1.381 . . . . 14.79 109.647 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -99.07 143.58 29.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -1.116 . . . . 17.81 109.296 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -108.95 20.85 17.96 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.026 -1.102 . . . . 29.76 108.026 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.424 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.2 OUTLIER -68.01 165.63 17.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.346 -0.846 . . . . 18.26 109.524 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 2.6 t -105.6 131.08 22.06 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 8.2 108.859 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 82' ' ' SER . 33.5 Cg_endo -84.65 -165.96 4.15 Favored 'Cis proline' 0 C--N 1.309 -1.548 0 CA-C-O 122.521 0.967 . . . . 7.79 111.674 -1.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.579 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 7.1 tpp180 -152.73 92.48 1.66 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.794 -2.299 . . . . 26.05 104.794 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 95.3 t -81.62 157.4 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.782 0.801 . . . . 8.68 112.021 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.8 m-85 -139.81 88.45 2.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.718 -0.614 . . . . 14.07 111.297 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mm -71.93 113.88 9.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.921 -2.252 . . . . 9.34 104.921 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.2 -154.52 29.18 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.796 -2.922 . . . . 12.42 105.796 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -83.01 0.34 45.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.218 -1.754 . . . . 44.86 108.622 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.46 110.01 19.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 t -74.35 142.33 45.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.675 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 1.9 pt -107.2 -22.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.979 -1.076 . . . . 20.45 109.166 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.28 19.05 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.212 -1.155 . . . . 13.82 110.212 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.79 -145.25 15.3 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.198 -1.161 . . . . 12.42 110.198 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.6 t -71.8 -60.53 2.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 t -51.38 -24.2 4.56 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.428 0.632 . . . . 0.0 109.483 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 3.5 t70 -76.73 -51.4 11.52 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.808 . . . . 27.06 109.394 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.2 tt -51.27 -58.91 4.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 15.31 109.975 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.2 -54.23 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.551 -0.718 . . . . 0.0 109.865 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' VAL . 74.3 m -44.68 -36.69 3.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.335 -0.853 . . . . 21.79 109.119 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 94' ' ' LEU . 32.3 mt -80.83 -43.49 19.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.493 -0.754 . . . . 0.0 111.409 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.456 ' OE1' HD11 ' A' ' 35' ' ' LEU . 22.9 tp60 -61.01 -56.2 23.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.872 -1.142 . . . . 0.0 111.018 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -59.54 -26.0 64.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.742 -1.224 . . . . 0.0 108.911 -179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.8 m -79.18 -60.82 2.22 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.17 -7.93 6.01 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.061 -1.215 . . . . 25.64 110.061 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -70.12 -26.15 63.83 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.064 -1.256 . . . . 50.26 108.856 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 88' ' ' LEU . 7.3 tp -60.08 -62.34 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.819 . . . . 24.17 110.717 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.12 -28.8 42.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.8 -49.48 68.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.317 -0.994 . . . . 28.03 108.317 178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.436 ' NH1' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.22 -33.39 65.32 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.412 -1.329 . . . . 40.96 107.412 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.51 -41.0 66.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.88 -0.785 . . . . 15.05 108.88 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -64.77 -52.07 58.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.731 -0.605 . . . . 0.0 111.693 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.96 -34.1 27.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.836 -1.165 . . . . 38.64 111.007 -177.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 101' ' ' ILE . 19.9 pt -99.55 -18.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.63 -1.294 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.6 40.95 7.51 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.605 -0.998 . . . . 18.54 110.605 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.75 -10.98 56.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.09 -1.241 . . . . 10.84 109.436 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.692 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.58 178.15 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.417 HE21 ' HG2' ' A' ' 38' ' ' LYS . 7.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.63 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.617 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.558 . . . . 18.33 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -79.31 -66.44 0.87 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 29.77 109.368 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -59.94 -14.32 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.422 -0.799 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -61.27 -75.74 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.178 -0.951 . . . . 20.03 110.483 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -74.24 -36.44 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 12.91 109.818 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.407 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 50.7 m-20 -56.14 -38.23 70.56 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 28.33 109.81 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.3 m -74.1 -12.46 60.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.095 -1.003 . . . . 0.0 109.86 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -97.63 -45.37 6.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 22.87 110.72 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.21 130.67 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.828 -1.17 . . . . 25.19 110.116 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.67 157.21 36.28 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.018 -1.104 . . . . 34.61 108.018 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.89 131.54 46.14 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.897 1.731 . . . . 11.72 111.588 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.74 21.76 68.08 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 120.488 -0.863 . . . . 10.24 111.073 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -140.11 132.76 28.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.972 -1.311 . . . . 25.36 109.415 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.74 133.75 41.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.401 -0.812 . . . . 10.89 109.404 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.93 142.9 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.673 -0.862 . . . . 15.82 108.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 18' ' ' ILE . 28.9 t -125.91 126.8 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 8.94 111.202 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -94.18 116.91 29.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 9.93 107.881 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.8 pt -127.82 -171.93 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 122.635 1.207 . . . . 10.62 111.527 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.5 mtmt -149.32 87.47 5.27 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 105.823 -1.918 . . . . 38.73 105.823 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 21' ' ' THR . 16.7 Cg_exo -47.21 73.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.712 1.608 . . . . 24.58 110.861 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 22.8 p -161.88 -37.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.038 -1.097 . . . . 34.82 108.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.39 129.76 28.47 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 21.46 109.434 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -56.98 -24.55 57.99 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.404 2.07 . . . . 13.86 112.579 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.65 -41.64 87.9 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.38 -1.45 . . . . 0.0 108.76 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.664 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -61.12 -35.06 76.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.72 -1.215 . . . . 59.59 107.72 178.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -54.62 -47.98 72.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 179.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.58 76.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.316 -0.865 . . . . 0.0 108.841 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -70.95 -41.66 70.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.467 -0.771 . . . . 45.49 109.75 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -71.31 -37.33 71.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 34.97 111.281 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -76.46 -58.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 110.525 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -58.51 -22.75 56.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.623 -1.298 . . . . 17.28 109.945 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -64.92 -25.65 67.97 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.049 -1.032 . . . . 24.11 108.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -92.99 -0.82 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.81 . . . . 44.07 110.066 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 35' ' ' LEU . 21.1 mt -87.91 130.9 44.88 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.935 -1.103 . . . . 19.63 108.465 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.23 65.93 1.05 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.766 1.644 . . . . 21.54 110.592 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.6 mm -80.71 147.88 6.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 14.4 mttt -54.82 -166.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 29.41 110.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.642 ' CD ' ' H ' ' A' ' 39' ' ' GLN . 1.7 mp0 -52.63 -131.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.834 0.826 . . . . 0.0 111.983 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.97 49.18 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.537 -1.025 . . . . 15.27 110.537 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -97.51 -30.44 12.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.307 -1.113 . . . . 8.78 108.723 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -95.9 133.83 39.6 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.092 -0.707 . . . . 7.13 109.092 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 22.1 tt0 -142.61 174.3 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 22.03 110.003 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 41.5 m-85 -136.98 110.68 8.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.438 -1.319 . . . . 16.33 107.438 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.11 104.77 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 6.58 111.886 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.8 m-20 -81.44 102.53 10.58 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.512 -0.921 . . . . 15.32 108.512 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.5 pt -64.08 -2.13 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.193 -0.942 . . . . 10.92 111.54 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.25 -17.89 23.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.788 -1.195 . . . . 21.72 108.739 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 13.42 1.74 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.466 -0.771 . . . . 22.45 109.471 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.529 ' C ' HD22 ' A' ' 51' ' ' ASN . 14.5 t -142.81 -0.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 25.63 109.847 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.529 HD22 ' C ' ' A' ' 50' ' ' THR . 3.5 m-80 67.2 -171.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 56.21 31.37 18.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.833 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -53.71 10.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 18.87 109.806 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.2 m120 -54.94 -37.42 66.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 45.21 110.817 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.9 mp0 -62.1 -46.96 86.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.91 -1.119 . . . . 33.02 110.167 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.67 -54.75 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.784 -1.197 . . . . 9.84 110.172 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -56.81 -41.11 77.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.523 -1.36 . . . . 17.84 107.705 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 6.0 m-20 -54.56 -33.93 60.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.959 -1.496 . . . . 18.84 106.959 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -79.67 -48.32 13.9 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.108 -0.637 . . . . 12.99 109.385 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.7 mt -52.69 -33.65 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.047 -1.033 . . . . 14.61 108.283 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 5.5 tp-100 -59.58 -54.85 41.78 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.321 0.581 . . . . 40.45 109.538 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.41 -42.27 83.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 41.81 110.347 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.7 tp -62.6 -47.23 84.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 21.77 110.562 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.2 p -108.94 -63.39 1.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.266 -0.896 . . . . 11.38 109.671 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.02 -38.97 1.02 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.399 -1.481 . . . . 14.79 109.399 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.32 140.29 32.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -1.151 . . . . 17.81 110.012 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' NH1' ' O32' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -106.34 24.79 11.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.504 -0.924 . . . . 29.76 108.504 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.804 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.96 169.32 16.14 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.556 0.693 . . . . 18.26 110.909 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.629 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 10.9 t -110.9 133.36 21.27 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.291 -1.003 . . . . 8.2 108.291 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.6 Cg_endo -86.74 -163.76 2.75 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 CA-C-O 122.617 1.007 . . . . 7.79 111.86 -1.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -145.04 95.72 2.73 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.489 -2.041 . . . . 26.05 105.489 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG21 HD12 ' A' ' 85' ' ' LEU . 94.4 t -85.54 156.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.366 -0.834 . . . . 8.68 111.653 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' N ' HG12 ' A' ' 72' ' ' VAL . 78.4 m-85 -144.74 91.33 2.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.604 -0.685 . . . . 14.07 111.549 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.58 115.37 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.01 -2.218 . . . . 9.34 105.01 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.45 -155.56 18.13 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 105.707 -2.957 . . . . 12.42 105.707 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.76 5.26 16.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.215 -1.756 . . . . 44.86 108.637 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 m-20 -89.52 115.04 26.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.387 -0.821 . . . . 0.0 110.793 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 t -77.41 141.92 39.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.306 -0.871 . . . . 0.0 109.678 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.2 pt -109.64 -17.65 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.163 -0.961 . . . . 20.45 109.197 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.11 -160.19 21.3 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.071 -1.212 . . . . 13.82 110.071 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' CA ' HH21 ' A' ' 71' ' ' ARG . . . -89.26 -148.25 17.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.054 -1.218 . . . . 12.42 110.054 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.55 -60.37 2.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -1.005 . . . . 0.0 110.026 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 t -51.24 -25.38 5.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.192 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.38 -47.91 25.37 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.423 -0.798 . . . . 27.06 109.03 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.0 tt -54.04 -59.41 4.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.457 -0.777 . . . . 15.31 110.015 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -51.19 -51.38 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.371 -0.831 . . . . 0.0 110.309 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 9.0 m -46.82 -34.36 5.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.153 -0.967 . . . . 21.79 108.975 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.24 -38.94 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 111.734 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.417 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.5 OUTLIER -60.21 -59.19 5.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -62.08 -19.21 62.71 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.98 -1.075 . . . . 0.0 109.633 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.0 m -81.49 -45.5 15.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.062 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.77 -11.16 27.65 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.308 -1.117 . . . . 25.64 110.308 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -69.3 -25.5 64.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.279 . . . . 50.26 108.32 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.4 tp -59.91 -67.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.568 0.699 . . . . 24.17 110.848 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -52.32 -29.61 24.33 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -64.63 -46.78 81.1 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.828 -1.175 . . . . 28.03 107.828 178.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.485 ' NH1' HG22 ' A' ' 79' ' ' ILE . 7.1 ttt180 -59.51 -34.12 72.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.897 -1.149 . . . . 40.96 107.897 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . 10.4 mp -70.15 -40.48 74.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.612 -0.884 . . . . 15.05 108.612 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.32 -52.49 46.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.815 -0.553 . . . . 0.0 112.185 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -49.76 -29.34 7.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.691 -1.255 . . . . 38.64 110.926 -177.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.0 pt -102.7 -22.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.731 -1.231 . . . . 0.0 109.011 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.498 ' O ' ' CE ' ' A' ' 38' ' ' LYS . . . 90.0 47.54 3.86 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.387 -1.085 . . . . 18.54 110.387 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.15 -14.98 28.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.147 -1.208 . . . . 10.84 110.0 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.684 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -94.6 177.82 5.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.724 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.629 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.413 -0.588 . . . . 18.33 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -89.1 -72.95 0.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 29.77 111.384 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 2' ' ' GLN . 10.9 pt-20 -58.08 -23.65 55.48 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.302 -0.873 . . . . 0.0 111.672 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -61.93 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.791 -1.193 . . . . 20.03 111.482 -177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.36 -39.34 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.268 -0.895 . . . . 12.91 110.57 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 70.0 m-20 -54.38 -37.3 64.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 28.33 108.979 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.0 m -74.71 -11.23 60.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.376 -0.827 . . . . 0.0 109.192 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.44 -51.24 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 22.87 109.688 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -78.91 133.82 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 25.19 109.621 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 9' ' ' ILE . 6.6 mp0 -144.53 152.32 52.84 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.028 -1.101 . . . . 34.61 108.028 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.88 129.05 32.89 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.246 1.298 . . . . 11.72 109.243 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.53 22.83 78.11 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.349 -1.5 . . . . 10.24 109.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.77 128.56 42.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -1.064 . . . . 25.36 108.973 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -100.37 129.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.461 -0.774 . . . . 10.89 109.272 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.05 142.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.34 -0.985 . . . . 15.82 108.34 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG12 HG23 ' A' ' 18' ' ' ILE . 40.5 t -124.12 123.72 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 8.94 111.055 -177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.05 117.35 29.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 9.93 107.574 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 16' ' ' VAL . 16.5 pt -130.06 -172.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.578 1.18 . . . . 10.62 111.518 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 21' ' ' THR . 26.2 mtmt -150.2 85.58 5.42 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 105.841 -1.911 . . . . 38.73 105.841 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 21' ' ' THR . 18.4 Cg_exo -45.83 81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.483 1.456 . . . . 24.58 110.766 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' O ' ' A' ' 19' ' ' LYS . 32.6 m -173.67 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.169 -1.048 . . . . 34.82 108.169 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 127.08 36.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.799 . . . . 21.46 108.841 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.68 -22.69 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.192 1.928 . . . . 13.86 113.075 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' CG ' HG12 ' A' ' 106' ' ' GSH . 29.3 m-85 -68.72 -42.35 77.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.284 -1.51 . . . . 0.0 108.96 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -37.2 79.48 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 26' ' ' ARG . 8.0 mmm-85 -62.21 -41.75 98.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.192 -0.67 . . . . 59.59 109.192 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -54.02 -49.5 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.12 -0.987 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.2 75.85 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.155 -0.966 . . . . 0.0 108.909 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.52 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 3.8 mm-40 -71.14 -42.28 69.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.361 -0.837 . . . . 45.49 109.723 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 33' ' ' SER . 48.4 mt-10 -70.89 -35.83 72.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.548 -0.72 . . . . 34.97 111.142 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.626 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -79.0 -56.45 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.927 -1.108 . . . . 0.0 110.798 -178.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -58.67 -23.91 60.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.457 -1.402 . . . . 17.28 109.891 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 2.5 p -63.28 -19.35 64.5 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.977 -1.077 . . . . 24.11 108.321 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -92.99 -4.38 52.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.539 -0.725 . . . . 44.07 110.071 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.715 HD12 HD23 ' A' ' 32' ' ' LEU . 21.5 mt -88.74 129.78 47.47 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.014 -1.054 . . . . 19.63 108.979 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.11 68.43 1.89 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.563 1.508 . . . . 21.54 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.6 mm -80.44 142.42 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.247 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -57.3 156.25 7.85 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.231 -0.918 . . . . 29.41 110.076 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -58.31 141.56 50.71 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.478 0.656 . . . . 0.0 111.664 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.26 47.16 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.524 -0.735 . . . . 15.27 112.04 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.08 -35.1 9.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.75 -1.441 . . . . 8.78 110.072 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 37' ' ' ILE . 63.8 tp -93.54 134.91 35.32 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.485 -0.76 . . . . 7.13 109.719 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -144.37 175.05 10.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 22.03 109.708 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.52 ' CD1' ' OE1' ' A' ' 29' ' ' GLN . 39.7 m-85 -137.63 109.06 6.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.078 -1.452 . . . . 16.33 107.078 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.26 106.43 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 6.58 111.682 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' OD1' HD11 ' A' ' 18' ' ' ILE . 8.0 m-20 -83.79 98.31 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.597 -0.69 . . . . 15.32 109.3 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.93 -9.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 10.92 110.811 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -96.07 40.65 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.824 -1.176 . . . . 21.72 107.824 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.47 10.32 0.43 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.47 -0.892 . . . . 22.45 110.657 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 t -127.86 -3.38 5.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.329 -2.1 . . . . 25.63 105.329 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 71.88 -175.24 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.676 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER 54.64 18.44 2.05 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 52' ' ' HIS . 1.8 m -29.96 -56.58 0.18 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.443 -0.799 . . . . 18.87 110.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -59.26 -33.01 70.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.412 -0.805 . . . . 45.21 111.859 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' HIS . 61.5 mm-40 -60.61 -46.84 88.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.708 -1.245 . . . . 33.02 109.124 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' HA ' ' CB ' ' A' ' 1' ' ' ALA . 2.5 mp -63.29 -55.42 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 9.84 109.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.3 mt-30 -57.67 -41.14 80.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 17.84 108.474 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.1 -35.61 59.81 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.84 -1.171 . . . . 18.84 107.84 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -80.0 -44.01 20.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.87 -0.789 . . . . 12.99 108.87 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.44 -37.02 46.54 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.517 -1.29 . . . . 14.61 107.517 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -61.23 -55.98 25.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.808 -0.812 . . . . 40.45 108.808 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.99 -37.22 83.82 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.4 -0.813 . . . . 41.81 110.127 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.94 -52.14 52.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 21.77 109.881 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.4 p -109.72 -65.39 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.599 -0.688 . . . . 11.38 109.852 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 155.46 -42.18 0.58 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.703 -1.237 . . . . 14.79 110.042 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -96.94 139.4 33.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -1.173 . . . . 17.81 110.363 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.01 31.3 6.14 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.392 -0.966 . . . . 29.76 108.392 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.34 173.05 10.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.676 0.751 . . . . 18.26 111.295 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.597 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 6.1 t -113.11 129.14 24.83 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 107.669 -1.234 . . . . 8.2 107.669 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.6 Cg_endo -82.59 -166.13 4.74 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 CA-C-O 122.504 0.96 . . . . 7.79 112.02 -0.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.518 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -145.73 90.42 1.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 105.42 -2.067 . . . . 26.05 105.42 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 73' ' ' PHE . 93.3 t -83.93 157.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 8.68 112.355 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' N ' HG12 ' A' ' 72' ' ' VAL . 58.0 m-85 -145.14 89.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 14.07 111.111 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 101' ' ' ILE . 3.6 mm -71.13 116.41 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.006 -2.22 . . . . 9.34 105.006 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.26 -158.88 16.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 105.867 -2.893 . . . . 12.42 105.867 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -80.96 2.98 24.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.197 -1.766 . . . . 44.86 108.787 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 97' ' ' ARG . 17.2 m-20 -88.76 114.77 25.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.365 -0.835 . . . . 0.0 110.219 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -75.53 142.15 42.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 110.079 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -108.76 -20.64 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.174 -0.954 . . . . 20.45 108.822 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.07 -162.22 21.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.04 -1.224 . . . . 13.82 110.04 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.78 -148.27 12.47 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.137 -1.185 . . . . 12.42 110.137 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.5 t -70.53 -60.44 2.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.993 . . . . 0.0 110.04 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.8 t -50.61 -24.18 3.1 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.448 -0.783 . . . . 0.0 109.282 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.65 -49.13 16.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.424 -0.798 . . . . 27.06 109.283 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.66 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.4 tt -52.54 -59.88 3.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 15.31 110.043 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -48.78 -53.13 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.254 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.7 t -44.91 -36.0 3.11 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.119 -0.988 . . . . 21.79 109.246 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 94' ' ' LEU . 41.6 mt -81.66 -41.2 21.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.507 -0.746 . . . . 0.0 111.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -57.65 -57.68 11.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.81 -1.181 . . . . 0.0 110.63 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -61.91 -26.1 67.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.998 -1.064 . . . . 0.0 109.671 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.0 m -80.15 -24.26 40.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.01 -7.52 82.0 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.616 -0.994 . . . . 25.64 110.616 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.06 -26.15 63.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.934 -1.333 . . . . 50.26 108.392 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.526 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.13 -64.52 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.766 -0.583 . . . . 24.17 110.777 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.77 -29.61 40.85 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.402 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.21 -48.05 74.73 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.777 -1.194 . . . . 28.03 107.777 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.463 HH21 ' CG ' ' A' ' 77' ' ' ASP . 10.4 tpt180 -57.21 -32.71 66.78 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.681 -1.229 . . . . 40.96 107.681 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -72.43 -40.7 66.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.57 -0.9 . . . . 15.05 108.57 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.43 -53.41 48.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.661 -0.649 . . . . 0.0 111.647 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -33.57 15.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.747 -1.22 . . . . 38.64 110.714 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 74' ' ' ILE . 15.0 pt -99.57 -17.43 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.672 -1.267 . . . . 0.0 109.006 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.5 42.57 8.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.216 -1.154 . . . . 18.54 110.216 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.7 -12.92 52.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 10.84 109.525 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.7 174.75 6.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.449 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.662 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.611 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.781 -0.452 . . . . 18.33 109.781 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' C ' ' O ' ' A' ' 1' ' ' ALA . 11.6 mt-30 30.06 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.825 -0.547 . . . . 29.77 111.339 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 1' ' ' ALA . 16.7 pt-20 -56.17 -12.14 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.14 -71.28 0.18 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.344 -0.847 . . . . 20.03 110.666 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.1 m -74.64 -40.92 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 12.91 110.559 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 11.7 m120 -54.78 -35.99 64.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.223 -0.923 . . . . 28.33 109.509 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.8 m -75.1 -12.83 60.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.156 -0.965 . . . . 0.0 109.437 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -96.78 -49.81 4.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 22.87 110.549 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 126.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 25.19 109.819 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 157.07 43.46 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.358 -0.979 . . . . 34.61 108.358 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.68 130.34 39.91 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.748 1.632 . . . . 11.72 111.299 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.93 24.38 60.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.952 -0.859 . . . . 10.24 110.952 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -143.28 135.36 26.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.326 . . . . 25.36 109.952 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.8 137.37 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.36 -0.837 . . . . 10.89 109.257 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.59 143.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 15.82 108.732 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.3 t -125.17 121.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.399 -0.813 . . . . 8.94 110.535 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -89.97 123.31 33.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.504 -1.295 . . . . 9.93 107.504 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' HB3' ' A' ' 70' ' ' PRO . 38.7 pt -133.71 -172.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.447 1.117 . . . . 10.62 111.723 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.2 mtmt -144.02 96.67 5.42 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.236 -1.764 . . . . 38.73 106.236 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' OG1' ' A' ' 21' ' ' THR . 11.2 Cg_exo -51.28 75.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.601 1.534 . . . . 24.58 110.586 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 19' ' ' LYS . 4.9 m -170.68 -32.74 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.739 -0.837 . . . . 34.82 108.739 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.33 127.14 39.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 21.46 109.767 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.37 -12.09 19.0 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.213 1.942 . . . . 13.86 112.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CG ' HG12 ' A' ' 106' ' ' GSH . 17.3 m-85 -72.25 -45.04 61.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.614 -1.304 . . . . 0.0 109.552 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -36.52 84.2 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.46 -33.29 69.59 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.671 -1.603 . . . . 59.59 106.671 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.13 -59.66 5.11 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.722 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -30.53 64.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.371 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.502 ' CD ' ' CD1' ' A' ' 44' ' ' PHE . 6.5 mm-40 -68.66 -32.91 73.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.224 -0.923 . . . . 45.49 108.841 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -71.63 -40.62 69.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 34.97 111.02 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -77.67 -59.48 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.896 -1.127 . . . . 0.0 111.017 -178.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 35' ' ' LEU . 4.9 mt -57.21 -22.66 42.45 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.806 -1.184 . . . . 17.28 110.215 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -66.56 -33.41 75.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.027 -1.045 . . . . 24.11 109.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -94.75 9.37 39.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 44.07 111.03 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 32' ' ' LEU . 14.4 mt -90.09 134.72 31.09 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.537 -1.352 . . . . 19.63 108.969 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.46 64.18 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 121.814 1.676 . . . . 21.54 110.231 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.507 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.7 mm -84.74 144.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.37 -0.831 . . . . 0.0 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -55.84 153.34 8.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.119 -0.988 . . . . 29.41 109.914 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -56.14 138.1 50.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 111.482 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.05 14.14 51.72 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.534 -0.729 . . . . 15.27 111.831 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.88 -21.74 14.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.825 -1.397 . . . . 8.78 109.828 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 37' ' ' ILE . 43.1 tp -102.78 127.82 49.77 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 7.13 109.387 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 44' ' ' PHE . 17.1 tp10 -142.77 164.69 29.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 22.03 109.85 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.502 ' CD1' ' CD ' ' A' ' 29' ' ' GLN . 14.1 m-85 -126.19 114.4 18.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.342 -1.355 . . . . 16.33 107.342 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -95.59 102.6 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 6.58 111.553 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.24 102.98 9.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.695 -1.224 . . . . 15.32 107.695 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 56' ' ' ILE . 21.5 pt -61.74 -1.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 10.92 111.434 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -93.11 -13.55 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.714 -1.241 . . . . 21.72 109.147 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 7.16 5.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 22.45 109.578 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 t -143.94 -0.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.157 -0.964 . . . . 25.63 109.936 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t30 68.51 -159.09 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 108.592 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.38 16.88 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.918 -1.113 . . . . 0.0 108.537 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -41.8 -59.03 1.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.46 -0.775 . . . . 18.87 110.483 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.3 m-20 -53.48 -36.52 61.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 45.21 110.765 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.23 -45.37 84.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.976 -1.078 . . . . 33.02 110.213 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 47' ' ' ILE . 2.5 mp -65.51 -56.1 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.889 -1.132 . . . . 9.84 109.771 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -55.85 -43.2 76.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.696 -1.224 . . . . 17.84 107.696 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 2.5 m-20 -55.93 -34.69 65.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.032 -1.469 . . . . 18.84 107.032 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -77.09 -46.1 24.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.823 -0.806 . . . . 12.99 108.823 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.1 mt -53.6 -36.26 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.762 -1.199 . . . . 14.61 107.762 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 21.1 tp60 -61.12 -57.07 14.05 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.957 -0.757 . . . . 40.45 108.957 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -65.9 -34.52 78.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.223 -0.923 . . . . 41.81 110.09 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.17 -52.75 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 21.77 109.89 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.565 HG21 HH11 ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.88 -61.88 1.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.588 -0.695 . . . . 11.38 109.606 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 151.73 -37.85 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.682 -1.367 . . . . 14.79 109.682 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.62 130.57 47.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.243 -1.151 . . . . 17.81 110.622 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 37.15 1.54 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.174 -1.047 . . . . 29.76 108.174 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.479 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -83.77 168.91 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.052 0.93 . . . . 18.26 111.688 -177.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.549 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 5.7 t -120.79 129.23 25.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.106 -1.442 . . . . 8.2 107.106 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.6 Cg_endo -75.94 -166.88 5.35 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 CA-C-O 122.425 0.927 . . . . 7.79 111.78 1.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.565 HH11 HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -148.71 89.75 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.553 -2.017 . . . . 26.05 105.553 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 85' ' ' LEU . 82.5 t -85.01 155.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.8 0.81 . . . . 8.68 111.934 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.428 ' N ' HG12 ' A' ' 72' ' ' VAL . 63.0 m-85 -145.42 90.79 2.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 14.07 110.566 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.01 112.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.731 -1.951 . . . . 9.34 105.731 177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.85 -152.7 45.67 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 106.497 -2.641 . . . . 12.42 106.497 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -83.42 -0.67 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.534 -1.568 . . . . 44.86 109.09 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.541 ' CB ' ' HE ' ' A' ' 97' ' ' ARG . 7.4 m-20 -89.05 115.8 26.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.747 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 t -73.76 150.92 40.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.26 -26.82 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.194 -0.941 . . . . 20.45 109.592 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.91 -145.67 17.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.879 -1.288 . . . . 13.82 109.879 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.3 -144.18 10.93 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.998 -1.241 . . . . 12.42 109.998 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.03 -62.17 1.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.437 -1.037 . . . . 0.0 110.023 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.6 t -53.49 -25.53 16.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.446 -0.783 . . . . 0.0 109.572 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.38 -46.84 37.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.281 -0.887 . . . . 27.06 109.115 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.8 tt -54.55 -59.7 4.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.577 -0.702 . . . . 15.31 109.912 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -50.97 -48.72 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.796 . . . . 0.0 110.492 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 4.6 t -50.05 -43.44 51.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.833 -1.167 . . . . 21.79 109.292 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.2 -35.58 63.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.381 -0.824 . . . . 0.0 111.428 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -59.84 -61.47 2.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.87 -1.144 . . . . 0.0 110.274 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 87' ' ' SER . 2.2 pp0? -62.07 -20.15 63.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 110.102 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.4 m -82.43 -22.77 35.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.92 66.33 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.437 -1.065 . . . . 25.64 110.437 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -68.49 -27.81 66.46 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.986 -1.303 . . . . 50.26 108.704 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.55 -64.64 0.87 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 24.17 110.311 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -53.83 -29.95 43.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.447 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.1 m -63.48 -47.06 83.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 28.03 108.357 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.46 -37.46 78.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.971 -1.122 . . . . 40.96 107.971 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.0 mp -72.07 -34.47 68.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.518 -0.919 . . . . 15.05 108.518 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -64.92 -57.6 8.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.784 -0.572 . . . . 0.0 111.737 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -47.66 -34.17 7.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.907 -1.121 . . . . 38.64 110.665 -178.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.5 pt -100.29 -11.66 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.816 -1.178 . . . . 0.0 109.331 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.94 41.56 22.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.229 -1.148 . . . . 18.54 110.229 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.04 54.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -1.197 . . . . 10.84 109.243 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 1.7 pp -97.59 -174.22 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 109.558 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.635 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.456 -0.572 . . . . 18.33 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.445 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 2.0 mm100 -83.22 -73.02 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 29.77 109.182 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.81 -6.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.625 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.19 -74.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 20.03 110.617 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.0 m -73.26 -38.42 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 12.91 110.186 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 94.3 m-20 -55.98 -35.26 66.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.001 -1.062 . . . . 28.33 109.496 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -74.85 -13.07 60.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.906 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -97.4 -41.33 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 22.87 110.654 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -79.24 140.56 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.849 -1.157 . . . . 25.19 110.249 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -150.05 136.86 11.08 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.076 -1.083 . . . . 34.61 108.076 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.78 133.33 50.3 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 120.999 1.133 . . . . 11.72 109.739 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 79.66 18.44 73.18 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.081 -1.608 . . . . 10.24 109.081 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -137.88 135.31 36.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -1.078 . . . . 25.36 109.489 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.53 134.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.293 -0.879 . . . . 10.89 109.744 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.87 140.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.335 -0.987 . . . . 15.82 108.335 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.66 127.87 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.217 -0.927 . . . . 8.94 111.177 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.49 121.35 34.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.064 -1.087 . . . . 9.93 108.064 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.3 pt -131.34 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.331 1.062 . . . . 10.62 111.337 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 21' ' ' THR . 4.4 mtmp? -146.31 91.19 5.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 106.077 -1.823 . . . . 38.73 106.077 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' OG1' ' A' ' 21' ' ' THR . 16.8 Cg_exo -46.37 83.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.616 1.544 . . . . 24.58 110.484 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.4 m -177.78 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 34.82 108.395 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.85 125.74 41.1 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 21.46 109.765 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.24 -19.12 40.68 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.321 2.014 . . . . 13.86 112.605 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -69.9 -42.91 72.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.611 -1.306 . . . . 0.0 109.627 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -65.86 -34.29 77.8 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.07 -42.62 99.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.79 -0.819 . . . . 59.59 108.79 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.6 HH11 ' HG2' ' A' ' 27' ' ' ARG . 6.5 mtt-85 -53.57 -45.07 69.81 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.231 -0.918 . . . . 0.0 108.656 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -36.49 78.93 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 108.849 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 7.5 mt-30 -70.62 -44.02 68.08 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.694 0.759 . . . . 45.49 109.333 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -70.97 -36.47 72.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.652 -0.655 . . . . 34.97 111.177 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.52 -56.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.88 -1.138 . . . . 0.0 110.211 -178.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.834 HD23 HD12 ' A' ' 35' ' ' LEU . 1.9 mt -59.43 -21.3 59.79 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.757 -1.215 . . . . 17.28 109.254 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.654 -0.869 . . . . 24.11 108.654 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -92.82 -0.01 57.33 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.48 -0.762 . . . . 44.07 110.127 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.834 HD12 HD23 ' A' ' 32' ' ' LEU . 18.0 mt -87.77 128.71 53.31 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.766 -1.209 . . . . 19.63 108.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.9 69.22 0.85 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.648 1.566 . . . . 21.54 109.417 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 2.4 mm -80.43 153.42 4.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.579 -0.701 . . . . 0.0 109.21 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -54.88 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.522 -0.736 . . . . 29.41 110.034 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.559 ' O ' ' O ' ' A' ' 38' ' ' LYS . 11.8 mt-30 -53.33 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.726 0.774 . . . . 0.0 111.036 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.85 54.67 0.75 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.079 -1.208 . . . . 15.27 110.079 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -98.13 -27.02 14.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.576 -0.955 . . . . 8.78 109.3 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -97.09 131.73 43.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.762 -0.829 . . . . 7.13 108.762 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.3 tt0 -141.23 173.07 11.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.85 . . . . 22.03 109.929 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.504 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 43.9 m-85 -135.35 111.75 9.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.349 -1.352 . . . . 16.33 107.349 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.74 104.9 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.872 . . . . 6.58 111.971 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.8 m-20 -82.25 101.79 10.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.614 -0.884 . . . . 15.32 108.614 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 56' ' ' ILE . 21.4 pt -61.97 -1.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 10.92 111.256 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 t -93.5 -17.06 23.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 21.72 109.303 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.0 12.82 1.23 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 22.45 109.52 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 7.3 t -140.81 -17.08 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 25.63 109.674 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 50' ' ' THR . 6.3 t-20 81.14 -175.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.451 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.4 OUTLIER 58.49 24.18 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 108.873 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 52' ' ' HIS . 3.6 p -43.32 -51.93 6.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.805 . . . . 18.87 110.292 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -53.81 -35.4 61.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 45.21 110.144 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.03 -44.89 87.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.057 -1.027 . . . . 33.02 109.753 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.41 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.2 mp -66.44 -53.9 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.019 . . . . 9.84 109.647 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.53 -42.12 82.27 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.701 -1.222 . . . . 17.84 107.701 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.35 -33.67 63.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.067 -1.456 . . . . 18.84 107.067 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -77.35 -45.26 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.787 -0.82 . . . . 12.99 108.787 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -55.49 -38.11 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.962 -1.125 . . . . 14.61 107.962 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 4.2 tp-100 -59.09 -49.29 78.43 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.522 0.677 . . . . 40.45 109.44 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -66.37 -54.22 27.05 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 41.81 110.65 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.81 -36.0 81.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 21.77 111.442 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 12.9 p -105.59 -68.38 0.87 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.021 -1.049 . . . . 11.38 109.812 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 144.26 -41.25 1.12 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.7 -1.76 . . . . 14.79 108.7 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.58 142.45 29.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.553 -0.969 . . . . 17.81 109.855 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.426 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -109.86 26.93 10.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 29.76 107.992 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.49 168.07 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.946 0.879 . . . . 18.26 111.238 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.639 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.7 t -113.22 132.39 22.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.309 -1.367 . . . . 8.2 107.309 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 82' ' ' SER . 23.1 Cg_endo -83.06 -167.52 5.64 Favored 'Cis proline' 0 C--N 1.306 -1.675 0 CA-C-O 122.616 1.007 . . . . 7.79 112.114 -0.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 91.77 2.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.716 -2.327 . . . . 26.05 104.716 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 79' ' ' ILE . 80.8 t -83.69 158.54 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.72 0.771 . . . . 8.68 112.175 -175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.484 ' N ' HG12 ' A' ' 72' ' ' VAL . 65.6 m-85 -146.32 84.36 1.63 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.808 -0.557 . . . . 14.07 111.55 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -70.7 114.43 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.885 -2.265 . . . . 9.34 104.885 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -158.09 30.69 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 105.658 -2.977 . . . . 12.42 105.658 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -81.35 0.98 34.79 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.426 -1.632 . . . . 44.86 109.403 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -87.42 115.09 24.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 110.516 -179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -73.1 136.47 44.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.258 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.684 ' C ' HD12 ' A' ' 79' ' ' ILE . 2.8 pp -105.59 -7.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.159 -0.963 . . . . 20.45 109.281 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 79' ' ' ILE . . . 115.34 -154.88 16.67 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.225 -1.15 . . . . 13.82 110.225 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 -141.52 12.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.34 -1.104 . . . . 12.42 110.34 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.2 p -71.42 -66.42 0.63 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.594 -0.944 . . . . 0.0 110.333 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 t -49.01 -29.39 4.83 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 109.358 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.56 -47.26 33.73 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.283 -0.886 . . . . 27.06 109.139 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.3 tt -54.58 -58.5 7.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.57 -0.706 . . . . 15.31 109.664 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.71 -49.0 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.383 -0.823 . . . . 0.0 110.526 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.535 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 6.5 m -45.29 -37.58 4.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.932 -1.105 . . . . 21.79 109.09 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.26 -38.77 34.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.453 -0.78 . . . . 0.0 111.84 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -59.95 -60.48 3.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.831 -1.168 . . . . 0.0 111.017 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 87' ' ' SER . 1.6 pp0? -58.65 -24.02 60.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.0 m -80.74 -57.0 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.69 -8.49 6.89 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.702 -1.359 . . . . 25.64 109.702 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -69.29 -26.42 64.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.313 -1.11 . . . . 50.26 108.566 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp -60.09 -65.42 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 24.17 110.599 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.61 -28.44 32.5 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -64.35 -47.85 77.79 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.442 -0.947 . . . . 28.03 108.442 178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' CG ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -58.18 -34.03 69.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.97 -1.122 . . . . 40.96 107.97 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 98' ' ' LEU . 7.9 mp -72.42 -40.82 66.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.495 -0.753 . . . . 15.05 109.292 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.97 -52.14 57.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.0 111.808 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -51.19 -33.14 26.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.819 -1.176 . . . . 38.64 111.114 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.1 pt -100.72 -14.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.0 43.49 7.56 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.354 -1.099 . . . . 18.54 110.354 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.25 -16.55 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.242 . . . . 10.84 109.839 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.64 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -94.4 179.11 5.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 109.771 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.685 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.639 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.241 0.543 . . . . 18.33 109.564 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.721 ' NE2' ' H ' ' A' ' 3' ' ' GLU . 2.4 pm0 -76.07 -53.14 8.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.04 -1.037 . . . . 29.77 109.68 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.721 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 11.1 pt-20 -64.21 -18.96 65.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.905 -1.122 . . . . 0.0 109.237 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.78 -71.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.506 -0.746 . . . . 20.03 110.613 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.5 m -72.63 -37.97 57.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.275 -0.891 . . . . 12.91 110.108 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 69.4 m-20 -55.39 -38.42 68.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.184 -0.947 . . . . 28.33 109.521 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -74.14 -11.9 60.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.507 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 42.6 mttm -97.55 -45.03 6.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 22.87 110.47 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -78.63 139.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 25.19 109.56 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -149.81 136.17 10.61 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.213 -1.032 . . . . 34.61 108.213 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.45 124.75 15.82 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 120.752 0.968 . . . . 11.72 109.628 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.62 55.18 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.368 -1.493 . . . . 10.24 109.368 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 8' ' ' LYS . 25.0 ttpt -137.29 135.67 37.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.335 -1.097 . . . . 25.36 109.409 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.96 132.9 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.829 . . . . 10.89 109.403 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.48 139.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 15.82 108.805 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 18' ' ' ILE . 40.0 t -121.76 126.94 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 8.94 110.794 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.08 120.01 33.73 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.604 -1.258 . . . . 9.93 107.604 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 16' ' ' VAL . 46.1 pt -132.52 -174.3 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 122.615 1.198 . . . . 10.62 112.232 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' A' ' 21' ' ' THR . 28.7 mttm -141.54 95.09 7.29 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 105.558 -2.015 . . . . 38.73 105.558 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 21' ' ' THR . 14.0 Cg_exo -49.9 76.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.37 1.38 . . . . 24.58 110.834 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.656 ' N ' ' O ' ' A' ' 19' ' ' LYS . 87.8 m -172.0 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.228 -0.656 . . . . 34.82 109.228 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.79 124.64 47.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 21.46 110.266 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.12 -20.05 29.34 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.193 1.928 . . . . 13.86 112.872 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -66.9 -47.47 71.71 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.481 -1.387 . . . . 0.0 108.784 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' HG12 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -63.02 -36.22 82.85 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -60.59 -40.78 93.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.163 -1.051 . . . . 59.59 108.163 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -47.79 77.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.21 75.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.297 -0.877 . . . . 0.0 108.915 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.467 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 9.6 mt-30 -69.89 -40.98 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 45.49 109.59 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 68.8 mm-40 -69.33 -39.85 77.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.597 -0.689 . . . . 34.97 111.364 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -77.07 -55.93 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.882 -1.136 . . . . 0.0 110.947 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.637 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -56.75 -26.3 56.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.738 -1.226 . . . . 17.28 109.536 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.527 ' C ' HE21 ' A' ' 34' ' ' GLN . 1.7 t -64.41 -26.94 68.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.16 -0.963 . . . . 24.11 109.02 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.553 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -92.03 0.31 57.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 44.07 110.288 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' ILE . 18.7 mt -87.65 133.54 37.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.763 -1.21 . . . . 19.63 108.319 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -67.24 62.99 0.7 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.578 1.519 . . . . 21.54 109.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.0 mm -79.92 141.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -55.78 152.78 9.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.275 -0.891 . . . . 29.41 109.977 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 39' ' ' GLN . 24.8 mp0 -57.08 141.15 46.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.436 0.636 . . . . 0.0 111.431 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.0 9.18 39.24 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.484 -0.76 . . . . 15.27 111.902 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -30.42 12.17 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.823 -1.399 . . . . 8.78 109.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.8 tp -96.58 131.76 42.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.518 -0.739 . . . . 7.13 109.543 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.7 tp10 -141.85 171.43 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 22.03 109.444 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CG ' ' OE1' ' A' ' 29' ' ' GLN . 39.3 m-85 -133.23 110.02 9.83 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.145 -1.428 . . . . 16.33 107.145 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.98 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.476 -0.765 . . . . 6.58 111.434 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 3.8 m-20 -81.81 100.69 9.71 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.445 -0.946 . . . . 15.32 108.445 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 28.6 pt -62.41 1.92 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 10.92 110.734 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 46' ' ' ASP . 17.5 p -95.83 -23.17 17.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 21.72 109.04 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.13 9.62 2.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 22.45 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 14.2 t -137.05 -7.69 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.841 . . . . 25.63 109.404 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.574 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.2 OUTLIER 69.6 -163.81 0.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.497 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.3 OUTLIER 54.63 21.47 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.994 -1.066 . . . . 0.0 108.545 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -40.29 -59.91 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 18.87 110.739 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 7.9 m120 -54.18 -35.06 61.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 45.21 111.034 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.99 -46.36 88.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.179 . . . . 33.02 109.963 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -66.01 -53.18 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.979 -1.076 . . . . 9.84 109.518 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -56.53 -44.44 80.82 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.566 -1.272 . . . . 17.84 107.566 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 54' ' ' ASN . 24.9 m-20 -53.61 -33.03 53.57 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.977 -1.49 . . . . 18.84 106.977 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -78.64 -48.56 14.83 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.94 -0.763 . . . . 12.99 108.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.7 mt -52.02 -36.4 50.02 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.524 -1.287 . . . . 14.61 107.524 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.9 tp60 -61.96 -55.31 30.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.794 -0.817 . . . . 40.45 108.794 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -39.19 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 41.81 109.678 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.2 tp -64.09 -45.62 87.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 21.77 109.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.636 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -117.64 -71.71 0.72 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.633 -0.667 . . . . 11.38 109.569 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.636 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 158.47 -34.26 0.5 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.317 -1.513 . . . . 14.79 109.317 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -95.93 137.13 35.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 17.81 110.019 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' O31' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -110.88 30.19 7.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.066 -1.087 . . . . 29.76 108.066 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.33 171.04 11.51 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.926 0.869 . . . . 18.26 111.501 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.64 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 5.3 t -115.26 132.12 23.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.494 -1.299 . . . . 8.2 107.494 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.741 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 28.5 Cg_endo -81.04 -164.84 4.09 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 CA-C-O 122.032 0.763 . . . . 7.79 110.925 0.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.741 ' NH1' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -150.81 93.25 1.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.376 -2.083 . . . . 26.05 105.376 177.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' A' ' 79' ' ' ILE . 94.1 t -85.61 156.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.827 0.822 . . . . 8.68 112.352 -175.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.0 m-85 -145.37 92.92 2.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.875 -0.516 . . . . 14.07 110.606 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 98' ' ' LEU . 8.4 mm -72.43 113.74 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.832 -1.914 . . . . 9.34 105.832 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.58 -145.62 42.26 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 106.622 -2.591 . . . . 12.42 106.622 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -87.56 -3.48 58.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.677 -1.484 . . . . 44.86 109.5 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.36 116.47 25.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.221 -0.924 . . . . 0.0 110.619 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -75.77 143.97 41.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.778 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.7 pp -113.43 -18.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.189 -0.944 . . . . 20.45 109.335 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.43 -159.2 19.96 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.109 -1.196 . . . . 13.82 110.109 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -92.51 -143.7 12.98 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.391 -1.064 . . . . 12.42 110.655 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.417 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 t -71.33 -62.63 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -1.015 . . . . 0.0 110.383 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 t -51.0 -24.99 4.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.359 -0.838 . . . . 0.0 109.189 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.6 m-20 -76.05 -45.52 33.81 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 27.06 109.219 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.572 ' O ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt -55.0 -58.41 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 15.31 109.829 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -52.06 -52.3 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.487 -0.758 . . . . 0.0 111.003 -178.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' VAL . 5.0 t -44.84 -38.99 4.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.059 -1.025 . . . . 21.79 109.251 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.84 -41.5 23.14 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.545 -0.722 . . . . 0.0 111.631 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -55.83 29.53 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.868 -1.145 . . . . 0.0 110.398 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -62.1 -25.49 67.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.944 -1.098 . . . . 0.0 109.452 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.9 m -77.98 -62.22 1.74 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.419 -0.8 . . . . 0.0 109.024 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -9.25 5.53 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.09 -1.204 . . . . 25.64 110.09 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.22 -24.36 64.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.117 -1.225 . . . . 50.26 108.177 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.61 -67.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.638 -0.664 . . . . 24.17 110.47 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -51.58 -28.99 15.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.455 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.22 -49.18 70.69 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.074 -1.084 . . . . 28.03 108.074 178.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.5 ' CG ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -56.68 -34.65 67.59 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.926 -1.139 . . . . 40.96 107.926 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 74' ' ' ILE . 8.3 mp -72.89 -38.52 66.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.479 -0.934 . . . . 15.05 108.479 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -64.49 -53.64 44.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.576 . . . . 0.0 111.555 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -50.14 -34.87 23.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 38.64 110.76 -178.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.58 -15.3 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.69 -1.256 . . . . 0.0 109.007 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.66 44.39 8.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.588 -1.005 . . . . 18.54 110.588 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.45 55.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -1.219 . . . . 10.84 109.87 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.649 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -95.79 -177.55 4.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.783 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.5 -179.895 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.64 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.516 -0.55 . . . . 18.33 109.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.53 -71.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 29.77 109.415 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.33 -11.31 4.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.26 -73.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 20.03 110.572 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -72.94 -37.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 12.91 109.884 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 18.0 m120 -55.73 -38.34 69.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.184 -0.948 . . . . 28.33 109.301 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 m -74.18 -10.03 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -95.96 -53.5 3.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 22.87 109.627 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -79.57 128.11 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.844 . . . . 25.19 110.067 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HA ' ' HZ3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.36 155.67 39.45 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.072 -1.084 . . . . 34.61 108.072 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.56 130.06 38.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.895 1.73 . . . . 11.72 111.537 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.89 64.4 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.874 -0.89 . . . . 10.24 110.874 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -142.47 133.33 25.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.351 . . . . 25.36 109.928 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.23 136.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.89 109.037 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.79 144.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 15.82 108.55 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.66 126.88 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 8.94 110.77 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -92.68 123.91 36.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 9.93 107.571 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.92 -176.43 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.383 1.087 . . . . 10.62 111.342 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 21' ' ' THR . 14.6 mtmm -143.32 92.73 6.61 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.385 -1.709 . . . . 38.73 106.385 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' C ' ' OG1' ' A' ' 21' ' ' THR . 12.2 Cg_exo -47.79 82.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.629 1.553 . . . . 24.58 110.442 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 179.1 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.025 -0.731 . . . . 34.82 109.025 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.88 130.63 28.4 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 21.46 110.266 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -59.69 -20.33 57.77 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.393 2.062 . . . . 13.86 112.654 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 106' ' ' GSH . 25.4 m-85 -70.37 -43.96 69.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.533 -1.355 . . . . 0.0 109.622 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.68 -32.37 74.01 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.3 mmm-85 -64.04 -43.71 94.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.643 -0.873 . . . . 59.59 108.643 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG2' ' NH1' ' A' ' 27' ' ' ARG . 2.1 mtt-85 -51.75 -45.46 63.69 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -38.0 83.55 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -70.21 -42.15 72.71 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.43 -0.794 . . . . 45.49 109.296 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.74 -38.36 76.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.683 . . . . 34.97 111.078 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.653 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.81 -58.17 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 35' ' ' LEU . 1.8 mt -57.71 -21.46 40.84 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.512 -1.367 . . . . 17.28 109.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -65.94 -24.96 66.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.052 -1.03 . . . . 24.11 108.769 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -91.32 1.38 57.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 44.07 110.191 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 32' ' ' LEU . 16.7 mt -90.48 126.78 55.19 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.903 -1.123 . . . . 19.63 109.163 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.55 67.64 0.76 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.773 1.648 . . . . 21.54 109.66 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.16 150.66 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.406 -0.809 . . . . 0.0 108.907 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 39' ' ' GLN . 30.0 mttm -53.47 -169.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.85 . . . . 29.41 110.309 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 38' ' ' LYS . 56.6 mm-40 -51.52 -127.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.529 0.681 . . . . 0.0 111.344 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.37 53.18 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.421 -1.072 . . . . 15.27 110.421 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -101.08 -23.33 14.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -1.045 . . . . 8.78 108.942 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' A' ' 37' ' ' ILE . 56.0 tp -102.73 131.89 49.25 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.565 -0.902 . . . . 7.13 108.565 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 25.9 tt0 -141.5 173.9 11.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.305 -0.872 . . . . 22.03 110.04 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.512 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 38.5 m-85 -135.22 109.84 8.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.57 -1.27 . . . . 16.33 107.57 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.58 103.49 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 6.58 111.096 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.0 m-20 -80.98 101.5 9.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.219 -0.925 . . . . 15.32 108.731 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.3 -2.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.089 -1.007 . . . . 10.92 110.237 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' THR . 10.5 p -96.28 -29.79 13.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 21.72 109.346 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.55 18.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 22.45 109.273 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.519 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 10.7 t -140.5 -13.77 0.99 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -0.88 . . . . 25.63 109.91 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' CG ' ' N ' ' A' ' 52' ' ' HIS . 0.5 OUTLIER 78.7 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.545 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 2.4 m170 53.61 12.32 0.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.702 -1.249 . . . . 0.0 108.406 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -35.97 -67.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.718 -0.614 . . . . 18.87 111.077 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -53.96 -31.51 50.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.227 -0.921 . . . . 45.21 111.067 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' OE1' ' CE1' ' A' ' 52' ' ' HIS . 57.4 mt-10 -65.26 -46.61 79.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.86 -1.15 . . . . 33.02 110.041 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.44 -53.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.952 -1.092 . . . . 9.84 109.453 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.27 -43.43 83.08 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.824 -1.176 . . . . 17.84 107.824 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -54.78 -33.84 61.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.217 -1.401 . . . . 18.84 107.217 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -78.8 -49.21 13.36 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.969 -0.692 . . . . 12.99 109.136 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.06 -32.89 49.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.434 -0.951 . . . . 14.61 108.434 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 3.9 tp-100 -59.77 -53.89 52.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.675 -0.641 . . . . 40.45 109.385 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -66.92 -48.25 69.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 41.81 111.031 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.62 -39.02 92.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 21.77 110.554 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 10.5 p -106.49 -66.67 0.99 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.32 -0.862 . . . . 11.38 109.912 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 143.48 -42.15 1.1 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.694 -1.763 . . . . 14.79 108.694 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' NH1' ' A' ' 71' ' ' ARG . . . -98.22 136.62 38.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -1.02 . . . . 17.81 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -102.44 25.42 9.04 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.313 -0.995 . . . . 29.76 108.313 179.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.805 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -83.02 169.45 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.67 . . . . 18.26 110.354 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.589 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 10.9 t -113.67 138.53 22.68 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 107.916 -1.142 . . . . 8.2 107.916 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 82' ' ' SER . 30.6 Cg_endo -84.95 -165.92 4.05 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 CA-C-O 122.299 0.875 . . . . 7.79 111.203 -0.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.805 HH12 ' H ' ' A' ' 68' ' ' THR . 1.4 tpm_? -143.41 92.77 2.4 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.131 -2.174 . . . . 26.05 105.131 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 79' ' ' ILE . 77.2 t -83.63 156.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.877 . . . . 8.68 111.387 -176.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' N ' HG12 ' A' ' 72' ' ' VAL . 74.3 m-85 -146.22 92.05 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.635 -0.666 . . . . 14.07 111.105 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -72.97 106.32 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.598 -2.001 . . . . 9.34 105.598 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.96 -152.1 46.81 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 105.793 -2.923 . . . . 12.42 105.793 -176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HZ3' ' HA ' ' A' ' 10' ' ' GLN . 31.8 mttm -81.76 4.06 23.46 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.388 -1.654 . . . . 44.86 108.507 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.683 ' CB ' HH21 ' A' ' 97' ' ' ARG . 23.6 m-20 -89.63 108.96 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.0 110.754 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 t -74.44 141.99 44.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.8 pp -111.29 -13.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 20.45 109.443 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.96 -163.89 15.24 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.309 -1.117 . . . . 13.82 110.309 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' N ' ' OD2' ' A' ' 84' ' ' ASP . . . -86.58 -146.26 9.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.23 -1.148 . . . . 12.42 110.23 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -72.61 -59.7 2.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.553 -0.969 . . . . 0.0 110.049 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -50.24 -26.48 4.75 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 108.922 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 81' ' ' GLY . 16.7 m-20 -75.23 -47.81 26.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.526 -0.734 . . . . 27.06 109.09 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 tt -53.89 -59.15 5.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 15.31 109.776 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.603 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -52.35 -50.73 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 110.539 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' VAL . 1.5 t -46.26 -41.54 13.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 21.79 109.869 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.85 -40.08 55.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 112.173 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -59.27 -59.5 5.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.646 -1.284 . . . . 0.0 110.858 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -57.96 -22.69 50.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.333 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 m -79.82 -60.09 2.48 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 109.119 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 -11.72 6.46 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.62 -1.392 . . . . 25.64 109.62 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 96' ' ' THR . 36.7 tp10 -69.24 -25.58 64.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -1.163 . . . . 50.26 108.994 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.3 tp -58.48 -64.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.861 . . . . 24.17 110.356 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -52.61 -27.41 16.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -63.57 -48.2 78.4 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.425 -0.91 . . . . 28.03 108.784 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.743 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.0 mmm180 -58.73 -34.28 71.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.052 . . . . 40.96 108.17 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 mp -70.6 -39.68 73.65 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.805 -0.813 . . . . 15.05 108.805 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -66.03 -53.83 33.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.767 -0.583 . . . . 0.0 111.941 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.743 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -49.47 -33.36 14.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.207 . . . . 38.64 110.612 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.22 -13.23 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.697 -1.252 . . . . 0.0 109.331 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.46 46.42 8.91 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.549 -1.02 . . . . 18.54 110.549 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.07 -14.47 41.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -1.16 . . . . 10.84 109.586 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.659 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -95.48 174.61 6.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 109.951 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.649 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.63 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.489 -0.56 . . . . 18.33 109.489 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -90.14 -72.77 0.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 29.77 109.15 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.37 -9.04 1.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.57 -72.91 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.78 . . . . 20.03 110.018 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.7 m -73.62 -40.32 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 12.91 110.126 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.463 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 73.8 m-20 -56.08 -27.23 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.201 -0.937 . . . . 28.33 110.399 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 m -74.71 -21.7 59.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.08 -1.012 . . . . 0.0 110.528 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -97.58 -45.36 6.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.973 -1.079 . . . . 22.87 111.293 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.39 129.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.014 -1.054 . . . . 25.19 110.123 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -146.79 153.05 45.91 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 34.61 108.664 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.03 122.86 12.56 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.218 1.279 . . . . 11.72 109.963 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 84.0 24.32 49.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.83 -1.308 . . . . 10.24 109.83 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -139.23 134.58 32.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -1.145 . . . . 25.36 109.232 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.02 137.36 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 10.89 110.11 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -145.51 153.06 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.499 -0.926 . . . . 15.82 108.499 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.94 121.65 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.234 -0.916 . . . . 8.94 110.629 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.98 121.1 31.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.201 -1.407 . . . . 9.93 107.201 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 70' ' ' PRO . 34.2 pt -133.48 -168.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 122.472 1.129 . . . . 10.62 111.872 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.636 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.2 mtmt -145.59 96.65 4.75 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 106.205 -1.776 . . . . 38.73 106.205 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.4 Cg_exo -51.82 74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.379 1.386 . . . . 24.58 110.736 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.636 ' N ' ' O ' ' A' ' 19' ' ' LYS . 11.5 m -171.32 -32.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.919 -0.771 . . . . 34.82 108.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.22 128.57 34.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 21.46 110.074 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.82 -13.28 25.85 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.162 1.908 . . . . 13.86 112.118 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CG ' HG12 ' A' ' 106' ' ' GSH . 19.1 m-85 -71.34 -47.5 56.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.709 -1.244 . . . . 0.0 109.706 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -28.39 70.01 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.015 -1.053 . . . . 0.0 108.9 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -61.27 -42.64 98.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.29 -1.004 . . . . 59.59 108.29 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -54.24 -49.14 70.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.176 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -37.43 75.46 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.878 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.54 -42.15 71.59 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.333 -0.854 . . . . 45.49 109.618 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.77 -37.33 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.386 -0.821 . . . . 34.97 111.02 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.681 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.28 -57.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.99 -1.069 . . . . 0.0 110.197 -178.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.663 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -55.38 -24.62 30.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 17.28 109.394 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -65.28 -27.9 68.96 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.119 -0.988 . . . . 24.11 108.489 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -90.89 3.66 53.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.812 . . . . 44.07 110.286 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 35' ' ' LEU . 20.0 mt -91.83 131.5 35.39 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.795 -1.191 . . . . 19.63 109.257 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.88 64.61 0.43 Allowed 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.707 1.605 . . . . 21.54 110.31 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.8 mm -82.25 149.05 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 108.887 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 39' ' ' GLN . 16.4 mmmt -53.22 -174.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 29.41 110.057 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.604 ' NE2' ' H ' ' A' ' 39' ' ' GLN . 4.3 mp0 -52.32 -121.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.674 -0.641 . . . . 0.0 111.123 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 48.31 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.402 -0.904 . . . . 15.27 110.866 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -100.81 -18.26 16.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.241 -1.152 . . . . 8.78 109.372 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -105.56 126.7 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 7.13 108.83 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 36.7 tt0 -140.4 164.97 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 22.03 109.689 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.618 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 23.3 m-85 -126.45 114.91 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.593 -1.262 . . . . 16.33 107.593 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.87 102.06 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 6.58 111.131 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 48' ' ' THR . 7.4 m-20 -80.44 100.06 8.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.478 -1.304 . . . . 15.32 107.478 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CG2' HG21 ' A' ' 56' ' ' ILE . 14.6 pt -61.17 2.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 10.92 110.749 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 46' ' ' ASP . 5.1 t -94.88 -20.24 19.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.999 -1.063 . . . . 21.72 109.086 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.58 13.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 22.45 109.309 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 10.1 t -140.69 -14.71 0.94 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.22 -0.925 . . . . 25.63 109.902 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 50' ' ' THR . 1.1 m-20 78.97 -176.19 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.8 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.403 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER 57.76 30.16 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 109.089 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 p -44.69 -54.12 6.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 18.87 109.906 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.0 m-20 -54.15 -37.32 64.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 45.21 110.732 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -62.24 -46.58 88.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.92 -1.112 . . . . 33.02 109.636 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG21 ' CG2' ' A' ' 47' ' ' ILE . 2.7 mp -65.9 -55.7 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.969 -1.082 . . . . 9.84 109.59 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -56.69 -40.45 75.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.694 -1.254 . . . . 17.84 107.878 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 22.9 m-20 -55.04 -32.53 61.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.015 -1.476 . . . . 18.84 107.015 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -78.8 -47.94 15.74 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.766 -0.827 . . . . 12.99 108.766 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -54.53 -33.59 60.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.375 -0.972 . . . . 14.61 108.375 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.7 tp60 -59.25 -55.78 30.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.751 -0.593 . . . . 40.45 109.8 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -66.7 -50.42 62.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.028 -1.045 . . . . 41.81 111.106 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.06 -34.83 78.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.867 -1.146 . . . . 21.77 110.657 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.6 p -110.74 -70.44 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.306 -0.871 . . . . 11.38 109.915 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 147.04 -41.85 0.94 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.606 -1.798 . . . . 14.79 108.606 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.22 140.39 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.436 -1.037 . . . . 17.81 110.047 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' NH1' ' C3 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -109.85 24.43 13.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.192 -1.04 . . . . 29.76 108.192 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.95 174.1 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.923 0.868 . . . . 18.26 110.935 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.563 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 9.8 t -118.61 134.33 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.454 -1.313 . . . . 8.2 107.454 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -80.7 -163.93 3.62 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 CA-C-O 122.245 0.852 . . . . 7.79 111.257 0.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 91.74 1.89 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.296 -2.113 . . . . 26.05 105.296 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 85' ' ' LEU . 92.2 t -84.65 157.81 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.822 0.82 . . . . 8.68 112.185 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 72' ' ' VAL . 57.6 m-85 -145.22 88.28 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.801 -0.562 . . . . 14.07 110.624 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.598 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.4 mp -71.0 109.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.469 -2.048 . . . . 9.34 105.469 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.57 -154.64 52.1 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.036 -2.826 . . . . 12.42 106.036 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -84.51 0.2 50.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.354 -1.674 . . . . 44.86 108.934 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.7 114.91 25.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -71.69 149.45 45.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.366 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.0 -23.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.95 . . . . 20.45 109.342 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.64 -142.71 14.08 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.948 -1.261 . . . . 13.82 109.948 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -111.06 -144.19 9.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.898 -1.281 . . . . 12.42 109.898 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 t -71.04 -61.12 1.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -1.003 . . . . 0.0 109.801 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.9 t -52.99 -26.27 14.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 1.5 m-20 -73.53 -48.33 33.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.345 -0.847 . . . . 27.06 109.236 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.76 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.382 -0.824 . . . . 15.31 109.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.42 -49.43 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 0.0 110.015 -178.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -49.5 -41.32 40.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 21.79 109.357 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt -75.46 -36.67 60.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 111.253 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.403 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 -62.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.995 -1.066 . . . . 0.0 110.644 -178.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -61.19 -16.61 46.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.949 -1.095 . . . . 0.0 109.971 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.675 ' N ' ' OE1' ' A' ' 90' ' ' GLN . 13.5 m -85.25 -18.61 33.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.891 . . . . 0.0 109.425 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.79 -13.49 52.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.891 -1.283 . . . . 25.64 109.891 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.55 -26.76 65.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.149 -1.207 . . . . 50.26 108.966 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.95 -63.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 24.17 110.157 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -53.1 -31.31 41.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.1 m -63.56 -43.99 95.46 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.696 -1.224 . . . . 28.03 107.696 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -60.0 -35.65 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.403 -0.962 . . . . 40.96 108.403 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.9 mp -71.18 -40.23 71.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.445 -0.784 . . . . 15.05 109.237 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -65.08 -53.53 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 112.29 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -47.57 -31.54 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.728 -1.233 . . . . 38.64 110.503 -177.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 pt -104.17 -14.18 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.918 -1.114 . . . . 0.0 109.649 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.26 41.94 11.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.433 -1.067 . . . . 18.54 110.433 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.13 -12.32 53.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 10.84 109.561 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -96.62 -174.82 3.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.389 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.657 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 18.33 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' C ' ' H ' ' A' ' 4' ' ' PHE . 52.5 mt-30 -138.6 -76.15 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 29.77 108.988 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -58.71 -5.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 108.977 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 2' ' ' GLN . 1.6 m-85 -62.91 -70.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 20.03 110.25 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 2.2 m -73.1 -40.34 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 12.91 110.097 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 8.6 m-20 -54.79 -38.27 67.09 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.073 -1.017 . . . . 28.33 109.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -74.72 -12.35 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.212 -0.93 . . . . 0.0 109.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -97.24 -46.8 5.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.206 -0.934 . . . . 22.87 110.608 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.1 135.09 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.776 -1.202 . . . . 25.19 109.385 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.49 150.36 40.25 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.715 -0.846 . . . . 34.61 108.715 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.39 124.37 15.91 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.41 1.407 . . . . 11.72 110.021 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 41' ' ' LEU . . . 81.08 28.45 45.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.764 -1.334 . . . . 10.24 109.764 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -140.91 137.22 32.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 25.36 109.761 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.63 135.05 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.382 -0.824 . . . . 10.89 109.643 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.42 141.39 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.048 . . . . 15.82 108.172 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 t -124.19 127.28 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 8.94 111.078 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.84 121.04 34.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.24 -1.393 . . . . 9.93 107.24 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 70' ' ' PRO . 28.0 pt -131.14 -176.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.361 1.077 . . . . 10.62 111.254 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 21' ' ' THR . 19.5 mtmt -143.9 91.81 6.51 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.077 -1.823 . . . . 38.73 106.077 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' ' OG1' ' A' ' 21' ' ' THR . 13.1 Cg_exo -47.18 78.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.892 1.728 . . . . 24.58 111.05 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' LYS . 88.2 m -174.1 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.852 -0.796 . . . . 34.82 108.852 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.75 130.04 29.95 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 21.46 109.857 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -57.94 -21.59 50.37 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.277 1.985 . . . . 13.86 112.209 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -70.43 -38.18 74.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.635 -1.291 . . . . 0.0 108.523 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -36.63 82.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.672 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -64.08 -40.53 96.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.918 -0.771 . . . . 59.59 108.918 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.9 OUTLIER -53.66 -48.84 69.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.433 -0.792 . . . . 0.0 109.291 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.52 72.98 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.372 -0.83 . . . . 0.0 109.161 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.626 ' NE2' ' CG ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -70.57 -43.39 69.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.375 -0.828 . . . . 45.49 109.477 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 22.0 mm-40 -71.13 -35.78 71.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.554 -0.716 . . . . 34.97 111.256 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -76.48 -58.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 110.478 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.826 HD23 HD12 ' A' ' 35' ' ' LEU . 2.9 mt -58.99 -17.98 29.95 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.563 -1.336 . . . . 17.28 109.634 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 t -65.87 -29.93 70.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 24.11 109.037 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 30' ' ' GLU . 1.6 mp0 -91.72 5.88 48.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 44.07 110.49 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.826 HD12 HD23 ' A' ' 32' ' ' LEU . 15.9 mt -90.56 127.98 50.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.758 -1.213 . . . . 19.63 109.304 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.43 68.99 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.8 1.666 . . . . 21.54 109.94 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.6 mm -82.13 150.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.416 -0.802 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 39' ' ' GLN . 1.5 mmmm -54.68 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.466 -0.771 . . . . 29.41 110.392 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.599 ' O ' ' O ' ' A' ' 38' ' ' LYS . 91.1 mm-40 -52.61 -137.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.618 0.723 . . . . 0.0 110.884 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.27 52.82 0.09 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.107 -1.197 . . . . 15.27 110.107 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -98.52 -20.28 17.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -1.048 . . . . 8.78 109.151 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 37' ' ' ILE . 57.6 tp -103.54 129.7 50.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.632 -0.877 . . . . 7.13 108.632 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 3.9 tp10 -142.13 164.89 28.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.995 . . . . 22.03 109.955 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 29' ' ' GLN . 56.5 m-85 -125.96 111.75 15.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.319 -1.363 . . . . 16.33 107.319 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.9 t -94.47 101.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 6.58 111.305 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.9 m-20 -81.16 101.42 9.65 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.873 . . . . 15.32 108.644 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.0 pt -63.12 -6.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 10.92 109.251 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 p -96.92 43.08 1.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.332 -0.988 . . . . 21.72 108.332 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.14 14.09 0.45 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 22.45 107.801 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -139.49 -2.94 1.54 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.19 -1.041 . . . . 25.63 108.19 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.7 OUTLIER 70.21 -176.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.806 178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.3 m80 53.61 18.06 1.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.007 -1.058 . . . . 0.0 108.552 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -32.96 -55.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.403 0.621 . . . . 18.87 110.861 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -57.85 -33.3 68.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 45.21 111.275 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' HIS . 73.2 mm-40 -63.45 -43.7 96.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.829 -1.17 . . . . 33.02 109.925 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -65.8 -56.76 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.983 -1.073 . . . . 9.84 109.581 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -54.9 -43.06 72.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.555 -1.276 . . . . 17.84 107.555 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.28 -33.61 65.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.41 -1.33 . . . . 18.84 107.41 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -76.6 -47.33 22.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 12.99 108.732 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.0 mt -54.78 -36.5 64.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.901 -1.148 . . . . 14.61 107.901 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 1.1 tp-100 -59.67 -52.37 65.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.266 0.555 . . . . 40.45 110.045 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.0 -51.0 66.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 41.81 110.839 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.94 -32.43 73.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.086 -1.009 . . . . 21.77 110.721 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.3 p -110.06 -74.05 0.66 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 11.38 109.53 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 148.22 -37.86 1.05 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.985 -1.646 . . . . 14.79 108.985 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -102.68 134.74 45.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -1.002 . . . . 17.81 109.908 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -105.44 32.5 4.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.538 -0.912 . . . . 29.76 108.538 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 167.72 19.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 18.26 110.294 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.54 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 11.9 t -113.55 134.5 21.98 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.288 -1.004 . . . . 8.2 108.288 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HB3' HG22 ' A' ' 18' ' ' ILE . 29.5 Cg_endo -86.08 -170.62 7.0 Favored 'Cis proline' 0 C--N 1.309 -1.513 0 C-N-CA 124.83 -0.904 . . . . 7.79 110.119 -0.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.732 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -137.08 102.78 4.94 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.54 -2.022 . . . . 26.05 105.54 176.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 85' ' ' LEU . 98.1 t -90.07 159.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 8.68 111.763 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' VAL . 60.8 m-85 -146.21 90.92 2.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.623 -0.673 . . . . 14.07 110.836 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -72.65 112.97 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.801 -1.926 . . . . 9.34 105.801 177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.87 -152.47 39.55 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.401 -2.679 . . . . 12.42 106.401 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -83.37 -0.16 48.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.514 -1.58 . . . . 44.86 108.708 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' HB3' HH21 ' A' ' 97' ' ' ARG . 5.7 m-20 -89.45 115.05 26.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 0.0 110.599 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 t -73.71 150.71 41.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 109.449 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.98 -22.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 20.45 109.225 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.22 -146.75 18.39 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.581 -1.408 . . . . 13.82 109.581 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . -102.19 -149.2 21.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.604 -1.398 . . . . 12.42 109.604 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.55 ' N ' ' O12' ' A' ' 106' ' ' GSH . 1.2 t -71.26 -59.47 2.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -1.181 . . . . 0.0 109.657 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.0 t -50.27 -27.31 5.85 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 -46.85 32.15 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.853 -0.795 . . . . 27.06 108.853 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 72' ' ' VAL . 5.0 tt -55.3 -59.78 4.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.581 -0.699 . . . . 15.31 110.353 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.53 -49.08 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.419 -0.8 . . . . 0.0 110.472 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.33 36.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.875 -1.141 . . . . 21.79 109.564 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.9 mt -74.1 -38.04 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 111.988 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -60.3 -59.11 5.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -178.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -60.47 -24.45 65.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.003 -1.061 . . . . 0.0 109.664 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.0 m -80.76 -24.63 38.53 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.443 -0.786 . . . . 0.0 109.378 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.14 -9.61 76.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.32 -1.112 . . . . 25.64 110.32 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.71 -26.53 65.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.046 -1.267 . . . . 50.26 108.872 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 tp -59.53 -64.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 24.17 110.605 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -53.27 -31.12 42.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -63.67 -46.38 85.86 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.974 -1.121 . . . . 28.03 107.974 178.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' A' ' 77' ' ' ASP . 9.6 tpt180 -58.81 -38.32 78.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.294 -1.002 . . . . 40.96 108.294 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.32 -36.19 71.5 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.657 -0.868 . . . . 15.05 108.657 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -65.87 -54.65 23.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.706 -0.621 . . . . 0.0 111.974 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -50.21 -33.17 18.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.163 . . . . 38.64 110.908 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -100.12 -11.44 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.778 -1.201 . . . . 0.0 109.409 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.15 40.63 15.82 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.462 -1.055 . . . . 18.54 110.462 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.46 -20.49 29.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.136 -1.214 . . . . 10.84 109.3 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.3 pp -96.18 -175.87 3.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' C ' HD12 ' A' ' 104' ' ' LEU . 49.0 mt-30 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.49 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.689 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.441 -0.577 . . . . 18.33 109.441 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.423 ' C ' ' N ' ' A' ' 4' ' ' PHE . 48.7 tt0 -172.11 -82.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 29.77 109.409 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -8.86 0.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 108.617 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' C ' ' A' ' 2' ' ' GLN . 1.1 m-85 -62.32 -68.28 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.406 -0.809 . . . . 20.03 110.214 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.8 m -73.68 -39.81 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 12.91 110.244 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.4 m120 -55.64 -34.96 65.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.12 -0.987 . . . . 28.33 109.043 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.4 m -74.63 -12.73 60.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -96.66 -48.32 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 22.87 109.848 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.51 132.06 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 25.19 109.635 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.91 157.25 34.38 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.132 -1.062 . . . . 34.61 108.132 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.28 130.62 36.43 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.708 1.605 . . . . 11.72 111.312 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.73 28.18 65.64 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 120.408 -0.901 . . . . 10.24 110.944 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -140.62 132.85 28.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.316 . . . . 25.36 109.7 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.36 136.86 31.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.379 -0.825 . . . . 10.89 109.263 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.67 142.37 23.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.564 -0.902 . . . . 15.82 108.564 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 45' ' ' VAL . 40.5 t -125.63 125.92 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 8.94 110.968 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -93.79 121.89 35.7 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.903 -1.147 . . . . 9.93 107.903 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.3 pt -131.07 -175.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.613 1.197 . . . . 10.62 111.839 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 21' ' ' THR . 39.2 mttm -140.92 97.39 7.11 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 105.166 -2.161 . . . . 38.73 105.166 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 21' ' ' THR . 10.3 Cg_exo -51.12 71.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.441 1.427 . . . . 24.58 110.895 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 19' ' ' LYS . 24.7 m -170.03 -32.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.185 -0.947 . . . . 34.82 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -97.32 133.17 24.19 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 21.46 109.882 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.46 -24.11 77.01 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 122.411 2.074 . . . . 13.86 112.991 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -67.23 -47.87 69.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.366 -1.458 . . . . 0.0 109.921 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -33.8 72.05 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -61.75 -42.24 98.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.548 -0.908 . . . . 59.59 108.548 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 27' ' ' ARG . 7.4 mtt-85 -56.15 -45.06 79.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 109.077 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.17 76.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.029 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -70.33 -41.16 73.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.466 -0.771 . . . . 45.49 109.488 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 26' ' ' ARG . 55.4 mm-40 -72.4 -39.08 68.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.614 -0.679 . . . . 34.97 111.64 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.676 HD13 ' C ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.91 -56.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.766 -1.209 . . . . 0.0 109.769 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.659 ' N ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -60.81 -19.01 58.81 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.577 -1.327 . . . . 17.28 109.536 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -66.54 -27.7 67.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.039 -1.038 . . . . 24.11 108.706 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 30' ' ' GLU . 2.3 mp0 -91.53 -0.07 57.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 44.07 110.393 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 32' ' ' LEU . 15.7 mt -87.8 129.69 49.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.771 -1.206 . . . . 19.63 108.626 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.8 67.11 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.441 1.427 . . . . 21.54 109.451 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 42' ' ' LEU . 2.9 mm -76.97 150.65 5.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.154 -0.966 . . . . 0.0 108.64 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' GLN . 6.9 mmmt -52.75 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 29.41 110.557 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' LYS . 90.5 mt-30 -52.03 -124.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.628 0.728 . . . . 0.0 111.88 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.25 48.62 1.17 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.425 -1.07 . . . . 15.27 110.425 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -33.92 12.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -1.094 . . . . 8.78 109.201 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 37' ' ' ILE . 66.0 tp -92.83 133.79 35.72 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.544 0.688 . . . . 7.13 109.472 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 19.0 tt0 -143.57 174.05 11.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.471 -0.768 . . . . 22.03 109.055 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.518 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 26.7 m-85 -136.82 109.62 7.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.084 -1.45 . . . . 16.33 107.084 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 16' ' ' VAL . 78.0 t -95.0 107.13 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 6.58 111.967 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.5 m-20 -82.45 100.06 9.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.595 -0.891 . . . . 15.32 108.595 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.63 2.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 10.92 111.145 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -94.97 -31.0 13.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.873 -1.142 . . . . 21.72 108.395 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.47 22.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.48 -0.762 . . . . 22.45 109.658 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.539 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.1 t -141.22 -2.47 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.134 -0.978 . . . . 25.63 109.996 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' C ' ' CG ' ' A' ' 52' ' ' HIS . 4.5 m-20 65.25 -168.6 0.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.492 -0.755 . . . . 0.0 109.994 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 51.37 19.14 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.481 HG22 ' NZ ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -35.68 -62.2 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.727 -0.608 . . . . 18.87 110.78 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.5 m120 -56.13 -36.74 68.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 45.21 110.805 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 1.1 mp0 -61.83 -44.57 96.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.937 -1.102 . . . . 33.02 109.912 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.32 -54.18 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.666 -1.271 . . . . 9.84 109.627 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -56.91 -44.91 82.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.566 -1.334 . . . . 17.84 107.765 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.97 -34.72 57.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 18.84 107.284 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -78.36 -46.88 18.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.87 -0.732 . . . . 12.99 109.218 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.3 mt -52.59 -38.29 59.76 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.116 -1.068 . . . . 14.61 108.116 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -57.17 -55.54 33.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.641 -0.874 . . . . 40.45 108.641 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.08 -29.16 68.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.848 . . . . 41.81 109.585 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 63' ' ' LEU . 2.0 tt -64.5 -68.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.951 . . . . 21.77 109.792 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -52.95 2.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.801 -0.562 . . . . 11.38 109.721 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 152.72 -42.93 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.051 -1.547 . . . . 14.79 111.128 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . . . -96.48 144.62 26.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.839 -1.389 . . . . 17.81 110.69 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.55 23.89 13.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.55 -0.907 . . . . 29.76 108.55 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.754 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -82.38 170.03 15.77 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 18.26 110.589 -178.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.68 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 3.7 t -111.18 132.44 21.73 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 107.839 -1.171 . . . . 8.2 107.839 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 82' ' ' SER . 27.8 Cg_endo -83.98 -168.32 5.97 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 CA-C-O 122.533 0.972 . . . . 7.79 112.15 -0.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.754 HH12 ' H ' ' A' ' 68' ' ' THR . 1.8 tpm_? -146.01 90.4 1.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.635 -1.987 . . . . 26.05 105.635 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 73' ' ' PHE . 88.3 t -83.78 155.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.279 -0.888 . . . . 8.68 111.794 -176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' N ' HG12 ' A' ' 72' ' ' VAL . 81.8 m-85 -142.69 91.77 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 14.07 111.535 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.0 mm -72.02 114.3 10.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 105.249 -2.13 . . . . 9.34 105.249 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.38 -159.1 11.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.959 -2.856 . . . . 12.42 105.959 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -78.3 1.71 20.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.211 -1.758 . . . . 44.86 108.699 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.616 ' CB ' HH21 ' A' ' 97' ' ' ARG . 1.4 m-20 -88.43 112.09 22.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.735 . . . . 0.0 110.055 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 t -76.79 143.65 39.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.267 -0.896 . . . . 0.0 110.453 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 ' NH1' ' A' ' 97' ' ' ARG . 1.8 pt -107.37 -21.41 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.028 . . . . 20.45 108.92 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.26 -146.63 18.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.218 -1.153 . . . . 13.82 110.218 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.91 -143.67 13.31 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.227 -1.149 . . . . 12.42 110.227 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 t -72.6 -61.73 1.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.517 -0.99 . . . . 0.0 109.964 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -52.73 -23.68 7.22 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.59 -0.694 . . . . 0.0 109.5 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.53 -51.55 12.67 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 27.06 109.272 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 85' ' ' LEU . 5.3 tt -50.92 -60.3 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 15.31 110.037 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.54 -51.93 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 110.066 -178.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 86' ' ' VAL . 3.2 t -44.44 -37.7 3.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.229 -0.92 . . . . 21.79 108.953 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HB2' HD13 ' A' ' 94' ' ' LEU . 42.2 mt -81.89 -40.96 21.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 111.507 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.53 -58.66 7.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.88 -1.137 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -24.83 66.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.004 -1.06 . . . . 0.0 109.411 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.2 m -79.87 -45.51 18.53 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.3 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.3 -9.22 26.69 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.377 -1.089 . . . . 25.64 110.377 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' HG21 ' A' ' 96' ' ' THR . 8.5 tp10 -69.69 -25.11 63.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.988 -1.301 . . . . 50.26 108.534 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.8 tp -60.07 -63.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.479 0.657 . . . . 24.17 110.732 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.17 -28.26 39.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.448 -0.782 . . . . 0.0 108.915 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -65.4 -50.05 66.92 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.65 -0.82 . . . . 28.03 108.803 178.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.616 HH21 ' CB ' ' A' ' 77' ' ' ASP . 27.1 mtp180 -58.91 -31.05 68.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.912 -1.144 . . . . 40.96 107.912 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.37 -40.49 67.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.051 -1.092 . . . . 15.05 108.051 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -64.9 -52.3 57.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.93 -0.481 . . . . 0.0 111.888 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -33.2 24.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.71 -1.244 . . . . 38.64 110.691 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 101' ' ' ILE . 18.7 pt -99.76 -16.34 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.693 -1.255 . . . . 0.0 108.764 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.18 44.28 8.19 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.428 -1.069 . . . . 18.54 110.428 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.92 -13.85 46.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -1.155 . . . . 10.84 109.657 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 1.1 pt? -95.01 -175.61 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.504 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.68 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.352 0.596 . . . . 18.33 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.97 -79.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 29.77 109.127 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -59.43 -9.53 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.06 -69.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.414 -0.804 . . . . 20.03 111.218 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 6' ' ' ASN . 1.9 m -73.27 -38.68 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 12.91 110.5 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.43 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 98.2 m-20 -55.73 -34.06 64.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.043 -1.036 . . . . 28.33 109.442 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.8 m -74.58 -13.83 60.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.022 -1.049 . . . . 0.0 110.001 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -97.42 -45.75 6.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.012 -1.055 . . . . 22.87 110.693 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -79.48 129.09 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.909 -1.12 . . . . 25.19 110.389 -179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.77 158.52 35.21 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 107.965 -1.124 . . . . 34.61 107.965 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -56.7 135.9 73.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.743 1.629 . . . . 11.72 111.418 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.81 27.64 68.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.75 -0.94 . . . . 10.24 110.75 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -142.6 131.85 23.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.347 . . . . 25.36 109.619 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.5 127.79 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.218 -0.926 . . . . 10.89 108.959 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.88 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.613 -0.884 . . . . 15.82 108.613 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 18' ' ' ILE . 32.7 t -125.31 126.11 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.541 -0.724 . . . . 8.94 111.259 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -92.67 119.1 31.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.574 -1.269 . . . . 9.93 107.574 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.3 pt -129.34 -173.79 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 122.311 1.053 . . . . 10.62 111.345 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 21' ' ' THR . 24.1 mtmt -146.2 88.04 6.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.95 -1.871 . . . . 38.73 105.95 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.544 ' O ' ' OG1' ' A' ' 21' ' ' THR . 17.7 Cg_exo -45.79 77.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.851 1.701 . . . . 24.58 110.834 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 19' ' ' LYS . 15.6 m -174.07 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.082 -1.081 . . . . 34.82 108.082 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 126.16 42.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 109.083 -0.71 . . . . 21.46 109.083 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.82 -24.6 56.83 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.069 1.846 . . . . 13.86 112.166 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -70.39 -38.18 74.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.799 -1.188 . . . . 0.0 108.782 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -36.35 84.02 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.593 HH11 ' HG3' ' A' ' 26' ' ' ARG . 9.5 mmm-85 -65.27 -42.93 92.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.962 -0.755 . . . . 59.59 108.962 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -50.14 -45.37 53.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.147 -0.971 . . . . 0.0 108.771 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.71 82.12 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.616 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -71.41 -45.77 61.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.791 . . . . 45.49 109.652 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -69.99 -34.41 73.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.524 -0.735 . . . . 34.97 110.787 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -77.93 -57.58 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 0.0 110.83 -178.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.694 HD23 HD12 ' A' ' 35' ' ' LEU . 1.1 mt -59.49 -20.89 58.7 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.593 -1.317 . . . . 17.28 109.487 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 m -64.5 -22.29 66.92 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.142 -0.974 . . . . 24.11 108.415 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -93.02 -2.21 55.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.486 -0.759 . . . . 44.07 109.963 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.694 HD12 HD23 ' A' ' 32' ' ' LEU . 18.8 mt -88.7 130.38 45.33 Favored Pre-proline 0 N--CA 1.484 1.267 0 O-C-N 120.86 -1.15 . . . . 19.63 108.956 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.53 67.19 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.669 1.58 . . . . 21.54 109.875 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.1 mm -80.49 149.56 5.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 108.685 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 39' ' ' GLN . 36.6 mttt -53.56 -168.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.345 -0.847 . . . . 29.41 110.29 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.597 ' CD ' ' H ' ' A' ' 39' ' ' GLN . 21.8 mp0 -52.01 -123.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.6 0.714 . . . . 0.0 111.748 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 51.14 1.8 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.628 -0.989 . . . . 15.27 110.628 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.59 -27.31 14.07 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.549 -0.971 . . . . 8.78 108.796 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HB2' HG21 ' A' ' 37' ' ' ILE . 55.3 tp -97.25 130.87 44.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.606 -0.887 . . . . 7.13 108.606 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 44' ' ' PHE . 1.2 tp10 -140.62 172.97 11.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.442 -0.786 . . . . 22.03 109.874 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 35.9 m-85 -135.74 110.06 8.43 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.416 -1.327 . . . . 16.33 107.416 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.9 103.16 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 6.58 111.676 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 1.3 m-20 -81.29 100.87 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.671 -0.863 . . . . 15.32 108.671 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 56' ' ' ILE . 25.8 pt -63.69 -0.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.165 -0.96 . . . . 10.92 111.098 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 t -92.31 -14.34 28.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.717 -1.239 . . . . 21.72 108.965 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.54 8.04 4.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.789 . . . . 22.45 109.307 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -142.97 -0.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 25.63 109.797 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' C ' ' N ' ' A' ' 53' ' ' THR . 13.3 t-20 67.38 -156.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 55.28 12.32 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.803 -1.186 . . . . 0.0 108.684 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -37.83 -62.89 0.51 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.524 -0.735 . . . . 18.87 110.892 -178.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -53.53 -32.57 51.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 45.21 110.481 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -65.67 -45.28 83.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.889 -1.132 . . . . 33.02 109.82 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 47' ' ' ILE . 2.4 mp -67.21 -50.29 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.922 -1.111 . . . . 9.84 109.469 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -58.07 -42.38 85.4 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.275 -1.38 . . . . 17.84 107.275 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.09 -33.11 64.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.036 -1.468 . . . . 18.84 107.036 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -78.78 -51.82 9.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.98 -0.748 . . . . 12.99 108.98 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.44 -32.55 50.33 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.134 -1.061 . . . . 14.61 108.134 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 39.6 tp60 -59.13 -54.56 45.6 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.808 -0.557 . . . . 40.45 109.849 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -67.47 -49.61 62.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 41.81 110.878 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -65.28 -33.33 75.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.036 -1.04 . . . . 21.77 110.993 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 11.7 p -107.91 -66.75 1.01 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.162 -0.961 . . . . 11.38 109.47 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 141.96 -41.37 1.22 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.757 -1.737 . . . . 14.79 108.757 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.5 140.85 32.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 17.81 109.655 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -106.15 25.67 10.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.363 -0.977 . . . . 29.76 108.363 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.82 ' H ' HH12 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -83.85 168.04 16.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.036 0.922 . . . . 18.26 111.471 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' ' CB1' ' A' ' 106' ' ' GSH . 14.7 t -112.54 134.79 21.54 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 107.725 -1.213 . . . . 8.2 107.725 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB3' HG22 ' A' ' 18' ' ' ILE . 22.3 Cg_endo -85.62 -162.97 2.69 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 CA-C-O 122.512 0.963 . . . . 7.79 111.929 -0.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.82 HH12 ' H ' ' A' ' 68' ' ' THR . 1.5 tpm_? -144.94 97.38 3.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.271 -2.122 . . . . 26.05 105.271 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 85' ' ' LEU . 99.3 t -86.87 157.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 8.68 111.483 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.461 ' N ' HG12 ' A' ' 72' ' ' VAL . 70.4 m-85 -144.92 91.21 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 14.07 111.503 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 mm -72.37 112.12 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.343 -2.095 . . . . 9.34 105.343 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 -153.13 36.03 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 105.476 -3.05 . . . . 12.42 105.476 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -83.65 2.82 35.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.219 -1.754 . . . . 44.86 108.67 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.661 ' CB ' HH21 ' A' ' 97' ' ' ARG . 5.5 m-20 -88.84 113.38 24.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 110.3 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.5 t -75.1 145.8 41.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.441 -0.787 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 72' ' ' VAL . 2.6 pp -111.92 -16.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.264 -0.898 . . . . 20.45 109.334 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.92 -149.36 18.05 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.237 -1.145 . . . . 13.82 110.237 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.73 -147.52 20.93 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.096 -1.202 . . . . 12.42 110.096 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 t -71.78 -62.73 1.31 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.479 -1.012 . . . . 0.0 110.218 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.5 t -52.25 -24.46 7.37 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.71 -47.35 31.91 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.358 -0.839 . . . . 27.06 109.111 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.6 tt -54.6 -59.39 4.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.536 -0.728 . . . . 15.31 110.189 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -51.5 -50.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 110.436 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.666 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 22.7 m -47.59 -36.86 11.34 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.03 -1.044 . . . . 21.79 109.049 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.0 mt -82.47 -37.81 24.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 0.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.42 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.47 -60.22 4.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.694 -1.254 . . . . 0.0 110.728 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.666 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.0 pp0? -61.42 -17.79 55.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.005 -1.059 . . . . 0.0 109.588 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.447 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 73.3 m -80.51 -63.47 1.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.72 -13.02 4.51 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.125 -1.19 . . . . 25.64 110.125 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.02 -29.65 67.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.15 -1.206 . . . . 50.26 108.535 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.08 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.574 -0.704 . . . . 24.17 111.051 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -54.97 -28.62 52.92 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -64.64 -48.92 73.07 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.616 -0.833 . . . . 28.03 108.816 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.661 HH21 ' CB ' ' A' ' 77' ' ' ASP . 29.0 mtp180 -60.46 -31.29 70.29 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.968 -1.123 . . . . 40.96 107.968 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.75 -39.08 70.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.288 -1.004 . . . . 15.05 108.288 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -66.04 -54.15 29.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.919 -0.488 . . . . 0.0 111.913 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -49.73 -32.65 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.786 -1.196 . . . . 38.64 110.947 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 pt -100.29 -14.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.625 -1.297 . . . . 0.0 109.07 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.35 44.13 8.97 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.291 -1.124 . . . . 18.54 110.291 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.27 38.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.236 . . . . 10.84 109.653 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.04 -179.97 5.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.577 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.597 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.621 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.378 -0.601 . . . . 18.33 109.378 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -76.63 -71.16 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.957 . . . . 29.77 109.99 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.658 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.3 pm0 -58.06 -10.16 1.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.879 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -61.48 -75.58 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 20.03 110.69 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -73.95 -35.67 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.97 . . . . 12.91 110.017 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -56.43 -35.56 67.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.183 -0.948 . . . . 28.33 109.377 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -75.0 -13.22 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.916 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -97.02 -47.74 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.124 -0.985 . . . . 22.87 110.349 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -79.5 133.38 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 25.19 110.385 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -151.25 160.06 32.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.903 -1.147 . . . . 34.61 107.903 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.77 130.27 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.754 1.636 . . . . 11.72 111.435 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.49 22.99 63.55 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 120.335 -0.936 . . . . 10.24 111.046 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -141.12 134.11 29.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.974 -1.309 . . . . 25.36 109.62 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.9 t -100.66 133.98 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.479 -0.763 . . . . 10.89 109.435 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -140.64 141.22 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.487 -0.931 . . . . 15.82 108.487 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.74 124.14 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.824 . . . . 8.94 111.307 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -91.61 120.51 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.588 -1.264 . . . . 9.93 107.588 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.453 HG22 ' HB3' ' A' ' 70' ' ' PRO . 43.7 pt -133.45 -170.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 122.667 1.223 . . . . 10.62 112.192 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 21' ' ' THR . 20.1 mtmt -146.57 96.43 4.45 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 105.707 -1.96 . . . . 38.73 105.707 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -50.68 82.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.282 1.321 . . . . 24.58 110.504 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -179.36 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 34.82 109.699 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.36 122.33 56.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.252 -0.905 . . . . 21.46 109.082 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -54.56 -10.89 2.67 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.34 2.027 . . . . 13.86 112.765 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CG ' HG12 ' A' ' 106' ' ' GSH . 22.2 m-85 -73.68 -49.98 23.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.422 -1.424 . . . . 0.0 110.186 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -26.76 68.03 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.667 -1.271 . . . . 0.0 107.896 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -62.97 -37.69 88.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.092 -1.077 . . . . 59.59 108.092 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -59.17 -50.51 73.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 108.991 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -36.8 74.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.312 -0.868 . . . . 0.0 109.003 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 44' ' ' PHE . 5.5 mm-40 -69.39 -42.85 74.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 45.49 109.705 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.16 -38.16 69.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.493 -0.754 . . . . 34.97 110.876 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -75.93 -54.95 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.016 -1.053 . . . . 0.0 110.405 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.607 ' N ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -58.36 -22.6 54.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.322 -1.486 . . . . 17.28 108.726 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -65.39 -29.89 70.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.936 . . . . 24.11 108.585 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -89.1 0.46 56.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.453 -0.779 . . . . 44.07 109.562 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 ' OE1' ' A' ' 89' ' ' GLN . 25.4 mt -89.3 131.51 40.34 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.127 -0.983 . . . . 19.63 108.696 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.84 66.6 1.26 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.843 1.695 . . . . 21.54 110.418 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 42' ' ' LEU . 3.1 mm -81.05 146.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.98 -1.075 . . . . 0.0 108.492 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 39' ' ' GLN . 11.1 mtmt -54.39 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.199 -0.938 . . . . 29.41 110.96 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.55 ' O ' ' O ' ' A' ' 38' ' ' LYS . 52.7 mt-30 -52.42 -133.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.766 0.793 . . . . 0.0 111.784 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.51 50.24 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.336 -1.106 . . . . 15.27 110.336 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -97.04 -29.75 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -1.093 . . . . 8.78 108.726 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 37' ' ' ILE . 62.3 tp -94.98 132.02 40.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.978 -0.749 . . . . 7.13 108.978 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 44' ' ' PHE . 11.6 tp10 -143.47 169.43 17.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.434 -0.791 . . . . 22.03 109.387 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 27.2 m-85 -132.03 109.64 10.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.3 -1.37 . . . . 16.33 107.3 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.47 103.2 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 6.58 112.068 -176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 4.0 m-20 -81.51 102.65 10.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 15.32 108.193 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 pt -62.94 0.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.364 -0.835 . . . . 10.92 111.765 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -95.93 -26.43 15.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.71 -1.244 . . . . 21.72 109.451 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 20.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 22.45 109.596 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 11.0 t -143.3 1.94 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.148 -0.97 . . . . 25.63 109.702 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.702 ' ND2' ' N ' ' A' ' 52' ' ' HIS . 0.1 OUTLIER 65.41 -176.51 0.18 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.702 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 60.26 20.89 10.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.666 -1.271 . . . . 0.0 108.391 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.31 -61.68 1.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 18.87 110.789 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.08 -32.7 68.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 45.21 111.218 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 4.7 mp0 -62.46 -44.36 96.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.86 -1.15 . . . . 33.02 110.101 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.68 -53.22 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.144 . . . . 9.84 109.553 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.07 -44.94 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.609 -1.307 . . . . 17.84 107.511 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -55.7 -33.33 64.07 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.003 -1.48 . . . . 18.84 107.003 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.95 -47.75 17.85 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.937 -0.764 . . . . 12.99 108.937 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.4 mt -53.15 -35.02 59.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.882 -1.155 . . . . 14.61 107.882 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 37.1 tp60 -60.62 -54.74 41.71 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.228 0.537 . . . . 40.45 109.982 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -66.2 -45.3 81.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.966 -1.084 . . . . 41.81 110.693 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.99 -40.73 91.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.987 -1.071 . . . . 21.77 110.68 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 18.1 p -107.83 -65.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.786 . . . . 11.38 109.761 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 140.89 -38.49 1.55 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.786 -2.125 . . . . 14.79 107.786 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' HB3' HH21 ' A' ' 71' ' ' ARG . . . -98.21 138.33 35.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.682 -0.893 . . . . 17.81 109.813 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -112.52 38.37 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.206 -1.035 . . . . 29.76 108.206 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.461 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -88.29 166.78 14.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.245 1.021 . . . . 18.26 112.623 -177.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.634 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 4.4 t -114.79 126.77 27.51 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 8.2 107.22 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.722 ' O ' ' NH1' ' A' ' 71' ' ' ARG . 35.4 Cg_endo -82.34 -173.93 12.53 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 CA-C-O 122.148 0.811 . . . . 7.79 111.222 1.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.737 ' HG2' ' NH1' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -140.94 98.7 3.44 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.215 -2.143 . . . . 26.05 105.215 176.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 73' ' ' PHE . 67.2 t -89.4 157.95 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.745 0.783 . . . . 8.68 112.6 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' N ' HG12 ' A' ' 72' ' ' VAL . 68.9 m-85 -146.5 88.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.839 -0.538 . . . . 14.07 111.329 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 74' ' ' ILE . 1.2 mp -72.44 124.39 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 104.433 -2.432 . . . . 9.34 104.433 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.26 -160.24 17.49 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 106.501 -2.64 . . . . 12.42 106.501 -176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -83.21 -1.95 54.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.395 -1.65 . . . . 44.86 109.984 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' HB2' HH21 ' A' ' 97' ' ' ARG . 4.2 m-20 -89.31 124.2 34.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.018 -1.051 . . . . 0.0 110.356 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 t -75.0 147.12 41.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 110.025 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -109.28 -21.09 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.681 -0.859 . . . . 20.45 108.681 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.99 -153.01 19.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.941 -1.264 . . . . 13.82 109.941 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.99 -147.02 21.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.966 -1.254 . . . . 12.42 109.966 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O11' ' A' ' 106' ' ' GSH . 1.3 t -69.71 -61.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -1.103 . . . . 0.0 109.863 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -51.06 -23.64 3.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.553 -0.717 . . . . 0.0 109.293 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.01 -47.38 25.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.451 -0.78 . . . . 27.06 109.016 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 85' ' ' LEU . 4.7 tt -54.24 -60.03 3.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 15.31 109.834 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -50.27 -52.16 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.082 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.616 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 37.4 m -46.16 -35.92 5.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.143 -0.973 . . . . 21.79 108.899 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 94' ' ' LEU . 71.8 mt -82.08 -40.05 22.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 111.615 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.707 ' OE1' HD11 ' A' ' 35' ' ' LEU . 25.2 tp60 -58.71 -59.11 5.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.837 -1.164 . . . . 0.0 110.777 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 87' ' ' SER . 3.3 pp0? -62.81 -19.74 64.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.927 -1.108 . . . . 0.0 109.768 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.552 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 70.7 m -83.86 -24.28 30.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.32 -9.54 76.57 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.106 -1.197 . . . . 25.64 110.106 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.128 -1.219 . . . . 50.26 108.21 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' ' 88' ' ' LEU . 9.1 tp -60.6 -65.81 0.63 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.44 0.638 . . . . 24.17 110.887 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -54.01 -28.29 37.29 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -48.45 73.51 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.683 -0.858 . . . . 28.03 108.683 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.688 ' CB ' HH11 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -59.84 -33.87 72.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.762 -1.199 . . . . 40.96 107.762 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.1 -38.0 75.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.29 -1.004 . . . . 15.05 108.29 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -64.93 -58.03 7.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.917 -0.49 . . . . 0.0 111.635 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.39 -28.36 3.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.914 -1.116 . . . . 38.64 111.087 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 pt -103.74 -19.8 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.709 -1.244 . . . . 0.0 109.214 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.39 41.89 7.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.38 -1.088 . . . . 18.54 110.38 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.78 -13.97 49.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -1.205 . . . . 10.84 109.437 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -95.07 -176.37 3.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 109.367 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.121 -0.987 . . . . 0.0 109.609 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.634 ' OE1' ' O ' ' A' ' 69' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.445 -0.576 . . . . 18.33 109.445 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.417 ' H ' ' HG2' ' A' ' 2' ' ' GLN . 6.6 pt20 -56.51 -43.19 79.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 29.77 109.268 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -62.18 -38.21 88.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.956 -1.09 . . . . 0.0 109.031 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -56.86 14.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 20.03 109.846 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.8 HG21 ' CZ ' ' A' ' 59' ' ' TYR . 14.9 m -73.14 -39.7 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.65 -0.656 . . . . 12.91 110.964 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.502 ' N ' HG23 ' A' ' 5' ' ' VAL . 12.0 m120 -57.21 -34.26 68.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.797 -1.189 . . . . 28.33 109.973 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 m -74.14 -13.59 60.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.021 -1.05 . . . . 0.0 109.426 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -96.98 -52.42 3.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 22.87 110.3 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -80.19 126.29 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 25.19 109.989 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.13 155.37 40.03 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.121 -1.066 . . . . 34.61 108.121 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.25 132.35 51.71 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.926 1.751 . . . . 11.72 111.411 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 22.75 64.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.767 -0.933 . . . . 10.24 110.767 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.77 135.1 27.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.875 -1.368 . . . . 25.36 110.121 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.15 135.42 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 10.89 108.99 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.33 141.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.39 -0.967 . . . . 15.82 108.39 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 18' ' ' ILE . 21.8 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.386 -0.821 . . . . 8.94 110.426 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -90.86 119.04 30.74 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.148 -1.427 . . . . 9.93 107.148 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 70' ' ' PRO . 19.7 pt -130.32 -175.04 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.294 1.045 . . . . 10.62 111.178 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.76 ' O ' ' N ' ' A' ' 21' ' ' THR . 21.6 mtmt -146.19 88.65 6.21 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.459 -1.682 . . . . 38.73 106.459 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.609 ' O ' HG23 ' A' ' 21' ' ' THR . 12.9 Cg_exo -46.76 69.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.016 1.81 . . . . 24.58 110.921 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.76 ' N ' ' O ' ' A' ' 19' ' ' LYS . 20.8 p -162.3 -36.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.007 -1.108 . . . . 34.82 108.007 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 128.94 32.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 21.46 109.469 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.98 -20.2 43.88 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.056 1.837 . . . . 13.86 111.756 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.66 -40.89 72.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.677 -1.265 . . . . 0.0 108.518 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -36.48 83.67 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.556 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.2 OUTLIER -65.14 -36.06 83.07 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.792 -0.818 . . . . 59.59 108.792 178.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.72 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -56.54 -50.67 71.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 0.0 109.243 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . . . -56.94 -34.03 67.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.24 -36.89 74.78 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.282 -0.886 . . . . 45.49 108.696 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 33' ' ' SER . 67.1 mm-40 -71.4 -39.69 70.97 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.811 -0.555 . . . . 34.97 111.4 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -77.15 -65.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.837 -1.165 . . . . 0.0 110.925 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.648 ' H ' HG23 ' A' ' 31' ' ' ILE . 3.1 mt -52.8 -22.77 5.75 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.853 -1.155 . . . . 17.28 110.191 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 30' ' ' GLU . 5.0 p -66.64 -26.17 66.94 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.755 -1.215 . . . . 24.11 108.773 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -93.3 4.11 54.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.373 -0.829 . . . . 44.07 110.506 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 32' ' ' LEU . 16.5 mt -90.46 131.46 38.18 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.83 -1.168 . . . . 19.63 109.385 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -66.67 66.72 0.53 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.898 1.732 . . . . 21.54 110.132 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' LYS . 1.9 mm -81.67 153.37 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.214 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' O ' ' A' ' 39' ' ' GLN . 3.2 mmmm -54.05 -168.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 29.41 110.028 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 38' ' ' LYS . 40.1 mt-30 -51.78 -134.09 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.6 0.714 . . . . 0.0 110.831 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.09 54.57 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.063 -1.215 . . . . 15.27 110.063 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -100.37 -17.69 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.402 -1.058 . . . . 8.78 109.241 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.3 tp -105.54 130.33 53.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.64 -0.874 . . . . 7.13 108.64 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 44' ' ' PHE . 28.8 tt0 -139.37 173.51 11.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 22.03 110.17 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.486 ' N ' ' CG ' ' A' ' 43' ' ' GLU . 40.0 m-85 -134.58 110.82 9.58 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.782 -1.192 . . . . 16.33 107.782 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.3 t -96.19 104.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 6.58 111.621 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' HD11 ' A' ' 18' ' ' ILE . 13.5 m-20 -81.33 103.19 10.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.055 -1.091 . . . . 15.32 108.055 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.7 pt -62.41 -3.85 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.172 -0.955 . . . . 10.92 110.811 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -93.8 -15.83 24.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.954 -1.091 . . . . 21.72 109.286 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.04 10.8 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 22.45 109.467 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 15.3 t -142.86 -18.53 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.248 -0.907 . . . . 25.63 110.059 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 50' ' ' THR . 0.5 OUTLIER 84.33 -170.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.597 -0.689 . . . . 0.0 109.452 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER 56.17 24.21 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 108.792 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 8.7 p -42.84 -52.83 4.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 18.87 110.394 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.9 m-20 -52.63 -34.72 52.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 45.21 110.481 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -64.69 -45.09 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.129 . . . . 33.02 109.28 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.43 -50.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.05 -1.032 . . . . 9.84 109.43 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 53' ' ' THR . 3.0 mt-30 -57.65 -39.54 77.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.5 -1.375 . . . . 17.84 107.447 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 54' ' ' ASN . 11.8 m-20 -56.31 -32.56 64.74 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.189 -1.412 . . . . 18.84 107.189 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 5.4 t80 -76.13 -51.56 11.95 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.064 -0.717 . . . . 12.99 109.064 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 22.5 mt -54.22 -32.06 54.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.059 -1.089 . . . . 14.61 108.059 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 65' ' ' GLY . 6.3 tp-100 -63.2 -56.5 16.1 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.458 -0.777 . . . . 40.45 110.167 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -55.59 15.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 41.81 111.733 -177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -31.56 72.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.904 -1.122 . . . . 21.77 111.229 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.6 p -109.9 -63.32 1.39 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.974 -1.079 . . . . 11.38 109.81 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.601 ' O ' ' NE2' ' A' ' 61' ' ' GLN . . . 140.73 -45.59 0.97 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.944 -1.662 . . . . 14.79 108.944 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' NH1' ' A' ' 71' ' ' ARG . . . -98.05 138.49 35.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.983 . . . . 17.81 109.261 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.967 HH11 ' HG2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -107.64 26.43 10.29 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.912 -1.144 . . . . 29.76 107.912 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 173.26 12.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.743 -0.598 . . . . 18.26 109.588 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.564 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 12.5 t -117.79 137.64 24.53 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 8.2 108.559 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 18' ' ' ILE . 23.0 Cg_endo -84.72 -165.73 3.98 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.678 -0.968 . . . . 7.79 110.585 -0.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.877 ' NH1' ' HB3' ' A' ' 66' ' ' ALA . 1.8 tpt180 -148.46 98.08 2.84 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.848 -1.908 . . . . 26.05 105.848 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 85' ' ' LEU . 93.5 t -84.16 159.87 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -0.87 . . . . 8.68 111.219 -176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 72' ' ' VAL . 77.4 m-85 -145.34 94.9 2.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.7 -0.625 . . . . 14.07 110.783 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 101' ' ' ILE . 6.7 mm -72.92 105.59 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.775 -1.935 . . . . 9.34 105.775 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.07 -147.25 48.96 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.723 -2.951 . . . . 12.42 105.723 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -84.37 3.44 35.89 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.477 -1.602 . . . . 44.86 108.791 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.672 ' CB ' HH21 ' A' ' 97' ' ' ARG . 74.7 m-20 -89.94 109.06 20.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.479 -0.763 . . . . 0.0 110.756 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 t -74.05 145.14 44.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 109.281 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -113.33 -22.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.205 -0.935 . . . . 20.45 109.33 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA2' HH21 ' A' ' 71' ' ' ARG . . . 134.62 -154.44 21.48 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.788 -1.325 . . . . 13.82 109.788 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' H ' ' CG ' ' A' ' 84' ' ' ASP . . . -101.13 -142.85 13.19 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.005 -1.238 . . . . 12.42 110.005 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.3 t -71.67 -66.07 0.68 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.444 -1.033 . . . . 0.0 110.501 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t -51.65 -24.48 5.63 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.571 ' CG ' ' H ' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -74.97 -47.95 26.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.373 -0.829 . . . . 27.06 109.369 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.685 HD12 HG21 ' A' ' 72' ' ' VAL . 5.6 tt -55.03 -58.8 6.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.434 -0.791 . . . . 15.31 110.516 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -48.93 -47.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.805 . . . . 0.0 110.664 -178.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -43.25 47.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 21.79 109.172 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.9 mt -72.86 -41.08 65.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 111.984 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -59.4 -57.22 13.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.846 -1.159 . . . . 0.0 110.615 -177.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -25.45 67.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 109.323 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.5 m -82.58 -19.24 38.85 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.37 64.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.273 -1.131 . . . . 25.64 110.273 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 96' ' ' THR . 23.7 tt0 -67.67 -25.35 65.66 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.143 -1.21 . . . . 50.26 109.152 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.62 -63.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 24.17 110.295 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -52.17 -27.36 14.15 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.475 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -62.71 -48.13 80.6 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.417 -0.913 . . . . 28.03 108.678 179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.702 ' NH1' HE22 ' A' ' 100' ' ' GLN . 22.5 mmm180 -60.42 -32.91 71.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.043 -1.036 . . . . 40.96 108.539 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 98' ' ' LEU . 8.4 mp -71.96 -39.43 69.35 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.399 -0.813 . . . . 15.05 109.243 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -65.74 -52.03 54.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.646 -0.658 . . . . 0.0 111.876 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.702 HE22 ' NH1' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -47.83 -34.2 8.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 38.64 110.404 -178.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 74' ' ' ILE . 17.7 pt -101.98 -11.37 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.846 -1.159 . . . . 0.0 109.268 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 43.58 14.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.427 -1.069 . . . . 18.54 110.427 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.52 -17.18 34.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.162 -1.199 . . . . 10.84 109.67 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 3.8 pp -97.46 -177.48 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 109.469 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.631 -179.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.636 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 108.829 -0.804 . . . . 1.72 108.829 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' C ' ' N ' ' A' ' 4' ' ' PHE . 18.9 mt-30 -107.38 -74.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 2.48 109.375 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 1.4 pt-20 -56.03 -9.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.069 -1.019 . . . . 2.18 108.819 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' N ' ' C ' ' A' ' 2' ' ' GLN . 1.5 m-85 -61.98 -72.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.5 109.788 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -74.53 -36.32 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.27 110.317 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 2' ' ' GLN . 6.1 m120 -58.37 -36.58 73.72 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.795 -1.19 . . . . 1.22 109.655 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -73.81 -13.35 60.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.37 109.302 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -97.19 -48.65 5.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 1.3 110.329 -179.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.0 125.44 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.777 -1.202 . . . . 0.32 109.018 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.3 148.32 31.29 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.327 -0.99 . . . . 2.09 108.327 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.21 135.93 30.92 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.196 1.931 . . . . 0.27 111.741 -178.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.17 72.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.386 -1.085 . . . . 0.24 110.386 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -144.11 140.05 29.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.022 -1.281 . . . . 1.59 110.233 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.94 137.17 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.12 109.515 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.38 143.47 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.15 108.505 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 18' ' ' ILE . 57.2 t -125.0 123.79 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.12 110.584 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -91.49 119.99 31.92 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.126 -1.435 . . . . 0.16 107.126 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG23 HG12 ' A' ' 16' ' ' VAL . 37.3 pt -131.28 -173.17 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.312 1.053 . . . . 0.19 111.676 -177.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 21' ' ' THR . 27.1 mtmt -147.13 90.94 5.24 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 106.926 -1.509 . . . . 1.24 106.926 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 21' ' ' THR . 12.6 Cg_exo -45.9 75.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.507 1.472 . . . . 0.37 110.383 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.727 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.2 m -169.21 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.927 -0.768 . . . . 1.18 108.927 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.56 131.5 25.82 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.23 110.266 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -60.04 -19.68 57.12 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 122.249 1.966 . . . . 0.32 112.054 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -70.22 -41.38 73.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.764 -1.21 . . . . 0.3 109.026 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -33.71 76.66 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.36 -0.936 . . . . 1.1 108.592 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -62.38 -45.43 93.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 2.71 108.779 179.483 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.663 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -49.22 -46.75 46.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.958 -1.088 . . . . 2.44 109.589 -179.396 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.76 80.96 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.14 -1.024 . . . . 0.22 108.559 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -69.06 -46.62 67.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 1.26 109.868 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -37.84 85.14 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.607 -0.683 . . . . 1.87 111.231 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -77.5 -54.8 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.81 -1.181 . . . . 0.53 110.861 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 35' ' ' LEU . 4.4 mt -58.18 -20.79 43.9 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.675 -1.266 . . . . 0.18 108.987 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -66.87 -28.08 68.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 1.31 109.404 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -91.22 3.09 55.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 1.58 109.896 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 32' ' ' LEU . 15.6 mt -91.5 127.01 52.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.29 109.556 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.14 65.24 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.922 1.748 . . . . 0.27 109.916 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 42' ' ' LEU . 15.1 mm -78.45 146.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.574 -0.898 . . . . 0.25 108.574 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 39' ' ' GLN . 8.1 mttt -52.59 -178.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -0.984 . . . . 1.79 108.807 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 41' ' ' LEU . 47.6 mt-30 -52.05 -123.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.994 -1.066 . . . . 2.55 111.948 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.42 49.36 0.06 OUTLIER Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.439 -0.788 . . . . 0.37 111.534 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -105.05 -24.76 12.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.265 . . . . 0.28 109.395 179.136 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 37' ' ' ILE . 18.8 tp -102.58 131.4 49.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.16 109.086 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.6 161.9 36.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 2.01 109.897 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -125.02 116.49 22.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.435 -1.32 . . . . 0.16 107.435 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.71 105.31 17.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.446 -0.784 . . . . 0.17 111.997 -177.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 18' ' ' ILE . 26.0 m-20 -80.75 100.43 8.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.011 -1.107 . . . . 1.12 108.011 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 pt -61.96 -2.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.25 111.589 -178.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 -22.11 18.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.705 -1.247 . . . . 1.24 109.222 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.63 15.6 1.0 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.57 109.341 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 4.11 1.44 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.068 -1.02 . . . . 0.6 109.976 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 65.98 -175.6 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 2.41 109.394 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 53' ' ' THR . 6.0 m170 59.59 18.99 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 2.21 109.754 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -34.47 -65.14 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.542 -0.724 . . . . 0.89 110.377 -179.685 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 3.6 m-20 -54.73 -36.64 64.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 1.21 111.37 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.91 -45.45 92.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.641 -1.287 . . . . 2.12 109.713 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.03 -51.94 54.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.998 -1.064 . . . . 0.22 109.002 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -57.79 -42.94 85.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.784 -1.198 . . . . 0.46 107.774 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -56.35 -32.86 65.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.182 -1.414 . . . . 1.12 107.182 178.129 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -79.03 -50.91 10.33 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.011 -0.737 . . . . 1.21 109.011 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.9 mt -54.68 -28.1 45.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.007 -1.058 . . . . 0.25 108.221 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 65' ' ' GLY . 7.2 tp60 -63.1 -56.44 16.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.709 . . . . 1.36 109.652 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -69.75 -38.05 76.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.447 -0.783 . . . . 2.26 110.749 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -64.85 -40.52 95.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.125 -0.984 . . . . 0.93 110.164 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 1.9 p -113.09 -70.8 0.79 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.308 -0.87 . . . . 0.71 109.266 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 64' ' ' THR . . . 154.85 -36.2 0.67 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.411 -1.476 . . . . 0.33 109.411 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB3' ' NH2' ' A' ' 71' ' ' ARG . . . -102.21 130.15 48.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.36 110.292 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 25.36 5.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.565 -1.272 . . . . 1.63 107.565 177.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.605 HG22 ' O2 ' ' A' ' 106' ' ' GSH . 0.0 OUTLIER -79.95 167.81 20.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.658 0.742 . . . . 0.33 110.04 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' O ' ' OE1' ' A' ' 106' ' ' GSH . 8.4 t -115.72 136.92 22.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.23 107.438 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -78.46 -165.02 4.3 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 CA-C-O 122.562 0.984 . . . . 0.22 111.871 -0.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -146.6 90.71 1.95 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.453 -2.054 . . . . 2.18 105.453 177.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 85' ' ' LEU . 22.0 t -84.25 151.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.12 111.394 -176.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.85 92.25 2.43 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.797 -0.565 . . . . 0.2 110.284 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 74' ' ' ILE . 3.3 mm -71.65 107.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.576 -2.009 . . . . 0.53 105.576 177.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.84 -147.59 50.45 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.505 -2.638 . . . . 0.18 106.505 -176.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.34 -4.89 59.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.539 -1.565 . . . . 1.88 109.356 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.798 ' HB3' HH21 ' A' ' 97' ' ' ARG . 11.9 m-20 -89.03 117.22 27.88 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.096 -1.003 . . . . 1.26 110.76 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -74.31 151.68 39.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.28 110.092 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.47 -19.48 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.51 109.377 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.68 -150.38 19.51 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.176 -1.17 . . . . 0.31 110.176 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.07 -142.02 11.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.343 -1.103 . . . . 0.22 110.343 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -71.78 -61.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.539 -0.977 . . . . 0.68 110.271 -179.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -53.57 -27.61 27.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.457 -0.777 . . . . 0.33 109.622 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.09 -45.64 56.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.306 -0.871 . . . . 1.6 109.07 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.2 tt -56.5 -64.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.629 -0.67 . . . . 0.22 109.732 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -45.53 -47.52 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.24 110.11 -178.458 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -48.43 47.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.905 -1.122 . . . . 0.92 109.288 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.18 -31.89 62.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.27 -0.894 . . . . 0.2 111.553 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' C ' ' CD ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -61.36 -60.27 3.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.574 -1.328 . . . . 2.06 109.372 -178.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -25.74 67.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 2.46 110.514 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.8 m -79.61 -25.29 41.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.234 -0.917 . . . . 0.58 110.783 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.48 -11.43 70.18 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.11 -1.196 . . . . 0.29 110.11 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.95 -31.26 70.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 1.95 108.567 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.86 -63.34 1.33 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.475 -0.766 . . . . 0.3 110.638 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -54.95 -30.22 58.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.457 -0.942 . . . . 0.27 108.457 -178.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 1.2 m -65.34 -41.55 93.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.989 -1.115 . . . . 0.3 107.989 178.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.798 HH21 ' HB3' ' A' ' 77' ' ' ASP . 1.2 tpt180 -64.6 -34.84 79.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.332 -0.988 . . . . 2.33 108.332 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.74 -32.93 68.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.409 -0.807 . . . . 0.25 109.023 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -70.0 -57.26 5.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 1.77 111.84 -178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -44.88 -30.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.688 -1.258 . . . . 0.35 110.407 -177.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.6 pt -104.65 -15.76 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.949 -1.094 . . . . 0.27 108.885 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.3 43.56 10.45 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.346 -1.102 . . . . 0.16 110.346 179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -13.38 49.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.068 -1.254 . . . . 0.18 109.564 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.725 ' H ' HD23 ' A' ' 104' ' ' LEU . 2.4 pt? -95.02 -175.32 3.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 1.14 109.326 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.943 -1.027 . . . . 1.88 108.984 179.206 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GSH . . . . . 0.622 ' CD1' ' SG2' ' A' ' 106' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_